Clustering O 0 0.00865866243839264
of O 0 0.0021135862916707993
missense O 0 0.0039475117810070515
mutations O 0 0.00043790924246422946
in O 0 0.00044701044680550694
the O 0 0.0030311360023915768
ataxia B-Disease 1 1.0
- I-Disease 1 0.9993174076080322
telangiectasia I-Disease 1 0.9998412132263184
gene O 0 0.0005183711764402688
in O 0 0.00016548464191146195
a O 0 0.0004977106582373381
sporadic B-Disease 0 0.14590883255004883
T I-Disease 1 0.999994158744812
- I-Disease 1 0.968197226524353
cell I-Disease 0 0.47194889187812805
leukaemia I-Disease 1 0.9994685053825378
. O 0 0.0015792939811944962

Ataxia B-Disease 1 0.9999997615814209
- I-Disease 1 0.999907374382019
telangiectasia I-Disease 1 0.9999983310699463
( O 0 0.44500237703323364
A B-Disease 1 0.9999910593032837
- I-Disease 1 0.9997547268867493
T I-Disease 1 0.9999486207962036
) O 0 0.00014496948278974742
is O 0 6.516684516100213e-05
a O 0 0.00020649390353355557
recessive B-Disease 0 0.004262271802872419
multi I-Disease 1 0.9999258518218994
- I-Disease 1 0.9999415874481201
system I-Disease 1 0.9784049391746521
disorder I-Disease 1 1.0
caused O 1 0.9999866485595703
by O 0 0.0002711895212996751
mutations O 0 0.00010401019972050563
in O 0 8.268128294730559e-05
the O 0 0.0001784393098205328
ATM O 0 0.0009628788684494793
gene O 0 0.000184704054845497
at O 0 0.0007259522099047899
11q22 O 1 0.7833132147789001
- O 0 0.0020176288671791553
q23 O 1 0.8251339793205261
( O 0 0.0005932566709816456
ref O 0 0.01027225237339735
. O 0 0.00013735229731537402
3 O 0 0.0004182429111097008
) O 0 0.0003130244149360806
. O 0 0.0005678277229890227

The O 0 0.004280323628336191
risk O 0 0.002724027493968606
of O 0 0.08446796983480453
cancer B-Disease 1 0.9999920129776001
, O 0 0.0011619897559285164
especially O 0 0.00363064743578434
lymphoid B-Disease 1 0.9999958276748657
neoplasias I-Disease 1 0.9999974966049194
, O 0 0.0004916234756819904
is O 0 0.00025914443540386856
substantially O 0 0.0006504544289782643
elevated O 0 0.03623645752668381
in O 0 0.0005181132582947612
A B-Disease 1 0.9999860525131226
- I-Disease 1 0.9999897480010986
T I-Disease 1 0.9999996423721313
patients O 0 0.0006454738904722035
and O 0 0.00014350035053212196
has O 0 0.0001801171019906178
long O 0 0.0002149280917365104
been O 0 0.00021178860333748162
associated O 0 0.0004401839687488973
with O 0 0.0007473190198652446
chromosomal O 1 0.9999991655349731
instability O 1 1.0
. O 0 0.3409677743911743

By O 0 0.0027971789240837097
analysing O 0 0.013010909780859947
tumour B-Disease 1 0.9999980926513672
DNA O 0 0.002687086584046483
from O 0 0.0007688001496717334
patients O 0 0.0003744372515939176
with O 0 0.000165953955729492
sporadic B-Disease 0 0.19968363642692566
T I-Disease 1 0.9999649524688721
- I-Disease 0 0.3608982563018799
cell I-Disease 0 0.06027959659695625
prolymphocytic I-Disease 1 0.9998605251312256
leukaemia I-Disease 1 0.9999923706054688
( O 0 0.010784109123051167
T B-Disease 1 0.9998096823692322
- I-Disease 0 0.019550839439034462
PLL I-Disease 1 0.9987302422523499
) O 0 0.0002697161689866334
, O 0 0.00013251788914203644
a O 0 0.0002622628235258162
rare O 0 0.0009492812678217888
clonal B-Disease 0 0.06372062116861343
malignancy I-Disease 1 0.9927937984466553
with O 0 0.00014590777573175728
similarities O 0 0.0003402048023417592
to O 0 0.00015329496818594635
a O 0 0.0005450963508337736
mature B-Disease 0 0.005665076430886984
T I-Disease 1 0.9996100068092346
- I-Disease 0 0.007563918363302946
cell I-Disease 0 0.002711107023060322
leukaemia I-Disease 1 0.8072052597999573
seen O 0 0.0004615545622073114
in O 0 0.00030395822250284255
A B-Disease 1 0.999390721321106
- I-Disease 1 0.9944085478782654
T I-Disease 1 0.9998992681503296
, O 0 0.0001303210447076708
we O 0 5.378667265176773e-05
demonstrate O 0 0.00017026012938003987
a O 0 9.497383143752813e-05
high O 0 0.00023173325462266803
frequency O 0 8.745002560317516e-05
of O 0 0.00029163018916733563
ATM O 0 0.0034491559490561485
mutations O 0 0.0006709141307510436
in O 0 0.0010741297155618668
T B-Disease 1 0.9997851252555847
- I-Disease 0 0.05226750299334526
PLL I-Disease 1 0.9955028891563416
. O 0 0.0025103872176259756

In O 0 0.00155203090980649
marked O 0 0.002222722861915827
contrast O 0 0.0004174142377451062
to O 0 0.00010449135152157396
the O 0 0.0002814404433593154
ATM O 0 0.0014939542161300778
mutation O 0 0.00014824896061327308
pattern O 0 0.00029284163611009717
in O 0 0.00035865127574652433
A B-Disease 1 0.9999681711196899
- I-Disease 1 0.9988728165626526
T I-Disease 1 0.9998416900634766
, O 0 8.496377995470539e-05
the O 0 8.973262447398156e-05
most O 0 5.6154483900172636e-05
frequent O 0 0.00012144144420744851
nucleotide O 0 0.00033213404822163284
changes O 0 0.0001307362545048818
in O 0 0.00017278362065553665
this O 0 0.0002915940131060779
leukaemia B-Disease 1 0.9979775547981262
were O 0 0.0010657025268301368
missense O 0 0.008593639358878136
mutations O 0 0.001976314000785351
. O 0 0.0012756000505760312

These O 0 0.0006546004442498088
clustered O 0 0.0012954248813912272
in O 0 0.00016812946705613285
the O 0 0.00018082367023453116
region O 0 0.0001729072246234864
corresponding O 0 9.090774256037548e-05
to O 0 4.936875484418124e-05
the O 0 0.00014254380948841572
kinase O 0 0.0003756163641810417
domain O 0 0.000178777365363203
, O 0 7.772421668050811e-05
which O 0 3.421421934035607e-05
is O 0 3.6711484426632524e-05
highly O 0 9.768419113242999e-05
conserved O 0 0.00013271503848955035
in O 0 0.0001543346734251827
ATM O 0 0.0017653274117037654
- O 0 0.0004896544851362705
related O 0 0.0002099911798723042
proteins O 0 0.00011118283873656765
in O 0 0.0002239914028905332
mouse O 0 0.0007490859134122729
, O 0 0.00021641688363160938
yeast O 0 0.0011245636269450188
and O 0 0.00028742101858370006
Drosophila O 0 0.002343647414818406
. O 0 0.000548295269254595

The O 0 0.004029196687042713
resulting O 0 0.0036990689113736153
amino O 0 0.0013546356931328773
- O 0 0.0015235715545713902
acid O 0 0.0008888218435458839
substitutions O 0 0.00041814844007603824
are O 0 2.3539729227195494e-05
predicted O 0 0.00014606564946006984
to O 0 6.32835435681045e-05
interfere O 0 0.0005021897377446294
with O 0 0.0001420909829903394
ATP O 1 0.979060173034668
binding O 0 0.0006735422066412866
or O 0 0.0005016530049033463
substrate O 0 0.001160473795607686
recognition O 0 0.0015708236023783684
. O 0 0.0010955370962619781

Two O 0 0.0009134963038377464
of O 0 0.0018170166295021772
seventeen O 0 0.007622666656970978
mutated O 0 0.03518608212471008
T B-Disease 1 0.9971113204956055
- I-Disease 0 0.004473189823329449
PLL I-Disease 0 0.09109151363372803
samples O 0 0.00024231875431723893
had O 0 0.000184760065167211
a O 0 0.00017488084267824888
previously O 0 0.0002492662752047181
reported O 0 0.0005290332483127713
A B-Disease 1 0.9833530187606812
- I-Disease 1 0.9381673336029053
T I-Disease 1 0.9993911981582642
allele O 0 0.003791806986555457
. O 0 0.001211942289955914

In O 0 0.0012536089634522796
contrast O 0 0.0009457925334572792
, O 0 0.0002489945327397436
no O 0 0.0001437205501133576
mutations O 0 0.0001348952209809795
were O 0 9.14532647584565e-05
detected O 0 0.0003437205159571022
in O 0 0.0001171474505099468
the O 0 0.000250270968535915
p53 O 0 0.0009600624325685203
gene O 0 0.00021598607418127358
, O 0 8.451796747976914e-05
suggesting O 0 0.00029498443473130465
that O 0 7.689021731493995e-05
this O 0 0.00037124648224562407
tumour B-Disease 1 1.0
suppressor O 1 0.999464213848114
is O 0 0.0002546995528973639
not O 0 7.833742711227387e-05
frequently O 0 0.00021677417680621147
altered O 0 0.0007286834297701716
in O 0 0.0004135870549362153
this O 0 0.0005277444724924862
leukaemia B-Disease 1 0.999184787273407
. O 0 0.0017638079589232802

Occasional O 0 0.00850808434188366
missense O 0 0.007248102221637964
mutations O 0 0.0006036938284523785
in O 0 0.00031188499997369945
ATM O 0 0.001642321702092886
were O 0 0.0001592164480825886
also O 0 9.601101191947237e-05
found O 0 8.30726494314149e-05
in O 0 0.0003209762799087912
tumour B-Disease 1 0.9999984502792358
DNA O 0 0.0007363586337305605
from O 0 0.00021914701210334897
patients O 0 0.0001686048344708979
with O 0 0.00014579067646991462
B B-Disease 1 0.5661658644676208
- I-Disease 0 0.010962088592350483
cell I-Disease 0 0.004886374808847904
non I-Disease 0 0.0034414087422192097
- I-Disease 0 0.41496866941452026
Hodgkins I-Disease 1 0.9999998807907104
lymphomas I-Disease 1 0.9999358654022217
( O 0 0.0008792157168500125
B B-Disease 0 0.006695542950183153
- I-Disease 0 0.0008880028035491705
NHL I-Disease 0 0.0009599403128959239
) O 0 6.14859745837748e-05
and O 0 5.423963375505991e-05
a O 0 0.0002724812366068363
B B-Disease 0 0.0030971092637628317
- I-Disease 0 0.002476189285516739
NHL I-Disease 0 0.010449819266796112
cell O 0 0.003762956941500306
line O 0 0.003644912736490369
. O 0 0.0009445848409086466

The O 0 0.001396089093759656
evidence O 0 0.00044534532935358584
of O 0 0.00019889065879397094
a O 0 0.00016926138778217137
significant O 0 9.79881442617625e-05
proportion O 0 5.660200986312702e-05
of O 0 0.0001540936646051705
loss O 0 0.08478526026010513
- O 0 0.0005714474827982485
of O 0 0.0003294063499197364
- O 0 0.0010285169119015336
function O 0 0.00014020057278685272
mutations O 0 5.994935054332018e-05
and O 0 5.132656588102691e-05
a O 0 0.0001296240370720625
complete O 0 0.00036080251447856426
absence O 0 0.0005377669585868716
of O 0 0.0002593792451079935
the O 0 0.0003031953237950802
normal O 0 0.00019342404266353697
copy O 0 0.00013659214891958982
of O 0 8.502182026859373e-05
ATM O 0 0.0006795169902034104
in O 0 7.230258779600263e-05
the O 0 0.0001145067362813279
majority O 0 8.340078056789935e-05
of O 0 0.00036152865504845977
mutated O 0 0.009167141281068325
tumours B-Disease 1 0.9999750852584839
establishes O 0 0.004595102276653051
somatic O 0 0.0026497303042560816
inactivation O 0 0.00459320517256856
of O 0 0.0003003276069648564
this O 0 6.374093936756253e-05
gene O 0 9.972735279006884e-05
in O 0 7.16178838047199e-05
the O 0 0.00020326566300354898
pathogenesis O 0 0.014282336458563805
of O 0 0.0019723393488675356
sporadic B-Disease 1 0.9996906518936157
T I-Disease 1 0.9999979734420776
- I-Disease 1 0.7835589051246643
PLL I-Disease 1 0.9983239769935608
and O 0 0.00020420509099494666
suggests O 0 0.00014480645768344402
that O 0 4.5589975343318656e-05
ATM O 0 0.000950885412748903
acts O 0 0.0004657044482883066
as O 0 0.000502494745887816
a O 0 0.0030610731337219477
tumour B-Disease 1 1.0
suppressor O 1 0.9998169541358948
. O 0 0.0022143018431961536

As O 0 0.002213971922174096
constitutional O 0 0.0021517814602702856
DNA O 0 0.001393762999214232
was O 0 0.0007703944575041533
not O 0 7.35387293389067e-05
available O 0 4.0995044400915504e-05
, O 0 6.97933865012601e-05
a O 0 0.0002871386823244393
putative O 0 0.004125547129660845
hereditary O 1 0.9995971322059631
predisposition O 1 0.9999244213104248
to O 1 0.8854638934135437
T B-Disease 1 0.9999996423721313
- I-Disease 1 0.9430582523345947
PLL I-Disease 1 0.9977720379829407
will O 0 0.00020960590336471796
require O 0 7.07751969457604e-05
further O 0 0.0001503734092693776
investigation O 0 0.0006098097655922174
. O 0 0.00023082825646270066
. O 0 0.0005830128211528063

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 0 0.043002985417842865
kinase O 0 0.0023407270200550556
is O 0 0.00017873235628940165
involved O 0 0.0001339773734798655
in O 0 9.469973883824423e-05
the O 0 0.00019724349840544164
modulation O 0 0.00029467715648934245
of O 0 0.0002791912411339581
the O 0 0.0012223655357956886
Ca2 O 1 0.8196992874145508
+ O 0 0.0380089096724987
homeostasis O 1 0.9984515905380249
in O 0 0.004898608662188053
skeletal O 1 0.9999998807907104
muscle O 1 0.9999998807907104
cells O 1 0.9952129125595093
. O 0 0.0017178120324388146

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999855756759644
DM B-Disease 1 1.0
) O 0 0.001237635500729084
, O 0 0.0002731293789111078
the O 0 0.00037608048296533525
most O 0 0.00045736151514574885
prevalent O 1 0.9986628293991089
muscular B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 1 0.9988110065460205
adults O 0 0.0005897433729842305
, O 0 0.0001450657146051526
is O 0 0.00010348645446356386
caused O 0 0.003203155007213354
by O 0 0.00013313026283867657
( O 0 0.0004965371917933226
CTG O 1 0.9940977096557617
) O 0 0.0002339229395147413
n O 0 0.00035092467442154884
- O 0 0.00028293687500990927
repeat O 0 0.00030363703262992203
expansion O 0 0.00036694094887934625
in O 0 5.335357127478346e-05
a O 0 5.315191447152756e-05
gene O 0 5.633136970573105e-05
encoding O 0 5.0710252253338695e-05
a O 0 0.0001278282725252211
protein O 0 0.0003241582016926259
kinase O 0 0.0010373658733442426
( O 0 0.0006439420976676047
DM B-Disease 1 0.9998997449874878
protein O 0 0.0015270805452018976
kinase O 0 0.0015371199697256088
; O 0 0.00028232918702997267
DMPK O 1 0.9996812343597412
) O 0 0.0003414479724597186
and O 0 0.00016818640870042145
involves O 0 0.00037043512566015124
changes O 0 0.00028280416154302657
in O 0 0.0006480404990725219
cytoarchitecture O 1 0.9996034502983093
and O 0 0.0022146906703710556
ion O 1 0.7480857968330383
homeostasis O 1 0.9978898167610168
. O 0 0.0018507500644773245

To O 0 0.0006121133919805288
obtain O 0 0.0002987894113175571
clues O 0 0.0007872498244978487
to O 0 0.0001765147317200899
the O 0 0.0002791156293824315
normal O 0 0.0004022673238068819
biological O 0 0.000493013474624604
role O 0 0.000542508321814239
of O 0 0.0010317896958440542
DMPK O 1 0.9999964237213135
in O 0 0.0013610821915790439
cellular O 0 0.0301333200186491
ion O 0 0.019391531124711037
homeostasis O 1 0.9850955605506897
, O 0 0.00014925148570910096
we O 0 4.9917431169888005e-05
have O 0 2.3335216610576026e-05
compared O 0 0.00010213960194960237
the O 0 0.00017396328621543944
resting O 0 0.0064000329002738
[ O 0 0.002113469410687685
Ca2 O 0 0.006629536394029856
+ O 0 0.0016346508637070656
] O 0 0.0007708296179771423
i O 0 0.00019315163081046194
, O 0 5.7399305660510436e-05
the O 0 8.634224650450051e-05
amplitude O 0 0.00025563326198607683
and O 0 0.0001021750649670139
shape O 0 0.0006515022250823677
of O 0 0.0017093973001465201
depolarization O 1 0.9998852014541626
- O 1 0.9411651492118835
induced O 1 0.9984299540519714
Ca2 O 0 0.1560513824224472
+ O 0 0.004943379200994968
transients O 0 0.004529780242592096
, O 0 0.00012762694677803665
and O 0 6.463232421083376e-05
the O 0 0.0001342605537502095
content O 0 0.00010294964158674702
of O 0 0.00033309232094325125
ATP O 1 0.9999129772186279
- O 0 0.007251341361552477
driven O 0 0.0038576421793550253
ion O 0 0.005130174569785595
pumps O 0 0.0065903086215257645
in O 0 0.0006381703424267471
cultured O 0 0.0662677139043808
skeletal O 1 0.9999850988388062
muscle O 1 0.9998886585235596
cells O 0 0.0012776044895872474
of O 0 0.0005509019247256219
wild O 0 0.0011029887245967984
- O 0 0.000649364257697016
type O 0 0.00037654058542102575
and O 0 0.00019918064936064184
DMPK O 1 0.999971866607666
[ O 0 0.005278919357806444
- O 0 0.005658647045493126
/ O 0 0.006125512532889843
- O 0 0.002717144787311554
] O 0 0.0038905811961740255
knockout O 0 0.2654971778392792
mice O 0 0.0035667840857058764
. O 0 0.0007772530079819262

In O 0 0.0028502061031758785
vitro O 0 0.004763547796756029
- O 0 0.002736219670623541
differentiated O 0 0.005794736556708813
DMPK O 1 0.9999744892120361
[ O 0 0.008540025912225246
- O 0 0.005592544563114643
/ O 0 0.0054201832972466946
- O 0 0.001961753936484456
] O 0 0.0017869335133582354
myotubes O 0 0.007601216901093721
exhibit O 0 0.0009039849974215031
a O 0 0.0004184630233794451
higher O 0 0.0004891178105026484
resting O 0 0.0037337616086006165
[ O 0 0.0014513678615912795
Ca2 O 0 0.0034093796275556087
+ O 0 0.0013207372976467013
] O 0 0.0006807454046793282
i O 0 0.00016914716979954392
than O 0 3.124920112895779e-05
do O 0 3.60592057404574e-05
wild O 0 0.00021601859771180898
- O 0 0.000497686502058059
type O 0 0.0005247576627880335
myotubes O 0 0.3236020505428314
because O 0 0.00010180297249462456
of O 0 0.00014605867909267545
an O 0 0.0001029025370371528
altered O 0 0.00022380053997039795
open O 0 0.00016616168431937695
probability O 0 3.6563724279403687e-05
of O 0 0.0002107154141413048
voltage O 0 0.001860325108282268
- O 0 0.000815867620985955
dependent O 0 0.0003707126306835562
l O 0 0.0019419739255681634
- O 0 0.0010171245085075498
type O 0 0.0009266377310268581
Ca2 O 0 0.003340077120810747
+ O 0 0.0018688179552555084
and O 0 0.0004268728953320533
Na O 1 0.5384874939918518
+ O 0 0.0023234542459249496
channels O 0 0.0005505449371412396
. O 0 0.0005528397741727531

The O 0 0.007085168268531561
mutant O 0 0.02474864013493061
myotubes O 1 0.9795172214508057
exhibit O 0 0.004187199752777815
smaller O 0 0.0006525909993797541
and O 0 0.00030689575942233205
slower O 0 0.0014872397296130657
Ca2 O 0 0.001858229748904705
+ O 0 0.0007402149494737387
responses O 0 0.00012875653919763863
upon O 0 0.00022467970848083496
triggering O 0 0.002136427443474531
by O 0 0.0002502869756426662
acetylcholine O 0 0.00472731189802289
or O 0 0.0006185498205013573
high O 0 0.0015275836922228336
external O 0 0.001569361425936222
K O 0 0.006121507380157709
+ O 0 0.0030145468190312386
. O 0 0.0006561639020219445

In O 0 0.0020153066143393517
addition O 0 0.0006669374997727573
, O 0 0.00022910049301572144
we O 0 0.00012132003757869825
observed O 0 0.00011361411452526227
that O 0 4.284444003133103e-05
these O 0 7.61660048738122e-05
Ca2 O 0 0.005692741833627224
+ O 0 0.004659503698348999
transients O 0 0.00608645798638463
partially O 0 0.0014068827731534839
result O 0 0.00017260397726204246
from O 0 0.00015406824240926653
an O 0 0.00012077982682967559
influx O 0 0.0005379327922128141
of O 0 0.00041867251275107265
extracellular O 0 0.0024517038837075233
Ca2 O 0 0.0026473121251910925
+ O 0 0.0006404105806723237
through O 0 0.0002181908639613539
the O 0 0.0004403870552778244
l O 0 0.0038015872705727816
- O 0 0.0014659026637673378
type O 0 0.0013398290611803532
Ca2 O 0 0.003739764913916588
+ O 0 0.0026515128556638956
channel O 0 0.0015871904324740171
. O 0 0.0006346747977659106

Neither O 0 0.003979125991463661
the O 0 0.000834531441796571
content O 0 0.00017926386499311775
nor O 0 0.00018461425497662276
the O 0 0.0001178160309791565
activity O 0 0.00022225290013011545
of O 0 0.000465058081317693
Na O 1 0.9997773766517639
+ O 0 0.0052989632822573185
/ O 0 0.004258212633430958
K O 0 0.004165161866694689
+ O 0 0.0028934646397829056
ATPase O 0 0.008934669196605682
and O 0 0.0013273539952933788
sarcoplasmic O 1 0.9861025810241699
reticulum O 1 0.9165886044502258
Ca2 O 0 0.04598934203386307
+ O 0 0.005501613952219486
- O 0 0.0021056642290204763
ATPase O 0 0.0026856125332415104
are O 0 6.485613266704604e-05
affected O 0 0.0004989329027011991
by O 0 0.00043253126204945147
DMPK O 1 0.9999737739562988
absence O 0 0.03398649021983147
. O 0 0.0020350960548967123

In O 0 0.0017994092777371407
conclusion O 0 0.0010620604734867811
, O 0 0.00018895685207098722
our O 0 0.0002569591742940247
data O 0 6.986550579313189e-05
suggest O 0 0.00017529069737065583
that O 0 0.00011327477841405198
DMPK O 1 0.9984102249145508
is O 0 0.00023526880249846727
involved O 0 0.00017775717424228787
in O 0 0.0001682075671851635
modulating O 0 0.0011726705124601722
the O 0 0.00024965062038972974
initial O 0 0.00016611162573099136
events O 0 0.00020538920944090933
of O 0 0.0004579299420583993
excitation O 0 0.040249086916446686
- O 0 0.13960088789463043
contraction O 1 0.9157482385635376
coupling O 0 0.00741690956056118
in O 0 0.002272422658279538
skeletal O 1 0.9999998807907104
muscle O 1 0.9999997615814209
. O 0 0.0019241945119574666
. O 0 0.001396159641444683

Constitutional O 0 0.03742988035082817
RB1 O 1 0.9999604225158691
- O 0 0.011163798160851002
gene O 0 0.0008674427517689764
mutations O 0 0.00032536571961827576
in O 0 0.0002486662124283612
patients O 0 0.000283737521385774
with O 0 0.00022834420087747276
isolated O 0 0.06749670952558517
unilateral B-Disease 0 0.2597394287586212
retinoblastoma I-Disease 1 0.999944806098938
. O 0 0.003426736919209361

In O 0 0.0016184396808966994
most O 0 0.0005468688323162496
patients O 0 0.00040728706517256796
with O 0 0.0002095008094329387
isolated O 0 0.00926875788718462
unilateral B-Disease 1 0.75080806016922
retinoblastoma I-Disease 1 0.9999995231628418
, O 0 0.16738717257976532
tumor B-Disease 1 0.999987006187439
development O 0 0.001568299368955195
is O 0 0.00013480625057127327
initiated O 0 0.001079302397556603
by O 0 0.00014483103586826473
somatic O 0 0.000955576600972563
inactivation O 0 0.0029740878380835056
of O 0 0.000405596976634115
both O 0 0.00011572307994356379
alleles O 0 0.00019280202104710042
of O 0 0.00039437817758880556
the O 0 0.003325150813907385
RB1 O 1 0.9999916553497314
gene O 0 0.0015954890986904502
. O 0 0.0008347119437530637

However O 0 0.0013711993815377355
, O 0 0.00022807873028796166
some O 0 8.540658018318936e-05
of O 0 0.0003333140048198402
these O 0 0.0002189152000937611
patients O 0 0.0005319738411344588
can O 0 0.00025023758644238114
transmit O 0 0.0027609760873019695
retinoblastoma B-Disease 1 0.9993714690208435
predisposition O 1 0.9261900782585144
to O 0 0.0005998001433908939
their O 0 0.00048019879614003
offspring O 0 0.001881208037957549
. O 0 0.0007838935707695782

To O 0 0.0005445022834464908
determine O 0 0.00023500403040088713
the O 0 0.00027421116828918457
frequency O 0 0.0001656412350712344
and O 0 7.864130748203024e-05
nature O 0 0.000365649932064116
of O 0 0.0007186075672507286
constitutional O 0 0.0635436549782753
RB1 O 1 0.9999990463256836
- O 0 0.02450799010694027
gene O 0 0.0006803821306675673
mutations O 0 0.00028298457618802786
in O 0 0.00020380904607009143
patients O 0 0.000254486920312047
with O 0 0.00013567801215685904
isolated O 0 0.0052487486973404884
unilateral B-Disease 0 0.01813708432018757
retinoblastoma I-Disease 1 0.9996293783187866
, O 0 0.00029519794043153524
we O 0 9.93689100141637e-05
analyzed O 0 0.00013151222083251923
DNA O 0 0.00037312755011953413
from O 0 0.00036410189932212234
peripheral O 1 0.9932407140731812
blood O 1 0.9572944045066833
and O 0 0.004196343943476677
from O 1 0.9978849291801453
tumor B-Disease 1 1.0
tissue O 1 0.999985933303833
. O 0 0.0016296469839289784

The O 0 0.0008316247840411961
analysis O 0 0.000195787608390674
of O 0 0.000584351597353816
tumors B-Disease 1 0.9998512268066406
from O 0 0.0003685056581161916
54 O 0 0.0008324937662109733
( O 0 0.0001624909637030214
71 O 0 0.0005593651439994574
% O 0 8.187433559214696e-05
) O 0 6.64445324218832e-05
of O 0 0.0001816590374801308
76 O 0 0.0012208241969347
informative O 0 0.0007861118647269905
patients O 0 0.00024106103228405118
showed O 0 0.00040022857137955725
loss O 0 0.0005755865713581443
of O 0 0.0005346533725969493
constitutional O 0 0.00789316464215517
heterozygosity O 1 0.9999977350234985
( O 1 0.9574633240699768
LOH O 1 0.9999997615814209
) O 0 0.0010011603590101004
at O 0 0.0033310414291918278
intragenic O 1 0.9661146402359009
loci O 0 0.007681543007493019
. O 0 0.0012644050875678658

Three O 0 0.0011384353274479508
of O 0 0.001521330326795578
13 O 0 0.006444950588047504
uninformative O 1 0.9731953144073486
patients O 0 0.0018214344745501876
had O 0 0.0015880579594522715
constitutional O 0 0.00308081298135221
deletions O 0 0.01419634185731411
. O 0 0.002232539001852274

For O 0 0.0004862781206611544
39 O 0 0.0010548402788117528
randomly O 0 0.00047762272879481316
selected O 0 0.0012758144875988364
tumors B-Disease 1 0.9999862909317017
, O 0 0.0012194215087220073
SSCP O 1 0.9999958276748657
, O 0 0.0012265255209058523
hetero O 0 0.23274774849414825
- O 0 0.0015724952099844813
duplex O 0 0.0031472386326640844
analysis O 0 0.00011337926116539165
, O 0 0.00011473035556264222
sequencing O 0 0.0003173132718075067
, O 0 7.576929783681408e-05
and O 0 9.848886111285537e-05
Southern O 0 0.0009660549694672227
blot O 0 0.0029995194636285305
analysis O 0 0.00012533464177977294
were O 0 0.0001395552681060508
used O 0 0.00012900601723231375
to O 0 0.00014972800272516906
identify O 0 0.0005131967482157052
mutations O 0 0.001096922904253006
. O 0 0.0005978111876174808

Mutations O 0 0.001648424775339663
were O 0 0.0003314125642646104
detected O 0 0.0004537152126431465
in O 0 0.00012870179489254951
21 O 0 0.00045443978160619736
( O 0 0.0001371928519802168
91 O 0 0.0005132754449732602
% O 0 0.00010507948172744364
) O 0 0.00014350282435771078
of O 0 0.0007376621360890567
23 O 1 0.7597334384918213
tumors B-Disease 1 0.9999997615814209
with O 0 0.20214395225048065
LOH O 1 0.9999998807907104
. O 0 0.005462721921503544

In O 0 0.0011056455550715327
6 O 0 0.0010364782065153122
( O 0 0.00017588269838597625
38 O 0 0.00021505642507690936
% O 0 7.25636855349876e-05
) O 0 6.408786430256441e-05
of O 0 0.00034045398933812976
16 O 0 0.293027400970459
tumors B-Disease 1 0.9999998807907104
without O 0 0.05364963412284851
LOH O 1 0.9999998807907104
, O 0 0.0002974404487758875
one O 0 0.0001513830793555826
mutation O 0 0.00022537507175002247
was O 0 0.0005713613936677575
detected O 0 0.000542752502951771
, O 0 7.39219831302762e-05
and O 0 4.573898695525713e-05
in O 0 6.038886203896254e-05
9 O 0 0.0003222250670660287
( O 0 0.00011752048158086836
56 O 0 0.00021578968153335154
% O 0 6.158103497000411e-05
) O 0 4.545028423308395e-05
of O 0 0.00028169865254312754
the O 0 0.013610325753688812
tumors B-Disease 1 1.0
without O 1 0.6287775635719299
LOH O 1 1.0
, O 0 0.0005480016698129475
both O 0 0.000196704117115587
mutations O 0 0.0002657966106198728
were O 0 0.0003306863072793931
found O 0 0.0005374671891331673
. O 0 0.0007768177310936153

Thus O 0 0.0009234898607246578
, O 0 0.00011651799286482856
a O 0 8.794954919721931e-05
total O 0 8.14045051811263e-05
of O 0 0.00012624167720787227
45 O 0 0.0002409705048194155
mutations O 0 0.00014915074279997498
were O 0 0.00012041287845931947
identified O 0 0.00023692127433605492
in O 0 0.00036865955917164683
tumors B-Disease 1 0.9998983144760132
of O 0 0.005461965221911669
36 O 0 0.03501954302191734
patients O 0 0.004807660356163979
. O 0 0.0011733175488188863

Thirty O 0 0.0042000217363238335
- O 0 0.0006234997417777777
nine O 0 0.00021461232972797006
of O 0 0.00014270402607508004
the O 0 0.00023858014901634306
mutations O 0 0.00018524799088481814
- O 0 0.00023289257660508156
including O 0 6.426889740396291e-05
34 O 0 0.0001799049787223339
small O 0 0.0001056728360708803
mutations O 0 0.00015712910681031644
, O 0 0.00010906058741966262
2 O 0 0.0002655159623827785
large O 0 0.0002657971053849906
structural O 0 0.012845207005739212
alterations O 0 0.1861906498670578
, O 0 0.0002634939446579665
and O 0 0.00024559698067605495
hypermethylation O 1 0.981504499912262
in O 0 0.0008736614836379886
3 O 0 0.17993955314159393
tumors O 1 0.9999984502792358
- O 0 0.000765541335567832
were O 0 9.287878492614254e-05
not O 0 2.8195085178595036e-05
detected O 0 0.00011566252942429855
in O 0 5.0269307394046336e-05
the O 0 0.00024895230308175087
corresponding O 0 0.0009682314121164382
peripheral O 1 0.9998086094856262
blood O 1 0.997250497341156
DNA O 0 0.008010408841073513
. O 0 0.0015441719442605972

In O 0 0.001105641946196556
6 O 0 0.0010433372808620334
( O 0 0.00022826236090622842
17 O 0 0.0002496677916496992
% O 0 5.034876085119322e-05
) O 0 2.1468071281560697e-05
of O 0 6.820118869654834e-05
the O 0 0.00017883960390463471
36 O 0 0.0005211271345615387
patients O 0 0.00017500195826869458
, O 0 6.689215661026537e-05
a O 0 0.00017555983504280448
mutation O 0 0.00022927179816178977
was O 0 0.0007001387421041727
detected O 0 0.00028186419513076544
in O 0 6.470699736382812e-05
constitutional O 0 0.0002763912780210376
DNA O 0 0.00021615499281324446
, O 0 5.42260859219823e-05
and O 0 6.20011705905199e-05
1 O 0 0.00013006730296183378
of O 0 0.00011234427074668929
these O 0 3.9165148336905986e-05
mutations O 0 0.00011751778947655112
is O 0 9.586352825863287e-05
known O 0 0.00018010543135460466
to O 0 9.878126729745418e-05
be O 0 0.00011281126353424042
associated O 0 0.0001763508771546185
with O 0 0.0002615232369862497
reduced O 0 0.0020444802939891815
expressivity O 1 0.9608445167541504
. O 0 0.0016483869403600693

The O 0 0.0018585905199870467
presence O 0 0.0006940794992260635
of O 0 0.00035326427314430475
a O 0 0.0004956081975251436
constitutional O 0 0.001050245831720531
mutation O 0 0.00042149535147473216
was O 0 0.00047546415589749813
not O 0 3.7625817640218884e-05
associated O 0 5.472333214129321e-05
with O 0 2.604294968477916e-05
an O 0 0.00010130096052307636
early O 0 0.0007553782197646797
age O 0 0.0014461983228102326
at O 0 0.01446586288511753
treatment O 0 0.04842405766248703
. O 0 0.0011240412713959813

In O 0 0.0018222148064523935
1 O 0 0.0018770956667140126
patient O 0 0.0009970692917704582
, O 0 0.00048722955398261547
somatic O 0 0.009822051972150803
mosaicism O 1 0.9996470212936401
was O 0 0.0031632925383746624
demonstrated O 0 0.0007722151349298656
by O 0 4.679611083702184e-05
molecular O 0 0.00010399254824733362
analysis O 0 2.8718477551592514e-05
of O 0 0.00011936671944567934
DNA O 0 0.00038630602648481727
and O 0 0.0001991905301110819
RNA O 0 0.0012955161510035396
from O 0 0.0009255166514776647
peripheral O 1 0.9997223019599915
blood O 1 0.989251434803009
. O 0 0.0015716268680989742

In O 0 0.0025095148012042046
2 O 0 0.002090347930788994
patients O 0 0.00036668774555437267
without O 0 0.0001772639516275376
a O 0 0.0004739595460705459
detectable O 0 0.005243697203695774
mutation O 0 0.00042416242649778724
in O 0 0.0005822442471981049
peripheral O 1 0.9999138116836548
blood O 1 0.9961875081062317
, O 0 0.0009109530365094543
mosaicism O 1 0.9992901086807251
was O 0 0.0022337608970701694
suggested O 0 0.00018557575822342187
because O 0 6.413806113414466e-05
1 O 0 0.0001221978891408071
of O 0 0.00020680722082033753
the O 0 0.0009018625714816153
patients O 0 0.049141235649585724
showed O 1 0.9994187355041504
multifocal O 1 1.0
tumors B-Disease 1 1.0
and O 0 0.0010445293737575412
the O 0 0.0005136548425070941
other O 0 0.00013761867012362927
later O 0 0.0006992692360654473
developed O 0 0.001361425849609077
bilateral B-Disease 0 0.009207534603774548
retinoblastoma I-Disease 1 0.999596893787384
. O 0 0.0029275263659656048

In O 0 0.0016156419878825545
conclusion O 0 0.0012777415104210377
, O 0 0.0003269646258559078
our O 0 0.00019671759218908846
results O 0 9.768178279045969e-05
emphasize O 0 0.00030716738547198474
that O 0 7.071300933603197e-05
the O 0 0.00035007059341296554
manifestation O 1 0.8313044309616089
and O 0 0.0008869898156262934
transmissibility O 1 0.9722154140472412
of O 0 0.0020649780053645372
retinoblastoma B-Disease 1 0.9789819121360779
depend O 0 0.00022880229516886175
on O 0 0.0001217762182932347
the O 0 0.00010146947170142084
nature O 0 0.00011665028432616964
of O 0 9.012556256493554e-05
the O 0 0.00015176073065958917
first O 0 0.00019717092800419778
mutation O 0 6.252222374314442e-05
, O 0 2.2092650397098623e-05
its O 0 1.9298920960864052e-05
time O 0 4.183626515441574e-05
in O 0 5.306040111463517e-05
development O 0 0.0001318801660090685
, O 0 6.059030056349002e-05
and O 0 3.5064458643319085e-05
the O 0 0.00011207143688807264
number O 0 3.917994035873562e-05
and O 0 5.6006028898991644e-05
types O 0 0.00010371684766141698
of O 0 0.0007927283877506852
cells O 0 0.0020694537088274956
that O 0 5.6974702602019534e-05
are O 0 2.5836465283646248e-05
affected O 0 0.0003184130182489753
. O 0 0.00013473056606017053
. O 0 0.0006154829752631485

Hereditary B-Disease 1 0.9999945163726807
deficiency I-Disease 1 0.9999992847442627
of I-Disease 0 0.12618547677993774
the I-Disease 0 0.04502108693122864
fifth I-Disease 1 0.9708288908004761
component I-Disease 0 0.0027232065331190825
of I-Disease 0 0.0005950246704742312
complement I-Disease 0 0.0010346589842811227
in O 0 0.0006265729898586869
man O 0 0.0032312972471117973
. O 0 0.0008769608684815466

I O 0 0.09964051097631454
. O 0 0.0038291369564831257

Clinical O 0 0.018016444519162178
, O 0 0.0025904567446559668
immunochemical O 1 0.9997714161872864
, O 0 0.0008328516851179302
and O 0 0.00048717999015934765
family O 0 0.0013322565937414765
studies O 0 0.0007425498915836215
. O 0 0.0007827250519767404

The O 0 0.0017471486935392022
first O 0 0.0013837688602507114
recognized O 0 0.0012597469612956047
human O 0 0.0012681673979386687
kindred O 1 0.9867638945579529
with O 0 0.003302142722532153
hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.9996844530105591
the I-Disease 1 0.9566656351089478
fifth I-Disease 1 0.9964906573295593
component I-Disease 0 0.0028977447655051947
of I-Disease 0 0.0005521212005987763
complement I-Disease 0 0.002710111904889345
( O 0 0.0013294732198119164
C5 O 1 0.9999884366989136
) O 0 0.0002850503660738468
is O 0 0.00016298767877742648
described O 0 0.0009057860588654876
. O 0 0.0005758521729148924

The O 0 0.0021641601342707872
proband O 0 0.3054450452327728
, O 0 0.00027923169545829296
a O 0 0.00032965076388791203
20 O 0 0.0006139895413070917
- O 0 0.0007447852403856814
year O 0 0.00036467902828007936
- O 0 0.0009204999660141766
old O 0 0.0022195016499608755
black O 0 0.0045015583746135235
female O 0 0.01598399505019188
with O 0 0.2202400118112564
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 1 0.9999942779541016
age O 1 0.9974592328071594
11 O 1 0.6036440134048462
, O 0 0.0010824522469192743
lacked O 0 0.4667936861515045
serum O 1 0.9998520612716675
hemolytic O 1 0.9999998807907104
complement O 0 0.04884841665625572
activity O 0 0.001725397421978414
, O 0 0.0003106720978394151
even O 0 0.000288573995931074
during O 0 0.0017559545813128352
remission O 0 0.01563980244100094
. O 0 0.0015874698292464018

C5 O 1 0.9999839067459106
was O 0 0.17527009546756744
undetectable O 0 0.08015044033527374
in O 0 0.0005286340601742268
her O 0 0.00078933360055089
serum O 0 0.005846838932484388
by O 0 0.0003421174187678844
both O 0 0.0004397810553200543
immunodiffusion O 1 0.9999221563339233
and O 0 0.013125532306730747
hemolytic O 1 1.0
assays O 0 0.008449545130133629
. O 0 0.0016166698187589645

Other O 0 0.0012456676922738552
complement O 0 0.002176963957026601
components O 0 0.001496550627052784
were O 0 0.00029681867454200983
normal O 0 0.0006225200486369431
during O 0 0.0011361452052369714
remission O 0 0.006263182032853365
of O 0 0.009771742857992649
lupus O 1 1.0
, O 0 0.010672983713448048
but O 0 0.0009456307743676007
C1 O 1 0.9999905824661255
, O 0 0.0010959890205413103
C4 O 1 0.9999947547912598
, O 0 0.0010133021278306842
C2 O 1 0.999659538269043
, O 0 0.0005940918927080929
and O 0 0.0008694418938830495
C3 O 1 0.9999901056289673
levels O 0 0.013125056400895119
fell O 1 0.8921640515327454
during O 0 0.009972397238016129
exacerbations O 1 0.9953923225402832
. O 0 0.0020382090006023645

A O 0 0.008571349084377289
younger O 0 0.0034521121997386217
half O 0 0.0009787812596186996
- O 0 0.0013548098504543304
sister O 0 0.0010327533818781376
, O 0 0.0001193791176774539
who O 0 0.00015691888984292746
had O 0 0.00041917970520444214
no O 0 0.0010517386253923178
underlying O 1 0.9999958276748657
disease O 1 1.0
, O 0 0.22765229642391205
was O 0 0.364824116230011
also O 0 0.0001446298265364021
found O 0 0.00010447322711115703
to O 0 0.00030135264387354255
lack O 0 0.004488369915634394
immunochemically O 1 0.999995231628418
detectable O 1 0.9999181032180786
C5 O 1 0.999993085861206
. O 0 0.0023081847466528416

By O 0 0.00654105469584465
hemolytic O 1 0.9999996423721313
assay O 0 0.004388653673231602
, O 0 0.0003862822486553341
she O 0 0.00025296478997915983
exhibited O 0 0.0008950286428444088
1 O 0 0.000312464137095958
- O 0 0.00025698001263663173
2 O 0 9.661346848588437e-05
% O 0 2.4427101379842497e-05
of O 0 8.11736608739011e-05
the O 0 0.0003478162980172783
normal O 0 0.0012221551733091474
serum O 1 0.9381868243217468
C5 O 1 0.9998782873153687
level O 0 0.0008237043512053788
and O 0 0.0002028726157732308
normal O 0 0.0002916680241469294
concentrations O 0 0.0003905454359482974
of O 0 0.00017609901260584593
other O 0 0.00010804894554894418
complement O 0 0.0018264054087921977
components O 0 0.002937460318207741
. O 0 0.0008983341977000237

C5 O 1 0.9995162487030029
levels O 0 0.001865744823589921
of O 0 0.00039312016451731324
other O 0 6.716304051224142e-05
family O 0 0.0001279917050851509
members O 0 6.614594167331234e-05
were O 0 6.796700472477823e-05
either O 0 6.851623766124249e-05
normal O 0 0.00012199229240650311
or O 0 7.491841824958101e-05
approximately O 0 0.00015384965809062123
half O 0 0.000258784944890067
- O 0 0.00039963386370800436
normal O 0 0.00020564689475577325
, O 0 6.626058893743902e-05
consistent O 0 0.00014560256386175752
with O 0 8.096632518572733e-05
autosomal O 0 0.0024114763364195824
codominant O 1 0.9992651343345642
inheritance O 0 0.003120683366432786
of O 0 0.001973559847101569
the O 0 0.004654407501220703
gene O 0 0.007413638290017843
determining O 0 0.4055437743663788
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.008730395697057247

Normal O 1 0.6438987255096436
hemolytic O 1 0.9999995231628418
titers O 1 0.995449960231781
were O 0 0.0017232403624802828
restored O 0 0.002769316313788295
to O 0 0.0003134113794658333
both O 0 0.0004135043127462268
homozygous O 0 0.008122350089251995
C5 B-Disease 1 0.9999998807907104
- I-Disease 1 0.9996482133865356
deficient I-Disease 1 0.9999953508377075
( O 0 0.07228484749794006
C5D B-Disease 1 1.0
) O 0 0.0011047034058719873
sera O 0 0.008544395677745342
by O 0 8.992244693217799e-05
addition O 0 0.00015971093671396375
of O 0 0.0004051603318657726
highly O 0 0.001721948035992682
purified O 1 0.9888577461242676
human O 0 0.023412954062223434
C5 O 1 0.9999861717224121
. O 0 0.0014296064618974924

In O 0 0.003222505562007427
specific O 0 0.0017282087355852127
C5 O 1 0.9999700784683228
titrations O 1 0.7352810502052307
, O 0 0.0004184379067737609
however O 0 0.00017503381241112947
, O 0 9.055525879375637e-05
it O 0 7.097451452864334e-05
was O 0 0.0003994889266323298
noted O 0 0.00018232190632261336
that O 0 5.68575705983676e-05
when O 0 9.859118290478364e-05
limited O 0 9.103586489800364e-05
amounts O 0 0.00013933230366092175
of O 0 0.0004353902186267078
C5 O 1 0.9999134540557861
were O 0 0.0003560607729014009
assayed O 0 0.001028978149406612
in O 0 6.638100603595376e-05
the O 0 7.595203351229429e-05
presence O 0 0.00012191193673061207
of O 0 0.0001881434873212129
low O 0 0.00039941255818121135
dilutions O 0 0.003214101539924741
of O 0 0.0008499114192090929
either O 0 0.0029465421102941036
C5D B-Disease 1 1.0
serum O 1 0.9986634254455566
, O 0 0.0004766417550854385
curving O 0 0.0023924410343170166
rather O 0 0.0001819992030505091
than O 0 0.00010393901902716607
linear O 0 0.00021330548042897135
dose O 0 0.0012745424173772335
- O 0 0.0006328940507955849
response O 0 0.00024979060981422663
plots O 0 0.0005105469608679414
were O 0 0.00011631462984951213
consistently O 0 0.0003215551550965756
obtained O 0 0.00010849123646039516
, O 0 0.00010664830188034102
suggesting O 0 0.00024834772921167314
some O 0 0.00010727669723564759
inhibitory O 0 0.0016437730519101024
effect O 0 0.0011364147067070007
. O 0 0.0009831116767600179

Further O 0 0.0026152392383664846
studies O 0 0.00030062234145589173
suggested O 0 0.00039500469574704766
that O 0 9.955955465557054e-05
low O 0 0.0004795922141056508
dilutions O 0 0.005007636733353138
of O 0 0.0022391940001398325
C5D B-Disease 1 1.0
serum O 1 0.8142497539520264
contain O 0 0.000567496579606086
a O 0 0.00028313169605098665
factor O 0 0.00037858463474549353
( O 0 0.00011720153270289302
or O 0 0.00011466955038486049
factors O 0 8.160891593433917e-05
) O 0 5.7673314586281776e-05
interfering O 0 0.00023509679886046797
at O 0 0.00020490588212851435
some O 0 4.066633846377954e-05
step O 0 0.0002609473594930023
in O 0 0.00012862241419497877
the O 0 0.0006108609959483147
hemolytic O 1 0.9999966621398926
assay O 0 0.0031220540404319763
of O 0 0.0049776481464505196
C5 O 1 0.9999955892562866
, O 0 0.0003895710106007755
rather O 0 9.998645691666752e-05
than O 0 6.66341875330545e-05
a O 0 0.000248695578193292
true O 0 0.002058529993519187
C5 O 1 0.9999946355819702
inhibitor O 1 0.9976848363876343
or O 0 0.0019424399361014366
inactivator O 1 0.9943124055862427
. O 0 0.0013705503661185503

Of O 0 0.003424936207011342
clinical O 0 0.0016725780442357063
interest O 0 0.00023135000083129853
are O 0 2.9420083592412993e-05
( O 0 9.292820323025808e-05
a O 0 0.00014406822447199374
) O 0 6.80459852446802e-05
the O 0 0.00024519971339032054
documentation O 0 0.0008102958672679961
of O 0 0.004442894831299782
membranous O 1 1.0
glomerulonephritis B-Disease 1 1.0
, O 1 0.9999953508377075
vasculitis B-Disease 1 1.0
, O 1 0.9991394281387329
and O 1 0.9954501986503601
arthritis B-Disease 1 1.0
in O 0 0.006804946344345808
an O 0 0.0006046716589480639
individual O 0 0.0003692393656820059
lacking O 1 0.8641424179077148
C5 O 1 0.999998927116394
( O 0 0.0003057969734072685
and O 0 0.00013877237506676465
its O 0 0.00012778049858752638
biologic O 0 0.007619965355843306
functions O 0 0.00021658906189259142
) O 0 8.197379065677524e-05
, O 0 6.350868352456018e-05
and O 0 9.779091487871483e-05
( O 0 0.0002208835503552109
b O 0 0.0003534235875122249
) O 0 6.05287314101588e-05
a O 0 0.00016659843095112592
remarkable O 0 0.0008996850810945034
propensity O 0 0.0034856062848120928
to O 0 0.0010513238376006484
bacterial B-Disease 1 0.9999998807907104
infections I-Disease 1 0.9999996423721313
in O 0 0.0020716467406600714
the O 0 0.0035019353963434696
proband O 1 0.9996986389160156
, O 0 0.00015861185966059566
even O 0 7.016876770649105e-05
during O 0 0.0002702376514207572
periods O 0 0.00021661343635059893
of O 0 0.00031154294265434146
low O 0 0.000492534541990608
- O 0 0.0006082894979044795
dose O 0 0.000733685796149075
or O 0 0.0001665836462052539
alternate O 0 0.0005345247336663306
- O 0 0.0019305989844724536
day O 0 0.0021655363962054253
corticosteroid O 1 0.9989670515060425
therapy O 0 0.3645894229412079
. O 0 0.0009893816895782948

Other O 0 0.0006830816273577511
observations O 0 0.0006932462565600872
indicate O 0 0.00026779386098496616
that O 0 7.457229366991669e-05
the O 0 0.0004911255673505366
C5D B-Disease 1 0.9999984502792358
state O 0 0.00042745764949359
is O 0 0.00013643760757986456
compatible O 0 0.00024569957167841494
with O 0 8.52999510243535e-05
normal O 0 0.0005399652291089296
coagulation O 0 0.034082163125276566
function O 0 0.0003065407508984208
and O 0 0.0001264539605472237
the O 0 0.0002860574168153107
capacity O 0 0.0005331183201633394
to O 0 0.0002100824931403622
mount O 0 0.009935399517416954
a O 0 0.0022179901134222746
neutrophilic O 1 0.9998815059661865
leukocytosis O 1 0.9999487400054932
during O 1 0.9988601207733154
pyogenic B-Disease 1 0.999990701675415
infection I-Disease 1 0.9998670816421509
. O 0 0.0008155349642038345
. O 0 0.0009115795255638659

Susceptibility O 1 0.955162763595581
to O 0 0.03944029659032822
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 1 0.9739486575126648
twins O 1 0.7076227068901062
: O 0 0.00018780295795295388
the O 0 0.0001488912821514532
role O 0 0.00033877522218972445
of O 0 0.0003466912603471428
genes O 0 0.00032424720120616257
, O 0 0.0003619425115175545
HLA O 1 0.999985933303833
, O 0 0.0002821895177476108
and O 0 0.0002105045859934762
the O 0 0.000557547842618078
environment O 0 0.0011580521240830421
. O 0 0.000676901254337281

OBJECTIVE O 0 0.0037966477684676647
To O 0 0.00031204530387185514
determine O 0 9.934712579706684e-05
the O 0 0.00021802097035106272
relative O 0 0.0004053351003676653
effects O 0 0.0006587222451344132
of O 0 0.0005278807948343456
genetic O 0 0.0007527918787673116
and O 0 0.0003633173764683306
environmental O 0 0.0008102267747744918
factors O 0 0.0003503497573547065
in O 0 0.0004961380618624389
susceptibility O 1 0.9770573377609253
to O 1 0.9418473839759827
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 1 0.9999971389770508
AS B-Disease 1 0.9999982118606567
) O 0 0.0011236426653340459
. O 0 0.0007160689565353096

METHODS O 0 0.006068667862564325
Twins O 0 0.007044633384793997
with O 0 0.000322836684063077
AS B-Disease 0 0.004096513614058495
were O 0 0.00012145417713327333
identified O 0 7.934515451779589e-05
from O 0 8.189643995137885e-05
the O 0 0.00021847190510015935
Royal O 0 0.213510662317276
National O 1 0.9918245673179626
Hospital O 1 0.9999992847442627
for O 1 0.9667448997497559
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 1.0
database O 0 0.46526896953582764
. O 0 0.0026606253813952208

Clinical O 0 0.013150898739695549
and O 0 0.001834325259551406
radiographic O 0 0.024056408554315567
examinations O 0 0.001819159253500402
were O 0 0.0005177916609682143
performed O 0 0.0005651378305628896
to O 0 0.0001873233268270269
establish O 0 0.0011779210763052106
diagnoses O 0 0.4458652436733246
, O 0 0.0007366745267063379
and O 0 0.002783172531053424
disease O 1 0.9999994039535522
severity O 1 0.9998248219490051
was O 1 0.9172207117080688
assessed O 0 0.00029693072428926826
using O 0 5.0675538659561425e-05
a O 0 0.00010560243390500546
combination O 0 0.00023057441285345703
of O 0 0.00038463951204903424
validated O 0 0.0013542281230911613
scoring O 0 0.00121111492626369
systems O 0 0.002241820329800248
. O 0 0.0006549680256284773

HLA O 1 0.9863561391830444
typing O 0 0.012421702966094017
for O 0 0.002506591845303774
HLA O 1 0.9999804496765137
- O 0 0.08260250836610794
B27 O 1 0.9992325305938721
, O 0 0.0023532395716756582
HLA O 1 0.9999045133590698
- O 0 0.011235074140131474
B60 O 1 0.9937166571617126
, O 0 0.0007652291678823531
and O 0 0.0012501153396442533
HLA O 1 0.9999971389770508
- O 1 0.8128302097320557
DR1 O 1 0.9994463324546814
was O 0 0.0017334123840555549
performed O 0 0.0008714657160453498
by O 0 0.00019814868574030697
polymerase O 0 0.0010642061242833734
chain O 0 0.0005036693764850497
reaction O 0 0.00019825433264486492
with O 0 5.121948561281897e-05
sequence O 0 0.00018212782742921263
- O 0 0.0004003983922302723
specific O 0 0.00011951819033129141
primers O 0 0.0008505235309712589
, O 0 0.00024099898291751742
and O 0 0.0001908224367070943
zygosity O 1 0.8214622139930725
was O 0 0.0017351089045405388
assessed O 0 0.0007445693481713533
using O 0 0.00027974467957392335
microsatellite O 0 0.009891700930893421
markers O 0 0.009171975776553154
. O 0 0.0014817740302532911

Genetic O 0 0.0030287306290119886
and O 0 0.0006977274897508323
environmental O 0 0.0007553293253295124
variance O 0 0.00019026976951863617
components O 0 0.0005125538446009159
were O 0 0.00012113126285839826
assessed O 0 0.00013090268475934863
with O 0 4.055216777487658e-05
the O 0 0.00011805241229012609
program O 0 0.00025966105749830604
Mx O 0 0.0052643464878201485
, O 0 8.656582213006914e-05
using O 0 2.399859658908099e-05
data O 0 1.8310211089556105e-05
from O 0 3.5733726690523326e-05
this O 0 2.7058227715315297e-05
and O 0 3.32296549458988e-05
previous O 0 7.097011985024437e-05
studies O 0 6.130161636974663e-05
of O 0 0.0002677693555597216
twins O 0 0.007758839521557093
with O 0 0.0005115976673550904
AS B-Disease 1 0.9944593906402588
. O 0 0.0012888899073004723

RESULTS O 0 0.0018608281388878822
Six O 0 0.0005674792919307947
of O 0 0.0007573661860078573
8 O 0 0.0028196293860673904
monozygotic O 1 0.9382237792015076
( O 0 0.004711902234703302
MZ O 1 0.9999853372573853
) O 0 0.0010556152556091547
twin O 0 0.0063100396655499935
pairs O 0 0.0005323759978637099
were O 0 0.0007758548017591238
disease O 1 0.9983084201812744
concordant O 0 0.011835997924208641
, O 0 0.0002924543514382094
compared O 0 0.00013284113083500415
with O 0 5.4597087000729516e-05
4 O 0 0.00022066000383347273
of O 0 0.0002593532844912261
15 O 0 0.0008140993304550648
B27 O 1 0.9503366351127625
- O 0 0.0011221696622669697
positive O 0 0.00039324312820099294
dizygotic O 0 0.015823040157556534
( O 0 0.0006955491844564676
DZ O 1 0.9949530959129333
) O 0 0.0002186769706895575
twin O 0 0.0010063358349725604
pairs O 0 0.00015969904779922217
( O 0 0.0001006517923087813
27 O 0 0.0002677371958270669
% O 0 6.850356294307858e-05
) O 0 3.447597919148393e-05
and O 0 3.730825847014785e-05
4 O 0 0.00014448522415477782
of O 0 0.00026517038349993527
32 O 0 0.001007570419460535
DZ O 1 0.9992938041687012
twin O 0 0.004961741156876087
pairs O 0 0.00033925616298802197
overall O 0 0.0003667220298666507
( O 0 0.00013712249347008765
12 O 0 0.00024119115551002324
. O 0 8.18155676824972e-05
5 O 0 0.00027946129557676613
% O 0 0.0001851992419688031
) O 0 0.0003645325487013906
. O 0 0.0005996047402732074

Nonsignificant O 1 0.9865773916244507
increases O 0 0.0014128105249255896
in O 0 0.00022110520512796938
similarity O 0 0.00033314849133603275
with O 0 8.576535037718713e-05
regard O 0 0.00022442941553890705
to O 0 0.00017612033116165549
age O 0 0.0018783833365887403
at O 1 0.9919953346252441
disease O 1 0.999998927116394
onset O 1 0.9999958276748657
and O 0 0.0003463336906861514
all O 0 0.00010284073505317792
of O 0 0.0005607460043393075
the O 0 0.058444004505872726
disease O 1 0.9999929666519165
severity O 1 0.8241409063339233
scores O 0 0.0007131327292881906
assessed O 0 0.00022784876637160778
were O 0 0.00010170186578761786
noted O 0 0.0002033821801887825
in O 0 0.00039477087557315826
disease O 1 0.9999884366989136
- O 1 0.7697525024414062
concordant O 1 0.9694774150848389
MZ O 1 0.9999935626983643
twins O 0 0.015193678438663483
compared O 0 0.0007504483219236135
with O 0 0.00046233402099460363
concordant O 0 0.1924924999475479
DZ O 1 0.9999924898147583
twins O 1 0.5764400362968445
. O 0 0.0026999497786164284

HLA O 1 0.9999814033508301
- O 1 0.6111008524894714
B27 O 1 0.9924329519271851
and O 0 0.0013630551984533668
B60 O 1 0.9354769587516785
were O 0 0.0003718062653206289
associated O 0 0.0002407725405646488
with O 0 0.00011683687625918537
the O 0 0.0022252402268350124
disease O 1 0.9999974966049194
in O 0 0.009125839918851852
probands O 1 0.9999920129776001
, O 0 0.0001618097157916054
and O 0 7.637226372025907e-05
the O 0 0.00018010938947554678
rate O 0 0.00017913176270667464
of O 0 0.00036075199022889137
disease O 1 0.9996217489242554
concordance O 0 0.00977217685431242
was O 0 0.011962574906647205
significantly O 0 0.0009178786422125995
increased O 0 0.0002886364527512342
among O 0 0.00033863959833979607
DZ O 1 0.9994940757751465
twin O 0 0.004215159919112921
pairs O 0 0.00020045066776219755
in O 0 0.00012906384654343128
which O 0 7.810090755810961e-05
the O 0 0.00027317157946527004
co O 0 0.0014962343266233802
- O 0 0.0009645200334489346
twin O 0 0.003021243726834655
was O 0 0.0011555870296433568
positive O 0 0.0002779132919386029
for O 0 0.00016724511806387454
both O 0 0.00033158008591271937
B27 O 1 0.9998219609260559
and O 0 0.003668400691822171
DR1 O 1 0.999930739402771
. O 0 0.0019474680302664638

Additive O 0 0.01638968102633953
genetic O 0 0.002122426638379693
effects O 0 0.001677998574450612
were O 0 0.0002532471262384206
estimated O 0 0.00012202159996377304
to O 0 5.708352546207607e-05
contribute O 0 0.00014519607066176832
97 O 0 0.0003849012719001621
% O 0 3.533097333274782e-05
of O 0 8.754072041483596e-05
the O 0 0.00019546659314073622
population O 0 9.27051660255529e-05
variance O 0 0.00020638605928979814
. O 0 0.0004342236206866801

CONCLUSION O 0 0.01702689565718174
Susceptibility O 0 0.012007124722003937
to O 0 0.000728869519662112
AS B-Disease 0 0.16017362475395203
is O 0 0.00028303047292865813
largely O 0 0.0002558609994594008
genetically O 0 0.00020862850942648947
determined O 0 0.0001461308274883777
, O 0 4.9098227464128286e-05
and O 0 5.317031536833383e-05
the O 0 0.00016146879352163523
environmental O 0 0.0005367241101339459
trigger O 0 0.001684905611909926
for O 0 0.00028125697281211615
the O 0 0.07910441607236862
disease O 1 0.9999996423721313
is O 0 0.0025335841346532106
probably O 0 0.004699306562542915
ubiquitous O 0 0.009679125621914864
. O 0 0.0008739179465919733

HLA O 1 0.9999496936798096
- O 0 0.01151802483946085
B27 O 0 0.021570784971117973
accounts O 0 0.00016389077063649893
for O 0 5.895855065318756e-05
a O 0 7.634532812517136e-05
minority O 0 7.738910790067166e-05
of O 0 9.834001684794202e-05
the O 0 0.0003170339041389525
overall O 0 0.0012516927672550082
genetic O 0 0.0009634785237722099
susceptibility O 0 0.1110350713133812
to O 0 0.0008789652492851019
AS B-Disease 1 0.9991592168807983
. O 0 0.0014758558245375752

Cell O 0 0.0545462928712368
cycle O 0 0.007841918617486954
- O 0 0.0022260425612330437
dependent O 0 0.0009699155343696475
colocalization O 0 0.022204043343663216
of O 0 0.0019059731857851148
BARD1 O 1 0.9999922513961792
and O 0 0.0015426367754116654
BRCA1 O 0 0.006998587399721146
proteins O 0 0.00039182358887046576
in O 0 0.0002789916761685163
discrete O 0 0.0010044804075732827
nuclear O 0 0.002674252027645707
domains O 0 0.001931481179781258
. O 0 0.0009107234654948115

Germ O 1 0.9999483823776245
- O 0 0.00996874924749136
line O 0 0.0015195655869320035
mutations O 0 0.00020654512627515942
of O 0 0.0003539752506185323
the O 0 0.0008462543482892215
BRCA1 O 1 0.7391631603240967
gene O 0 0.0008066768641583622
predispose O 0 0.0035391657147556543
women O 0 0.0002741040079854429
to O 0 0.00018139283929485828
early O 0 0.0025418265722692013
- O 1 0.9689000844955444
onset O 1 0.9999997615814209
breast B-Disease 1 1.0
and I-Disease 1 0.9999892711639404
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
by O 0 0.001013812841847539
compromising O 0 0.003291541012004018
the O 0 0.0005156961269676685
genes O 0 0.0002781088696792722
presumptive O 0 0.019268497824668884
function O 0 0.00023104225692804903
as O 0 0.0003179989580530673
a O 0 0.001608941238373518
tumor B-Disease 1 0.9999957084655762
suppressor O 1 0.9963381290435791
. O 0 0.0013047500979155302

Although O 0 0.00102296844124794
the O 0 0.0007249369518831372
biochemical O 0 0.003190761199221015
properties O 0 0.0010252495994791389
of O 0 0.001952523598447442
BRCA1 O 1 0.9979150891304016
polypeptides O 0 0.0012923082103952765
are O 0 5.127676558913663e-05
not O 0 5.0874055887106806e-05
understood O 0 0.00030939135467633605
, O 0 0.00010002908675232902
their O 0 5.788865018985234e-05
expression O 0 0.00031173814204521477
pattern O 0 0.0008034334168769419
and O 0 0.0003706670249812305
subcellular O 0 0.004490929190069437
localization O 0 0.002029079245403409
suggest O 0 0.00017536325321998447
a O 0 0.00012149507529102266
role O 0 0.00040329890907742083
in O 0 0.0003675833868328482
cell O 0 0.0028244303539395332
- O 0 0.0014637572458013892
cycle O 0 0.0026897743809968233
regulation O 0 0.0011029227171093225
. O 0 0.0008452433976344764

When O 0 0.013184054754674435
resting O 1 0.9815034866333008
cells O 0 0.0024963514879345894
are O 0 0.000108218657260295
induced O 0 0.0018241240177303553
to O 0 0.00018182798521593213
proliferate O 0 0.0011763748480007052
, O 0 9.784873691387475e-05
the O 0 0.00016515013703610748
steady O 0 0.0007763177854940295
- O 0 0.00041605019941926
state O 0 0.00010101486259372905
levels O 0 0.00012936029816046357
of O 0 0.00012149113899795339
BRCA1 O 0 0.00202767550945282
increase O 0 0.00015541492030024529
in O 0 0.00020884665718767792
late O 0 0.001809838693588972
G1 O 1 0.8161866664886475
and O 0 0.00011164094030391425
reach O 0 0.00013717611727770418
a O 0 0.0001246930769411847
maximum O 0 0.00025642610853537917
during O 0 0.0012458740966394544
S O 0 0.011606001295149326
phase O 0 0.006880560424178839
. O 0 0.0010738095734268427

Moreover O 0 0.003894147230312228
, O 0 0.000414244452258572
in O 0 0.0005116664688102901
S O 1 0.542183518409729
phase O 1 0.7933996319770813
cells O 0 0.005140161607414484
, O 0 0.0006317357183434069
BRCA1 O 0 0.00998073723167181
polypeptides O 0 0.0019364936742931604
are O 0 0.0001340121525572613
hyperphosphorylated O 0 0.015909064561128616
and O 0 0.0003221077495254576
accumulate O 0 0.0007633715285919607
into O 0 0.00048399411025457084
discrete O 0 0.001244959537871182
subnuclear O 1 0.8495878577232361
foci O 0 0.05306435003876686
termed O 0 0.07626566290855408
" O 0 0.004267239011824131
BRCA1 O 1 0.6022141575813293
nuclear O 0 0.009936541318893433
dots O 0 0.006772981025278568
. O 0 0.0014310170663520694

" O 0 0.01478942297399044
BRCA1 O 0 0.4951772391796112
associates O 0 0.0030362671241164207
in O 0 0.000629241403657943
vivo O 0 0.001294636749662459
with O 0 0.0001406036753905937
a O 0 0.0007935105822980404
structurally O 0 0.011724615469574928
related O 0 0.0012375183869153261
protein O 0 0.0026766008231788874
termed O 1 0.6653064489364624
BARD1 O 1 0.9999828338623047
. O 0 0.0027880852576345205

Here O 0 0.003209225833415985
we O 0 0.00023677133140154183
show O 0 0.00021029534400440753
that O 0 4.183905912213959e-05
the O 0 0.00012578806490637362
steady O 0 0.0006278504733927548
- O 0 0.00035820333869196475
state O 0 5.46765404578764e-05
levels O 0 0.00015591811097692698
of O 0 0.00020480352395679802
BARD1 O 1 0.9999812841415405
, O 0 0.0002657813602127135
unlike O 0 0.00021976973221171647
those O 0 5.036690708948299e-05
of O 0 0.0004379958554636687
BRCA1 O 1 0.9896740913391113
, O 0 0.0003149999538436532
remain O 0 0.00030359046650119126
relatively O 0 0.00019672603229992092
constant O 0 0.0004951326991431415
during O 0 0.0034815145190805197
cell O 0 0.01937326043844223
cycle O 0 0.015106595121324062
progression O 1 0.8314762711524963
. O 0 0.0012482748134061694

However O 0 0.003959455993026495
, O 0 0.0019322525477036834
immunostaining O 1 0.9193870425224304
revealed O 0 0.0042599779553711414
that O 0 0.0006073266849853098
BARD1 O 1 0.9998351335525513
resides O 0 0.004453260451555252
within O 0 0.0009443621966056526
BRCA1 O 0 0.02142558991909027
nuclear O 0 0.0020634611137211323
dots O 0 0.0011411606101319194
during O 0 0.0008451519533991814
S O 0 0.002629244467243552
phase O 0 0.0007173786871135235
of O 0 0.0002223741466877982
the O 0 0.0004543483955785632
cell O 0 0.0014224511105567217
cycle O 0 0.0007983813993632793
, O 0 7.350423402385786e-05
but O 0 3.211873990949243e-05
not O 0 2.677106749615632e-05
during O 0 0.00042079234845004976
the O 0 0.0008213248220272362
G1 O 1 0.9987083673477173
phase O 0 0.008857074193656445
. O 0 0.0010356184793636203

Nevertheless O 0 0.01418542955070734
, O 0 0.0021924253087490797
BARD1 O 1 0.9992819428443909
polypeptides O 0 0.002438965952023864
are O 0 5.2153693104628474e-05
found O 0 8.038104715524241e-05
exclusively O 0 8.934276411309838e-05
in O 0 5.0546095735626295e-05
the O 0 9.43286795518361e-05
nuclear O 0 0.0004446767852641642
fractions O 0 0.0002796177286654711
of O 0 0.00013799277076032013
both O 0 0.0001819228782551363
G1 O 1 0.9987156391143799
- O 0 0.0012802539858967066
and O 0 0.0004753513203468174
S O 0 0.23695585131645203
- O 0 0.003949285950511694
phase O 0 0.018171466886997223
cells O 0 0.00283478619530797
. O 0 0.0006792483618482947

Therefore O 0 0.0018647753167897463
, O 0 0.0007225395529530942
progression O 0 0.0025676002260297537
to O 0 0.0003791081835515797
S O 0 0.18334609270095825
phase O 0 0.003333383472636342
is O 0 0.0001746800116961822
accompanied O 0 0.0005984842428006232
by O 0 6.391502392943949e-05
the O 0 0.00019911494746338576
aggregation O 0 0.0004593144403770566
of O 0 0.0006785449804738164
nuclear O 0 0.009938233532011509
BARD1 O 1 0.9996589422225952
polypeptides O 0 0.0031699242535978556
into O 0 0.00113803637214005
BRCA1 O 0 0.44514501094818115
nuclear O 0 0.009176874533295631
dots O 0 0.0063184830360114574
. O 0 0.0015262158121913671

This O 0 0.0014324642252177
cell O 0 0.004070265684276819
cycle O 0 0.0027150500100106
- O 0 0.001560834120027721
dependent O 0 0.0007408528472296894
colocalization O 0 0.019169636070728302
of O 0 0.0018002608558163047
BARD1 O 1 0.9999971389770508
and O 0 0.0011829473078250885
BRCA1 O 0 0.008271774277091026
indicates O 0 0.00048032469931058586
a O 0 0.00023148549371398985
role O 0 0.0004960335791110992
for O 0 0.0002989404310937971
BARD1 O 1 0.99992835521698
in O 0 0.0020794898737221956
BRCA1 O 1 0.9997318387031555
- O 1 0.6627452373504639
mediated O 1 0.9920944571495056
tumor B-Disease 1 0.9999983310699463
suppression O 1 0.9999843835830688
. O 0 0.0028357990086078644

Ethnic O 0 0.0028735550586134195
differences O 0 0.001222724560648203
in O 0 0.0006754564237780869
the O 0 0.001482272637076676
HFE O 1 0.9882504940032959
codon O 0 0.0074175093322992325
282 O 0 0.01219702884554863
( O 0 0.0025058912578970194
Cys O 1 0.9987689852714539
/ O 1 0.663324773311615
Tyr O 1 0.9919330477714539
) O 0 0.0009935082634910941
polymorphism O 0 0.001698056934401393
. O 0 0.0009638025076128542

Recent O 0 0.0018146235961467028
studies O 0 0.00025022588670253754
have O 0 6.54918621876277e-05
shown O 0 0.0003427505725994706
that O 0 0.0004686431202571839
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 1 0.9999998807907104
HH B-Disease 1 1.0
) O 0 0.0008515412337146699
is O 0 0.00014334771549329162
likely O 0 0.00010974545875797048
to O 0 7.859706965973601e-05
be O 0 9.221653454005718e-05
caused O 0 0.001099319546483457
by O 0 0.000147055194247514
homozygosity O 0 0.34396934509277344
for O 0 0.00020819051133003086
a O 0 0.0007522075320594013
Cys282Tyr O 1 0.9815623760223389
mutation O 0 0.0004032212309539318
in O 0 0.00017744151409715414
the O 0 0.00053677789401263
HFE O 1 0.9890180826187134
gene O 0 0.0005722743808291852
located O 0 0.0013532714219763875
4 O 0 0.0012726100394502282
. O 0 0.0006391326314769685

5 O 0 0.007085456978529692
Mb O 0 0.035991691052913666
telomeric O 0 0.054216526448726654
to O 0 0.003312052460387349
HLA O 1 0.9999743700027466
- O 0 0.017545193433761597
A O 0 0.006321279797703028
. O 0 0.0017492620972916484

Population O 0 0.0003886955382768065
studies O 0 0.00012815486115869135
of O 0 0.00017611091607250273
this O 0 9.864101593848318e-05
polymorphism O 0 0.00026853993767872453
are O 0 2.3007693016552366e-05
facilitated O 0 0.0004010998527519405
by O 0 7.042175275273621e-05
the O 0 0.00017628968635108322
fact O 0 0.00013785796181764454
that O 0 4.5470140321413055e-05
the O 0 0.0002435570495435968
Cys282Tyr O 1 0.9797654747962952
mutation O 0 0.0005221100873313844
creates O 0 0.0007636203663423657
a O 0 0.0008695914875715971
Rsal O 1 0.9956439733505249
restriction O 0 0.0019439085153862834
site O 0 0.002218973822891712
. O 0 0.0009152744896709919

We O 0 0.0010651772608980536
have O 0 0.0001488674315623939
studied O 0 0.00026202164008282125
the O 0 0.0003233655879739672
codon O 0 0.002472860738635063
282 O 0 0.005995105020701885
( O 0 0.0024917996488511562
Cys O 1 0.9961498975753784
/ O 0 0.278076708316803
Tyr O 1 0.8147581219673157
) O 0 0.0004656176606658846
polymorphism O 0 0.0003891287196893245
in O 0 0.00011700164759531617
different O 0 4.261940921423957e-05
ethnic O 0 0.0002829120203386992
groups O 0 0.000197575893253088
. O 0 0.0005826650303788483

In O 0 0.0012982310727238655
agreement O 0 0.0005123032606206834
with O 0 0.00018865584570448846
previous O 0 0.0004138834774494171
observations O 0 0.0003402489237487316
the O 0 0.0009112022235058248
Tyr O 1 0.9659860134124756
allele O 0 0.0008965572924353182
appeared O 0 0.0006251425947993994
to O 0 7.90580888860859e-05
be O 0 8.617246930953115e-05
rare O 0 0.0003792874631471932
or O 0 0.00016731099458411336
absent O 0 0.0007817000732757151
in O 0 0.0002612456155475229
Asiatic O 0 0.008518685586750507
( O 0 0.00035185227170586586
Indian O 0 0.0006092334515415132
, O 0 0.0001868732215370983
Chinese O 0 0.0013712053187191486
) O 0 0.00034057782613672316
populations O 0 0.00039166337228380144
. O 0 0.0006214055465534329

The O 0 0.0020446835551410913
highest O 0 0.001787863438948989
allele O 0 0.0003411688085179776
frequency O 0 0.00010428449604660273
( O 0 7.49112805351615e-05
7 O 0 0.00018514310067985207
. O 0 2.622262945806142e-05
5 O 0 0.00011026133870473132
% O 0 5.510530172614381e-05
) O 0 6.62204110994935e-05
was O 0 0.0002488825120963156
found O 0 0.00017735862638801336
in O 0 0.00032160268165171146
Swedes O 0 0.0030547771602869034
. O 0 0.001018129987642169

Saamis O 1 0.9039661884307861
( O 0 0.0013392535038292408
2 O 0 0.0007023466750979424
% O 0 0.0001920505310408771
) O 0 9.586114902049303e-05
and O 0 0.00012694204633589834
Mordvinians O 0 0.13412074744701385
( O 0 0.0003507952205836773
1 O 0 0.0002745512465480715
. O 0 5.461140244733542e-05
8 O 0 0.00025092449504882097
% O 0 9.263836545869708e-05
) O 0 7.670377817703411e-05
had O 0 0.00020717647566925734
significantly O 0 0.00020561648125294596
lower O 0 0.00024447511532343924
frequencies O 0 8.692342089489102e-05
of O 0 0.0002079338300973177
the O 0 0.0007689803605899215
Tyr O 1 0.9818853735923767
allele O 0 0.0031735182274132967
. O 0 0.0011871046153828502

Comparisons O 0 0.0024641905911266804
with O 0 0.0005564319435507059
allele O 0 0.0005306860548444092
frequencies O 0 0.0001440080814063549
based O 0 8.208674262277782e-05
on O 0 0.00020603764278348535
prevalence O 0 0.0008915254729799926
estimates O 0 0.00013624805433209985
of O 0 0.0006374256336130202
HH B-Disease 1 0.9999955892562866
showed O 0 0.0011154121020808816
some O 0 0.0001044222226482816
disagreements O 0 0.0008249796228483319
with O 0 0.00017698730516713113
the O 0 0.0006392023642547429
RFLP O 0 0.13040180504322052
data O 0 0.0002462014090269804
, O 0 0.0001900224742712453
particularly O 0 0.0003049279621336609
in O 0 0.0003830893838312477
Finns O 0 0.008168509230017662
. O 0 0.0012733478797599673

The O 0 0.0052828723564744
newly O 0 0.012201142497360706
described O 0 0.005758283194154501
HFE O 1 0.9984685778617859
marker O 0 0.004756971728056669
provides O 0 0.0002554120437707752
a O 0 0.00015638952027074993
new O 0 7.758181891404092e-05
approach O 0 0.0001137653598561883
to O 0 4.789775630342774e-05
the O 0 0.0001691729703452438
screening O 0 0.0002059661492239684
of O 0 0.0006373594515025616
HH B-Disease 1 0.999998927116394
as O 0 0.0004934967728331685
well O 0 0.000121713885164354
as O 0 7.70177721278742e-05
studies O 0 2.742078504525125e-05
of O 0 8.391029405174777e-05
the O 0 0.00018563432968221605
relationship O 0 0.00033629266545176506
between O 0 0.0007291752262972295
the O 0 0.005952175240963697
HFE O 1 0.9999984502792358
Tyr O 1 0.9998602867126465
allele O 0 0.0028259565588086843
and O 0 0.0005774251185357571
different O 0 0.0007181105320341885
disorders O 1 0.9999996423721313
including O 1 0.9992544054985046
cancer B-Disease 1 0.9999997615814209

Autosomal B-Disease 1 0.99924635887146
dominant I-Disease 1 0.9999963045120239
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999978542327881
associated O 0 0.001726551097817719
with O 0 0.0002887313603423536
a O 0 0.0004877961764577776
missense O 0 0.0015815716469660401
mutation O 0 0.0003208214766345918
encoding O 0 0.00047478839405812323
Gly23 O 1 0.9904398918151855
- O 0 0.003284131409600377
- O 0 0.0015394745860248804
> O 0 0.0019394358387216926
Val O 0 0.029261300340294838
in O 0 0.0012354571372270584
neurophysin O 1 0.9996142387390137
II O 1 0.9999935626983643
. O 0 0.0035391049459576607

Autosomal B-Disease 1 0.9970893263816833
dominant I-Disease 1 0.9999817609786987
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 1 0.9974011182785034
ADNDI B-Disease 1 0.9999997615814209
) O 0 0.0008772618020884693
is O 0 0.00036975188413634896
an O 0 0.002738025039434433
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 1 1.0
by O 1 0.9991875290870667
progressive O 1 1.0
degeneration O 1 1.0
of O 1 0.9999463558197021
the O 1 0.9996681213378906
magnocellular O 1 0.9999932050704956
neurons O 0 0.002566676354035735
of O 0 0.00040432382957078516
the O 0 0.0007008350221440196
hypothalamus O 0 0.2657999098300934
leading O 0 0.0009902899619191885
to O 0 0.00016670981131028384
decreased O 0 0.0005318662151694298
ability O 0 9.725237759994343e-05
to O 0 0.00010707844194257632
produce O 0 0.0003507933870423585
the O 0 0.0009017422562465072
hormone O 0 0.09725634008646011
arginine O 0 0.013131474144756794
vasopressin O 0 0.20208123326301575
( O 0 0.0023102127015590668
AVP O 1 0.9987965822219849
) O 0 0.0010260639246553183
. O 0 0.0008419681107625365

Affected O 0 0.0038356068544089794
individuals O 0 0.0002495906373951584
are O 0 6.273484177654609e-05
not O 0 8.196847193175927e-05
symptomatic O 1 0.9966084957122803
at O 1 0.8060503005981445
birth O 0 0.03037562221288681
, O 0 0.0002281585766468197
but O 0 0.00015811112825758755
usually O 0 0.0003014681860804558
develop O 0 0.0036488287150859833
diabetes B-Disease 1 0.9999687671661377
insipidus I-Disease 1 0.9997764229774475
at O 0 0.07230505347251892
1 O 0 0.0011839685030281544
- O 0 0.0012850313214585185
6 O 0 0.0012841245625168085
yr O 0 0.01100870594382286
of O 0 0.0007737368578091264
age O 0 0.001797602977603674
. O 0 0.0010988975409418344

The O 0 0.0022326537873595953
genetic O 0 0.0010056416504085064
locus O 0 0.00145262002479285
of O 0 0.0008795132162049413
the O 0 0.004537664819508791
disease O 1 0.9999699592590332
is O 0 0.0004377347941044718
the O 0 0.002717449562624097
AVP O 1 0.9999980926513672
- O 0 0.22266332805156708
neurophysin O 1 0.9997745156288147
II O 1 0.9999986886978149
( O 0 0.004841345828026533
NPII O 1 0.999991774559021
) O 0 0.00046185299288481474
gene O 0 0.00031290503102354705
, O 0 0.00014196975098457187
and O 0 0.00021527551871258765
mutations O 0 0.00033695041202008724
that O 0 0.00022462615743279457
cause O 1 0.9996168613433838
ADNDI B-Disease 1 0.9999998807907104
have O 0 0.00016579293878749013
been O 0 7.477517647203058e-05
found O 0 4.820357571588829e-05
in O 0 3.464426481514238e-05
both O 0 2.18076729652239e-05
the O 0 0.00010043002112070099
signal O 0 0.0003618703631218523
peptide O 0 0.00042756987386383116
of O 0 0.00019534847524482757
the O 0 0.0005810983711853623
prepro O 1 0.9998918771743774
- O 1 0.6736526489257812
AVP O 1 0.9999881982803345
- O 0 0.0264179315418005
NPII O 1 0.9997667670249939
precursor O 0 0.01653263531625271
and O 0 0.000609487877227366
within O 0 0.0015047085471451283
NPII O 1 0.999976396560669
itself O 0 0.004814011510461569
. O 0 0.0011350827990099788

An O 0 0.001954824198037386
affected O 0 0.002140821423381567
girl O 0 0.002450391184538603
who O 0 0.00024010725610423833
presented O 0 0.00036517600528895855
at O 0 0.0005530136404559016
9 O 0 0.00046523945638909936
months O 0 0.00021925527835264802
of O 0 0.0001744807668728754
age O 0 0.0003382940194569528
and O 0 0.00022023540805093944
her O 0 0.0005521996063180268
similarly O 0 0.0006739621749147773
affected O 0 0.001004960504360497
younger O 0 0.0026996415108442307
brother O 0 0.005339810624718666
and O 0 0.00023429081193171442
father O 0 0.001702076755464077
were O 0 9.3734277470503e-05
all O 0 3.8122259866213426e-05
found O 0 3.292933979537338e-05
to O 0 3.5691358789335936e-05
have O 0 2.7312345991958864e-05
a O 0 0.0001215909214806743
novel O 0 0.000360795296728611
missense O 0 0.0013819265877828002
mutation O 0 0.00039719551568850875
( O 0 0.0004035879101138562
G1758 O 1 0.9987671375274658
- O 0 0.005211723502725363
- O 0 0.0018554343841969967
> O 0 0.0017232175450772047
T O 0 0.0017972514033317566
) O 0 5.140729990671389e-05
encoding O 0 5.512317147804424e-05
the O 0 0.0001371054822811857
amino O 0 0.00037251407047733665
acid O 0 0.0011175377294421196
substitution O 0 0.0021973794791847467
Gly23 O 1 0.9993459582328796
- O 0 0.007484253030270338
- O 0 0.0027300056535750628
> O 0 0.0033682750072330236
Val O 0 0.03456830978393555
within O 0 0.001931769889779389
NPII O 1 0.9997760653495789
. O 0 0.0021691902074962854

The O 0 0.0030731246806681156
mutation O 0 0.0012122002663090825
was O 0 0.001072328188456595
confirmed O 0 0.0004695322422776371
by O 0 0.0001808390225050971
restriction O 0 0.0007177178049460053
endonuclease O 0 0.005377205088734627
analysis O 0 0.000644687213934958
. O 0 0.0011672426480799913

A O 0 0.026116682216525078
T1 O 1 0.9974639415740967
- O 0 0.003750147530809045
weighted O 0 0.0009513733675703406
magnetic O 0 0.0013502035290002823
resonance O 0 0.0012116087600588799
imaging O 0 0.0009387441677972674
of O 0 0.0006832951912656426
the O 0 0.004471327643841505
fathers O 1 0.996942937374115
pituitary O 1 0.9999995231628418
gland O 1 0.9999886751174927
demonstrates O 0 0.2657293975353241
an O 0 0.0026858001947402954
attenuated O 1 0.9957857728004456
posterior O 1 0.9998809099197388
pituitary O 1 0.9999996423721313
bright O 1 0.9973600506782532
spot O 0 0.031125016510486603
. O 0 0.0023922817781567574

This O 0 0.0015890684444457293
mutation O 0 0.0012470291694626212
may O 0 0.00028427259530872107
be O 0 6.31800721748732e-05
valuable O 0 0.0003576072340365499
for O 0 0.00013691226195078343
developing O 0 0.0003764616558328271
models O 0 0.0003320536343380809
of O 0 0.001045777928084135
dominantly B-Disease 1 0.9999924898147583
inherited I-Disease 1 1.0
neurodegeneration I-Disease 1 1.0
, O 0 0.0016205327119678259
as O 0 0.000211872422369197
the O 0 0.00016995616897474974
early O 0 0.0001692460646154359
age O 0 0.00019104417879134417
of O 0 0.00031506811501458287
onset O 1 0.9999921321868896
of O 1 0.9987971782684326
symptoms O 1 0.9999991655349731
suggests O 0 0.0016798306023702025
that O 0 9.045048500411212e-05
this O 0 8.027671719901264e-05
mutation O 0 0.00016409232921432704
may O 0 0.00014074491627980024
be O 0 8.395520853810012e-05
particularly O 0 0.0002175133122364059
deleterious O 0 0.0009433800587430596
to O 0 0.00024472418590448797
the O 0 0.0012110110837966204
magnocellular O 1 0.9998687505722046
neuron O 1 0.9902411699295044
. O 0 0.0009247348643839359
. O 0 0.0008416917407885194

Frequent O 0 0.005919267423450947
inactivation O 0 0.05894968658685684
of O 0 0.023942414671182632
PTEN O 1 0.9999995231628418
/ O 1 0.9992684721946716
MMAC1 O 1 0.9999966621398926
in O 0 0.04875519126653671
primary O 1 0.999758780002594
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.006136315409094095

Sporadic B-Disease 1 0.9999666213989258
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 0.001795525080524385
the O 0 0.0006093409028835595
most O 0 0.0002120367280440405
common O 0 0.00029178871773183346
male B-Disease 0 0.0023219359572976828
cancer I-Disease 0 0.4606403112411499
in O 0 0.00017269367526751012
the O 0 0.00030989234801381826
Western O 0 0.0008697179146111012
world O 0 0.0005825159605592489
, O 0 9.391742059960961e-05
yet O 0 5.341802898328751e-05
many O 0 1.2792171219189186e-05
of O 0 6.095552453189157e-05
the O 0 0.00016792456153780222
major O 0 0.000754253997001797
genetic O 0 0.00020137977844569832
events O 0 0.0003376646200194955
involved O 0 0.00024330776068381965
in O 0 0.00014693467528559268
the O 0 0.0003312691405881196
progression O 0 0.00394175760447979
of O 0 0.0010108110727742314
this O 0 0.0003902768949046731
often O 0 0.0007963985553942621
fatal O 1 0.9999997615814209
cancer B-Disease 1 0.9999868869781494
remain O 0 0.0012667241971939802
to O 0 0.00035894272150471807
be O 0 0.00032699579605832696
elucidated O 0 0.010367276147007942
. O 0 0.001176428166218102

Numerous O 0 0.008306409232318401
cytogenetic O 1 0.8693063259124756
and O 0 0.001949789933860302
allelotype O 1 0.9991796612739563
studies O 0 0.0002583226887509227
have O 0 5.4937081586103886e-05
reported O 0 0.00014086146256886423
frequent O 0 0.0002290712291141972
loss O 0 0.0008354492019861937
of O 0 0.0009125324431806803
heterozygosity O 1 0.9998639822006226
on O 0 0.004721025470644236
chromosomal O 1 0.9995161294937134
arm O 1 0.9999760389328003
10q O 1 0.9999985694885254
in O 1 0.9715969562530518
sporadic B-Disease 1 0.9999966621398926
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.006352861411869526

Deletion O 0 0.00693717272952199
mapping O 0 0.0013666480081155896
studies O 0 0.00019621668616309762
have O 0 7.662628195248544e-05
unambiguously O 0 0.0006335179787129164
identified O 0 0.00011625630577327684
a O 0 0.0001288756902795285
region O 0 0.0002075586817227304
of O 0 0.00046774849761277437
chromosome O 0 0.0036243482027202845
10q23 O 1 0.9990606904029846
to O 0 0.00016587640857324004
be O 0 5.2507919463096187e-05
the O 0 0.00014187746273819357
minimal O 0 0.000332762865582481
area O 0 0.00029666279442608356
of O 0 0.000705605314578861
loss O 0 0.38582003116607666
. O 0 0.0011690547689795494

A O 0 0.007406091317534447
new O 0 0.0025781928561627865
tumor B-Disease 1 0.9999170303344727
suppressor O 1 0.9953287839889526
gene O 0 0.0017268419032916427
, O 0 0.0012531683314591646
PTEN O 1 0.9999971389770508
/ O 1 0.9980193376541138
MMAC1 O 1 0.9999972581863403
, O 0 0.000727325037587434
was O 0 0.0016356970882043242
isolated O 0 0.0008856310159899294
recently O 0 0.00027575480635277927
at O 0 0.00022365228505805135
this O 0 2.3684515326749533e-05
region O 0 0.00010499274503672495
of O 0 0.00033097018604166806
chromosome O 0 0.007980274967849255
10q23 O 1 0.9999327659606934
and O 0 0.00024920020950958133
found O 0 0.00010692579235183075
to O 0 6.539843889186159e-05
be O 0 6.927520007593557e-05
inactivated O 0 0.0009317629155702889
by O 0 6.826182652730495e-05
mutation O 0 0.00014969873882364482
in O 0 0.00026736402651295066
three O 0 0.003456366714090109
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.9997578263282776
lines O 0 0.011929446831345558
. O 0 0.0007547314162366092

We O 0 0.0036485842429101467
screened O 0 0.00894466508179903
80 O 0 0.08417181670665741
prostate B-Disease 1 0.9999994039535522
tumors I-Disease 1 0.9999971389770508
by O 0 0.0004908707342110574
microsatellite O 0 0.003900368930771947
analysis O 0 0.0001240225974470377
and O 0 9.650205902289599e-05
found O 0 0.0002353363233851269
chromosome O 0 0.0008276886073872447
10q23 O 1 0.8236891031265259
to O 0 0.00021573291451204568
be O 0 9.894399408949539e-05
deleted O 0 0.00030332340975292027
in O 0 0.00016636840882711112
23 O 0 0.0008029534947127104
cases O 0 0.0003389374178368598
. O 0 0.0006539021269418299

We O 0 0.0006667448324151337
then O 0 0.00033475819509476423
proceeded O 0 0.0006111824186518788
with O 0 6.62950988044031e-05
sequence O 0 7.1747213951312e-05
analysis O 0 3.3897831599460915e-05
of O 0 0.00015257894119713455
the O 0 0.0006435303366743028
entire O 0 0.0209859199821949
PTEN O 1 0.9999966621398926
/ O 1 0.9367944002151489
MMAC1 O 1 0.9999558925628662
coding O 0 0.0017811480211094022
region O 0 0.0005722623318433762
and O 0 0.00020289389067329466
tested O 0 0.000505153788253665
for O 0 0.0001364335766993463
homozygous O 0 0.0004610192554537207
deletion O 0 0.0003790868795476854
with O 0 9.540300379740074e-05
new O 0 0.0003156068851239979
intragenic O 1 0.8779509663581848
markers O 0 0.0012358633102849126
in O 0 0.00016810944362077862
these O 0 3.332816413603723e-05
23 O 0 0.0002947541361209005
cases O 0 0.00011004821863025427
with O 0 0.00024299246433656663
10q23 O 1 0.9997686743736267
loss O 1 0.9281392693519592
of O 0 0.01308085210621357
heterozygosity O 1 0.9999518394470215
. O 0 0.003377119777724147

The O 0 0.0010787927312776446
identification O 0 0.00031554128509014845
of O 0 0.0003391311620362103
the O 0 0.0004979681107215583
second O 0 0.0008762726210989058
mutational O 0 0.0038307905197143555
event O 0 0.0007239545811899006
in O 0 0.00017024323460645974
10 O 0 0.0001830962864914909
( O 0 0.0001241711142938584
43 O 0 0.0004890877171419561
% O 0 0.0003995629958808422
) O 0 0.0010318731656298041
tumors B-Disease 1 0.9999674558639526
establishes O 1 0.9009471535682678
PTEN O 1 0.9999985694885254
/ O 1 0.9527193307876587
MMAC1 O 1 0.9999228715896606
as O 0 0.0005332006840035319
a O 0 0.00045058270916342735
main O 0 0.0010508076520636678
inactivation O 0 0.002906722715124488
target O 0 0.00038282983587123454
of O 0 0.0005859876982867718
10q O 1 0.9992058873176575
loss O 1 0.9743046164512634
in O 0 0.010339196771383286
sporadic B-Disease 1 0.9999948740005493
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0023378257174044847
. O 0 0.0013859852915629745

Risk O 0 0.006074958480894566
reversals O 0 0.00962107628583908
in O 0 0.0007760037551634014
predictive O 0 0.0020465750712901354
testing O 0 0.0025413427501916885
for O 0 0.003909375984221697
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.0083890650421381

The O 0 0.0014797116164118052
first O 0 0.0007199416868388653
predictive O 0 0.0011338433250784874
testing O 0 0.0012014185776934028
for O 0 0.0007953562308102846
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9688693881034851
HD B-Disease 1 0.9894992113113403
) O 0 0.00013098983617965132
was O 0 0.00016214379866141826
based O 0 2.3736231014481746e-05
on O 0 4.132522371946834e-05
analysis O 0 2.542539186833892e-05
of O 0 0.0001769796945154667
linked O 0 0.0009897022973746061
polymorphic O 0 0.0013203548733144999
DNA O 0 0.0007639268296770751
markers O 0 0.000788527715485543
to O 0 0.00014393613673746586
estimate O 0 0.0001037260444718413
the O 0 9.849101479630917e-05
likelihood O 0 0.00015623719082213938
of O 0 0.00033101497683674097
inheriting O 0 0.0056899734772741795
the O 0 0.001218208810314536
mutation O 0 0.0005124417366459966
for O 0 0.000521451816894114
HD B-Disease 0 0.15209631621837616
. O 0 0.0006375186494551599

Limits O 0 0.0009462571470066905
to O 0 0.0001940898655448109
accuracy O 0 0.00024361952091567218
included O 0 0.00018827772873919457
recombination O 0 0.0002421012322884053
between O 0 0.0001020111158140935
the O 0 0.00023718482407275587
DNA O 0 0.0004212744242977351
markers O 0 0.0010261430870741606
and O 0 0.0001501848455518484
the O 0 0.0003570509434211999
mutation O 0 0.00036675904993899167
, O 0 0.00019658372912090272
pedigree O 0 0.0010754511458799243
structure O 0 0.0008514503133483231
, O 0 0.00011613698006840423
and O 0 7.376494613708928e-05
whether O 0 4.361358514870517e-05
DNA O 0 0.00016393829719163477
samples O 0 7.518135680584237e-05
were O 0 7.395329885184765e-05
available O 0 2.9686727430089377e-05
from O 0 6.9973393692635e-05
family O 0 0.00022240341058932245
members O 0 0.0002544999879319221
. O 0 0.0006017171544954181

With O 0 0.0005623206379823387
direct O 0 0.0003262739919591695
tests O 0 0.00016919685003813356
for O 0 7.545507105533034e-05
the O 0 0.0005308302934281528
HD B-Disease 1 0.5876474976539612
mutation O 0 0.000242379741393961
, O 0 6.872576341265813e-05
we O 0 3.8748799852328375e-05
have O 0 1.2118784979975317e-05
assessed O 0 5.991390935378149e-05
the O 0 4.4476124458014965e-05
accuracy O 0 6.908281648065895e-05
of O 0 0.00011553421063581482
results O 0 9.02233223314397e-05
obtained O 0 8.100122067844495e-05
by O 0 6.206102261785418e-05
linkage O 0 0.0008240143652074039
approaches O 0 0.00041610930929891765
when O 0 0.00016314313688781112
requested O 0 0.0001585504796821624
to O 0 5.485259316628799e-05
do O 0 3.885029582306743e-05
so O 0 2.86832801066339e-05
by O 0 2.8923403078806587e-05
the O 0 0.0001904432865558192
test O 0 0.0005465233698487282
individuals O 0 0.00023753559798933566
. O 0 0.0005529332556761801

For O 0 0.000667142157908529
six O 0 0.0003810437337961048
such O 0 9.944835619535297e-05
individuals O 0 8.564048766857013e-05
, O 0 0.00013320797006599605
there O 0 0.00015426127356477082
was O 0 0.0006482653552666306
significant O 0 0.0005218082806095481
disparity O 0 0.002403132850304246
between O 0 0.00038851419230923057
the O 0 0.0008048025774769485
tests O 0 0.0006922222673892975
. O 0 0.0005126252654008567

Three O 0 0.0010521223302930593
went O 0 0.0010799628216773272
from O 0 0.0002376479678787291
a O 0 0.0003761231782846153
decreased O 0 0.001529401051811874
risk O 0 0.00010344521433580667
to O 0 4.819622336071916e-05
an O 0 7.763969188090414e-05
increased O 0 0.00016856464208103716
risk O 0 0.00012435679673217237
, O 0 6.905581540195271e-05
while O 0 4.1257932025473565e-05
in O 0 5.672412953572348e-05
another O 0 0.00010447142994962633
three O 0 6.32207011221908e-05
the O 0 0.00029578927205875516
risk O 0 0.0008846838609315455
was O 0 0.018985731527209282
decreased O 0 0.16805444657802582
. O 0 0.0013318685814738274

Knowledge O 0 0.002532845363020897
of O 0 0.000978177529759705
the O 0 0.0005068124737590551
potential O 0 0.0004836011794395745
reasons O 0 0.00016212293121498078
for O 0 5.129632700118236e-05
these O 0 2.2334228560794145e-05
changes O 0 8.045956928981468e-05
in O 0 0.00010108443530043587
results O 0 0.00014484470011666417
and O 0 9.796638187253848e-05
impact O 0 0.00025886413641273975
of O 0 0.0003108338569290936
these O 0 9.412578219780698e-05
risk O 0 0.0003103352210018784
reversals O 0 0.011454793624579906
on O 0 0.0005515692173503339
both O 0 0.0002743607619777322
patients O 0 0.0002657297009136528
and O 0 0.00013781855523120612
the O 0 0.00041681519360281527
counseling O 0 0.0014961082488298416
team O 0 0.0003801425045821816
can O 0 4.5710650738328695e-05
assist O 0 0.00020828621927648783
in O 0 9.844172018347308e-05
the O 0 0.00015622020873706788
development O 0 0.00023044957197271287
of O 0 0.0001824714709073305
strategies O 0 0.0002617267891764641
for O 0 9.895531547954306e-05
the O 0 0.000505461182910949
prevention O 1 0.8529734015464783
and O 0 0.00025916367303580046
, O 0 0.0001286322221858427
where O 0 0.00015154787979554385
necessary O 0 0.0002075705269817263
, O 0 7.623154670000076e-05
management O 0 0.00014736907905898988
of O 0 0.0002412003668723628
a O 0 0.0006157922325655818
risk O 0 0.00045784504618495703
reversal O 0 0.0018227475229650736
in O 0 0.00019252870697528124
any O 0 0.00011829310824396089
predictive O 0 0.0005177531857043505
testing O 0 0.0003954669809900224
program O 0 0.0002573568490333855
. O 0 0.00013130046136211604
. O 0 0.00039568301872350276

A O 0 0.008218892849981785
novel O 0 0.0030564141925424337
common O 0 0.0006701109232380986
missense O 0 0.002710124710574746
mutation O 0 0.0005872412584722042
G301C O 0 0.008452553302049637
in O 0 0.00024377544468734413
the O 0 0.0003619670169427991
N O 0 0.0023003751412034035
- O 0 0.0015307551948353648
acetylgalactosamine O 1 0.7832441926002502
- O 0 0.001722745131701231
6 O 0 0.0019867434166371822
- O 0 0.0034858647268265486
sulfate O 0 0.08013296872377396
sulfatase O 1 0.8601444959640503
gene O 0 0.0014654978876933455
in O 0 0.0011913320049643517
mucopolysaccharidosis B-Disease 1 0.9998579025268555
IVA I-Disease 1 0.9999885559082031
. O 0 0.004627024754881859

Mucopolysaccharidosis B-Disease 1 0.9999873638153076
IVA I-Disease 1 0.999998927116394
( O 1 0.6210057139396667
MPS B-Disease 1 0.9999090433120728
IVA I-Disease 1 0.9999996423721313
) O 0 0.0016705116722732782
is O 0 0.000510852609295398
an O 0 0.0006701052188873291
autosomal B-Disease 0 0.14953935146331787
recessive I-Disease 1 0.9999945163726807
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 1 0.9999997615814209
by O 0 0.0016906600212678313
a O 0 0.0017911972245201468
genetic B-Disease 1 0.730077862739563
defect I-Disease 1 0.9999985694885254
in O 0 0.0013314486714079976
N O 0 0.060026489198207855
- O 0 0.0023399991914629936
acetylgalactosamine O 1 0.815257728099823
- O 0 0.0017891541356220841
6 O 0 0.0024761799722909927
- O 0 0.004214465618133545
sulfate O 1 0.9354351162910461
sulfatase O 1 0.9997716546058655
( O 0 0.007605548948049545
GALNS O 1 0.9999916553497314
) O 0 0.0011970230843871832
. O 0 0.0010085107060149312

In O 0 0.0011620534351095557
previous O 0 0.0007945414981804788
studies O 0 0.00019489934493321925
, O 0 0.00013105715333949775
we O 0 6.414742529159412e-05
have O 0 1.8005484889727086e-05
found O 0 4.0588536649011075e-05
two O 0 5.41072768101003e-05
common O 0 0.0001886624813778326
mutations O 0 0.0001794295822037384
in O 0 0.00030237928149290383
Caucasians O 0 0.014656477607786655
and O 0 0.00044802445336245
Japanese O 0 0.171371191740036
, O 0 0.000553539430256933
respectively O 0 0.001560021424666047
. O 0 0.000712268752977252

To O 0 0.0024216726887971163
characterize O 0 0.006066787522286177
the O 0 0.0011654949048534036
mutational O 0 0.013668490573763847
spectrum O 0 0.0009890623623505235
in O 0 0.00013955087342765182
various O 0 9.045704791788012e-05
ethnic O 0 0.0001363654446322471
groups O 0 5.064066135673784e-05
, O 0 8.384894317714497e-05
mutations O 0 0.00012334727216511965
in O 0 0.00013508470146916807
the O 0 0.0005171827506273985
GALNS O 1 0.9999616146087646
gene O 0 0.0003045226912945509
in O 0 0.0003030615043826401
Colombian O 0 0.05838518962264061
MPS B-Disease 1 0.9999028444290161
IVA I-Disease 1 1.0
patients O 0 0.0030327674467116594
were O 0 0.0004140813834965229
investigated O 0 0.0023270128294825554
, O 0 0.00027699986821971834
and O 0 0.0001839340984588489
genetic O 0 0.0003248319844715297
backgrounds O 0 0.00038967779255472124
were O 0 0.00020592569489963353
extensively O 0 0.0005063348799012601
analyzed O 0 0.00018882140284404159
to O 0 6.373206269927323e-05
identify O 0 9.370147017762065e-05
racial O 0 0.0004104077524971217
origin O 0 0.00010969713184749708
, O 0 9.78335301624611e-05
based O 0 4.5791144657414407e-05
on O 0 0.00014611454389523715
mitochondrial O 0 0.0010219519026577473
DNA O 0 0.0009218876948580146
( O 0 0.0004018254694528878
mtDNA O 0 0.0006778042879886925
) O 0 0.00042668916285037994
lineages O 0 0.002721891039982438
. O 0 0.0008753712754696608

Three O 0 0.0016638014931231737
novel O 0 0.0020635928958654404
missense O 0 0.0036325007677078247
mutations O 0 0.0005176298436708748
never O 0 0.00048456742661073804
identified O 0 0.0001328644430032
previously O 0 0.00010079893399961293
in O 0 5.773649172624573e-05
other O 0 2.2809324946138076e-05
populations O 0 3.8965317799011245e-05
and O 0 4.298284329706803e-05
found O 0 6.40904254396446e-05
in O 0 6.97346476954408e-05
16 O 0 0.00015119985619094223
out O 0 7.656741217942908e-05
of O 0 0.0002789905993267894
19 O 0 0.001806679298169911
Colombian O 0 0.018528301268815994
MPS B-Disease 1 0.9975959658622742
IVA I-Disease 1 0.999996542930603
unrelated O 0 0.004915961064398289
alleles O 0 0.0005805347464047372
account O 0 0.00025579589419066906
for O 0 0.00025405778433196247
84 O 0 0.00223751668818295
. O 0 0.0008365715621039271

2 O 0 0.0012196050956845284
% O 0 0.0001589299354236573
of O 0 0.00024064585159067065
the O 0 0.0002752332075033337
alleles O 0 0.0003358658868819475
in O 0 0.00012305031123105437
this O 0 0.00011114363587694243
study O 0 0.0002641592582222074
. O 0 0.00043217436177656054

The O 0 0.008539157919585705
G301C O 1 0.9967969059944153
and O 0 0.0019441876793280244
S162F O 1 0.9848870635032654
mutations O 0 0.0008575381361879408
account O 0 0.00029298209119588137
for O 0 0.0002960293786600232
68 O 0 0.0032157734967768192
. O 0 0.001350492937490344

4 O 0 0.0027505671605467796
% O 0 0.0004701030848082155
and O 0 0.00035142587148584425
10 O 0 0.0008781582582741976
. O 0 0.0008534302469342947

5 O 0 0.0015095853013917804
% O 0 0.0002938666439149529
of O 0 0.0004751472151838243
mutations O 0 0.0003713657788466662
, O 0 0.00016396032879129052
respectively O 0 0.0004381535400170833
, O 0 0.000122163983178325
whereas O 0 0.00013750743528362364
the O 0 0.00022674008505418897
remaining O 0 0.0007697590044699609
F69V O 1 0.9994803071022034
is O 0 0.00012777026859112084
limited O 0 6.155831943033263e-05
to O 0 5.4085609008325264e-05
a O 0 0.00025982526130974293
single O 0 0.0005028099985793233
allele O 0 0.001076595624908805
. O 0 0.0005602964665740728

The O 0 0.004641314502805471
skewed O 0 0.004284447059035301
prevalence O 0 0.0026125991716980934
of O 0 0.0011357709299772978
G301C O 1 0.9967342615127563
in O 0 0.0005209359806030989
only O 0 0.0002457787632010877
Colombian O 0 0.0022068447433412075
patients O 0 0.000334232667228207
and O 0 0.00015493434329982847
haplotype O 0 0.0006254981271922588
analysis O 0 7.625458965776488e-05
by O 0 9.203889931086451e-05
restriction O 0 0.0003031953237950802
fragment O 0 0.0006244732649065554
length O 0 0.00023355121084023267
polymorphisms O 0 0.0005152462981641293
in O 0 0.00017428008140996099
the O 0 0.0005591230583377182
GALNS O 1 0.9998441934585571
gene O 0 0.0003071828687097877
suggest O 0 0.00015874621749389917
that O 0 6.940677849343047e-05
G301C O 0 0.006051728036254644
originated O 0 0.00035142002161592245
from O 0 0.00013653210771735758
a O 0 0.000381328456569463
common O 0 0.0006064180633984506
ancestor O 0 0.00682765943929553
. O 0 0.0013361201854422688

Investigation O 0 0.00220886361785233
of O 0 0.0007446773233823478
the O 0 0.00048281822819262743
genetic O 0 0.0003005045873578638
background O 0 0.0003573792346287519
by O 0 0.00012298321234993637
means O 0 0.00014109468611422926
of O 0 0.00021162530174478889
mtDNA O 0 0.0002042331179836765
lineages O 0 0.0002945376036223024
indicate O 0 0.00013689344632439315
that O 0 4.865376467932947e-05
all O 0 5.529827831196599e-05
our O 0 0.000288930197712034
patients O 0 0.00014317833120003343
are O 0 1.7033193216775544e-05
probably O 0 0.00024827104061841965
of O 0 0.0003560095210559666
native O 0 0.0014557462418451905
American O 0 0.003051511477679014
descent O 0 0.012052597478032112

Low O 0 0.0040054926648736
frequency O 0 0.0007778443396091461
of O 0 0.000703430559951812
BRCA1 O 0 0.03655963018536568
germline O 0 0.006535666063427925
mutations O 0 0.00019343952590133995
in O 0 0.00012822600547224283
45 O 0 0.0006315705250017345
German O 1 0.9999350309371948
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.0032790375407785177
. O 0 0.0017250444507226348

In O 0 0.0011491052573546767
this O 0 0.00016292721556965262
study O 0 7.857309537939727e-05
we O 0 4.785347482538782e-05
investigated O 0 0.0003987340605817735
45 O 0 0.0009913225658237934
German O 1 0.9996693134307861
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
families O 0 0.0010174948256462812
for O 0 0.00041292209061793983
germline O 0 0.11146887391805649
mutations O 0 0.00025925092631950974
in O 0 0.0002269256510771811
the O 0 0.0008615308324806392
BRCA1 O 0 0.2524533271789551
gene O 0 0.0010798650328069925
. O 0 0.0007045503589324653

We O 0 0.0006077134748920798
identified O 0 0.0003147078678011894
four O 0 0.00026844191597774625
germline O 0 0.003934056032449007
mutations O 0 0.0003193204465787858
in O 0 0.0003321232507005334
three O 0 0.0009507530485279858
breast B-Disease 1 0.9999490976333618
cancer I-Disease 1 0.9990785121917725
families O 0 0.0002398610522504896
and O 0 0.00019578050705604255
in O 0 0.0005144848837517202
one O 0 0.031584057956933975
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 0.006384556647390127
. O 0 0.00010702289728214964
among O 0 4.667012399295345e-05
these O 0 1.8119895685231313e-05
were O 0 5.539132689591497e-05
one O 0 0.00016345191397704184
frameshift O 0 0.002229380188509822
mutation O 0 0.00018071403610520065
, O 0 7.547767017967999e-05
one O 0 7.859977631596848e-05
nonsense O 0 0.002374271396547556
mutation O 0 0.0002453678462188691
, O 0 8.342504588654265e-05
one O 0 7.931036816444248e-05
novel O 0 0.00033616734435781837
splice O 0 0.0021543640177696943
site O 0 0.0011813775636255741
mutation O 0 0.00029468670254573226
, O 0 9.276159107685089e-05
and O 0 0.00011490991892060265
one O 0 0.0002364945103181526
missense O 0 0.004472081083804369
mutation O 0 0.0014686103677377105
. O 0 0.0010091132717207074

The O 0 0.002614275785163045
missense O 0 0.006150831934064627
mutation O 0 0.0008862641407176852
was O 0 0.0009784899884834886
also O 0 0.000152164269820787
found O 0 0.00011074076610384509
in O 0 0.0002867053262889385
2 O 0 0.0007523957756347954
. O 0 0.0006696110940538347

8 O 0 0.0016452183481305838
% O 0 0.0001537241187179461
of O 0 0.0001598331000423059
the O 0 0.0001816846925066784
general O 0 0.0003397068358026445
population O 0 7.272398215718567e-05
, O 0 8.948020695243031e-05
suggesting O 0 0.00017895884229801595
that O 0 4.650108530768193e-05
it O 0 5.879695891053416e-05
is O 0 0.00013580979430116713
not O 0 0.00027730321744456887
disease O 1 0.9999345541000366
associated O 0 0.002340741455554962
. O 0 0.0016590474406257272

The O 0 0.0019554519094526768
average O 0 0.0008224650518968701
age O 0 0.0007259933627210557
of O 0 0.0022181104868650436
disease O 1 0.9999997615814209
onset O 1 0.9999998807907104
in O 0 0.002665758365765214
those O 0 0.0002446802973281592
families O 0 0.00035094679333269596
harbouring O 1 0.9998966455459595
causative O 1 0.9841426014900208
mutations O 0 0.0009863050654530525
was O 0 0.00319331930950284
between O 0 0.0012862366857007146
32 O 0 0.0023246505297720432
. O 0 0.0011941719567403197

3 O 0 0.004711696412414312
and O 0 0.0009438620763830841
37 O 0 0.0029881855007261038
. O 0 0.0013492793077602983

4 O 0 0.002738123992457986
years O 0 0.0006167814135551453
, O 0 0.00017110820044763386
whereas O 0 0.00018105001072399318
the O 0 0.00024324444530066103
family O 0 0.0006340695545077324
harbouring O 1 0.9693928360939026
the O 0 0.0009245590772479773
missense O 0 0.0022633487824350595
mutation O 0 0.00021443766308948398
had O 0 0.0001504887331975624
an O 0 7.794934208504856e-05
average O 0 0.00010041538189398125
age O 0 0.00015886644541751593
of O 0 0.0004392226110212505
onset O 1 0.9990382194519043
of O 0 0.04187334328889847
51 O 0 0.010461609810590744
. O 0 0.0013888280373066664

2 O 0 0.007780021522194147
years O 0 0.0020640785805881023
. O 0 0.0016423121560364962

These O 0 0.0007009652908891439
findings O 0 0.0006311206961981952
show O 0 0.0006568847456946969
that O 0 0.00021184598153922707
BRCA1 O 0 0.006638954393565655
is O 0 0.00021185280638746917
implicated O 0 0.0019687777385115623
in O 0 0.00022239831741899252
a O 0 0.00023382974904961884
small O 0 0.0002066546439891681
fraction O 0 0.0006681086379103363
of O 0 0.16391070187091827
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
families O 0 0.0005689112585969269
suggesting O 0 0.0005283116479404271
the O 0 0.00015756391803734004
involvement O 0 0.0004549967707134783
of O 0 0.0002748927508946508
another O 0 0.0010454481234773993
susceptibility O 0 0.02905167080461979
gene O 0 0.0010117741767317057
( O 0 0.0010391775285825133
s O 0 0.005913439206779003
) O 0 0.001532641239464283

Paternal O 1 0.9940681457519531
transmission O 1 0.9999849796295166
of O 1 0.9999990463256836
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.9999687671661377

We O 0 0.0012694044271484017
report O 0 0.0003251461894251406
a O 0 0.0002848672738764435
rare O 0 0.000578224309720099
case O 0 0.0006596262101083994
of O 0 0.008160172030329704
paternally O 1 0.9999994039535522
transmitted O 1 0.9999998807907104
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
DM B-Disease 1 1.0
) O 0 0.00511564128100872
. O 0 0.0012825368903577328

The O 0 0.003863873891532421
proband O 0 0.14559277892112732
is O 0 0.00023363185755442828
a O 0 0.00023910801974125206
23 O 0 0.0007950575673021376
year O 0 0.00037193106254562736
old O 0 0.008032104931771755
, O 0 0.00404289411380887
mentally B-Disease 1 0.9999997615814209
retarded I-Disease 1 0.9999997615814209
male O 1 0.99860018491745
who O 1 0.9983249306678772
suffers O 1 1.0
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 1.0
. O 1 0.9995434880256653

He O 0 0.0049242605455219746
presented O 0 0.0032964665442705154
with O 0 0.00223945383913815
respiratory O 1 1.0
and O 1 0.665394127368927
feeding O 1 0.9965348243713379
difficulties O 1 0.9996873140335083
at O 1 0.9909051060676575
birth O 0 0.076618492603302
. O 0 0.0014283463824540377

His O 0 0.007396159693598747
two O 0 0.0032094335183501244
sibs O 1 0.9997538924217224
suffer O 1 0.9727596044540405
from O 0 0.006849877070635557
childhood O 1 0.9999982118606567
onset O 1 1.0
DM B-Disease 1 1.0
. O 0 0.02129446342587471

Their O 0 0.0009775451617315412
late O 0 0.0019374487455934286
father O 0 0.0017175929388031363
had O 0 0.00027664174558594823
the O 0 0.0001844207290560007
adult O 0 0.0001548923901282251
type O 0 0.00045667027006857097
of O 0 0.0032061252277344465
DM B-Disease 1 1.0
, O 0 0.00041401467751711607
with O 0 0.0002248558448627591
onset O 1 0.9936836957931519
around O 0 0.0013018765021115541
30 O 0 0.0010277173714712262
years O 0 0.00062175327911973
. O 0 0.0005835086922161281

Only O 0 0.00040479685412719846
six O 0 0.00032846242538653314
other O 0 7.17517250450328e-05
cases O 0 9.529317321721464e-05
of O 0 0.00046778886462561786
paternal O 1 0.9749256372451782
transmission O 1 0.9999856948852539
of O 1 0.9999985694885254
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 0.07260655611753464
been O 0 0.0007606137660332024
reported O 0 0.0005282830097712576
recently O 0 0.0008476973744109273
. O 0 0.0005456421058624983

We O 0 0.0008897869847714901
review O 0 0.00048542505828663707
the O 0 0.0003523191553540528
sex O 0 0.000705490994732827
related O 0 0.0006098638405092061
effects O 0 0.0026474620681256056
on O 0 0.0034510723780840635
transmission O 1 0.9995724558830261
of O 1 0.9999415874481201
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.8922904133796692

Decreased O 0 0.11035827547311783
fertility O 0 0.005903872195631266
of O 0 0.0008250722894445062
males O 0 0.00029200801509432495
with O 0 0.0002674218558240682
adult O 0 0.0014036842621862888
onset O 1 0.9999979734420776
DM B-Disease 1 1.0
and O 0 0.0014668605290353298
contraction O 0 0.007897286675870419
of O 0 0.0003398560220375657
the O 0 0.00035447769914753735
repeat O 0 0.0007419674075208604
upon O 0 0.0003691714082378894
male O 0 0.0007778057479299605
transmission O 0 0.0007475045858882368
contribute O 0 0.00024839324760250747
to O 0 7.73474239395e-05
the O 0 0.00020351930288597941
almost O 0 0.00033894096850417554
absent O 0 0.0008206468774005771
occurrence O 0 0.0008136285468935966
of O 0 0.0009071342064999044
paternal O 1 0.7809375524520874
transmission O 1 0.9998321533203125
of O 1 0.9999905824661255
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9709388613700867

Also O 0 0.0010168756125494838
the O 0 0.0005493760691024363
fathers O 0 0.0008555973181501031
of O 0 0.0003355196095071733
the O 0 0.0009093565749935806
reported O 0 0.0025507279206067324
congenitally O 1 0.9937280416488647
affected O 0 0.0012635743478313088
children O 0 0.00022204406559467316
showed O 0 0.00044485123362392187
, O 0 0.00010938908235402778
on O 0 0.00015079672448337078
average O 0 0.00021040525462012738
, O 0 0.0001725138135952875
shorter O 0 0.0009498833678662777
CTG O 1 0.9729708433151245
repeat O 0 0.003117575543001294
lengths O 0 0.002455818234011531
and O 0 0.0003215395554434508
hence O 0 0.0006147364038042724
less O 0 0.00034368986962363124
severe O 1 0.9997811913490295
clinical O 1 0.9592828154563904
symptoms O 1 0.9999747276306152
than O 0 0.0008920534746721387
the O 0 0.0013185982825234532
mothers O 0 0.000967637519352138
of O 0 0.0007832369301468134
children O 0 0.005169217009097338
with O 1 0.9884903430938721
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9968389272689819

We O 0 0.0013053219299763441
conclude O 0 0.0018156439764425159
that O 0 0.00026987434830516577
paternal O 0 0.007475852966308594
transmission O 1 0.9950284361839294
of O 1 0.9999673366546631
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 1 0.9947858452796936
rare O 0 0.08492004126310349
and O 0 0.0004611341573763639
preferentially O 0 0.000913296127691865
occurs O 0 0.00029079033993184566
with O 0 0.0001362719776807353
onset O 1 0.6055589318275452
of O 0 0.019746623933315277
DM B-Disease 1 1.0
past O 0 0.0010238882387056947
30 O 0 0.000301854161079973
years O 0 0.0001244495651917532
in O 0 8.132288348861039e-05
the O 0 0.000245107599766925
father O 0 0.0019728660117834806
. O 0 0.0004165486607234925
. O 0 0.0006259913207031786

The O 0 0.010147936642169952
RB1 O 1 0.9992842078208923
gene O 0 0.0018342355033382773
mutation O 0 0.00040888949297368526
in O 0 0.00024009947082959116
a O 0 0.0005967699689790606
child O 0 0.005388570483773947
with O 0 0.0024758593644946814
ectopic B-Disease 1 0.9999978542327881
intracranial I-Disease 1 0.9999997615814209
retinoblastoma I-Disease 1 0.9999985694885254
. O 0 0.006805907469242811

The O 0 0.012831754982471466
RB1 O 1 0.9996531009674072
gene O 0 0.0016514536691829562
mutation O 0 0.0006174712907522917
was O 0 0.0008327361429110169
investigated O 0 0.000645976688247174
in O 0 0.0001519249053671956
a O 0 0.00034687522565945983
child O 0 0.002238350221887231
with O 0 0.0007820320315659046
ectopic B-Disease 1 0.9999767541885376
intracranial I-Disease 1 0.9999971389770508
retinoblastoma I-Disease 1 0.9990819692611694
using O 0 0.0002001710672629997
DNA O 0 0.00022238370729610324
obtained O 0 0.00010276711691403762
from O 0 9.026729821925983e-05
both O 0 0.00010989709699060768
the O 0 0.0009348778985440731
pineal B-Disease 1 0.9999483823776245
and I-Disease 0 0.01456820871680975
retinal I-Disease 1 0.9999997615814209
tumours I-Disease 1 0.9999998807907104
of O 1 0.9586831331253052
the O 1 0.9888811707496643
patient O 0 0.4249207377433777
. O 0 0.0012520111631602049

A O 0 0.005271280184388161
nonsense O 0 0.007785801775753498
mutation O 0 0.00043605847167782485
in O 0 0.00022781966254115105
exon O 0 0.0022575370967388153
17 O 0 0.000762395968195051
( O 0 0.00026369348051957786
codon O 0 0.0009321837569586933
556 O 0 0.0020320129115134478
) O 0 0.00010725337779149413
of O 0 0.00027626691735349596
the O 0 0.000759599672164768
RB1 O 1 0.9998384714126587
gene O 0 0.00035763264168053865
was O 0 0.0004595478530973196
found O 0 6.666520494036376e-05
to O 0 5.384512405726127e-05
be O 0 4.5737546315649524e-05
present O 0 0.0002753195585682988
homozygously O 0 0.012780456803739071
in O 0 0.0002041116385953501
both O 0 0.00018064305186271667
the O 0 0.0007956665940582752
retinal B-Disease 1 0.9999170303344727
and I-Disease 0 0.00427644420415163
the I-Disease 1 0.99518221616745
pineal I-Disease 1 0.9999998807907104
tumours I-Disease 1 1.0
. O 0 0.004832216072827578

The O 0 0.0018212436698377132
same O 0 0.000514473591465503
mutation O 0 0.0003521158650983125
was O 0 0.0007464055088348687
present O 0 0.00044226524187251925
heterozygously O 0 0.008325335569679737
in O 0 0.0001704742171568796
the O 0 0.00012141388288000599
DNA O 0 0.00012291919847484678
from O 0 6.284154369495809e-05
the O 0 0.0001192037234432064
constitutional O 0 0.000358643417712301
cells O 0 0.0001540108205517754
of O 0 0.00017359065532218665
the O 0 0.00037222259561531246
patient O 0 0.0008016148349270225
, O 0 0.00012761585821863264
proving O 0 0.000662146252579987
it O 0 6.124621722847223e-05
to O 0 6.68707289150916e-05
be O 0 6.722506805090234e-05
of O 0 0.00040811646613292396
germline O 0 0.018455421552062035
origin O 0 0.0012340090470388532
. O 0 0.0010788666550070047

The O 0 0.002039427636191249
initial O 0 0.0011867597931995988
mutation O 0 0.0005374766769818962
was O 0 0.0009141684276983142
shown O 0 0.00020811591821257025
to O 0 7.195454963948578e-05
have O 0 4.696891119237989e-05
occurred O 0 0.000526691903360188
in O 0 0.00017101409321185201
the O 0 0.00048621531459502876
paternally O 0 0.01413046196103096
derived O 0 0.0021346656139940023
RB1 O 1 0.9993649125099182
allele O 0 0.0029941110406070948
. O 0 0.0009060251759365201

The O 0 0.001995314611122012
mutation O 0 0.0004530388687271625
is O 0 7.344404730247334e-05
in O 0 5.5312630138359964e-05
an O 0 5.913795030210167e-05
area O 0 0.00014239721349440515
of O 0 7.895781891420484e-05
the O 0 0.000122224009828642
gene O 0 7.713300874456763e-05
that O 0 2.469401624694001e-05
encodes O 0 9.327214502263814e-05
the O 0 0.00010102216765517369
protein O 0 0.0001902117219287902
- O 0 0.0002446772705297917
binding O 0 7.235210796352476e-05
region O 0 0.00013242453860584646
known O 0 0.00014723592903465033
as O 0 0.00013854666030965745
the O 0 0.00037669227458536625
pocket O 0 0.004880591295659542
region O 0 0.0005138972774147987
and O 0 0.00019093418086413294
has O 0 0.00011592972441576421
been O 0 9.529353701509535e-05
detected O 0 0.00029733043629676104
in O 0 7.421275950036943e-05
other O 0 4.7384106437675655e-05
cases O 0 0.00016871884872671217
of O 0 0.0013840352185070515
retinoblastoma B-Disease 1 0.9999881982803345
. O 0 0.0014435219345614314
. O 0 0.0011339632328599691

Low O 0 0.005254512652754784
levels O 0 0.001103523769415915
of O 0 0.0006355996592901647
beta O 0 0.001696804421953857
hexosaminidase O 0 0.3392294645309448
A O 0 0.0015350071480497718
in O 0 0.0003066605713684112
healthy O 0 0.0004517793422564864
individuals O 0 6.274226325331256e-05
with O 0 0.00018581905169412494
apparent O 1 0.9998010993003845
deficiency O 1 1.0
of O 1 0.999305009841919
this O 0 0.004083313979208469
enzyme O 0 0.007387431338429451
. O 0 0.0009193351143039763

Appreciable O 0 0.04526613652706146
beta O 0 0.006491516251116991
hexosaminidase O 0 0.060241494327783585
A O 0 0.0030783009715378284
( O 0 0.0006900459993630648
hex O 0 0.0027219844050705433
A O 0 0.0010558224748820066
) O 0 0.0001447150862077251
activity O 0 0.00019542317022569478
has O 0 0.00010558389476500452
been O 0 0.00013316301919985563
detected O 0 0.0008263064082711935
in O 0 0.0006457566632889211
cultured O 1 0.997934103012085
skin O 1 0.9999997615814209
fibroblasts O 1 0.9999991655349731
and O 1 0.9997370839118958
melanoma B-Disease 1 1.0
tissue O 1 0.9999980926513672
from O 0 0.12245932221412659
healthy O 0 0.002288801595568657
individuals O 0 9.943289478542283e-05
previously O 0 0.00042322135413996875
reported O 0 0.0003822683938778937
as O 0 0.0003996969317086041
having O 0 0.0012409815099090338
deficiency B-Disease 1 0.9999904632568359
of I-Disease 0 0.055993568152189255
hex I-Disease 1 0.9837221503257751
A I-Disease 0 0.00956573523581028
activity O 0 0.000787009485065937
indistinguishable O 0 0.0004154943744651973
from O 0 7.580529199913144e-05
that O 0 3.04584809782682e-05
of O 0 0.00024265678075607866
patients O 0 0.0009845889871940017
with O 0 0.06405522674322128
Tay B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
Sachs I-Disease 1 0.9999998807907104
disease I-Disease 1 1.0
( O 1 0.98441481590271
TSD B-Disease 1 0.9999982118606567
) O 0 0.0018443113658577204
. O 0 0.0011220520827919245

Identification O 0 0.0018964813789352775
and O 0 0.0008219867595471442
quantitation O 0 0.008560486137866974
of O 0 0.0011067056329920888
hex O 0 0.01034447830170393
A O 0 0.0019986294209957123
, O 0 0.00021414914226625115
amounting O 0 0.0009379293187521398
to O 0 0.0002447682782076299
3 O 0 0.0008753695874474943
. O 0 0.0007253073272295296

5 O 0 0.0034381088335067034
% O 0 0.0008021786925382912
- O 0 0.001916785491630435
6 O 0 0.001756936078891158
. O 0 0.0007335885311476886

9 O 0 0.0020944862626492977
% O 0 0.0001702849694993347
of O 0 0.00026959917158819735
total O 0 0.0005230006645433605
beta O 0 0.0013675553491339087
hexosaminidase O 1 0.710951566696167
activity O 0 0.0004762207099702209
, O 0 8.534405787941068e-05
has O 0 5.17629632668104e-05
been O 0 6.550441321451217e-05
obtained O 0 0.0001120748565881513
by O 0 0.00024319157819263637
cellulose O 1 0.9309635162353516
acetate O 1 0.8219937086105347
gel O 1 0.5638144016265869
electrophoresis O 0 0.005919755902141333
, O 0 0.00107280642259866
DEAE O 1 0.9999220371246338
- O 0 0.005857753101736307
cellulose O 0 0.05976402387022972
ion O 0 0.002518561901524663
- O 0 0.001352183404378593
exchange O 0 0.0007870825356803834
chromatography O 0 0.007839412428438663
, O 0 0.0004791861865669489
radial O 0 0.15107382833957672
immunodiffusion O 1 0.999968409538269
, O 0 0.0014156043762341142
and O 0 0.0013796882703900337
radioimmunoassay O 1 0.9992602467536926
. O 0 0.003016568021848798

Previous O 0 0.0035482679959386587
family O 0 0.0010543247917667031
studies O 0 0.0002123808953911066
suggested O 0 0.00021478776761796325
that O 0 4.513661042437889e-05
these O 0 3.137245948892087e-05
individuals O 0 4.417701347847469e-05
may O 0 0.00020901276730000973
be O 0 0.0001657692191656679
compound O 0 0.006558225490152836
heterozygotes O 0 0.002327736932784319
for O 0 0.00013210521137807518
the O 0 0.00028704010765068233
common O 0 0.0005929441540502012
mutant O 0 0.38323843479156494
TSD B-Disease 1 0.9999808073043823
gene O 0 0.0003595559683162719
and O 0 0.00015916074335109442
a O 0 0.0002502936404198408
rare O 0 0.0007134542101994157
( O 0 0.0004025297239422798
allelic O 0 0.005866439081728458
) O 0 0.0004509685095399618
mutant O 0 0.002648670691996813
gene O 0 0.0007690276252105832
. O 0 0.0004570315359160304

Thus O 0 0.002511188853532076
, O 0 0.0002855898055713624
the O 0 0.0003498697769828141
postulated O 0 0.002541558351367712
rate O 0 0.0004844068025704473
mutant O 0 0.0009207709808833897
gene O 0 0.00014126297901384532
appears O 0 0.0001370907120872289
to O 0 3.5361172194825485e-05
code O 0 2.764050805126317e-05
for O 0 1.726687332848087e-05
the O 0 6.54538962407969e-05
expression O 0 0.00010916453175013885
of O 0 0.00018872421060223132
low O 0 0.0003044565091840923
amounts O 0 0.0002651759423315525
of O 0 0.00042939092963933945
hex O 0 0.006798484828323126
A O 0 0.0031167962588369846
. O 0 0.0008414126932621002

Heterozygotes O 0 0.02423289231956005
for O 0 0.0007888500695116818
the O 0 0.001162536209449172
rare O 0 0.0021185462828725576
mutant O 0 0.019887808710336685
may O 0 0.0003011122753378004
be O 0 6.764668069081381e-05
indistinguishable O 0 0.0005176988779567182
from O 0 0.00019183967378921807
heterozygotes O 0 0.001371635589748621
for O 0 0.00012803297431673855
the O 0 0.0005209977389313281
common O 0 0.0016649120952934027
TSD B-Disease 1 0.9999692440032959
mutant O 0 0.2843882143497467
. O 0 0.0017879859078675508

However O 0 0.002567281946539879
, O 0 0.0006654504686594009
direct O 0 0.00040805325261317194
visualization O 0 0.0028253276832401752
and O 0 0.000663577753584832
quantitation O 0 0.012179144658148289
of O 0 0.0019902256317436695
hex O 0 0.006190050393342972
A O 0 0.0009106076904572546
by O 0 0.00010565279080765322
the O 0 0.00016362874885089695
methods O 0 0.00021049092174507678
described O 0 0.0006092733237892389
may O 0 0.00029469007859006524
prevent O 0 0.0008794997702352703
false O 0 0.0008745433879084885
- O 0 0.0016725112218409777
positive O 0 0.00041458458872511983
prenatal O 0 0.0036739190109074116
diagnosis O 0 0.0024048553314059973
of O 0 0.0036176613066345453
TSD B-Disease 1 0.9999996423721313
in O 0 0.0017304675420746207
fetuses O 0 0.003286276711151004
having O 0 0.0002095139934681356
the O 0 0.00019040313782170415
incomplete O 0 0.0009670328581705689
hex B-Disease 0 0.0284346342086792
A I-Disease 0 0.38950321078300476
deficiency I-Disease 1 0.9999550580978394
of O 0 0.000978467520326376
the O 0 0.0013728236081078649
type O 0 0.0010585780255496502
described O 0 0.0003430704528000206
in O 0 0.0001559576776344329
the O 0 0.00025662375264801085
four O 0 0.00041238588164560497
healthy O 0 0.002134293783456087
individuals O 0 0.0005920685362070799

The O 0 0.01513627078384161
tumor B-Disease 1 0.999957799911499
suppressor O 1 0.995063841342926
gene O 0 0.007361007854342461
Smad4 O 1 0.9999799728393555
/ O 1 0.9760876893997192
Dpc4 O 1 0.9978697299957275
is O 0 0.0002923411666415632
required O 0 0.00014231020759325475
for O 0 0.0001399960310664028
gastrulation O 0 0.4707793593406677
and O 0 0.0002721146447584033
later O 0 0.0004749612999148667
for O 0 0.00017505884170532227
anterior O 0 0.3345707356929779
development O 0 0.0010659928666427732
of O 0 0.001096938387490809
the O 0 0.0030510674696415663
mouse O 0 0.008795621804893017
embryo O 0 0.004938526079058647
. O 0 0.0007757960702292621

Mutations O 0 0.002204692456871271
in O 0 0.0009347923914901912
the O 0 0.0026604989543557167
SMAD4 O 1 0.999998927116394
/ O 1 0.9996975660324097
DPC4 O 1 0.9999998807907104
tumor B-Disease 1 0.9999982118606567
suppressor O 1 0.9262354373931885
gene O 0 0.0004785993951372802
, O 0 0.00010715688404161483
a O 0 0.00013893586583435535
key O 0 0.0007650151965208352
signal O 0 0.0008714179857634008
transducer O 0 0.001483577536419034
in O 0 0.00018510568770579994
most O 0 0.00027665914967656136
TGFbeta O 1 0.9995852112770081
- O 0 0.007565721403807402
related O 0 0.0009776746155694127
pathways O 0 0.003020146396011114
, O 0 0.00011209837975911796
are O 0 1.5498395441682078e-05
involved O 0 8.798191993264481e-05
in O 0 0.00011708971578627825
50 O 0 0.0003023818717338145
% O 0 0.00034745788434520364
of O 0 0.41399967670440674
pancreatic B-Disease 1 1.0
cancers I-Disease 1 0.9999991655349731
. O 0 0.005748899653553963

Homozygous O 0 0.039671964943408966
Smad4 O 1 0.9971612691879272
mutant O 1 0.6477240324020386
mice O 0 0.009552981704473495
die O 0 0.003356154076755047
before O 0 0.0005734883598051965
day O 0 0.0009226626716554165
7 O 0 0.0015056723495945334
. O 0 0.0006327733863145113

5 O 0 0.004711150657385588
of O 0 0.003977608401328325
embryogenesis O 0 0.3735101521015167
. O 0 0.003421416273340583

Mutant O 0 0.02146264724433422
embryos O 0 0.001735198893584311
have O 0 0.00012474646791815758
reduced O 0 0.00026721719768829644
size O 0 0.00024800747632980347
, O 0 0.00021733004541601986
fail O 0 0.0005699665634892881
to O 0 0.0002540946297813207
gastrulate O 0 0.050366632640361786
or O 0 0.0004253792285453528
express O 0 0.0004107498680241406
a O 0 0.0007724225870333612
mesodermal O 1 0.9042976498603821
marker O 0 0.23241034150123596
, O 0 0.000496947206556797
and O 0 0.00042694792500697076
show O 0 0.0028317132964730263
abnormal O 1 0.9116268754005432
visceral O 1 0.9998359680175781
endoderm O 1 0.999983549118042
development O 0 0.012354827485978603
. O 0 0.001576910144649446

Growth B-Disease 1 0.9970535039901733
retardation I-Disease 1 0.999948263168335
of O 0 0.004498979542404413
the O 0 0.2658989131450653
Smad4 O 1 0.9999995231628418
- O 1 0.9735822081565857
deficient O 0 0.05265343189239502
embryos O 0 0.0004152147739659995
results O 0 0.00010342006135033444
from O 0 0.00016462660278193653
reduced O 0 0.0006007899646647274
cell O 0 0.001219629542902112
proliferation O 0 0.0020435056649148464
rather O 0 0.0001987964496947825
than O 0 0.00016700258129276335
increased O 0 0.0006649838760495186
apoptosis O 0 0.010925515554845333
. O 0 0.0010268845362588763

Aggregation O 0 0.005731539335101843
of O 0 0.0027459277771413326
mutant O 1 0.605719268321991
Smad4 O 1 0.9999865293502808
ES O 1 0.9997239708900452
cells O 0 0.0006243982934392989
with O 0 0.00010244961595162749
wild O 0 0.0006041654851287603
- O 0 0.0010593639453873038
type O 0 0.0010203775018453598
tetraploid O 0 0.015716642141342163
morulae O 1 0.9913710355758667
rescues O 0 0.039427779614925385
the O 0 0.004007190000265837
gastrulation B-Disease 1 0.9999523162841797
defect I-Disease 1 0.9999691247940063
. O 0 0.005091874394565821

These O 0 0.0006703990511596203
results O 0 0.0003252937749493867
indicate O 0 0.00039427445153705776
that O 0 0.00015385258302558213
Smad4 O 1 0.8559411764144897
is O 0 0.00017603034211788327
initially O 0 0.00013043665967416018
required O 0 4.9196085456060246e-05
for O 0 4.963074024999514e-05
the O 0 0.00021965430642012507
differentiation O 0 0.0006882927846163511
of O 0 0.0004900161293335259
the O 0 0.001590521540492773
visceral O 1 0.9994531273841858
endoderm O 1 0.9999439716339111
and O 0 0.0003751963668037206
that O 0 9.076101559912786e-05
the O 0 0.00045763837988488376
gastrulation B-Disease 1 0.9993914365768433
defect I-Disease 1 0.9971693158149719
in O 0 0.00038794754073023796
the O 0 0.0007935729809105396
epiblast O 1 0.9998611211776733
is O 0 0.0004241470596753061
secondary O 0 0.000714493915438652
and O 0 0.00029572416679002345
non O 0 0.0009698134963400662
- O 0 0.0022753498051315546
cell O 0 0.0013285991735756397
autonomous O 0 0.0013997068163007498
. O 0 0.0004978589713573456

Rescued O 0 0.2962111532688141
embryos O 0 0.010608412325382233
show O 0 0.007003105245530605
severe O 1 0.9995637536048889
anterior O 1 0.9999923706054688
truncations O 1 0.999964714050293
, O 0 0.001290549524128437
indicating O 0 0.0011941133998334408
a O 0 0.00025116620236076415
second O 0 0.00040379262645728886
important O 0 0.00017103659047279507
role O 0 0.00045832383329980075
for O 0 0.00024394283536821604
Smad4 O 1 0.9993681311607361
in O 0 0.002433671150356531
anterior O 1 0.9999786615371704
patterning O 1 0.9999573230743408
during O 1 0.9976840019226074
embryogenesis O 1 0.9976012110710144
. O 0 0.002270062454044819

Prevalence O 0 0.01810958795249462
of O 0 0.006359805818647146
p16 O 1 0.9891064763069153
and O 0 0.004605185240507126
CDK4 O 1 0.9999927282333374
germline O 1 0.8406909704208374
mutations O 0 0.0007605634164065123
in O 0 0.00047262501902878284
48 O 0 0.012463131919503212
melanoma B-Disease 1 1.0
- O 1 0.9729102253913879
prone O 0 0.2817094922065735
families O 0 0.0004173185443505645
in O 0 0.0004959144280292094
France O 0 0.002754870103672147
. O 0 0.0012413539225235581

The O 0 0.007732884958386421
French O 1 0.5054603815078735
Familial B-Disease 1 0.9999903440475464
Melanoma I-Disease 1 1.0
Study O 0 0.004945294000208378
Group O 0 0.0018843719735741615
. O 0 0.0012133746640756726

Germline O 0 0.48444437980651855
mutations O 0 0.0017218595603480935
in O 0 0.00043903320329263806
the O 0 0.0011254241690039635
p16 O 0 0.37675443291664124
and O 0 0.0010977236088365316
CDK4 O 1 0.9999814033508301
genes O 0 0.00022488823742605746
have O 0 3.971744445152581e-05
been O 0 6.052400203770958e-05
reported O 0 6.562296039192006e-05
in O 0 4.452492430573329e-05
a O 0 0.00014095484220888466
subset O 0 0.0006609061383642256
of O 0 0.0023454029578715563
melanoma B-Disease 1 0.9999998807907104
pedigrees O 1 0.7559131383895874
, O 0 0.0004390156245790422
but O 0 7.237584941321984e-05
their O 0 6.466530612669885e-05
prevalence O 0 0.0006304747657850385
is O 0 8.842416718835011e-05
not O 0 5.5455970141338184e-05
well O 0 0.00019187004363629967
known O 0 0.0008763189543969929
. O 0 0.000699237163644284

We O 0 0.0010986473644152284
searched O 0 0.0017508167074993253
for O 0 0.00024628499522805214
such O 0 0.00021006885799579322
germline O 0 0.0036166280042380095
mutations O 0 0.00023635274555999786
in O 0 0.0002551783691160381
48 O 0 0.001316447276622057
French O 1 0.9819746613502502
melanoma B-Disease 1 1.0
- O 1 0.916069507598877
prone O 0 0.010387415997684002
families O 0 0.00013270035560708493
selected O 0 9.666840196587145e-05
according O 0 2.43590802710969e-05
to O 0 2.289580152137205e-05
two O 0 2.6809086193679832e-05
major O 0 0.00023429258726537228
criteria O 0 8.578514825785533e-05
families O 0 7.08539446350187e-05
with O 0 7.131978054530919e-05
at O 0 0.000326269306242466
least O 0 4.608100789482705e-05
three O 0 4.051119685755111e-05
affected O 0 6.638226477662101e-05
members O 0 3.985445437137969e-05
( O 0 9.210238204104826e-05
n O 0 0.00029162128339521587
= O 0 0.0003022097807843238
20 O 0 0.00018948980141431093
) O 0 4.8951147618936375e-05
or O 0 3.5676250263350084e-05
families O 0 2.6589959816192277e-05
with O 0 1.8923630705103278e-05
two O 0 4.9534279241925105e-05
affected O 0 0.00013092014705762267
members O 0 3.789336915360764e-05
, O 0 2.9357446692301892e-05
one O 0 2.7610050892690197e-05
of O 0 7.11981556378305e-05
them O 0 5.861881436430849e-05
affected O 0 0.00010877527529373765
before O 0 0.00010702442523324862
the O 0 8.95409903023392e-05
age O 0 8.532224455848336e-05
of O 0 0.0001283838355448097
50 O 0 0.00027913294616155326
( O 0 0.00010137729987036437
n O 0 0.0002167357160942629
= O 0 0.00031050803954713047
28 O 0 0.000272583361947909
) O 0 5.718257307307795e-05
, O 0 4.7490058932453394e-05
and O 0 6.286036659730598e-05
one O 0 9.25518324947916e-05
additional O 0 0.0002445790742058307
minor O 0 0.006460719276219606
criterion O 0 0.0064471070654690266
. O 0 0.0015105658676475286

Sixteen O 0 0.010383138433098793
different O 0 0.0007639559917151928
p16 O 0 0.10622185468673706
germline O 0 0.0296163447201252
mutations O 0 0.000279935949947685
were O 0 9.381413110531867e-05
found O 0 8.385390538023785e-05
in O 0 9.911567030940205e-05
21 O 0 0.0002684198843780905
families O 0 8.377301855944097e-05
, O 0 8.722789789317176e-05
while O 0 9.650371794123203e-05
one O 0 0.00023075916396919638
germline O 0 0.013438113033771515
mutation O 0 0.00047046507825143635
, O 0 0.0003417456173337996
Arg24His O 1 0.9979196190834045
, O 0 0.00031493057031184435
was O 0 0.0008423263789154589
detected O 0 0.0005864455597475171
in O 0 0.0001868732215370983
the O 0 0.0006602972862310708
CDK4 O 1 0.9999661445617676
gene O 0 0.00234404974617064
. O 0 0.0009136546868830919

The O 0 0.0013001365587115288
frequency O 0 0.0003350538609083742
of O 0 0.0004733080859296024
p16 O 0 0.006889455020427704
gene O 0 0.00031821063021197915
mutation O 0 0.00011024871491827071
in O 0 4.364629421615973e-05
our O 0 5.5551136028952897e-05
sample O 0 2.193013824580703e-05
( O 0 4.801528848474845e-05
44 O 0 0.00012029810750391334
% O 0 4.845549483434297e-05
) O 0 3.342279160278849e-05
is O 0 3.193079464836046e-05
among O 0 3.81651843781583e-05
the O 0 0.00010192623449256644
highest O 0 0.00043506993097253144
rates O 0 0.00010152163304155692
yet O 0 8.680289465701208e-05
reported O 0 0.00010514604218769819
and O 0 7.1326045144815e-05
the O 0 0.00042285193921998143
CDK4 O 1 0.9999170303344727
mutation O 0 0.00026562786661088467
is O 0 6.27110421191901e-05
the O 0 0.00015852930664550513
second O 0 0.0006138397729955614
mutation O 0 0.00024045754980761558
detected O 0 0.0003648570564109832
in O 0 0.00013365520862862468
this O 0 9.515768761048093e-05
gene O 0 0.0003515523858368397
worldwide O 0 0.0006222589872777462
. O 0 0.0006893979734741151

In O 0 0.0018702505622059107
summary O 0 0.0018148627132177353
, O 0 0.0002639369631651789
our O 0 0.0002841950627043843
results O 0 0.0001528576685814187
show O 0 0.00021556757565122098
frequent O 0 0.00018087831267621368
involvement O 0 0.0005415267078205943
of O 0 0.00035258830757811666
the O 0 0.0010220326948910952
p16 O 1 0.8106082081794739
gene O 0 0.0004730685905087739
in O 0 0.00046786756138317287
familial B-Disease 1 0.9988797307014465
melanoma I-Disease 1 1.0
and O 0 0.000778497545979917
confirm O 0 0.0003539563622325659
the O 0 0.00015455513494089246
role O 0 0.000217756925849244
of O 0 0.00030065877945162356
the O 0 0.001040331437252462
CDK4 O 1 0.999984622001648
gene O 0 0.0005531059578061104
as O 0 0.0004996552597731352
a O 0 0.0013420768082141876
melanoma B-Disease 1 0.9999978542327881
- O 0 0.18925504386425018
predisposing O 0 0.34864678978919983
gene O 0 0.0011081061093136668
. O 0 0.0002562303561717272
. O 0 0.0006631952710449696

Progression O 0 0.07025982439517975
of O 0 0.00747643643990159
somatic O 0 0.3065214455127716
CTG O 1 0.9988788962364197
repeat O 0 0.002368620363995433
length O 0 0.00033664650982245803
heterogeneity O 0 0.0006868214695714414
in O 0 0.0002121955039910972
the O 0 0.0008253357955254614
blood O 1 0.9509862661361694
cells O 1 0.6849787831306458
of O 1 0.9987019300460815
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.999971866607666
. O 0 0.0059102559462189674

The O 0 0.0012323673581704497
genetic O 0 0.0004914304590784013
basis O 0 0.00032565800938755274
of O 0 0.02715081162750721
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999986886978149
DM B-Disease 1 1.0
) O 0 0.0004772395477630198
is O 0 8.894341590348631e-05
the O 0 9.626337850932032e-05
expansion O 0 0.0003466661146376282
of O 0 0.0001845617953222245
an O 0 0.00043597619514912367
unstable O 1 0.9881051778793335
CTG O 1 0.9991125464439392
repeat O 0 0.001652241451665759
in O 0 0.00014490963076241314
the O 0 0.00017895032942760736
34 O 0 0.0003692532773129642
UTR O 0 0.00429484061896801
of O 0 0.00033286373945884407
the O 0 0.0006622371729463339
DM B-Disease 1 0.9999891519546509
protein O 0 0.0007787439390085638
kinase O 0 0.0006188287516124547
gene O 0 0.0001850301632657647
on O 0 0.0002351815637666732
chromosome O 0 0.0009266933193430305
19 O 0 0.0021915605757385492
. O 0 0.0010290370555594563

One O 0 0.0006726357387378812
of O 0 0.000552346755284816
the O 0 0.00040542095666751266
principal O 0 0.0005609336658380926
features O 0 0.0001737955171847716
of O 0 0.00026521741528995335
the O 0 0.003569072112441063
DM B-Disease 1 1.0
mutation O 0 0.0006304251146502793
is O 0 8.762332436162978e-05
an O 0 0.00010072495206259191
extraordinarily O 0 0.0007210925687104464
high O 0 0.00031409459188580513
level O 0 0.0003156141028739512
of O 0 0.0004599986132234335
somatic O 0 0.050651002675294876
mosaicism O 1 0.9998088479042053
, O 0 0.00034500937908887863
due O 0 0.00032029367866925895
to O 0 7.001651101745665e-05
an O 0 9.587706153979525e-05
extremely O 0 0.00020249190856702626
high O 0 0.00025579173234291375
degree O 0 0.0003310238244011998
of O 0 0.000581021886318922
somatic O 0 0.00802052952349186
instability O 0 0.012430409900844097
both O 0 0.00012606964446604252
within O 0 0.00016581491217948496
and O 0 0.000137200448079966
between O 0 0.000461117917438969
different O 0 0.00021032340009696782
tissues O 0 0.09350798279047012
. O 0 0.0010451886337250471

This O 0 0.002397211967036128
instability O 0 0.04223569110035896
appears O 0 0.0010499566560611129
to O 0 0.00014448024739976972
be O 0 7.216091034933925e-05
biased O 0 0.00021536975691560656
towards O 0 0.0004288857744541019
further O 0 0.00019490659178700298
expansion O 0 0.0006347200833261013
and O 0 8.666395297041163e-05
continuous O 0 0.00016885581135284156
throughout O 0 0.0001229846093337983
the O 0 0.00015886583423707634
life O 0 0.00016529412823729217
of O 0 0.00012136898294556886
an O 0 0.00010105753608513623
individual O 0 7.097946217982098e-05
, O 0 5.948341640760191e-05
features O 0 0.00010336160630686209
that O 0 3.407940675970167e-05
could O 0 6.909849616931751e-05
be O 0 3.102196569670923e-05
associated O 0 5.78518993279431e-05
with O 0 4.251168138580397e-05
the O 0 0.00023363431682810187
progressive O 0 0.11896689981222153
nature O 0 0.0011391687439754605
of O 0 0.0033871002960950136
the O 1 0.990530788898468
disease O 1 0.9999996423721313
. O 0 0.002239609370008111

Although O 0 0.0011913456255570054
increasing O 0 0.0009814692893996835
measured O 0 0.0006408401532098651
allele O 0 0.0004911522846668959
size O 0 0.0002517440007068217
between O 0 0.0004140395321883261
patients O 0 0.0003293206391390413
clearly O 0 0.0002462079864926636
correlates O 0 0.0005730963312089443
with O 0 7.442829519277439e-05
an O 0 0.00014460734382737428
increased O 0 0.00032766986987553537
severity O 0 0.00511265778914094
of O 0 0.04455088824033737
symptoms O 1 0.9999440908432007
and O 0 0.0004541024682112038
an O 0 0.00017663258768152446
earlier O 0 0.0003226837143301964
age O 0 0.00020419769862201065
of O 0 0.0006043948233127594
onset O 1 0.9999963045120239
, O 0 0.00023002547095529735
this O 0 8.322759094880894e-05
correlation O 0 0.0001292525266762823
is O 0 4.598684245138429e-05
not O 0 2.194574335590005e-05
precise O 0 9.667466656537727e-05
and O 0 0.00010463134094607085
measured O 0 0.0003027025959454477
allele O 0 0.00026836819597519934
length O 0 0.0001482512307120487
cannot O 0 8.527230966137722e-05
be O 0 1.99175610759994e-05
used O 0 5.353082451620139e-05
as O 0 5.745418093283661e-05
an O 0 4.680704296333715e-05
accurate O 0 0.00012297241482883692
predictor O 0 0.0009042071760632098
of O 0 0.000414861278841272
age O 0 0.0012118193553760648
of O 0 0.035024307668209076
onset O 1 0.9999994039535522
. O 0 0.006366193760186434

In O 0 0.0012027284828945994
order O 0 0.00029572698986157775
to O 0 9.913741087075323e-05
further O 0 0.0002075905358651653
characterize O 0 0.0010235162917524576
the O 0 0.0005147414049133658
dynamics O 0 0.0023931625764817
of O 0 0.012042632326483727
DM B-Disease 1 1.0
CTG O 1 0.9999955892562866
repeat O 0 0.4944261610507965
somatic O 0 0.044204529374837875
instability O 0 0.33111536502838135
, O 0 0.00021288775315042585
we O 0 9.494178084423766e-05
have O 0 2.1333411496016197e-05
studied O 0 0.0001261037978110835
repeat O 0 0.0004507534031290561
length O 0 8.636289567220956e-05
changes O 0 5.573478483711369e-05
over O 0 8.301041088998318e-05
time O 0 0.0001192410200019367
in O 0 0.0004623362037818879
111 O 1 0.9965469241142273
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9007982611656189
with O 0 0.0006475583650171757
varying O 0 0.0007489481358788908
clinical O 0 0.007856394164264202
severity O 1 0.9576811790466309
and O 0 0.0031238936353474855
CTG O 1 0.9998124241828918
repeat O 0 0.0012428765185177326
size O 0 0.00013024140207562596
over O 0 5.5432177759939805e-05
time O 0 3.065091368625872e-05
intervals O 0 5.5666208936600015e-05
of O 0 8.688405068824068e-05
1 O 0 0.00034171793959103525
- O 0 0.0008144539315253496
7 O 0 0.0007907210965640843
years O 0 0.000721717718988657
. O 0 0.0007742709713056684

We O 0 0.0008631825330667198
have O 0 8.556031389161944e-05
found O 0 5.702052658307366e-05
a O 0 0.00013508986739907414
direct O 0 0.00014063733397051692
progression O 0 0.0008199938456527889
of O 0 0.00020558317191898823
the O 0 0.0002586450718808919
size O 0 0.00027000531554222107
heterogeneity O 0 0.0004378168086986989
over O 0 0.00016350895748473704
time O 0 9.596257586963475e-05
related O 0 7.321964221773669e-05
to O 0 0.00011783129593823105
initial O 0 0.0005184671026654541
CTG O 1 0.8392463326454163
repeat O 0 0.0015205222880467772
size O 0 0.0002341329090995714
and O 0 7.721145811956376e-05
the O 0 0.00011879701924044639
time O 0 0.00010040926281362772
interval O 0 0.00028466686489991844
and O 0 0.00010007573291659355
always O 0 0.0001557894138386473
biased O 0 0.0003329431056044996
towards O 0 0.0006688533467240632
further O 0 0.000574437843170017
expansion O 0 0.0024048553314059973
. O 0 0.0009056078270077705

Attempts O 0 0.002415639581158757
to O 0 0.0005829819710925221
mathematically O 0 0.0006771354819647968
model O 0 0.00045259558828547597
the O 0 0.00033214889117516577
dynamics O 0 0.0013821324100717902
have O 0 0.00010799763549584895
proved O 0 0.0010439552133902907
only O 0 0.00015323504339903593
partially O 0 0.0010446864180266857
successful O 0 0.000389929540688172
suggesting O 0 0.00021466778707690537
that O 0 2.61851710092742e-05
individual O 0 2.6985740987583995e-05
specific O 0 3.900472802342847e-05
genetic O 0 0.00022347344201989472
and O 0 0.000682257057633251
/ O 1 0.9752126932144165
or O 0 0.0006862551090307534
environmental O 0 0.0008834055624902248
factors O 0 0.00019006252114195377
also O 0 9.187754767481238e-05
play O 0 0.00010188590385951102
a O 0 0.00018729243311099708
role O 0 0.000582648441195488
in O 0 0.0006516590947285295
somatic O 0 0.0552930124104023
mosaicism O 1 0.9998630285263062
. O 0 0.0008478197851218283
. O 0 0.001133852987550199

Aspartylglucosaminuria B-Disease 1 0.9999147653579712
among O 0 0.004132668953388929
Palestinian O 0 0.01797984354197979
Arabs O 0 0.015605363994836807
. O 0 0.002646681386977434

Aspartylglucosaminuria B-Disease 1 0.9999998807907104
( O 1 0.9915477633476257
AGU B-Disease 1 0.9999996423721313
) O 0 0.0009639963391236961
is O 0 0.0002705139631871134
a O 0 0.000576752470806241
rare O 0 0.01590288244187832
disorder B-Disease 1 0.9999996423721313
of I-Disease 1 0.9999226331710815
glycoprotein I-Disease 1 0.9999998807907104
metabolism I-Disease 1 0.999997615814209
caused O 1 0.9992475509643555
by O 0 0.00021172643755562603
the O 0 0.0006727075669914484
deficiency B-Disease 1 0.9999284744262695
of I-Disease 0 0.0016945645911619067
the I-Disease 0 0.0321228913962841
lysosomal I-Disease 1 0.9999916553497314
enzyme I-Disease 1 0.8927245140075684
aspartylglucosaminidase I-Disease 1 0.9999772310256958
( O 0 0.002792354905977845
AGA O 1 0.999453604221344
) O 0 0.0008414543117396533
. O 0 0.0008362018852494657

AGU B-Disease 1 0.9999990463256836
is O 0 0.003434104612097144
inherited O 1 0.997703492641449
as O 0 0.0016694043297320604
an O 0 0.001076373504474759
autosomal O 1 0.9170315265655518
recessive O 1 0.999893307685852
trait O 1 0.9983946681022644
and O 0 0.002210434293374419
occurs O 0 0.0003439999418333173
with O 0 6.298168591456488e-05
a O 0 0.00023447629064321518
high O 0 0.000389549823012203
frequency O 0 5.8994541177526116e-05
in O 0 2.9889522920711897e-05
Finland O 0 0.00016231564222835004
because O 0 4.537406493909657e-05
of O 0 0.0001380138419335708
a O 0 0.0007100735092535615
founder O 0 0.03383367136120796
effect O 0 0.0018751509487628937
. O 0 0.0010173289338126779

While O 0 0.002341445302590728
very O 0 0.0005169782089069486
few O 0 0.000554108468350023
patients O 0 0.0006131684640422463
with O 0 0.0005695698200725019
AGU B-Disease 1 0.9999997615814209
have O 0 0.0002075222582789138
been O 0 0.00015293319302145392
reported O 0 0.00011764538794523105
from O 0 0.00011612933303695172
non O 0 0.0003227095876354724
- O 0 0.0006128427921794355
Finnish O 0 0.0019354986725375056
origin O 0 0.00019029696704819798
, O 0 0.00011454681953182444
we O 0 0.00017951308109331876
diagnosed O 1 0.996698796749115
the O 0 0.004259595647454262
disorder O 1 0.9999995231628418
in O 0 0.006172182038426399
8 O 0 0.01429746299982071
patients O 0 0.00026371286367066205
originating O 0 0.0003657329361885786
from O 0 0.00014881831884849817
3 O 0 0.00023052783217281103
unrelated O 0 0.00020669918740168214
families O 0 5.178962601348758e-05
, O 0 3.3706157410051674e-05
all O 0 2.69332140305778e-05
Palestinian O 0 0.0003417452971916646
Arabs O 0 0.0003509086091071367
from O 0 0.0001006494858302176
the O 0 0.00014525270671583712
region O 0 0.0002962433500215411
of O 0 0.0006380912382155657
Jerusalem O 1 0.502818763256073
. O 0 0.0012072231620550156

The O 0 0.004020430613309145
clinical O 0 0.006700901780277491
diagnosis O 1 0.9868959784507751
of O 1 0.9996509552001953
AGU B-Disease 1 1.0
is O 0 0.0016440377803519368
often O 0 0.00015489828365389258
difficult O 0 0.00016107389819808304
, O 0 6.792462954763323e-05
in O 0 4.095936310477555e-05
particular O 0 5.0096361519536003e-05
early O 0 0.00011871686001541093
in O 0 5.899949246668257e-05
the O 0 0.00010955600009765476
course O 0 0.00024488288909196854
of O 0 0.0002823537215590477
the O 0 0.2797624170780182
disease O 1 0.9999996423721313
, O 0 0.00026990752667188644
and O 0 8.66622940520756e-05
most O 0 5.163408422959037e-05
of O 0 0.00017207319615408778
the O 0 0.0009315010975115001
patients O 0 0.0007818111917003989
are O 0 7.984475087141618e-05
diagnosed O 1 0.9980267882347107
after O 0 0.0005707447999157012
the O 0 0.0003189699200447649
age O 0 0.00037075774162076414
of O 0 0.0005588977364823222
5 O 0 0.0011767614632844925
years O 0 0.0010273815132677555
. O 0 0.0006779257673770189

However O 0 0.002443865640088916
, O 0 0.0005718577303923666
since O 0 0.0005240503815002739
these O 0 0.00013577844947576523
patients O 0 0.00043590349378064275
excrete O 0 0.002926552202552557
early O 0 0.0004965398111380637
large O 0 0.00022790527145843953
amounts O 0 0.00015986831567715853
of O 0 0.00030586461070925
aspartylglucosamine O 1 0.9480641484260559
in O 0 0.0003871656081173569
urine O 0 0.001164830639027059
, O 0 0.00014079124957788736
biochemical O 0 0.001083191018551588
screening O 0 0.00025916341110132635
is O 0 9.96952221612446e-05
easy O 0 0.00014853791799396276
by O 0 0.0001820467587094754
urine O 0 0.002122713951393962
chromatography O 0 0.12373615056276321
. O 0 0.00041895275353454053
. O 0 0.0006383692380040884

Detection O 0 0.004288945347070694
of O 0 0.000990751781500876
heterozygous O 0 0.0007831200491636992
carriers O 0 0.0003475655394140631
of O 0 0.0003564797225408256
the O 0 0.003618974471464753
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999773502349854
telangiectasia I-Disease 1 0.9999971389770508
( O 0 0.0049819340929389
ATM O 0 0.0072762672789394855
) O 0 0.00028529262635856867
gene O 0 0.0003049591032322496
by O 0 0.00025208070292137563
G2 O 1 0.9917104840278625
phase O 0 0.012884545139968395
chromosomal O 1 0.822067141532898
radiosensitivity O 1 0.9998358488082886
of O 1 0.9915589094161987
peripheral O 1 0.9999998807907104
blood O 1 0.999998927116394
lymphocytes O 1 0.9999480247497559
. O 0 0.001685066963545978

In O 0 0.012428021058440208
ataxia B-Disease 1 0.9999995231628418
- I-Disease 1 0.9998025298118591
telangiectasia I-Disease 1 0.9999988079071045
( O 0 0.41901180148124695
A B-Disease 1 0.999998927116394
- I-Disease 1 0.9999936819076538
T I-Disease 1 0.9999995231628418
) O 0 0.00036820259992964566
patients O 0 0.00023003379465080798
, O 0 7.836118311388418e-05
mutations O 0 9.663558739703149e-05
in O 0 8.11420104582794e-05
a O 0 0.00018812557391356677
single O 0 0.00022916951274964958
gene O 0 0.0002059787220787257
, O 0 0.00016722756845410913
ATM O 0 0.0017201554728671908
, O 0 0.00013038430188316852
result O 0 0.00013899418991059065
in O 0 0.0001672891085036099
an O 0 0.0011661474127322435
autosomal B-Disease 1 0.9999997615814209
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 1 0.6785343885421753
embraces O 0 0.448485404253006
a O 0 0.0006008408963680267
variety O 0 0.00021345990535337478
of O 0 0.0003634543973021209
clinical O 0 0.0012463731691241264
features O 0 0.0006773219793103635
and O 0 0.0004046184185426682
manifests O 0 0.005531079601496458
extreme O 1 0.7400562763214111
radiosensitivity O 1 0.9997966885566711
and O 0 0.00023215540568344295
a O 0 0.00029245545738376677
strong O 0 0.00038871626020409167
pre O 0 0.003091425634920597
- O 0 0.0021666947286576033
disposition O 0 0.006417382042855024
to O 0 0.0012489942600950599
malignancy B-Disease 1 0.9991480112075806
. O 0 0.0017792093567550182

Heterozygotes O 0 0.019885707646608353
for O 0 0.0006375425728037953
the O 0 0.0008135487441904843
ATM O 0 0.0043527185916900635
gene O 0 0.0002621773164719343
have O 0 3.796390228671953e-05
no O 0 7.59942049626261e-05
clinical O 0 0.0001515113253844902
expression O 0 0.00015034647367428988
of O 0 0.0007380394963547587
A B-Disease 1 0.9999985694885254
- I-Disease 1 0.9999940395355225
T I-Disease 1 0.9999992847442627
but O 0 0.00023638429411221296
may O 0 0.00022184070257935673
be O 0 0.00019374520343262702
cancer B-Disease 0 0.0699809342622757
prone O 0 0.0049116238951683044
with O 0 0.00012242543743923306
a O 0 0.00033271111897192895
moderate O 0 0.0010765284532681108
increase O 0 0.0001588328304933384
in O 0 0.0001670677011134103
in O 0 0.00034691873588599265
vitro O 0 0.003617706010118127
radiosensitivity O 1 0.8300100564956665
. O 0 0.0012519242009148002

We O 0 0.0013734473614022136
performed O 0 0.0016934064915403724
a O 0 0.0007248820038512349
blind O 0 0.0022022651974111795
chromosomal O 0 0.001751720323227346
analysis O 0 0.00025081110652536154
on O 0 0.0008786420221440494
G2 O 1 0.9998483657836914
- O 0 0.001981795998290181
phase O 0 0.002146890852600336
lymphocytes O 0 0.001375345280393958
from O 0 0.0001287905324716121
7 O 0 0.0005162061424925923
unrelated O 0 0.0016051509883254766
A B-Disease 1 0.9995612502098083
- I-Disease 1 0.9993688464164734
T I-Disease 1 0.9999872446060181
patients O 0 0.0004940154030919075
, O 0 0.00024415875668637455
13 O 0 0.0008456255891360343
obligate O 0 0.0030991854146122932
A B-Disease 1 0.9999028444290161
- I-Disease 1 0.9991384744644165
T I-Disease 1 0.9999880790710449
heterozygotes O 0 0.0074700843542814255
( O 0 0.0002991867368109524
parents O 0 5.998852429911494e-05
of O 0 0.0001637064851820469
the O 0 0.00047887160326354206
patients O 0 0.0004197662929072976
) O 0 8.031437755562365e-05
, O 0 6.39390418655239e-05
and O 0 8.870304009178653e-05
14 O 0 0.0002579188731033355
normal O 0 0.0001960702647920698
controls O 0 0.00018737369100563228
following O 0 0.00018486403860151768
X O 0 0.0006834860541857779
- O 0 0.0005126252654008567
irradiation O 0 0.0005179182626307011
with O 0 6.175781163619831e-05
1 O 0 0.0002807996061164886
Gy O 0 0.003774685552343726
in O 0 7.735325198154896e-05
order O 0 8.729147521080449e-05
to O 0 4.101561717106961e-05
evaluate O 0 0.0001336573768639937
this O 0 6.788913742639124e-05
cytogenetic O 0 0.0015676110051572323
method O 0 9.114758722716942e-05
as O 0 0.00015575761790387332
a O 0 0.00021656758326571435
tool O 0 0.0005476017249748111
for O 0 0.0001406638912158087
detection O 0 0.0006541371694765985
of O 0 0.0006912327953614295
ATM O 0 0.32428789138793945
carriers O 0 0.002649778500199318
. O 0 0.0008276776061393321

Both O 0 0.003965233452618122
A B-Disease 1 0.9995105266571045
- I-Disease 1 0.9990646243095398
T I-Disease 1 0.9999876022338867
homozygotes O 0 0.07369928061962128
and O 0 0.000613618060015142
heterozygotes O 0 0.004815030377358198
showed O 0 0.0007744568283669651
significantly O 0 0.0002749903069343418
increased O 0 0.00015795414219610393
levels O 0 0.00026891351444646716
of O 0 0.0005171127850189805
radiation O 1 0.9997065663337708
- O 0 0.1619909107685089
induced O 1 0.9937313199043274
chromatid O 1 0.999336302280426
damage O 1 0.5336127281188965
relative O 0 0.00038122941623441875
to O 0 7.839989848434925e-05
that O 0 5.5015716498019174e-05
of O 0 0.00026846263790503144
normal O 0 0.0005980665446259081
controls O 0 0.0009064425830729306
. O 0 0.0005775407189503312

These O 0 0.0004547028220258653
results O 0 0.00029131589690223336
show O 0 0.0003390320925973356
that O 0 5.835900446982123e-05
the O 0 0.000589792849496007
G2 O 1 0.9995730519294739
- O 0 0.002921719802543521
phase O 0 0.008032864890992641
chromosomal O 0 0.08158906549215317
radiosensitivity O 1 0.9984252452850342
assay O 0 0.0016710652271285653
can O 0 6.60444056848064e-05
be O 0 3.6561912565957755e-05
used O 0 3.50013178831432e-05
for O 0 2.9151580747566186e-05
the O 0 0.00012587553646881133
detection O 0 0.0004941190127283335
of O 0 0.0012969631934538484
A B-Disease 1 0.9999927282333374
- I-Disease 1 0.999943733215332
T I-Disease 1 0.9999902248382568
heterozygotes O 0 0.02711980603635311
. O 0 0.0013998388312757015

In O 0 0.001547953230328858
combination O 0 0.0008761740755289793
with O 0 0.000168428712640889
molecular O 0 0.00048113393131643534
genetic O 0 0.00014108690083958209
analyses O 0 0.00011842288222396746
, O 0 6.766195292584598e-05
this O 0 5.1305967645021155e-05
test O 0 9.577552555128932e-05
may O 0 6.0112273786216974e-05
be O 0 1.1115617780887987e-05
of O 0 3.668429053504951e-05
value O 0 3.487470530671999e-05
in O 0 3.329154060338624e-05
studies O 0 2.468982529535424e-05
of O 0 0.00016927365504670888
familial B-Disease 1 0.9624700546264648
and I-Disease 0 0.03730665519833565
sporadic I-Disease 1 0.9995434880256653
cancers I-Disease 1 0.9998996257781982
aimed O 0 0.0017761015333235264
at O 0 0.0007259456324391067
determination O 0 0.00028547359397634864
of O 0 0.00014077889500185847
the O 0 0.0001439087063772604
potential O 0 0.00020114181097596884
involvement O 0 0.000525960698723793
of O 0 0.0005772777367383242
ATM O 0 0.0750194787979126
mutations O 0 0.0005607439670711756
in O 0 0.0010071106953546405
tumor B-Disease 1 0.9999997615814209
risk O 0 0.011541316285729408
or O 0 0.0008916884544305503
development O 0 0.0014945496805012226
. O 0 0.00030131018138490617
. O 0 0.000509460165631026

Ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999237060546875
telangiectasia I-Disease 1 0.9999833106994629
: O 0 0.0008239052258431911
identification O 0 0.0002862732217181474
and O 0 0.00020339593174867332
detection O 0 0.000580163614358753
of O 0 0.0007333460380323231
founder O 1 0.9954172372817993
- O 0 0.0029835421591997147
effect O 0 0.0003736757207661867
mutations O 0 0.0001146439608419314
in O 0 8.310688281198964e-05
the O 0 0.00016852124826982617
ATM O 0 0.001705001574009657
gene O 0 0.0002066134475171566
in O 0 0.00013798395229969174
ethnic O 0 0.00031697313534095883
populations O 0 0.00047586311120539904
. O 0 0.0005126735777594149

To O 0 0.0010739455465227365
facilitate O 0 0.0014668648364022374
the O 0 0.0006677655619569123
evaluation O 0 0.0005465520080178976
of O 0 0.0008530575432814658
ATM O 0 0.021140243858098984
heterozygotes O 0 0.003644618671387434
for O 0 0.0002078783290926367
susceptibility O 0 0.0014618808636441827
to O 0 0.00031442870385944843
other O 0 0.00035867610131390393
diseases O 1 0.999995231628418
, O 0 0.0004961754893884063
such O 0 0.00031772555666975677
as O 1 0.9799260497093201
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999992847442627
, O 0 0.00046585092786699533
we O 0 6.302975089056417e-05
have O 0 2.3979517209227197e-05
attempted O 0 0.00020545833103824407
to O 0 6.0183800087543204e-05
define O 0 0.00014266699145082384
the O 0 0.0001799474994186312
most O 0 0.00010410248796688393
common O 0 0.00017996398673858494
mutations O 0 0.00015444523887708783
and O 0 9.139710164163262e-05
their O 0 6.716573261655867e-05
frequencies O 0 0.00020849845896009356
in O 0 0.0003473683027550578
ataxia B-Disease 1 0.9999983310699463
- I-Disease 1 0.9993484616279602
telangiectasia I-Disease 1 0.9999986886978149
( O 0 0.03355909883975983
A B-Disease 1 0.999990701675415
- I-Disease 1 0.9994828701019287
T I-Disease 1 0.9999246597290039
) O 0 0.0003558339085429907
homozygotes O 0 0.001782126841135323
from O 0 0.00023344592773355544
10 O 0 0.0002700017357710749
ethnic O 0 0.0005058601964265108
populations O 0 0.00036168156657367945
. O 0 0.0005471999174915254

Both O 0 0.0016019173199310899
genomic O 0 0.001291360822506249
mutations O 0 0.00035488486173562706
and O 0 0.00011451481987023726
their O 0 9.082681208383292e-05
effects O 0 0.0006436273106373847
on O 0 0.00045856807264499366
cDNA O 0 0.003885251469910145
were O 0 0.0008445940911769867
characterized O 0 0.003272655652835965
. O 0 0.0009312845068052411

Protein O 0 0.005173004698008299
- O 0 0.0021761793177574873
truncation O 0 0.003109060227870941
testing O 0 0.0002816772030200809
of O 0 0.00021191606356296688
the O 0 0.00035176007077097893
entire O 0 0.0011775038437917829
ATM O 0 0.0020045789424329996
cDNA O 0 0.0015391975175589323
detected O 0 0.0007266813772730529
92 O 0 0.000917489523999393
( O 0 0.00017683497571852058
66 O 0 0.0005878213560208678
% O 0 0.00016303661686833948
) O 0 0.00015176579472608864
truncating O 0 0.0017909979214891791
mutations O 0 0.00021060775907244533
in O 0 0.00020413812308106571
140 O 0 0.0015207270625978708
mutant O 0 0.003354673972353339
alleles O 0 0.0010096330661326647
screened O 0 0.0021534038241952658
. O 0 0.0007801729952916503

The O 0 0.004866503179073334
haplotyping O 1 0.9801443815231323
of O 0 0.0021968171931803226
patients O 0 0.0007083203527145088
with O 0 0.00015709571016486734
identical O 0 0.00043168620322830975
mutations O 0 0.00018908263882622123
indicates O 0 0.00021874872618354857
that O 0 2.7351394237484783e-05
almost O 0 4.600943429977633e-05
all O 0 2.021053842327092e-05
of O 0 6.115091673564166e-05
these O 0 2.32882648560917e-05
represent O 0 0.00011388779239496216
common O 0 0.00016579483053646982
ancestry O 0 0.00027262282674200833
and O 0 0.00017287986702285707
that O 0 7.846347580198199e-05
very O 0 0.00018510496011003852
few O 0 0.0004590434837155044
spontaneously O 0 0.005896834656596184
recurring O 1 0.7602882981300354
ATM O 0 0.4368061423301697
mutations O 0 0.0012967600487172604
exist O 0 0.000863001449033618
. O 0 0.0009768904419615865

Assays O 0 0.003999299835413694
requiring O 0 0.0009569250396452844
minimal O 0 0.0007505113608203828
amounts O 0 0.00026052226894535124
of O 0 0.0002795881300698966
genomic O 0 0.00041876197792589664
DNA O 0 0.00047660351265221834
were O 0 0.00013099795614834875
designed O 0 0.0002227465738542378
to O 0 7.102645031409338e-05
allow O 0 9.635862079448998e-05
rapid O 0 0.0008467835141345859
screening O 0 0.000243646718445234
for O 0 0.0001004256191663444
common O 0 0.0002176770067308098
ethnic O 0 0.0006614234298467636
mutations O 0 0.0015816898085176945
. O 0 0.0011568850604817271

These O 0 0.0008757450268603861
rapid O 0 0.0031897027511149645
assays O 0 0.0012033586390316486
detected O 0 0.0006894494872540236
mutations O 0 0.00010751654917839915
in O 0 7.493077282560989e-05
76 O 0 0.00031118077458813787
% O 0 6.867585034342483e-05
of O 0 0.00016343135212082416
Costa O 0 0.0007180454558692873
Rican O 0 0.0024775781203061342
patients O 0 0.0002503328141756356
( O 0 0.0001229316258104518
3 O 0 0.0002209905651398003
) O 0 4.554213228402659e-05
, O 0 3.030194784514606e-05
50 O 0 4.6054738049861044e-05
% O 0 2.86475242319284e-05
of O 0 0.0001222864812007174
Norwegian O 0 0.0010043111396953464
patients O 0 0.0002272931014886126
( O 0 0.0001405227230861783
1 O 0 0.00017411180306226015
) O 0 3.6177487345412374e-05
, O 0 2.7701571525540203e-05
25 O 0 8.450829773209989e-05
% O 0 3.301883043604903e-05
of O 0 0.00018195337906945497
Polish O 1 0.9964375495910645
patients O 0 0.0015414298977702856
( O 0 0.0003553137357812375
4 O 0 0.0004195478686597198
) O 0 7.236163219204172e-05
, O 0 6.155391747597605e-05
and O 0 4.355868441052735e-05
14 O 0 0.00015507504576817155
% O 0 6.798761751269922e-05
of O 0 0.00019643158884719014
Italian O 0 0.006843718700110912
patients O 0 0.0009598717442713678
( O 0 0.000292865646770224
1 O 0 0.0004545058764051646
) O 0 6.177059549372643e-05
, O 0 4.8835514462552965e-05
as O 0 6.757870869478211e-05
well O 0 4.438579344423488e-05
as O 0 9.384885197505355e-05
in O 0 0.00013554545876104385
patients O 0 0.00018919048306997865
of O 0 0.0006371857016347349
Amish O 1 0.9642989039421082
/ O 0 0.024881212040781975
Mennonite O 0 0.01166739221662283
and O 0 0.00049929681699723
Irish O 0 0.0017774139996618032
English O 0 0.0008898900123313069
backgrounds O 0 0.000842601410113275
. O 0 0.0007772938115522265

Additional O 0 0.002076299162581563
mutations O 0 0.0005735261947847903
were O 0 0.00014516465307679027
observed O 0 0.00011152283695992082
in O 0 8.22702786535956e-05
Japanese O 0 0.000940149009693414
, O 0 0.00016518069605808705
Utah O 0 0.0022935103625059128
Mormon O 0 0.00214201956987381
, O 0 0.0002168111823266372
and O 0 0.0002179318107664585
African O 0 0.0016863018972799182
American O 0 0.008492146618664265
patients O 0 0.002528546843677759
. O 0 0.0011247601360082626

These O 0 0.0007481228094547987
assays O 0 0.0009512541582807899
should O 0 0.00013797263090964407
facilitate O 0 0.00031032931292429566
screening O 0 0.000223240684135817
for O 0 0.00017377728363499045
A B-Disease 1 0.9971255660057068
- I-Disease 1 0.9781996607780457
T I-Disease 1 0.9996956586837769
heterozygotes O 0 0.002407808555290103
in O 0 0.0001811791880754754
the O 0 0.000230621692026034
populations O 0 0.00010984994878526777
studied O 0 0.00034169157152064145
. O 0 0.00019401917234063148
. O 0 0.00043974898289889097

The O 0 0.005743723828345537
von B-Disease 1 0.8192288279533386
Hippel I-Disease 1 0.9998278617858887
- I-Disease 1 0.9965224266052246
Lindau I-Disease 1 0.9999661445617676
tumor I-Disease 1 0.999994158744812
suppressor O 1 0.8259709477424622
gene O 0 0.0004681305435951799
is O 0 0.00011845405970234424
required O 0 6.210566789377481e-05
for O 0 8.871285535860807e-05
cell O 0 0.000693180481903255
cycle O 0 0.0007043881341814995
exit O 0 0.0012891979422420263
upon O 0 0.001260104589164257
serum O 0 0.04164344444870949
withdrawal O 0 0.00793074257671833
. O 0 0.0012027949560433626

The O 0 0.0029149428009986877
inactivation O 0 0.007580490782856941
of O 0 0.0010353862307965755
the O 0 0.001526055857539177
von B-Disease 1 0.9402496218681335
Hippel I-Disease 1 0.9998629093170166
- I-Disease 1 0.9041376113891602
Lindau I-Disease 1 0.9995023012161255
( I-Disease 0 0.005962679162621498
VHL I-Disease 1 0.9999963045120239
) I-Disease 0 0.0029279578011482954
tumor I-Disease 1 0.9999771118164062
suppressor O 1 0.9979867935180664
gene O 0 0.0014253067784011364
predisposes O 1 0.5792615413665771
affected O 0 0.0005458179512061179
individuals O 0 5.2499002777040005e-05
to O 0 0.0001854823640314862
the O 0 0.002783107338473201
human O 1 0.9999667406082153
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 1 0.6960368752479553
is O 0 0.0008517067763023078
associated O 0 0.000662660168018192
with O 0 0.0009743307018652558
sporadic B-Disease 1 0.9999841451644897
renal I-Disease 1 1.0
cell I-Disease 1 1.0
carcinomas I-Disease 1 1.0
( O 1 0.9999871253967285
RCC B-Disease 1 1.0
) O 0 0.004175263457000256
and O 0 0.0021920788567513227
brain B-Disease 1 0.9999059438705444
hemangioblastomas I-Disease 1 0.9999254941940308
. O 0 0.0024089014623314142

VHL O 1 0.9967026114463806
- O 0 0.010828853584825993
negative O 0 0.001606989186257124
786 O 0 0.16460588574409485
- O 0 0.010871636681258678
0 O 0 0.004652748350054026
RCC B-Disease 1 0.999998927116394
cells O 0 0.0027727249544113874
are O 0 0.00013524567475542426
tumorigenic O 0 0.2658472955226898
in O 0 0.0006583231152035296
nude O 0 0.247646301984787
mice O 0 0.0016711861826479435
which O 0 9.619042975828052e-05
is O 0 8.146065374603495e-05
suppressed O 0 0.0007991551537998021
by O 0 8.309895929414779e-05
the O 0 0.00031264356221072376
reintroduction O 0 0.004665786866098642
of O 0 0.0021280180662870407
VHL B-Disease 1 0.9999821186065674
. O 0 0.003192894160747528

Remarkably O 0 0.01699211075901985
, O 0 0.000849530566483736
this O 0 0.0002743712393566966
occurs O 0 0.00041058327769860625
without O 0 0.00011726099910447374
affecting O 0 0.00037903839256614447
the O 0 0.00036628893576562405
growth O 0 0.0006155269220471382
rate O 0 0.00013059894263278693
and O 0 0.0001309608487645164
cell O 0 0.0004331160744186491
cycle O 0 0.0006397353135980666
profile O 0 0.0001954235485754907
of O 0 0.00022809897200204432
these O 0 0.000123908874229528
cells O 0 0.00045779504580423236
in O 0 0.00038694756221957505
culture O 0 0.0012294802581891418
. O 0 0.0005140241701155901

The O 0 0.004292599856853485
786 O 0 0.027608167380094528
- O 0 0.0025146144907921553
0 O 0 0.0008853863109834492
cell O 0 0.0010704410960897803
line O 0 0.0007228025933727622
, O 0 0.0001679886190686375
like O 0 0.0003452375531196594
many O 0 0.00036474334774538875
cancer B-Disease 1 0.9999566078186035
cells O 0 0.024783851578831673
, O 0 0.00018768946756608784
fails O 0 0.0004572673060465604
to O 0 8.755775343161076e-05
exit O 0 0.0005656262510456145
the O 0 0.0004937275662086904
cell O 0 0.0015065351035445929
cycle O 0 0.001442010048776865
upon O 0 0.0012589492835104465
serum O 0 0.11742784827947617
withdrawal O 0 0.00931455660611391
. O 0 0.0008911033510230482

Here O 0 0.0023439996875822544
, O 0 0.00037182524101808667
it O 0 8.94198237801902e-05
is O 0 7.669031765544787e-05
shown O 0 7.80939735705033e-05
that O 0 3.290008316980675e-05
reintroduction O 0 0.0005087793688289821
of O 0 0.00015561480540782213
the O 0 0.00034355962998233736
wild O 0 0.0010342637542635202
- O 0 0.0012809851905331016
type O 0 0.0013377052964642644
VHL B-Disease 1 0.9994220733642578
gene O 0 0.0005353042506612837
restores O 0 0.002182485768571496
the O 0 0.00022894849826116115
ability O 0 0.00015870382776483893
of O 0 0.0007814036798663437
VHL O 1 0.9999997615814209
- O 1 0.9991689920425415
negative O 0 0.01977132074534893
RCC B-Disease 1 1.0
cancer I-Disease 1 0.9998959302902222
cells O 0 0.0007399612804874778
to O 0 0.000187768237083219
exit O 0 0.0006784655270166695
the O 0 0.00037122968933545053
cell O 0 0.0012392675271257758
cycle O 0 0.0010974998585879803
and O 0 0.0002285711670992896
enter O 0 0.0014750760747119784
G0 O 1 0.9991443157196045
/ O 0 0.006034552119672298
quiescence O 0 0.008532301522791386
in O 0 0.0007280133431777358
low O 0 0.0016988808056339622
serum O 0 0.012148668989539146
. O 0 0.0009613228030502796

Both O 0 0.005643781274557114
VHL O 1 0.9999597072601318
- O 0 0.006073076277971268
positive O 0 0.0007258881814777851
and O 0 0.0005946439923718572
VHL O 1 0.9999936819076538
- O 0 0.16673226654529572
negative O 0 0.0013945583486929536
RCC B-Disease 1 0.9999977350234985
cells O 0 0.0009426019387319684
exit O 0 0.0006142532220110297
the O 0 0.0003607939288485795
cell O 0 0.0009386525489389896
cycle O 0 0.0012190405977889895
by O 0 0.00026363114011473954
contact O 0 0.0012982015032321215
inhibition O 0 0.005012859124690294
. O 0 0.0013770124642178416

The O 0 0.005320051684975624
cyclin O 0 0.014859403483569622
- O 0 0.0030750599689781666
dependent O 0 0.0008060290711000562
kinase O 0 0.003130513010546565
inhibitor O 0 0.017440082505345345
, O 0 0.0007843646453693509
p27 O 0 0.17545992136001587
, O 0 0.00035667585325427353
accumulates O 0 0.0026212178636342287
upon O 0 0.0008237961446866393
serum O 0 0.020956045016646385
withdrawal O 0 0.0015137223526835442
, O 0 8.292748680105433e-05
only O 0 2.3383692678180523e-05
in O 0 3.27768902934622e-05
the O 0 8.525278826709837e-05
presence O 0 0.00026285459171049297
of O 0 0.00047189672477543354
VHL B-Disease 1 0.9999995231628418
, O 0 0.00031191445305012167
as O 0 0.00010284975724061951
a O 0 7.664060831302777e-05
result O 0 7.080368959577754e-05
of O 0 9.180967754218727e-05
the O 0 0.00020157149992883205
stabilization O 0 0.0012406128225848079
of O 0 0.0005157988634891808
the O 0 0.000981622957624495
protein O 0 0.0010238921968266368
. O 0 0.0005942737334407866

We O 0 0.0008029481396079063
propose O 0 0.00043623620877042413
that O 0 5.421781315817498e-05
the O 0 0.00013299804413691163
loss O 0 0.0003905111807398498
of O 0 0.00030864423024468124
wild O 0 0.0014494078932330012
- O 0 0.0020494956988841295
type O 0 0.0016744823660701513
VHL B-Disease 1 0.9999133348464966
gene O 0 0.0002138545096386224
results O 0 5.283561040414497e-05
in O 0 2.8871816539322026e-05
a O 0 0.00011447486758697778
specific O 0 0.00013366960047278553
cellular O 0 0.0026565769221633673
defect O 1 0.999496340751648
in O 0 0.00144569028634578
serum O 1 0.9976504445075989
- O 0 0.0021391913760453463
dependent O 0 0.00025290739722549915
growth O 0 0.0002145084145013243
control O 0 0.00018774102500174195
, O 0 0.00010202512930845842
which O 0 0.00011117161193396896
may O 0 0.0003971152473241091
initiate O 0 0.0052497792057693005
tumor B-Disease 1 0.999988317489624
formation O 1 0.998995840549469
. O 0 0.0019005239009857178

This O 0 0.0008781804936006665
is O 0 0.00047194998478516936
corrected O 0 0.001523710205219686
by O 0 9.654404129832983e-05
the O 0 0.00016666055307723582
reintroduction O 0 0.0012550151441246271
of O 0 0.00036459750845097005
wild O 0 0.0014245794154703617
- O 0 0.003651045262813568
type O 0 0.003128094132989645
VHL B-Disease 1 0.9999898672103882
, O 0 0.0010342095047235489
implicating O 1 0.9978887438774109
VHL B-Disease 1 0.9999631643295288
as O 0 0.0005712339770980179
the O 0 0.0003397469990886748
first O 0 0.0010420067701488733
tumor B-Disease 1 0.99969482421875
suppressor O 0 0.013583753257989883
involved O 0 0.00031102891080081463
in O 0 9.186956594930962e-05
the O 0 0.0001075528489309363
regulation O 0 0.0001492033916292712
of O 0 0.00022788310889154673
cell O 0 0.001157888793386519
cycle O 0 0.0014710782561451197
exit O 0 0.0007641889387741685
, O 0 8.36928520584479e-05
which O 0 5.169537689653225e-05
is O 0 4.2694668081821874e-05
consistent O 0 7.268821354955435e-05
with O 0 4.181241456535645e-05
its O 0 0.00013746680633630604
gatekeeper O 0 0.028773818165063858
function O 0 0.00022251710470300168
in O 0 0.00027453553047962487
the O 0 0.0026382238138467073
kidney O 1 0.9999995231628418
. O 0 0.0008725299849174917
. O 0 0.001161658321507275

Piebaldism B-Disease 1 0.9999964237213135
with O 0 0.21476587653160095
deafness B-Disease 1 1.0
: O 0 0.0018884364981204271
molecular O 0 0.0006667556590400636
evidence O 0 0.0003002425655722618
for O 0 0.0001400944747729227
an O 0 0.0004108659632038325
expanded O 0 0.10610934346914291
syndrome O 1 0.9999997615814209
. O 0 0.0023950624745339155

In O 0 0.0012139953905716538
a O 0 0.0008891911711543798
South O 0 0.0013990385923534632
African O 0 0.0013780973386019468
girl O 0 0.002027359325438738
of O 0 0.0010035401210188866
Xhosa O 1 0.9987597465515137
stock O 0 0.003284424776211381
with O 0 0.000941110251005739
severe O 1 0.9999996423721313
piebaldism B-Disease 1 1.0
and O 1 0.9999351501464844
profound O 1 1.0
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 1 0.9548872113227844
identified O 0 0.0006094362470321357
a O 0 0.0002714106813073158
novel O 0 0.0004055689205415547
missense O 0 0.0008539711125195026
substitution O 0 0.0006615439197048545
at O 0 0.0003596605092752725
a O 0 0.00013703922741115093
highly O 0 0.0002188667858717963
conserved O 0 0.00022572626767214388
residue O 0 0.0007565481937490404
in O 0 0.0001308936916757375
the O 0 0.00023885921109467745
intracellular O 0 0.0008770448039285839
kinase O 0 0.000382112106308341
domain O 0 0.00016199499077629298
of O 0 0.00028609420405700803
the O 0 0.0010254336521029472
KIT O 1 0.9975842237472534
proto O 1 0.998099148273468
- O 0 0.11233330518007278
oncogene O 1 0.972590982913971
, O 0 0.0019434624118730426
R796G O 1 0.7678715586662292
. O 0 0.001994463847950101

Though O 0 0.008093769662082195
auditory B-Disease 1 0.9462469816207886
anomalies I-Disease 0 0.07419578731060028
have O 0 0.0002465556317474693
been O 0 0.0001779905433068052
observed O 0 0.00017618869605939835
in O 0 0.0001807099033612758
mice O 0 0.0004015752056147903
with O 0 0.00010169236338697374
dominant O 0 0.002679242054000497
white O 0 0.006395855452865362
spotting O 1 0.9910997748374939
( O 0 0.0025237444788217545
W O 1 0.954010009765625
) O 0 0.0002856954815797508
due O 0 0.0005044364370405674
to O 0 0.0005100205889903009
KIT O 1 0.9992801547050476
mutations O 0 0.0026467065326869488
, O 0 0.0014968158211559057
deafness B-Disease 1 1.0
is O 0 0.0007406646618619561
not O 0 0.00011835289478767663
typical O 0 0.0005484787980094552
in O 0 0.0003710920282173902
human O 0 0.0014092896599322557
piebaldism B-Disease 1 0.999622106552124
. O 0 0.0014132902724668384

Thus O 0 0.0024950539227575064
, O 0 0.0004206489829812199
the O 0 0.0005108314799144864
occurrence O 0 0.0020657344721257687
of O 0 0.03340926766395569
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 0 0.38089412450790405
this O 0 0.00039759554783813655
patient O 0 0.0005475006764754653
extends O 0 0.0005577258998528123
considerably O 0 0.0002650184615049511
the O 0 0.00010182335245190188
phenotypic O 0 0.00038926565321162343
range O 0 0.00014998707047197968
of O 0 0.00030567136127501726
piebaldism B-Disease 1 0.9038375020027161
due O 0 0.0007593419868499041
to O 0 0.00030067653278820217
KIT O 0 0.2824017405509949
gene O 0 0.00033344372059218585
mutation O 0 0.00021471177751664072
in O 0 0.00014939927496016026
humans O 0 0.00022905551304575056
and O 0 0.00011048067244701087
tightens O 0 0.0009557159501127899
the O 0 0.00020588938787113875
clinical O 0 0.0003834838280454278
similarity O 0 0.0005505922017619014
between O 0 0.0013858138117939234
piebaldism B-Disease 1 0.9997571110725403
and O 0 0.0002474434731993824
the O 0 0.00029318718588910997
various O 0 0.00023845778196118772
forms O 0 0.0008976711542345583
of O 1 0.999813973903656
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.2642442286014557
. O 0 0.002772316336631775

Cycloheximide O 1 0.8523545265197754
facilitates O 0 0.003272282425314188
the O 0 0.0005207867361605167
identification O 0 0.00036899602855555713
of O 0 0.0005568953929468989
aberrant O 0 0.005474532023072243
transcripts O 0 0.0011656597489491105
resulting O 0 0.0004832629638258368
from O 0 0.00012624119699466974
a O 0 0.00018397707026451826
novel O 0 0.0003740610263776034
splice O 0 0.002145118312910199
- O 0 0.0007121527451090515
site O 0 0.00044984533451497555
mutation O 0 0.00015641041682101786
in O 0 0.00016856094589456916
COL17A1 O 1 0.9992703795433044
in O 0 0.0003756397927645594
a O 0 0.0005769552662968636
patient O 0 0.001781356637366116
with O 0 0.0011335689341649413
generalized O 1 0.9998531341552734
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999985694885254
. O 0 0.007561501115560532

Patients O 0 0.02952912077307701
with O 0 0.004011279903352261
generalized O 1 0.9999314546585083
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999980926513672
often O 0 0.0010444624349474907
show O 0 0.0011306324740871787
decreased O 0 0.0009888140484690666
expression O 0 0.00018550535605754703
of O 0 0.0004731831431854516
type O 1 0.8645444512367249
XVII O 1 1.0
collagen O 1 0.9999969005584717
, O 0 0.00048576106200926006
a O 0 0.0006003188900649548
transmembrane O 0 0.0033689250703901052
hemidesmosomal O 0 0.02488754689693451
protein O 0 0.0009671268635429442
encoded O 0 0.00040449213702231646
by O 0 0.0003805748710874468
COL17A1 O 1 0.9976087808609009
. O 0 0.002167639322578907

This O 0 0.0007831398397684097
report O 0 0.00033925779280252755
documents O 0 0.00023777058231644332
a O 0 0.00030583899933844805
novel O 0 0.0008522499119862914
splice O 0 0.003858397249132395
- O 0 0.0012788117164745927
site O 0 0.0011044993298128247
mutation O 0 0.0003681887174025178
in O 0 0.0003090997925028205
COL17A1 O 1 0.9990435242652893
in O 0 0.0006092265248298645
a O 0 0.0007563477265648544
patient O 0 0.0014071868499740958
with O 0 0.0010258420370519161
generalized O 1 0.9999178647994995
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999997615814209
, O 0 0.0010657674865797162
and O 0 0.00022009434178471565
applies O 0 0.00013068466796539724
a O 0 0.00014727565576322377
new O 0 0.0001364135678159073
methodology O 0 0.00023497534857597202
to O 0 9.718442743178457e-05
define O 0 0.0003571656998246908
and O 0 0.00019469557446427643
characterize O 0 0.001820949139073491
the O 0 0.0009192423312924802
resulting O 0 0.0011724196374416351
mRNA O 0 0.0011186896590515971
splice O 0 0.005171164404600859
variants O 0 0.0013948968844488263
. O 0 0.0006870001088827848

Mutational O 0 0.022838013246655464
analysis O 0 0.0004248080658726394
of O 0 0.0009025519830174744
COL17A1 O 1 0.9999192953109741
identified O 0 0.0010269255144521594
a O 0 0.0007430171244777739
maternally O 0 0.006060246843844652
inherited O 1 0.9655471444129944
G O 0 0.49567440152168274
- O 0 0.002279699081555009
to O 0 0.0005934201180934906
- O 0 0.0027534160763025284
T O 0 0.010196620598435402
transversion O 0 0.013581465929746628
at O 0 0.0005433259648270905
the O 0 0.0001563108089612797
- O 0 0.0002105116145685315
1 O 0 0.00013320923608262092
position O 0 0.00017283075430896133
of O 0 0.00025950392591767013
exon O 0 0.003246336942538619
32 O 0 0.0013591081369668245
. O 0 0.0008412086172029376

This O 0 0.0011316356249153614
acceptor O 0 0.0026771046686917543
splice O 0 0.008890603668987751
- O 0 0.002570633077993989
site O 0 0.0009024014580063522
mutation O 0 0.00027207055245526135
led O 0 0.0003447129565756768
to O 0 8.157375850714743e-05
the O 0 0.00020646399934776127
formation O 0 0.0014929218450561166
of O 0 0.000693018373567611
aberrant O 0 0.0073825158178806305
transcripts O 0 0.0008623365429230034
present O 0 0.00038748609949834645
at O 0 0.0009150202968157828
extremely O 0 0.0008727317326702178
low O 0 0.000929393689148128
levels O 0 0.0010176518699154258
. O 0 0.0005484609864652157

Based O 0 0.0008253962732851505
on O 0 0.0004210260813124478
our O 0 0.00038871922879479825
recent O 0 0.000274994526989758
finding O 0 0.00030109932413324714
that O 0 0.0002404385304544121
cycloheximide O 1 0.9970121383666992
stabilized O 1 0.9687888622283936
mutant O 0 0.02474067732691765
COL17A1 O 1 0.9996553659439087
transcripts O 0 0.0026036060880869627
in O 0 0.0004956542979925871
keratinocytes O 0 0.0037044903729110956
homozygous O 0 0.0006185589008964598
for O 0 8.279616304207593e-05
a O 0 0.0002795809123199433
frameshift O 0 0.006138682831078768
mutation O 0 0.0002562252338975668
, O 0 7.975495827849954e-05
the O 0 0.00015041528968140483
effects O 0 0.00035066885175183415
of O 0 0.0002619342121761292
the O 0 0.0006567827076651156
splice O 0 0.008273988962173462
- O 0 0.0010290134232491255
site O 0 0.0005140238790772855
mutation O 0 0.00010667007154552266
on O 0 0.00011284460197202861
splicing O 0 0.0005371417501010001
of O 0 0.00041214065277017653
COL17A1 O 1 0.9995253086090088
transcripts O 0 0.0011140672722831368
were O 0 0.00019286897440906614
determined O 0 0.00010965758701786399
using O 0 9.763958951225504e-05
reverse O 0 0.000637729826848954
transcriptase O 0 0.0016065018717199564
polymerase O 0 0.001094825565814972
chain O 0 0.0004521203809417784
reaction O 0 0.00018051115330308676
of O 0 0.00010948580893455073
total O 0 0.00015159338363446295
RNA O 0 0.00037990481359884143
from O 0 0.0001760464656399563
keratinocytes O 0 0.0023855925537645817
incubated O 0 0.0009384328732267022
for O 0 0.00015247233386617154
2 O 0 0.00094534334493801
. O 0 0.0006695351912640035

5 O 0 0.002755294321104884
h O 0 0.001688281074166298
in O 0 0.00014660172746516764
the O 0 0.00020367151591926813
presence O 0 0.00035919828223995864
or O 0 0.00013019621837884188
absence O 0 0.0006234937463887036
of O 0 0.0006483006291091442
10 O 0 0.0015133735723793507
microg O 1 0.9950522780418396
cycloheximide O 1 0.9898764491081238
per O 0 0.0016958710039034486
ml O 0 0.008030402474105358
. O 0 0.0009289511945098639

Using O 0 0.0006514742854051292
this O 0 0.0001787606452126056
approach O 0 0.00032837598701007664
, O 0 0.00013099319767206907
an O 0 0.00022589118452742696
abnormally O 0 0.0024619598407298326
spliced O 0 0.0015164694050326943
transcript O 0 0.0008982821018435061
was O 0 0.0003088488010689616
identified O 0 5.431276804301888e-05
that O 0 1.4928526979929302e-05
contains O 0 3.6577050195774063e-05
an O 0 3.654469037428498e-05
extra O 0 0.00010497212497284636
264 O 0 0.00036544117028824985
bases O 0 0.00033401447581127286
upstream O 0 0.00046290108002722263
from O 0 0.00012258210335858166
exon O 0 0.0008481789263896644
32 O 0 0.00025948017719201744
, O 0 8.317855827044696e-05
resulting O 0 0.00021457673574332148
in O 0 0.00013028414105065167
a O 0 0.0003797166864387691
premature O 0 0.0022225629072636366
termination O 0 0.002022738568484783
codon O 0 0.0016121615190058947
27 O 0 0.0012568429810926318
bp O 0 0.002323681954294443
downstream O 0 0.0008879453525878489
from O 0 0.0001605302095413208
the O 0 0.00040804859600029886
cryptic O 0 0.002702204044908285
splice O 0 0.007523420266807079
site O 0 0.004223911091685295
. O 0 0.0016243475256487727

Three O 0 0.0008956343517638743
other O 0 0.00030533524113707244
splice O 0 0.003919702023267746
variants O 0 0.0006502194446511567
, O 0 0.00016606174176558852
including O 0 7.857302261982113e-05
one O 0 6.29747228231281e-05
derived O 0 8.344263187609613e-05
from O 0 7.973518222570419e-05
the O 0 0.00011788660049205646
skipping O 0 0.000727888778783381
of O 0 0.0003656382905319333
exon O 0 0.0019850486423820257
32 O 0 0.00041278827120549977
, O 0 0.00016166815476026386
were O 0 0.00014881235256325454
also O 0 0.000273880927124992
identified O 0 0.0008448347798548639
. O 0 0.0006139989127404988

These O 0 0.0006080704042688012
results O 0 0.0002837602514773607
indicate O 0 0.0002695374714676291
the O 0 0.00027703234809450805
usefulness O 0 0.0012313512852415442
of O 0 0.0008262954070232809
cycloheximide O 1 0.999880313873291
treatment O 0 0.0033620158210396767
in O 0 0.00022594504116568714
evaluating O 0 0.00031791042420081794
the O 0 0.00028745364397764206
abnormal O 0 0.001203480176627636
processing O 0 0.0004851100384257734
of O 0 0.00031331280479207635
mRNA O 0 0.0004022246284876019
due O 0 0.00015938081196509302
to O 0 7.048618863336742e-05
splice O 0 0.001582925207912922
- O 0 0.0006785262376070023
site O 0 0.0004482525691855699
mutations O 0 0.00013605527055915445
, O 0 9.537934238323942e-05
because O 0 9.928528743330389e-05
( O 0 0.00023983842402230948
i O 0 0.0005260835750959814
) O 0 0.0002234896383015439
aberrant O 0 0.0019457910675555468
splicing O 0 0.0006519258604384959
often O 0 9.419618436368182e-05
generates O 0 0.0002527996548451483
a O 0 0.00033639767207205296
premature O 0 0.0021094470284879208
termination O 0 0.0021550231613218784
codon O 0 0.0017035453347489238
, O 0 0.00032256191479973495
( O 0 0.00038238154957070947
ii O 0 0.061080172657966614
) O 0 0.0001795601419871673
transcripts O 0 0.00044968241127207875
with O 0 0.00013930851127952337
premature O 0 0.0021912280935794115
termination O 0 0.0016440550098195672
codons O 0 0.0008041783003136516
can O 0 4.996019561076537e-05
occur O 0 0.00012737661018036306
at O 0 0.0005376293556764722
low O 0 0.0005683003691956401
or O 0 0.000355724710971117
undetectable O 0 0.011023624800145626
levels O 0 0.000644056242890656
due O 0 0.0002929873880930245
to O 0 0.00012138958118157461
nonsense O 0 0.0025521195493638515
- O 0 0.001019901130348444
mediated O 0 0.0014773125294595957
mRNA O 0 0.000846750452183187
decay O 0 0.0017219529254361987
, O 0 0.00011220168380532414
and O 0 0.0001013578730635345
( O 0 0.0002391116868238896
iii O 0 0.006527886725962162
) O 0 0.00014623509196098894
the O 0 0.00015627594257239252
levels O 0 0.00015425714082084596
of O 0 6.892042438266799e-05
these O 0 2.5989282221416943e-05
transcripts O 0 0.0003824240411631763
can O 0 3.5839315387420356e-05
be O 0 4.908614937448874e-05
increased O 0 0.00018408412870485336
by O 0 0.000240273293456994
cycloheximide O 1 0.6203073263168335
. O 0 0.0013804933987557888

A O 0 0.007416916079819202
deletion O 0 0.004398285876959562
mutation O 0 0.0006268387078307569
in O 0 0.00040687588625587523
COL17A1 O 1 0.9992159605026245
in O 0 0.0003317355876788497
five O 0 0.0002963416336569935
Austrian O 0 0.002522416179999709
families O 0 0.00042733701411634684
with O 0 0.0007897688774392009
generalized O 1 0.9995368719100952
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999899864196777
represents O 0 0.0067090438678860664
propagation O 0 0.0024333770852535963
of O 0 0.0007035029120743275
an O 0 0.0006840112037025392
ancestral O 0 0.04383751377463341
allele O 0 0.0033268185798078775
. O 0 0.0011660029413178563

Patients O 0 0.01917438395321369
with O 0 0.0033477938268333673
generalized O 1 0.9996960163116455
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.999998927116394
, O 0 0.0014276336878538132
a O 0 0.000960639794357121
usually O 0 0.00028789605130441487
nonlethal O 0 0.0030342356767505407
form O 0 0.000905418477486819
of O 0 0.002462720964103937
junctional B-Disease 1 0.999998927116394
epidermolysis I-Disease 1 0.9999997615814209
bullosa I-Disease 1 0.9999920129776001
, O 0 0.0009194354061037302
have O 0 0.00019309419440105557
generalized O 0 0.0022435530554503202
blistering B-Disease 1 0.9999116659164429
, O 0 0.18523009121418
nail B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 1 0.998634397983551
patchy B-Disease 1 0.9999996423721313
alopecia I-Disease 1 1.0
, O 1 0.9990251064300537
and O 1 0.9971091151237488
dental B-Disease 1 1.0
abnormalities I-Disease 1 1.0
. O 0 0.07472896575927734

Skin B-Disease 1 0.9999953508377075
fragility I-Disease 1 0.9999815225601196
in O 0 0.0011245902860537171
most O 0 0.00019122881349176168
cases O 0 0.0001345983037026599
is O 0 9.067622886504978e-05
due O 0 0.00017464204574935138
to O 0 6.90267188474536e-05
mutations O 0 8.235552377300337e-05
in O 0 8.035483187995851e-05
the O 0 0.00020031614985782653
gene O 0 0.00017760029004421085
encoding O 0 0.0003024475590791553
type O 0 0.02087293565273285
XVII O 1 1.0
collagen O 1 1.0
( O 1 0.6741302013397217
COL17A1 O 1 0.999992847442627
) O 0 0.0012098674196749926
. O 0 0.0010641468688845634

Recently O 0 0.006208517123013735
, O 0 0.0006925594643689692
we O 0 0.00017370772548019886
reported O 0 0.0001702705048955977
five O 0 0.00010319102875655517
Austrian O 0 0.0021383455023169518
families O 0 0.00036886506131850183
with O 0 0.0007605318096466362
generalized O 1 0.9996896982192993
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999901056289673
who O 0 0.0016376731218770146
share O 0 0.0005738274194300175
the O 0 0.0006158978794701397
same O 0 0.0007839655736461282
COL17A1 O 1 0.9999814033508301
mutation O 0 0.004011805634945631
. O 0 0.0014045304851606488

Affected O 0 0.0025724556762725115
individuals O 0 0.0001717756676953286
in O 0 0.00011187336349394172
three O 0 8.413728937739506e-05
families O 0 6.516349094454199e-05
are O 0 2.0017303540953435e-05
homozygous O 0 0.000239352069911547
for O 0 9.558465535519645e-05
4003delTC O 1 0.9984031319618225
, O 0 0.00031246384605765343
whereas O 0 0.00020992232020944357
those O 0 4.676051685237326e-05
in O 0 8.66236150613986e-05
two O 0 8.907098526833579e-05
others O 0 0.00020196587138343602
are O 0 0.00013581174425780773
compound O 0 0.042515434324741364
heterozygotes O 0 0.02027764916419983
. O 0 0.001296058064326644

To O 0 0.0008068851893767715
determine O 0 0.00032243464374914765
if O 0 0.00014203094178810716
the O 0 0.0001869589468697086
occurrence O 0 0.0008038713713176548
of O 0 0.000593613600358367
4003delTC O 1 0.9414048194885254
in O 0 0.0002832369355019182
these O 0 7.536562770837918e-05
unrelated O 0 0.000491577957291156
families O 0 0.00017943214334081858
signifies O 0 0.001904335804283619
propagation O 0 0.0007870184490457177
of O 0 0.0002763043448794633
an O 0 0.00023346106172539294
ancestral O 0 0.004991121124476194
allele O 0 0.0003882711462210864
or O 0 0.00017446762649342418
a O 0 0.0003622984513640404
mutational O 0 0.017602289095520973
hot O 0 0.00608003418892622
spot O 0 0.0015289634466171265
, O 0 0.00014895093045197427
haplotypes O 0 0.0005015742499381304
were O 0 0.0001237848773598671
determined O 0 0.00016301330470014364
for O 0 0.00011029120651073754
polymorphisms O 0 0.000713038258254528
both O 0 0.00021826870215591043
within O 0 0.00040829955833032727
and O 0 0.0007371302926912904
flanking O 1 0.9998762607574463
COL17A1 O 1 0.9999992847442627
. O 0 0.005337465554475784

Five O 0 0.005371859762817621
intragenic O 1 0.6597341299057007
polymorphisms O 0 0.002838429529219866
were O 0 0.0002889517054427415
chosen O 0 0.00035049105645157397
based O 0 9.09696682356298e-05
on O 0 0.00021011113130953163
their O 0 0.00024141892208717763
informativeness O 1 0.9544832706451416
. O 0 0.0018773172050714493

One O 0 0.0007353250402957201
of O 0 0.0004439389449544251
these O 0 7.548112625954673e-05
, O 0 9.985010547097772e-05
not O 0 4.1603681893320754e-05
previously O 0 0.00014871079474687576
reported O 0 0.00013696594396606088
, O 0 9.91761771729216e-05
was O 0 0.0007948338170535862
2988 O 1 0.8701369166374207
A O 0 0.0026934416964650154
or O 0 0.00029987498419359326
C O 0 0.0006244669784791768
that O 0 5.01130816701334e-05
introduces O 0 0.000336910889018327
a O 0 0.00011101154814241454
new O 0 0.00011001747043337673
restriction O 0 0.0003353034262545407
site O 0 0.0007267132168635726
for O 0 0.0003780006372835487
Eco0109 O 1 0.9965027570724487
I O 0 0.04987256973981857
. O 0 0.0015777706867083907

All O 0 0.0009425733587704599
the O 0 0.0008617648272775114
4003delTC O 0 0.14759528636932373
alleles O 0 0.0006560745532624424
showed O 0 0.000471956969704479
the O 0 0.000237960834056139
same O 0 0.0001227361208293587
haplotype O 0 0.000484315532958135
for O 0 6.935186684131622e-05
these O 0 6.00220519118011e-05
five O 0 0.0003480181912891567
polymorphic O 0 0.0029813784640282393
markers O 0 0.0070267245173454285
. O 0 0.001779968268238008

Fourteen O 0 0.012952268123626709
microsatellite O 0 0.016974452883005142
polymorphisms O 0 0.0014405448455363512
were O 0 0.00020317670714575797
selected O 0 0.0001471313735237345
based O 0 4.346029891166836e-05
on O 0 7.546529377577826e-05
their O 0 7.790118252160028e-05
high O 0 0.0008347776019945741
heterozygosity O 0 0.0153236985206604
and O 0 0.00011077669478254393
their O 0 6.645042594755068e-05
location O 0 0.00042065599700435996
within O 0 0.0006568352691829205
10q23 O 1 0.9958672523498535
- O 0 0.010741524398326874
q25 O 1 0.9946714043617249
near O 1 0.8908984661102295
COL17A1 O 1 0.999822199344635
. O 0 0.004443061538040638

Three O 0 0.0010061307111755013
families O 0 0.000478293834021315
shared O 0 0.0006406389293260872
microsatellite O 0 0.007434542290866375
polymorphisms O 0 0.001666763098910451
covering O 0 0.002908251481130719
at O 0 0.0010353067191317677
most O 0 0.00015146740770433098
19 O 0 0.0007367720827460289
cM O 0 0.0006278037326410413
, O 0 0.0001588809973327443
whereas O 0 0.00020396769104991108
the O 0 0.00012793949281331152
others O 0 8.851966413203627e-05
shared O 0 0.00015593328862451017
smaller O 0 0.00011366612307028845
regions O 0 0.0001012104912661016
consistent O 0 0.00022949138656258583
with O 0 9.017164120450616e-05
cross O 0 0.0008808356942608953
- O 0 0.00056932691950351
over O 0 0.00015467424236703664
events O 0 0.00022794873802922666
during O 0 0.0002932173665612936
passage O 0 0.0002509943151380867
of O 0 0.00016552061424590647
this O 0 7.332927634706721e-05
mutation O 0 0.0001170132527477108
through O 0 0.00015641219215467572
several O 0 0.0003111389232799411
generations O 0 0.0021492561791092157
. O 0 0.0009846467291936278

These O 0 0.0006004591123200953
results O 0 0.00033531588269397616
indicate O 0 0.00037350994534790516
that O 0 9.704283729661256e-05
4003delTC O 0 0.010984156280755997
occurs O 0 0.00032094967900775373
on O 0 0.00017235579434782267
a O 0 0.00023787170357536525
single O 0 0.00035183652653358877
ancestral O 0 0.00483308732509613
allele O 0 0.001543904305435717
. O 0 0.00029614282539114356
. O 0 0.0004891626304015517

The O 0 0.00520575325936079
haptoglobin O 0 0.08191317319869995
- O 0 0.003326327307149768
gene O 0 0.0007050505955703557
deletion O 0 0.001086586038582027
responsible O 0 0.0008346360409632325
for O 0 0.00048423869884572923
anhaptoglobinemia B-Disease 1 0.9992712140083313
. O 0 0.0014563576551154256

We O 0 0.0010712561197578907
have O 0 0.00011704360804287717
found O 0 0.0001601740950718522
an O 0 0.00013504092930816114
allelic O 0 0.0017300235340371728
deletion O 0 0.0010208804160356522
of O 0 0.000547064293641597
the O 0 0.0009304153500124812
haptoglobin O 1 0.9002137780189514
( O 0 0.0005763833760283887
Hp O 0 0.002165765268728137
) O 0 0.00010372199903940782
gene O 0 8.098092075670138e-05
from O 0 5.873323971172795e-05
an O 0 0.00013201151159591973
individual O 0 0.00015818684187252074
with O 0 0.0003993271093349904
anhaptoglobinemia B-Disease 1 0.9998998641967773
. O 0 0.0032823854126036167

The O 0 0.005275475326925516
Hp O 0 0.008257188834249973
gene O 0 0.0006355642690323293
cluster O 0 0.0008206738857552409
consists O 0 0.00019790812802966684
of O 0 0.00023331306874752045
coding O 0 0.0002941186248790473
regions O 0 0.00013177230721339583
of O 0 0.0003000611031893641
the O 0 0.0005176428821869195
alpha O 0 0.0008435569470748305
chain O 0 0.0005427270662039518
and O 0 0.00010000199836213142
beta O 0 0.00027203603531233966
chain O 0 0.00024368107551708817
of O 0 0.00010985026165144518
the O 0 0.0003889388754032552
haptoglobin O 0 0.013609756715595722
gene O 0 0.0004801850882358849
( O 0 0.00024442828726023436
Hp O 0 0.0009181502973660827
) O 0 5.135301034897566e-05
and O 0 4.895749952993356e-05
of O 0 0.00012406945461407304
the O 0 0.00030391651671379805
alpha O 0 0.0008175954571925104
chain O 0 0.0005204679328016937
and O 0 0.00012479348515626043
beta O 0 0.0003039460862055421
chain O 0 0.00023329263785853982
of O 0 0.00013386781211011112
the O 0 0.0003748467133846134
haptoglobin O 0 0.0940227136015892
- O 0 0.0010016026208177209
related O 0 0.000389367516618222
gene O 0 0.00041169184260070324
( O 0 0.00033431078190915287
Hpr O 0 0.017273906618356705
) O 0 0.00014310843835119158
, O 0 8.368646376766264e-05
in O 0 8.928289753384888e-05
tandem O 0 0.0008716911543160677
from O 0 0.00017079377721529454
the O 0 0.00035990247852168977
5 O 0 0.001057761488482356
side O 0 0.0017889200244098902
. O 0 0.0009984743082895875

Southern O 0 0.015710314735770226
blot O 0 0.027955681085586548
and O 0 0.0013152736937627196
PCR O 0 0.002436703769490123
analyses O 0 0.0003381365677341819
have O 0 4.474545858101919e-05
indicated O 0 0.00012685843103099614
that O 0 2.3544598661828786e-05
the O 0 7.904006633907557e-05
individual O 0 4.426929081091657e-05
with O 0 0.00014044476847629994
anhaptoglobinemia B-Disease 1 0.9998112320899963
was O 0 0.004437859170138836
homozygous O 0 0.0003614912857301533
for O 0 5.0828861276386306e-05
the O 0 0.0001461142674088478
gene O 0 0.0001384881470585242
deletion O 0 0.00026622318546287715
and O 0 6.098529411247e-05
that O 0 3.636142355389893e-05
the O 0 0.0001711122749838978
gene O 0 0.00015917608106974512
deletion O 0 0.0003157735918648541
was O 0 0.0005222678883001208
included O 0 0.00015269916912075132
at O 0 0.00021605360961984843
least O 0 5.113612860441208e-05
from O 0 6.493918044725433e-05
the O 0 0.00015125740901567042
promoter O 0 0.0019921003840863705
region O 0 0.00034841205342672765
of O 0 0.0004754994879476726
Hp O 0 0.004893442615866661
to O 0 0.00041066919220611453
Hpr O 0 0.023670565336942673
alpha O 0 0.0009851707145571709
but O 0 5.687308294000104e-05
not O 0 2.1600386389764026e-05
to O 0 0.00014250601816456765
Hpr O 0 0.01783604547381401
beta O 0 0.0022375923581421375
( O 0 0.0009077684371732175
Hpdel O 1 0.995283305644989
) O 0 0.0009202956571243703
. O 0 0.000802257505711168

In O 0 0.0009835183154791594
addition O 0 0.00038163483259268105
, O 0 0.00011517594975885004
we O 0 4.4220301788300276e-05
found O 0 4.087254637852311e-05
seven O 0 7.575861673103645e-05
individuals O 0 3.166642636642791e-05
with O 0 7.445462688338012e-05
hypohaptoglobinemia B-Disease 1 0.9984853863716125
in O 0 0.0003097918815910816
three O 0 0.00011568997433641925
families O 0 8.448638254776597e-05
, O 0 6.130155816208571e-05
and O 0 3.677063068607822e-05
the O 0 8.91746676643379e-05
genotypes O 0 0.0003721330431289971
of O 0 0.00011302941129542887
six O 0 0.00010563537216512486
of O 0 0.0001348108780803159
the O 0 0.00018964670016430318
seven O 0 0.00022098318731877953
individuals O 0 3.9659080357523635e-05
were O 0 6.1013910453766584e-05
found O 0 9.99825497274287e-05
to O 0 0.00015901982260402292
be O 0 0.00046128060785122216
Hp2 O 1 0.9997634291648865
/ O 1 0.8910331130027771
Hpdel O 1 0.9993667006492615
. O 0 0.0034532949794083834

The O 0 0.004484917502850294
phenotypes O 0 0.004511072766035795
and O 0 0.0006013513775542378
genotypes O 0 0.001594192930497229
in O 0 0.00014980667037889361
one O 0 6.959473830647767e-05
of O 0 8.528888429282233e-05
these O 0 2.456408219586592e-05
three O 0 5.5237251217477024e-05
families O 0 7.232465577544644e-05
showed O 0 0.00021033984376117587
the O 0 0.00020578633120749146
father O 0 0.0006613705190829933
to O 0 0.00017267985094804317
be O 0 0.0002458591479808092
hypohaptoglobinemic B-Disease 1 0.9711006283760071
( O 0 0.000993724912405014
Hp2 O 1 0.9948817491531372
) O 0 0.0005287565290927887
and O 0 0.0005024449783377349
Hp2 O 1 0.9998365640640259
/ O 1 0.9467094540596008
Hpdel O 1 0.9997653365135193
, O 0 0.00036562103196047246
the O 0 0.0003715738421306014
mother O 0 0.0006183311925269663
to O 0 0.00016480845806654543
be O 0 0.00015797128435224295
Hp2 O 1 0.5562920570373535
- O 0 0.0010559356305748224
1 O 0 0.0004483431694097817
and O 0 0.0004568277217913419
Hp1 O 1 0.9991466999053955
/ O 0 0.2656254470348358
Hp2 O 1 0.9945093989372253
, O 0 0.00018739906954579055
one O 0 5.6532531743869185e-05
of O 0 0.00010329380893381312
the O 0 0.00013161472452338785
two O 0 5.6812910770531744e-05
children O 0 0.00012005963071715087
to O 0 9.73208443610929e-05
be O 0 0.00015170473488979042
hypohaptoglobinemic B-Disease 1 0.8495528697967529
( O 0 0.0008869323064573109
Hp2 O 1 0.9951093792915344
) O 0 0.0004900146741420031
and O 0 0.000517493870574981
Hp2 O 1 0.9999558925628662
/ O 1 0.9789208769798279
Hpdel O 1 0.9999253749847412
, O 0 0.00036454209475778043
and O 0 0.00017266173381358385
the O 0 0.000265715760178864
other O 0 0.00010683570144465193
child O 0 0.0005383257521316409
to O 0 0.0001981993264053017
be O 0 0.00025874743005260825
Hp1 O 1 0.9927350282669067
and O 0 0.0010356421116739511
Hp1 O 1 0.9999936819076538
/ O 1 0.998467743396759
Hpdel O 1 0.9999314546585083
, O 0 0.0005253084236755967
showing O 0 0.0008220685995183885
an O 0 0.0002607344649732113
anomalous O 0 0.002679758006706834
inheritance O 0 0.0022411849349737167
of O 0 0.0019878915045410395
Hp O 1 0.9320359826087952
phenotypes O 0 0.0023223755415529013
in O 0 0.0003509049420244992
the O 0 0.0006819983245804906
child O 0 0.0018740580417215824
with O 0 0.0007079890347085893
Hp1 O 1 0.9999721050262451
. O 0 0.002682924270629883

The O 0 0.011098233051598072
Hp2 O 1 0.9999721050262451
/ O 1 0.99480140209198
Hpdel O 1 0.9994387030601501
individuals O 0 0.00023447988496627659
had O 0 0.0002644535852596164
an O 0 0.00019929121481254697
extremely O 0 0.0003821290156338364
low O 0 0.00020191754447296262
level O 0 0.00019064784282818437
of O 0 0.0002512078790459782
Hp O 0 0.0025289247278124094
( O 0 0.0002606877824291587
mean O 0 0.0005278334720060229
+ O 0 0.0009847835171967745
/ O 0 0.00101803382858634
- O 0 0.0007311765220947564
SD O 0 0.0030434506479650736
= O 0 0.0005302610225044191
0 O 0 0.00015523171168752015
. O 0 0.00010946150723611936
049 O 0 0.004876446910202503
+ O 0 0.0012830011546611786
/ O 0 0.0010355297708883882
- O 0 0.0005020141252316535
0 O 0 0.00019263557624071836
. O 0 0.0001347301877103746
043 O 0 0.006173551548272371
mg O 0 0.004271338228136301
/ O 0 0.0019220326794311404
ml O 0 0.0016886621015146375
; O 0 0.00013192091137170792
n O 0 0.0004085419641342014
= O 0 0.00041656254325062037
6 O 0 0.00036829139571636915
) O 0 3.820673009613529e-05
, O 0 3.352362909936346e-05
compared O 0 6.29518399364315e-05
with O 0 2.9042750611552037e-05
the O 0 0.00015378835087176412
level O 0 0.00029335549334064126
( O 0 0.00012328708544373512
1 O 0 0.00012458089622668922
. O 0 4.9339952965965495e-05
64 O 0 0.0002794362371787429
+ O 0 0.000641624559648335
/ O 0 0.0007708645425736904
- O 0 0.0005639700684696436
1 O 0 0.00032553510391153395
. O 0 0.00014372877194546163
07 O 0 0.006918017752468586
mg O 0 0.00700368219986558
/ O 0 0.002218000590801239
ml O 0 0.0023521920666098595
) O 0 0.00011402447853470221
obtained O 0 0.0001224133011419326
from O 0 0.00023056473582983017
52 O 0 0.0014954174403101206
healthy O 0 0.0015290363226085901
volunteers O 0 0.0013658388052135706
having O 0 0.0012150532566010952
phenotype O 0 0.0043842969462275505
Hp2 O 1 0.9981141090393066
, O 0 0.0005281908670440316
whereas O 0 0.0006001180736348033
the O 0 0.0004788777732755989
serum O 0 0.005077776499092579
Hp O 0 0.001881468459032476
level O 0 0.00023458006035070866
of O 0 0.00014206997002474964
an O 0 7.863845530664548e-05
individual O 0 4.065408211317845e-05
with O 0 0.00015841399726923555
Hp1 O 1 0.9999712705612183
/ O 1 0.9915300607681274
Hpdel O 1 0.9999047517776489
was O 0 0.009630195796489716
0 O 0 0.0013051764108240604
. O 0 0.0007004775106906891

50 O 0 0.005900956224650145
mg O 0 0.02938901074230671
/ O 0 0.009391662664711475
ml O 0 0.005572674795985222
, O 0 0.0002404082624707371
which O 0 5.018682713853195e-05
was O 0 0.0002142104203812778
approximately O 0 9.383121505379677e-05
half O 0 6.479603325715289e-05
the O 0 6.59739671391435e-05
level O 0 0.0002077356621157378
of O 0 0.0002581461740192026
Hp O 0 0.001816850621253252
in O 0 0.00022599803924094886
control O 0 0.0007176029030233622
sera O 0 0.007657485548406839
from O 0 0.0002711223205551505
the O 0 0.00043350461055524647
Hp1 O 1 0.8499354720115662
phenotype O 0 0.0007509320275858045
( O 0 0.00011879181693075225
1 O 0 0.00014027665019966662
. O 0 3.345512232044712e-05
26 O 0 0.00022638816153630614
+ O 0 0.00035150963230989873
/ O 0 0.0004697460390161723
- O 0 0.0003127446398139
0 O 0 0.00011426219862187281
. O 0 5.9224519645795226e-05
33 O 0 0.0005255311843939126
mg O 0 0.0022067271638661623
/ O 0 0.0011690290411934257
ml O 0 0.0014653876423835754
; O 0 9.199397027259693e-05
n O 0 0.0003501764149405062
= O 0 0.00039431281038559973
9 O 0 0.0002577099367044866
) O 0 6.157368625281379e-05
, O 0 5.8880785218207166e-05
showing O 0 0.00021432072389870882
a O 0 0.0002850762102752924
gene O 0 0.0005759405321441591
- O 0 0.0019095232710242271
dosage O 0 0.0034614228643476963
effect O 0 0.001289613894186914
. O 0 0.000813910155557096

The O 0 0.0013528448762372136
other O 0 0.00026320916367694736
allele O 0 0.000768383324611932
( O 0 0.0004875586600974202
Hp2 O 1 0.7847371697425842
) O 0 0.00014001473027747124
of O 0 0.00016595711349509656
individuals O 0 7.047106919344515e-05
with O 0 0.00027099516591988504
Hp2 O 1 0.9999997615814209
/ O 1 0.9998797178268433
Hpdel O 1 0.9999880790710449
was O 0 0.00257305265404284
found O 0 8.49556818138808e-05
to O 0 4.2990217480110005e-05
have O 0 2.0178033082629554e-05
, O 0 2.8664797355304472e-05
in O 0 4.1973096813308075e-05
all O 0 5.392411185312085e-05
exons O 0 0.0009558292804285884
, O 0 0.00014291807019617409
no O 0 0.00017803940863814205
mutation O 0 0.0001664531446294859
, O 0 0.00011002334213117138
by O 0 0.00011546845780685544
DNA O 0 0.0007457098690792918
sequencing O 0 0.0019057445460930467
. O 0 0.0008142777951434255

On O 0 0.0006067376816645265
the O 0 0.00020759152539540082
basis O 0 6.124592619016767e-05
of O 0 0.00011376687325537205
the O 0 0.00015724782133474946
present O 0 0.0001431675482308492
study O 0 6.544959614984691e-05
, O 0 6.846934411441907e-05
the O 0 0.00020428553398232907
mechanism O 0 0.000537154555786401
of O 0 0.000689896522089839
anhaptoglobinemia B-Disease 1 0.9989965558052063
and O 0 0.0002621950698085129
the O 0 0.00025456506409682333
mechanism O 0 0.0004701593134086579
of O 0 0.00034651727764867246
anomalous O 0 0.006497552618384361
inheritance O 0 0.0032126079313457012
of O 0 0.016381124034523964
Hp O 1 0.9995356798171997
phenotypes O 0 0.006049772724509239
were O 0 0.0005521919811144471
well O 0 0.00035878209746442735
explained O 0 0.0011118730762973428
. O 0 0.000717066926881671

However O 0 0.001924811745993793
, O 0 0.00036009569885209203
the O 0 0.00035317972651682794
mechanism O 0 0.0010215460788458586
of O 0 0.0018555057467892766
hypohaptoglobinemia B-Disease 1 0.9999890327453613
remains O 1 0.570475161075592
unknown O 0 0.012871772982180119

ATM O 0 0.07641113549470901
mutations O 0 0.0024969344958662987
and O 0 0.0009080063318833709
phenotypes O 0 0.005085356533527374
in O 0 0.0030064661987125874
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999606609344482
telangiectasia I-Disease 1 0.9999860525131226
families O 0 0.0003024672041647136
in O 0 0.00015777951921336353
the O 0 0.0002805464609991759
British O 0 0.0009217181359417737
Isles O 0 0.0011267896043136716
: O 0 0.0001383349153911695
expression O 0 0.00010909501725109294
of O 0 0.00020816392498090863
mutant O 0 0.0013531000586226583
ATM O 0 0.00147508445661515
and O 0 8.259744208771735e-05
the O 0 0.00021302216919139028
risk O 0 0.00030821491964161396
of O 0 0.37607282400131226
leukemia B-Disease 1 1.0
, O 1 0.9999996423721313
lymphoma B-Disease 1 1.0
, O 1 0.9999827146530151
and O 1 0.99997878074646
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
. O 0 0.005255734547972679

We O 0 0.00106713455170393
report O 0 0.0001805645297281444
the O 0 0.00020235544070601463
spectrum O 0 0.00041360597242601216
of O 0 0.0003335155488457531
59 O 0 0.002006126567721367
ATM O 0 0.0030450818594545126
mutations O 0 0.0004090215952601284
observed O 0 0.0003907485515810549
in O 0 0.0006942743202671409
ataxia B-Disease 1 0.9999983310699463
- I-Disease 1 0.9990910291671753
telangiectasia I-Disease 1 0.9999986886978149
( O 0 0.09380258619785309
A B-Disease 1 0.9999982118606567
- I-Disease 1 0.9999836683273315
T I-Disease 1 0.999998927116394
) O 0 0.000226749136345461
patients O 0 0.00014207919593900442
in O 0 8.089639595709741e-05
the O 0 0.0002309002447873354
British O 0 0.0015789150493219495
Isles O 0 0.0064512924291193485
. O 0 0.0010437692981213331

Of O 0 0.004499003291130066
51 O 0 0.005455509293824434
ATM O 0 0.006606599316000938
mutations O 0 0.000350907095707953
identified O 0 0.00018958088185172528
in O 0 6.452818342950195e-05
families O 0 6.187665712786838e-05
native O 0 0.0001611746847629547
to O 0 6.73286194796674e-05
the O 0 0.0001480944047216326
British O 0 0.0005962551804259419
Isles O 0 0.0013909968547523022
, O 0 0.00011612269008764997
11 O 0 0.0003364815202075988
were O 0 0.00019783154129981995
founder O 0 0.003513582982122898
mutations O 0 0.00028775061946362257
, O 0 9.160285844700411e-05
and O 0 5.390164369600825e-05
2 O 0 0.0001003201468847692
of O 0 0.0001199192411149852
these O 0 4.853651989833452e-05
11 O 0 0.00040319314575754106
conferred O 0 0.00087160017574206
a O 0 0.0006643051747232676
milder O 0 0.0022605247795581818
clinical O 0 0.0010778855066746473
phenotype O 0 0.0008190598455257714
with O 0 0.00015544236521236598
respect O 0 0.00041147603769786656
to O 0 0.000418551207985729
both O 0 0.0020639465656131506
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
and O 1 0.9999275207519531
cellular O 1 0.9999405145645142
features O 0 0.0036816014908254147
. O 0 0.0011701069306582212

We O 0 0.0006508580408990383
report O 0 0.00012392234930302948
, O 0 5.2272000175435096e-05
in O 0 4.240317139192484e-05
two O 0 7.064182864269242e-05
A B-Disease 1 0.9049453139305115
- I-Disease 0 0.4516075551509857
T I-Disease 1 0.9953885078430176
families O 0 0.000198127148905769
, O 0 8.524498844053596e-05
an O 0 0.00010649983596522361
ATM O 0 0.0014276010915637016
mutation O 0 0.00033473430084995925
( O 0 0.000392736226785928
7271T O 1 0.9888582229614258
- O 0 0.0033561158925294876
- O 0 0.0013389474479481578
> O 0 0.0013951235450804234
G O 0 0.002104786690324545
) O 0 0.00010991135786753148
that O 0 5.9568108554231e-05
may O 0 0.00011457042273832485
be O 0 4.936018740409054e-05
associated O 0 4.7123830881901085e-05
with O 0 3.5834600566886365e-05
an O 0 0.00016396892897319049
increased O 0 0.0005766662070527673
risk O 0 0.0007023366633802652
of O 1 0.9589389562606812
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999978542327881
in O 0 0.0012323661940172315
both O 0 0.00037346684257499874
homozygotes O 0 0.021435409784317017
and O 0 0.00032170081976801157
heterozygotes O 0 0.0030654591973870993
( O 0 0.0002629616647027433
relative O 0 0.00030230460106395185
risk O 0 0.00014649707009084523
12 O 0 0.00022378901485353708
. O 0 5.456605867948383e-05
7 O 0 0.0002692251873668283
; O 0 0.00011560076382011175
P O 0 0.002433710265904665
= O 0 0.0007351891254074872
. O 0 0.00022978786728344858
0025 O 0 0.28136882185935974
) O 0 0.00015970772074069828
, O 0 7.968553836690262e-05
although O 0 4.8240548494504765e-05
there O 0 4.3604810343822464e-05
is O 0 5.46240626135841e-05
a O 0 0.0001416043087374419
less O 0 0.00029473056201823056
severe O 1 0.9999608993530273
A B-Disease 1 0.9999996423721313
- I-Disease 1 0.9999685287475586
T I-Disease 1 0.9999834299087524
phenotype O 0 0.0004933952004648745
in O 0 5.771535143139772e-05
terms O 0 3.809503687079996e-05
of O 0 8.949080074671656e-05
the O 0 0.0002603097527753562
degree O 0 0.0018080462468788028
of O 1 0.9970865845680237
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
. O 1 0.9966751337051392

This O 0 0.001135213766247034
mutation O 0 0.0010192249901592731
( O 0 0.0006011365330778062
7271T O 1 0.9917051792144775
- O 0 0.004627697169780731
- O 0 0.00227014790289104
> O 0 0.0023420958314090967
G O 0 0.0016811442328616977
) O 0 8.512265048921108e-05
also O 0 5.280357436276972e-05
allows O 0 1.7793649021768942e-05
expression O 0 5.033714114688337e-05
of O 0 8.636900020064786e-05
full O 0 0.00014396441110875458
- O 0 0.00022306089522317052
length O 0 9.238737402483821e-05
ATM O 0 0.0006356063531711698
protein O 0 0.00017991935601457953
at O 0 0.00018185001681558788
a O 0 9.180416236631572e-05
level O 0 0.00014082239067647606
comparable O 0 0.00022162398090586066
with O 0 4.185454599792138e-05
that O 0 7.00303353369236e-05
in O 0 0.0003444743051659316
unaffected O 0 0.002531202742829919
individuals O 0 0.00036619746242649853
. O 0 0.0007499425555579364

In O 0 0.0016279781702905893
addition O 0 0.0006470423541031778
, O 0 0.00013135981862433255
we O 0 5.283521022647619e-05
have O 0 2.0408169802976772e-05
studied O 0 0.00021139981981832534
18 O 0 0.0007613232592120767
A B-Disease 1 0.9997559189796448
- I-Disease 1 0.9999024868011475
T I-Disease 1 0.9999984502792358
patients O 0 0.0003915416600648314
, O 0 0.00010081671644002199
in O 0 9.856937685981393e-05
15 O 0 0.0002500212285667658
families O 0 0.00010313515667803586
, O 0 0.0001214576477650553
who O 0 0.00039981715963222086
developed O 1 0.987375020980835
leukemia B-Disease 1 1.0
, O 1 0.9999127388000488
lymphoma B-Disease 1 1.0
, O 1 0.9970001578330994
preleukemic O 1 0.9999998807907104
T O 1 0.9999992847442627
- O 1 0.8471720814704895
cell O 0 0.027196377515792847
proliferation O 0 0.4090675115585327
, O 0 0.0007529613212682307
or O 1 0.9780277013778687
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 0.10063130408525467
mostly O 0 0.0009546648361720145
in O 0 0.0008604081231169403
childhood O 1 0.8230677843093872
. O 0 0.0014381271321326494

A O 0 0.005202598869800568
wide O 0 0.0013244104338809848
variety O 0 0.0005445388378575444
of O 0 0.0010005187941715121
ATM O 0 0.010410072281956673
mutation O 0 0.0003788138856180012
types O 0 0.00022979443019721657
, O 0 0.00018081745656672865
including O 0 0.00021510008082259446
missense O 0 0.0019296566024422646
mutations O 0 0.00030863628489896655
and O 0 0.00021797836234327406
in O 0 0.00036759916110895574
- O 0 0.0014795276802033186
frame O 0 0.004367487970739603
deletions O 0 0.0016206800937652588
, O 0 0.000186324687092565
were O 0 0.00012820056872442365
seen O 0 0.00045558487181551754
in O 0 0.00023537538072559983
these O 0 0.00014101048873271793
patients O 0 0.0007816990255378187
. O 0 0.0010079467901960015

We O 0 0.0008276358130387962
also O 0 0.00017759537149686366
show O 0 0.00013999668590258807
that O 0 2.3706368665443733e-05
25 O 0 8.250644896179438e-05
% O 0 3.238237331970595e-05
of O 0 0.00010914724407484755
all O 0 0.0002131704823113978
A B-Disease 1 0.9998493194580078
- I-Disease 1 0.9996635913848877
T I-Disease 1 0.9999855756759644
patients O 0 0.00032467005075886846
carried O 0 0.00025892953271977603
in O 0 0.0002471687621437013
- O 0 0.0010922565124928951
frame O 0 0.0022928863763809204
deletions O 0 0.00202548666857183
or O 0 0.00039821647806093097
missense O 0 0.0019178192596882582
mutations O 0 0.00016595140914432704
, O 0 6.360311817843467e-05
many O 0 1.9932345821871422e-05
of O 0 0.00010243866563541815
which O 0 6.412302172975615e-05
were O 0 0.0001179320242954418
also O 0 6.48322602501139e-05
associated O 0 7.163482223404571e-05
with O 0 7.26387370377779e-05
expression O 0 0.0002817637287080288
of O 0 0.0007356699206866324
mutant O 0 0.1922474503517151
ATM O 0 0.04376070201396942
protein O 0 0.0021701098885387182
. O 0 0.0007145630661398172

The O 0 0.008801019750535488
DMPK O 1 0.9998626708984375
gene O 0 0.003017721464857459
of O 0 0.04275471344590187
severely O 1 0.9999996423721313
affected O 1 0.9999972581863403
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999932050704956
is O 0 0.36213377118110657
hypermethylated O 1 0.9999901056289673
proximal O 1 0.9998214840888977
to O 0 0.0005633555119857192
the O 0 0.000666115724015981
largely O 0 0.0012149352114647627
expanded O 0 0.0021512694656848907
CTG O 1 0.9850503206253052
repeat O 0 0.005882333964109421
. O 0 0.0008094835211522877

Using O 0 0.0012770660687237978
methylation O 0 0.001511842361651361
- O 0 0.0015849944902583957
sensitive O 0 0.0011471769539639354
restriction O 0 0.0004320404550526291
enzymes O 0 0.0003342260024510324
, O 0 0.00010978439240716398
we O 0 6.452405796153471e-05
characterized O 0 0.0001396091829519719
the O 0 8.399843500228599e-05
methylation O 0 0.0001346310309600085
pattern O 0 0.00025337201077491045
on O 0 0.00011612135858740658
the O 0 0.00013530824799090624
5 O 0 0.0001741148007567972
side O 0 0.0001489931164542213
of O 0 0.00019217032240703702
the O 0 0.000491448154207319
CTG O 1 0.9917678833007812
repeat O 0 0.0009610553388483822
in O 0 0.00014441537496168166
the O 0 0.00029863446252420545
DMPK O 1 0.9991797804832458
gene O 0 0.00020373717416077852
of O 0 0.0002442849799990654
normal O 0 0.00033562089083716273
individuals O 0 4.76639143016655e-05
and O 0 0.00013775915431324393
of O 0 0.0008434918127022684
patients O 0 0.32599595189094543
affected O 1 0.9235742688179016
with O 1 0.9782477021217346
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 0.429464191198349
showing O 0 0.00549284415319562
expansions O 0 0.003039682749658823
of O 0 0.0005105357267893851
the O 0 0.0006671303999610245
repetitive O 0 0.006358301732689142
sequence O 0 0.0009806028101593256
. O 0 0.0007522914675064385

The O 0 0.0024298527278006077
gene O 0 0.0009115668945014477
segment O 0 0.0008065116126090288
analyzed O 0 0.00016656555817462504
corresponds O 0 0.00018303081742487848
to O 0 4.894423909718171e-05
the O 0 0.00022142672969494015
genomic O 0 0.001241612946614623
SacI O 0 0.3613467216491699
- O 0 0.001860767020843923
HindIII O 0 0.009714231826364994
fragment O 0 0.001031742780469358
carrying O 0 0.0007854297873564065
exons O 0 0.0019159646471962333
11 O 0 0.0009941373718902469
- O 0 0.001585061545483768
15 O 0 0.0012365863658487797
. O 0 0.0008672220283187926

There O 0 0.0011276659788563848
is O 0 0.00033946047187782824
constitutive O 0 0.0021859747357666492
methylation O 0 0.00045366203994490206
in O 0 0.00022735875973012298
intron O 0 0.0039014623034745455
12 O 0 0.0007251428905874491
at O 0 0.0004842031339649111
restriction O 0 0.00019610671733971685
sites O 0 0.00013328598288353533
of O 0 0.00034469799720682204
SacII O 1 0.9923843741416931
and O 0 0.0005661842878907919
HhaI O 1 0.9977263808250427
, O 0 0.0002665497886482626
localized O 0 0.0004389951063785702
1 O 0 0.00018399882537778467
, O 0 6.947186921024695e-05
159 O 0 0.00028942921198904514
- O 0 0.0003756960213650018
1 O 0 0.00018889503553509712
, O 0 9.894795948639512e-05
232 O 0 0.0007548975991085172
bp O 0 0.0017085260478779674
upstream O 0 0.0006135039729997516
of O 0 0.00024939392460510135
the O 0 0.0006789130857214332
CTG O 1 0.9993911981582642
repeat O 0 0.0016408358933404088
, O 0 0.00013249856419861317
whereas O 0 0.000154718232806772
most O 0 5.2331706683617085e-05
, O 0 4.660639024223201e-05
if O 0 3.1805011531105265e-05
not O 0 1.692707883194089e-05
all O 0 2.0779898477485403e-05
, O 0 3.23497224599123e-05
of O 0 7.300714059965685e-05
the O 0 0.00011302025086479262
other O 0 4.266926771379076e-05
sites O 0 0.00019211205653846264
of O 0 0.0005010584718547761
SacII O 1 0.999985933303833
, O 0 0.0016403195913881063
HhaI O 1 0.9999396800994873
, O 0 0.00047174241626635194
and O 0 0.0003836981486529112
HpaII O 1 0.9176771640777588
in O 0 0.00020393560407683253
this O 0 9.764303104020655e-05
region O 0 0.00021764358098153025
are O 0 3.794106305576861e-05
unmethylated O 0 0.005145153030753136
, O 0 0.00012829634943045676
in O 0 8.157920819940045e-05
normal O 0 0.00018337949586566538
individuals O 0 3.1902367481961846e-05
and O 0 5.568702545133419e-05
most O 0 8.93252290552482e-05
of O 0 0.00043990224367007613
the O 0 0.004132431466132402
patients O 0 0.003341763047501445
. O 0 0.0009216057369485497

In O 0 0.0008521658019162714
a O 0 0.00037679949309676886
number O 0 0.00013329158537089825
of O 0 0.0005007447325624526
young O 0 0.0027103889733552933
and O 0 0.0038440516218543053
severely O 1 0.999992847442627
affected O 1 0.6927399039268494
patients O 0 0.001498297555372119
, O 0 0.00014475316856987774
however O 0 6.961359031265602e-05
, O 0 4.257793625583872e-05
complete O 0 0.00012084353511454538
methylation O 0 0.00011466014257166535
of O 0 9.691909508546814e-05
these O 0 3.583060242817737e-05
restriction O 0 0.00010334405669709668
sites O 0 6.971496623009443e-05
was O 0 0.00021631807612720877
found O 0 6.068056245567277e-05
in O 0 9.958472946891561e-05
the O 0 0.0003328872553538531
mutated O 0 0.001845823717303574
allele O 0 0.0014241295866668224
. O 0 0.0006175730959512293

In O 0 0.0012110733659937978
most O 0 0.00018182469648309052
of O 0 0.0002882148837670684
these O 0 0.00012008150952169672
patients O 0 0.00016471388516947627
, O 0 8.029094897210598e-05
the O 0 0.0002931318012997508
onset O 1 0.9998235106468201
of O 1 0.9760161638259888
the O 1 0.9999960660934448
disease O 1 1.0
was O 1 1.0
congenital O 1 1.0
. O 1 0.863091230392456

Preliminary O 0 0.0037432555109262466
in O 0 0.001631157472729683
vivo O 0 0.006880009546875954
footprinting O 0 0.012715001590549946
data O 0 0.00012690271250903606
gave O 0 0.00016809646331239492
evidence O 0 0.0001009120314847678
for O 0 4.7401194024132565e-05
protein O 0 0.00025182991521432996
- O 0 0.0003657893685158342
DNA O 0 0.0002068395697278902
contact O 0 0.00016431105905212462
in O 0 0.00011480215471237898
normal O 0 0.0001719562424113974
genes O 0 8.718067692825571e-05
at O 0 0.00030939283897168934
an O 0 0.00019440842152107507
Sp1 O 0 0.006685633212327957
consensus O 0 0.0004316242993809283
binding O 0 0.00012998854799661785
site O 0 0.0003730055468622595
upstream O 0 0.0004045736859552562
of O 0 0.00019971960864495486
the O 0 0.0006386280874721706
CTG O 1 0.9983371496200562
repeat O 0 0.001424699556082487
and O 0 8.941385749494657e-05
for O 0 3.480208033579402e-05
a O 0 9.866143955150619e-05
significant O 0 0.00011578125122468919
reduction O 0 0.00015844195149838924
of O 0 0.00012652728764805943
this O 0 5.376318586058915e-05
interaction O 0 8.178639836842194e-05
in O 0 7.992130849743262e-05
cells O 0 0.0001805886422516778
with O 0 5.7091583585133776e-05
a O 0 0.0007632162887603045
hypermethylated O 1 0.9999701976776123
DMPK O 1 0.9999986886978149
gene O 0 0.0020261171739548445
. O 0 0.00042985047912225127
. O 0 0.0005180585430935025

The O 0 0.015419396571815014
hemochromatosis B-Disease 1 0.9999998807907104
gene O 0 0.002090172143653035
product O 0 0.0009186704992316663
complexes O 0 0.0013267600443214178
with O 0 0.00012293609324842691
the O 0 0.0006676293560303748
transferrin O 1 0.7513967156410217
receptor O 0 0.0005592515226453543
and O 0 0.0001774002448655665
lowers O 0 0.001059963135048747
its O 0 9.81849298113957e-05
affinity O 0 0.00020392314763739705
for O 0 0.00014619647117797285
ligand O 0 0.002286161296069622
binding O 0 0.0009284670813940465
. O 0 0.0011688665254041553

We O 0 0.001324585871770978
recently O 0 0.0011761272326111794
reported O 0 0.0002879089443013072
the O 0 0.00018931011436507106
positional O 0 0.0015178038738667965
cloning O 0 0.0004687550535891205
of O 0 0.00016784579202067107
a O 0 0.00030390635947696865
candidate O 0 0.0005619401927106082
gene O 0 0.0006298041553236544
for O 0 0.0007632392225787044
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 1 0.9999992847442627
HFE O 1 0.9999996423721313
. O 0 0.004653769079595804

The O 0 0.001541030709631741
gene O 0 0.0005614589899778366
product O 0 0.00024547104840166867
, O 0 6.70821318635717e-05
a O 0 9.946183126885444e-05
member O 0 0.0001024004741339013
of O 0 0.0001892594009405002
the O 0 0.0004943668027408421
major O 0 0.0517265647649765
histocompatibility O 1 0.9999995231628418
complex O 1 0.921650767326355
class O 0 0.0044482615776360035
I O 0 0.07607152312994003
- O 0 0.0006489839870482683
like O 0 0.00014519967953674495
family O 0 0.000131831387989223
, O 0 6.542613118654117e-05
was O 0 0.00020796078024432063
found O 0 3.9918693801155314e-05
to O 0 2.837668034771923e-05
have O 0 2.6542127670836635e-05
a O 0 0.00011026932770619169
mutation O 0 0.00025170823209919035
, O 0 0.00020447179849725217
Cys O 0 0.14377368986606598
- O 0 0.0017160222632810473
282 O 0 0.005762660875916481
- O 0 0.0034561206120997667
- O 0 0.002606229856610298
> O 0 0.0037289841566234827
Tyr O 0 0.21780326962471008
( O 0 0.0011013592593371868
C282Y O 0 0.38867002725601196
) O 0 0.0001674071972956881
, O 0 6.676419434370473e-05
in O 0 7.583718979731202e-05
85 O 0 0.0003275421040598303
% O 0 0.00011841589002870023
of O 0 0.0007595742936246097
patient O 0 0.004673382267355919
chromosomes O 0 0.003774030599743128
. O 0 0.001599513809196651

This O 0 0.0017682574689388275
mutation O 0 0.0009997464949265122
eliminates O 0 0.0013193758204579353
the O 0 0.00038419244810938835
ability O 0 0.00033682354842312634
of O 0 0.0006314571364782751
HFE O 1 0.9982859492301941
to O 0 0.0003468049690127373
associate O 0 0.0006709378212690353
with O 0 0.00028624868718907237
beta2 O 1 0.9997314810752869
- O 0 0.048778288066387177
microglobulin O 1 0.9996212720870972
( O 0 0.0009509378578513861
beta2m O 1 0.9445561766624451
) O 0 0.00031722435960546136
and O 0 0.00037302938289940357
prevents O 0 0.0017289556562900543
cell O 0 0.013097668997943401
- O 0 0.002855192171409726
surface O 0 0.002105355728417635
expression O 0 0.0011539184488356113
. O 0 0.0006304925191216171

A O 0 0.005790293216705322
second O 0 0.001889364211820066
mutation O 0 0.0002772812731564045
that O 0 6.487778591690585e-05
has O 0 5.232117837294936e-05
no O 0 7.94251827755943e-05
effect O 0 0.0002035410434473306
on O 0 0.00042745069367811084
beta2m O 1 0.9997203946113586
association O 0 0.0016389068914577365
, O 0 0.0004481718351598829
H63D O 1 0.999996542930603
, O 0 0.0002962699218187481
was O 0 0.0005176596459932625
found O 0 9.431249054614455e-05
in O 0 6.354467041091993e-05
eight O 0 8.666262874612585e-05
out O 0 5.84451190661639e-05
of O 0 0.0002220398309873417
nine O 0 0.0006085632485337555
patients O 0 0.00024065918114501983
heterozygous O 0 0.00015830695338081568
for O 0 8.514928777003661e-05
the O 0 0.0008098523248918355
C282Y O 1 0.9996033310890198
mutant O 0 0.04539014771580696
. O 0 0.001816620584577322

In O 0 0.0011074854992330074
this O 0 0.0002784803509712219
report O 0 0.0002341027866350487
, O 0 0.00011875784548465163
we O 0 0.00010758196731330827
demonstrate O 0 0.00038856916944496334
in O 0 0.0002874977944884449
cultured O 0 0.0030950247310101986
293 O 0 0.009621712379157543
cells O 0 0.0014872157480567694
overexpressing O 0 0.008304344490170479
wild O 0 0.0007812621770426631
- O 0 0.0006630514981225133
type O 0 0.0007511044968850911
or O 0 0.0004784830380231142
mutant O 0 0.004021167755126953
HFE O 1 0.9876044988632202
proteins O 0 9.772164048627019e-05
that O 0 2.8769905838998966e-05
both O 0 3.174364974256605e-05
the O 0 0.0001207281238748692
wild O 0 0.0003572920395527035
- O 0 0.0009815008379518986
type O 0 0.0007821941399015486
and O 0 0.0007635155925527215
H63D O 1 0.9999991655349731
HFE O 1 0.9999750852584839
proteins O 0 0.0010142669780179858
form O 0 0.00046016069245524704
stable O 0 0.0018638807814568281
complexes O 0 0.0014022733084857464
with O 0 0.00014837837079539895
the O 0 0.0007982802344486117
transferrin O 1 0.996615469455719
receptor O 0 0.0026884032413363457
( O 0 0.0009967881487682462
TfR O 1 0.6268361806869507
) O 0 0.0010636876104399562
. O 0 0.0008370612049475312

The O 0 0.006597314495593309
C282Y O 1 0.9860931634902954
mutation O 0 0.0020349216647446156
nearly O 0 0.0010653056669980288
completely O 0 0.001061387942172587
prevents O 0 0.0004213973297737539
the O 0 0.00015208595141302794
association O 0 0.00017837823543231934
of O 0 0.00024105964985210449
the O 0 0.0006798814283683896
mutant O 0 0.012512121349573135
HFE O 1 0.9977102279663086
protein O 0 0.0005392457242123783
with O 0 0.00020252936519682407
the O 0 0.001411445438861847
TfR O 1 0.9959904551506042
. O 0 0.0026037199422717094

Studies O 0 0.0013690280029550195
on O 0 0.0011699493043124676
cell O 0 0.003266894491389394
- O 0 0.0009968631202355027
associated O 0 0.0004954797914251685
transferrin O 0 0.010949961841106415
at O 0 0.0008563811425119638
37 O 0 0.00039324519457295537
degrees O 0 0.0002930465852841735
C O 0 0.0006461965385824442
suggest O 0 0.00015913996321614832
that O 0 3.978681706939824e-05
the O 0 0.00024340383242815733
overexpressed O 0 0.003945399075746536
wild O 0 0.0012278107460588217
- O 0 0.00171425542794168
type O 0 0.0018352641491219401
HFE O 1 0.8839035630226135
protein O 0 0.0004908957635052502
decreases O 0 0.0003372137143742293
the O 0 0.00014251186803448945
affinity O 0 0.00017093568749260157
of O 0 0.00021537858992815018
the O 0 0.0006282795802690089
TfR O 1 0.9971209168434143
for O 0 0.0012692067539319396
transferrin O 1 0.9785348176956177
. O 0 0.001688578398898244

The O 0 0.010106483474373817
overexpressed O 1 0.7690470218658447
H63D O 1 0.9998713731765747
protein O 0 0.001235870411619544
does O 0 0.00014897606160957366
not O 0 2.2896674636285752e-05
have O 0 1.3835999197908677e-05
this O 0 2.504349140508566e-05
effect O 0 9.223676170222461e-05
, O 0 4.1073071770370007e-05
providing O 0 8.778933988651261e-05
the O 0 0.00012613891158252954
first O 0 0.00011616055417107418
direct O 0 8.920401887735352e-05
evidence O 0 0.00011672173422994092
for O 0 4.7239100240403786e-05
a O 0 0.00015882040315773338
functional O 0 0.0003369699988979846
consequence O 0 0.0011457276996225119
of O 0 0.0009807556634768844
the O 0 0.005315663293004036
H63D O 1 0.9999980926513672
mutation O 0 0.0033717602491378784
. O 0 0.0010996561031788588

Addition O 0 0.0014671776443719864
of O 0 0.0016637492226436734
soluble O 0 0.017167605459690094
wild O 0 0.002746222075074911
- O 0 0.004140931181609631
type O 0 0.006375965196639299
HFE O 1 0.9999879598617554
/ O 1 0.867728590965271
beta2m O 1 0.9969479441642761
heterodimers O 0 0.144820436835289
to O 0 0.0008634432451799512
cultured O 0 0.012705625034868717
cells O 0 0.0007766784983687103
also O 0 0.0001518511853646487
decreased O 0 0.000451838131994009
the O 0 0.00014286112855188549
apparent O 0 0.0007286306354217231
affinity O 0 0.000175280321855098
of O 0 0.00021194273722358048
the O 0 0.0005445951828733087
TfR O 0 0.24255236983299255
for O 0 8.327895193360746e-05
its O 0 7.462010398739949e-05
ligand O 0 0.00041265058098360896
under O 0 0.00025474492576904595
steady O 0 0.0009591622510924935
- O 0 0.00034805515315383673
state O 0 0.00010414696589577943
conditions O 0 0.0001738845166983083
, O 0 6.763654528185725e-05
both O 0 3.863961683236994e-05
in O 0 0.0001794406707631424
293 O 0 0.005363954696804285
cells O 0 0.0009074151748791337
and O 0 0.00022416337742470205
in O 0 0.0012522831093519926
HeLa O 1 0.9999532699584961
cells O 0 0.0051517426036298275
. O 0 0.0006637925398536026

Furthermore O 0 0.002567571122199297
, O 0 0.0003382867434993386
at O 0 0.00035812787245959044
4 O 0 0.00025318533880636096
degrees O 0 0.00036017331876792014
C O 0 0.0009854555828496814
, O 0 0.00017211667727679014
the O 0 0.00034413591492921114
added O 0 0.000859189429320395
soluble O 0 0.002519652247428894
complex O 0 0.001982080051675439
of O 0 0.002364574233070016
HFE O 1 0.9999979734420776
/ O 1 0.9819117784500122
beta2m O 1 0.9852548837661743
inhibited O 0 0.002709530759602785
binding O 0 0.0002650682581588626
of O 0 0.0007296593976207078
transferrin O 0 0.30388566851615906
to O 0 0.0009943892946466804
HeLa O 1 0.9964118599891663
cell O 0 0.0018893335945904255
TfR O 0 0.009584714658558369
in O 0 0.00017136716633103788
a O 0 0.0003753750934265554
concentration O 0 0.16086140275001526
- O 0 0.0018131567630916834
dependent O 0 0.0005240484024398029
manner O 0 0.0009331274777650833
. O 0 0.0006506360368803144

Scatchard O 0 0.02065925858914852
plots O 0 0.003570707282051444
of O 0 0.0005895298672839999
these O 0 9.132375998888165e-05
data O 0 6.150333501864225e-05
indicate O 0 0.000102639889519196
that O 0 3.49338588421233e-05
the O 0 0.00017913689953275025
added O 0 0.0005531038623303175
heterodimer O 0 0.0035547008737921715
substantially O 0 0.0006363227730616927
reduced O 0 0.00012583759962581098
the O 0 0.00011711080878740177
affinity O 0 0.00023948607849888504
of O 0 0.0007542381063103676
TfR O 1 0.9983468055725098
for O 0 0.0026925462298095226
transferrin O 1 0.9891079664230347
. O 0 0.002158341696485877

These O 0 0.00031220659730024636
results O 0 0.0002487368765287101
establish O 0 0.00036595770507119596
a O 0 0.00027646770467981696
molecular O 0 0.0007119098445400596
link O 0 0.0011330972192808986
between O 0 0.0010583250550553203
HFE O 1 0.9997720122337341
and O 0 0.0003491522220429033
a O 0 0.00037912349216639996
key O 0 0.0007765234913676977
protein O 0 0.0002653297269716859
involved O 0 0.0003634992754086852
in O 0 0.0004751478845719248
iron O 1 0.9999946355819702
transport O 0 0.03340235352516174
, O 0 0.00031380727887153625
the O 0 0.0007005765219219029
TfR O 1 0.9965407252311707
, O 0 0.00022282770078163594
and O 0 8.898192754713818e-05
raise O 0 0.00012790960317943245
the O 0 9.296296047978103e-05
possibility O 0 0.0001997077779378742
that O 0 6.280942761804909e-05
alterations O 0 0.0007721474976278841
in O 0 0.00010972840391332284
this O 0 7.307351188501343e-05
regulatory O 0 0.00028572353767231107
mechanism O 0 0.0006483858451247215
may O 0 0.00014699339226353914
play O 0 0.00010325304901925847
a O 0 9.90361295407638e-05
role O 0 0.00019798250286839902
in O 0 0.00015023426385596395
the O 0 0.0006674982723779976
pathogenesis O 1 0.9998247027397156
of O 1 0.9996042847633362
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.9985823631286621
. O 0 0.0029909813310950994

Genomic O 0 0.0033740554936230183
organization O 0 0.0005285582737997174
of O 0 0.0006696920609101653
the O 0 0.002026367699727416
UBE3A O 1 0.9999897480010986
/ O 1 0.9706805944442749
E6 O 1 0.999971866607666
- O 0 0.012765255756676197
AP O 0 0.004162158351391554
gene O 0 0.0004444487567525357
and O 0 0.0002467141312081367
related O 0 0.0008890709141269326
pseudogenes O 0 0.014874860644340515
. O 0 0.0015539061278104782

The O 0 0.005678425543010235
UBE3A O 0 0.212271049618721
gene O 0 0.0008505944861099124
encodes O 0 0.0005430582677945495
the O 0 0.0005339381168596447
E6 O 1 0.9927721619606018
- O 0 0.002948965411633253
AP O 0 0.0031177829951047897
ubiquitin O 0 0.006936318706721067
- O 0 0.0011970835039392114
protein O 0 0.00056837237207219
ligase O 0 0.002808173419907689
and O 0 0.00016819954907987267
has O 0 9.635752212489024e-05
recently O 0 0.00020303243945818394
been O 0 0.00010338566062273458
shown O 0 0.00011060273391194642
to O 0 9.70085893641226e-05
be O 0 0.000192716033780016
mutated O 0 0.004224851727485657
in O 1 0.6253143548965454
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999140501022339
who O 0 0.14077727496623993
lack O 1 0.9986360669136047
15q11 O 1 0.9999997615814209
- O 1 0.9717398881912231
q13 O 1 0.9980699419975281
deletions O 0 0.004008520394563675
or O 0 0.0005962656578049064
chromosome O 0 0.0013470954727381468
15 O 0 0.0018237186595797539
paternal O 0 0.056089889258146286
uniparental B-Disease 1 0.9999864101409912
disomy I-Disease 1 0.9999649524688721
. O 0 0.006756467744708061

Previous O 0 0.010744494386017323
UBE3A O 1 0.7667592763900757
cDNA O 0 0.004278084728866816
analysis O 0 0.00016411814431194216
has O 0 0.00010797065624501556
shown O 0 0.00014644692419096828
a O 0 0.00016564628458581865
coding O 0 0.0004045568930450827
region O 0 0.00027707565459422767
of O 0 0.00039547300548292696
approximately O 0 0.0010393081465736032
2 O 0 0.0016516171162948012
. O 0 0.000744532560929656

6 O 0 0.005772214382886887
kb O 0 0.00568098109215498
and O 0 0.0003451541415415704
a O 0 0.00042470419430173934
3 O 0 0.000721649790648371
- O 0 0.0012224066304042935
untranslated O 0 0.0038236351683735847
region O 0 0.000706205319147557
( O 0 0.0002969791821669787
UTR O 0 0.006958597339689732
) O 0 0.00012734311167150736
of O 0 0.00025661420659162104
< O 0 0.0016921284841373563
50 O 0 0.0005112510989420116
bp O 0 0.0020680250599980354
, O 0 0.00010967662819894031
whereas O 0 9.699322981759906e-05
Northern O 0 0.00019664409046526998
analysis O 0 3.915599882020615e-05
has O 0 3.8303191104205325e-05
indicated O 0 8.907038863981143e-05
mRNA O 0 8.170579530997202e-05
sizes O 0 2.798870082187932e-05
of O 0 9.80739641818218e-05
5 O 0 0.0003422431764192879
- O 0 0.0007888937834650278
8 O 0 0.0012302767718210816
kb O 0 0.005434123333543539
. O 0 0.0009996907319873571

We O 0 0.0010123458923771977
have O 0 0.00012002574658254161
analyzed O 0 0.0002133563393726945
additional O 0 0.00015285503468476236
cDNA O 0 0.002051407238468528
clones O 0 0.0013169018784537911
and O 0 0.00011929833272006363
provide O 0 5.5244941904675215e-05
evidence O 0 9.738098742673174e-05
for O 0 6.434555689338595e-05
an O 0 0.00011011906462954357
additional O 0 0.0002597485145088285
0 O 0 0.000395913259126246
. O 0 0.00037404478644020855

5 O 0 0.0018662243383005261
kb O 0 0.0027248954866081476
of O 0 0.000492909864988178
5 O 0 0.0007835175492800772
- O 0 0.0011313770664855838
UTR O 0 0.00916993897408247
and O 0 0.00020043250697199255
> O 0 0.0006066562491469085
2 O 0 0.0002740501658990979
kb O 0 0.0010441550984978676
of O 0 0.00046153899165801704
3 O 0 0.001969157252460718
- O 0 0.004178571980446577
UTR O 0 0.15037834644317627
. O 0 0.0012785466387867928

We O 0 0.0010716123506426811
have O 0 0.00011724959767889231
established O 0 0.0002770381688605994
the O 0 0.00023057441285345703
genomic O 0 0.0004238259280100465
organization O 0 0.0002788608253467828
of O 0 0.00075668771751225
UBE3A O 1 0.9942247271537781
and O 0 0.00025447746156714857
the O 0 0.00022190097661223263
sequence O 0 0.00018982544133905321
of O 0 0.0004289587668608874
intron O 0 0.14268632233142853
- O 0 0.0026042202953249216
exon O 0 0.0036351452581584454
borders O 0 0.0010480568744242191
. O 0 0.0006774134235456586

We O 0 0.0011792677687481046
have O 0 9.960874740500003e-05
also O 0 8.462490950478241e-05
mapped O 0 0.00029342237394303083
two O 0 9.255430632038042e-05
highly O 0 0.00040028354851529
homologous O 0 0.0013753492385149002
processed O 0 0.0011026273714378476
pseudogenes O 0 0.003611880587413907
, O 0 0.0005421361420303583
UBE3AP1 O 1 0.9999394416809082
and O 0 0.0011778785847127438
UBE3AP2 O 1 0.9998577833175659
, O 0 0.000286230118945241
to O 0 7.763317989883944e-05
chromosomes O 0 0.00021934144024271518
2 O 0 0.00016621332906652242
and O 0 7.769064541207626e-05
21 O 0 0.0004001357010565698
, O 0 0.00015134828572627157
respectively O 0 0.00020169337221886963
, O 0 8.981617429526523e-05
and O 0 8.935964433476329e-05
determined O 0 0.00016890879487618804
their O 0 8.311766578117386e-05
genomic O 0 0.0010994336334988475
organization O 0 0.0007780963787809014
. O 0 0.0007719219429418445

These O 0 0.0004743245372083038
results O 0 0.000189258687896654
will O 0 6.158537871669978e-05
form O 0 5.345655154087581e-05
the O 0 7.281405123649165e-05
basis O 0 6.025449329172261e-05
for O 0 3.163063229294494e-05
studies O 0 4.267537224222906e-05
of O 0 0.00015304463158827275
mutation O 0 0.0003692610189318657
and O 0 0.00030472889193333685
imprinting O 0 0.07014533132314682
of O 0 0.08542442321777344
UBE3A O 1 0.9999924898147583
. O 0 0.0032108963932842016

Mutation O 0 0.007159899920225143
spectrum O 0 0.003601872595027089
and O 0 0.00098244973924011
genotype O 0 0.0033471209462732077
- O 0 0.002066157292574644
phenotype O 0 0.0014134543016552925
analyses O 0 0.00041833860450424254
in O 0 0.001091875834390521
Cowden B-Disease 1 0.9999997615814209
disease I-Disease 1 0.9999998807907104
and O 1 0.998872697353363
Bannayan B-Disease 1 1.0
- I-Disease 1 1.0
Zonana I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.0017079616663977504
two O 0 0.0016527781262993813
hamartoma B-Disease 1 0.9999996423721313
syndromes I-Disease 1 0.9999996423721313
with O 1 0.9913691878318787
germline O 1 0.9999998807907104
PTEN O 1 0.9999998807907104
mutation O 0 0.009780495427548885
. O 0 0.0019771428778767586

The O 0 0.030747229233384132
tumour B-Disease 1 0.9999998807907104
suppressor O 1 0.9999383687973022
gene O 0 0.01509558130055666
PTEN O 1 0.9998483657836914
, O 0 0.000558671890757978
which O 0 0.00013646793377120048
maps O 0 0.00027115773991681635
to O 0 0.00036762547097168863
10q23 O 1 0.9423089623451233
. O 0 0.0022572469897568226

3 O 0 0.0018141752807423472
and O 0 0.0002709419350139797
encodes O 0 0.00034480963950045407
a O 0 0.00022618233924731612
403 O 0 0.0008190680528059602
amino O 0 0.00033219007309526205
acid O 0 0.0006537644076161087
dual O 0 0.0005683144554495811
specificity O 0 0.0006643833476118743
phosphatase O 0 0.010106168687343597
( O 0 0.0004674001829698682
protein O 0 0.00046491448301821947
tyrosine O 0 0.0023173189256340265
phosphatase O 0 0.020135782659053802
; O 0 0.0002309246629010886
PTPase O 1 0.98759925365448
) O 0 0.00020262709585949779
, O 0 9.761174442246556e-05
was O 0 0.0003702743269968778
shown O 0 0.00012466430780477822
recently O 0 0.00018932638340629637
to O 0 4.040339990751818e-05
play O 0 9.187911928165704e-05
a O 0 0.00018207903485745192
broad O 0 0.00038193093496374786
role O 0 0.0008972376235760748
in O 0 0.0012526285136118531
human O 0 0.061669182032346725
malignancy B-Disease 1 0.9999974966049194
. O 0 0.002928506350144744

Somatic O 1 0.978461742401123
PTEN O 1 0.9998111128807068
deletions O 0 0.017408462241292
and O 0 0.0008499868563376367
mutations O 0 0.0003490114177111536
were O 0 0.0001703166199149564
observed O 0 0.0002514364605303854
in O 0 0.00033516917028464377
sporadic B-Disease 0 0.26847660541534424
breast I-Disease 1 0.9999881982803345
, I-Disease 0 0.2981330454349518
brain I-Disease 1 0.9999997615814209
, I-Disease 1 0.9935963153839111
prostate I-Disease 1 1.0
and I-Disease 1 0.999994158744812
kidney I-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.9999092817306519
lines O 0 0.0012758837547153234
and O 0 8.755308226682246e-05
in O 0 0.00011081218690378591
several O 0 0.0001735231198836118
primary O 0 0.0016102975932881236
tumours B-Disease 1 0.9999958276748657
such O 0 0.000804465264081955
as O 1 0.9735605716705322
endometrial B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 1 0.9999997615814209
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 1.0
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 1 0.7801948189735413

In O 0 0.0016893838765099645
addition O 0 0.0012623630464076996
, O 0 0.0007733484962955117
PTEN O 1 0.999409556388855
was O 0 0.0008596350089646876
identified O 0 0.00018168329552281648
as O 0 0.0001603567216079682
the O 0 0.0002965821768157184
susceptibility O 0 0.0009138174937106669
gene O 0 0.0002740355266723782
for O 0 0.00016038025205489248
two O 0 0.0013684937730431557
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
Cowden B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9997950196266174
CD B-Disease 1 0.9995920062065125
; O 0 0.0011872255709022284
MIM O 1 0.9999043941497803
158350 O 1 0.9965117573738098
) O 0 0.0004944483516737819
and O 0 0.0007223973516374826
Bannayan B-Disease 1 0.999471127986908
- I-Disease 0 0.06879013031721115
Zonana I-Disease 1 0.998673677444458
( I-Disease 0 0.0023103379644453526
BZS I-Disease 1 0.9840765595436096
) I-Disease 0 0.0007269030320458114
or I-Disease 0 0.0008127925102598965
Ruvalcaba I-Disease 1 0.9930393099784851
- I-Disease 0 0.01286693848669529
Riley I-Disease 1 0.9951745867729187
- I-Disease 1 0.9867923259735107
Smith I-Disease 1 0.9976339340209961
syndrome I-Disease 1 1.0
( O 1 0.9954274892807007
MIM O 1 0.9999996423721313
153480 O 1 0.9999902248382568
) O 0 0.0029044870752841234
. O 0 0.0016365960473194718

Constitutive O 0 0.02529025636613369
DNA O 0 0.0023973032366484404
from O 0 0.0007457297178916633
37 O 0 0.0016385839553549886
CD B-Disease 0 0.0022493929136544466
families O 0 0.00018270999134983867
and O 0 0.00019860605243593454
seven O 0 0.0006552184349857271
BZS B-Disease 1 0.9866260290145874
families O 0 0.00042280161869712174
was O 0 0.001145743066444993
screened O 0 0.0011733254650607705
for O 0 0.000653758819680661
germline O 1 0.9987769722938538
PTEN O 1 0.9999845027923584
mutations O 0 0.002729897852987051
. O 0 0.001307952799834311

PTEN O 1 0.9991938471794128
mutations O 0 0.0009907070780172944
were O 0 0.0002212732651969418
identified O 0 9.778988896869123e-05
in O 0 6.635859608650208e-05
30 O 0 9.414265514351428e-05
of O 0 0.00014995619130786508
37 O 0 0.00043911815737374127
( O 0 0.00020871724700555205
81 O 0 0.0006564647774212062
% O 0 0.00021997389558237046
) O 0 0.00022424099734053016
CD B-Disease 0 0.0010953346500173211
families O 0 0.00013314334501046687
, O 0 0.00010129129805136472
including O 0 0.00015154095308389515
missense O 0 0.0011266544461250305
and O 0 0.00024250874412246048
nonsense O 0 0.03230653703212738
point O 0 0.0014765334781259298
mutations O 0 0.0004068726266268641
, O 0 0.0002042697451543063
deletions O 0 0.0015225077513605356
, O 0 0.0002836623461917043
insertions O 0 0.002089590532705188
, O 0 0.00023088724992703646
a O 0 0.00048646493814885616
deletion O 0 0.003719025757163763
/ O 0 0.004909485578536987
insertion O 0 0.0028796347323805094
and O 0 0.000652081158477813
splice O 0 0.013765586540102959
site O 0 0.005110326688736677
mutations O 0 0.0015684159006923437
. O 0 0.0007385710487142205

These O 0 0.0009564533247612417
mutations O 0 0.0003630718856584281
were O 0 0.00022272065689321607
scattered O 0 0.00037090087425895035
over O 0 0.0001494836324127391
the O 0 0.0001612167980056256
entire O 0 0.0004401982296258211
length O 0 0.00011232543329242617
of O 0 0.0003918344445992261
PTEN O 1 0.9998227953910828
, O 0 7.396992441499606e-05
with O 0 2.8134627427789383e-05
the O 0 7.065248064463958e-05
exception O 0 9.820010745897889e-05
of O 0 8.556994725950062e-05
the O 0 0.00014125961752142757
first O 0 0.0001894679298857227
, O 0 0.00013312163355294615
fourth O 0 0.0011781074572354555
and O 0 0.0002483958378434181
last O 0 0.0009920892771333456
exons O 0 0.003998638596385717
. O 0 0.0011085901642218232

A O 0 0.008685333654284477
hot O 0 0.008106146939098835
spot O 0 0.00328998826444149
for O 0 0.00040564144728705287
PTEN O 1 0.99383544921875
mutation O 0 0.00040369798080064356
in O 0 0.00024416783708147705
CD B-Disease 0 0.001128654577769339
was O 0 0.0003950991958845407
identified O 0 0.00011466145951999351
in O 0 8.792003063717857e-05
exon O 0 0.0009504713234491646
5 O 0 0.00012592812709044665
that O 0 3.6477977118920535e-05
contains O 0 6.782559648854658e-05
the O 0 0.00017598805425222963
PTPase O 1 0.5097143650054932
core O 0 0.0025715527590364218
motif O 0 0.0007642355631105602
, O 0 7.196525257313624e-05
with O 0 3.174183439114131e-05
13 O 0 0.0001493326126364991
of O 0 0.00013957962801214308
30 O 0 0.00026535146753303707
( O 0 0.00013293047959450632
43 O 0 0.000372130743926391
% O 0 0.00019577695638872683
) O 0 0.00014056157669983804
CD B-Disease 0 0.0011526484740898013
mutations O 0 0.0001724429166642949
identified O 0 0.00011869171430589631
in O 0 0.0001285700564039871
this O 0 0.00016922137001529336
exon O 0 0.004362334497272968
. O 0 0.000715635425876826

Seven O 0 0.0009622840443626046
of O 0 0.0005095279193483293
30 O 0 0.0005304648075252771
( O 0 0.0002354324096813798
23 O 0 0.0004958529607392848
% O 0 8.456264185952023e-05
) O 0 4.266568794264458e-05
were O 0 3.4577820770209655e-05
within O 0 5.0874834414571524e-05
the O 0 0.0001703517191344872
core O 0 0.001202838378958404
motif O 0 0.0008077491074800491
, O 0 7.528760033892468e-05
the O 0 8.767179679125547e-05
majority O 0 5.9350713854655623e-05
( O 0 4.611837357515469e-05
five O 0 3.7761627027066424e-05
of O 0 7.114928303053603e-05
seven O 0 0.00014224211918190122
) O 0 5.405869160313159e-05
of O 0 8.830047590890899e-05
which O 0 7.283197192009538e-05
were O 0 0.00014888362784404308
missense O 0 0.0016706365859135985
mutations O 0 0.00033740364597178996
, O 0 0.00012122601037845016
possibly O 0 0.00043487042421475053
pointing O 0 0.0004320046864449978
to O 0 9.133246931014583e-05
the O 0 0.00014273192209657282
functional O 0 0.0002001863031182438
significance O 0 0.00044397154124453664
of O 0 0.0003710778837557882
this O 0 0.0002098318509524688
region O 0 0.0014695686986669898
. O 0 0.0009973561391234398

Germline O 1 0.9997091889381409
PTEN O 1 0.9998399019241333
mutations O 0 0.0005774237215518951
were O 0 0.00016805142513476312
identified O 0 9.243567183148116e-05
in O 0 4.552758400677703e-05
four O 0 4.539968722383492e-05
of O 0 0.00012262884411029518
seven O 0 0.0002283498615724966
( O 0 0.0002348694106331095
57 O 0 0.0007350023952312768
% O 0 0.0003096914733760059
) O 0 0.00035045912954956293
BZS B-Disease 1 0.514679491519928
families O 0 0.0007236765814013779
studied O 0 0.0018086452037096024
. O 0 0.0014182707527652383

Interestingly O 0 0.006219883449375629
, O 0 0.0005201359163038433
none O 0 0.0002694478025659919
of O 0 0.00019151874585077167
these O 0 6.764668069081381e-05
mutations O 0 0.00017667371139395982
was O 0 0.0007024083170108497
observed O 0 0.00021389448374975473
in O 0 0.0001910733408294618
the O 0 0.0006688176654279232
PTPase O 1 0.9987685084342957
core O 0 0.46573999524116516
motif O 0 0.013718209229409695
. O 0 0.0013196974759921432

It O 0 0.0008196603157557547
is O 0 0.00022104280651547015
also O 0 0.00010052566358353943
worthy O 0 0.00045922514982521534
of O 0 0.00022323281154967844
note O 0 0.0001434573787264526
that O 0 4.086752232979052e-05
a O 0 0.00013745002797804773
single O 0 0.00018726741836871952
nonsense O 0 0.0012032394297420979
point O 0 0.00043515407014638186
mutation O 0 0.00025343988090753555
, O 0 0.00021115687559358776
R233X O 1 0.9413092136383057
, O 0 0.00021700600336771458
was O 0 0.0004712078080046922
observed O 0 0.0001537162170279771
in O 0 0.00013237832172308117
the O 0 0.0002696387527976185
germline O 0 0.0029736945871263742
DNA O 0 0.0004119234508834779
from O 0 0.0001617384550627321
two O 0 0.00016443486674688756
unrelated O 0 0.0010469730477780104
CD B-Disease 0 0.002302303910255432
families O 0 0.00018263964739162475
and O 0 0.00020239211153239012
one O 0 0.0006208603153936565
BZS B-Disease 1 0.9985677003860474
family O 0 0.0038596256636083126
. O 0 0.0016992948949337006

Genotype O 0 0.018879584968090057
- O 0 0.005244343541562557
phenotype O 0 0.001242919242940843
studies O 0 9.265850530937314e-05
were O 0 7.86284072091803e-05
not O 0 3.448571442277171e-05
performed O 0 0.00017124612350016832
on O 0 7.940556679386646e-05
this O 0 2.821090311044827e-05
small O 0 6.224489334272221e-05
group O 0 8.282514318125322e-05
of O 0 0.000512657396029681
BZS B-Disease 1 0.9998574256896973
families O 0 0.0016273707151412964
. O 0 0.001499922713264823

However O 0 0.0029727364890277386
, O 0 0.0010307453339919448
genotype O 0 0.0032353047281503677
- O 0 0.0017650676891207695
phenotype O 0 0.001005440717563033
analysis O 0 0.00019956369942519814
inthe O 0 0.004478435032069683
group O 0 0.0002460779796820134
of O 0 0.0005453736521303654
CD B-Disease 0 0.003690417157486081
families O 0 0.00013653107453137636
revealed O 0 0.00038039914215914905
two O 0 4.361932587926276e-05
possible O 0 8.493600034853444e-05
associations O 0 7.328887295443565e-05
worthy O 0 0.00036708859261125326
of O 0 0.0002603050379548222
follow O 0 0.0002629152440931648
- O 0 0.0005437592626549304
up O 0 0.00035684878821484745
in O 0 0.00017216756532434374
independent O 0 0.00016430072719231248
analyses O 0 0.0004924883251078427
. O 0 0.0007969785947352648

The O 0 0.0015079559525474906
first O 0 0.0005590655491687357
was O 0 0.0006709877634420991
an O 0 0.00012462626909837127
association O 0 0.00016974205209407955
noted O 0 7.59569593355991e-05
in O 0 4.555381747195497e-05
the O 0 9.254494943888858e-05
group O 0 6.553127605002373e-05
of O 0 0.0003086975193582475
CD B-Disease 0 0.016740785911679268
families O 0 0.0003719608939718455
with O 0 0.015736520290374756
breast B-Disease 1 0.9999998807907104
disease I-Disease 1 1.0
. O 0 0.007539861835539341

A O 0 0.0037977087777107954
correlation O 0 0.0007791953394189477
was O 0 0.0009272127063013613
observed O 0 0.0002658427110873163
between O 0 0.00016150205919984728
the O 0 0.0002971168141812086
presence O 0 0.0004827707598451525
/ O 0 0.0008230978273786604
absence O 0 0.0006914775003679097
of O 0 0.0005421198438853025
a O 0 0.0017240609740838408
PTEN O 1 0.9999184608459473
mutation O 0 0.00029154180083423853
and O 0 9.235768811777234e-05
the O 0 0.0002139744465239346
type O 0 0.0007092999294400215
of O 0 0.0019122660160064697
breast O 1 0.9997051358222961
involvement O 1 0.9939168095588684
( O 0 0.06443741172552109
unaffected O 1 0.9784348011016846
versus O 1 0.9856206178665161
benign O 1 0.9999892711639404
versus O 1 0.9998824596405029
malignant O 1 0.9999998807907104
) O 0 0.0023273704573512077
. O 0 0.0020027202554047108

Specifically O 0 0.0015859674895182252
and O 0 0.0003066468343604356
more O 0 6.966485671000555e-05
directly O 0 0.00014848988212179393
, O 0 0.00010510352876735851
an O 0 0.00013696542009711266
association O 0 0.0003925268247257918
was O 0 0.0005257948068901896
also O 0 6.835197564214468e-05
observed O 0 6.389978807419538e-05
between O 0 8.551937207812443e-05
the O 0 0.00010532846499700099
presence O 0 0.00019210987375117838
of O 0 0.0005082163843326271
a O 0 0.009623466059565544
PTEN O 1 0.9999997615814209
mutation O 1 0.7479700446128845
and O 1 0.9973560571670532
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.09622853994369507

Secondly O 0 0.044828299432992935
, O 0 0.0008420739322900772
there O 0 0.00023554914514534175
appeared O 0 0.0002869413292501122
to O 0 7.662657299079001e-05
be O 0 5.820660953759216e-05
an O 0 0.00016344350297003984
interdependent O 0 0.0031705782748758793
association O 0 0.0004780363233294338
between O 0 0.00034057899028994143
mutations O 0 0.000298913597362116
upstream O 0 0.0011712773703038692
and O 0 0.00014217391435522586
within O 0 0.00018016724789049476
the O 0 0.00046839838614687324
PTPase O 1 0.997666597366333
core O 0 0.006698540411889553
motif O 0 0.0014502516714856029
, O 0 0.00015389836335089058
the O 0 0.00023469817824661732
core O 0 0.0010819161543622613
motif O 0 0.0007428486132994294
containing O 0 0.00023839961795601994
the O 0 0.0001037898546201177
majority O 0 6.412148650269955e-05
of O 0 0.00021859192929696292
missense O 0 0.0037418475840240717
mutations O 0 0.00039390064193867147
, O 0 9.972478437703103e-05
and O 0 5.29332464793697e-05
the O 0 0.00014592197840102017
involvement O 0 0.0006299903034232557
of O 0 0.00036029997863806784
all O 0 0.00019239436369389296
major O 0 0.13797619938850403
organ O 1 0.9999701976776123
systems O 1 0.8310912847518921
( O 0 0.0009229317074641585
central O 0 0.011909589171409607
nervous O 1 0.9910332560539246
system O 0 0.008660218678414822
, O 0 0.12254736572504044
thyroid O 1 1.0
, O 1 0.9993202686309814
breast O 1 1.0
, O 1 0.997744083404541
skin O 1 1.0
and O 1 0.9999971389770508
gastrointestinal O 1 1.0
tract O 1 1.0
) O 1 0.6167080402374268
. O 0 0.0019633977208286524

However O 0 0.0018485378241166472
, O 0 0.00042679105536080897
these O 0 5.2136390877421945e-05
observations O 0 0.00013925765233580023
would O 0 7.707947952440009e-05
need O 0 7.313652895390987e-05
to O 0 4.433861977304332e-05
be O 0 2.902854794228915e-05
confirmed O 0 7.180978718679398e-05
by O 0 2.818215943989344e-05
studying O 0 6.760423275409266e-05
a O 0 9.253973985323682e-05
larger O 0 8.842147508403286e-05
number O 0 4.6800036216154695e-05
of O 0 0.00046354843652807176
CD B-Disease 0 0.004761662799865007
families O 0 0.0005197530845180154
. O 0 0.0007040892378427088

Molecular O 1 0.9612417817115784
defects O 1 0.9999845027923584
leading O 0 0.09914791584014893
to O 0 0.0006898764404468238
human O 0 0.0021617563907057047
complement B-Disease 1 0.8168858885765076
component I-Disease 1 0.9999991655349731
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.0007690496859140694
an O 0 0.0003241149242967367
African O 0 0.0010778486030176282
- O 0 0.0011669930536299944
American O 0 0.0007394397398456931
family O 0 0.0007079511997289956
. O 0 0.0008752229041419923

Complement B-Disease 1 0.8739444017410278
component I-Disease 1 0.9999948740005493
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 1 0.9990550875663757
C6D B-Disease 1 0.9999998807907104
) O 0 0.0014066175790503621
was O 0 0.0031637062784284353
diagnosed O 0 0.05448293685913086
in O 0 9.89122927421704e-05
a O 0 0.00015714051551185548
16 O 0 0.00042978019337169826
- O 0 0.0006343335844576359
year O 0 0.0002374807809246704
- O 0 0.0003786202287301421
old O 0 0.000858111132401973
African O 0 0.001001658383756876
- O 0 0.0012542313197627664
American O 0 0.0012095781276002526
male O 0 0.002333763288334012
with O 0 0.0038422662764787674
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 0.07580684870481491

The O 0 0.003770142560824752
patients O 0 0.0014829576248303056
father O 0 0.003169137751683593
and O 0 0.00031788949854671955
two O 0 0.00023657659767195582
brothers O 0 0.003163072979077697
also O 0 0.0003863682795781642
had O 0 0.002051993040367961
C6D B-Disease 1 0.9999992847442627
, O 0 0.00026033955509774387
but O 0 4.857717431150377e-05
gave O 0 0.00014379045751411468
no O 0 0.00010865645890589803
history O 0 0.0005600981530733407
of O 0 0.0033893464133143425
meningitis B-Disease 1 1.0
or O 1 0.8576590418815613
other O 0 0.005171851254999638
neisserial B-Disease 1 0.9999998807907104
infection I-Disease 1 0.9999926090240479
. O 0 0.0024701873771846294

By O 0 0.0009273067116737366
using O 0 0.00033569560036994517
exon O 0 0.0024591260589659214
- O 0 0.0006157851312309504
specific O 0 0.00011027900472981855
polymerase O 0 0.0010028587421402335
chain O 0 0.0006599720800295472
reaction O 0 0.00043445589835755527
( O 0 0.00024117044813465327
PCR O 0 0.001190957729704678
) O 0 0.0001481596555095166
/ O 0 0.0005579157150350511
single O 0 0.00021641276543959975
- O 0 0.0006007000920362771
strand O 0 0.0006911352975293994
conformation O 0 0.00048156152479350567
polymorphism O 0 0.00017516336811240762
as O 0 8.870853343978524e-05
a O 0 0.00014293989806901664
screening O 0 0.00015914588584564626
step O 0 0.00026382572832517326
and O 0 6.985151412663981e-05
nucleotide O 0 0.00023175531532615423
sequencing O 0 0.000168938931892626
of O 0 0.00012664533278439194
target O 0 0.00024839036632329226
exons O 0 0.0007512798765674233
, O 0 8.189269283320755e-05
we O 0 4.5486704038921744e-05
determined O 0 4.9320849939249456e-05
that O 0 3.055469278478995e-05
the O 0 0.00017843848036136478
proband O 0 0.4074920117855072
was O 0 0.0012936581624671817
a O 0 0.0004978345241397619
compound O 0 0.004922909662127495
heterozygote O 0 0.0024759089574217796
for O 0 0.0001676589745329693
two O 0 0.00034564852830953896
C6 O 1 0.999990701675415
gene O 0 0.0015014767413958907
mutations O 0 0.0013804631307721138
. O 0 0.0008583385497331619

The O 0 0.0019301892025396228
first O 0 0.0009138270979747176
, O 0 0.0003141026827506721
1195delC O 0 0.006302312482148409
located O 0 0.0007595185888931155
in O 0 0.00020208027854096144
exon O 0 0.0015223518712446094
7 O 0 0.0004811252001672983
, O 0 9.553116979077458e-05
is O 0 6.084553388063796e-05
a O 0 0.00013912360009271652
novel O 0 0.00036606151843443513
mutation O 0 0.000165932098752819
, O 0 7.218794780783355e-05
while O 0 6.227575795492157e-05
the O 0 0.00013544689863920212
second O 0 0.00044940237421542406
, O 0 0.0001583640114404261
1936delG O 0 0.0060266489163041115
in O 0 0.00030877755489200354
exon O 0 0.0019614684861153364
12 O 0 0.00038597971433773637
, O 0 9.382951975567266e-05
has O 0 4.635612640413456e-05
been O 0 5.8691199228633195e-05
described O 0 0.00016781537851784378
before O 0 0.0002005422138608992
to O 0 0.00016663959831930697
cause O 0 0.287386953830719
C6D B-Disease 1 0.9999966621398926
in O 0 0.0004904915695078671
an O 0 0.0002663557243067771
unrelated O 0 0.0008256940636783838
African O 0 0.002384094288572669
- O 0 0.003000517375767231
American O 0 0.0009018694399856031
individual O 0 0.0002374844189034775
. O 0 0.0005096881650388241

Both O 0 0.0023020675871521235
mutations O 0 0.0012474890099838376
result O 0 0.0005545903695747256
in O 0 0.0006927126087248325
premature O 0 0.03394781053066254
termination O 0 0.01439990010112524
codons O 0 0.004009636119008064
and O 0 0.0013783349422737956
C6 O 1 0.999988317489624
null O 0 0.006111741531640291
alleles O 0 0.002214729553088546
. O 0 0.001460560248233378

Allele O 0 0.004752348177134991
- O 0 0.0015986422076821327
specific O 0 0.00022352969972416759
PCR O 0 0.0012242973316460848
indicated O 0 0.0002439661038806662
that O 0 5.6905526435002685e-05
the O 0 0.0003046519123017788
probands O 0 0.2794554829597473
two O 0 0.00027022219728678465
brothers O 0 0.0018047359772026539
also O 0 0.0002745638194028288
inherited O 0 0.07915005832910538
the O 0 0.0017483072588220239
1195delC O 1 0.9994675517082214
mutation O 0 0.00044890446588397026
from O 0 0.00018710429139900953
their O 0 7.925321551738307e-05
heterozygous O 0 0.00021409668261185288
mother O 0 0.00041659039561636746
and O 0 0.00014822209777776152
the O 0 0.0004404412175063044
1936delG O 1 0.9432587027549744
mutation O 0 0.00027635597507469356
from O 0 0.00020123619469814003
their O 0 0.0001188927999464795
homozygous O 0 0.0009063108591362834
father O 0 0.002133554546162486
. O 0 0.0003727576113305986
. O 0 0.0007033548317849636

PAX6 O 1 0.999242901802063
mutations O 0 0.013550530187785625
reviewed O 0 0.005274216644465923
. O 0 0.001953692873939872

Mutations O 0 0.004819126334041357
in O 0 0.0013883791398257017
PAX6 O 1 0.9878830313682556
are O 0 0.00012277651694603264
responsible O 0 0.000398428353946656
for O 0 0.00019924789376091212
human O 0 0.0035901586525142193
aniridia B-Disease 1 0.9999998807907104
and O 0 0.000505481380969286
have O 0 6.976284203119576e-05
also O 0 6.235313776414841e-05
been O 0 7.839863246772438e-05
found O 0 7.523306703660637e-05
in O 0 0.0001643337745917961
patients O 0 0.0002577819104772061
with O 0 0.0004713900270871818
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 1 0.9978445768356323
with O 1 0.9999850988388062
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 1 0.9999915361404419
with O 1 0.9931064248085022
autosomal B-Disease 1 0.9999940395355225
dominant I-Disease 1 0.9999998807907104
keratitis I-Disease 1 1.0
, O 0 0.008565968833863735
and O 0 0.0008097304962575436
with O 0 0.0011609813664108515
isolated B-Disease 1 0.9999479055404663
foveal I-Disease 1 1.0
hypoplasia I-Disease 1 1.0
. O 0 0.018181122839450836

No O 0 0.0025969159323722124
locus O 0 0.003209322225302458
other O 0 0.00014670913515146822
than O 0 0.0002492311177775264
chromosome O 0 0.0019312613876536489
11p13 O 1 0.999068558216095
has O 0 0.00043035350972786546
been O 0 0.0003956774016842246
implicated O 0 0.012366237118840218
in O 0 0.0016278403345495462
aniridia B-Disease 1 0.9999998807907104
, O 0 0.0008690874092280865
and O 0 0.00076817546505481
PAX6 O 1 0.9999542236328125
is O 0 0.00024447325267829
clearly O 0 0.00029536575311794877
the O 0 0.0001716029510134831
major O 0 0.0008250435930676758
, O 0 9.874605893855914e-05
if O 0 5.165920811123215e-05
not O 0 2.7824818971566856e-05
only O 0 4.1981704271165654e-05
, O 0 0.0001291064399993047
gene O 0 0.00047141764662228525
responsible O 0 0.0012835424859076738
. O 0 0.0009360580006614327

Twenty O 0 0.006572008598595858
- O 0 0.001792613067664206
eight O 0 0.0005057177622802556
percent O 0 0.0001793202682165429
of O 0 0.00025410624220967293
identified O 0 0.0005406669224612415
PAX6 O 1 0.9961225390434265
mutations O 0 0.0004627005837392062
are O 0 9.274001058656722e-05
C O 0 0.002321273321285844
- O 0 0.0017430352745577693
T O 0 0.004013925325125456
changes O 0 0.00018800435645971447
at O 0 0.0007454717997461557
CpG O 0 0.0034034065902233124
dinucleotides O 0 0.027409933507442474
, O 0 0.0001655599189689383
20 O 0 0.00017251595272682607
% O 0 5.139219865668565e-05
are O 0 2.067730383714661e-05
splicing O 0 0.0005001360550522804
errors O 0 0.0005650155944749713
, O 0 0.0001027399703161791
and O 0 4.308650750317611e-05
more O 0 2.7903923182748258e-05
than O 0 3.611739884945564e-05
30 O 0 0.00010799269512062892
% O 0 5.866444917046465e-05
are O 0 2.1881878637941554e-05
deletion O 0 0.000649108609650284
or O 0 0.0006011863588355482
insertion O 0 0.004789488390088081
events O 0 0.0024062292650341988
. O 0 0.001672729616984725

There O 0 0.0012602017959579825
is O 0 0.0003845513565465808
a O 0 0.000623157771769911
noticeably O 0 0.004764370620250702
elevated O 0 0.077508345246315
level O 0 0.0004672149079851806
of O 0 0.00020173990924376994
mutation O 0 9.861375292530283e-05
in O 0 6.671086157439277e-05
the O 0 0.00011809968418674543
paired O 0 0.00027025924646295607
domain O 0 0.00010183015547227114
compared O 0 8.900280226953328e-05
with O 0 2.9761642508674413e-05
the O 0 0.0001048762715072371
rest O 0 0.0003090293612331152
of O 0 0.00022780883591622114
the O 0 0.000624844164121896
gene O 0 0.0010020665358752012
. O 0 0.0006898313877172768

Increased O 0 0.003041982650756836
mutation O 0 0.0004665644373744726
in O 0 0.0002281026536365971
the O 0 0.0004960695514455438
homeodomain O 0 0.004901273176074028
is O 0 0.0002516743843443692
accounted O 0 0.0003519472375046462
for O 0 5.308971230988391e-05
by O 0 9.32535549509339e-05
the O 0 0.0005106944008730352
hypermutable O 1 0.9791075587272644
CpG O 0 0.01774928905069828
dinucleotide O 0 0.020597821101546288
in O 0 0.0007699989364482462
codon O 0 0.002836772473528981
240 O 0 0.002766380086541176
. O 0 0.0006278618238866329

Very O 0 0.0013708233600482345
nearly O 0 0.0008420507656410336
all O 0 0.00016384200716856867
mutations O 0 0.0002916368830483407
appear O 0 0.0002565361501183361
to O 0 0.00017783734074328095
cause O 0 0.0016767403576523066
loss O 0 0.0010702371364459395
of O 0 0.0002624504268169403
function O 0 0.00010301445581717417
of O 0 0.0002104289160342887
the O 0 0.0004579098313115537
mutant O 0 0.0015928206266835332
allele O 0 0.0002936624805442989
, O 0 5.095154847367667e-05
and O 0 2.5483577701379545e-05
more O 0 1.099254222935997e-05
than O 0 1.8639673726283945e-05
80 O 0 0.00011014554183930159
% O 0 3.7998383049853146e-05
of O 0 0.00022091891150921583
exonic O 1 0.6891675591468811
substitutions O 0 0.0013805471826344728
result O 0 0.0003724171547219157
in O 0 0.0003569232940208167
nonsense O 0 0.005580552387982607
codons O 0 0.0036467956379055977
. O 0 0.0007893945439718664

In O 0 0.0012297009816393256
a O 0 0.0005635381094180048
gene O 0 0.00022169142903294414
with O 0 5.808063724543899e-05
such O 0 9.411339851794764e-05
extraordinarily O 0 0.0012727116700261831
high O 0 0.0006002067239023745
sequence O 0 0.00016508370754308999
conservation O 0 0.00022214147611521184
throughout O 0 0.00015108312072698027
evolution O 0 0.00034853245597332716
, O 0 7.521914812969044e-05
there O 0 7.629147148691118e-05
are O 0 3.0081229851930402e-05
presumed O 0 0.0009719931404106319
undiscovered O 0 0.018483109772205353
missense O 0 0.004111278336495161
mutations O 0 0.00045942762517370284
, O 0 0.00012557869195006788
these O 0 3.7420068110805005e-05
are O 0 1.96400833374355e-05
hypothesized O 0 0.0002595405385363847
to O 0 9.314202179666609e-05
exist O 0 0.00012111833348171785
in O 0 0.00016032323765102774
as O 0 0.00026682947645895183
- O 0 0.0008212515967898071
yet O 0 0.0004963698447681963
unidentified O 0 0.002216721884906292
phenotypes O 0 0.002291474025696516
. O 0 0.00036284903762862086
. O 0 0.0005551462527364492

Genetic O 0 0.005220130551606417
heterogeneity O 0 0.005614214111119509
and O 0 0.0007445609080605209
penetrance O 0 0.004198157228529453
analysis O 0 0.00018264696700498462
of O 0 0.00034072058042511344
the O 0 0.0010628302115947008
BRCA1 O 1 0.9921054840087891
and O 0 0.0007312691304832697
BRCA2 O 1 0.6677267551422119
genes O 0 0.0008844444528222084
in O 0 0.00559850363060832
breast B-Disease 1 0.9999971389770508
cancer I-Disease 1 0.9999881982803345
families O 0 0.001612236606888473
. O 0 0.0013784082839265466

The O 1 0.9942962527275085
Breast B-Disease 1 1.0
Cancer I-Disease 1 0.9999998807907104
Linkage O 1 0.9997537732124329
Consortium O 0 0.054066047072410583
. O 0 0.0024308294523507357

The O 0 0.002271983539685607
contribution O 0 0.0023425729013979435
of O 0 0.002668291563168168
BRCA1 O 1 0.9929942488670349
and O 0 0.0021567302756011486
BRCA2 O 1 0.9995647072792053
to O 0 0.32772520184516907
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 1 0.9998020529747009
assessed O 0 0.0011715099681168795
by O 0 0.00017414950707461685
linkage O 0 0.0009038234711624682
and O 0 0.00011383208766346797
mutation O 0 6.937224679859355e-05
analysis O 0 2.2025878934073262e-05
in O 0 4.9980833864538e-05
237 O 0 0.0006694878684356809
families O 0 7.068199192872271e-05
, O 0 3.967239535995759e-05
each O 0 9.74593513092259e-06
with O 0 1.7402546291123144e-05
at O 0 9.84356229309924e-05
least O 0 3.0514738682541065e-05
four O 0 5.975307431071997e-05
cases O 0 9.181484347209334e-05
of O 0 0.007849792018532753
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999961853027344
, O 0 0.0003118053136859089
collected O 0 0.0002878436353057623
by O 0 0.00022841474856249988
the O 0 0.03388788923621178
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.99986732006073
Consortium O 0 0.013064499013125896
. O 0 0.0018464992754161358

Families O 0 0.0009706928976811469
were O 0 0.0002772152074612677
included O 0 0.00018142120097763836
without O 0 8.91864110599272e-05
regard O 0 0.00017261203902307898
to O 0 6.361335545079783e-05
the O 0 0.00025104169617407024
occurrence O 0 0.0021554057020694017
of O 1 0.9004907608032227
ovarian B-Disease 1 1.0
or I-Disease 1 0.8954460024833679
other I-Disease 0 0.0020581402350217104
cancers I-Disease 1 0.9998059868812561
. O 0 0.002037995494902134

Overall O 0 0.27770712971687317
, O 0 0.01125487219542265
disease O 1 0.999994158744812
was O 1 0.8425554037094116
linked O 0 0.006453505717217922
to O 0 0.00026290270034223795
BRCA1 O 0 0.0019062090432271361
in O 0 9.771288023330271e-05
an O 0 5.935727676842362e-05
estimated O 0 7.468195690307766e-05
52 O 0 0.0001048006015480496
% O 0 2.4774970370344818e-05
of O 0 9.662470984039828e-05
families O 0 7.856755109969527e-05
, O 0 6.970778485992923e-05
to O 0 8.707697998033836e-05
BRCA2 O 0 0.0009068525396287441
in O 0 7.416331936838105e-05
32 O 0 0.00014504055434372276
% O 0 4.238829205860384e-05
of O 0 0.0001273399539059028
families O 0 0.00012931540550198406
, O 0 6.414620293071494e-05
and O 0 5.0020455091726035e-05
to O 0 9.267353016184643e-05
neither O 0 0.0002032193442573771
gene O 0 6.928364746272564e-05
in O 0 5.5039807193679735e-05
16 O 0 0.00020703329937532544
% O 0 4.4852222345070913e-05
( O 0 7.103308598743752e-05
95 O 0 0.00023623510787729174
% O 0 6.0145357565488666e-05
confidence O 0 0.0004993127076886594
interval O 0 0.0004491428844630718
[ O 0 0.0007763965986669064
CI O 0 0.09791838377714157
] O 0 0.0006778476526960731
6 O 0 0.00030469984631054103
% O 0 6.300937820924446e-05
- O 0 0.00023062762920744717
28 O 0 0.0003810767666436732
% O 0 0.00011247408110648394
) O 0 0.00010076453327201307
, O 0 0.00012934647384099662
suggesting O 0 0.0005429894663393497
other O 0 0.00016044374206103384
predisposition O 1 0.5226418972015381
genes O 0 0.0018736120546236634
. O 0 0.0010714377276599407

The O 0 0.0013282874133437872
majority O 0 0.0002958175027742982
( O 0 0.00025427585933357477
81 O 0 0.0007830308750271797
% O 0 0.00010387818474555388
) O 0 7.675813685636967e-05
of O 0 0.00027467956533655524
the O 0 0.14892332255840302
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
families O 0 0.00043600591016002
were O 0 0.0002000100357690826
due O 0 0.00031747002503834665
to O 0 0.0001415803999407217
BRCA1 O 0 0.07931793481111526
, O 0 6.748533633071929e-05
with O 0 2.8375463443808258e-05
most O 0 5.891325054108165e-05
others O 0 9.696771303424612e-05
( O 0 0.00010287485929438844
14 O 0 0.0003840584249701351
% O 0 0.0001148080627899617
) O 0 0.0001379301684210077
due O 0 0.0004669397312682122
to O 0 0.0004420903278514743
BRCA2 O 0 0.4607495963573456
. O 0 0.001502424944192171

Conversely O 0 0.0055113378912210464
, O 0 0.0003626015968620777
the O 0 0.00018760788952931762
majority O 0 7.148073200369254e-05
of O 0 0.0001423281355528161
families O 0 0.0001403713831678033
with O 0 0.00017769327678252012
male B-Disease 0 0.002387889428064227
and I-Disease 0 0.002571479417383671
female I-Disease 1 0.9999485015869141
breast I-Disease 1 1.0
cancer I-Disease 1 0.9999958276748657
were O 0 0.0004757044662255794
due O 0 0.0007131171296350658
to O 0 0.00022649744641967118
BRCA2 O 0 0.029615946114063263
( O 0 0.0003982440393883735
76 O 0 0.0015858853003010154
% O 0 0.00043211213778704405
) O 0 0.000499756308272481
. O 0 0.0007596532814204693

The O 0 0.0014552305219694972
largest O 0 0.001293775043450296
proportion O 0 0.0004608911694958806
( O 0 0.00015856044774409384
67 O 0 0.00026841016369871795
% O 0 7.030848792055622e-05
) O 0 4.0092279959935695e-05
of O 0 8.213968249037862e-05
families O 0 8.181214070646092e-05
due O 0 0.0001681581634329632
to O 0 6.388297333614901e-05
other O 0 5.4563250159844756e-05
genes O 0 0.00010930035205092281
was O 0 0.0003331758198328316
found O 0 4.308486677473411e-05
in O 0 3.6605142668122426e-05
families O 0 2.6857960619963706e-05
with O 0 2.343284540984314e-05
four O 0 4.9955433496506885e-05
or O 0 5.737785613746382e-05
five O 0 5.924157812842168e-05
cases O 0 8.253957639681175e-05
of O 0 0.0028215148486196995
female O 1 0.9999899864196777
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999990463256836
only O 0 0.0009040263830684125
. O 0 0.0007645517471246421

These O 0 0.0006826427415944636
estimates O 0 0.0003841996076516807
were O 0 0.00017282810586038977
not O 0 7.628172170370817e-05
substantially O 0 0.0004378745798021555
affected O 0 0.00019196777429897338
either O 0 6.77570715197362e-05
by O 0 4.212869316688739e-05
changing O 0 0.00012240675278007984
the O 0 0.0002255291910842061
assumed O 0 0.0009276765631511807
penetrance O 0 0.005029203835874796
model O 0 0.0006421298603527248
for O 0 0.0002551190264057368
BRCA1 O 0 0.007994602434337139
or O 0 0.00022737176914233714
by O 0 0.00010603005648590624
including O 0 0.00017701905744615942
or O 0 0.00048312617582269013
excluding O 0 0.002285126131027937
BRCA1 O 1 0.6926705837249756
mutation O 0 0.0013157957000657916
data O 0 0.0003506474895402789
. O 0 0.0005732984864152968

Among O 0 0.0009674945613369346
those O 0 0.00018636127060744911
families O 0 0.00032137433299794793
with O 0 0.0004914493765681982
disease O 1 0.9999969005584717
due O 1 0.9548404216766357
to O 0 0.0019635455682873726
BRCA1 O 1 0.849810779094696
that O 0 9.77694580797106e-05
were O 0 7.306472980417311e-05
tested O 0 0.00011827573325717822
by O 0 2.0213698007864878e-05
one O 0 2.4681185095687397e-05
of O 0 8.011167665245011e-05
the O 0 0.00018821957928594202
standard O 0 0.00020438664068933576
screening O 0 0.00010943008965114132
methods O 0 0.00014437739446293563
, O 0 7.835909491404891e-05
mutations O 0 8.741776400711387e-05
were O 0 7.6151336543262e-05
detected O 0 0.00024953592219389975
in O 0 6.09407652518712e-05
the O 0 0.00013819649757351726
coding O 0 0.00024282805679831654
sequence O 0 9.62078629527241e-05
or O 0 7.610994362039492e-05
splice O 0 0.0006538012530654669
sites O 0 9.364412835566327e-05
in O 0 3.9649585232837126e-05
an O 0 4.071468356414698e-05
estimated O 0 7.71973209339194e-05
63 O 0 0.00018209988775197417
% O 0 3.900606679962948e-05
( O 0 6.694933836115524e-05
95 O 0 0.00020425474212970585
% O 0 0.00011184553295606747
CI O 0 0.009383964352309704
51 O 0 0.0006062868051230907
% O 0 0.00016602168034296483
- O 0 0.00040206321864388883
77 O 0 0.0006830745260231197
% O 0 0.0001553648617118597
) O 0 0.00015933172835502774
. O 0 0.00039030815241858363

The O 0 0.0022894986905157566
estimated O 0 0.0009517183061689138
sensitivity O 0 0.0009993364801630378
was O 0 0.0007151035242713988
identical O 0 0.00022747456387151033
for O 0 7.849623943911865e-05
direct O 0 7.670012564631179e-05
sequencing O 0 0.00033343417453579605
and O 0 0.00014493020717054605
other O 0 0.0001166447254945524
techniques O 0 0.0011645067716017365
. O 0 0.0009911148808896542

The O 0 0.005063074175268412
penetrance O 0 0.024661950767040253
of O 0 0.0033674142323434353
BRCA2 O 1 0.9150744080543518
was O 0 0.0017188844503834844
estimated O 0 0.00023268660879693925
by O 0 8.16452011349611e-05
maximizing O 0 0.0006339813116937876
the O 0 0.00026604405138641596
LOD O 0 0.0903468132019043
score O 0 0.00033236845047213137
in O 0 0.0004497184418141842
BRCA2 O 0 0.18057535588741302
- O 0 0.0014103020075708628
mutation O 0 0.00026316253934055567
families O 0 0.00012449348287191242
, O 0 8.010335295693949e-05
over O 0 0.00016802192840259522
all O 0 0.00011607618216658011
possible O 0 0.000625795335508883
penetrance O 0 0.010196398943662643
functions O 0 0.00122702622320503
. O 0 0.0011806503171101213

The O 0 0.0016897163586691022
estimated O 0 0.0008288535173051059
cumulative O 0 0.0011824696557596326
risk O 0 0.0005736718885600567
of O 0 0.002158721908926964
breast B-Disease 1 0.9999881982803345
cancer I-Disease 1 0.9995177984237671
reached O 0 0.0025962218642234802
28 O 0 0.0009832133073359728
% O 0 8.803512901067734e-05
( O 0 9.278521611122414e-05
95 O 0 0.0002404334954917431
% O 0 8.815029286779463e-05
CI O 0 0.01006027776747942
9 O 0 0.0006319778622128069
% O 0 8.669088856549934e-05
- O 0 0.00023517574300058186
44 O 0 0.00015437470574397594
% O 0 4.2775889596669e-05
) O 0 2.2994508981355466e-05
by O 0 2.8229767849552445e-05
age O 0 0.00010328868665965274
50 O 0 9.80686309048906e-05
years O 0 9.216239413945004e-05
and O 0 6.482520984718576e-05
84 O 0 0.00040421015000902116
% O 0 6.56253396300599e-05
( O 0 0.00011149849888170138
95 O 0 0.00028205689159221947
% O 0 8.859753143042326e-05
CI O 0 0.005126568954437971
43 O 0 0.0003137390303891152
% O 0 7.693232328165323e-05
- O 0 0.0002429090964142233
95 O 0 0.00021364804706536233
% O 0 7.00429518474266e-05
) O 0 4.142086618230678e-05
by O 0 5.45232069271151e-05
age O 0 0.00026815233286470175
70 O 0 0.000782888091634959
years O 0 0.0008709716494195163
. O 0 0.0006976795848459005

The O 0 0.01525735855102539
corresponding O 1 0.9995717406272888
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 1 0.8861182928085327
were O 0 0.0009712642058730125
0 O 0 0.0008610147051513195
. O 0 0.0006030152435414493

4 O 0 0.001726337242871523
% O 0 0.00023299695749301463
( O 0 0.00020683719776570797
95 O 0 0.00043070485116913915
% O 0 0.00011827043636003509
CI O 0 0.005785677582025528
0 O 0 0.0001646601886022836
% O 0 5.1967032050015405e-05
- O 0 0.0001510507136117667
1 O 0 6.62785314489156e-05
% O 0 3.2438631023978814e-05
) O 0 2.3399841666105203e-05
by O 0 1.7691618268145248e-05
age O 0 5.693732964573428e-05
50 O 0 5.325028905645013e-05
years O 0 3.8510417653014883e-05
and O 0 3.8651229260722175e-05
27 O 0 0.00017844494141172618
% O 0 4.0342572901863605e-05
( O 0 5.7474349887343124e-05
95 O 0 0.0002680764300748706
% O 0 7.70419355831109e-05
CI O 0 0.005535256117582321
0 O 0 0.00010793176625156775
% O 0 4.5056967792334035e-05
- O 0 0.00012521911412477493
47 O 0 0.00016260503616649657
% O 0 7.335432019317523e-05
) O 0 4.7340661694761366e-05
by O 0 7.010470289969817e-05
age O 0 0.0003665535768959671
70 O 0 0.000800728565081954
years O 0 0.0008493475615978241
. O 0 0.0007725363248027861

The O 0 0.0036450724583119154
lifetime O 0 0.00543236592784524
risk O 0 0.0023956389632076025
of O 1 0.8889243006706238
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999954700469971
appears O 0 0.001464943983592093
similar O 0 0.00011602019367273897
to O 0 6.092554031056352e-05
the O 0 0.00016401693574152887
risk O 0 0.00021655208547599614
in O 0 0.0002506521122995764
BRCA1 O 1 0.9887767434120178
carriers O 0 0.0004907051916234195
, O 0 0.00010104972898261622
but O 0 4.740101576317102e-05
there O 0 4.255175372236408e-05
was O 0 0.00021419407858047634
some O 0 2.8541993742692284e-05
suggestion O 0 0.00024211875279434025
of O 0 0.0001327243953710422
a O 0 0.000358518969733268
lower O 0 0.001030478160828352
risk O 0 0.00023124988365452737
in O 0 0.00026897090720012784
BRCA2 O 0 0.00477515859529376
carriers O 0 0.0003701878013089299
< O 0 0.0008277591550722718
50 O 0 0.0001701873989077285
years O 0 0.00019586659618653357
of O 0 0.0004065870598424226
age O 0 0.0012057280400767922
. O 0 0.0010825414210557938

Eye B-Disease 1 0.9999610185623169
movement I-Disease 1 0.9979552030563354
abnormalities I-Disease 1 0.9994093179702759
correlate O 0 0.0037220376543700695
with O 0 0.0006085011409595609
genotype O 0 0.0032034162431955338
in O 0 0.0010945862159132957
autosomal O 1 0.9735540747642517
dominant O 1 0.9999934434890747
cerebellar B-Disease 1 1.0
ataxia I-Disease 1 1.0
type I-Disease 1 1.0
I I-Disease 1 0.999998927116394
. O 0 0.004193895496428013

We O 0 0.002081791404634714
compared O 0 0.0021465783938765526
horizontal O 0 0.005411157850176096
eye O 0 0.4358311891555786
movements O 0 0.002999234013259411
( O 0 0.00152429414447397
visually O 0 0.003026996273547411
guided O 0 0.004936301149427891
saccades O 1 0.9919976592063904
, O 0 0.0007156101637519896
antisaccades O 1 0.9937777519226074
, O 0 0.0003321023832540959
and O 0 0.0002484098367858678
smooth O 0 0.0022846763022243977
pursuit O 0 0.008231421932578087
) O 0 0.00011379073839634657
in O 0 9.084898920264095e-05
control O 0 0.00020944049174431711
subjects O 0 0.00026771321427077055
( O 0 0.00013012695126235485
n O 0 0.0003607799590099603
= O 0 0.0004416907613631338
14 O 0 0.00033763900864869356
) O 0 7.666472083656117e-05
and O 0 7.954304601298645e-05
patients O 0 0.00013997896166983992
with O 0 6.699519144603983e-05
three O 0 0.00012352890917100012
forms O 0 0.0004117640492040664
of O 0 0.007038175128400326
autosomal O 1 0.9996501207351685
dominant O 1 0.9999953508377075
cerebellar B-Disease 1 1.0
ataxias I-Disease 1 1.0
type I-Disease 1 0.9999488592147827
I I-Disease 1 0.999890923500061
spinocerebellar B-Disease 1 0.9999971389770508
ataxias I-Disease 1 0.9990208148956299
1 I-Disease 0 0.000641279446426779
and I-Disease 0 0.0002049224713118747
2 I-Disease 0 0.000336429598974064
( O 0 0.000318542355671525
SCA1 B-Disease 1 0.7995323538780212
, O 0 0.00018709662253968418
n O 0 0.0003035881381947547
= O 0 0.00033073555096052587
11 O 0 0.00048212858382612467
; O 0 0.00014858378563076258
SCA2 B-Disease 1 0.6636524200439453
, O 0 0.0002660957688931376
n O 0 0.00041562924161553383
= O 0 0.00034605327527970076
10 O 0 0.00015884704771451652
) O 0 0.00011154729872941971
and O 0 0.00030167921795509756
SCA3 B-Disease 1 0.9999996423721313
/ O 1 0.8990578651428223
Machado B-Disease 1 0.90346360206604
- I-Disease 0 0.012617675587534904
Joseph I-Disease 1 0.8958795666694641
disease I-Disease 1 0.9999961853027344
( O 0 0.011073675006628036
MJD B-Disease 1 1.0
) O 0 0.0004599067906383425
( O 0 0.00023075433273334056
n O 0 0.0004753845860250294
= O 0 0.0007024056394584477
16 O 0 0.0007921094656921923
) O 0 0.0003225723630748689
. O 0 0.00038780205068178475

In O 0 0.00598567258566618
SCA1 B-Disease 1 0.9989979863166809
, O 0 0.0015579232713207603
saccade O 0 0.011933769099414349
amplitude O 0 0.0013536176411435008
was O 0 0.001431162003427744
significantly O 0 0.000622237625066191
increased O 0 0.00034879721351899207
, O 0 0.0002093380899168551
resulting O 0 0.0007219060207717121
in O 0 0.0007533194147981703
hypermetria B-Disease 1 0.9960564374923706
. O 0 0.0019374211551621556

The O 0 0.0041888863779604435
smooth O 0 0.007699238136410713
pursuit O 0 0.022325556725263596
gain O 0 0.0039709098637104034
was O 0 0.01124908309429884
decreased O 0 0.015505766496062279
. O 0 0.0012190325651317835

In O 0 0.006675969809293747
SCA2 B-Disease 1 0.9998261332511902
, O 0 0.001939320471137762
saccade O 0 0.021631890907883644
velocity O 0 0.003771912306547165
was O 0 0.006107776891440153
markedly O 0 0.016654331237077713
decreased O 0 0.006056669168174267
. O 0 0.000991442590020597

The O 0 0.0014324369840323925
percentage O 0 0.0004831225087400526
of O 0 0.00040292961057275534
errors O 0 0.0009634041925892234
in O 0 0.0007775172125548124
antisaccades O 1 0.9999765157699585
was O 0 0.0384126640856266
greatly O 0 0.0008032710175029933
increased O 0 0.00024576703435741365
and O 0 0.00010773514077300206
was O 0 0.0004980775411240757
significantly O 0 0.0002767668047454208
correlated O 0 0.0002335552271688357
with O 0 0.0001258817792404443
age O 0 0.0032424030359834433
at O 1 0.9992928504943848
disease O 1 0.9999996423721313
onset O 1 0.9999997615814209
. O 0 0.007906139828264713

In O 0 0.0014698697486892343
addition O 0 0.0003619263006839901
, O 0 9.996481094276533e-05
a O 0 0.00017439445946365595
correlation O 0 0.00021197160822339356
between O 0 0.00035781628685072064
smooth O 0 0.0016821087338030338
pursuit O 0 0.005824635270982981
gain O 0 0.0005199373699724674
and O 0 9.560480975778773e-05
the O 0 0.00013758587010670453
number O 0 8.393022289965302e-05
of O 0 0.000407924730097875
trinucleotide O 1 0.9970397353172302
repeats O 0 0.0028998469933867455
was O 0 0.002367808250710368
found O 0 0.0008086817688308656
. O 0 0.0010071314172819257

In O 0 0.012853083200752735
SCA3 B-Disease 1 0.9999997615814209
, O 0 0.006213914602994919
gaze B-Disease 1 0.9743027091026306
- I-Disease 0 0.28422629833221436
evoked I-Disease 1 0.9943580031394958
nystagmus I-Disease 1 0.9971374273300171
was O 0 0.004248835612088442
often O 0 0.0002336066827410832
present O 0 0.00036846473813056946
as O 0 0.0003658487112261355
was O 0 0.0019574437756091356
saccade O 0 0.04537639021873474
hypometria O 1 0.9452148675918579
and O 0 0.0004768032522406429
smooth O 0 0.002376549644395709
pursuit O 0 0.012746501713991165
gain O 0 0.003125938819721341
was O 0 0.014942971058189869
markedly O 0 0.03159660845994949
decreased O 0 0.005557311698794365
. O 0 0.0007322964374907315

Three O 0 0.0021531330421566963
major O 0 0.00323905935510993
criteria O 0 0.0006095576100051403
, O 0 0.0006797770620323718
saccade O 0 0.01242856029421091
amplitude O 0 0.001717286417260766
, O 0 0.0003838390111923218
saccade O 0 0.006047210190445185
velocity O 0 0.000882389722391963
, O 0 0.00015141225594561547
and O 0 9.05314227566123e-05
presence O 0 0.00034322409192100167
of O 0 0.0007108668214641511
gaze B-Disease 1 0.993115246295929
- I-Disease 1 0.5824673771858215
evoked I-Disease 1 0.915999710559845
nystagmus I-Disease 0 0.1837230771780014
, O 0 0.0002577411360107362
permitted O 0 0.00016531493747606874
the O 0 0.00017290987307205796
correct O 0 0.00036670349072664976
assignment O 0 0.00030211269040592015
of O 0 0.0001478987978771329
90 O 0 0.00015670178981963545
% O 0 4.267032636562362e-05
of O 0 0.00010608446609694511
the O 0 0.00035259939613752067
SCA1 B-Disease 1 0.9999268054962158
, O 0 0.00016055912419687957
90 O 0 0.00012674296158365905
% O 0 4.887166869593784e-05
of O 0 0.00014484761049970984
the O 0 0.0005224032793194056
SCA2 B-Disease 1 0.9999809265136719
, O 0 0.00024093831598293036
and O 0 0.00010919805208686739
93 O 0 0.0003478287544567138
% O 0 4.622157575795427e-05
of O 0 0.00010636120714480057
the O 0 0.00035482985549606383
patients O 0 0.0003555745061021298
with O 0 0.0002328901318833232
SCA3 B-Disease 1 1.0
to O 0 0.0002429239102639258
their O 0 9.374367073178291e-05
genetically O 0 0.00037649463047273457
confirmed O 0 0.0003216416225768626
patient O 0 0.0003319340175949037
group O 0 9.570806287229061e-05
and O 0 0.00012481345038395375
, O 0 0.00013270997442305088
therefore O 0 0.0001318970025749877
, O 0 0.00015821897250134498
may O 0 0.0002744243247434497
help O 0 0.0005874500493519008
orient O 0 0.00969787873327732
diagnoses O 0 0.004502152558416128
of O 0 0.02669043466448784
SCA1 B-Disease 1 1.0
, O 0 0.06384870409965515
SCA2 B-Disease 1 0.9999997615814209
, O 0 0.0007582793477922678
and O 0 0.0006737135699950159
SCA3 B-Disease 1 0.9999997615814209
at O 0 0.002721885684877634
early O 0 0.0005982472794130445
clinical O 0 0.00041200354462489486
stages O 0 0.0010713755618780851
of O 0 0.0010321534937247634
the O 1 0.8574135303497314
diseases O 1 0.9999998807907104
. O 0 0.0009203982190228999
. O 0 0.0009641273063607514

Genetic O 0 0.002511140890419483
basis O 0 0.00060441461391747
and O 0 0.0005917616654187441
molecular O 0 0.003182239830493927
mechanism O 1 0.7927462458610535
for O 1 0.9441551566123962
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 1 0.9870017766952515

Ventricular B-Disease 1 1.0
fibrillation I-Disease 1 0.9999997615814209
causes O 1 0.976531445980072
more O 0 0.00022036669543012977
than O 0 0.00011140995775349438
300 O 0 0.00028996559558436275
, O 0 0.00010920451313722879
000 O 0 0.0005101703573018312
sudden O 0 0.0014346294337883592
deaths O 0 0.00028419290902093053
each O 0 3.9996310079004616e-05
year O 0 0.00011338045442244038
in O 0 0.00011125538730993867
the O 0 0.0004475711320992559
USA O 0 0.0038240873254835606
alone O 0 0.0010362936882302165
. O 0 0.0005060384864918888

In O 0 0.0005855184281244874
approximately O 0 0.00031382610904984176
5 O 0 0.0002726083039306104
- O 0 0.0002480675757396966
12 O 0 0.00011770664423238486
% O 0 2.8850265152868815e-05
of O 0 6.949406815692782e-05
these O 0 3.51202797901351e-05
cases O 0 6.776714144507423e-05
, O 0 8.929882460506633e-05
there O 0 5.8688849094323814e-05
are O 0 2.4641720301588066e-05
no O 0 0.00030868779867887497
demonstrable O 1 0.9999197721481323
cardiac O 1 1.0
or O 1 0.997689962387085
non O 1 0.999707043170929
- O 1 0.9998306035995483
cardiac O 1 0.9999958276748657
causes O 0 0.061069417744874954
to O 0 0.0001451686694053933
account O 0 5.290569242788479e-05
for O 0 2.7610050892690197e-05
the O 0 0.00014136242680251598
episode O 0 0.0008686312357895076
, O 0 9.353917266707867e-05
which O 0 4.8265577788697556e-05
is O 0 8.868899749359116e-05
therefore O 0 0.00021319121879059821
classified O 0 0.0016867867670953274
as O 1 0.5197630524635315
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 1 0.9999991655349731
IVF B-Disease 1 0.9999997615814209
) O 0 0.002006399678066373
. O 0 0.0011195313418284059

A O 0 0.0031317779794335365
distinct O 0 0.0006613912992179394
group O 0 0.0004478630144149065
of O 0 0.003336959285661578
IVF B-Disease 1 0.9999998807907104
patients O 0 0.0020006257109344006
has O 0 0.0002275587321491912
been O 0 0.00011063871352234855
found O 0 6.945570930838585e-05
to O 0 5.809554204461165e-05
present O 0 0.00013266618771012872
with O 0 6.490266241598874e-05
a O 0 0.0005639829905703664
characteristic O 0 0.22722776234149933
electrocardiographic O 1 0.999990701675415
pattern O 1 0.9718814492225647
. O 0 0.002114811446517706

Because O 0 0.0007976274937391281
of O 0 0.00041611844790168107
the O 0 0.0003062527102883905
small O 0 0.00012060270819347352
size O 0 0.00013295316603034735
of O 0 0.00016858908929862082
most O 0 0.00012909092765767127
pedigrees O 0 0.0005740388878621161
and O 0 0.00011602484300965443
the O 0 0.0002486585872247815
high O 0 0.0011447950964793563
incidence O 0 0.0030824437271803617
of O 0 0.002455637091770768
sudden B-Disease 1 0.9999923706054688
death I-Disease 1 0.9992893934249878
, O 0 0.00029522666591219604
however O 0 9.726425196276978e-05
, O 0 6.517803558381274e-05
molecular O 0 0.00015308083675336093
genetic O 0 0.00010657338862074539
studies O 0 0.00012296724889893085
of O 0 0.0009411670034751296
IVF B-Disease 1 0.9999862909317017
have O 0 0.00013879816106054932
not O 0 7.432926940964535e-05
yet O 0 0.00014732257113792002
been O 0 0.00022132160665933043
done O 0 0.0006885036709718406
. O 0 0.0007178419618867338

Because O 0 0.12537769973278046
IVF B-Disease 1 0.9999992847442627
causes O 1 0.9999964237213135
cardiac O 1 1.0
rhythm O 1 1.0
disturbance O 1 1.0
, O 0 0.0008901795954443514
we O 0 0.00022383255418390036
investigated O 0 0.0007084655808284879
whether O 0 0.00030097420676611364
malfunction O 0 0.15150636434555054
of O 0 0.0006373074720613658
ion O 0 0.0023649309296160936
channels O 0 0.0003997736785095185
could O 0 0.0003124826471321285
cause O 0 0.00583431264385581
the O 0 0.001176612451672554
disorder O 1 0.9999904632568359
by O 0 0.00030556938145309687
studying O 0 0.0005664247437380254
mutations O 0 0.0002341072540730238
in O 0 0.00016848654195200652
the O 0 0.0005989262135699391
cardiac O 1 0.9998346567153931
sodium O 0 0.004952335264533758
channel O 0 0.0013477163156494498
gene O 0 0.0012187748216092587
SCN5A O 1 0.9993519186973572
. O 0 0.0015645540552213788

We O 0 0.0009401507559232414
have O 0 0.00014538198593072593
now O 0 0.00012167245586169884
identified O 0 0.00012122277257731184
a O 0 0.00017683951591607183
missense O 0 0.0007105582626536489
mutation O 0 0.0001533189497422427
, O 0 7.630747859366238e-05
a O 0 0.000202585753868334
splice O 0 0.004148493055254221
- O 0 0.0011450687889009714
donor O 0 0.0005826650303788483
mutation O 0 0.00021141153411008418
, O 0 0.0001389338867738843
and O 0 0.00012391195923555642
a O 0 0.0003549731627572328
frameshift O 0 0.004236549139022827
mutation O 0 0.00018535117851570249
in O 0 9.3870323325973e-05
the O 0 0.00018264225218445063
coding O 0 0.0003860464785248041
region O 0 0.00032672935049049556
of O 0 0.0005714294966310263
SCN5A O 1 0.9999837875366211
in O 0 0.0008268214878626168
three O 0 0.0007041891803964972
IVF B-Disease 1 0.9981105327606201
families O 0 0.0007099619251675904
. O 0 0.0008784118108451366

We O 0 0.0011368910782039165
show O 0 0.0008577057160437107
that O 0 8.371664443984628e-05
sodium O 0 0.0003383037110324949
channels O 0 8.374777098651975e-05
with O 0 2.7946267437073402e-05
the O 0 0.00014356017345562577
missense O 0 0.0013502086512744427
mutation O 0 0.00040827118209563196
recover O 0 0.0011965817539021373
from O 0 0.00029260944575071335
inactivation O 0 0.006620677653700113
more O 0 9.147838136414066e-05
rapidly O 0 0.00036307433038018644
than O 0 5.702939233742654e-05
normal O 0 9.464222239330411e-05
and O 0 3.747999653569423e-05
that O 0 2.5718958568177186e-05
the O 0 0.0001924075768329203
frameshift O 0 0.0035644068848341703
mutation O 0 0.0004159152158536017
causes O 0 0.0006657780613750219
the O 0 0.00035506283165887
sodium O 0 0.0007484607631340623
channel O 0 0.00017666527128312737
to O 0 7.252315117511898e-05
be O 0 0.00011178752174600959
non O 0 0.0007993333274498582
- O 0 0.0013754547107964754
functional O 0 0.0016757164848968387
. O 0 0.0007590699824504554

Our O 0 0.002028154442086816
results O 0 0.0002775378234218806
indicate O 0 0.00022944415104575455
that O 0 7.515848847106099e-05
mutations O 0 0.0003342056297697127
in O 0 0.00048711575800552964
cardiac O 1 0.9999637603759766
ion O 1 0.53215092420578
- O 0 0.0031913616694509983
channel O 0 0.0002769943093881011
genes O 0 7.698031549807638e-05
contribute O 0 0.00010827957157744095
to O 0 4.6539593313355e-05
the O 0 0.00017650665540713817
risk O 0 0.0002576863334979862
of O 0 0.0010566727723926306
developing O 1 0.7423192858695984
IVF B-Disease 1 0.9999977350234985
. O 0 0.0008763376390561461
. O 0 0.0009488327195867896

Molecular O 0 0.0055937510915100574
heterogeneity O 0 0.005874971859157085
in O 0 0.0017973796930164099
mucopolysaccharidosis B-Disease 1 0.9998975992202759
IVA I-Disease 1 0.9999812841415405
in O 0 0.0006103136111050844
Australia O 0 0.000374828145140782
and O 0 0.00010427336383145303
Northern O 0 0.00037823026650585234
Ireland O 0 0.0003061697934754193
: O 0 0.00013268770999275148
nine O 0 0.00022726428869646043
novel O 0 0.00045609453809447587
mutations O 0 0.00022640047245658934
including O 0 0.00035125520662404597
T312S O 1 0.9995962977409363
, O 0 0.00045930437045171857
a O 0 0.0003968577366322279
common O 0 0.0003748002927750349
allele O 0 0.00043151158024556935
that O 0 0.00012226910621393472
confers O 0 0.0020683137699961662
a O 0 0.0019116129260510206
mild O 1 0.9866093993186951
phenotype O 0 0.015350774861872196
. O 0 0.0016895995941013098

Mucopolysaccharidosis B-Disease 1 0.9999790191650391
IVA I-Disease 1 0.9999986886978149
( O 1 0.702748715877533
MPS B-Disease 1 0.9999294281005859
IVA I-Disease 1 0.9999998807907104
) O 0 0.0016572214663028717
is O 0 0.0003983269853051752
an O 0 0.0006261903326958418
autosomal B-Disease 1 0.5638951063156128
recessive I-Disease 1 0.9999946355819702
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 1 0.9999995231628418
by O 0 0.0005523256841115654
a O 0 0.0016084754606708884
genetic B-Disease 0 0.30589962005615234
defect I-Disease 1 0.9999974966049194
in O 0 0.001207763678394258
N O 0 0.04283968731760979
- O 0 0.002186285797506571
acetylgalactosamine O 0 0.4082005023956299
- O 0 0.0014155133394524455
6 O 0 0.0018876187968999147
- O 0 0.0033737956546247005
sulfate O 1 0.9477365612983704
sulfatase O 1 0.9998564720153809
( O 0 0.005614128895103931
GALNS O 1 0.9999908208847046
) O 0 0.0013446944067254663
. O 0 0.0011230171658098698

Previous O 0 0.0016941312933340669
studies O 0 0.0001987591094803065
of O 0 0.0003979243047069758
patients O 0 0.00024500949075445533
from O 0 0.00018626003293320537
a O 0 0.0003831600770354271
British O 0 0.0011494571808725595
- O 0 0.0007192144985310733
Irish O 0 0.0005755997844971716
population O 0 4.3945579818682745e-05
showed O 0 0.00014894211199134588
that O 0 3.2717554859118536e-05
the O 0 0.00017084753199014813
I113F O 1 0.8795398473739624
mutation O 0 0.0002702664933167398
is O 0 5.819284706376493e-05
the O 0 0.00014637433923780918
most O 0 9.201669308822602e-05
common O 0 9.73998467088677e-05
single O 0 0.0003261063829995692
mutation O 0 0.0003743546549230814
among O 0 0.0006842821603640914
MPS B-Disease 1 0.9999910593032837
IVA I-Disease 1 1.0
patients O 1 0.5670452117919922
and O 0 0.0009304950945079327
produces O 0 0.00186042336281389
a O 0 0.002549051772803068
severe O 1 0.9999858140945435
clinical O 1 0.9955299496650696
phenotype O 1 0.8957977294921875
. O 0 0.0020418744534254074

We O 0 0.0010542203672230244
studied O 0 0.0010856278240680695
mutations O 0 0.00044588075252249837
in O 0 0.00016201830294448882
the O 0 0.00048383313696831465
GALNS O 1 0.997589111328125
gene O 0 0.00025753112277016044
from O 0 0.00015906378393992782
23 O 0 0.0006565373623743653
additional O 0 0.0003458831342868507
MPS B-Disease 1 0.9927527904510498
IVA I-Disease 1 0.9999997615814209
patients O 0 0.001073752180673182
( O 0 0.00023706704087089747
15 O 0 0.00028687651501968503
from O 0 8.915374928619713e-05
Australia O 0 0.0001630910555832088
, O 0 5.66110793442931e-05
8 O 0 0.0001562228862894699
from O 0 6.990416295593604e-05
Northern O 0 0.0003955299616791308
Ireland O 0 0.00042353698518127203
) O 0 6.794768705731258e-05
, O 0 6.737100920872763e-05
with O 0 3.98322990804445e-05
various O 0 0.00014928195741958916
clinical O 0 0.003274141578003764
phenotypes O 1 0.9433693289756775
( O 0 0.025546396151185036
severe O 1 0.9999921321868896
, O 0 0.0003494693955872208
16 O 0 0.0005875423667021096
cases O 0 9.298229269916192e-05
; O 0 5.443893314804882e-05
intermediate O 0 0.00046054288395680487
, O 0 7.87827157182619e-05
4 O 0 0.00023782227071933448
cases O 0 0.00012884497118648142
; O 0 0.00010092492448166013
mild O 0 0.0016553814057260752
, O 0 0.00018382523558102548
3 O 0 0.0005378107889555395
cases O 0 0.00029693328542634845
) O 0 0.00042477180249989033
. O 0 0.0007249114569276571

We O 0 0.0009206052054651082
found O 0 0.00016293810040224344
two O 0 7.14532143319957e-05
common O 0 0.00018168157839681953
mutations O 0 0.00013628810120280832
that O 0 3.5529305023374036e-05
together O 0 7.546925189672038e-05
accounted O 0 0.0001851904089562595
for O 0 3.136710438411683e-05
32 O 0 8.68234274093993e-05
% O 0 3.339351314934902e-05
of O 0 8.438863005721942e-05
the O 0 0.0002300816122442484
44 O 0 0.0005312145804055035
unrelated O 0 0.0008075098157860339
alleles O 0 0.00034250918542966247
in O 0 0.00030336962663568556
these O 0 0.00021377457596827298
patients O 0 0.0009800302796065807
. O 0 0.0007713501690886915

One O 0 0.001429215888492763
is O 0 0.000464429467683658
the O 0 0.0006255085463635623
T312S O 1 0.9556961059570312
mutation O 0 0.0005799018545076251
, O 0 0.00015319457452278584
a O 0 0.0002697835152503103
novel O 0 0.0004743984609376639
mutation O 0 0.00023171294014900923
found O 0 0.0001441267813788727
exclusively O 0 0.00033411450567655265
in O 0 0.0003849086060654372
milder O 0 0.006467336788773537
patients O 0 0.001870558480732143
. O 0 0.0010846963850781322

The O 0 0.0013742074370384216
other O 0 0.00022976682521402836
is O 0 0.0001456985337426886
the O 0 0.0002484178403392434
previously O 0 0.0005164159811101854
described O 0 0.0010964672546833754
I113F O 1 0.9767797589302063
that O 0 0.0004846773808822036
produces O 0 0.0009339275420643389
a O 0 0.0015561181353405118
severe O 1 0.9999330043792725
phenotype O 1 0.6397436261177063
. O 0 0.002371003618463874

The O 0 0.008235553279519081
I113F O 1 0.9678947329521179
and O 0 0.002054879441857338
T312S O 1 0.7173460721969604
mutations O 0 0.000587228627409786
accounted O 0 0.0005690068937838078
for O 0 8.608393545728177e-05
8 O 0 0.00027218653121963143
( O 0 8.67037961143069e-05
18 O 0 0.00016132691234815866
% O 0 4.305878610466607e-05
) O 0 2.7961617888649926e-05
and O 0 3.573979120119475e-05
6 O 0 0.00020449656585697085
( O 0 8.380282088182867e-05
14 O 0 0.0001782945910235867
% O 0 6.0519327234942466e-05
) O 0 3.605954771046527e-05
of O 0 0.00013554043835029006
44 O 0 0.0006150362314656377
unrelated O 0 0.0014161188155412674
alleles O 0 0.000665063678752631
, O 0 0.0005562526639550924
respectively O 0 0.0017270531971007586
. O 0 0.0006943994085304439

The O 0 0.0027649570256471634
relatively O 0 0.001252564718015492
high O 0 0.00213418435305357
residual O 0 0.11772500723600388
GALNS O 1 0.999975323677063
activity O 0 0.0018250758294016123
seen O 0 0.0007230243645608425
when O 0 0.00019670937035698444
the O 0 0.00031432165997102857
T312S O 0 0.0231978427618742
mutant O 0 0.0031738835386931896
cDNA O 0 0.002426845720037818
is O 0 0.00026540507678873837
overexpressed O 0 0.0018905334873124957
in O 0 0.00023998733377084136
mutant O 0 0.001761494786478579
cells O 0 0.0002780123904813081
provides O 0 4.773196269525215e-05
an O 0 3.2494357583345845e-05
explanation O 0 0.00014781253412365913
for O 0 8.666659414302558e-05
the O 0 0.00042747921543195844
mild O 0 0.031780749559402466
phenotype O 0 0.0017069773748517036
in O 0 0.00035811879206448793
patients O 0 0.0002831030578818172
with O 0 0.00016216681979130954
this O 0 0.0002850193704944104
mutation O 0 0.0009292326285503805
. O 0 0.0008967055473476648

The O 0 0.0016528922133147717
distribution O 0 0.0003713528567459434
and O 0 0.00011424215335864574
relative O 0 0.000171848718309775
frequencies O 0 5.752078504883684e-05
of O 0 0.0001253278460353613
the O 0 0.0003496867138892412
I113F O 1 0.9949303269386292
and O 0 0.00048248606617562473
T312S O 1 0.9950639605522156
mutations O 0 0.00029452916351146996
in O 0 0.00011300354526611045
Australia O 0 0.0001638995308894664
corresponded O 0 0.000270473217824474
to O 0 5.344054807210341e-05
those O 0 4.661972707253881e-05
observed O 0 0.00011021339742001146
in O 0 0.00013188167940825224
Northern O 0 0.000479399343021214
Ireland O 0 0.00031675532227382064
and O 0 0.00011608293425524607
are O 0 1.4325354641187005e-05
unique O 0 5.387383862398565e-05
to O 0 3.809322151937522e-05
these O 0 1.760319537424948e-05
two O 0 3.602030119509436e-05
populations O 0 6.548056262545288e-05
, O 0 7.234790246002376e-05
suggesting O 0 0.00019919584156014025
that O 0 4.278295091353357e-05
both O 0 6.103480700403452e-05
mutations O 0 0.00010080989159177989
were O 0 0.00010017074237111956
probably O 0 0.00025173151516355574
introduced O 0 0.00015774792700540274
to O 0 5.004268678021617e-05
Australia O 0 0.00013290930655784905
by O 0 4.04966740461532e-05
Irish O 0 0.00043234843178652227
migrants O 0 0.00022348090715240687
during O 0 0.0005497107631526887
the O 0 0.00033911046921275556
19th O 0 0.004971091635525227
century O 0 0.004025761503726244
. O 0 0.0008362188818864524

Haplotype O 0 0.007839478552341461
analysis O 0 0.0004646402667276561
using O 0 0.00035028913407586515
6 O 0 0.0011334907030686736
RFLPs O 0 0.016968820244073868
provides O 0 0.00022133553284220397
additional O 0 9.372095519211143e-05
data O 0 3.7416215491248295e-05
that O 0 2.7563199182623066e-05
the O 0 0.0001830182591220364
I113F O 0 0.07927166670560837
mutation O 0 0.000331154209561646
originated O 0 0.00039158144500106573
from O 0 0.00021326240675989538
a O 0 0.0004197659145575017
common O 0 0.0005130622303113341
ancestor O 0 0.006637464743107557
. O 0 0.0016827606596052647

The O 0 0.0009842728031799197
other O 0 0.00029088847804814577
9 O 0 0.0009259061189368367
novel O 0 0.0006968984962441027
mutations O 0 0.00014627751079387963
identified O 0 8.046294533414766e-05
in O 0 6.813610525568947e-05
these O 0 2.9744167477474548e-05
23 O 0 0.00040462572360411286
patients O 0 0.0001004222795017995
were O 0 5.154248356120661e-05
each O 0 2.1252188162179664e-05
limited O 0 2.2910458937985823e-05
to O 0 3.661299706436694e-05
a O 0 0.0002562858280725777
single O 0 0.00038661499274894595
family O 0 0.0006271207821555436
. O 0 0.0008215869311243296

These O 0 0.00028769602067768574
data O 0 0.00013366425991989672
provide O 0 9.108311496675014e-05
further O 0 0.00014025901327840984
evidence O 0 0.0002550910576246679
for O 0 0.00014135702804196626
extensive O 0 0.0015066915657371283
allelic O 0 0.006609306205064058
heterogeneity O 0 0.0038719719741493464
in O 0 0.0015665703685954213
MPS B-Disease 1 0.9991441965103149
IVA I-Disease 1 0.9999988079071045
in O 0 0.0014016682980582118
British O 0 0.007686941884458065
- O 0 0.003330132458359003
Irish O 0 0.002694207476451993
patients O 0 0.0001754406839609146
and O 0 7.175802602432668e-05
provide O 0 5.851136302226223e-05
evidence O 0 9.587587555870414e-05
for O 0 3.6715158785227686e-05
their O 0 4.806870856555179e-05
transmission O 0 0.00016781347221694887
to O 0 4.533133687800728e-05
Australia O 0 0.00011887477012351155
by O 0 6.516336725326255e-05
British O 0 0.000710553489625454
- O 0 0.000637059158179909
Irish O 0 0.0007486519170925021
migrants O 0 0.00025697925593703985
. O 0 0.00016202603001147509
. O 0 0.00038969950401224196

Identification O 0 0.001935565029270947
of O 0 0.002187296748161316
constitutional O 0 0.01930910535156727
WT1 O 1 0.9999970197677612
mutations O 0 0.0013697845861315727
, O 0 0.0002187533100368455
in O 0 0.00020474375924095511
patients O 0 0.0005274550057947636
with O 0 0.0005194345721974969
isolated O 1 0.999983549118042
diffuse B-Disease 1 1.0
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 0.006759892217814922
and O 0 0.00048760094796307385
analysis O 0 0.0001149504678323865
of O 0 0.0004621634434442967
genotype O 0 0.004218756221234798
/ O 0 0.006630632560700178
phenotype O 0 0.0008236925932578743
correlations O 0 0.00021365599241107702
by O 0 5.232147668721154e-05
use O 0 3.291552638984285e-05
of O 0 0.00014956446830183268
a O 0 0.00037616296322084963
computerized O 0 0.0010119571816176176
mutation O 0 0.0005256797885522246
database O 0 0.0003716032369993627
. O 0 0.0005171432858332992

Constitutional O 0 0.004359643440693617
mutations O 0 0.0005593437235802412
of O 0 0.0006347355665639043
the O 0 0.001568943029269576
WT1 O 1 0.9997907280921936
gene O 0 0.0005026873550377786
, O 0 0.00014038369408808649
encoding O 0 0.00014497335359919816
a O 0 0.0005328435217961669
zinc O 1 0.9924112558364868
- O 0 0.0013001151382923126
finger O 0 0.003938250709325075
transcription O 0 0.0017094201175495982
factor O 0 0.0007257871911861002
involved O 0 0.0006153469439595938
in O 0 0.0012524769408628345
renal O 1 1.0
and O 1 0.995947539806366
gonadal O 1 1.0
development O 1 0.9327211976051331
, O 0 0.0001344455376965925
are O 0 1.1812063348770607e-05
found O 0 3.237221244489774e-05
in O 0 6.061531894374639e-05
most O 0 7.593812915729359e-05
patients O 0 0.0002028385642915964
with O 0 0.0003949903475586325
Denys B-Disease 1 1.0
- I-Disease 1 0.9999995231628418
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9991219639778137
DDS B-Disease 1 1.0
) O 0 0.0013092139270156622
, O 0 0.0008097698446363211
or O 0 0.002370824571698904
diffuse B-Disease 1 0.9999921321868896
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 1 0.9999878406524658
DMS B-Disease 1 0.9999998807907104
) O 0 0.00044833801803179085
associated O 0 0.000264046189840883
with O 0 0.0003456760896369815
pseudohermaphroditism B-Disease 1 0.9999995231628418
and O 0 0.016636479645967484
/ O 1 0.9990423321723938
or O 1 0.9639756679534912
Wilms B-Disease 1 1.0
tumor I-Disease 1 1.0
( O 0 0.44167211651802063
WT B-Disease 1 0.9999912977218628
) O 0 0.001248649787157774
. O 0 0.001030792249366641

Most O 0 0.0027274703606963158
mutations O 0 0.0019757929258048534
in O 0 0.002009614137932658
DDS B-Disease 1 0.999998927116394
patients O 0 0.0017225572373718023
lie O 0 0.0023646545596420765
in O 0 0.0003401237481739372
exon O 0 0.0018149768002331257
8 O 0 0.000372799375327304
or O 0 0.00014291318075265735
exon O 0 0.0010022599017247558
9 O 0 0.0003813733346760273
, O 0 8.624225301900879e-05
encoding O 0 0.0001965395058505237
zinc O 0 0.0053779371082782745
finger O 0 0.004990370478481054
2 O 0 0.0009930790401995182
or O 0 0.0006219094502739608
zinc O 1 0.9818284511566162
finger O 0 0.21329179406166077
3 O 0 0.0007526277331635356
, O 0 0.00015453301602974534
respectively O 0 0.00014954834477975965
, O 0 4.6940611355239525e-05
with O 0 4.268978227628395e-05
a O 0 0.0002994464011862874
hot O 0 0.0025234336499124765
spot O 0 0.0021693336311727762
( O 0 0.0005277592572383583
R394W O 0 0.01747194305062294
) O 0 0.00023057263751979917
in O 0 0.00031092128483578563
exon O 0 0.0046264673583209515
9 O 0 0.0026201747823506594
. O 0 0.0008078876417130232

We O 0 0.0005941278650425375
analyzed O 0 0.0002306606329511851
a O 0 0.0001405023504048586
series O 0 0.00013808635412715375
of O 0 0.00023496417270507663
24 O 0 0.0010685031302273273
patients O 0 0.00028181393281556666
, O 0 0.0001595501962583512
10 O 0 0.00026282554608769715
with O 0 0.00021323330292943865
isolated B-Disease 0 0.49741706252098083
DMS I-Disease 1 0.9999997615814209
( O 0 0.012475327588617802
IDMS B-Disease 1 0.9999765157699585
) O 0 0.0002550728095229715
, O 0 9.847823821473867e-05
10 O 0 0.0002031098847510293
with O 0 0.00021421676501631737
DDS B-Disease 1 0.9999936819076538
, O 0 0.00034949553082697093
and O 0 0.0003337391244713217
4 O 0 0.0013526483671739697
with O 0 0.001105699804611504
urogenital B-Disease 1 1.0
abnormalities I-Disease 1 1.0
and O 1 0.999354898929596
/ O 1 0.9999861717224121
or O 1 0.8470571041107178
WT B-Disease 1 0.9999974966049194
. O 0 0.0037112932186573744

We O 0 0.002377487951889634
report O 0 0.0012809119652956724
WT1 O 0 0.40720435976982117
heterozygous O 0 0.000696422765031457
mutations O 0 0.00017755186127033085
in O 0 0.00015232527221087366
16 O 0 0.0005893124616704881
patients O 0 0.00023884506663307548
, O 0 9.924193000188097e-05
4 O 0 0.0003975004074163735
of O 0 0.0005739753250963986
whom O 0 0.0009866876062005758
presented O 0 0.0027545448392629623
with O 0 0.0018939700676128268
IDMS B-Disease 1 0.999996542930603
. O 0 0.005009077023714781

One O 0 0.001989479875192046
male O 0 0.001553144189529121
and O 0 0.0004263584560249001
two O 0 0.0006038486026227474
female O 1 0.6309393644332886
IDMS B-Disease 1 0.9999997615814209
patients O 0 0.29058605432510376
with O 0 0.0062520806677639484
WT1 O 1 0.9999998807907104
mutations O 1 0.8629681468009949
underwent O 1 0.999998927116394
normal O 1 0.9209654331207275
puberty O 1 0.9994580149650574
. O 0 0.0011715730652213097

Two O 0 0.001981955487281084
mutations O 0 0.0012291927123442292
associated O 0 0.0006020906148478389
with O 0 0.0004737712151836604
IDMS B-Disease 1 0.9999464750289917
are O 0 4.576385981636122e-05
different O 0 2.322022737644147e-05
from O 0 7.021844066912308e-05
those O 0 6.779817340429872e-05
described O 0 0.0006700598169118166
in O 0 0.0021476184483617544
DDS B-Disease 1 1.0
patients O 0 0.15557831525802612
. O 0 0.0018127044895663857

No O 0 0.008204461075365543
WT1 O 1 0.9996577501296997
mutations O 0 0.0009276579949073493
were O 0 0.00021696442854590714
detected O 0 0.0002597014245111495
in O 0 8.860260277288035e-05
the O 0 0.00017943386046681553
six O 0 0.0004058385093230754
other O 0 0.0002754227025434375
IDMS B-Disease 1 0.9999995231628418
patients O 0 0.002193635795265436
, O 0 0.0002732616849243641
suggesting O 0 0.0009834133088588715
genetic O 0 0.00040743735735304654
heterogeneity O 0 0.001710092299617827
of O 0 0.003854133188724518
this O 0 0.007714911364018917
disease O 1 0.9999984502792358
. O 0 0.002199064241722226

We O 0 0.0009853644296526909
analyzed O 0 0.001526923617348075
genotype O 0 0.0029199644923210144
/ O 0 0.0031204877886921167
phenotype O 0 0.0008823456591926515
correlations O 0 0.00038755705463699996
, O 0 7.190434553194791e-05
on O 0 8.459553646389395e-05
the O 0 8.200021693482995e-05
basis O 0 3.0124891054583713e-05
of O 0 6.779817340429872e-05
the O 0 0.0001264574530068785
constitution O 0 0.0001393243292113766
of O 0 0.00027754626353271306
a O 0 0.0007761524175293744
WT1 O 1 0.9930111765861511
mutation O 0 0.0002337949408683926
database O 0 0.00010824209311977029
of O 0 0.00024735875194892287
84 O 0 0.005066039506345987
germ O 1 0.9999974966049194
- O 0 0.02933548204600811
line O 0 0.0016200845129787922
mutations O 0 0.00013775835395790637
, O 0 5.6175587815232575e-05
to O 0 4.147295840084553e-05
compare O 0 8.990667265607044e-05
the O 0 0.00011821619409602135
distribution O 0 8.844188414514065e-05
and O 0 0.00010601661779219285
type O 0 0.00030133884865790606
of O 0 0.0005549811758100986
mutations O 0 0.0002159201685572043
, O 0 8.313827856909484e-05
according O 0 4.371330942376517e-05
to O 0 5.591562876361422e-05
the O 0 0.00018031436775345355
different O 0 0.000121582459541969
symptoms O 1 0.9206722974777222
. O 0 0.0017103039426729083

This O 0 0.0006497877184301615
demonstrated O 0 0.0015408516628667712
( O 0 0.0003101432812400162
1 O 0 0.0003509322414174676
) O 0 0.00010898189066210762
the O 0 0.00013296531687956303
association O 0 0.00019617816724348813
between O 0 0.00011796801118180156
mutations O 0 0.0001314149412792176
in O 0 9.114557906286791e-05
exons O 0 0.0005673126433975995
8 O 0 0.00032321270555257797
and O 0 0.00013396180293057114
9 O 0 0.0006101917242631316
and O 0 0.00028092574211768806
DMS B-Disease 1 0.9998798370361328
; O 0 0.0001538731303298846
( O 0 0.00019269470067229122
2 O 0 0.00032251060474663973
) O 0 0.00011923351121367887
among O 0 0.0001395566068822518
patients O 0 0.00025611851015128195
with O 0 0.0003378499241080135
DMS B-Disease 1 0.9999886751174927
, O 0 0.0002431087923469022
a O 0 0.00012946210335940123
higher O 0 0.00010156103962799534
frequency O 0 3.895863119396381e-05
of O 0 7.691486098337919e-05
exon O 0 0.0007501173531636596
8 O 0 0.0003259180230088532
mutations O 0 0.00011659958545351401
among O 0 0.00010270215716445819
46 O 0 0.0005897512310184538
, O 0 0.0006329060415737331
XY O 1 0.9966427087783813
patients O 0 0.0005334767047315836
with O 0 0.00024298969947267324
female O 0 0.002421244280412793
phenotype O 0 0.0008979722624644637
than O 0 0.00010257511166855693
among O 0 0.00018417788669466972
46 O 0 0.0007207129965536296
, O 0 0.0006245450349524617
XY O 1 0.9990001320838928
patients O 0 0.0006920850719325244
with O 0 0.00022682049893774092
sexual O 0 0.0015398669056594372
ambiguity O 0 0.01988516002893448
or O 0 0.0023728259839117527
male O 0 0.0042786248959600925
phenotype O 0 0.0013605320127680898
; O 0 8.324211376020685e-05
and O 0 0.00010549774742685258
( O 0 0.0001522725506220013
3 O 0 0.0002268250536872074
) O 0 6.340847176034003e-05
statistically O 0 3.934997585020028e-05
significant O 0 5.607774801319465e-05
evidence O 0 8.028619777178392e-05
that O 0 3.81798563466873e-05
mutations O 0 5.814702672068961e-05
in O 0 7.991574238985777e-05
exons O 0 0.0005290360422804952
8 O 0 0.0003394967061467469
and O 0 0.00014893643674440682
9 O 0 0.0004359549784567207
preferentially O 0 0.00044942719978280365
affect O 0 0.00020536845840979367
amino O 0 0.00016293094085995108
acids O 0 8.528068428859115e-05
with O 0 4.207841993775219e-05
different O 0 4.5160293666413054e-05
functions O 0 0.00016911666898522526
. O 0 0.00021106752683408558
. O 0 0.0005331375868991017

The O 0 0.01038721576333046
185delAG O 1 0.9967257976531982
BRCA1 O 0 0.050931163132190704
mutation O 0 0.0004982987884432077
originated O 0 0.0005049603059887886
before O 0 0.00017538580868858844
the O 0 8.374929166166112e-05
dispersion O 0 0.00027507057529874146
of O 0 0.00016709112969692796
Jews O 0 0.000489362864755094
in O 0 9.830437920754775e-05
the O 0 0.0001719562424113974
diaspora O 0 0.00023709936067461967
and O 0 9.493825200479478e-05
is O 0 8.173633250407875e-05
not O 0 5.5747430451447144e-05
limited O 0 9.762832632986829e-05
to O 0 0.00020273686095606536
Ashkenazim O 0 0.019705060869455338
. O 0 0.001564433565363288

The O 0 0.0038090909365564585
185delAG O 1 0.9327624440193176
mutation O 0 0.0008808793500065804
in O 0 0.000491479120682925
BRCA1 O 0 0.07884560525417328
is O 0 0.00030187430093064904
detected O 0 0.0005997304106131196
in O 0 0.00015626550884917378
Ashkenazi O 0 0.0009826223831623793
Jews O 0 0.00043845767504535615
both O 0 0.00015551838441751897
in O 0 0.0006266153650358319
familial B-Disease 1 0.9999781847000122
breast I-Disease 1 1.0
and I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.0026711735408753157
in O 0 0.0002802190138027072
the O 0 0.00046152601134963334
general O 0 0.000792751437984407
population O 0 0.00018443235603626817
. O 0 0.0003529567620716989

All O 0 0.002066847635433078
tested O 0 0.0031952536664903164
Ashkenazi O 0 0.004901271779090166
mutation O 0 0.0007492879522033036
carriers O 0 0.00030300082289613783
share O 0 6.419967394322157e-05
the O 0 0.00011705588985932991
same O 0 0.00011473210906842723
allelic O 0 0.0022019247990101576
pattern O 0 0.0015863465378060937
at O 0 0.0019282940775156021
the O 0 0.0017641951562836766
BRCA1 O 1 0.8320531249046326
locus O 0 0.006379603408277035
. O 0 0.0010406564688310027

Our O 0 0.0017712918343022466
previous O 0 0.0006806331221014261
study O 0 0.00018033843662124127
showed O 0 0.00030710059218108654
that O 0 4.018384061055258e-05
this O 0 5.610336665995419e-05
Ashkenazi O 0 0.001145659014582634
mutation O 0 0.000164245895575732
also O 0 6.858802225906402e-05
occurs O 0 9.94990041363053e-05
in O 0 6.969269452383742e-05
Iraqi O 0 0.001123386318795383
Jews O 0 0.0003245317202527076
with O 0 0.00010421362821944058
a O 0 0.00034307147143408656
similar O 0 0.0003484250046312809
allelic O 0 0.008782918564975262
pattern O 0 0.008145392872393131
. O 0 0.0023771622218191624

We O 0 0.0008883531554602087
extended O 0 0.0006617822800762951
our O 0 0.00016855887952260673
analysis O 0 3.530002504703589e-05
to O 0 5.425303243100643e-05
other O 0 6.551303522428498e-05
non O 0 0.0003369653131812811
- O 0 0.0006593415164388716
Ashkenazi O 0 0.0013409549137577415
subsets O 0 0.000867885013576597
354 O 0 0.001345912809483707
of O 0 0.0002668712113518268
Moroccan O 0 0.0014241208555176854
origin O 0 0.000285458896541968
, O 0 0.00025246411678381264
200 O 0 0.0008221454336307943
Yemenites O 0 0.010926979593932629
and O 0 0.00033060976420529187
150 O 0 0.0007941977819427848
Iranian O 0 0.00196706410497427
Jews O 0 0.0027858843095600605
. O 0 0.001350406906567514

Heteroduplex O 0 0.12907084822654724
analysis O 0 0.0005205011111684144
complemented O 0 0.0009927013888955116
by O 0 8.361197251360863e-05
direct O 0 9.161613706965e-05
DNA O 0 0.00032702574389986694
sequencing O 0 0.0005877334042452276
of O 0 0.0005739832413382828
abnormally O 0 0.0048402114771306515
migrating O 0 0.0008146984037011862
bands O 0 0.0010103735839948058
were O 0 0.0003802098799496889
employed O 0 0.0013997654896229506
. O 0 0.0006187460967339575

Four O 0 0.0006429565837606788
of O 0 0.00040478931623511016
Moroccan O 0 0.0012370911426842213
origin O 0 0.00016984486137516797
( O 0 0.00010393346019554883
1 O 0 0.00015717136557213962
. O 0 4.3037314753746614e-05
1 O 0 8.919006359064952e-05
% O 0 4.780074596055783e-05
) O 0 3.6686040402855724e-05
and O 0 4.604933928931132e-05
none O 0 8.803697710391134e-05
of O 0 0.00015301427629310638
the O 0 0.0006028612842783332
Yemenites O 1 0.9770821928977966
or O 0 0.00030814262572675943
Iranians O 0 0.0008494156063534319
was O 0 0.00042708328692242503
a O 0 0.00020091103215236217
carrier O 0 0.00038761168252676725
of O 0 0.00022561135119758546
the O 0 0.001204300089739263
185delAG O 1 0.999678373336792
mutation O 0 0.0020416509360074997
. O 0 0.000929580710362643

BRCA1 O 1 0.856589138507843
allelic O 0 0.022238492965698242
patterns O 0 0.0011711277766153216
were O 0 0.00021259787899907678
determined O 0 0.00015918731514830142
for O 0 3.436529732425697e-05
four O 0 3.8958038203418255e-05
of O 0 6.4324754930567e-05
these O 0 1.7520727851660922e-05
individuals O 0 1.5553447155980393e-05
and O 0 3.216456389054656e-05
for O 0 3.8653917727060616e-05
12 O 0 0.00029032136080786586
additional O 0 0.00015329568122979254
non O 0 0.0006091011455282569
- O 0 0.0010146691929548979
Ashkenazi O 0 0.0030957902781665325
185delAG O 0 0.21459849178791046
mutation O 0 0.0005358377820812166
carriers O 0 0.0004044182423967868
who O 0 0.000544194015674293
had O 1 0.5597618222236633
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.007584867998957634

Six O 0 0.004027392715215683
non O 0 0.0026836926117539406
- O 0 0.0015119288582354784
Ashkenazi O 0 0.00201805611141026
individuals O 0 0.00012278858048375696
shared O 0 0.00016956830222625285
the O 0 0.0002549828786868602
common O 0 0.000273752462817356
Ashkenazi O 0 0.0043398551642894745
haplotype O 0 0.0011089160107076168
, O 0 0.00014408664719667286
four O 0 0.00010622294212225825
had O 0 0.00017417773779015988
a O 0 0.0001566590799484402
closely O 0 0.00021174317225813866
related O 0 0.00034833847894333303
pattern O 0 0.001221978454850614
, O 0 0.0001735719561111182
and O 0 9.964922355720773e-05
the O 0 0.0002814404433593154
rest O 0 0.000677910284139216
( O 0 0.0002672893169801682
n O 0 0.0004939123173244298
= O 0 0.0005512677598744631
6 O 0 0.0004068171256221831
) O 0 0.00010912861034739763
displayed O 0 0.0005003706901334226
a O 0 0.0003443710447754711
distinct O 0 0.000725985097233206
BRCA1 O 0 0.22975967824459076
allelic O 0 0.03716498240828514
pattern O 0 0.02381659671664238
. O 0 0.0026629497297108173

We O 0 0.0012361059198156
conclude O 0 0.001327145379036665
that O 0 0.00011785511742345989
the O 0 0.0006151361158117652
185delAG O 1 0.9746735692024231
BRCA1 O 0 0.25138816237449646
mutation O 0 0.0004723876481875777
occurs O 0 0.00016454434080515057
in O 0 7.558024663012475e-05
some O 0 5.006435821997002e-05
non O 0 0.0002739201008807868
- O 0 0.00044945659465156496
Ashkenazi O 0 0.0007577007636427879
populations O 0 0.00012330120080150664
at O 0 0.0002654850541148335
rates O 0 9.138918539974838e-05
comparable O 0 0.0001723479072097689
with O 0 4.5096945541445166e-05
that O 0 7.974430627655238e-05
of O 0 0.0006686398410238326
Ashkenazim O 1 0.6944173574447632
. O 0 0.0019829783122986555

The O 0 0.0015642547514289618
majority O 0 0.0002599680155981332
of O 0 0.000645111664198339
Jewish O 0 0.003051338717341423
185delAG O 1 0.9995723366737366
mutation O 0 0.0006608935073018074
carriers O 0 0.00020004513498861343
have O 0 3.261182428104803e-05
a O 0 0.00014169872156344354
common O 0 0.0002794506144709885
allelic O 0 0.004787427373230457
pattern O 0 0.0033192019909620285
, O 0 0.00032337786979041994
supporting O 0 0.00046576219028793275
the O 0 0.000592996715568006
founder O 0 0.03706492856144905
effect O 0 0.0006165662198327482
notion O 0 0.0005584966856986284
, O 0 0.0001223282451974228
but O 0 4.514625470619649e-05
dating O 0 0.0002587536000646651
the O 0 8.809475548332557e-05
mutations O 0 5.423575566965155e-05
origin O 0 3.2336643926100805e-05
to O 0 3.3444117434555665e-05
an O 0 5.808894275105558e-05
earlier O 0 0.00019244298164267093
date O 0 0.0002244300558231771
than O 0 7.731490768492222e-05
currently O 0 0.0002071237249765545
estimated O 0 0.0004737630661111325
. O 0 0.0006767974118702114

However O 0 0.0014372002333402634
, O 0 0.0002901724656112492
the O 0 0.00018475161050446332
different O 0 7.415101572405547e-05
allelic O 0 0.002269189106300473
pattern O 0 0.0012664551613852382
at O 0 0.001370905665680766
the O 0 0.0006491872482001781
BRCA1 O 0 0.011340351775288582
locus O 0 0.001055654021911323
even O 0 0.00010491408465895802
in O 0 6.712469621561468e-05
some O 0 4.181173426331952e-05
Jewish O 0 0.00042312778532505035
mutation O 0 0.00027693569427356124
carriers O 0 0.000399633077904582
, O 0 0.00011842784442706034
might O 0 0.00011352910223649815
suggest O 0 0.00010893908620346338
that O 0 4.037551116198301e-05
the O 0 0.00019762340525630862
mutation O 0 0.00029742345213890076
arose O 0 0.0011140672722831368
independently O 0 0.0002587104099802673
. O 0 0.00018452380027156323
. O 0 0.000503193587064743

Crystal O 0 0.05472614988684654
structure O 0 0.004665837623178959
of O 0 0.0024790437892079353
the O 0 0.007417724467813969
hemochromatosis B-Disease 1 1.0
protein O 0 0.033430591225624084
HFE O 1 0.9996609687805176
and O 0 0.0003593258443288505
characterization O 0 0.0008684285567142069
of O 0 0.00031290025799535215
its O 0 0.00017605922766961157
interaction O 0 0.00023960278485901654
with O 0 0.00041343647171743214
transferrin O 1 0.9957917928695679
receptor O 0 0.0027269201818853617
. O 0 0.0005975568201392889

HFE O 1 0.9963285326957703
is O 0 0.0009134754072874784
an O 0 0.0005989127093926072
MHC O 1 0.6943302750587463
- O 0 0.0012322190450504422
related O 0 0.0003833559458144009
protein O 0 0.00017121380369644612
that O 0 4.087754132342525e-05
is O 0 4.9997473979601637e-05
mutated O 0 0.00029259128496050835
in O 0 0.00021814803767483681
the O 0 0.001990229357033968
iron B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.9997748732566833

HFE O 1 0.9372722506523132
binds O 0 0.009752308949828148
to O 0 0.001769457245245576
transferrin O 1 0.7838496565818787
receptor O 0 0.0025714244693517685
( O 0 0.0008148762863129377
TfR O 1 0.6222020983695984
) O 0 0.00021194314467720687
and O 0 0.00014140448183752596
reduces O 0 0.00024234790180344135
its O 0 0.00010775517876027152
affinity O 0 0.000457293470390141
for O 0 0.0004876476596109569
iron O 1 0.9999942779541016
- O 0 0.038736727088689804
loaded O 0 0.009269515052437782
transferrin O 1 0.857204794883728
, O 0 0.0012059009168297052
implicating O 1 0.9987227320671082
HFE O 1 0.9999951124191284
in O 0 0.27666226029396057
iron O 1 0.9999998807907104
metabolism O 1 0.9997733235359192
. O 0 0.00256915669888258

The O 0 0.006346301641315222
2 O 0 0.0037212190218269825
. O 0 0.0013446816010400653

6 O 0 0.014820470474660397
A O 0 0.012057413347065449
crystal O 0 0.3327186107635498
structure O 0 0.004240936599671841
of O 0 0.0031323523726314306
HFE O 1 0.9998581409454346
reveals O 0 0.0034555804450064898
the O 0 0.0003834315575659275
locations O 0 0.0004181890981271863
of O 0 0.0019770851358771324
hemochromatosis B-Disease 1 1.0
mutations O 0 0.0018321055686101317
and O 0 0.0005717558669857681
a O 0 0.0013425536453723907
patch O 1 0.9998857975006104
of O 0 0.027793053537607193
histidines O 1 0.9999673366546631
that O 0 0.00010806881618918851
could O 0 6.23205560259521e-05
be O 0 2.5360202926094644e-05
involved O 0 8.722890197532251e-05
in O 0 0.00019477208843454719
pH O 0 0.012928832322359085
- O 0 0.0021257095504552126
dependent O 0 0.000606967369094491
interactions O 0 0.0005480193649418652
. O 0 0.0008140691788867116

We O 0 0.002324544358998537
also O 0 0.0007911514840088785
demonstrate O 0 0.0011895066127181053
that O 0 0.0004742103337775916
soluble O 0 0.1193590760231018
TfR O 1 0.9985337257385254
and O 0 0.0018432328943163157
HFE O 1 0.9994325041770935
bind O 0 0.001418188912793994
tightly O 0 0.0007232818170450628
at O 0 0.0005151728400960565
the O 0 0.00025480787735432386
basic O 0 0.0005307869869284332
pH O 0 0.0006978145684115589
of O 0 0.00021422511781565845
the O 0 0.0004457411414477974
cell O 0 0.002410400891676545
surface O 0 0.0006258880603127182
, O 0 7.03804034856148e-05
but O 0 2.4370467144763097e-05
not O 0 2.2902353521203622e-05
at O 0 0.0001704374881228432
the O 0 0.0002411768800811842
acidic O 0 0.0019723649602383375
pH O 0 0.002619720995426178
of O 0 0.001899105147458613
intracellular O 1 0.5057278275489807
vesicles O 0 0.16853591799736023
. O 0 0.002193656750023365

TfR O 1 0.9896175265312195
HFE O 1 0.9898083806037903
stoichiometry O 0 0.00934509001672268
( O 0 0.0006975805154070258
2 O 0 0.0007055668975226581
1 O 0 0.000400611839722842
) O 0 0.00011142600124003366
differs O 0 0.00023182184668257833
from O 0 0.00029170303605496883
TfR O 0 0.03202497214078903
transferrin O 0 0.018111130222678185
stoichiometry O 0 0.0018237680196762085
( O 0 0.00023350492119789124
2 O 0 0.00033616076689213514
2 O 0 0.0002957018732558936
) O 0 6.218792259460315e-05
, O 0 4.395773430587724e-05
implying O 0 0.00016189028974622488
a O 0 5.9759568102890626e-05
different O 0 2.4860431949491613e-05
mode O 0 0.00031007849611341953
of O 0 0.00020127822062931955
binding O 0 0.000274099555099383
for O 0 0.000291142932837829
HFE O 1 0.9997841715812683
and O 0 0.0011425529373809695
transferrin O 1 0.9714177250862122
to O 0 0.0009887231281027198
TfR O 1 0.9964390397071838
, O 0 0.00030759404762648046
consistent O 0 0.00022904893558006734
with O 0 0.00011200690641999245
our O 0 0.0004746911290567368
demonstration O 0 0.003752702847123146
that O 0 0.00039121840381994843
HFE O 1 0.9999474287033081
, O 0 0.0011992828221991658
transferrin O 1 0.9893145561218262
, O 0 0.00045203781337477267
and O 0 0.000380346376914531
TfR O 1 0.5962423086166382
form O 0 0.0005842343089170754
a O 0 0.001275618327781558
ternary O 0 0.055070389062166214
complex O 0 0.016361363232135773
. O 0 0.0014654783299192786

Identification O 0 0.000973532150965184
of O 0 0.000719295407179743
three O 0 0.00034277152735739946
novel O 0 0.0005969417979940772
mutations O 0 0.00013871506962459534
and O 0 7.678178371861577e-05
a O 0 0.00015735821216367185
high O 0 0.0002566755865700543
frequency O 0 8.294694271171466e-05
of O 0 0.00010192944318987429
the O 0 0.00025567764532752335
Arg778Leu O 1 0.9799813628196716
mutation O 0 0.00040722632547840476
in O 0 0.0005770070129074156
Korean O 1 0.6883049011230469
patients O 0 0.0013159152586013079
with O 0 0.0007986561395227909
Wilson B-Disease 1 0.9999865293502808
disease I-Disease 1 0.9999996423721313
. O 0 0.00466490350663662

Four O 0 0.002124853665009141
mutations O 0 0.002261226996779442
- O 0 0.0036439953837543726
- O 0 0.003504006192088127
R778L O 1 0.9795579314231873
, O 0 0.0009445034083910286
A874V O 1 0.9877362847328186
, O 0 0.0006411642534658313
L1083F O 1 0.7849287986755371
, O 0 0.0003568823158275336
and O 0 0.00035169703187420964
2304delC O 1 0.9459515810012817
- O 0 0.0021164054051041603
- O 0 0.0005085580050945282
in O 0 0.0001210287373396568
the O 0 0.0003671342565212399
copper O 1 0.9804645776748657
- O 0 0.0009576698066666722
transporting O 0 0.0024120938032865524
enzyme O 0 0.0005997338448651135
, O 0 0.0001683635200606659
P O 0 0.0020991854835301638
- O 0 0.0009474290418438613
type O 0 0.001050665508955717
ATPase O 0 0.0384129136800766
( O 0 0.0009387883474119008
ATP7B O 1 0.999832272529602
) O 0 0.00017759689944796264
, O 0 9.88036990747787e-05
were O 0 7.12725959601812e-05
identified O 0 0.0001365983916912228
in O 0 0.0003299997770227492
Korean O 1 0.9507155418395996
Patients O 0 0.00797252543270588
with O 0 0.0029753041453659534
Wilson B-Disease 1 0.9999992847442627
disease I-Disease 1 1.0
. O 0 0.011948352679610252

Arg778Leu O 1 0.9984164237976074
, O 0 0.0007920974167063832
the O 0 0.000372343638446182
most O 0 0.00013859210594091564
frequently O 0 0.0001605788856977597
reported O 0 0.00010086527618113905
mutation O 0 7.655061926925555e-05
of O 0 0.00014455577183980495
this O 0 0.0001461821375414729
enzyme O 0 0.00038643513107672334
, O 0 0.0001062620576703921
was O 0 0.00021817754895891994
found O 0 4.109752262593247e-05
in O 0 3.7693451304221526e-05
six O 0 8.701381739228964e-05
of O 0 0.00017682080215308815
eight O 0 0.0005020241369493306
unrelated O 0 0.0013550956500694156
patients O 0 0.000370082154404372
studied O 0 0.0004893594305031002
, O 0 0.00010839589958777651
an O 0 0.00013500718341674656
allele O 0 0.00019161116506438702
frequency O 0 0.0001313999091507867
of O 0 0.000346390123013407
37 O 0 0.001491004484705627
. O 0 0.0011563776060938835

5 O 0 0.002042346866801381
% O 0 0.0003659027279354632
, O 0 0.00015029715723358095
which O 0 7.137407374102622e-05
is O 0 7.412627019220963e-05
considerably O 0 0.00026879197685047984
higher O 0 7.888735854066908e-05
than O 0 2.7582129405345768e-05
those O 0 1.955760490091052e-05
in O 0 6.375139491865411e-05
other O 0 8.012711623450741e-05
Asian O 0 0.0012168381363153458
populations O 0 0.00037994523881934583
. O 0 0.0005185513291507959

The O 0 0.0021381480619311333
novel O 0 0.0014692265540361404
single O 0 0.0004146881401538849
nucleotide O 0 0.0010424957145005465
deletion O 0 0.0009651147411204875
, O 0 0.0002657717268448323
2304delC O 1 0.9717857241630554
, O 0 0.00033678548061288893
was O 0 0.0005303136422298849
found O 0 0.00015810511831659824
in O 0 0.0002316546015208587
one O 0 0.00047573429765179753
patient O 0 0.0015654594171792269
. O 0 0.0010390368988737464

Since O 0 0.0019617017824202776
a O 0 0.0005710491677746177
mutation O 0 0.0002973264781758189
at O 0 0.0005952629144303501
cDNA O 0 0.0020587474573403597
nucleotide O 0 0.001968356315046549
2302 O 0 0.27422669529914856
( O 0 0.0006074690609239042
2302insC O 0 0.08611931651830673
) O 0 0.00016018524183891714
had O 0 0.00016214395873248577
been O 0 0.00013350133667699993
previously O 0 0.00016020219482015818
described O 0 0.0002104742598021403
, O 0 4.4152253394713625e-05
this O 0 2.2533837181981653e-05
region O 0 9.715644409880042e-05
of O 0 0.0001862340868683532
the O 0 0.0015459278365597129
ATP7B O 1 0.9999998807907104
gene O 0 0.0014851974556222558
may O 0 0.00032926726271398365
be O 0 0.00012106497160857543
susceptible O 0 0.0008070604526437819
to O 0 0.00028220622334629297
gene O 0 0.0019571753218770027
rearrangements O 1 0.9997920393943787
causing O 1 0.9999996423721313
Wilson B-Disease 1 0.9999990463256836
disease I-Disease 1 0.9999998807907104
. O 0 0.004871252924203873

Disruption O 0 0.01796923764050007
of O 0 0.0011579152196645737
splicing O 0 0.0012274471810087562
regulated O 0 0.00028917056624777615
by O 0 8.412637544097379e-05
a O 0 0.0004106296692043543
CUG O 1 0.9998958110809326
- O 0 0.0014151838840916753
binding O 0 0.0004232912033330649
protein O 0 0.001131162396632135
in O 0 0.0029394803568720818
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.398241251707077

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999958276748657
DM B-Disease 1 1.0
) O 0 0.002128504915162921
is O 0 0.0003966839285567403
caused O 0 0.001454533776268363
by O 0 0.00012769988097716123
a O 0 0.0004055787867400795
CTG O 1 0.860327959060669
expansion O 0 0.0008065680740401149
in O 0 0.00010149589797947556
the O 0 0.00011100804840680212
3 O 0 0.0001723712484817952
untranslated O 0 0.0012008070480078459
region O 0 0.0002990190696436912
of O 0 0.0005074834916740656
the O 0 0.003148154355585575
DM B-Disease 1 0.9999998807907104
gene O 0 0.0034055549185723066
. O 0 0.0014169808709993958

One O 0 0.0016746990149840713
model O 0 0.0022308656480163336
of O 0 0.004937055055052042
DM B-Disease 1 1.0
pathogenesis O 1 0.9999717473983765
suggests O 0 0.0014878840884193778
that O 0 0.0001985119452001527
RNAs O 0 0.0008252072148025036
from O 0 0.00010672226926544681
the O 0 0.00011012547474820167
expanded O 0 0.00020991711062379181
allele O 0 8.20147615741007e-05
create O 0 5.5668122513452545e-05
a O 0 8.400341175729409e-05
gain O 0 0.00017874804325401783
- O 0 0.00030354122282005847
of O 0 0.0002397586067672819
- O 0 0.0005427783471532166
function O 0 0.00012504741607699543
mutation O 0 0.00010237811511615291
by O 0 4.159146192250773e-05
the O 0 0.00016750110080465674
inappropriate O 0 0.00044756129500456154
binding O 0 7.080207433318719e-05
of O 0 0.0001790223177522421
proteins O 0 0.00022210546012502164
to O 0 0.00025791936786845326
the O 0 0.001358537352643907
CUG O 1 0.9999504089355469
repeats O 0 0.007342596538364887
. O 0 0.0016732090152800083

Data O 0 0.0007603252888657153
presented O 0 0.000992974964901805
here O 0 0.00047915035975165665
indicate O 0 0.00027332271565683186
that O 0 5.699073153664358e-05
the O 0 0.00018617481691762805
conserved O 0 0.0009017241536639631
heterogeneous O 0 0.002690751338377595
nuclear O 0 0.007121603470295668
ribonucleoprotein O 1 0.9939143061637878
, O 0 0.0006240710499696434
CUG O 1 0.9980584979057312
- O 0 0.0007013878785073757
binding O 0 0.00018391077173873782
protein O 0 0.0003798179386649281
( O 0 0.00042194355046376586
CUG O 1 0.9999499320983887
- O 0 0.013632410205900669
BP O 0 0.30271825194358826
) O 0 0.00024151105026248842
, O 0 0.00012926547788083553
may O 0 0.00018677898333407938
mediate O 0 0.0010784596670418978
the O 0 0.0007459919434040785
trans O 0 0.004473270382732153
- O 0 0.0011656155111268163
dominant O 0 0.0008256715955212712
effect O 0 0.00019430503016337752
of O 0 0.00020971422782167792
the O 0 0.000482001545606181
RNA O 0 0.001958308042958379
. O 0 0.0006868527852930129

CUG O 1 0.9999814033508301
- O 0 0.38649076223373413
BP O 0 0.3976856768131256
was O 0 0.0012062269961461425
found O 0 0.00011823231761809438
to O 0 7.279829151229933e-05
bind O 0 0.00018714122415985912
to O 0 0.00010852103878278285
the O 0 0.0007561039528809488
human O 0 0.009007240645587444
cardiac O 1 0.9999998807907104
troponin O 1 1.0
T O 1 0.9999957084655762
( O 0 0.0014388721901923418
cTNT O 1 0.5196744799613953
) O 0 0.0002348853013245389
pre O 0 0.0017437030328437686
- O 0 0.0009851026115939021
messenger O 0 0.0010810126550495625
RNA O 0 0.000361795217031613
and O 0 7.498346531065181e-05
regulate O 0 0.00020073604537174106
its O 0 0.00010994468902936205
alternative O 0 0.000541567278560251
splicing O 0 0.002826270880177617
. O 0 0.0006709991721436381

Splicing O 0 0.009609293192625046
of O 0 0.004950876347720623
cTNT O 1 0.999329686164856
was O 0 0.1641680747270584
disrupted O 1 0.9661910533905029
in O 0 0.0055902376770973206
DM B-Disease 1 1.0
striated O 1 0.9999970197677612
muscle O 1 0.9999748468399048
and O 0 0.0010004877112805843
in O 0 0.0004911714931949973
normal O 0 0.000986561761237681
cells O 0 0.0003319684765301645
expressing O 0 0.0003592188295442611
transcripts O 0 0.000735175795853138
that O 0 0.00013366375060286373
contain O 0 0.000696627190336585
CUG O 1 0.9996477365493774
repeats O 0 0.004343053791671991
. O 0 0.0009908146457746625

Altered O 0 0.006919666193425655
expression O 0 0.0010195286013185978
of O 0 0.0004861246852669865
genes O 0 0.00033499093842692673
regulated O 0 0.0006836665561422706
posttranscriptionally O 1 0.5288220047950745
by O 0 0.0005714776925742626
CUG O 1 0.999998927116394
- O 0 0.1738504022359848
BP O 0 0.18890829384326935
therefore O 0 0.00025044166250154376
may O 0 0.0002064974542008713
contribute O 0 0.000490727776195854
to O 0 0.0013005766086280346
DM B-Disease 1 1.0
pathogenesis O 1 0.9999943971633911
. O 0 0.0014678345760330558
. O 0 0.0013708964688703418

Identification O 0 0.0008144709863699973
of O 0 0.0007061218493618071
a O 0 0.0008153294329531491
novel O 0 0.0015925581101328135
nonsense O 0 0.0034970068372786045
mutation O 0 0.0002863190893549472
and O 0 9.734014020068571e-05
a O 0 0.0002557873376645148
missense O 0 0.0007529562572017312
substitution O 0 0.0003864240716211498
in O 0 0.00010404828935861588
the O 0 0.00030296301702037454
vasopressin O 0 0.023885270580649376
- O 0 0.0025797528214752674
neurophysin O 1 0.9885835647583008
II O 1 0.9997820258140564
gene O 0 0.000328347843606025
in O 0 0.00010888922406593338
two O 0 8.176455594366416e-05
Spanish O 0 0.0008013383485376835
kindreds O 0 0.0061509134247899055
with O 0 0.0005570411449298263
familial B-Disease 1 0.9999994039535522
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999997615814209
. O 0 0.012137663550674915

Familial B-Disease 1 0.9999899864196777
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 1 0.9999516010284424
FNDI B-Disease 1 1.0
) O 0 0.0009431582293473184
is O 0 0.00024717042106203735
an O 0 0.00034224349656142294
autosomal B-Disease 1 0.9722511172294617
dominant I-Disease 1 0.9999995231628418
disease I-Disease 1 1.0
caused O 1 1.0
by O 1 0.9998838901519775
deficiency O 1 1.0
in O 1 0.5935916304588318
the O 1 0.9407356977462769
antidiuretic O 1 0.9999895095825195
hormone O 1 0.9925014972686768
arginine O 0 0.014161904342472553
vasopressin O 0 0.03723346069455147
( O 0 0.00046873875544406474
AVP O 0 0.03895387053489685
) O 0 9.556087024975568e-05
encoded O 0 5.676287764799781e-05
by O 0 4.6825753088342026e-05
the O 0 0.0003232225717511028
AVP O 1 0.9996764659881592
- O 0 0.005588925909250975
neurophysin O 1 0.9996247291564941
II O 1 0.9999995231628418
( O 0 0.010523037984967232
AVP O 1 0.9999866485595703
- O 0 0.019257843494415283
NPII O 1 0.9990087747573853
) O 0 0.00042113102972507477
gene O 0 0.0003858082345686853
on O 0 0.0005896537913940847
chromosome O 0 0.003103034570813179
20p13 O 1 0.9934321045875549
. O 0 0.002603856148198247

In O 0 0.001389254815876484
this O 0 0.0002627453359309584
study O 0 0.00015113672998268157
, O 0 6.377973477356136e-05
we O 0 3.4109772968804464e-05
analyzed O 0 4.9816284445114434e-05
two O 0 2.51978199230507e-05
families O 0 6.675833719782531e-05
with O 0 0.00013450285769067705
FNDI B-Disease 1 0.9999774694442749
using O 0 0.00021741875389125198
direct O 0 0.00024101785675156862
automated O 0 0.0010278363479301333
fluorescent O 0 0.0015088263899087906
, O 0 0.00016171499737538397
solid O 0 0.0008995145908556879
phase O 0 0.0016141145024448633
, O 0 0.00014496948278974742
single O 0 0.00018758569785859436
- O 0 0.0002629017108120024
stranded O 0 0.0003876150003634393
DNA O 0 0.00017043098341673613
sequencing O 0 0.00017897180805448443
of O 0 0.00026854200405068696
PCR O 0 0.0028171271551400423
- O 0 0.001867238781414926
amplified O 0 0.00432878453284502
AVP O 1 0.9998557567596436
- O 0 0.010572363622486591
NPII O 1 0.9994133710861206
DNA O 0 0.0030024866573512554
. O 0 0.0008467980660498142

In O 0 0.000789058452937752
one O 0 0.00019422110926825553
of O 0 0.00023260008310899138
the O 0 0.00019793568935710937
families O 0 0.0001667863252805546
, O 0 0.0001399613538524136
affected O 0 0.0002457682276144624
individuals O 0 5.801187944598496e-05
presented O 0 0.0004779068985953927
a O 0 0.00045004949788562953
novel O 0 0.0007462354842573404
nonsense O 0 0.0018713547615334392
mutation O 0 0.00017833776655606925
in O 0 7.199230458354577e-05
exon O 0 0.0006941480096429586
3 O 0 0.000106146588223055
of O 0 8.06185562396422e-05
the O 0 0.00015183612413238734
gene O 0 0.00010904092050623149
, O 0 4.282891677576117e-05
consisting O 0 9.05813358258456e-05
in O 0 4.403955608722754e-05
a O 0 0.00016587894060648978
G O 0 0.0014735416043549776
to O 0 0.00023510711616836488
T O 0 0.004221781622618437
transition O 0 0.0013093175366520882
at O 0 0.0012596072629094124
nucleotide O 0 0.0012134831631556153
2101 O 0 0.02042095549404621
, O 0 0.00018228872795589268
which O 0 6.417079566745088e-05
produces O 0 8.344103844137862e-05
a O 0 0.00012229394633322954
stop O 0 0.00026037031784653664
signal O 0 0.00038428694824688137
in O 0 0.00016477798635605723
codon O 0 0.0012199141783639789
82 O 0 0.0019235279178246856
( O 0 0.0011351814027875662
Glu O 0 0.16652745008468628
) O 0 0.00041255459655076265
of O 0 0.0011470867320895195
NPII O 1 0.9999353885650635
. O 0 0.002933052834123373

The O 0 0.003688385244458914
premature O 0 0.013015883043408394
termination O 0 0.0034771892242133617
eliminates O 0 0.001202648738399148
part O 0 0.00029453617753461003
of O 0 0.0002775854663923383
the O 0 0.0006461471784859896
C O 0 0.0018377851229161024
- O 0 0.0007654815563000739
terminal O 0 0.0008106306195259094
domain O 0 0.00019496346067171544
of O 0 0.00038995430804789066
NPII O 1 0.999893307685852
, O 0 0.00022087132674641907
including O 0 0.00010928294068435207
a O 0 0.00016509236593265086
cysteine O 0 0.0005357023910619318
residue O 0 0.0009307904983870685
in O 0 0.00017652618407737464
position O 0 0.000287646078504622
85 O 0 0.0004204972356092185
, O 0 0.00010724989988375455
which O 0 4.7550689487252384e-05
could O 0 4.455049565876834e-05
be O 0 1.9140577933285385e-05
involved O 0 6.782145646866411e-05
in O 0 5.8775658544618636e-05
the O 0 0.00022746805916540325
correct O 0 0.0008407880086451769
folding O 0 0.0032932909671217203
of O 0 0.0015142267802730203
the O 0 0.004229603335261345
prohormone O 1 0.9999067783355713
. O 0 0.0021730088628828526

In O 0 0.0009231374715454876
the O 0 0.0006072054384276271
second O 0 0.0007115672924555838
family O 0 0.0003121821500826627
, O 0 0.00010764785838546231
a O 0 0.00019269765471108258
G279A O 0 0.007872981950640678
substitution O 0 0.0009265600237995386
at O 0 0.0004914531018584967
position O 0 0.0002584574685897678
- O 0 0.0002077457756968215
1 O 0 8.626767521491274e-05
of O 0 6.499531446024776e-05
the O 0 0.00019096150936093181
signal O 0 0.0009853931842371821
peptide O 0 0.001038766116835177
was O 0 0.0004689559282269329
observed O 0 0.00010783011384774
in O 0 8.056383376242593e-05
all O 0 6.616814789595082e-05
affected O 0 0.0003766808076761663
individuals O 0 0.00020414433674886823
. O 0 0.0005437458166852593

This O 0 0.001562827150337398
missense O 0 0.00516519183292985
mutation O 0 0.00084558135131374
, O 0 0.00028656539507210255
which O 0 0.0003076808643527329
replaces O 0 0.018647734075784683
Ala O 1 0.8430894613265991
with O 0 0.0006407342152670026
Thr O 1 0.9997875094413757
, O 0 0.0004519578942563385
is O 0 0.00018959298904519528
frequent O 0 0.0004002619825769216
among O 0 0.001420679036527872
FNDI B-Disease 1 1.0
patients O 0 0.28599828481674194
and O 0 0.00036702718352898955
is O 0 0.0001351331447949633
thought O 0 0.00021117943106219172
to O 0 6.610003038076684e-05
reduce O 0 0.0001305710757151246
the O 0 0.00014052996993996203
efficiency O 0 0.0003693104663398117
of O 0 0.00023097818484529853
cleavage O 0 0.005984157789498568
by O 0 0.0004743663303088397
signal O 0 0.003996952902525663
peptidases O 0 0.030576488003134727
. O 0 0.0005422061076387763
. O 0 0.0006379677797667682

Genetic O 0 0.005790122784674168
heterogeneity O 0 0.009973010048270226
of O 0 0.0386221744120121
Saethre B-Disease 1 1.0
- I-Disease 1 0.9999991655349731
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.0009675185428932309
due O 0 0.0014463724801316857
to O 0 0.0005021662800572813
TWIST O 1 0.9990876913070679
and O 0 0.003818943165242672
FGFR O 1 0.9999997615814209
mutations O 0 0.004594122990965843
. O 0 0.0010714592644944787

Thirty O 0 0.015714310109615326
- O 0 0.0032679138239473104
two O 0 0.0003075896529480815
unrelated O 0 0.0012400922132655978
patients O 0 0.00038325614877976477
with O 0 0.0001292801316594705
features O 0 0.0004799232992809266
of O 0 0.03752485290169716
Saethre B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.0009651423897594213
a O 0 0.0009354820940643549
common O 0 0.0007425513467751443
autosomal B-Disease 0 0.11746074259281158
dominant I-Disease 1 0.9996500015258789
condition I-Disease 1 0.9999563694000244
of O 1 0.9999936819076538
craniosynostosis B-Disease 1 1.0
and O 1 0.9999991655349731
limb B-Disease 1 1.0
anomalies I-Disease 1 0.9999996423721313
, O 0 0.0015225838869810104
were O 0 0.0003696292405948043
screened O 0 0.0004576059291139245
for O 0 7.885848026489839e-05
mutations O 0 9.496224083704874e-05
in O 0 0.000237176675000228
TWIST O 1 0.997359573841095
, O 0 0.0017183601157739758
FGFR2 O 1 0.9999991655349731
, O 0 0.0014031650498509407
and O 0 0.0012576812878251076
FGFR3 O 1 0.9999843835830688
. O 0 0.002571643330156803

Nine O 0 0.004171042237430811
novel O 0 0.0018742192769423127
and O 0 0.0003833517257589847
three O 0 0.0004289569042157382
recurrent O 1 0.9403350949287415
TWIST O 1 0.999220609664917
mutations O 0 0.0006340051768347621
were O 0 0.0002289581170771271
found O 0 0.00015611806884407997
in O 0 0.00021994290000293404
12 O 0 0.0005076362867839634
families O 0 0.00033553512184880674
. O 0 0.0007531012524850667

Seven O 0 0.0015460778959095478
families O 0 0.0003050398954655975
were O 0 0.00010524373647058383
found O 0 8.083525608526543e-05
to O 0 6.706249405397102e-05
have O 0 4.862658170168288e-05
the O 0 0.00047608590102754533
FGFR3 O 1 0.999996542930603
P250R O 1 0.9999861717224121
mutation O 0 0.0008093810174614191
, O 0 0.00013104455138090998
and O 0 9.379642142448574e-05
one O 0 9.499449515715241e-05
individual O 0 7.499812636524439e-05
was O 0 0.0003903144970536232
found O 0 7.898137118900195e-05
to O 0 6.323493289528415e-05
have O 0 3.3633979910518974e-05
an O 0 0.00021888931223656982
FGFR2 O 1 0.9999569654464722
VV269 O 1 0.9996299743652344
- O 0 0.0059977988712489605
270 O 0 0.00539031159132719
deletion O 0 0.006144174840301275
. O 0 0.0018756918143481016

To O 0 0.0007717199623584747
date O 0 0.0007496828329749405
, O 0 0.00012668689305428416
our O 0 0.0001682797446846962
detection O 0 0.00040173009620048106
rate O 0 9.747538570081815e-05
for O 0 5.9995101764798164e-05
TWIST O 0 0.017996158450841904
or O 0 0.0007310092332772911
FGFR O 1 0.9999163150787354
mutations O 0 0.0002123300509992987
is O 0 6.324770947685465e-05
68 O 0 0.0002091186324832961
% O 0 4.695095412898809e-05
in O 0 0.00011173148232046515
our O 0 0.0007432465790770948
Saethre B-Disease 1 0.9999992847442627
- I-Disease 1 0.9999945163726807
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 0.16592444479465485
, O 0 0.00032013433519750834
including O 0 0.00026668549980968237
our O 0 0.0002879166277125478
five O 0 0.0003109334211330861
patients O 0 0.00037480457103811204
elsewhere O 0 0.0005356477340683341
reported O 0 0.0004022944194730371
with O 0 0.0003501744067762047
TWIST O 1 0.9985693693161011
mutations O 0 0.0025932476855814457
. O 0 0.0012185669038444757

More O 0 0.00044738169526681304
than O 0 0.00016435305587947369
35 O 0 0.000313374912366271
different O 0 9.896098345052451e-05
TWIST O 0 0.006892506033182144
mutations O 0 0.00021725008264183998
are O 0 2.8221262255101465e-05
now O 0 9.335418872069567e-05
known O 0 0.00018853966321330518
in O 0 0.00016502232756465673
the O 0 0.00042674309224821627
literature O 0 0.0007951125153340399
. O 0 0.0005703526549041271

The O 0 0.0029559095855802298
most O 0 0.0005358244525268674
common O 0 0.0006061516469344497
phenotypic O 0 0.001994646154344082
features O 0 0.0003761167172342539
, O 0 9.933594992617145e-05
present O 0 9.598921315046027e-05
in O 0 6.346769805531949e-05
more O 0 2.0188135749776848e-05
than O 0 2.1241814465611242e-05
a O 0 5.69633994018659e-05
third O 0 0.0002112918155035004
of O 0 0.00021819793619215488
our O 0 0.0003486605710349977
patients O 0 0.00024063851742539555
with O 0 0.00016927398974075913
TWIST O 1 0.9997184872627258
mutations O 0 0.0005784360109828413
, O 0 0.0002696277224458754
are O 0 0.0001484707900090143
coronal B-Disease 1 0.9988585710525513
synostosis I-Disease 1 0.9999202489852905
, O 0 0.001241323072463274
brachycephaly B-Disease 1 0.9983682036399841
, O 0 0.001224776147864759
low B-Disease 0 0.012322118505835533
frontal I-Disease 1 0.9999973773956299
hairline I-Disease 1 1.0
, O 1 0.9972320199012756
facial B-Disease 1 1.0
asymmetry I-Disease 1 0.9999998807907104
, O 1 0.9990563988685608
ptosis B-Disease 1 0.9999997615814209
, O 0 0.00652603805065155
hypertelorism B-Disease 1 0.9995107650756836
, O 0 0.0006284149712882936
broad B-Disease 0 0.0015922276070341468
great I-Disease 1 0.9947640895843506
toes I-Disease 1 0.9999549388885498
, O 0 0.0011314863804727793
and O 0 0.001315722824074328
clinodactyly B-Disease 1 0.9999246597290039
. O 0 0.0020951528567820787

Significant O 0 0.0046657053753733635
intra O 0 0.4654446840286255
- O 0 0.0060840873047709465
and O 0 0.0006894406978972256
interfamilial O 0 0.3186330199241638
phenotypic O 0 0.003738192841410637
variability O 0 0.0007621119148097932
is O 0 0.00011918997188331559
present O 0 0.00014346750685945153
for O 0 9.131556726060808e-05
either O 0 0.00042570149526000023
TWIST O 1 0.9580386877059937
mutations O 0 0.0017294734716415405
or O 0 0.0019257244421169162
FGFR O 1 0.9999949932098389
mutations O 0 0.003392355050891638
. O 0 0.0011442149989306927

The O 0 0.0020591297652572393
overlap O 0 0.000973308167885989
in O 0 0.0003880039439536631
clinical O 0 0.0006801309064030647
features O 0 0.00035878378548659384
and O 0 0.00011570752394618466
the O 0 0.00021285141701810062
presence O 0 0.0002734889858402312
, O 0 5.3523526730714366e-05
in O 0 3.449683208600618e-05
the O 0 6.907754868734628e-05
same O 0 6.702229438815266e-05
genes O 0 5.201780368224718e-05
, O 0 2.890330506488681e-05
of O 0 9.612790745450184e-05
mutations O 0 8.490766049362719e-05
for O 0 3.0767412681598216e-05
more O 0 2.5678180463728495e-05
than O 0 4.729576176032424e-05
one O 0 0.00015974062262102962
craniosynostotic B-Disease 1 0.9970268607139587
condition I-Disease 0 0.01061390433460474
- O 0 0.0006638981867581606
such O 0 0.00010250823834212497
as O 0 0.0003256592608522624
Saethre B-Disease 1 0.9999535083770752
- I-Disease 0 0.14398996531963348
Chotzen I-Disease 1 0.9998643398284912
, I-Disease 0 0.0008031612378545105
Crouzon I-Disease 1 0.9998956918716431
, I-Disease 0 0.0007418765453621745
and I-Disease 0 0.0013062141370028257
Pfeiffer I-Disease 1 0.9999992847442627
syndromes I-Disease 1 0.9999932050704956
- O 0 0.006491565611213446
support O 0 0.0003043467877432704
the O 0 0.00021701594232581556
hypothesis O 0 0.0002681387704797089
that O 0 0.00010771316010504961
TWIST O 0 0.031260374933481216
and O 0 0.000382958329282701
FGFRs O 1 0.7791060209274292
are O 0 4.518933201325126e-05
components O 0 0.00018842931604012847
of O 0 0.00013485834642779082
the O 0 0.000191927159903571
same O 0 0.0001571021566633135
molecular O 0 0.0003747841692529619
pathway O 0 0.0005283962818793952
involved O 0 0.00014397402992472053
in O 0 9.407553443452343e-05
the O 0 0.00022741081193089485
modulation O 0 0.0008757550385780632
of O 0 0.017809085547924042
craniofacial O 1 1.0
and O 1 0.9998751878738403
limb O 1 1.0
development O 1 0.9992755055427551
in O 0 0.00459715723991394
humans O 0 0.0008789451094344258
. O 0 0.0002242890914203599
. O 0 0.00040420048753730953

Mutation O 0 0.0016273816581815481
analysis O 0 0.00032489426666870713
of O 0 0.0016803039470687509
UBE3A O 1 0.9999997615814209
in O 1 0.9999942779541016
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999909400939941
. O 0 0.02500167116522789

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9997161030769348
AS B-Disease 1 0.9999923706054688
) O 0 0.0005935842636972666
is O 0 0.00027629960095509887
caused O 0 0.0023390306159853935
by O 0 0.0003132360870949924
chromosome O 0 0.0047490340657532215
15q11 O 1 0.9999825954437256
- O 0 0.13430653512477875
q13 O 1 0.9611713886260986
deletions O 0 0.0014022772666066885
of O 0 0.0004179535317234695
maternal O 0 0.0014695010613650084
origin O 0 0.00025977520272135735
, O 0 0.00020617205882444978
by O 0 0.00018947770877275616
paternal O 0 0.011580025777220726
uniparental B-Disease 1 0.9999994039535522
disomy I-Disease 1 0.9999998807907104
( O 0 0.3650636672973633
UPD B-Disease 1 0.9999986886978149
) O 0 0.00033613512641750276
15 O 0 0.0003912120300810784
, O 0 0.0001461594074498862
by O 0 0.00023016106570139527
imprinting O 1 0.9996441602706909
defects O 1 0.9999997615814209
, O 0 0.0005486599402502179
and O 0 0.00015542219625785947
by O 0 0.00014194280083756894
mutations O 0 0.00016794423572719097
in O 0 0.0003219401405658573
the O 0 0.00168532133102417
UBE3A O 1 0.9999185800552368
gene O 0 0.002049518283456564
. O 0 0.0011099593248218298

UBE3A O 0 0.3180825710296631
encodes O 0 0.0035764670465141535
a O 0 0.0016497791511937976
ubiquitin O 0 0.008443821221590042
- O 0 0.0020217462442815304
protein O 0 0.00107961508911103
ligase O 0 0.00445019593462348
and O 0 0.0006198078626766801
shows O 0 0.0012272431049495935
brain O 1 0.972724437713623
- O 0 0.0021370903123170137
specific O 0 0.0006281287642195821
imprinting O 0 0.010987305082380772
. O 0 0.0017718634335324168

Here O 0 0.0029079969972372055
we O 0 0.0006209934363141656
describe O 0 0.0013836825964972377
UBE3A O 1 0.9349668622016907
coding O 0 0.003116868669167161
- O 0 0.0012678963830694556
region O 0 0.00048220049939118326
mutations O 0 0.00019871894619427621
detected O 0 0.00032059982186183333
by O 0 9.153788414550945e-05
SSCP O 1 0.683351993560791
analysis O 0 5.18430897500366e-05
in O 0 9.371005580760539e-05
13 O 0 0.0006565430085174739
AS B-Disease 0 0.027589427307248116
individuals O 0 0.00012708216672763228
or O 0 0.00043626432307064533
families O 0 0.00038756258436478674
. O 0 0.0008794569876044989

Two O 0 0.0008964368607848883
identical O 0 0.0014119496336206794
de O 0 0.0032968397717922926
novo O 0 0.003963955212384462
5 O 0 0.0010146129643544555
- O 0 0.001172512536868453
bp O 0 0.0025931219570338726
duplications O 0 0.0017955388175323606
in O 0 0.00022564450046047568
exon O 0 0.0020194922108203173
16 O 0 0.0007550817099399865
were O 0 0.0003028353676199913
found O 0 0.0003621727228164673
. O 0 0.0007401168695650995

Among O 0 0.001041034352965653
the O 0 0.0003230774309486151
other O 0 0.00010323394235456362
11 O 0 0.000316568766720593
unique O 0 0.00023139191034715623
mutations O 0 0.00034834080724976957
, O 0 0.00013732636580243707
8 O 0 0.00045469068572856486
were O 0 9.814582153921947e-05
small O 0 0.00015583354979753494
deletions O 0 0.0008772501023486257
or O 0 0.0002367456181673333
insertions O 0 0.002006720518693328
predicted O 0 0.0006189661798998713
to O 0 0.00017636566190049052
cause O 0 0.02889593131840229
frameshifts O 1 0.9990436434745789
, O 0 0.00020015446352772415
1 O 0 0.00018991254910361022
was O 0 0.0002933256037067622
a O 0 8.782048098510131e-05
mutation O 0 6.126473454060033e-05
to O 0 4.433223875821568e-05
a O 0 0.00011938526586163789
stop O 0 0.00043635707697831094
codon O 0 0.00048457624507136643
, O 0 8.342703222297132e-05
1 O 0 0.0001530048029962927
was O 0 0.0003270207380410284
a O 0 0.00020637738634832203
missense O 0 0.0009139375761151314
mutation O 0 0.00019776589761022478
, O 0 8.167431951733306e-05
and O 0 7.164329872466624e-05
1 O 0 0.00021709600696340203
was O 0 0.000486743520013988
predicted O 0 0.0002889753959607333
to O 0 6.540648610098287e-05
cause O 0 0.0004634869983419776
insertion O 0 0.0008991648792289197
of O 0 0.0005314166774041951
an O 0 0.0004829309764318168
isoleucine O 0 0.16831591725349426
in O 0 0.00030501550645567477
the O 0 0.00046330393524840474
hect O 0 0.00670823035761714
domain O 0 0.0003205478424206376
of O 0 0.00035785039654001594
the O 0 0.0008241628529503942
UBE3A O 1 0.9995362758636475
protein O 0 0.0005069496692158282
, O 0 9.092004620470107e-05
which O 0 3.742528133443557e-05
functions O 0 7.304159953491762e-05
in O 0 0.0001838224270613864
E2 O 0 0.02649359218776226
binding O 0 0.00030284174135886133
and O 0 0.00038370818947441876
ubiquitin O 0 0.005748149938881397
transfer O 0 0.002044973662123084
. O 0 0.0013675112277269363

Eight O 0 0.0008603913593105972
of O 0 0.0004285875766072422
the O 0 0.0002815204206854105
cases O 0 0.00019064274965785444
were O 0 0.00018613255815580487
familial O 0 0.13197527825832367
, O 0 0.0003838584234472364
and O 0 0.00024794036289677024
five O 0 0.00030452501960098743
were O 0 0.0004775146080646664
sporadic O 0 0.0039155492559075356
. O 0 0.0010608778102323413

In O 0 0.0012577903689816594
two O 0 0.0004152585461270064
familial O 0 0.005834429059177637
cases O 0 0.000500128953717649
and O 0 0.00028466255753301084
one O 0 0.00021166384976822883
sporadic O 0 0.0018944930052384734
case O 0 0.0007596850045956671
, O 0 0.0004880087508354336
mosaicism O 1 0.921105146408081
for O 0 0.000769344624131918
UBE3A O 1 0.9999661445617676
mutations O 0 0.0005908708553761244
was O 0 0.0008073566714301705
detected O 0 0.0003722284745890647
in O 0 6.534768908750266e-05
the O 0 8.232175605371594e-05
mother O 0 0.00025106273824349046
of O 0 0.00019745179452002048
three O 0 0.00016489178233314306
AS B-Disease 1 0.9833223819732666
sons O 0 0.01221565529704094
, O 0 0.00013832513650413603
in O 0 0.00012947284267283976
the O 0 0.0002701737394090742
maternal O 0 0.0011374917812645435
grandfather O 0 0.004748024977743626
of O 0 0.0005884076235815883
two O 0 0.0001871890272013843
AS B-Disease 1 0.6462134718894958
first O 0 0.0004053098091389984
cousins O 0 0.0007996936910785735
, O 0 8.132537186611444e-05
and O 0 5.0118815124733374e-05
in O 0 6.37496923445724e-05
the O 0 0.00014989040209911764
mother O 0 0.0005269959801808
of O 0 0.0005068656173534691
an O 0 0.001037951442413032
AS B-Disease 1 0.999810516834259
daughter O 1 0.8249379396438599
. O 0 0.0027769843582063913

The O 0 0.0013285578461363912
frequencies O 0 0.00029840704519301653
with O 0 7.500627543777227e-05
which O 0 6.850578938610852e-05
we O 0 6.516584835480899e-05
detected O 0 0.0001940663787536323
mutations O 0 5.090356353321113e-05
were O 0 4.701592115452513e-05
5 O 0 0.00011271726543782279
( O 0 6.707739521516487e-05
14 O 0 0.0001385598734486848
% O 0 3.286233186372556e-05
) O 0 2.183406104450114e-05
of O 0 4.706553227151744e-05
35 O 0 0.00014063545677345246
in O 0 9.982564370147884e-05
sporadic O 0 0.0004771858511958271
cases O 0 8.531597995897755e-05
and O 0 0.00010077933256980032
8 O 0 0.0003048410580959171
( O 0 0.00010063566151075065
80 O 0 0.00014357124746311456
% O 0 3.695282430271618e-05
) O 0 2.485510049154982e-05
of O 0 9.659653733251616e-05
10 O 0 0.00016709654300939292
in O 0 0.00021841691341251135
familial O 0 0.00607613380998373
cases O 0 0.000798203400336206
. O 0 0.0005881856195628643
. O 0 0.0008032390032894909

The O 0 0.015960874035954475
hemochromatosis B-Disease 1 0.9999996423721313
845 O 1 0.9992524981498718
G O 1 0.9732378125190735
- O 0 0.004860483575612307
- O 0 0.0012222775258123875
> O 0 0.0006546881631948054
A O 0 0.0003972581762354821
and O 0 0.00012318650260567665
187 O 0 0.0006266332929953933
C O 0 0.0014130229828879237
- O 0 0.0011400512885302305
- O 0 0.0012634480372071266
> O 0 0.0017105890437960625
G O 0 0.0026114785578101873
mutations O 0 0.00030019765836186707
: O 0 0.00020753771241288632
prevalence O 0 0.0007790706004016101
in O 0 0.0003031849046237767
non O 0 0.00124579097609967
- O 0 0.001838374650105834
Caucasian O 0 0.005867691244930029
populations O 0 0.0006426860927604139
. O 0 0.0005985440802760422

Hemochromatosis B-Disease 1 0.9999992847442627
, O 0 0.004594105761498213
the O 0 0.08487332612276077
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 1 1.0
iron I-Disease 1 1.0
metabolism I-Disease 1 1.0
, O 0 0.004090780392289162
leads O 0 0.0029244020115584135
, O 0 0.00024292763555422425
if O 0 0.00028963322984054685
untreated O 1 0.9997579455375671
, O 0 0.000405257276725024
to O 0 0.0006422039004974067
progressive O 1 0.999984860420227
iron B-Disease 1 1.0
overload I-Disease 1 1.0
and O 1 0.9289044141769409
premature B-Disease 1 0.9999001026153564
death I-Disease 1 0.8819814920425415
. O 0 0.001245108200237155

The O 0 0.024653621017932892
hemochromatosis B-Disease 1 1.0
gene O 0 0.03475511074066162
, O 0 0.002222502836957574
HFE O 1 0.9999947547912598
, O 0 0.0006541358889080584
recently O 0 0.0006128734676167369
has O 0 7.988206198206171e-05
been O 0 6.942346226423979e-05
identified O 0 0.00011909658496733755
, O 0 5.6662502174731344e-05
and O 0 6.485557241830975e-05
characterization O 0 0.000427178165409714
of O 0 0.00032357528107240796
this O 0 0.0001371235412079841
gene O 0 0.00016231797053478658
has O 0 6.765685247955844e-05
shown O 0 4.843558417633176e-05
that O 0 1.799580240913201e-05
it O 0 1.800940117391292e-05
contains O 0 4.026178066851571e-05
two O 0 2.8515492886072025e-05
mutations O 0 4.9924099585041404e-05
that O 0 2.4620227122795768e-05
result O 0 7.746204937575385e-05
in O 0 0.00012432123185135424
amino O 0 0.0003004656464327127
acid O 0 0.0007468476542271674
substitutions O 0 0.0007867657695896924
- O 0 0.0003894332330673933
cDNA O 0 0.0011031989706680179
nucleotides O 0 0.0006876715342514217
845 O 0 0.004916815087199211
G O 0 0.002699053380638361
- O 0 0.0008264277130365372
- O 0 0.0007672756328247488
> O 0 0.0007290911162272096
A O 0 0.000978386029601097
( O 0 0.0003985875518992543
C282Y O 0 0.006761499680578709
) O 0 0.00011162264127051458
and O 0 8.101281127892435e-05
187 O 0 0.0004387873923406005
C O 0 0.0012940402375534177
- O 0 0.0006976263830438256
- O 0 0.0010256858076900244
> O 0 0.0021220571361482143
G O 0 0.012770917266607285
( O 0 0.00137037830427289
H63D O 1 0.9998986721038818
) O 0 0.0011772637953981757
. O 0 0.000750656530726701

Although O 0 0.01293986290693283
hemochromatosis B-Disease 1 1.0
is O 0 0.0008759228512644768
common O 0 0.0005041177500970662
in O 0 0.0004841524350922555
Caucasians O 0 0.010998503305017948
, O 0 0.0003338814130984247
affecting O 0 0.0007089794962666929
> O 0 0.001058553927578032
= O 0 0.0005035412032157183
1 O 0 0.00033107749186456203
/ O 0 0.0003720108652487397
300 O 0 0.00022704465663991868
individuals O 0 2.1988020307617262e-05
of O 0 8.547029574401677e-05
northern O 0 0.0002646704961080104
European O 0 0.00014904698764439672
origin O 0 0.00012428838817868382
, O 0 7.801002357155085e-05
it O 0 3.3224521757801995e-05
has O 0 3.4168700949521735e-05
not O 0 1.966240415640641e-05
been O 0 5.140656139701605e-05
recognized O 0 0.00011557254765648395
in O 0 0.0001412823621649295
other O 0 0.0001924273674376309
populations O 0 0.00032451102742925286
. O 0 0.0006395694217644632

The O 0 0.0024461825378239155
present O 0 0.0006392672657966614
study O 0 0.0002782704250421375
used O 0 0.0003759837127290666
PCR O 0 0.0019121040822938085
and O 0 0.00023301651526708156
restriction O 0 0.0005896781804040074
- O 0 0.0007465769886039197
enzyme O 0 0.0006082900799810886
digestion O 0 0.0008112352224998176
to O 0 5.000233431928791e-05
analyze O 0 0.00010263881995342672
the O 0 5.936282832408324e-05
frequency O 0 3.284998456365429e-05
of O 0 8.930308104027063e-05
the O 0 0.00031159105128608644
845 O 0 0.013886351138353348
G O 0 0.006329275202006102
- O 0 0.001196943107061088
- O 0 0.0006028054631315172
> O 0 0.0004600966931320727
A O 0 0.0002552732767071575
and O 0 9.88766405498609e-05
187 O 0 0.00039740229840390384
C O 0 0.0010368051007390022
- O 0 0.0007175133214332163
- O 0 0.0007717229309491813
> O 0 0.000994633766822517
G O 0 0.0011936891824007034
mutations O 0 0.0001534353505121544
in O 0 0.00019413797417655587
HLA O 1 0.9860025644302368
- O 0 0.0008113694493658841
typed O 0 0.00032803870271891356
samples O 0 0.00011625087063293904
from O 0 0.0001505651162005961
non O 0 0.00040446047205477953
- O 0 0.0005437828367576003
Caucasian O 0 0.001647376804612577
populations O 0 0.00015527079813182354
, O 0 9.148116805590689e-05
comprising O 0 0.0002201392489951104
Australian O 0 0.0012520875316113234
Aboriginal O 0 0.0022413984406739473
, O 0 0.0002053700154647231
Chinese O 0 0.0008858774090185761
, O 0 0.00022573572641704232
and O 0 0.0002823981049004942
Pacific O 0 0.003137812949717045
Islanders O 0 0.00411630654707551
. O 0 0.0012162819039076567

Results O 0 0.0017830906435847282
showed O 0 0.000778985908254981
that O 0 7.774007826810703e-05
the O 0 0.0002661107573658228
845 O 0 0.024028794839978218
G O 0 0.126788929104805
- O 0 0.0017139943083748221
- O 0 0.0011389104183763266
> O 0 0.000831656507216394
A O 0 0.0005090374033898115
mutation O 0 0.00022342783631756902
was O 0 0.0003078258305322379
present O 0 0.00011639517470030114
in O 0 4.677831384469755e-05
these O 0 1.7693104382487945e-05
populations O 0 2.993288217112422e-05
( O 0 5.2763956773560494e-05
allele O 0 7.233652286231518e-05
frequency O 0 2.418750591459684e-05
0 O 0 4.182525663054548e-05
. O 0 1.8635548258316703e-05
32 O 0 9.577689343132079e-05
% O 0 6.985670916037634e-05
) O 0 6.74658949719742e-05
, O 0 7.961528899613768e-05
and O 0 8.794334280537441e-05
, O 0 0.00012305642303545028
furthermore O 0 0.00035614767693914473
, O 0 0.0001623726129764691
it O 0 5.659196904161945e-05
was O 0 0.0005394956097006798
always O 0 0.00020032684551551938
seen O 0 0.00024242901417892426
in O 0 0.00015552551485598087
conjunction O 0 0.0006212089792825282
with O 0 0.00025513264699839056
HLA O 1 0.9999079704284668
haplotypes O 0 0.002656089374795556
common O 0 0.0003837186377495527
in O 0 0.00024531499366275966
Caucasians O 0 0.002049349481239915
, O 0 0.0001340121525572613
suggesting O 0 0.0003645448596216738
that O 0 8.976960089057684e-05
845 O 0 0.005931006744503975
G O 0 0.020414557307958603
- O 0 0.0019261459819972515
- O 0 0.0010874796425923705
> O 0 0.0011323710205033422
A O 0 0.0006736096693202853
may O 0 0.00017503682465758175
have O 0 2.4943383323261514e-05
been O 0 6.756826769560575e-05
introduced O 0 0.00010714502423070371
into O 0 0.0001047263722284697
these O 0 4.032018478028476e-05
populations O 0 8.921354310587049e-05
by O 0 0.00015553426055703312
Caucasian O 0 0.008894883096218109
admixture O 0 0.06588879227638245
. O 0 0.0028755548410117626

187 O 0 0.005680495873093605
C O 0 0.003957387991249561
- O 0 0.0013184004928916693
- O 0 0.0009968954836949706
> O 0 0.0011025759158656001
G O 0 0.0013905658852308989
was O 0 0.0005670313257724047
present O 0 0.00019138585776090622
at O 0 0.00026131386402994394
an O 0 0.00011022758553735912
allele O 0 0.00014334115257952362
frequency O 0 8.759499178268015e-05
of O 0 0.00018629732949193567
2 O 0 0.0009555733995512128
. O 0 0.0007310168584808707

68 O 0 0.00446179648861289
% O 0 0.00035447097616270185
in O 0 0.00016262457938864827
the O 0 0.0001546255953144282
two O 0 7.429753168253228e-05
populations O 0 0.00010266446770401672
analyzed O 0 0.0001904298405861482
( O 0 0.0002074597286991775
Australian O 0 0.0016391939716413617
Aboriginal O 0 0.0020650681108236313
and O 0 0.0003866741026286036
Chinese O 0 0.002700401470065117
) O 0 0.0006748593295924366
. O 0 0.000576422200538218

In O 0 0.001184523687697947
the O 0 0.0008364457753486931
Australian O 0 0.002091987058520317
Aboriginal O 0 0.0012839240953326225
samples O 0 0.00022904349316377193
, O 0 7.46964942663908e-05
187 O 0 0.00045517637045122683
C O 0 0.0011338179465383291
- O 0 0.0010084861423820257
- O 0 0.0008585985633544624
> O 0 0.0011378769995644689
G O 0 0.0014013040345162153
was O 0 0.0004210999177303165
found O 0 7.724887109361589e-05
to O 0 5.8890556829283014e-05
be O 0 5.452081313706003e-05
associated O 0 0.00012803530262317508
with O 0 0.0002130922512151301
HLA O 1 0.9999480247497559
haplotypes O 0 0.0030554684344679117
common O 0 0.000562964181881398
in O 0 0.00048030223115347326
Caucasians O 0 0.02771446853876114
, O 0 0.00023563629656564444
suggesting O 0 0.0002683801867533475
that O 0 3.423001544433646e-05
it O 0 4.322165113990195e-05
was O 0 0.0002510680351406336
introduced O 0 0.00019858693121932447
by O 0 9.516412683296949e-05
recent O 0 0.0005187641363590956
admixture O 0 0.004343064501881599
. O 0 0.0012055326951667666

In O 0 0.0013444741489365697
the O 0 0.0005817830096930265
Chinese O 0 0.000936789670959115
samples O 0 0.0001681196881690994
analyzed O 0 0.00012123746273573488
, O 0 5.629657243844122e-05
187 O 0 0.0004171194159425795
C O 0 0.0012139895698055625
- O 0 0.0007808688096702099
- O 0 0.0006704597035422921
> O 0 0.0008583548478782177
G O 0 0.0014160284772515297
was O 0 0.00038032259908504784
present O 0 0.00013952853623777628
in O 0 0.00010145389387616888
association O 0 0.00019231365877203643
with O 0 4.020917913294397e-05
a O 0 0.00019462134514469653
wide O 0 0.0003000728611368686
variety O 0 0.00021808937890455127
of O 0 0.0013287314213812351
HLA O 1 0.9999992847442627
haplotypes O 0 0.004517158027738333
, O 0 0.00022325964528135955
showing O 0 0.000295522331725806
this O 0 6.360250699799508e-05
mutation O 0 7.105367694748566e-05
to O 0 6.480920274043456e-05
be O 0 5.716976011171937e-05
widespread O 0 0.0003111365658696741
and O 0 0.00010810026287799701
likely O 0 0.00018290207663085312
to O 0 8.565158350393176e-05
predate O 0 0.0008788722916506231
the O 0 0.00019591905584093183
more O 0 3.944213312934153e-05
genetically O 0 0.00015963664918672293
restricted O 0 0.00012406684982124716
845 O 0 0.005149338860064745
G O 0 0.013746501877903938
- O 0 0.0030340987723320723
- O 0 0.0013578053331002593
> O 0 0.001405190210789442
A O 0 0.0014757320750504732
mutation O 0 0.000894351804163307
. O 0 0.0005486015579663217

Genotype O 0 0.032192207872867584
- O 0 0.007764026056975126
phenotype O 0 0.003225604072213173
correlations O 0 0.0018614536384120584
in O 0 0.0021187439560890198
attenuated B-Disease 1 0.9998347759246826
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999997615814209
. O 0 0.009608210064470768

Germ O 1 0.9997736811637878
- O 0 0.010582218877971172
line O 0 0.002067163120955229
mutations O 0 0.0003753705823328346
of O 0 0.0005523256841115654
the O 0 0.006574680563062429
tumor B-Disease 1 0.9999997615814209
suppressor O 1 0.9999604225158691
APC O 1 0.9996598958969116
are O 0 0.0002521220885682851
implicated O 0 0.010018440894782543
in O 0 0.002516437554731965
attenuated B-Disease 1 0.9997571110725403
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 1 0.9994644522666931
AAPC B-Disease 1 0.9999998807907104
) O 0 0.0004591253527905792
, O 0 0.00013930146815255284
a O 0 0.0003414118546061218
variant O 0 0.0015310898888856173
of O 0 0.0022022968623787165
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999924898147583
FAP B-Disease 1 0.9999996423721313
) O 0 0.003930768463760614
. O 0 0.0021819230169057846

AAPC B-Disease 1 0.9999428987503052
is O 0 0.0008504015859216452
recognized O 0 0.000445947254775092
by O 0 0.00013980288349557668
the O 0 0.000334312702761963
occurrence O 0 0.0010897844331339002
of O 0 0.0008698351448401809
< O 0 0.04001472517848015
100 O 0 0.003460340667515993
colonic B-Disease 1 0.9998204112052917
adenomas I-Disease 1 0.5942022204399109
and O 0 0.00020476309873629361
a O 0 0.0002899031387642026
later O 0 0.0008511445485055447
onset O 1 0.9998775720596313
of O 1 0.9999674558639526
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 0.19000805914402008
age O 0 0.0012418765109032393
> O 0 0.0011231963289901614
40 O 0 0.0003595506423152983
years O 0 0.00022654513304587454
) O 0 0.00015908502973616123
. O 0 0.00033851212356239557

The O 0 0.0015984572237357497
aim O 0 0.0013227981980890036
of O 0 0.0003435342223383486
this O 0 0.00010014686995418742
study O 0 0.00010037976608145982
was O 0 0.0004082108207512647
to O 0 0.00013514887541532516
assess O 0 0.0007921642391011119
genotype O 0 0.0016572357853874564
- O 0 0.002157912589609623
phenotype O 0 0.0017510816687718034
correlations O 0 0.0023047851864248514
in O 0 0.002177442889660597
AAPC B-Disease 1 0.9999946355819702
families O 0 0.0023559110704809427
. O 0 0.001741063199006021

By O 0 0.0013073498848825693
protein O 0 0.0011934606591239572
- O 0 0.001402882393449545
truncation O 0 0.00509407976642251
test O 0 0.0008484981954097748
( O 0 0.0003906848724000156
PTT O 0 0.00615895539522171
) O 0 0.00013844207569491118
assay O 0 0.00033276918111369014
, O 0 6.883923197165132e-05
the O 0 0.00013995279732625932
entire O 0 0.0005557055701501667
coding O 0 0.0003483351902104914
region O 0 0.00019833372789435089
of O 0 0.00018149525567423552
the O 0 0.0006962850457057357
APC B-Disease 1 0.9995738863945007
gene O 0 0.0005062630516476929
was O 0 0.0006627555121667683
screened O 0 0.0003854920796584338
in O 0 8.975145465228707e-05
affected O 0 0.00023540724941994995
individuals O 0 5.137284460943192e-05
from O 0 0.0004860598419327289
11 O 0 0.09468010812997818
AAPC B-Disease 1 0.9999997615814209
kindreds O 1 0.9810709357261658
, O 0 0.00038256956031545997
and O 0 0.00015650140994694084
their O 0 0.00011597838602028787
phenotypic O 0 0.001844783779233694
differences O 0 0.000820123590528965
were O 0 0.0005702216876670718
examined O 0 0.0024430006742477417
. O 0 0.0010333782993257046

Five O 0 0.0031271546613425016
novel O 0 0.005650544539093971
germ O 1 0.9998227953910828
- O 0 0.0291837640106678
line O 0 0.004632852505892515
APC B-Disease 1 0.9126735329627991
mutations O 0 0.0003655182081274688
were O 0 0.0001456036843592301
identified O 0 0.0002297182218171656
in O 0 0.00020812860748264939
seven O 0 0.001174120232462883
kindreds O 0 0.020458616316318512
. O 0 0.0019006159855052829

Mutations O 0 0.0023777391761541367
were O 0 0.0003693259786814451
located O 0 0.00046338673564605415
in O 0 8.026117575354874e-05
three O 0 3.635046959971078e-05
different O 0 9.846955435932614e-06
regions O 0 4.3651369196595624e-05
of O 0 0.00011473308404674754
the O 0 0.00034592149313539267
APC B-Disease 1 0.9907812476158142
gene O 0 0.00023111168411560357
( O 0 7.891685527283698e-05
1 O 0 8.557990076951683e-05
) O 0 1.9449576939223334e-05
at O 0 4.217451350996271e-05
the O 0 3.800367267103866e-05
5 O 0 7.083327363943681e-05
end O 0 0.00018684168753679842
spanning O 0 0.0006661916268058121
exons O 0 0.000577279890421778
4 O 0 0.00026099366368725896
and O 0 0.00010312670201528817
5 O 0 0.00020202847372274846
, O 0 9.407535981154069e-05
( O 0 7.652740168850869e-05
2 O 0 0.00018263266247231513
) O 0 4.5883069105912e-05
within O 0 9.104776108870283e-05
exon O 0 0.0007234131917357445
9 O 0 0.00042369161383248866
, O 0 6.411952927010134e-05
and O 0 5.363966556615196e-05
( O 0 0.0001033691005432047
3 O 0 0.00016826788487378508
) O 0 5.277789750834927e-05
at O 0 0.00013710888742934912
the O 0 0.00015627116954419762
3 O 0 0.00030474457889795303
distal O 0 0.002020117361098528
end O 0 0.000713105546310544
of O 0 0.000504226831253618
the O 0 0.0008303116192109883
gene O 0 0.0009781492408365011
. O 0 0.0005646095960400999

Variability O 0 0.0033247116953134537
in O 0 0.00031270403997041285
the O 0 0.00046386843314394355
number O 0 0.00022607539722230285
of O 1 0.7476425766944885
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 1 0.9988634586334229
most O 0 0.0002433616027701646
apparent O 0 0.0008970833150669932
in O 0 8.743593207327649e-05
individuals O 0 3.0253897421061993e-05
with O 0 4.150469248997979e-05
mutations O 0 8.329094271175563e-05
in O 0 0.00011045053543057293
region O 0 0.000347073539160192
1 O 0 0.0003820846031885594
, O 0 0.00014940752589609474
and O 0 0.00024778294027782977
upper O 1 0.999431312084198
- O 1 0.999624490737915
gastrointestinal O 1 0.9999923706054688
manifestations O 1 0.9998080134391785
were O 0 0.0005292511195875704
more O 0 0.00016858233720995486
severe O 1 0.9947688579559326
in O 0 0.0003459666622802615
them O 0 0.00032349012326449156
. O 0 0.0008365621324628592

In O 0 0.000942658691201359
individuals O 0 0.00011191978410352021
with O 0 9.558220335748047e-05
mutations O 0 0.00015276380872819573
in O 0 0.0001383264607284218
either O 0 0.00013008093810640275
region O 0 0.000262692803516984
2 O 0 0.00022507208632305264
or O 0 9.090930689126253e-05
region O 0 0.0001877138129202649
3 O 0 0.00013670965563505888
, O 0 3.557616219040938e-05
the O 0 5.6438915635226294e-05
average O 0 4.5899789256509393e-05
number O 0 2.4534678232157603e-05
of O 0 0.00028405015473254025
adenomas B-Disease 1 0.9808112382888794
tended O 0 0.00045524101005867124
to O 0 6.485031917691231e-05
be O 0 5.2919818699592724e-05
lower O 0 0.0001491476286901161
than O 0 2.102006874338258e-05
those O 0 1.2430318747647107e-05
in O 0 2.7190359105588868e-05
individuals O 0 1.7210028090630658e-05
with O 0 3.2369280233979225e-05
mutations O 0 6.908117939019576e-05
in O 0 6.962109182495624e-05
region O 0 0.00024852543720044196
1 O 0 0.00015899645222816616
, O 0 6.410803325707093e-05
although O 0 5.6924352975329384e-05
age O 0 0.00024602870689705014
at O 0 0.001272418536245823
diagnosis O 0 0.019493641331791878
was O 0 0.005251605063676834
similar O 0 0.0005194895202293992
. O 0 0.0006290861056186259

In O 0 0.0035402870271354914
all O 0 0.0019368808716535568
AAPC B-Disease 1 0.9998887777328491
kindreds O 0 0.016309775412082672
, O 0 0.00043539496255107224
a O 0 0.00034021487226709723
predominance O 0 0.005026455502957106
of O 0 0.004856504965573549
right O 1 0.9997193217277527
- O 1 0.9999939203262329
sided O 1 0.9999996423721313
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 1 0.9996896982192993
rectal B-Disease 1 1.0
polyp I-Disease 1 1.0
sparing O 1 0.9995779395103455
was O 0 0.4128495156764984
observed O 0 0.0019543799571692944
. O 0 0.0011539420811459422

No O 0 0.07398206740617752
desmoid B-Disease 1 0.9999969005584717
tumors I-Disease 1 0.9999969005584717
were O 0 0.0008212230168282986
found O 0 0.00040243324474431574
in O 0 0.0004385581996757537
these O 0 0.0002751156862359494
kindreds O 0 0.01285373605787754
. O 0 0.001365357544273138

Our O 0 0.0018566842190921307
data O 0 0.000274297985015437
suggest O 0 0.0003090054960921407
that O 0 7.889443077147007e-05
, O 0 0.00013045183732174337
in O 0 0.00038371916161850095
AAPC B-Disease 1 0.9999890327453613
families O 0 0.00022565203835256398
, O 0 6.398093682946637e-05
the O 0 9.994023275794461e-05
location O 0 0.00018905325850937515
of O 0 0.0002585624752100557
the O 0 0.0015127691440284252
APC B-Disease 1 0.9999603033065796
mutation O 0 0.0018746333662420511
may O 0 0.0006022191373631358
partially O 0 0.0023574144579470158
predict O 0 0.0005525852902792394
specific O 0 0.00020223816682118922
phenotypic O 0 0.0027865322772413492
expression O 0 0.0018692822195589542
. O 0 0.0009348245221190155

This O 0 0.0008413625764660537
should O 0 0.0001855004084063694
help O 0 0.00012622217764146626
in O 0 6.014874088577926e-05
the O 0 0.00012248114217072725
design O 0 0.00031226614373736084
of O 0 0.0004081771767232567
tailored O 0 0.0012935558333992958
clinical O 0 0.002114670816808939
- O 0 0.002011546865105629
management O 0 0.00046033618855290115
protocols O 0 0.0006331847980618477
in O 0 0.00010445080988574773
this O 0 6.092995317885652e-05
subset O 0 0.0003705006674863398
of O 0 0.001246355939656496
FAP B-Disease 1 0.9999977350234985
patients O 0 0.008382205851376057
. O 0 0.00048481253907084465
. O 0 0.0007457361207343638

Wilms B-Disease 1 0.9999938011169434
' I-Disease 1 0.6555652618408203
tumor I-Disease 1 0.9969108700752258
1 O 0 0.0011102479184046388
and O 0 0.0004699563141912222
Dax O 1 0.9997076392173767
- O 0 0.0011905323481187224
1 O 0 0.000444481847807765
modulate O 0 0.0006895838305354118
the O 0 0.00028803604072891176
orphan O 0 0.002940116450190544
nuclear O 0 0.003106647403910756
receptor O 0 0.0017111761262640357
SF O 1 0.9242892265319824
- O 0 0.0008344299858435988
1 O 0 0.0002949025365523994
in O 0 0.00013821691391058266
sex O 0 0.00042536621913313866
- O 0 0.0005177867133170366
specific O 0 0.00017353751172777265
gene O 0 0.0005143563612364233
expression O 0 0.0010297986445948482
. O 0 0.0006095965509302914

Products O 0 0.0026852525770664215
of O 0 0.0011469617020338774
steroidogenic O 1 0.9721483588218689
factor O 0 0.0014241737080737948
1 O 0 0.0008190528023988008
( O 0 0.0005428253789432347
SF O 1 0.9990547299385071
- O 0 0.001232760725542903
1 O 0 0.0004362599574960768
) O 0 0.00018399672990199178
and O 0 0.00047201503184624016
Wilms B-Disease 1 0.9999949932098389
tumor I-Disease 1 0.9999915361404419
1 O 0 0.006532744038850069
( O 0 0.0013572443276643753
WT1 O 1 0.9997674822807312
) O 0 0.0002334773016627878
genes O 0 0.0001295130787184462
are O 0 1.9059085389017127e-05
essential O 0 0.00021242281945887953
for O 0 0.00012139687169110402
mammalian O 0 0.0019179062219336629
gonadogenesis O 1 0.5440046191215515
prior O 0 0.0009570923866704106
to O 0 0.0003715520433615893
sexual O 0 0.001533987931907177
differentiation O 0 0.006477833725512028
. O 0 0.0013498577754944563

In O 0 0.0018280457006767392
males O 0 0.0006630145944654942
, O 0 0.0006321724504232407
SF O 1 0.9998238682746887
- O 0 0.0016428360249847174
1 O 0 0.0004941270453855395
participates O 0 0.0005864195991307497
in O 0 0.00012285533011890948
sexual O 0 0.0003039333096239716
development O 0 0.00019238721870351583
by O 0 9.105679782805964e-05
regulating O 0 0.0004092373128514737
expression O 0 0.00017064726853277534
of O 0 0.00028048898093402386
the O 0 0.0012410931522026658
polypeptide O 1 0.9953162670135498
hormone O 1 0.9948809146881104
Mullerian O 1 0.9998401403427124
inhibiting O 1 0.8832104206085205
substance O 1 0.9977518916130066
( O 0 0.006084202788770199
MIS O 1 0.9995481371879578
) O 0 0.0009552722331136465
. O 0 0.0008303223294205964

Here O 0 0.003148268209770322
, O 0 0.0007871718844398856
we O 0 0.00028778158593922853
show O 0 0.0008746309904381633
that O 0 0.0006150549161247909
WT1 O 1 0.9995187520980835
- O 0 0.015681950375437737
KTS O 1 0.9954482913017273
isoforms O 0 0.0018565533682703972
associate O 0 0.0009547212393954396
and O 0 0.00037063242052681744
synergize O 0 0.013014803640544415
with O 0 0.001087933429516852
SF O 1 0.999991774559021
- O 0 0.003863264573737979
1 O 0 0.0007453528232872486
to O 0 0.0004179567040409893
promote O 0 0.0024707606062293053
MIS O 1 0.9973300695419312
expression O 0 0.0025246040895581245
. O 0 0.00112079584505409

In O 0 0.0046353996731340885
contrast O 0 0.0028033943381160498
, O 0 0.0018065252806991339
WT1 O 1 0.9994049072265625
missense O 0 0.00791996717453003
mutations O 0 0.0005247581866569817
, O 0 0.0002223160699941218
associated O 0 0.0002524650772102177
with O 0 0.00022710267512593418
male B-Disease 0 0.008638442493975163
pseudohermaphroditism I-Disease 1 0.9999998807907104
in O 0 0.155050128698349
Denys B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999982118606567
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.0023770583793520927
fail O 0 0.0014598546549677849
to O 0 0.0004546167911030352
synergize O 1 0.7191620469093323
with O 0 0.0019105087267234921
SF O 1 0.9999990463256836
- O 0 0.02080410160124302
1 O 0 0.0019681118428707123
. O 0 0.0008831055019982159

Additionally O 0 0.0026589971967041492
, O 0 0.0003310074389446527
the O 0 0.00042638726881705225
X O 0 0.0036232962738722563
- O 0 0.0017277301521971822
linked O 0 0.0007782187894918025
, O 0 0.00013666886661667377
candidate O 0 0.0003026589984074235
dosage O 0 0.001062149996869266
- O 0 0.000758273177780211
sensitive O 0 0.0008936234517022967
sex O 0 0.0003812177455984056
- O 0 0.0006665752152912319
reversal O 0 0.001534978044219315
gene O 0 0.0003083983319811523
, O 0 0.00024425750598311424
Dax O 1 0.9994237422943115
- O 0 0.0020836330950260162
1 O 0 0.0005752108991146088
, O 0 0.0003295222413726151
antagonizes O 0 0.005659494549036026
synergy O 0 0.004310124553740025
between O 0 0.001782081788405776
SF O 1 0.9999953508377075
- O 0 0.004003864713013172
1 O 0 0.001019516959786415
and O 0 0.0004688933549914509
WT1 O 1 0.9996885061264038
, O 0 0.000204993222723715
most O 0 9.824881999520585e-05
likely O 0 7.356249989243224e-05
through O 0 3.9368635043501854e-05
a O 0 8.941828855313361e-05
direct O 0 9.452208178117871e-05
interaction O 0 0.0001644791045691818
with O 0 0.0003390683268662542
SF O 1 0.9999991655349731
- O 0 0.023517949506640434
1 O 0 0.0020550068002194166
. O 0 0.0009681484079919755

We O 0 0.0014826891710981727
propose O 0 0.001635940046980977
that O 0 0.0003141640918329358
WT1 O 1 0.9505897164344788
and O 0 0.0014916073996573687
Dax O 1 0.9999678134918213
- O 0 0.0031428912188857794
1 O 0 0.0005725136143155396
functionally O 0 0.0007658962858840823
oppose O 0 0.00023435516050085425
each O 0 2.5512832507956773e-05
other O 0 3.743441993719898e-05
in O 0 0.00016880173643585294
testis O 0 0.014925222843885422
development O 0 0.0009263402316719294
by O 0 0.0003917799040209502
modulating O 1 0.9530053734779358
SF O 1 0.9999923706054688
- O 0 0.0036393653135746717
1 O 0 0.0010674349032342434
- O 0 0.001758885569870472
mediated O 0 0.003785180626437068
transactivation O 0 0.01713186502456665
. O 0 0.0007337878341786563
. O 0 0.0008684401400387287

A O 0 0.008726716041564941
mouse O 0 0.0047103348188102245
model O 0 0.00169931270647794
for O 0 0.001238821423612535
Prader B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 0.9999996423721313
- O 1 0.9999868869781494
centre O 1 0.9989758729934692
mutations O 0 0.00263834185898304
. O 0 0.0010416354052722454

Imprinting O 0 0.017574874684214592
in O 0 0.0012081676395609975
the O 0 0.0019524216186255217
15q11 O 1 0.9989644289016724
- O 0 0.006151989102363586
q13 O 0 0.039736758917570114
region O 0 0.0012318064691498876
involves O 0 0.0003876640403177589
an O 0 0.00023623376910109073
imprinting O 0 0.019576793536543846
centre O 1 0.600527286529541
( O 0 0.0014007576974108815
IC O 1 0.9897567629814148
) O 0 0.0001873233268270269
, O 0 8.496118971379474e-05
mapping O 0 0.00017099027172662318
in O 0 8.665319910505787e-05
part O 0 0.00022421684116125107
to O 0 0.00011546647147042677
the O 0 0.0003968407108914107
promoter O 0 0.00594846298918128
and O 0 0.0003278411168139428
first O 0 0.0008321653585880995
exon O 0 0.005908704828470945
of O 0 0.0029302837792783976
SNRPN O 1 0.9999867677688599
. O 0 0.0036483502481132746

Deletion O 0 0.0055444613099098206
of O 0 0.0016613147454336286
this O 0 0.0008345255046151578
IC O 1 0.9929773211479187
abolishes O 0 0.032412394881248474
local O 0 0.0008147784974426031
paternally O 0 0.0045850323513150215
derived O 0 0.00037152087315917015
gene O 0 0.00023632252123206854
expression O 0 0.00019718897237908095
and O 0 0.00012873971718363464
results O 0 0.00021322151587810367
in O 0 0.0010850095422938466
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999982118606567
PWS B-Disease 1 1.0
) O 0 0.005489282310009003
. O 0 0.001205947482958436

We O 0 0.0009380471892654896
have O 0 9.470568329561502e-05
created O 0 0.00023074903583619744
two O 0 0.00010508869308978319
deletion O 0 0.0007720297435298562
mutations O 0 0.0004202455747872591
in O 0 0.00033818601514212787
mice O 0 0.0006743707344867289
to O 0 0.0002242046466562897
understand O 0 0.0010385490022599697
PWS B-Disease 1 0.9999998807907104
and O 0 0.0003569491964299232
the O 0 0.00042955102981068194
mechanism O 0 0.0006060760351829231
of O 0 0.0006519596790894866
this O 0 0.0004843582573812455
IC O 1 0.9960958361625671
. O 0 0.0014210998779162765

Mice O 0 0.03206081688404083
harbouring O 1 0.8251322507858276
an O 0 0.002027357229962945
intragenic O 1 0.9969083666801453
deletion O 0 0.0051412396132946014
in O 0 0.0007943336386233568
Snrpn O 1 0.9996426105499268
are O 0 0.00017576533718965948
phenotypically O 0 0.0033609645906835794
normal O 0 0.00043554918374866247
, O 0 0.00010628454037941992
suggesting O 0 0.00018558815645519644
that O 0 4.199704198981635e-05
mutations O 0 0.00012965765199624002
of O 0 0.0004106014675926417
SNRPN O 1 0.9999963045120239
are O 0 7.401487528113648e-05
not O 0 4.35976980952546e-05
sufficient O 0 0.00024070274957921356
to O 0 0.00039034217479638755
induce O 1 0.7199839949607849
PWS B-Disease 1 0.9999998807907104
. O 0 0.004763364791870117

Mice O 0 0.003813790623098612
with O 0 0.0002453987253829837
a O 0 0.0003125514485873282
larger O 0 0.0005243669147603214
deletion O 0 0.0007124275434762239
involving O 0 0.000708944455254823
both O 0 0.0003218768979422748
Snrpn O 1 0.9979591369628906
and O 0 0.0005419114022515714
the O 0 0.0018765194108709693
putative O 1 0.9989339709281921
PWS O 1 1.0
- O 1 0.9969762563705444
IC O 1 0.9921139478683472
lack O 0 0.000987671548500657
expression O 0 0.0002477860252838582
of O 0 0.000298193481285125
the O 0 0.0005259987665340304
imprinted O 0 0.006535251624882221
genes O 0 0.0009746621362864971
Zfp127 O 1 0.9981809854507446
( O 0 0.0007367013022303581
mouse O 0 0.001328656799159944
homologue O 0 0.003760747844353318
of O 0 0.001402040827088058
ZNF127 O 1 0.9999957084655762
) O 0 0.0006196546601131558
, O 0 0.0007065809331834316
Ndn O 1 0.8484917879104614
and O 0 0.0010046862298622727
Ipw O 1 0.9938154220581055
, O 0 0.0009206385002471507
and O 0 0.0004276340769138187
manifest O 0 0.0023678659927099943
several O 0 0.0005105026066303253
phenotypes O 0 0.0030727337580174208
common O 0 0.001666996511630714
to O 0 0.01966935023665428
PWS B-Disease 1 1.0
infants O 1 0.9999719858169556
. O 0 0.0028235253412276506

These O 0 0.00039231081609614193
data O 0 0.00014832575106993318
demonstrate O 0 0.00026781915221363306
that O 0 3.1097140890778974e-05
both O 0 2.622670763230417e-05
the O 0 6.0194306570338085e-05
position O 0 0.00015476426051463932
of O 0 0.00015877376426942647
the O 0 0.000510273443069309
IC O 1 0.9963682889938354
and O 0 0.00017876781930681318
its O 0 6.984838546486571e-05
role O 0 0.00017839149222709239
in O 0 5.202216925681569e-05
the O 0 9.907069761538878e-05
coordinate O 0 0.00014604224998038262
expression O 0 0.00013176376523915678
of O 0 0.00015570477989967912
genes O 0 0.00012388550385367125
is O 0 6.467429921030998e-05
conserved O 0 0.0001903759257402271
between O 0 0.00028482056222856045
mouse O 0 0.0006867513875477016
and O 0 0.0001679495326243341
human O 0 0.000251741090323776
, O 0 9.733698243508115e-05
and O 0 6.788293103454635e-05
indicate O 0 0.00011742481729015708
that O 0 4.382304541650228e-05
the O 0 0.0002138465497409925
mouse O 0 0.0003214494208805263
is O 0 5.244656131253578e-05
a O 0 0.00010121396189788356
suitable O 0 0.0002559659187681973
model O 0 0.00025328141055069864
system O 0 0.00012305266864132136
in O 0 8.1302881881129e-05
which O 0 2.6322097255615517e-05
to O 0 2.876425423892215e-05
investigate O 0 0.00014347188698593527
the O 0 0.00011154729872941971
molecular O 0 0.00027214110014028847
mechanisms O 0 0.00023766337835695595
of O 0 0.0002812231832649559
imprinting O 0 0.0014480538666248322
in O 0 7.683627336518839e-05
this O 0 3.835212919511832e-05
region O 0 8.589540811954066e-05
of O 0 0.0001514892210252583
the O 0 0.0005081170238554478
genome O 0 0.0006371760391630232
. O 0 0.00025013904087245464
. O 0 0.0004389329405967146

Mutations O 0 0.0014417938655242324
of O 0 0.0007689077756367624
the O 0 0.0008756992174312472
ATM O 0 0.004201591946184635
gene O 0 0.00040614913450554013
detected O 0 0.0006979934987612069
in O 0 0.0004009962431155145
Japanese O 1 0.8881019949913025
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999905824661255
telangiectasia I-Disease 1 0.9999994039535522
patients O 0 0.0024382711853832006
: O 0 0.00020988027972634882
possible O 0 0.00020133869838900864
preponderance O 0 0.0018303371034562588
of O 0 0.00032806373201310635
the O 0 0.00037784295273013413
two O 0 0.00023282418260350823
founder O 0 0.06302225589752197
mutations O 0 0.0019281316781416535
4612del165 O 1 0.9992648959159851
and O 0 0.0025316167157143354
7883del5 O 1 0.9995705485343933
. O 0 0.0025431797839701176

The O 0 0.0030816388316452503
ATM O 0 0.010777182877063751
( O 0 0.0011340788332745433
A O 1 0.99657142162323
- O 1 0.9941060543060303
T O 1 0.9999433755874634
, O 0 0.0002591631782706827
mutated O 0 0.0007252679788507521
) O 0 0.00012531480751931667
gene O 0 0.00018481432925909758
on O 0 0.0003162921348121017
human O 0 0.0009263260872103274
chromosome O 0 0.005907922983169556
11q22 O 1 0.9992475509643555
. O 0 0.002972001675516367

3 O 0 0.003344138152897358
has O 0 0.0003802900027949363
recently O 0 0.00048226898070424795
been O 0 0.00011595426622079685
identified O 0 0.00013847718946635723
as O 0 0.00011485142022138461
the O 0 0.00017246429342776537
gene O 0 0.00015899738355074078
responsible O 0 0.0002310004347236827
for O 0 9.995461732614785e-05
the O 0 0.000510022568050772
human O 0 0.33606868982315063
recessive B-Disease 1 0.9999988079071045
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.998285710811615
A B-Disease 1 0.9999996423721313
- I-Disease 1 0.999990701675415
T I-Disease 1 0.9999970197677612
) O 0 0.0005622394965030253
. O 0 0.0005667268997058272

In O 0 0.0010036490857601166
order O 0 0.0003158163744956255
to O 0 0.00010032464342657477
define O 0 0.00017881080566439778
the O 0 0.00013303090236149728
types O 0 0.0002603834727779031
of O 0 0.11006113141775131
disease O 1 1.0
- O 1 0.9999645948410034
causing O 1 0.9998688697814941
ATM O 0 0.010365759022533894
mutations O 0 0.00014706361980643123
in O 0 0.00015257341146934777
Japanese O 0 0.0038238277193158865
A B-Disease 1 0.9998056292533875
- I-Disease 1 0.9995711445808411
T I-Disease 1 0.9999943971633911
patients O 0 0.0002568138879723847
as O 0 0.00016532582230865955
well O 0 6.809493788750842e-05
as O 0 6.065272827981971e-05
to O 0 5.992980004521087e-05
look O 0 0.00014635255502071232
for O 0 9.57064185058698e-05
possible O 0 0.00039476354140788317
mutational O 0 0.022673964500427246
hotspots O 0 0.025663431733846664
, O 0 0.00032751623075455427
reverse O 0 0.0010578179499134421
- O 0 0.0006618888583034277
transcribed O 0 0.00045231281546875834
RNA O 0 0.00037522174534387887
derived O 0 0.00011790312419179827
from O 0 9.68514577834867e-05
ten O 0 0.0002094073424814269
patients O 0 0.00016030044935178012
belonging O 0 0.00035337137524038553
to O 0 9.961349860532209e-05
eight O 0 0.0003275411727372557
unrelated O 0 0.0009615517337806523
Japanese O 0 0.09094303101301193
A B-Disease 1 0.9999336004257202
- I-Disease 1 0.9912302494049072
T I-Disease 1 0.9992488026618958
families O 0 0.0002815955667756498
was O 0 0.0005554341478273273
analyzed O 0 0.0002245739015052095
for O 0 5.850650995853357e-05
mutations O 0 0.00013617079821415246
by O 0 7.033665315248072e-05
the O 0 0.00022686894226353616
restriction O 0 0.0005391945596784353
endonuclease O 0 0.005520367994904518
fingerprinting O 0 0.0029297026339918375
method O 0 0.0008813519962131977
. O 0 0.0009213024168275297

As O 0 0.0021023142617195845
has O 0 0.00026067186263389885
been O 0 0.0002017499355133623
reported O 0 0.0001738240389386192
by O 0 4.9621467042015865e-05
others O 0 9.419564594281837e-05
, O 0 9.363948629470542e-05
mutations O 0 8.952929056249559e-05
that O 0 4.659932528738864e-05
lead O 0 0.0002868639421649277
to O 0 0.00016940833302214742
exon O 0 0.0024006832391023636
skipping O 0 0.0022575026378035545
or O 0 0.000345627631759271
premature O 0 0.002142060548067093
protein O 0 0.0003976452280767262
truncation O 0 0.0031172065064311028
were O 0 0.00023194545065052807
also O 0 0.00021648293477483094
predominant O 0 0.0006766929291188717
in O 0 0.0002745735109783709
our O 0 0.0009277936769649386
mutants O 0 0.008321977220475674
. O 0 0.001253531314432621

Six O 0 0.001226702588610351
different O 0 0.00014098819519858807
mutations O 0 0.00017981286509893835
were O 0 9.451631922274828e-05
identified O 0 0.0001217765748151578
on O 0 0.00012110885290894657
12 O 0 0.00013413936540018767
of O 0 0.00016570505977142602
the O 0 0.0003686316485982388
16 O 0 0.0013187299482524395
alleles O 0 0.0008271911647170782
examined O 0 0.001563136582262814
. O 0 0.0009603052749298513

Four O 0 0.0015860580606386065
were O 0 0.0005363824893720448
deletions O 0 0.0009397021494805813
involving O 0 0.0005541705177165568
a O 0 0.0002729435218498111
loss O 0 0.0008381906081922352
of O 0 0.0002071320341201499
a O 0 0.0003315452777314931
single O 0 0.00024252955336123705
exon O 0 0.0012064379407092929
exon O 0 0.0011998575646430254
7 O 0 0.00041564350249245763
, O 0 0.00014245847705751657
exon O 0 0.0011144035961478949
16 O 0 0.0004973639734089375
, O 0 0.00018894026288762689
exon O 0 0.0016058770706877112
33 O 0 0.0010526347905397415
or O 0 0.0006540873437188566
exon O 0 0.00511762173846364
35 O 0 0.002335169119760394
. O 0 0.0010443241335451603

The O 0 0.002102448372170329
others O 0 0.0005201044259592891
were O 0 0.0003466489433776587
minute O 0 0.0004398688906803727
deletions O 0 0.001623926917091012
, O 0 0.00019464807701297104
4649delA O 0 0.008030426688492298
in O 0 0.0005057160742580891
exon O 0 0.0032979536335915327
33 O 0 0.0014893102925270796
and O 0 0.0005166380433365703
7883del5 O 0 0.028984131291508675
in O 0 0.0007898610783740878
exon O 0 0.007591568399220705
55 O 0 0.002386139938607812
. O 0 0.0010880184127017856

The O 0 0.004441958386451006
mutations O 0 0.002658429555594921
4612del165 O 1 0.9948441982269287
and O 0 0.0008077491074800491
7883del5 O 1 0.9979676604270935
were O 0 0.00021301893866620958
found O 0 5.4533655202249065e-05
in O 0 4.2035902879433706e-05
more O 0 1.7905791537486948e-05
than O 0 1.9091503418167122e-05
two O 0 2.804964969982393e-05
unrelated O 0 0.00018204953812528402
families O 0 5.700829206034541e-05
; O 0 3.2390958949690685e-05
44 O 0 0.00014758718316443264
% O 0 6.775965448468924e-05
( O 0 7.914671732578427e-05
7 O 0 0.00017296527221333236
of O 0 0.00012613338185474277
16 O 0 0.00022578179778065532
) O 0 4.1423474613111466e-05
of O 0 0.0001161501495516859
the O 0 0.00031458036391995847
mutant O 0 0.0011576451361179352
alleles O 0 0.0001730442891130224
had O 0 0.00013320085417944938
one O 0 5.6780198065098375e-05
of O 0 0.00011529604671522975
the O 0 0.0003482260799501091
two O 0 0.0003212493611499667
mutations O 0 0.001261032186448574
. O 0 0.0009479906293563545

The O 0 0.0046707633882761
4612del165 O 1 0.8544235229492188
mutations O 0 0.0004945641267113388
in O 0 8.468674786854535e-05
three O 0 4.194228313281201e-05
different O 0 1.7886131900013424e-05
families O 0 4.875985177932307e-05
were O 0 5.310697088134475e-05
all O 0 3.4284897992620245e-05
ascribed O 0 0.00028874626150354743
to O 0 5.935184162808582e-05
the O 0 0.00014572437794413418
same O 0 0.00025441241450607777
T O 0 0.4843139946460724
- O 0 0.0007502553635276854
- O 0 0.000497066299431026
> O 0 0.0005065198056399822
A O 0 0.0003878508578054607
substitution O 0 0.0003748888848349452
at O 0 0.00029990068287588656
the O 0 0.0001773303811205551
splice O 0 0.001986576011404395
donor O 0 0.0004756994603667408
site O 0 0.001089307595975697
in O 0 0.0004752068198285997
intron O 0 0.010821254923939705
33 O 0 0.0035745506174862385
. O 0 0.0014611334772780538

Microsatellite O 0 0.05729299783706665
genotyping O 0 0.013992286287248135
around O 0 0.0013466327218338847
the O 0 0.0008623373578302562
ATM O 0 0.0038143349811434746
locus O 0 0.0012231972068548203
also O 0 0.00013972239685244858
indicated O 0 0.00012296467320993543
that O 0 2.805023905239068e-05
a O 0 0.00010316967382095754
common O 0 0.00018021761206910014
haplotype O 0 0.0008583226008340716
was O 0 0.001009486266411841
shared O 0 0.00030574682750739157
by O 0 8.791851723799482e-05
the O 0 0.00024036195827648044
mutant O 0 0.0013349520741030574
alleles O 0 0.00025380647275596857
in O 0 0.00020967147429473698
both O 0 0.0003215039614588022
mutations O 0 0.000864602392539382
. O 0 0.0007610364118590951

This O 0 0.0007779058068990707
suggests O 0 0.0005077059613540769
that O 0 6.426644540624693e-05
these O 0 3.255366027588025e-05
two O 0 8.789606363279745e-05
founder O 0 0.01282572839409113
mutations O 0 0.0004942417144775391
may O 0 0.00021535434643737972
be O 0 8.691538096172735e-05
predominant O 0 0.0007273783558048308
among O 0 0.00022005992650520056
Japanese O 0 0.004526980686932802
ATM O 0 0.008099769242107868
mutant O 0 0.005851458292454481
alleles O 0 0.0014748849207535386
. O 0 0.0007715156534686685

W474C O 0 0.1983700394630432
amino O 0 0.004266311414539814
acid O 0 0.002851328579708934
substitution O 0 0.0012597211170941591
affects O 0 0.0004057996557094157
early O 0 0.00017006606503855437
processing O 0 0.00013266112364362925
of O 0 0.00013347930507734418
the O 0 0.0001986658899113536
alpha O 0 0.000275149242952466
- O 0 0.00015174828877206892
subunit O 0 0.00010835289867827669
of O 0 0.00017166514589916915
beta O 0 0.0005715708830393851
- O 0 0.0005617461865767837
hexosaminidase O 0 0.014303261414170265
A O 0 0.0006288127624429762
and O 0 0.00012773566413670778
is O 0 9.80670447461307e-05
associated O 0 0.00017395631584804505
with O 0 0.0003003361925948411
subacute O 1 0.9999997615814209
G B-Disease 1 0.9999978542327881
( I-Disease 1 0.5372314453125
M2 I-Disease 1 0.999955415725708
) I-Disease 0 0.0018693027086555958
gangliosidosis I-Disease 1 0.7659071683883667
. O 0 0.0011628895299509168

Mutations O 0 0.0022683332208544016
in O 0 0.000821999623440206
the O 0 0.0012979974271729589
HEXA O 1 0.9993079900741577
gene O 0 0.0003997606982011348
, O 0 9.181309724226594e-05
encoding O 0 3.877752533298917e-05
the O 0 0.00011306303349556401
alpha O 0 0.00028036118601448834
- O 0 0.00011076655209762976
subunit O 0 8.181214070646092e-05
of O 0 0.00011508121679071337
beta O 0 0.0004037920734845102
- O 0 0.0004772904794663191
hexosaminidase O 0 0.0059886351227760315
A O 0 0.000933006638661027
( O 0 0.0002960214333143085
Hex O 0 0.003897713730111718
A O 0 0.001198901329189539
) O 0 0.0001322178723057732
, O 0 7.978431676747277e-05
that O 0 4.8981593863572925e-05
abolish O 0 0.0019356838893145323
Hex O 0 0.004943422041833401
A O 0 0.002051528310403228
enzyme O 0 0.002221473027020693
activity O 0 0.004259506706148386
cause O 1 0.9999610185623169
Tay B-Disease 1 1.0
- I-Disease 1 0.9999988079071045
Sachs I-Disease 1 0.9999996423721313
disease I-Disease 1 0.9999998807907104
( O 1 0.9690529704093933
TSD B-Disease 1 0.9999997615814209
) O 0 0.0005062760319560766
, O 0 0.0002198145812144503
the O 0 0.0005527507164515555
fatal O 1 0.9998834133148193
infantile B-Disease 1 0.99970942735672
form I-Disease 0 0.0016704027075320482
of I-Disease 0 0.21527718007564545
G I-Disease 1 0.9998229146003723
( I-Disease 0 0.0016875345027074218
M2 I-Disease 1 0.9988162517547607
) I-Disease 0 0.00041255855467170477
gangliosidosis I-Disease 0 0.023414012044668198
, I-Disease 0 0.00020088577002752572
Type I-Disease 0 0.0008538397960364819
1 I-Disease 0 0.001054618158377707
. O 0 0.0006142599740996957

Less O 0 0.0055411760695278645
severe O 1 0.9998347759246826
, O 0 0.003977071028202772
subacute O 1 0.9999997615814209
( O 1 0.6885793209075928
juvenile O 1 0.9999772310256958
- O 1 0.9967873096466064
onset O 1 0.999997615814209
) O 0 0.0007134522311389446
and O 0 0.0017485712887719274
chronic O 1 1.0
( O 0 0.2875627875328064
adult O 0 0.005852207075804472
- O 1 0.9563330411911011
onset O 1 0.999916672706604
) O 0 0.0002858363150153309
variants O 0 0.00023060652893036604
are O 0 2.9720802558586e-05
characterized O 0 0.00022309749328996986
by O 0 8.784259262029082e-05
a O 0 0.00024245650274679065
broad O 0 0.0006761674885638058
spectrum O 0 0.0007576477364636958
of O 0 0.0009564816136844456
clinical O 0 0.04663822799921036
manifestations O 1 0.9999561309814453
and O 0 0.0008861809619702399
are O 0 6.482632306870073e-05
associated O 0 0.00013438785390462726
with O 0 8.045872527873144e-05
residual O 0 0.002413043985143304
levels O 0 0.0005194687400944531
of O 0 0.000495313957799226
Hex O 0 0.008910516276955605
A O 0 0.0033394168131053448
enzyme O 0 0.0021077580749988556
activity O 0 0.0012736455537378788
. O 0 0.0005109632038511336

We O 0 0.0009613438742235303
identified O 0 0.0006373913493007421
a O 0 0.0008605996263213456
1422 O 0 0.49114999175071716
G O 0 0.014656903222203255
- O 0 0.0024655363522469997
- O 0 0.0010999065125361085
> O 0 0.0012502510799095035
C O 0 0.0011461349204182625
( O 0 0.0002900640538427979
amino O 0 0.00043917715083807707
acid O 0 0.0008829692960716784
W474C O 0 0.006936078891158104
) O 0 0.00011548354086698964
substitution O 0 0.00023029452131595463
in O 0 4.0889703086577356e-05
the O 0 5.613510438706726e-05
first O 0 0.0001175262950710021
position O 0 0.00011939949763473123
of O 0 0.00021351792383939028
exon O 0 0.0014343630755320191
13 O 0 0.0004842211492359638
of O 0 0.0004760882002301514
HEXA O 1 0.9977734684944153
of O 0 0.0007237745448946953
a O 0 0.0007127916323952377
non O 0 0.0010488919215276837
- O 0 0.000944688799791038
Jewish O 0 0.0014213352696970105
proband O 1 0.9079437851905823
who O 0 0.0006262419046834111
manifested O 0 0.00401646550744772
a O 0 0.0012346020666882396
subacute O 1 0.9999055862426758
variant O 0 0.006568846758455038
of O 0 0.03442484885454178
G B-Disease 1 0.9999152421951294
( I-Disease 0 0.013316091150045395
M2 I-Disease 1 0.999745786190033
) I-Disease 0 0.001541667734272778
gangliosidosis I-Disease 0 0.2802368700504303
. O 0 0.0018783913692459464

On O 0 0.001937223831191659
the O 0 0.001227173488587141
second O 0 0.0029609163757413626
maternally O 0 0.014861030504107475
inherited O 1 0.9499375820159912
allele O 0 0.0012635206803679466
, O 0 0.0002640326274558902
we O 0 0.00010924512025667354
identified O 0 0.00011063353304052725
the O 0 0.00032408098923042417
common O 0 0.004419487901031971
infantile O 1 1.0
disease O 1 1.0
- O 1 0.9999828338623047
causing O 1 0.9999682903289795
4 O 0 0.004508277401328087
- O 0 0.0017448423895984888
bp O 0 0.0031519546173512936
insertion O 0 0.0017031674506142735
, O 0 0.000423060409957543
+ O 0 0.0026578125543892384
TATC O 1 0.9996404647827148
1278 O 1 0.9611507058143616
, O 0 0.0005571722285822034
in O 0 0.0004804623022209853
exon O 0 0.00563021469861269
11 O 0 0.0025765770114958286
. O 0 0.0011871487367898226

Pulse O 0 0.030918747186660767
- O 0 0.0028440195601433516
chase O 0 0.0015975411515682936
analysis O 0 0.00014726273366250098
using O 0 0.0003217630728613585
proband O 1 0.8784142136573792
fibroblasts O 0 0.010784389451146126
revealed O 0 0.0012480095028877258
that O 0 9.053497342392802e-05
the O 0 0.0003026460180990398
W474C O 0 0.11773481220006943
- O 0 0.0009440364665351808
containing O 0 0.00042801868403330445
alpha O 0 0.0004870504781138152
- O 0 0.00027981321909464896
subunit O 0 0.000377100397599861
precursor O 0 0.0013476560125127435
was O 0 0.0007425089133903384
normally O 0 0.00019252944912295789
synthesized O 0 0.00041820938349701464
, O 0 5.874651833437383e-05
but O 0 4.071169314556755e-05
not O 0 3.575656228349544e-05
phosphorylated O 0 0.0007858483004383743
or O 0 0.0001912009174702689
secreted O 0 0.0005533727235160768
, O 0 0.00010876055603148416
and O 0 8.917781815398484e-05
the O 0 0.00030946717015467584
mature O 0 0.001047254423610866
lysosomal O 0 0.033121321350336075
alpha O 0 0.001170567935332656
- O 0 0.0004714055103249848
subunit O 0 0.0003604233206715435
was O 0 0.00046467321226373315
not O 0 9.592826972948387e-05
detected O 0 0.0008757274481467903
. O 0 0.00044482896919362247

When O 0 0.0025722060818225145
the O 0 0.0017216777196153998
W474C O 0 0.10097882896661758
- O 0 0.0017903789412230253
containing O 0 0.000535668688826263
alpha O 0 0.0007001754129305482
- O 0 0.0003252869355492294
subunit O 0 0.0003742410917766392
was O 0 0.0010666715679690242
transiently O 0 0.004630135837942362
co O 0 0.001272058580070734
- O 0 0.00033966460614465177
expressed O 0 9.824376320466399e-05
with O 0 5.030277679907158e-05
the O 0 0.00017430467414669693
beta O 0 0.00033142141182906926
- O 0 0.0002281026536365971
subunit O 0 0.00014353045844472945
to O 0 5.972577855573036e-05
produce O 0 0.0001622054842300713
Hex O 0 0.0017380781937390566
A O 0 0.0010366006754338741
( O 0 0.0004676428798120469
alphabeta O 0 0.012357335537672043
) O 0 0.00013526798284146935
in O 0 0.0002361754304729402
COS O 1 0.9986563920974731
- O 0 0.002230192767456174
7 O 0 0.0013087901752442122
cells O 0 0.0002491579216439277
, O 0 4.853068821830675e-05
the O 0 0.00013566041889134794
mature O 0 0.0003866860643029213
alpha O 0 0.0003778269747272134
- O 0 0.00023351226991508156
subunit O 0 0.0002458722738083452
was O 0 0.00037711553159169853
present O 0 0.0001442674401914701
, O 0 4.909298149868846e-05
but O 0 2.4672124709468335e-05
its O 0 2.545931056374684e-05
level O 0 0.00014683201152365655
was O 0 0.00025137796183116734
much O 0 0.00010774459224194288
lower O 0 0.00011829061986645684
than O 0 1.6345997210009955e-05
that O 0 1.494044772698544e-05
from O 0 6.893423415021971e-05
normal O 0 0.00020321780175436288
alpha O 0 0.0003743353299796581
- O 0 0.0002861990069504827
subunit O 0 0.0003079820016864687
transfections O 0 0.0028973345179110765
, O 0 8.621751476312056e-05
although O 0 4.472246655495837e-05
higher O 0 5.665990829584189e-05
than O 0 2.487307028786745e-05
in O 0 4.895460369880311e-05
those O 0 8.962017454905435e-05
cells O 0 0.0005420591332949698
transfected O 0 0.0038432739675045013
with O 0 0.0001427994284313172
an O 0 0.0002074460790026933
alpha O 0 0.0009243309614248574
- O 0 0.00045018381206318736
subunit O 0 0.000355330528691411
associated O 0 0.00024733543978072703
with O 0 0.00041115100611932576
infantile O 1 0.999997615814209
TSD B-Disease 1 0.9999996423721313
. O 0 0.004063975065946579

Furthermore O 0 0.004083543084561825
, O 0 0.0004586205759551376
the O 0 0.00036827268195338547
precursor O 0 0.0016146785346791148
level O 0 0.0003697843349073082
of O 0 0.0001841351913753897
the O 0 0.0003291213361080736
W474C O 0 0.29457682371139526
alpha O 0 0.0010766171617433429
- O 0 0.00023823462834116071
subunit O 0 0.00015597863239236176
was O 0 0.00023995348601602018
found O 0 5.219031299930066e-05
to O 0 4.9786500312620774e-05
accumulate O 0 0.0001420236221747473
in O 0 5.428786971606314e-05
comparison O 0 7.512696902267635e-05
to O 0 6.390905036823824e-05
the O 0 0.00018419791013002396
normal O 0 0.00039738297346048057
alpha O 0 0.0006018381682224572
- O 0 0.0004298404383007437
subunit O 0 0.0007307191845029593
precursor O 0 0.005521171260625124
levels O 0 0.001347164623439312
. O 0 0.0006258573848754168

We O 0 0.0008799507631920278
conclude O 0 0.0008217333815991879
that O 0 0.00011050954344682395
the O 0 0.0003966440272051841
1422 O 1 0.7713246941566467
G O 0 0.08231198787689209
- O 0 0.0025522145442664623
- O 0 0.001320947427302599
> O 0 0.0012365580769255757
C O 0 0.0008801271906122565
mutation O 0 0.00013632485934067518
is O 0 3.67903703590855e-05
the O 0 0.00016092468285933137
cause O 0 0.00067370809847489
of O 0 0.0008440172532573342
Hex B-Disease 1 0.9987655878067017
A I-Disease 1 0.999704897403717
enzyme I-Disease 1 0.9999712705612183
deficiency I-Disease 1 1.0
in O 0 0.0013257518876343966
the O 0 0.002451405394822359
proband O 1 0.9996869564056396
. O 0 0.001539624179713428

The O 0 0.003660795744508505
resulting O 0 0.004514753818511963
W474C O 1 0.6103612780570984
substitution O 0 0.002926104236394167
clearly O 0 0.0008244856726378202
interferes O 0 0.0011749952100217342
with O 0 0.000122112178360112
alpha O 0 0.0005119142588227987
- O 0 0.00027971933013759553
subunit O 0 0.00024031980137806386
processing O 0 0.0002557373372837901
, O 0 4.9244907131651416e-05
but O 0 2.270320510433521e-05
because O 0 3.7863388570258394e-05
the O 0 0.00010609094169922173
base O 0 0.0005186268826946616
substitution O 0 0.000891708885319531
falls O 0 0.0022560658399015665
at O 0 0.0002767308906186372
the O 0 9.820984996622428e-05
first O 0 6.626803951803595e-05
position O 0 9.665135439718142e-05
of O 0 0.00014737217861693352
exon O 0 0.001344982534646988
13 O 0 0.0005091815255582333
, O 0 0.00016386732750106603
aberrant O 0 0.0018518795259296894
splicing O 0 0.0008262461633421481
may O 0 0.00015210856508929282
also O 0 5.761273860116489e-05
contribute O 0 0.00013879447942599654
to O 0 0.00012118485756218433
Hex B-Disease 0 0.1853843331336975
A I-Disease 1 0.9602288007736206
deficiency I-Disease 1 0.9999991655349731
in O 0 0.0007317776908166707
this O 0 0.0005579295102506876
proband O 1 0.9990554451942444
. O 0 0.0005757901817560196
. O 0 0.0007591488538309932

Two O 0 0.0012893626699224114
frequent O 0 0.0025970616843551397
missense O 0 0.010030743665993214
mutations O 0 0.004327883943915367
in O 0 0.4999183714389801
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.10517103970050812

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 1 0.59501051902771
an O 1 0.9848998785018921
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 1.0
by O 1 0.9998613595962524
early O 1 0.9999988079071045
childhood O 1 1.0
deafness B-Disease 1 1.0
and O 1 0.9999997615814209
goiter B-Disease 1 1.0
. O 1 0.9726588726043701

A O 0 0.003245423547923565
century O 0 0.002057588892057538
after O 0 0.00030539202271029353
its O 0 5.9429432440083474e-05
recognition O 0 0.00023950911418069154
as O 0 0.0002790597500279546
a O 0 0.0030468949116766453
syndrome O 1 0.9999997615814209
by O 0 0.000839275133330375
Vaughan O 1 0.997218132019043
Pendred O 1 0.9999872446060181
, O 0 0.0004873913712799549
the O 0 0.0013168053701519966
disease O 1 0.9999927282333374
gene O 0 0.002016895217821002
( O 0 0.0013261775020509958
PDS O 1 0.9999797344207764
) O 0 0.00029280027956701815
was O 0 0.0005513011710718274
mapped O 0 0.0004888572730123997
to O 0 0.00046891215606592596
chromosome O 0 0.0048833866603672504
7q22 O 1 0.9998880624771118
- O 1 0.6900931000709534
q31 O 1 0.9929414987564087
. O 0 0.0026360279880464077

1 O 0 0.0034094348084181547
and O 0 0.0004983330145478249
, O 0 0.00034511182457208633
recently O 0 0.00037775313830934465
, O 0 0.0001059334390447475
found O 0 6.172384019009769e-05
to O 0 7.682982686674222e-05
encode O 0 0.00032795019797049463
a O 0 0.0007544538239017129
putative O 0 0.01802010089159012
sulfate O 1 0.9988729357719421
transporter O 1 0.9941229224205017
. O 0 0.002778309164568782

We O 0 0.0012074554106220603
performed O 0 0.0006893413956277072
mutation O 0 0.00013551756273955107
analysis O 0 3.8379610487027094e-05
of O 0 0.0002024708519456908
the O 0 0.0005942884599789977
PDS B-Disease 1 0.9999656677246094
gene O 0 0.0003657388442661613
in O 0 0.0001517571072326973
patients O 0 0.00018141514738090336
from O 0 0.00022334989625960588
14 O 0 0.001054626191034913
Pendred B-Disease 1 0.8398128151893616
families O 0 0.0001770727103576064
originating O 0 0.00040173163870349526
from O 0 0.00012331741163507104
seven O 0 0.00016001866606529802
countries O 0 2.8971273422939703e-05
and O 0 7.253641524584964e-05
identified O 0 0.00021006604947615415
all O 0 0.00017450905579607934
mutations O 0 0.0007470527780242264
. O 0 0.0009178699110634625

The O 0 0.002953661372885108
mutations O 0 0.0004744825419038534
include O 0 0.00014961497799959034
three O 0 0.0001133372206822969
single O 0 0.0001948439603438601
base O 0 0.0010630935430526733
deletions O 0 0.0008430792368017137
, O 0 9.308510198025033e-05
one O 0 8.683427586220205e-05
splice O 0 0.0015699189389124513
site O 0 0.0009295000927522779
mutation O 0 0.0001674923114478588
and O 0 9.084379416890442e-05
10 O 0 0.00049170310376212
missense O 0 0.004145192448049784
mutations O 0 0.0014214124530553818
. O 0 0.0008995685493573546

One O 0 0.0017153886146843433
missense O 0 0.005403890740126371
mutation O 0 0.001011961023323238
( O 0 0.0005858865915797651
L236P O 1 0.9936848282814026
) O 0 0.00026226232876069844
was O 0 0.0004725340404547751
found O 0 8.789212006377056e-05
in O 0 5.6974975450430065e-05
a O 0 0.00012574020365718752
homozygous O 0 0.0002634477277752012
state O 0 5.111672362545505e-05
in O 0 6.050184310879558e-05
two O 0 5.943136056885123e-05
consanguineous O 0 0.002429486019536853
families O 0 0.00011088194150943309
and O 0 7.506437395932153e-05
in O 0 6.552090781042352e-05
a O 0 0.00014863793330732733
heterozygous O 0 5.806479384773411e-05
state O 0 3.240177102270536e-05
in O 0 4.3478787119966e-05
five O 0 8.402175444643945e-05
additional O 0 0.000172308151377365
non O 0 0.000974413298536092
- O 0 0.0017302598571404815
consanguineous O 0 0.00996839627623558
families O 0 0.0007612975896336138
. O 0 0.0009387526079080999

Another O 0 0.004296180326491594
missense O 0 0.007014504633843899
mutation O 0 0.0010676870588213205
( O 0 0.0007318753050640225
T416P O 1 0.9933517575263977
) O 0 0.00020200015569571406
was O 0 0.00037400214932858944
found O 0 8.5798732470721e-05
in O 0 7.252689101733267e-05
a O 0 0.00010471447603777051
homozygous O 0 0.00018422247376292944
state O 0 5.1721704949159175e-05
in O 0 4.4341028115013614e-05
one O 0 8.955295197665691e-05
family O 0 0.00013377492723520845
and O 0 8.730721310712397e-05
in O 0 0.0001125007911468856
a O 0 0.00019322680600453168
heterozygous O 0 8.320647611981258e-05
state O 0 4.622862979886122e-05
in O 0 7.255094533320516e-05
four O 0 0.00014841473603155464
families O 0 0.0003431488003116101
. O 0 0.0005352134467102587

Pendred B-Disease 1 0.9994722008705139
patients O 0 0.0026042701210826635
in O 0 0.0005732908030040562
three O 0 0.00036827268195338547
non O 0 0.0012802673736587167
- O 0 0.0015164981596171856
consanguineous O 0 0.0049653868190944195
families O 0 0.0001729306241031736
were O 0 0.00016095077444333583
shown O 0 0.00016692061035428196
to O 0 0.00013698854309041053
be O 0 0.00014974070654716343
compound O 0 0.005017006304115057
heterozygotes O 0 0.006032273173332214
for O 0 0.0006444277241826057
L236P O 1 0.9990647435188293
and O 0 0.0024099466390907764
T416P O 1 0.9993528723716736
. O 0 0.0018658245680853724

In O 0 0.000799431698396802
total O 0 0.0004014346923213452
, O 0 0.00013802555622532964
one O 0 7.794056728016585e-05
or O 0 6.16918841842562e-05
both O 0 4.791164610651322e-05
of O 0 0.00011849880684167147
these O 0 2.4925979232648388e-05
mutations O 0 5.652692561852746e-05
were O 0 3.669702709885314e-05
found O 0 2.9181037461967207e-05
in O 0 2.6827139663510025e-05
nine O 0 6.399393896572292e-05
of O 0 0.00010060150088975206
the O 0 0.0001999326195800677
14 O 0 0.0006037956918589771
families O 0 0.00019083080405835062
analyzed O 0 0.000604198663495481
. O 0 0.0006282050744630396

The O 0 0.0017342837527394295
identification O 0 0.0006642471998929977
of O 0 0.00043359550181776285
two O 0 0.00031537769245915115
frequent O 0 0.0011483019916340709
PDS B-Disease 1 0.9999921321868896
mutations O 0 0.0006348150200210512
will O 0 0.00011506826558616012
facilitate O 0 0.00024133975966833532
the O 0 0.0003495687269605696
molecular O 0 0.0016451494302600622
diagnosis O 1 0.994838535785675
of O 1 0.9999428987503052
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.8536815643310547

Insertional O 1 0.9405893087387085
mutation O 0 0.002036694437265396
by O 0 0.00044824229553341866
transposable O 0 0.02677183970808983
element O 0 0.004500041715800762
, O 0 0.0005579853896051645
L1 O 0 0.012458385899662971
, O 0 0.00015242755762301385
in O 0 0.00011881311365868896
the O 0 0.0005537391407415271
DMD B-Disease 1 0.99997878074646
gene O 0 0.0003934958658646792
results O 0 0.0002256346051581204
in O 0 0.00034356192918494344
X B-Disease 1 0.982523500919342
- I-Disease 1 0.9903945326805115
linked I-Disease 1 0.9965243935585022
dilated I-Disease 1 0.9999934434890747
cardiomyopathy I-Disease 1 1.0
. O 0 0.06340453028678894

X B-Disease 1 0.9984620809555054
- I-Disease 1 0.9968096613883972
linked I-Disease 1 0.9992808699607849
dilated I-Disease 1 0.9999995231628418
cardiomyopathy I-Disease 1 1.0
( O 1 0.9999409914016724
XLDCM B-Disease 1 1.0
) O 0 0.0005817794008180499
is O 0 0.0001807622902560979
a O 0 0.00022330561478156596
clinical O 0 0.00044600211549550295
phenotype O 0 0.0009336823713965714
of O 0 0.0015489233192056417
dystrophinopathy B-Disease 1 0.9999979734420776
which O 0 0.00023180882271844894
is O 0 0.00010215441579930484
characterized O 0 0.00033965197508223355
by O 0 0.00020193777163513005
preferential O 0 0.008751019835472107
myocardial B-Disease 1 1.0
involvement I-Disease 1 0.9978263974189758
without O 0 0.0009995135478675365
any O 0 0.0004079900390934199
overt O 0 0.006853568833321333
clinical O 0 0.02265910618007183
signs O 1 0.99818354845047
of O 1 0.9998960494995117
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 1 0.9957072138786316

To O 0 0.0012500392040237784
date O 0 0.001375493360683322
, O 0 0.00023708985827397555
several O 0 0.00019078351033385843
mutations O 0 0.00028464305796660483
in O 0 0.00043319762335158885
the O 0 0.18819156289100647
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 1 0.9999938011169434
, O 1 0.9967593550682068
DMD O 1 1.0
, O 0 0.0006519606104120612
have O 0 4.418527169036679e-05
been O 0 6.599169864784926e-05
identified O 0 0.0001358092704322189
in O 0 0.00014855987683404237
patients O 0 0.00042229366954416037
with O 0 0.00036354674375616014
XLDCM B-Disease 1 0.9999998807907104
, O 0 0.0005272768903523684
but O 0 8.329539559781551e-05
a O 0 0.00015152590640354902
pathogenic O 0 0.0004909855779260397
correlation O 0 0.00015559050370939076
of O 0 0.0002533306833356619
these O 0 0.0001587677252246067
cardiospecific O 1 0.9955278038978577
mutations O 0 0.0007218457176350057
in O 0 0.0006150991539470851
DMD O 1 0.9999961853027344
with O 0 0.0007154225604608655
the O 0 0.0472458153963089
XLDCM B-Disease 1 0.9999998807907104
phenotype O 0 0.004657377023249865
has O 0 0.00022908388928044587
remained O 0 0.000696579460054636
to O 0 0.00020918744849041104
be O 0 0.00027162034530192614
elucidated O 0 0.007241887040436268
. O 0 0.0014917749213054776

We O 0 0.0009945920901373029
report O 0 0.0002053939097095281
here O 0 0.000122297671623528
the O 0 7.464578811777756e-05
identification O 0 8.906988659873605e-05
of O 0 0.0001665428571868688
a O 0 0.000357838929630816
unique O 0 0.0005916587542742491
de O 0 0.0027459305711090565
novo O 0 0.0032274844124913216
L1 O 0 0.008419185876846313
insertion O 0 0.0011032525217160583
in O 0 0.00019410466484259814
the O 0 0.00042452869820408523
muscle O 0 0.005993116181343794
exon O 0 0.0029454075265675783
1 O 0 0.0004835735890083015
in O 0 0.00033919294946826994
DMD O 1 0.9997621178627014
in O 0 0.0003913351392839104
three O 0 0.0004601183463819325
XLDCM B-Disease 1 0.9999964237213135
patients O 0 0.000436289090430364
from O 0 0.00020042313553858548
two O 0 0.00015477959823329002
unrelated O 0 0.001298672752454877
Japanese O 0 0.008327748626470566
families O 0 0.0009378024260513484
. O 0 0.0012444935273379087

The O 0 0.0017085528234019876
insertion O 0 0.0022061853669583797
was O 0 0.0010932256700471044
a O 0 0.0003825732273980975
5 O 0 0.0004157625662628561
- O 0 0.00043576431926339865
truncated O 0 0.0008488985477015376
form O 0 0.00014683845802210271
of O 0 0.00023153447546064854
human O 0 0.0005006592837162316
L1 O 0 0.013868551701307297
inversely O 0 0.0010911589488387108
integrated O 0 0.0006225105025805533
in O 0 9.767394658410922e-05
the O 0 0.00015312869800254703
5 O 0 0.00026297540171071887
- O 0 0.0004056095494888723
untranslated O 0 0.0015386238228529692
region O 0 0.00026561165577732027
in O 0 0.0001338808360742405
the O 0 0.0003101491602137685
muscle O 0 0.4523380994796753
exon O 0 0.006090919021517038
1 O 0 0.0005700314650312066
, O 0 9.521032916381955e-05
which O 0 3.955494685214944e-05
affected O 0 0.00011983580770902336
the O 0 0.00011454670311650261
transcription O 0 0.00040539909969083965
or O 0 0.00012571216211654246
the O 0 0.00020553494687192142
stability O 0 0.0005695600411854684
of O 0 0.00043886873754672706
the O 0 0.0012338919332250953
muscle O 1 0.9979366064071655
form O 0 0.0007301611476577818
of O 0 0.014555783942341805
dystrophin O 1 0.9993278980255127
transcripts O 0 0.0006071600364521146
but O 0 2.7371977921575308e-05
not O 0 9.395549568580464e-06
that O 0 1.4169969290378504e-05
of O 0 0.00011075112706748769
the O 0 0.0006837747059762478
brain O 1 0.9999723434448242
or O 0 0.3206259310245514
Purkinje O 1 0.9999998807907104
cell O 1 0.5607163906097412
form O 0 0.0005143132875673473
, O 0 0.00018139733583666384
probably O 0 0.00030118838185444474
due O 0 0.00010464232036611065
to O 0 4.572154284687713e-05
its O 0 5.2637966291513294e-05
unique O 0 0.00013198635133448988
site O 0 0.0005813115276396275
of O 0 0.0004974825424142182
integration O 0 0.002152020111680031
. O 0 0.0010888074757531285

We O 0 0.0011818227358162403
speculate O 0 0.000804473296739161
that O 0 7.095150795066729e-05
this O 0 4.4914027967024595e-05
insertion O 0 0.00040962424827739596
of O 0 0.0002425984712317586
an O 0 0.0003392587532289326
L1 O 0 0.014878465794026852
sequence O 0 0.000725258607417345
in O 0 0.0009510442614555359
DMD O 1 0.9999927282333374
is O 0 0.00019702245481312275
responsible O 0 0.00021691063011530787
for O 0 2.5014371203724295e-05
some O 0 1.697067273198627e-05
of O 0 6.463657337008044e-05
the O 0 0.00012134826101828367
population O 0 2.869263698812574e-05
of O 0 0.00020299955212976784
Japanese O 0 0.06755369156599045
patients O 0 0.0007354708504863083
with O 0 0.0003678819048218429
XLDCM B-Disease 1 0.9999997615814209
. O 0 0.0009087103535421193
. O 0 0.0007343727047555149

Severe O 1 0.999842643737793
early O 1 0.988681435585022
- O 1 0.9999604225158691
onset O 1 1.0
obesity B-Disease 1 1.0
, O 1 0.9999920129776001
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.9999934434890747
red O 1 1.0
hair O 1 0.9999998807907104
pigmentation O 1 0.9999998807907104
caused O 1 0.9999974966049194
by O 0 0.008361517451703548
POMC O 1 0.9999991655349731
mutations O 0 0.0016124701360240579
in O 0 0.0007945054676383734
humans O 0 0.0014596350956708193
. O 0 0.0007324331090785563

Sequential O 0 0.006015194114297628
cleavage O 0 0.005658796988427639
of O 0 0.0008053742349147797
the O 0 0.0007659610128030181
precursor O 0 0.003774371463805437
protein O 0 0.0006600406486541033
pre O 0 0.0024289547000080347
- O 0 0.0010708774207159877
pro O 0 0.0026105025317519903
- O 0 0.0030548428185284138
opiomelanocortin O 1 0.9257684350013733
( O 0 0.0012025715550407767
POMC O 1 0.9788392186164856
) O 0 0.00031209527514874935
generates O 0 0.0006059564766474068
the O 0 0.0007001447374932468
melanocortin O 1 0.8749710321426392
peptides O 0 0.006425121799111366
adrenocorticotrophin O 1 0.9997406601905823
( O 0 0.007769136223942041
ACTH O 1 0.9995429515838623
) O 0 0.0008393574971705675
, O 0 0.0010816642316058278
melanocyte O 1 0.9983090162277222
- O 0 0.08100146800279617
stimulating O 1 0.8753812909126282
hormones O 0 0.4463113844394684
( O 0 0.0013498661573976278
MSH O 1 0.9963147044181824
) O 0 0.0003686045529320836
alpha O 0 0.0005659943562932312
, O 0 8.372454612981528e-05
beta O 0 0.00021264958195388317
and O 0 7.775067206239328e-05
gamma O 0 0.00018162491323892027
as O 0 7.11041793692857e-05
well O 0 5.448099909699522e-05
as O 0 6.636751641053706e-05
the O 0 0.00025637377984821796
opioid O 0 0.0033246956299990416
- O 0 0.0015454685781151056
receptor O 0 0.0009479220025241375
ligand O 0 0.003409632248803973
beta O 0 0.005140034947544336
- O 0 0.005229250993579626
endorphin O 0 0.05460498854517937
. O 0 0.0013413546839728951

While O 0 0.0010493566514924169
a O 0 0.000504156167153269
few O 0 0.0003237292112316936
cases O 0 0.00022487001842819154
of O 0 0.007340271957218647
isolated O 1 0.9999997615814209
ACTH B-Disease 1 1.0
deficiency I-Disease 1 1.0
have O 0 0.000273445708444342
been O 0 0.0003170381241943687
reported O 0 0.0004546540149021894
( O 0 0.000720101990737021
OMIM O 1 0.9999076128005981
201400 O 1 0.9996097683906555
) O 0 0.0002667445514816791
, O 0 0.00024965443299151957
an O 0 0.0006033487152308226
inherited O 1 0.9999997615814209
POMC O 1 1.0
defect O 1 1.0
has O 0 0.000842278590425849
not O 0 0.00012209388660266995
been O 0 0.0002112672373186797
described O 0 0.0005740716587752104
so O 0 0.0001789438392734155
far O 0 0.0004182584525551647
. O 0 0.0005487015005201101

Recent O 0 0.0027245483361184597
studies O 0 0.0004532878811005503
in O 0 0.0003761106345336884
animal O 0 0.0014228628715500236
models O 0 0.000613037555012852
elucidated O 0 0.0018948555225506425
a O 0 0.00022618773800786585
central O 0 0.00043149798875674605
role O 0 0.00033634237479418516
of O 0 0.0005171847296878695
alpha O 0 0.0023560309782624245
- O 0 0.002008155221119523
MSH O 1 0.5823457837104797
in O 0 0.00019912653078790754
the O 0 0.0001913832820719108
regulation O 0 0.00014519538672175258
of O 0 0.0001696182880550623
food O 0 0.0003891608212143183
intake O 0 0.00036026412271894515
by O 0 3.760588151635602e-05
activation O 0 0.0001279109565075487
of O 0 0.00014895887579768896
the O 0 0.0005358438938856125
brain O 1 0.9560359120368958
melanocortin O 1 0.9976235032081604
- O 0 0.0011892924085259438
4 O 0 0.0005028697196394205
- O 0 0.0006715142517350614
receptor O 0 0.0005409904406405985
( O 0 0.0003267605206929147
MC4 O 1 0.7316336631774902
- O 0 0.0015630264533683658
R O 0 0.0014387763803824782
; O 0 8.041155524551868e-05
refs O 0 0.0013967062113806605
3 O 0 0.00029658584389835596
- O 0 0.0003002446028403938
5 O 0 0.00022915641602594405
) O 0 4.865979644819163e-05
and O 0 7.17777365935035e-05
the O 0 0.0002083496074192226
linkage O 0 0.0012283324031159282
of O 0 0.000842444016598165
human O 0 0.014406580477952957
obesity B-Disease 1 0.9998317956924438
to O 0 0.00023598344705533236
chromosome O 0 0.0002822097158059478
2 O 0 0.00016721895372029394
in O 0 5.328585029928945e-05
close O 0 0.00012872657680418342
proximity O 0 0.00020421482622623444
to O 0 7.747091876808554e-05
the O 0 0.00036362215178087354
POMC O 1 0.9999232292175293
locus O 0 0.002244755392894149
, O 0 0.0001243710285052657
led O 0 0.00025529396953061223
to O 0 3.6313358577899635e-05
the O 0 9.610425331629813e-05
proposal O 0 0.00010021430352935567
of O 0 8.255397551693022e-05
an O 0 0.00013515286264009774
association O 0 0.0003998541214969009
of O 0 0.0010869426187127829
POMC O 1 0.9999995231628418
with O 0 0.003302907105535269
human O 1 0.9932045936584473
obesity B-Disease 1 0.9999996423721313
. O 0 0.002651361981406808

The O 0 0.002117075026035309
dual O 0 0.0020268403459340334
role O 0 0.0015402371063828468
of O 0 0.0016302848234772682
alpha O 0 0.011488626711070538
- O 0 0.010670526884496212
MSH O 1 0.9976328611373901
in O 0 0.0009457297855988145
regulating O 0 0.0023930897004902363
food O 0 0.0016409725649282336
intake O 0 0.00236922362819314
and O 0 0.0003381288261152804
influencing O 0 0.004620730876922607
hair O 1 0.9889869689941406
pigmentation O 1 0.9994335770606995
predicts O 0 0.0024590736720710993
that O 0 0.00012372068886179477
the O 0 0.00025137417833320796
phenotype O 0 0.0006284299306571484
associated O 0 0.0001624980941414833
with O 0 0.00013197904627304524
a O 0 0.0013216723455116153
defect O 1 0.9999808073043823
in O 0 0.005011007189750671
POMC O 1 0.9999964237213135
function O 0 0.0006378419348038733
would O 0 0.000248833151999861
include O 0 0.00039534125244244933
obesity B-Disease 1 0.9999371767044067
, O 0 0.0005705353105440736
alteration O 1 0.9992665648460388
in O 0 0.36177858710289
pigmentation O 1 0.9999998807907104
and O 1 0.9999960660934448
ACTH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.00723534869030118

The O 0 0.001993532059714198
observation O 0 0.0024199753534048796
of O 0 0.0012044928735122085
these O 0 0.00022739951964467764
symptoms O 0 0.01848362758755684
in O 0 0.00030677931499667466
two O 0 0.00024760441738180816
probands O 1 0.9694786667823792
prompted O 0 0.0007998232613317668
us O 0 0.00020817664335481822
to O 0 5.028062150813639e-05
search O 0 9.176617459161207e-05
for O 0 4.829532190342434e-05
mutations O 0 0.00015752395847812295
within O 0 0.00015318859368562698
their O 0 0.00026791467098519206
POMC O 1 0.9998278617858887
genes O 0 0.0011737814638763666
. O 0 0.0009036348783411086

Patient O 0 0.007786302361637354
1 O 0 0.0017012034077197313
was O 0 0.0013615514617413282
found O 0 0.0001069900463335216
to O 0 5.2194594900356606e-05
be O 0 4.758221621159464e-05
a O 0 0.00016520715143997222
compound O 0 0.0018005403690040112
heterozygote O 0 0.0012271864106878638
for O 0 6.918963481439278e-05
two O 0 3.777164238272235e-05
mutations O 0 7.832144183339551e-05
in O 0 9.323140693595633e-05
exon O 0 0.0013345819897949696
3 O 0 0.0005918795359320939
( O 0 0.0003926765057258308
G7013T O 1 0.973895251750946
, O 0 0.0006137678283266723
C7133delta O 1 0.9930341243743896
) O 0 0.0002511015336494893
which O 0 8.41986111481674e-05
interfere O 0 0.00019063841318711638
with O 0 6.324143760139123e-05
appropriate O 0 0.0002780559007078409
synthesis O 0 0.0014957485254853964
of O 0 0.0023343272041529417
ACTH O 1 0.9998434782028198
and O 0 0.001246931846253574
alpha O 0 0.0067383539862930775
- O 0 0.010224295780062675
MSH O 1 0.9976544976234436
. O 0 0.0016205335268750787

Patient O 0 0.008104600943624973
2 O 0 0.0017690503736957908
was O 0 0.001380551839247346
homozygous O 0 0.0005162847810424864
for O 0 4.7043722588568926e-05
a O 0 0.0001451462449040264
mutation O 0 0.00011892180918948725
in O 0 0.00015567745140288025
exon O 0 0.001751441857777536
2 O 0 0.0007564328843727708
( O 0 0.0004920502542518079
C3804A O 0 0.38284066319465637
) O 0 0.00045725901145488024
which O 0 0.00037738188984803855
abolishes O 0 0.029385004192590714
POMC O 1 0.999219536781311
translation O 0 0.0053742374293506145
. O 0 0.0016428829403594136

These O 0 0.0004563659313134849
findings O 0 0.0002930770569946617
represent O 0 0.0001277207920793444
the O 0 0.00010246503370581195
first O 0 0.00010341226879972965
examples O 0 0.000159300267114304
of O 0 0.0002077832177747041
a O 0 0.001178840408101678
genetic B-Disease 1 0.9687427282333374
defect I-Disease 1 0.9999994039535522
within O 0 0.0020087824668735266
the O 0 0.008065382950007915
POMC O 1 0.999923586845398
gene O 0 0.00045039562974125147
and O 0 0.0001167268565041013
define O 0 0.0002585331385489553
a O 0 0.0005224505439400673
new O 0 0.0015504402108490467
monogenic B-Disease 1 0.9999997615814209
endocrine I-Disease 1 1.0
disorder I-Disease 1 1.0
resulting O 1 0.994666576385498
in O 0 0.015467669814825058
early O 1 0.8806620240211487
- O 1 0.9995694756507874
onset O 1 0.9999998807907104
obesity B-Disease 1 1.0
, O 1 0.999923586845398
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.9999796152114868
red O 1 0.9999998807907104
hair O 1 0.9999991655349731
pigmentation O 1 0.9999978542327881
. O 0 0.0014480939134955406
. O 0 0.0010489283595234156

A O 0 0.004411966539919376
European O 0 0.0016245051519945264
multicenter O 0 0.00623728521168232
study O 0 0.0008697547600604594
of O 0 0.0034076303709298372
phenylalanine B-Disease 1 0.999998927116394
hydroxylase I-Disease 1 0.9999967813491821
deficiency I-Disease 1 1.0
: O 0 0.0007727878401055932
classification O 0 0.000601678213570267
of O 0 0.0005485173896886408
105 O 0 0.0017549985786899924
mutations O 0 0.0002302402863278985
and O 0 9.411788050783798e-05
a O 0 0.00017281393229495734
general O 0 0.00046260867384262383
system O 0 0.00019030639668926597
for O 0 9.969426901079714e-05
genotype O 0 0.0005889743333682418
- O 0 0.0003725044662132859
based O 0 9.09837253857404e-05
prediction O 0 0.0008461019024252892
of O 0 0.0012475710827857256
metabolic O 1 0.9999905824661255
phenotype O 1 0.5231538414955139
. O 0 0.0016832285327836871

Phenylketonuria B-Disease 1 0.9999955892562866
( O 1 0.9543198347091675
PKU B-Disease 1 0.9999986886978149
) O 0 0.002327860100194812
and O 0 0.0017832866869866848
mild B-Disease 1 0.9999803304672241
hyperphenylalaninemia I-Disease 1 1.0
( O 1 0.9999452829360962
MHP B-Disease 1 1.0
) O 0 0.0014244436752051115
are O 0 0.00036803295370191336
allelic B-Disease 1 0.9980894923210144
disorders I-Disease 1 0.9999998807907104
caused O 1 0.9999946355819702
by O 0 0.0007390815299004316
mutations O 0 0.00021201063646003604
in O 0 9.738712105900049e-05
the O 0 0.0002514359657652676
gene O 0 0.0004069480928592384
encoding O 0 0.0005583232268691063
phenylalanine O 0 0.07541767507791519
hydroxylase O 1 0.9979026317596436
( O 0 0.045409902930259705
PAH O 1 0.9999998807907104
) O 0 0.0014134981902316213
. O 0 0.001213514362461865

Previous O 0 0.0033431181218475103
studies O 0 0.0003306185535620898
have O 0 8.327783871209249e-05
suggested O 0 0.00021237968758214265
that O 0 9.19431186048314e-05
the O 0 0.00033277363399975
highly O 0 0.001080287853255868
variable O 0 0.0007085822871886194
metabolic O 1 0.9993257522583008
phenotypes O 1 0.9973517656326294
of O 1 0.9999983310699463
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
correlate O 1 0.9997194409370422
with O 1 0.992347240447998
PAH O 1 1.0
genotypes O 1 0.9657972455024719
. O 0 0.0018060463480651379

We O 0 0.0014552409993484616
identified O 0 0.0007527783163823187
both O 0 0.00036499815178103745
causative O 0 0.005303293466567993
mutations O 0 0.0007840691832825541
in O 0 0.0007826467044651508
686 O 1 0.9972278475761414
patients O 0 0.0006387581233866513
from O 0 0.0002664268249645829
seven O 0 0.0005999688291922212
European O 0 0.0006853348459117115
centers O 0 0.0011197489220649004
. O 0 0.0006281125824898481

On O 0 0.0009708714787848294
the O 0 0.000310691655613482
basis O 0 0.00012089701340300962
of O 0 0.00017596389807295054
the O 0 0.0003262313548475504
phenotypic O 0 0.0009819887345656753
characteristics O 0 0.0006085760542191565
of O 0 0.0010698263067752123
297 O 1 0.9659850001335144
functionally O 1 0.6904728412628174
hemizygous O 1 0.999749481678009
patients O 0 0.00026987920864485204
, O 0 6.928457150934264e-05
105 O 0 0.0002288740943185985
of O 0 0.00015866904868744314
the O 0 0.0001783486659405753
mutations O 0 6.317248335108161e-05
were O 0 4.940935832564719e-05
assigned O 0 7.631621701875702e-05
to O 0 3.0161887480062433e-05
one O 0 5.2727493311977014e-05
of O 0 0.0001748456561472267
four O 0 0.0003364416188560426
arbitrary O 0 0.00063053093617782
phenotype O 0 0.0023335814476013184
categories O 0 0.0012264911783859134
. O 0 0.0011096604866907

We O 0 0.001113436883315444
proposed O 0 0.0007613769266754389
and O 0 0.00025956478202715516
tested O 0 0.0003103725321125239
a O 0 0.00017797763575799763
simple O 0 0.00018774675845634192
model O 0 0.00016487512039020658
for O 0 5.762966611655429e-05
correlation O 0 0.00015033816453069448
between O 0 0.0003151020791847259
genotype O 0 0.0009777144296094775
and O 0 0.00030459120171144605
phenotypic O 0 0.002491266466677189
outcome O 0 0.001101202447898686
. O 0 0.0009128246456384659

The O 0 0.002852668520063162
observed O 0 0.0010563050163909793
phenotype O 0 0.0010248291073367
matched O 0 0.0003777424863073975
the O 0 0.0002488768077455461
predicted O 0 0.00048189819790422916
phenotype O 0 0.00023420638171955943
in O 0 5.5922668252605945e-05
79 O 0 0.00018986055511049926
% O 0 3.0268502086983062e-05
of O 0 6.217084592208266e-05
the O 0 0.00019528219127096236
cases O 0 8.895597420632839e-05
, O 0 5.978025365038775e-05
and O 0 4.1495113691780716e-05
in O 0 4.172025001025759e-05
only O 0 1.9077506294706836e-05
5 O 0 7.187391020124778e-05
of O 0 0.00017479264352004975
184 O 0 0.000932508846744895
patients O 0 0.00020638250862248242
was O 0 0.0004253840888850391
the O 0 0.0002943048602901399
observed O 0 0.0001683430018601939
phenotype O 0 0.00017689974629320204
more O 0 1.895159039122518e-05
than O 0 1.873397923191078e-05
one O 0 3.05377398035489e-05
category O 0 4.511492443270981e-05
away O 0 0.00010827895312104374
from O 0 9.202722867485136e-05
that O 0 0.00011409149010432884
expected O 0 0.0004456787137314677
. O 0 0.0004890206619165838

Among O 0 0.0008914978243410587
the O 0 0.00045790261356160045
seven O 0 0.0004878397157881409
contributing O 0 0.0009935388807207346
centers O 0 0.0004757438728120178
, O 0 0.00012219278141856194
the O 0 0.00018849471234716475
proportion O 0 0.0002466158475726843
of O 0 0.00037608121056109667
patients O 0 0.00026454663020558655
for O 0 0.00011294708383502439
whom O 0 0.00036047009052708745
the O 0 0.0004174566129222512
observed O 0 0.00033883113064803183
phenotype O 0 0.0004520445072557777
did O 0 0.00012696007615886629
not O 0 2.984531965921633e-05
match O 0 0.00012966840586159378
the O 0 0.00015147779777180403
predicted O 0 0.0003979117900598794
phenotype O 0 0.0002842709654942155
was O 0 0.00027267614495940506
4 O 0 0.00020021818636450917
% O 0 7.259150879690424e-05
- O 0 0.00020022373064421117
23 O 0 0.00034251148463226855
% O 0 0.00010163051047129557
( O 0 0.00021293727331794798
P O 0 0.0028697089292109013
< O 0 0.0024737112689763308
. O 0 0.00026692336541600525
0001 O 0 0.02094186842441559
) O 0 0.00013193349877838045
, O 0 7.133747567422688e-05
suggesting O 0 0.00015587768575642258
that O 0 2.7553554900805466e-05
differences O 0 7.904481753939763e-05
in O 0 6.728837615810335e-05
methods O 0 6.611050048377365e-05
used O 0 6.768589810235426e-05
for O 0 6.526672223117203e-05
mutation O 0 0.000213499617530033
detection O 0 0.001165058114565909
or O 0 0.00039833495975472033
phenotype O 0 0.0011062824632972479
classification O 0 0.0004954306059516966
may O 0 0.00012036856060149148
account O 0 3.992714482592419e-05
for O 0 2.3844788302085362e-05
a O 0 9.664443496149033e-05
considerable O 0 0.00033948326017707586
proportion O 0 0.00026943034026771784
of O 0 0.0008624120964668691
genotype O 0 0.008552850224077702
- O 0 0.011440924368798733
phenotype O 0 0.0034313739743083715
inconsistencies O 0 0.007292621769011021
. O 0 0.001843021484091878

Our O 0 0.0015845735324546695
data O 0 0.00024003631551750004
indicate O 0 0.0002194455883000046
that O 0 0.00011006867862306535
the O 0 0.001069396734237671
PAH O 1 1.0
- O 0 0.005495572462677956
mutation O 0 0.0003221652004867792
genotype O 0 0.0003430603537708521
is O 0 6.861496513010934e-05
the O 0 0.00012604417861439288
main O 0 0.0006478750729002059
determinant O 0 0.0021726968698203564
of O 0 0.0024279854260385036
metabolic O 1 0.9999620914459229
phenotype O 0 0.002800660440698266
in O 0 0.0007833738345652819
most O 0 0.0009143478819169104
patients O 1 0.7908861041069031
with O 1 0.9997650980949402
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 1 0.5242955088615417

In O 0 0.0009103301563300192
the O 0 0.0005127305630594492
present O 0 0.0003136798331979662
study O 0 8.151279325829819e-05
, O 0 5.9689908084692433e-05
the O 0 0.00011364879901520908
classification O 0 0.0003330008767079562
of O 0 0.0010816081194207072
105 O 1 0.9976294636726379
PAH O 1 1.0
mutations O 0 0.0006373858777806163
may O 0 0.00018267375708092004
allow O 0 5.997954212944023e-05
the O 0 9.994109132094309e-05
prediction O 0 0.0003163460933137685
of O 0 0.00018532713875174522
the O 0 0.000274518271908164
biochemical O 0 0.002054959535598755
phenotype O 0 0.0005746875540353358
in O 0 0.00018634798470884562
> O 0 0.0006341880070976913
10 O 0 0.00018769304733723402
, O 0 0.00014141175779514015
000 O 0 0.0011803539237007499
genotypes O 0 0.0013931193388998508
, O 0 0.00020439793297555298
which O 0 9.461378795094788e-05
may O 0 9.56836884142831e-05
be O 0 3.82539838028606e-05
useful O 0 7.970674050739035e-05
for O 0 3.334621942485683e-05
the O 0 0.00015144198550842702
management O 0 0.00047188950702548027
of O 0 0.0024960841983556747
hyperphenylalaninemia B-Disease 1 1.0
in O 0 0.06113951653242111
newborns O 0 0.1639917641878128
. O 0 0.0012117990991100669

Somatic O 0 0.018850240856409073
instability O 0 0.008809234946966171
of O 0 0.001544038183055818
the O 0 0.0035079577937722206
CTG O 1 0.9999755620956421
repeat O 0 0.005556357558816671
in O 0 0.0005454809870570898
mice O 0 0.0007924568490125239
transgenic O 0 0.001208615256473422
for O 0 0.00013588958245236427
the O 0 0.0014586059842258692
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 1 0.9746948480606079
is O 0 0.0007670592167414725
age O 0 0.000668415566906333
dependent O 0 0.0001492523297201842
but O 0 5.3843945352127776e-05
not O 0 2.9617984182550572e-05
correlated O 0 0.00010745443432824686
to O 0 5.2926683565601707e-05
the O 0 0.00025570488651283085
relative O 0 0.0009945087367668748
intertissue O 1 0.9976958632469177
transcription O 0 0.010829088278114796
levels O 0 0.003300128737464547
and O 0 0.0014080903492867947
proliferative O 1 0.9999736547470093
capacities O 0 0.35246020555496216
. O 0 0.0027998362202197313

A O 0 0.013587445951998234
( O 0 0.003524451283738017
CTG O 1 0.9779205322265625
) O 0 0.0007134447223506868
nexpansion O 0 0.005607227794826031
in O 0 0.00029962463304400444
the O 0 0.000344453495927155
3 O 0 0.0005200761370360851
- O 0 0.0005817156052216887
untranslated O 0 0.003071211976930499
region O 0 0.0006372148054651916
( O 0 0.0002733776636887342
UTR O 0 0.004830299410969019
) O 0 6.963145278859884e-05
of O 0 0.00014357124746311456
the O 0 0.00043707643635571003
DM O 1 0.9999902248382568
protein O 0 0.001206982764415443
kinase O 0 0.0009466219344176352
gene O 0 0.0005768019473180175
( O 0 0.000448455975856632
DMPK O 1 0.9998569488525391
) O 0 0.0002451906038913876
is O 0 0.00021171612024772912
responsible O 0 0.000845365459099412
for O 0 0.0014260418247431517
causing O 1 0.9999997615814209
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999998807907104
DM B-Disease 1 1.0
) O 0 0.0052504572086036205
. O 0 0.0014326253440231085

Major O 1 0.6593642234802246
instability O 1 0.9963515996932983
, O 0 0.0007280815625563264
with O 0 0.00017795355233829468
very O 0 0.000135337162646465
large O 0 0.00021483546879608184
expansions O 0 0.0012902716407552361
between O 0 0.00021726581326220185
generations O 0 0.0005825517582707107
and O 0 0.00016814998525660485
high O 0 0.0005221622996032238
levels O 0 0.00030840569525025785
of O 0 0.0003700840752571821
somatic O 0 0.007325372193008661
mosaicism O 1 0.9996547698974609
, O 0 0.0004642422718461603
is O 0 0.00018482489394955337
observed O 0 0.0003318466478958726
in O 0 0.0003151582495775074
patients O 0 0.0008640040759928524
. O 0 0.000841104076243937

There O 0 0.0014084953581914306
is O 0 0.00036456016823649406
a O 0 0.0002627939684316516
good O 0 0.0002528750919736922
correlation O 0 0.00013563119864556938
between O 0 0.00024582704645581543
repeat O 0 0.0006227431586012244
size O 0 0.0002119879936799407
( O 0 8.51463628350757e-05
at O 0 0.000124671685625799
least O 0 6.499370647361502e-05
in O 0 0.00013544005923904479
leucocytes O 1 0.6954907774925232
) O 0 0.0002034789795288816
, O 0 0.00015846974565647542
clinical O 0 0.0005652331165038049
severity O 0 0.0029452659655362368
and O 0 0.0006845336756668985
age O 0 0.0031319239642471075
of O 0 0.20075824856758118
onset O 1 0.9999997615814209
. O 0 0.005210299510508776

The O 0 0.008050631731748581
trinucleotide O 1 0.9950992465019226
repeat O 0 0.016493255272507668
instability O 0 0.08251767605543137
mechanisms O 0 0.0017516270745545626
involved O 0 0.0011994242668151855
in O 0 0.0020770439878106117
DM B-Disease 1 1.0
and O 0 0.0013186458963900805
other O 0 0.00042826723074540496
human O 1 0.7429635524749756
genetic B-Disease 1 0.9999942779541016
diseases I-Disease 1 1.0
are O 0 0.0005107683828100562
unknown O 0 0.004269217140972614
. O 0 0.0011474043130874634

We O 0 0.001668520737439394
studied O 0 0.0018952207174152136
somatic O 0 0.0050862873904407024
instability O 0 0.004746086895465851
by O 0 0.00028654138441197574
measuring O 0 0.003701417241245508
the O 0 0.0021920395083725452
CTG O 1 0.9987367987632751
repeat O 0 0.001400628942064941
length O 0 0.00017829866555985063
at O 0 0.0002261881745653227
several O 0 6.503771874122322e-05
ages O 0 0.00019034651631955057
in O 0 8.2374521298334e-05
various O 0 0.0001066618351615034
tissues O 0 0.0013797151623293757
of O 0 0.0008427233551628888
transgenic O 0 0.019972097128629684
mice O 0 0.0005317764589563012
carrying O 0 0.0003778622776735574
a O 0 0.0003359405091032386
( O 0 0.0004898958723060787
CTG O 1 0.9889805316925049
) O 0 0.00044804581557400525
55expansion O 0 0.009811906144022942
surrounded O 0 0.002706029685214162
by O 0 0.00014150659262668341
45 O 0 0.00026065445854328573
kb O 0 0.0010346530470997095
of O 0 0.00041023798985406756
the O 0 0.000547748408280313
human O 0 0.0031121920328587294
DM B-Disease 1 0.9999998807907104
region O 0 0.0012717073550447822
, O 0 0.0001888275146484375
using O 0 0.00010447423119330779
small O 0 0.00019001959299203008
- O 0 0.0012096749851480126
pool O 0 0.0026053490582853556
PCR O 0 0.00445646233856678
. O 0 0.0007188931340351701

These O 0 0.0015850277850404382
mice O 0 0.0015704811085015535
have O 0 6.059006409486756e-05
been O 0 0.00010484726954018697
shown O 0 0.000130704342154786
to O 0 7.68795216572471e-05
reproduce O 0 0.0003513645788189024
the O 0 0.00027982122264802456
intergenerational O 0 0.002392940456047654
and O 0 0.00035696718259714544
somatic O 0 0.0016592731699347496
instability O 0 0.0032903996761888266
of O 0 0.0008037863881327212
the O 0 0.0015318612568080425
55 O 0 0.003145067021250725
CTG O 1 0.9969871640205383
repeat O 0 0.002351745730265975
suggesting O 0 0.0006294046179391444
that O 0 8.632643584860489e-05
surrounding O 0 0.0008148785564117134
sequences O 0 0.00022754158999305218
and O 0 0.00015637968317605555
the O 0 0.0003642478259280324
chromatin O 0 0.0034058073069900274
environment O 0 0.0004693646915256977
are O 0 2.305469570273999e-05
involved O 0 0.00018474526586942375
in O 0 0.0005692919949069619
instability O 1 0.9816601276397705
mechanisms O 0 0.02984202839434147
. O 0 0.0020018848590552807

As O 0 0.0013918436598032713
observed O 0 0.0002972842485178262
in O 0 7.931521395221353e-05
some O 0 4.13812231272459e-05
of O 0 0.00017629758804105222
the O 0 0.00047816758160479367
tissues O 1 0.9150490760803223
of O 1 0.9989686012268066
DM B-Disease 1 1.0
patients O 1 0.767379105091095
, O 0 0.0001913311134558171
there O 0 9.086477075470611e-05
is O 0 4.488037302508019e-05
a O 0 9.66359511949122e-05
tendency O 0 0.00033065196475945413
for O 0 6.57615892123431e-05
repeat O 0 0.0005525897722691298
length O 0 0.00015059926954563707
and O 0 0.00017253139230888337
somatic O 0 0.001675585750490427
mosaicism O 0 0.022082572802901268
to O 0 0.00015379452088382095
increase O 0 5.685659925802611e-05
with O 0 2.139714706572704e-05
the O 0 0.00012421648716554046
age O 0 0.0002298601611983031
of O 0 0.0003470302326604724
the O 0 0.0012060542358085513
mouse O 0 0.0033879615366458893
. O 0 0.0009739515371620655

Furthermore O 0 0.004649569746106863
, O 0 0.00037735141813755035
we O 0 0.00011952970817219466
observed O 0 0.00011216402344871312
no O 0 7.788900984451175e-05
correlation O 0 6.689828296657652e-05
between O 0 0.00012678260100074112
the O 0 0.00029466141131706536
somatic O 0 0.0017946177395060658
mutation O 0 0.0005401354283094406
rate O 0 0.00044171602348797023
and O 0 0.00042376964120194316
tissue O 1 0.9998176693916321
proliferation O 1 0.9984727501869202
capacity O 0 0.007184762042015791
. O 0 0.0009466737392358482

The O 0 0.0029528357554227114
somatic O 0 0.0045728483237326145
mutation O 0 0.0007852183189243078
rates O 0 0.00017293624114245176
in O 0 8.869762677932158e-05
different O 0 4.931520743411966e-05
tissues O 0 0.0008789434214122593
were O 0 0.00010755388211691752
also O 0 4.658461330109276e-05
not O 0 1.9268354662926868e-05
correlated O 0 6.139521428849548e-05
to O 0 4.470234125619754e-05
the O 0 0.00014882569666951895
relative O 0 0.0005127634503878653
inter O 0 0.004908367525786161
- O 0 0.0027874065563082695
tissue O 0 0.001382889342494309
difference O 0 0.0001987452560570091
in O 0 8.625533519079909e-05
transcriptional O 0 0.0004138874064665288
levels O 0 8.242794865509495e-05
of O 0 5.833720206283033e-05
the O 0 8.954133227234706e-05
three O 0 8.81920859683305e-05
genes O 0 0.00017302828200627118
( O 0 0.00048536076792515814
DMAHP O 1 0.9999744892120361
, O 0 0.0007806899375282228
DMPK O 1 0.9995086193084717
and O 0 0.0004938826314173639
59 O 0 0.0009793664794415236
) O 0 0.00017245904018636793
surrounding O 0 0.0015366525622084737
the O 0 0.0008428326109424233
repeat O 0 0.003235246753320098
. O 0 0.0005307600949890912
. O 0 0.0006157828029245138

A O 0 0.006730323191732168
novel O 0 0.0031750965863466263
missense O 0 0.004146580584347248
mutation O 0 0.0005080531118437648
in O 0 0.0003100625181104988
patients O 0 0.0003472817479632795
from O 0 0.000270421413006261
a O 0 0.0010430366965010762
retinoblastoma B-Disease 1 0.9978559613227844
pedigree O 0 0.0077599347569048405
showing O 0 0.0011501805856823921
only O 0 0.00019022297055926174
mild O 0 0.0013942290097475052
expression O 0 0.0004784415941685438
of O 0 0.0009119083406403661
the O 0 0.038442328572273254
tumor B-Disease 1 0.9999982118606567
phenotype O 0 0.01901589334011078
. O 0 0.0014372646110132337

We O 0 0.0007751752273179591
have O 0 8.997786062536761e-05
used O 0 0.00010925606329692528
single O 0 0.00017902061517816037
strand O 0 0.0006008186028338969
conformation O 0 0.0007014831644482911
polymorphism O 0 0.0002410649467492476
analysis O 0 2.9853321393602528e-05
to O 0 2.8017249860567972e-05
study O 0 4.086054832441732e-05
the O 0 9.473729733144864e-05
27 O 0 0.000357892393367365
exons O 0 0.0007424841169267893
of O 0 0.0003828435146715492
the O 0 0.0008211584645323455
RB1 O 1 0.9999326467514038
gene O 0 0.0002237100707134232
in O 0 7.434047438437119e-05
individuals O 0 3.313510387670249e-05
from O 0 8.243785850936547e-05
a O 0 0.0002655969583429396
family O 0 0.0006452376837842166
showing O 0 0.0013936621835455298
mild O 0 0.006996863521635532
expression O 0 0.00048046483425423503
of O 0 0.0009527885122224689
the O 0 0.014847069047391415
retinoblastoma B-Disease 1 0.9999741315841675
phenotype O 0 0.052901312708854675
. O 0 0.0015454413369297981

In O 0 0.0017036993522197008
this O 0 0.0003251288435421884
family O 0 0.0005807812558487058
affected O 0 0.0005062856944277883
individuals O 0 0.00011530914343893528
developed O 0 0.013148969039320946
unilateral B-Disease 1 0.9998520612716675
tumors I-Disease 1 1.0
and O 0 0.0029292721301317215
, O 0 0.000204978758119978
as O 0 0.00011985201126663014
a O 0 0.00010590456076897681
result O 0 0.00013224159192759544
of O 0 0.00025289293262176216
linkage O 0 0.0026598130352795124
analysis O 0 0.00021474863751791418
, O 0 0.0003061452880501747
unaffected O 0 0.0023561923298984766
mutation O 0 0.00033246097154915333
carriers O 0 0.00021775277855340391
were O 0 6.435906107071787e-05
also O 0 5.218922160565853e-05
identified O 0 5.721295747207478e-05
within O 0 0.00011193024693056941
the O 0 0.0006324387504719198
pedigree O 0 0.005333978217095137
. O 0 0.0010644291760399938

A O 0 0.0054112765938043594
single O 0 0.0011629326036199927
band O 0 0.0020825625397264957
shift O 0 0.0007131870370358229
using O 0 0.00023890154261607677
SSCP O 1 0.9994649291038513
was O 0 0.0012268697610124946
identified O 0 0.00012799145770259202
in O 0 0.00014409901632461697
exon O 0 0.0010458953911438584
21 O 0 0.0005687723751179874
which O 0 7.76219239924103e-05
resulted O 0 0.0003074873529840261
in O 0 0.00011765693488996476
a O 0 0.00028514169389382005
missense O 0 0.0010495905298739672
mutation O 0 0.0002191704261349514
converting O 0 0.0004952223971486092
a O 0 0.0005310103297233582
cys O 0 0.09177939593791962
- O 0 0.0017070667818188667
- O 0 0.0008662458858452737
> O 0 0.0009866433683782816
arg O 0 0.0016093211015686393
at O 0 0.00036303800879977643
nucleotide O 0 0.00035297407885082066
position O 0 0.00031266530277207494
28 O 0 0.00047772953985258937
in O 0 0.00016853299166541547
the O 0 0.000522051879670471
exon O 0 0.0076423822902143
. O 0 0.001065711723640561

The O 0 0.0027545844204723835
mutation O 0 0.0014725610380992293
destroyed O 0 0.011666253209114075
an O 0 0.0007056738249957561
NdeI O 1 0.914981484413147
restriction O 0 0.0017539580585435033
enzyme O 0 0.001413850812241435
site O 0 0.002432136330753565
. O 0 0.0005756628233939409

Analysis O 0 0.0005923557910136878
of O 0 0.0004304545291233808
all O 0 0.00014385163376573473
family O 0 0.00033009418984875083
members O 0 0.00011725474178092554
demonstrated O 0 0.0003820807905867696
that O 0 6.285472773015499e-05
the O 0 0.00030290987342596054
missense O 0 0.0017039168160408735
mutation O 0 0.0005212530959397554
co O 0 0.0023567192256450653
- O 0 0.001989558106288314
segregated O 0 0.002476415364071727
with O 0 0.000278676365269348
patients O 0 0.002039800165221095
with O 0 0.04008027911186218
tumors B-Disease 1 1.0
or O 0 0.09043924510478973
who O 0 0.0004201009578537196
, O 0 0.00010331991506973282
as O 0 8.51806253194809e-05
a O 0 8.592040103394538e-05
result O 0 6.938017759239301e-05
of O 0 0.00013605864660348743
linkage O 0 0.0010448924731463194
analysis O 0 8.04084847914055e-05
had O 0 0.00017805350944399834
been O 0 0.00012568844249472022
predicted O 0 0.00019464326032903045
to O 0 8.174989488907158e-05
carry O 0 0.0002101017307722941
the O 0 0.0005593235255219042
predisposing O 0 0.027590898796916008
mutation O 0 0.0019773845560848713
. O 0 0.0011982893338426948

These O 0 0.00028043522615917027
observations O 0 0.0003598102193791419
point O 0 0.00022714662190992385
to O 0 5.295959999784827e-05
another O 0 0.00020170204516034573
region O 0 0.00024533626856282353
of O 0 0.00039376606582663953
the O 0 0.0015739856753498316
RB1 O 1 0.9999271631240845
gene O 0 0.0004654931544791907
where O 0 0.00020769880211446434
mutations O 0 7.923605880932882e-05
only O 0 3.593507790355943e-05
modify O 0 0.00012415039236657321
the O 0 0.00011147032637381926
function O 0 9.027884516399354e-05
of O 0 0.000161654272233136
the O 0 0.0003550396941136569
gene O 0 0.000231376921874471
and O 0 9.395988308824599e-05
raise O 0 0.0001773423864506185
important O 0 0.00013496895553544164
questions O 0 9.016802505357191e-05
for O 0 6.032934834365733e-05
genetic O 0 0.00027005423908121884
counseling O 0 0.0008262489573098719
in O 0 0.0001741232699714601
families O 0 0.00011877370707225055
with O 0 0.00011687385995173827
these O 0 9.469332144362852e-05
distinctive O 0 0.003971675876528025
phenotypes O 0 0.009274770505726337
. O 0 0.00039630269748158753
. O 0 0.0006212503649294376

Maternal B-Disease 1 0.9941832423210144
disomy I-Disease 1 0.9999876022338867
and O 1 0.9867227673530579
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 1 0.5164536833763123
with O 0 0.0013844325440004468
gamete O 1 0.9980171918869019
complementation O 1 0.9904042482376099
in O 0 0.0003734698984771967
a O 0 0.00022603810066357255
case O 0 0.00023022906680125743
of O 0 0.00020596280228346586
familial O 0 0.005736019928008318
translocation O 1 0.5307257175445557
( O 0 0.0003750590549316257
3 O 0 0.0002840471570380032
; O 0 5.9321289882063866e-05
15 O 0 0.00023908521689008921
) O 0 0.00010744480096036568
( O 0 0.0002796140033751726
p25 O 0 0.01800539158284664
; O 0 0.00024900404969230294
q11 O 0 0.11070854216814041
. O 0 0.00033048243494704366
2 O 0 0.0007328978390432894
) O 0 0.0003834493109025061
. O 0 0.0006373041542246938

Maternal B-Disease 1 0.9935764670372009
uniparental I-Disease 1 0.999996542930603
disomy I-Disease 1 0.9999988079071045
( I-Disease 1 0.8040379285812378
UPD I-Disease 1 0.9999990463256836
) I-Disease 0 0.0004237728426232934
for I-Disease 0 0.0001083086826838553
chromosome I-Disease 0 0.0002858837542589754
15 I-Disease 0 0.00022289912158157676
is O 0 5.4602554882876575e-05
responsible O 0 0.00010862291674129665
for O 0 2.1949763322481886e-05
an O 0 6.434592796722427e-05
estimated O 0 0.00012872093066107482
30 O 0 0.00011946658923989162
% O 0 3.3632502891123295e-05
of O 0 0.00012439141573850065
cases O 0 0.00021284897229634225
of O 0 0.029928985983133316
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999992847442627
PWS B-Disease 1 1.0
) O 0 0.005143625661730766
. O 0 0.0015168208628892899

We O 0 0.00085364532424137
report O 0 0.0001732503151288256
on O 0 8.107371104415506e-05
an O 0 6.049889634596184e-05
unusual O 0 0.00012929023068863899
case O 0 0.0001945601252373308
of O 0 0.00040113236173056066
maternal B-Disease 0 0.23677296936511993
disomy I-Disease 1 0.9999874830245972
15 I-Disease 0 0.004749818239361048
in O 0 0.0008228562655858696
PWS B-Disease 1 0.9999998807907104
that O 0 0.00014582739095203578
is O 0 4.291460936656222e-05
most O 0 3.136839222861454e-05
consistent O 0 6.818622932769358e-05
with O 0 4.584553971653804e-05
adjacent O 0 0.0010220726253464818
- O 0 0.0005710636032745242
1 O 0 0.0003363329160492867
segregation O 0 0.0009109262027777731
of O 0 0.00016284863522741944
a O 0 0.00027112074894830585
paternal O 0 0.0019077574834227562
t O 0 0.0016311185900121927
( O 0 0.00012963393237441778
3 O 0 0.0001844038488343358
; O 0 5.1767452532658353e-05
15 O 0 0.00024126247444655746
) O 0 0.00011593846284085885
( O 0 0.0003059144946746528
p25 O 0 0.014645765535533428
; O 0 0.00024635306908749044
q11 O 0 0.012496381998062134
. O 0 0.0001438730105292052
2 O 0 0.00022772584634367377
) O 0 4.6186505642253906e-05
with O 0 5.7344979722984135e-05
simultaneous O 0 0.0004210441838949919
maternal O 0 0.003495462005957961
meiotic O 1 0.9986425042152405
nondisjunction O 1 0.9995999932289124
for O 0 0.0007933699525892735
chromosome O 0 0.0030823308043181896
15 O 0 0.0017350965645164251
. O 0 0.000810653786174953

The O 0 0.003282907884567976
patient O 0 0.005029869265854359
( O 0 0.0012007629266008735
J O 1 0.8969759345054626
. O 0 0.00024100772861856967
B O 0 0.0007752654491923749
. O 0 5.730441625928506e-05
) O 0 2.9569666367024183e-05
, O 0 2.858819061657414e-05
a O 0 8.69679352035746e-05
17 O 0 0.00047443099902011454
- O 0 0.0005349237471818924
year O 0 0.00026644562603905797
- O 0 0.0004934935132041574
old O 0 0.000926875276491046
white O 0 0.0012876493856310844
male O 0 0.0009690823499113321
with O 0 0.0007533165044151247
PWS B-Disease 1 1.0
, O 0 0.001468045637011528
was O 0 0.0009999449830502272
found O 0 8.343483204953372e-05
to O 0 4.3379808630561456e-05
have O 0 2.2095939129940234e-05
47 O 0 0.00011804070527432486
chromosomes O 0 0.00012436746328603476
with O 0 7.097045454429463e-05
a O 0 0.00035606720484793186
supernumerary O 1 0.960734486579895
, O 0 0.0005246298387646675
paternal O 0 0.0043693603947758675
der O 1 0.6899566650390625
( O 0 0.0003506314242258668
15 O 0 0.00029625804745592177
) O 0 7.034980080788955e-05
consisting O 0 0.000125656311865896
of O 0 0.00014914535859134048
the O 0 0.00029218511190265417
short O 0 0.00033148584770970047
arm O 0 0.0019544668029993773
and O 0 0.00018762399849947542
the O 0 0.000635019619949162
proximal O 1 0.9994663596153259
long O 0 0.0010694165248423815
arm O 0 0.03588716313242912
of O 0 0.0015809625620022416
chromosome O 0 0.00480500515550375
15 O 0 0.0009854813106358051
, O 0 0.00029096531216055155
and O 0 0.00037112069549039006
distal O 1 0.9995150566101074
chromosome O 1 0.9929331541061401
arm O 1 0.9999408721923828
3p O 1 0.9999388456344604
. O 0 0.0050148931331932545

The O 0 0.004116027150303125
t O 0 0.0043746596202254295
( O 0 0.0003407339099794626
3 O 0 0.00026695619453676045
; O 0 6.23055748292245e-05
15 O 0 0.00020447162387426943
) O 0 7.614552305312827e-05
was O 0 0.00020732666598632932
present O 0 0.00010552613093750551
in O 0 6.191113061504439e-05
the O 0 8.258483285317197e-05
balanced O 0 7.817593723302707e-05
state O 0 3.47866807715036e-05
in O 0 6.042296809027903e-05
the O 0 0.00014462789113167673
patients O 0 0.00021755395573563874
father O 0 0.0015713149914517999
and O 0 0.0002483846910763532
a O 0 0.0013754382962360978
sister O 0 0.010593772865831852
. O 0 0.0014735725708305836

Fluorescent O 0 0.02105320245027542
in O 0 0.0011283934582024813
situ O 0 0.0060695139691233635
hybridization O 0 0.0007248277543112636
analysis O 0 0.0001896022295113653
demonstrated O 0 0.0008051516488194466
that O 0 0.00014275993453338742
the O 0 0.0008288275566883385
PWS B-Disease 1 0.9999983310699463
critical O 0 0.0022658866364508867
region O 0 0.0009530485258437693
resided O 0 0.0014187819324433804
on O 0 0.0003056553250644356
the O 0 0.0002529146440792829
derivative O 0 0.0004622472042683512
chromosome O 0 0.0004728697531390935
3 O 0 0.0002160000876756385
and O 0 9.547652734909207e-05
that O 0 3.1720712286187336e-05
there O 0 7.203631685115397e-05
was O 0 0.00025265771546401083
no O 0 8.870963210938498e-05
deletion O 0 0.0003285087295807898
of O 0 0.00026105091092176735
the O 0 0.0017429570434615016
PWS B-Disease 1 0.9999998807907104
region O 0 0.0009303821134380996
on O 0 0.0002455211360938847
the O 0 0.00022312939108815044
normal O 0 0.0002251978439744562
pair O 0 0.00031023641349747777
of O 0 0.0004019005282316357
15s O 0 0.05364200845360756
present O 0 0.000724552315659821
in O 0 0.0009987805970013142
J O 1 0.97585529088974
. O 0 0.0010333326645195484

B O 0 0.05438530445098877
. O 0 0.0040627457201480865

Methylation O 0 0.0026061160024255514
analysis O 0 0.00030602418701164424
at O 0 0.0008315566810779274
exon O 0 0.002254138933494687
alpha O 0 0.00046737707452848554
of O 0 0.00017935106006916612
the O 0 0.00030257273465394974
small O 0 0.0002480956900399178
nuclear O 0 0.0028886892832815647
ribonucleoprotein O 1 0.55355304479599
- O 0 0.000848796684294939
associated O 0 0.0002059524122159928
polypeptide O 0 0.0029617496766149998
N O 0 0.0030257285106927156
( O 0 0.0005995615501888096
SNRPN O 1 0.9995325803756714
) O 0 0.00028596605989150703
gene O 0 0.00021714053582400084
showed O 0 0.00016797997523099184
a O 0 0.00013788399519398808
pattern O 0 0.0002442181285005063
characteristic O 0 0.0002900651306845248
of O 0 0.00020582773140631616
only O 0 9.307151776738465e-05
the O 0 0.00026983654242940247
maternal O 0 0.0011287169763818383
chromosome O 0 0.0005361463408917189
15 O 0 0.0008470449247397482
in O 0 0.0006499022128991783
J O 1 0.5457270741462708
. O 0 0.0007932176231406629

B O 0 0.06035606935620308
. O 0 0.005246125161647797

Maternal B-Disease 1 0.8966655135154724
disomy I-Disease 1 0.9987756609916687
was O 0 0.004708446096628904
confirmed O 0 0.0006625022506341338
by O 0 0.00013634111382998526
polymerase O 0 0.0007908831466920674
chain O 0 0.0004440862685441971
reaction O 0 0.00016818543372210115
analysis O 0 2.1830168407177553e-05
of O 0 0.0001327173231402412
microsatellite O 0 0.0015812155324965715
repeats O 0 0.0005612963577732444
at O 0 0.0003881815355271101
the O 0 0.0003750640316866338
gamma O 0 0.0010937195038422942
- O 0 0.000998481409624219
aminobutyric O 0 0.009670650586485863
acid O 0 0.0012339954264461994
receptor O 0 0.0007087639532983303
beta3 O 0 0.006687995977699757
subunit O 0 0.001392881851643324
( O 0 0.0009492840035818517
GABRB3 O 1 0.9984807372093201
) O 0 0.0014551999047398567
locus O 0 0.006456481292843819
. O 0 0.0015687713166698813

A O 0 0.011248007416725159
niece O 1 0.656725287437439
( O 0 0.0017198330024257302
B O 0 0.0026819573249667883
. O 0 0.00017031434981618077
B O 0 0.0008459835080429912
. O 0 5.937732203165069e-05
) O 0 3.328306775074452e-05
with O 0 3.41275408572983e-05
45 O 0 0.0001330612285528332
chromosomes O 0 0.00012193367001600564
and O 0 6.0001970268785954e-05
the O 0 0.00011704114876920357
derivative O 0 0.00026920795789919794
3 O 0 0.00019924217485822737
but O 0 3.9992770325625315e-05
without O 0 3.9770959119778126e-05
the O 0 0.0001968511933228001
der O 0 0.0040898737497627735
( O 0 0.0002499459369573742
15 O 0 0.00033216632436960936
) O 0 9.22088001971133e-05
demonstrated O 0 0.0004437430761754513
a O 0 0.00031998634221963584
phenotype O 0 0.0005694222636520863
consistent O 0 0.00025280253612436354
with O 0 6.642912921961397e-05
that O 0 6.822545401519164e-05
reported O 0 0.00017271576507482678
for O 0 0.00010405564535176381
haploinsufficiency O 0 0.051231108605861664
of O 0 0.0016149608418345451
distal O 1 0.9997208714485168
3 O 0 0.008540849201381207
p O 0 0.0055181486532092094
. O 0 0.0009419296402484179

Uniparental B-Disease 1 0.9999954700469971
disomy I-Disease 1 0.9999711513519287
associated O 0 0.004807929042726755
with O 0 0.0011081780539825559
unbalanced O 0 0.010600091889500618
segregation O 0 0.21309517323970795
of O 0 0.002903495915234089
non O 0 0.16958533227443695
- O 0 0.3069228529930115
Robertsonian O 1 0.9992595314979553
translocations O 0 0.0034325888846069574
has O 0 0.00018424847803544253
been O 0 0.00013960346404928714
reported O 0 0.00017597698024474084
previously O 0 0.0001332685787929222
but O 0 4.494779568631202e-05
has O 0 3.49720248777885e-05
not O 0 1.9819524823105894e-05
, O 0 3.0266395697253756e-05
to O 0 2.9838603950338438e-05
our O 0 0.00010021850903285667
knowledge O 0 0.0002358651254326105
, O 0 7.665009616175666e-05
been O 0 5.7423723774263635e-05
observed O 0 7.57275556679815e-05
in O 0 6.043282337486744e-05
a O 0 0.00020629911159630865
case O 0 0.0006080892635509372
of O 0 0.003972745034843683
PWS B-Disease 1 1.0
. O 0 0.0057044196873903275

Furthermore O 0 0.00552657525986433
, O 0 0.000668986001983285
our O 0 0.00035581967676989734
findings O 0 0.00018707610433921218
are O 0 2.607841270219069e-05
best O 0 0.00015927659114822745
interpreted O 0 0.0003144847578369081
as O 0 0.00036131299566477537
true O 0 0.0014639176661148667
gamete O 0 0.1234435960650444
complementation O 1 0.9987202882766724
resulting O 0 0.035485751926898956
in O 0 0.0028605093248188496
maternal B-Disease 1 0.9994065761566162
UPD I-Disease 1 1.0
15 I-Disease 0 0.22047406435012817
and O 0 0.007159784436225891
PWS B-Disease 1 0.999998927116394

Schwartz B-Disease 1 0.901398777961731
- I-Disease 1 0.9943456053733826
Jampel I-Disease 1 0.9999967813491821
syndrome I-Disease 1 0.9999997615814209
type I-Disease 0 0.27485135197639465
2 I-Disease 0 0.011264374479651451
and O 0 0.0015909199137240648
Stuve B-Disease 1 0.9999995231628418
- I-Disease 1 0.999951958656311
Wiedemann I-Disease 1 0.9999990463256836
syndrome I-Disease 1 0.9999998807907104
: O 0 0.0003940654860343784
a O 0 0.00037661867099814117
case O 0 0.0004097476485185325
for O 0 0.0002080899284919724
" O 0 0.0009114262065850198
lumping O 0 0.005739368498325348
" O 0 0.001816193456761539
. O 0 0.0008846597629599273

Recent O 0 0.0018487039487808943
studies O 0 0.00037158673512749374
demonstrated O 0 0.00044323361362330616
the O 0 0.00015155422443058342
existence O 0 0.00021905009634792805
of O 0 0.00019909559341613203
a O 0 0.0002577784762252122
genetically O 0 0.0004080335784237832
distinct O 0 0.00010114439646713436
, O 0 7.04017438692972e-05
usually O 0 5.025310383643955e-05
lethal O 0 0.00026006565894931555
form O 0 7.126410491764545e-05
of O 0 0.00028324368759058416
the O 0 0.0008765374077484012
Schwartz B-Disease 1 0.9736407399177551
- I-Disease 1 0.9992406368255615
Jampel I-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
( O 1 0.9844560623168945
SJS B-Disease 1 0.9999963045120239
) O 0 0.0009071454405784607
of O 0 0.0057657379657030106
myotonia B-Disease 1 1.0
and O 1 0.9995853304862976
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 1 0.6491389870643616
which O 0 0.00036247065872885287
we O 0 0.0001982957182917744
called O 0 0.0008183441241271794
SJS B-Disease 1 0.9975643157958984
type I-Disease 0 0.002011937787756324
2 I-Disease 0 0.0015455457614734769
. O 0 0.0007058830233290792

This O 0 0.0033352691680192947
disorder O 1 0.999971866607666
is O 0 0.0005513846408575773
reminiscent O 0 0.10294123739004135
of O 0 0.0014135156525298953
another O 0 0.002600037259981036
rare O 0 0.003380771027877927
condition O 0 0.00783588271588087
, O 0 0.0003186669200658798
the O 0 0.0014004303375259042
Stuve B-Disease 1 0.9999992847442627
- I-Disease 1 0.9998993873596191
Wiedemann I-Disease 1 0.9999992847442627
syndrome I-Disease 1 1.0
( O 1 0.9958927631378174
SWS B-Disease 1 0.9999970197677612
) O 0 0.0003617503389250487
, O 0 0.00017755964654497802
which O 0 0.00012149264512117952
comprises O 0 0.00075315753929317
campomelia B-Disease 1 0.9868518710136414
at O 0 0.0060648671351373196
birth O 0 0.01806139387190342
with O 0 0.004896378144621849
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 1 0.9999785423278809
contractures B-Disease 1 1.0
, O 0 0.0012803905410692096
and O 0 0.0004891350981779397
early B-Disease 0 0.001826719962991774
death I-Disease 0 0.027947979047894478
. O 0 0.0008939148392528296

To O 0 0.0011348513653501868
test O 0 0.00048300830530934036
for O 0 0.00012720777885988355
possible O 0 0.0003501835744827986
nosologic O 1 0.5145752429962158
identity O 0 0.0006662043160758913
between O 0 0.0010266231838613749
these O 0 0.0005040024407207966
disorders O 1 0.9999994039535522
, O 0 0.0005175257101655006
we O 0 0.00010627795563777909
reviewed O 0 9.580137702869251e-05
the O 0 6.823007424827665e-05
literature O 0 5.673565101460554e-05
and O 0 3.64552324754186e-05
obtained O 0 3.2367803214583546e-05
a O 0 7.439025648636743e-05
follow O 0 6.904054316692054e-05
- O 0 0.00013841978216078132
up O 0 7.69525722716935e-05
of O 0 6.152492278488353e-05
the O 0 7.232520874822512e-05
only O 0 3.7830799556104466e-05
two O 0 5.134722960065119e-05
surviving O 0 0.0009363649296574295
patients O 0 0.00023776038142386824
, O 0 0.00010021391790360212
one O 0 9.158434113487601e-05
with O 0 0.00015243889356497675
SJS B-Disease 1 0.9979537725448608
type I-Disease 0 0.0008504425059072673
2 I-Disease 0 0.00032078323420137167
at O 0 0.00025691749760881066
age O 0 0.00013228747411631048
10 O 0 9.86698069027625e-05
years O 0 7.190942415036261e-05
and O 0 6.087530346121639e-05
another O 0 0.00016832469555083662
with O 0 0.0001983036781894043
SWS B-Disease 1 0.9987406134605408
at O 0 0.0018817712552845478
age O 0 0.0007155364146456122
7 O 0 0.001312977634370327
years O 0 0.0009137025335803628
. O 0 0.0007262881263159215

Patients O 0 0.007570689078420401
reported O 0 0.0015469938516616821
as O 0 0.0006256736232899129
having O 0 0.0006701045203953981
either O 0 0.002212836407124996
neonatal O 1 0.9999996423721313
SJS B-Disease 1 0.9999995231628418
or O 0 0.006721409969031811
SWS B-Disease 1 0.9417269825935364
presented O 0 0.0006351182819344103
a O 0 0.00023290191893465817
combination O 0 0.00028723396826535463
of O 0 0.00043879676377400756
a O 0 0.0015878962585702538
severe O 1 0.9999958276748657
, O 0 0.23248963057994843
prenatal O 1 0.9999942779541016
- O 1 0.9999977350234985
onset O 1 1.0
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 0.9999990463256836
with O 1 0.9999879598617554
congenital B-Disease 1 1.0
joint I-Disease 1 1.0
contractures I-Disease 1 1.0
, O 1 0.9999997615814209
respiratory O 1 1.0
and O 1 0.9997778534889221
feeding O 1 0.9976569414138794
difficulties O 1 0.9984694123268127
, O 0 0.0005783821688964963
tendency O 0 0.003038837807253003
to O 0 0.0010005705989897251
hyperthermia B-Disease 1 0.9999994039535522
, O 0 0.000439170456957072
and O 0 0.000197550660232082
frequent O 0 0.00041526230052113533
death O 0 0.016680316999554634
in O 0 0.0005795463221147656
infancy O 0 0.006950891576707363
) O 0 9.441938891541213e-05
with O 0 7.440309855155647e-05
a O 0 0.00039208459202200174
distinct O 0 0.0014549706829711795
campomelic B-Disease 1 0.9999991655349731
- I-Disease 1 0.9999414682388306
metaphyseal I-Disease 1 0.9999996423721313
skeletal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 0 0.26035749912261963

The O 0 0.00168731773737818
similarity O 0 0.0009102702606469393
of O 0 0.0006051798118278384
the O 0 0.0007243058062158525
clinical O 0 0.0018457586411386728
and O 0 0.0006524492055177689
radiographic O 1 0.9662736654281616
findings O 0 0.0005944751319475472
is O 0 7.37120135454461e-05
so O 0 5.251552283880301e-05
extensive O 0 0.00022378515859600157
that O 0 8.109752525342628e-05
these O 0 9.065842459676787e-05
disorders O 1 0.9999445676803589
appear O 0 0.00042093999218195677
to O 0 0.00018528260989114642
be O 0 9.646821126807481e-05
a O 0 0.00023108412278816104
single O 0 0.0004026415990665555
entity O 0 0.0009995030704885721
. O 0 0.0007689555641263723

The O 0 0.0016199294477701187
follow O 0 0.0005349303828552365
- O 0 0.0007445225492119789
up O 0 0.00023059509112499654
observation O 0 0.0003753211931325495
of O 0 0.0001559108350193128
an O 0 0.0001607326848898083
identical O 0 0.00020950959878973663
and O 0 9.076828428078443e-05
unique O 0 0.00018147275841329247
pattern O 0 0.0011472965124994516
of O 1 0.9590181112289429
progressive O 1 1.0
bone B-Disease 1 1.0
dysplasia I-Disease 1 1.0
in O 0 0.07724456489086151
the O 0 0.0012256443733349442
two O 0 0.00014278051094152033
patients O 0 0.0001293326640734449
( O 0 8.480440737912431e-05
one O 0 7.769931107759476e-05
with O 0 0.00015626491222064942
SJS B-Disease 1 0.9988724589347839
type I-Disease 0 0.0012009665369987488
2 I-Disease 0 0.0004567204159684479
, O 0 0.00010960114013869315
one O 0 0.0001193868592963554
with O 0 0.00018455160898156464
SWS B-Disease 1 0.9926099181175232
) O 0 0.0003158798790536821
surviving O 0 0.002604703651741147
beyond O 0 0.0015483725583180785
infancy O 0 0.00161369564011693
adds O 0 0.0003754586214199662
to O 0 6.592214049305767e-05
the O 0 8.665816130815074e-05
evidence O 0 0.00011667721264529973
in O 0 9.592131391400471e-05
favor O 0 0.00011936057853745297
of O 0 0.0002738976327236742
identity O 0 0.0013141199015080929
. O 0 0.0011737433960661292

The O 0 0.004895648453384638
hypothesis O 0 0.0018399452092126012
that O 0 0.0005078570102341473
SWS B-Disease 1 0.9553103446960449
and O 0 0.0008187784696929157
SJS B-Disease 1 0.9985367059707642
type I-Disease 0 0.00116231688298285
2 I-Disease 0 0.0003341957344673574
are O 0 2.1212987121543847e-05
the O 0 0.00014016219938639551
same O 0 0.00026015323237515986
disorder O 1 0.9999345541000366
should O 0 0.00020882215176243335
be O 0 8.59020437928848e-05
testable O 0 0.00036959926364943385
by O 0 0.00010553267202340066
molecular O 0 0.0005679695750586689
methods O 0 0.0003050207160413265
. O 0 0.00020712018886115402
. O 0 0.0005733028519898653

A O 0 0.0075642927549779415
mouse O 0 0.004092100076377392
model O 0 0.000937524891924113
of O 0 0.0025421157479286194
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 1 0.9999991655349731
defects O 1 1.0
in O 1 0.9998868703842163
hemostasis O 1 1.0
and O 1 0.998157799243927
thrombosis B-Disease 1 0.9999998807907104
. O 0 0.011308036744594574

von B-Disease 1 0.9965691566467285
Willebrand I-Disease 1 0.9999982118606567
factor I-Disease 1 0.9961745738983154
( I-Disease 1 0.5482913851737976
vWf I-Disease 1 0.9999650716781616
) I-Disease 1 0.9912238121032715
deficiency I-Disease 1 1.0
causes O 1 1.0
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 1 0.9999587535858154
humans O 0 0.28989994525909424
. O 0 0.001238965429365635

We O 0 0.0008705677464604378
generated O 0 0.00046139577170833945
a O 0 0.00040137104224413633
mouse O 0 0.0007339906296692789
model O 0 0.00028489931719377637
for O 0 8.601704030297697e-05
this O 0 0.00015426156460307539
disease O 0 0.4811325967311859
by O 0 0.0001457339822081849
using O 0 0.00018006592290475965
gene O 0 0.00045415511704050004
targeting O 0 0.001032269443385303
. O 0 0.000608826638199389

vWf B-Disease 1 0.9964291453361511
- I-Disease 1 0.9867329001426697
deficient I-Disease 1 0.9825990200042725
mice O 0 0.0024211269337683916
appeared O 0 0.0009938570437952876
normal O 0 0.0004595257341861725
at O 0 0.000928120338357985
birth O 0 0.0008319283369928598
; O 0 7.490535062970594e-05
they O 0 5.711102130590007e-05
were O 0 0.00016546508413739502
viable O 0 0.0008659397135488689
and O 0 0.00044506564154289663
fertile O 0 0.012161929160356522
. O 0 0.0013728812336921692

Neither O 0 0.02944682165980339
vWf O 0 0.12681634724140167
nor O 0 0.01392242219299078
vWf O 0 0.25658509135246277
propolypeptide O 1 0.998362123966217
( O 0 0.0033935257233679295
von B-Disease 1 0.9646169543266296
Willebrand I-Disease 1 0.9999995231628418
antigen O 1 0.999592125415802
II O 1 0.999998927116394
) O 0 0.00035266950726509094
were O 0 0.0003424509195610881
detectable O 0 0.0013946393737569451
in O 0 0.0002913269854616374
plasma O 0 0.0023062704131007195
, O 0 0.0003107716329395771
platelets O 0 0.007408348843455315
, O 0 0.0002932937059085816
or O 0 0.0004747261991724372
endothelial O 1 0.8985839486122131
cells O 0 0.0004788905498571694
of O 0 0.0003896105336025357
the O 0 0.0007355962879955769
homozygous O 0 0.0025661673862487078
mutant O 0 0.012796998955309391
mice O 0 0.002416149713099003
. O 0 0.0006662830710411072

The O 0 0.012593199498951435
mutant O 1 0.9953802824020386
mice O 1 0.8692271709442139
exhibited O 1 0.994629442691803
defects O 1 0.9999939203262329
in O 0 0.004464728757739067
hemostasis O 1 0.9999603033065796
with O 0 0.00048356992192566395
a O 0 0.0018372987397015095
highly O 0 0.1842060387134552
prolonged O 1 0.9999945163726807
bleeding O 1 1.0
time O 0 0.002446422353386879
and O 0 0.0014209062792360783
spontaneous O 1 0.8966211080551147
bleeding O 1 0.9999618530273438
events O 0 0.00038632721407338977
in O 0 0.00014349310367833823
approximately O 0 0.00012978160521015525
10 O 0 0.00014712801203131676
% O 0 8.906479342840612e-05
of O 0 0.0004244486044626683
neonates O 0 0.010632206685841084
. O 0 0.0009672135347500443

As O 0 0.0012024454772472382
in O 0 0.0003854316601064056
the O 0 0.0005706734955310822
human O 0 0.004335892852395773
disease O 1 0.9999682903289795
, O 0 0.0003325465368106961
the O 0 0.0006388688343577087
factor O 0 0.0021985704079270363
VIII O 1 0.999930739402771
level O 0 0.0010053010191768408
in O 0 0.00017158346599899232
these O 0 7.315633411053568e-05
mice O 0 0.000260545639321208
was O 0 0.0003287077124696225
reduced O 0 0.00011349489795975387
strongly O 0 6.96090137353167e-05
as O 0 4.869590702583082e-05
a O 0 7.571044261567295e-05
result O 0 5.5910084483912215e-05
of O 0 9.32845869101584e-05
the O 0 0.00028309281333349645
lack O 0 0.0004306613700464368
of O 0 0.000508953642565757
protection O 0 0.007500816136598587
provided O 0 0.0006100039463490248
by O 0 0.000497874862048775
vWf O 0 0.016380613669753075
. O 0 0.0008813368622213602

Defective O 1 0.9999901056289673
thrombosis B-Disease 1 0.9999946355819702
in O 0 0.014167490415275097
mutant O 1 0.9985101819038391
mice O 0 0.009458623826503754
was O 0 0.0008057725499384105
also O 0 9.638948540668935e-05
evident O 0 0.0003513540141284466
in O 0 6.856552499812096e-05
an O 0 7.514788740081713e-05
in O 0 0.00022650240862276405
vivo O 0 0.0015382715500891209
model O 0 0.000991231994703412
of O 1 0.8023328185081482
vascular B-Disease 1 1.0
injury I-Disease 1 1.0
. O 0 0.036986250430345535

In O 0 0.0011974215740337968
this O 0 0.00031834718538448215
model O 0 0.00044001443893648684
, O 0 0.00016176591452676803
the O 0 0.000807260163128376
exteriorized O 1 0.993891716003418
mesentery O 1 0.9917722344398499
was O 0 0.06683730334043503
superfused O 1 0.9996090531349182
with O 0 0.002307692775502801
ferric O 1 0.9999997615814209
chloride O 1 0.9745914936065674
and O 0 0.0003464008041191846
the O 0 0.0004355012206360698
accumulation O 0 0.020414363592863083
of O 0 0.008138773031532764
fluorescently O 1 0.9999045133590698
labeled O 1 0.5823270678520203
platelets O 0 0.4002925753593445
was O 0 0.001292414148338139
observed O 0 0.0004538058128673583
by O 0 0.0002732075226958841
intravital O 1 0.8081568479537964
microscopy O 0 0.005627262406051159
. O 0 0.0009819262195378542

We O 0 0.0012209633132442832
conclude O 0 0.00180641352199018
that O 0 0.0001939039648277685
these O 0 0.00010293177183484659
mice O 0 0.0004957603523507714
very O 0 0.00014133653894532472
closely O 0 0.0004685641033574939
mimic O 1 0.9832120537757874
severe O 1 0.9999995231628418
human O 1 0.9999971389770508
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 1 0.9656134843826294
will O 0 0.00034787654294632375
be O 0 4.7129760787356645e-05
very O 0 2.493750798748806e-05
useful O 0 3.324290446471423e-05
for O 0 2.0224633772158995e-05
investigating O 0 0.00014395301695913076
the O 0 0.00014566854224540293
role O 0 0.0003288324805907905
of O 0 0.0006181772914715111
vWf O 0 0.022118110209703445
in O 0 0.000412273861002177
normal O 0 0.0008608857751823962
physiology O 0 0.27968910336494446
and O 0 0.00043411084334366024
in O 0 0.0020782046485692263
disease O 1 0.999994158744812
models O 0 0.0016549715073779225
. O 0 0.0004086132103111595
. O 0 0.0007595570059493184

Oral O 0 0.05456113815307617
contraceptives O 0 0.026004333049058914
and O 0 0.0005936883389949799
the O 0 0.0008647073991596699
risk O 0 0.001894173794426024
of O 1 0.9996496438980103
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.8571123480796814

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 1.0
Clinical O 1 0.9989631175994873
Study O 0 0.002846113871783018
Group O 0 0.0019666783045977354
. O 0 0.0009749564924277365

BACKGROUND O 0 0.01324053481221199
Women O 0 0.0013307660119608045
with O 0 0.0001888069964479655
mutations O 0 0.00023851737205404788
in O 0 0.0001360122114419937
either O 0 0.0001524983672425151
the O 0 0.00048626190982759
BRCA1 O 0 0.43206048011779785
or O 0 0.0002697079034987837
the O 0 0.0006074164411984384
BRCA2 O 0 0.00455123744904995
gene O 0 0.0001655584928812459
have O 0 3.4094486181857064e-05
a O 0 0.00015763634291943163
high O 0 0.0008300193003378808
lifetime O 0 0.002811799757182598
risk O 0 0.01529892347753048
of O 1 0.9999825954437256
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.1800597459077835

Oral O 1 0.6167538166046143
contraceptives O 1 0.9947916865348816
protect O 1 0.9800704121589661
against O 1 0.9999622106552124
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
in O 0 0.0020789543632417917
general O 0 0.0025859784800559282
, O 0 0.00011754490697057918
but O 0 3.3391504985047504e-05
it O 0 1.6986121408990584e-05
is O 0 2.132962799805682e-05
not O 0 1.5686317055951804e-05
known O 0 8.044951391639188e-05
whether O 0 4.838318272959441e-05
they O 0 3.9300659409491345e-05
also O 0 7.122069655451924e-05
protect O 0 0.0004143708501942456
against O 0 0.000573261349927634
hereditary B-Disease 1 0.9999774694442749
forms I-Disease 1 0.9999707937240601
of I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.2881915867328644

METHODS O 0 0.002647662302479148
We O 0 0.0004206584417261183
enrolled O 0 0.0012247632257640362
207 O 0 0.0024302212987095118
women O 0 0.0006961257313378155
with O 0 0.0012393235228955746
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.008160446770489216
161 O 0 0.002197753870859742
of O 0 0.0004251534410286695
their O 0 0.00011704628559527919
sisters O 0 0.0007111788145266473
as O 0 9.759294334799051e-05
controls O 0 7.212175842141733e-05
in O 0 6.994869909249246e-05
a O 0 0.00023090708418749273
case O 0 0.0004627705202437937
- O 0 0.0008326151873916388
control O 0 0.0004859134496655315
study O 0 0.0002795779728330672
. O 0 0.0004255201492924243

All O 0 0.0009387231548316777
the O 0 0.0009454956161789596
patients O 0 0.0004335973644629121
carried O 0 0.0003433891397435218
a O 0 0.00030714162858203053
pathogenic O 0 0.0013782050227746367
mutation O 0 0.0001771760726114735
in O 0 8.439797238679603e-05
either O 0 0.0001562008255859837
BRCA1 O 0 0.004345642402768135
( O 0 0.00020792073337361217
179 O 0 0.0010057579493150115
women O 0 0.0002870015159714967
) O 0 0.00013960080104880035
or O 0 0.00038062548264861107
BRCA2 O 0 0.05294840782880783
( O 0 0.000632388168014586
28 O 0 0.0024126237258315086
women O 0 0.0007377782021649182
) O 0 0.0004923712695017457
. O 0 0.0006115308497101068

The O 0 0.0036698891781270504
control O 0 0.0021621964406222105
women O 0 0.0003593758156057447
were O 0 0.00012163197970949113
enrolled O 0 0.0002956108364742249
regardless O 0 0.00012110584793845192
of O 0 0.00016029280959628522
whether O 0 0.00013794332335237414
or O 0 0.00011309625551803038
not O 0 4.350384551798925e-05
they O 0 3.859681964968331e-05
had O 0 0.00022719170374330133
either O 0 0.0003139727341476828
mutation O 0 0.0006965755019336939
. O 0 0.000716959941200912

Lifetime O 0 0.007737892214208841
histories O 0 0.0018992072436958551
of O 0 0.0015490377554669976
oral O 0 0.2695567011833191
- O 0 0.03027224913239479
contraceptive O 0 0.0022053250577300787
use O 0 6.0835667682113126e-05
were O 0 5.432235047919676e-05
obtained O 0 6.119630415923893e-05
by O 0 4.814904241356999e-05
interview O 0 0.0002598535211291164
or O 0 8.417420031037182e-05
by O 0 4.3938372982665896e-05
written O 0 4.1616778617026284e-05
questionnaire O 0 0.00011108577746199444
and O 0 6.27247936790809e-05
were O 0 0.00010374464909546077
compared O 0 0.0002957410179078579
between O 0 0.00041841360507532954
patients O 0 0.000506161421071738
and O 0 0.00020665601186919957
control O 0 0.0016002305783331394
women O 0 0.0002840168308466673
, O 0 9.18489895411767e-05
after O 0 0.000283230998320505
adjustment O 0 0.0007518405909650028
for O 0 8.765583334024996e-05
year O 0 0.0002439595846226439
of O 0 0.0004239538393449038
birth O 0 0.002526487922295928
and O 0 0.0005916130030527711
parity O 0 0.12025514245033264
. O 0 0.0015102769248187542

RESULTS O 0 0.002453045453876257
The O 0 0.0010810508392751217
adjusted O 0 0.002062528394162655
odds O 0 0.002521893009543419
ratio O 0 0.0015088682994246483
for O 0 0.0029595033265650272
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
associated O 0 0.0008509685285389423
with O 0 0.00012964739289600402
any O 0 0.00010924044181592762
past O 0 0.00023069557209964842
use O 0 7.853323768358678e-05
of O 0 0.00027998050791211426
oral O 0 0.004679680801928043
contraceptives O 0 0.07489245384931564
was O 0 0.003443547058850527
0 O 0 0.0007686323951929808
. O 0 0.0006566249649040401

5 O 0 0.0017177237896248698
( O 0 0.000413213245337829
95 O 0 0.0005270959227345884
percent O 0 0.0002034886711044237
confidence O 0 0.0004931610892526805
interval O 0 0.00013816854334436357
, O 0 5.7539546105545014e-05
0 O 0 4.380933751235716e-05
. O 0 1.9781929950113408e-05
3 O 0 5.406787386164069e-05
to O 0 3.770387775148265e-05
0 O 0 0.00010739122808445245
. O 0 7.692557846894488e-05
8 O 0 0.0004414609575178474
) O 0 0.00027463005972094834
. O 0 0.0004320362932048738

The O 0 0.0036638060119003057
risk O 0 0.0010932721197605133
decreased O 0 0.000909346214029938
with O 0 6.451919762184843e-05
increasing O 0 0.00010529554856475443
duration O 0 0.00015352520858868957
of O 0 0.00014355400344356894
use O 0 0.0001022452415782027
( O 0 0.0001420658954884857
P O 0 0.0006931042298674583
for O 0 5.1697839808184654e-05
trend O 0 0.00020913916523568332
, O 0 7.111549348337576e-05
< O 0 0.0005186069174669683
0 O 0 0.00012473374954424798
. O 0 5.087667523184791e-05
001 O 0 0.00198765704408288
) O 0 5.79186889808625e-05
; O 0 2.3673948817304336e-05
use O 0 1.3888719877286348e-05
for O 0 1.2837705071433447e-05
six O 0 4.565828203340061e-05
or O 0 6.0167098126839846e-05
more O 0 2.3698141376371495e-05
years O 0 9.351901098852977e-05
was O 0 0.00030917199910618365
associated O 0 7.584094419144094e-05
with O 0 3.8213689549593255e-05
a O 0 0.00013926057727076113
60 O 0 0.0002961134596262127
percent O 0 0.0003372759383637458
reduction O 0 0.0007781082531437278
in O 0 0.0003405554161872715
risk O 0 0.0007700472488068044
. O 0 0.0007928246632218361

Oral O 0 0.06913962960243225
- O 0 0.012766613624989986
contraceptive O 0 0.007037699222564697
use O 0 0.0005173452664166689
protected O 0 0.01466947142034769
against O 1 0.9968698620796204
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999988079071045
both O 0 0.0002518102410249412
for O 0 0.00014470347377937287
carriers O 0 0.0001708055060589686
of O 0 0.00015040884318295866
the O 0 0.0005710673867724836
BRCA1 O 0 0.41433703899383545
mutation O 0 0.00022810351219959557
( O 0 0.0001542013924336061
odds O 0 0.00046858593123033643
ratio O 0 0.00011881560931215063
, O 0 6.177560135256499e-05
0 O 0 6.648014095844701e-05
. O 0 2.2784977772971615e-05
5 O 0 6.433537055272609e-05
; O 0 3.030171683349181e-05
95 O 0 0.0002067368186544627
percent O 0 9.436232357984409e-05
confidence O 0 0.00033589679514989257
interval O 0 0.000155281595652923
, O 0 5.626694473903626e-05
0 O 0 5.491853517014533e-05
. O 0 2.023943125095684e-05
3 O 0 5.0710925279418007e-05
to O 0 2.543412301747594e-05
0 O 0 6.920275336597115e-05
. O 0 3.378974361112341e-05
9 O 0 0.000260577944573015
) O 0 4.450693086255342e-05
and O 0 4.053353040944785e-05
for O 0 4.682182407123037e-05
carriers O 0 0.00012389446783345193
of O 0 0.00019471267296466976
the O 0 0.000609334500040859
BRCA2 O 0 0.2467634677886963
mutation O 0 0.00036716487375088036
( O 0 0.00017190117796417326
odds O 0 0.00044416708988137543
ratio O 0 0.0001344186021015048
, O 0 2.864979069272522e-05
0 O 0 3.955521242460236e-05
. O 0 2.395729643467348e-05
4 O 0 0.00010343624308006838
; O 0 2.9220414944575168e-05
95 O 0 0.0001290082436753437
percent O 0 8.610929944552481e-05
confidence O 0 0.0003691151214297861
interval O 0 0.0001309340150328353
, O 0 4.983543112757616e-05
0 O 0 3.94949056499172e-05
. O 0 1.5780786270624958e-05
2 O 0 5.020664684707299e-05
to O 0 3.9116628613555804e-05
1 O 0 0.00013100256910547614
. O 0 6.162739009596407e-05
1 O 0 0.00032946537248790264
) O 0 0.00021438326803036034
. O 0 0.000321585510391742

CONCLUSIONS O 0 0.010936022736132145
Oral O 0 0.014101694338023663
- O 0 0.005086489953100681
contraceptive O 0 0.0036421087570488453
use O 0 0.00014430387818720192
may O 0 0.00018443797307554632
reduce O 0 0.00017761264462023973
the O 0 0.00020562080317176878
risk O 0 0.0011104479199275374
of O 1 0.999839186668396
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.017162900418043137
women O 0 0.000497890985570848
with O 0 0.00016228700405918062
pathogenic O 0 0.0017090915935114026
mutations O 0 0.00017324404325336218
in O 0 0.0002102708676829934
the O 0 0.000929600209929049
BRCA1 O 1 0.9970409274101257
or O 0 0.0025525360833853483
BRCA2 O 1 0.8793204426765442
gene O 0 0.004758025985211134

A O 0 0.006878566928207874
Japanese O 0 0.00817527249455452
family O 0 0.0012853728840127587
with O 0 0.0006882439483888447
adrenoleukodystrophy B-Disease 1 0.9999991655349731
with O 0 0.00039126561023294926
a O 0 0.0006697470671497285
codon O 0 0.0018256987677887082
291 O 0 0.0014460219535976648
deletion O 0 0.000602306448854506
: O 0 0.00010879788897000253
a O 0 0.00024529604706913233
clinical O 0 0.0006898399442434311
, O 0 0.0003250163281336427
biochemical O 0 0.18458016216754913
, O 0 0.0006784642464481294
pathological O 1 0.9985162615776062
, O 0 0.0008339292253367603
and O 0 0.00039272126741707325
genetic O 0 0.0010107456473633647
report O 0 0.0008241243194788694
. O 0 0.0006288493750616908

We O 0 0.0011320831254124641
report O 0 0.0003404455492272973
a O 0 0.00032670353539288044
Japanese O 0 0.0020402914378792048
family O 0 0.0010359055595472455
with O 0 0.0015604924410581589
adrenoleukodystrophy B-Disease 1 1.0
( O 1 0.9999488592147827
ALD B-Disease 1 1.0
) O 0 0.0003390952479094267
with O 0 9.045273327501491e-05
a O 0 0.00015718562644906342
three O 0 0.0001412267447449267
base O 0 0.0007424133946187794
pair O 0 0.0006935998098924756
deletion O 0 0.0012557862792164087
( O 0 0.000490829348564148
delGAG O 0 0.1650809347629547
291 O 0 0.00322136003524065
) O 0 0.00022000873286742717
in O 0 0.00029742400511167943
the O 0 0.0013740335125476122
ALD B-Disease 1 0.9999998807907104
gene O 0 0.004294577054679394
. O 0 0.0017020214581862092

A O 0 0.004311209078878164
variety O 0 0.0010316568659618497
of O 0 0.0008760756463743746
phenotypes O 0 0.0018161709886044264
were O 0 0.0002936451055575162
observed O 0 0.00023993746435735375
within O 0 0.00020332109124865383
this O 0 0.00014134650700725615
family O 0 0.0006923298351466656
. O 0 0.0007039965712465346

While O 0 0.001598270027898252
the O 0 0.0012658486375585198
proband O 1 0.9976640939712524
( O 0 0.0009838978294283152
patient O 0 0.0010030707344412804
1 O 0 0.0006386192399077117
) O 0 0.00015471881488338113
was O 0 0.0005262417835183442
classified O 0 0.00032917968928813934
as O 0 0.00013149830920156091
having O 0 0.00017086266598198563
a O 0 0.00029767563682980835
rare O 0 0.0009456874686293304
intermediate O 0 0.0029922921676188707
type O 0 0.0006754281930625439
of O 0 0.0018937954446300864
adult O 0 0.0032084330450743437
cerebral O 1 0.999996542930603
and O 1 0.7486143112182617
cerebello O 1 1.0
- O 1 0.9999905824661255
brain O 1 0.999889612197876
stem O 0 0.0018964622868224978
forms O 0 0.0002278652973473072
, O 0 0.00011450116289779544
his O 0 0.0006227882113307714
younger O 0 0.003100384958088398
brother O 0 0.17018085718154907
( O 0 0.0007734457612968981
patient O 0 0.0007503579254262149
2 O 0 0.0007485116948373616
) O 0 0.00014529218606185168
and O 0 0.00018170684052165598
nephew O 0 0.28796839714050293
( O 0 0.0008884396520443261
patient O 0 0.0012351172044873238
3 O 0 0.000732566462829709
) O 0 0.0002044840803137049
had O 0 0.0004983613034710288
a O 0 0.0016217513475567102
childhood O 1 0.9998934268951416
ALD B-Disease 1 1.0
type O 1 0.9990577101707458
. O 0 0.004006379283964634

Another O 0 0.0061924150213599205
nephew O 1 0.7512704730033875
( O 0 0.0009638861520215869
patient O 0 0.0005510311457328498
4 O 0 0.0004889139090664685
) O 0 7.148032455006614e-05
of O 0 0.00018767264555208385
patient O 0 0.00047418096801266074
1 O 0 0.0004240039852447808
was O 0 0.000760925468057394
classified O 0 0.000387930020224303
as O 0 0.00016533448069822043
having O 0 0.00025745059247128665
an O 0 0.0002320117928320542
adolescent O 0 0.031885016709566116
form O 0 0.0021415171213448048
. O 0 0.0011771315475925803

The O 0 0.0034249722957611084
tau O 0 0.006305392365902662
level O 0 0.0012806302402168512
in O 0 0.0003027291386388242
the O 0 0.0008322256617248058
cerebrospinal O 1 0.999723494052887
fluid O 1 0.9995445609092712
( O 0 0.010201405733823776
CSF O 1 0.999160647392273
) O 0 0.00013329513603821397
in O 0 0.0001194278520415537
patient O 0 0.00038700358709320426
1 O 0 0.00023273451370187104
was O 0 0.0003524071944411844
as O 0 0.00011473144695628434
high O 0 0.0001766100322129205
as O 0 5.235606658970937e-05
that O 0 2.926690285676159e-05
of O 0 0.00018770342285279185
patients O 0 0.0012347220908850431
with O 0 0.46190112829208374
Alzheimers B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9977242350578308
AD B-Disease 0 0.3810921311378479
) O 0 0.0006297946674749255
. O 0 0.0003667944110929966

His O 0 0.022245854139328003
brain O 1 0.9985077977180481
magnetic O 0 0.012387645430862904
resonance O 0 0.010498086921870708
image O 0 0.08992881327867508
( O 0 0.003153180703520775
MRI O 1 0.9971756935119629
) O 0 0.0008109118207357824
showed O 0 0.001388154341839254
abnormalities B-Disease 0 0.05417424067854881
in I-Disease 0 0.00045250580296851695
the I-Disease 0 0.001240734476596117
bilateral I-Disease 1 0.9791414141654968
cerebellar I-Disease 1 1.0
hemispheres I-Disease 1 0.9999876022338867
and O 1 0.9984374642372131
brain O 1 0.9999998807907104
stem O 1 0.9990359544754028
, O 0 0.00019246591546107084
but O 0 5.400119334808551e-05
not O 0 3.0864623113302514e-05
in O 0 0.00012042872549500316
the O 0 0.0007087174453772604
cerebral O 1 0.9999266862869263
white O 1 0.5617729425430298
matter O 0 0.0007563754916191101
, O 0 0.0001429971307516098
where O 0 0.00011323545913910493
marked O 0 0.000511242775246501
reductions O 0 0.000736574234906584
of O 0 0.0005754552548751235
the O 0 0.026710668578743935
cerebral O 1 0.9999994039535522
blood O 1 0.9999783039093018
flow O 0 0.34524083137512207
and O 0 0.002550582168623805
oxygen O 0 0.31418782472610474
metabolism O 0 0.0040103597566485405
were O 0 0.00020849886641371995
clearly O 0 0.00018630338308867067
demonstrated O 0 0.0003597676404751837
by O 0 9.806479647522792e-05
positron O 0 0.002203424461185932
emission O 0 0.0010483585065230727
tomography O 0 0.0013105475809425116
( O 0 0.000953584851231426
PET O 0 0.014178648591041565
) O 0 0.0007878442411310971
. O 0 0.0008356554317288101

In O 0 0.00249675870873034
patients O 0 0.0009400307899340987
2 O 0 0.0005830850568599999
and O 0 0.00019333553791511804
3 O 0 0.0003253297181800008
, O 0 0.00010532987653277814
the O 0 0.0002190346276620403
autopsy O 0 0.0015582131454721093
findings O 0 0.0005894542555324733
showed O 0 0.0012215269962325692
massive O 1 0.8835165500640869
demyelination B-Disease 1 0.9999992847442627
of I-Disease 1 0.6252864599227905
the I-Disease 1 0.9820101857185364
cerebral I-Disease 1 0.999997615814209
white I-Disease 0 0.47636863589286804
matter I-Disease 0 0.00042435049545019865
with O 0 7.640504918526858e-05
sparing O 0 0.0006148785469122231
of O 0 0.0003262770769651979
the O 0 0.002032272983342409
U O 1 0.9999985694885254
- O 1 0.9853502511978149
fibers O 1 0.935946524143219
, O 0 0.00015443492156919092
compatible O 0 0.00015867932233959436
with O 0 4.765300764120184e-05
the O 0 0.00016715902893338352
findings O 0 0.00024512584786862135
of O 0 0.0014075051294639707
childhood O 1 0.9999903440475464
ALD B-Disease 1 1.0
. O 0 0.014917275868356228

Oleic O 1 0.5800043940544128
and O 0 0.00409765774384141
erucic O 1 0.994521975517273
acids O 0 0.002059439430013299
( O 0 0.0009832512587308884
Lorenzos O 1 0.9914705157279968
Oil O 0 0.002992804627865553
) O 0 8.718849858269095e-05
were O 0 5.91010793868918e-05
administered O 0 0.00015372033521998674
to O 0 6.740481330780312e-05
patients O 0 0.00013108378334436566
1 O 0 0.000160988827701658
and O 0 7.373139669653028e-05
4 O 0 0.0002229280216852203
, O 0 7.464095688192174e-05
but O 0 4.565767085296102e-05
sufficient O 0 0.00021984559134580195
effectiveness O 0 0.0002956136013381183
was O 0 0.00046063860645517707
not O 0 0.00011093249486293644
obtained O 0 0.0002831913297995925
. O 0 0.0005108594195917249

The O 0 0.0022340689320117235
findings O 0 0.00037069935933686793
in O 0 0.0001969214208656922
this O 0 7.061031647026539e-05
family O 0 0.00016403837071266025
suggest O 0 0.00016530105494894087
that O 0 7.2782117058523e-05
delGAG291 O 0 0.011579861864447594
is O 0 7.858494063839316e-05
part O 0 0.00013789741205982864
of O 0 0.0001653616054682061
the O 0 0.0003723397385329008
cause O 0 0.10239938646554947
of O 0 0.029950561001896858
Japanese O 1 0.9999674558639526
ALD B-Disease 1 1.0
with O 0 0.0010677380487322807
phenotypic O 0 0.008243595249950886
variations O 0 0.0018518822034820914
. O 0 0.0011380547657608986

Moreover O 0 0.0041182637214660645
, O 0 0.00032235964317806065
although O 0 9.002059960039333e-05
the O 0 0.0001053696614690125
scale O 0 0.0003363769792485982
of O 0 0.0001360879687126726
the O 0 0.0001751904346747324
study O 0 6.622748333029449e-05
is O 0 5.474692807183601e-05
limited O 0 5.289217006065883e-05
, O 0 4.145634738961235e-05
there O 0 4.258358239894733e-05
is O 0 4.5071577915223315e-05
a O 0 0.00011971381900366396
possibility O 0 0.0003556740120984614
that O 0 0.00011234405246796086
PET O 0 0.0019188702572137117
can O 0 8.504938159603626e-05
detect O 0 0.000405575119657442
an O 0 0.0004534976906143129
insidious B-Disease 1 0.9996452331542969
lesion I-Disease 1 0.9999830722808838
which O 0 0.0005865878192707896
is O 0 0.0003311058972030878
undetectable O 0 0.0036004523281008005
by O 0 0.00016282549768220633
computed O 0 0.0006353846983984113
tomogram O 1 0.9172226190567017
( O 0 0.0009922973113134503
CT O 0 0.07439280301332474
) O 0 0.00018685842223931104
or O 0 0.00021642472711391747
MRI O 0 0.002088018227368593
analysis O 0 8.213842374971136e-05
, O 0 8.194910333259031e-05
and O 0 6.548892997670919e-05
that O 0 3.8488651625812054e-05
the O 0 9.03423861018382e-05
higher O 0 0.0001184100256068632
level O 0 0.00016169158334378153
of O 0 0.00019836136198136955
tau O 0 0.001734056044369936
reflects O 0 0.0003722638066392392
the O 0 0.00016579736256971955
process O 0 0.0002302598295500502
of O 0 0.0011597820557653904
neuronal B-Disease 1 0.999964714050293
degeneration I-Disease 1 1.0
in O 1 0.9999209642410278
ALD B-Disease 1 1.0
. O 0 0.008569338358938694

Lorenzos O 1 0.9986739158630371
Oil O 0 0.0061471303924918175
should O 0 0.00013031309936195612
be O 0 3.580713746487163e-05
given O 0 2.77823146461742e-05
in O 0 6.30399736110121e-05
the O 0 0.0001641647977521643
early O 0 0.0005869827000424266
stage O 0 0.005477597005665302
. O 0 0.0004717287083622068
. O 0 0.0006156812887638807

Nonsense O 0 0.01814051903784275
mutation O 0 0.0008024195558391511
in O 0 0.00026924494886770844
exon O 0 0.0016920235939323902
4 O 0 0.0004663779109250754
of O 0 0.0004137242794968188
human O 0 0.0005503451102413237
complement O 0 0.001729036564938724
C9 O 1 0.9998612403869629
gene O 0 0.00027795095229521394
is O 0 7.384012133115903e-05
the O 0 0.00015752605395391583
major O 0 0.0009114653221331537
cause O 0 0.0017965774750337005
of O 0 0.001596137648448348
Japanese O 1 0.9998327493667603
complement B-Disease 1 0.9998723268508911
C9 I-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.005105696152895689

Deficiency B-Disease 1 0.9999616146087646
of I-Disease 0 0.003345042932778597
the I-Disease 0 0.002998798154294491
ninth I-Disease 1 0.997669517993927
component I-Disease 0 0.002845961833372712
of I-Disease 0 0.0006167590036056936
human I-Disease 0 0.00048244005301967263
complement I-Disease 0 0.001884930650703609
( O 0 0.0011941554257646203
C9 O 1 0.9998934268951416
) O 0 0.0001495061587775126
is O 0 6.293581827776507e-05
the O 0 0.00010759633732959628
most O 0 0.00010719438432715833
common O 0 0.0005054886569269001
complement B-Disease 1 0.9995781779289246
deficiency I-Disease 1 1.0
in O 0 0.004809131845831871
Japan O 1 0.5527377724647522
but O 0 9.075980051420629e-05
is O 0 7.949951395858079e-05
rare O 0 0.00021280533110257238
in O 0 0.00013540788495447487
other O 0 9.383452561451122e-05
countries O 0 0.00010246219608234242
. O 0 0.00043408331112004817

We O 0 0.0007167963776737452
studied O 0 0.0006051409291103482
the O 0 0.00034448137739673257
molecular O 0 0.0005240471218712628
basis O 0 0.00023703199985902756
of O 0 0.002138574607670307
C9 B-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9999994039535522
in O 0 0.0007796676945872605
four O 0 0.0008186334162019193
Japanese O 1 0.9926553964614868
C9 B-Disease 1 0.9999998807907104
- I-Disease 1 0.99928879737854
deficient I-Disease 1 0.9967383742332458
patients O 0 0.0008292319835163653
who O 0 0.0004425653023645282
had O 0 0.010365358553826809
suffered O 1 0.9999998807907104
from O 1 0.9999932050704956
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 1 0.687072217464447

Direct O 0 0.0020107105374336243
sequencing O 0 0.0022255373187363148
of O 0 0.001461633131839335
amplified O 0 0.009317911230027676
C9 O 1 0.9845322966575623
cDNA O 0 0.0030543312896043062
and O 0 0.00024488617782481015
DNA O 0 0.0004624419962055981
revealed O 0 0.0006771067855879664
a O 0 0.00031358745764009655
nonsense O 0 0.0019760201685130596
substitution O 0 0.0012393796350806952
( O 0 0.00035576560185290873
CGA O 0 0.008386495523154736
- O 0 0.0011301543563604355
- O 0 0.0012109673116356134
> O 0 0.001909839455038309
TGA O 0 0.007664634380489588
) O 0 0.00013513494923245162
at O 0 0.00034127518301829696
codon O 0 0.00044709653593599796
95 O 0 0.00023534463252872229
in O 0 6.624454545089975e-05
exon O 0 0.0006178315379656851
4 O 0 0.000155909190652892
in O 0 6.80232114973478e-05
the O 0 0.00021191927953623235
four O 0 0.0006867959164083004
C9 B-Disease 1 0.9999992847442627
- I-Disease 1 0.994032084941864
deficient I-Disease 0 0.4833209812641144
individuals O 0 0.00043100386392325163
. O 0 0.0008535356028005481

An O 0 0.0018211551941931248
allele O 0 0.0011210424127057195
- O 0 0.0005912078195251524
specific O 0 0.00017302432388532907
polymerase O 0 0.0011614979011937976
chain O 0 0.000890331924892962
reaction O 0 0.0006311128963716328
system O 0 0.00016502277867402881
designed O 0 0.0003070970706176013
to O 0 8.382591477129608e-05
detect O 0 0.00016297477122861892
exclusively O 0 6.425419269362465e-05
only O 0 1.6646275980747305e-05
one O 0 2.7890144338016398e-05
of O 0 6.952562398510054e-05
the O 0 0.0001582435506861657
normal O 0 0.0002754763117991388
and O 0 0.00010301200381945819
mutant O 0 0.0005200122250244021
alleles O 0 0.0001421214547008276
indicated O 0 0.00013616352225653827
that O 0 1.93420364666963e-05
all O 0 2.313656295882538e-05
the O 0 9.576850425219163e-05
four O 0 0.00014731161354575306
patients O 0 0.00014336030289996415
were O 0 6.37680568615906e-05
homozygous O 0 0.00015363738930318505
for O 0 3.664792893687263e-05
the O 0 0.00012940543820150197
mutation O 0 9.779436368262395e-05
in O 0 0.00010784882761072367
exon O 0 0.0008784771198406816
4 O 0 0.00019719892588909715
and O 0 4.3687683501048014e-05
that O 0 1.667827928031329e-05
the O 0 4.670547423302196e-05
parents O 0 4.476572939893231e-05
of O 0 0.00019786585471592844
patient O 0 0.0015620533376932144
2 O 0 0.001142967608757317
were O 0 0.0005744375521317124
heterozygous O 0 0.0010913454461842775
. O 0 0.0005692957784049213

The O 0 0.00302443141117692
common O 0 0.0008531078929081559
mutation O 0 0.0003789654583670199
at O 0 0.0005344105884432793
codon O 0 0.0005641604657284915
95 O 0 0.00026284807245247066
in O 0 8.38545456645079e-05
exon O 0 0.0013060063356533647
4 O 0 0.00041828479152172804
might O 0 0.0001566438440931961
be O 0 3.512383045745082e-05
responsible O 0 0.00018523208564147353
for O 0 0.00011928490857826546
most O 0 0.00047223284491337836
Japanese O 1 0.9979650974273682
C9 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.0021032318472862244
. O 0 0.0015789881581440568

BRCA1 O 0 0.014215854927897453
required O 0 0.0006181334028951824
for O 0 0.00020617461996152997
transcription O 0 0.0015742824180051684
- O 0 0.002651298651471734
coupled O 0 0.0037467535585165024
repair O 1 0.9963692426681519
of O 0 0.0633501261472702
oxidative O 1 0.9999876022338867
DNA O 1 0.9833800196647644
damage O 1 0.9998117089271545
. O 0 0.0017892707837745547

The O 1 0.5057251453399658
breast B-Disease 1 0.9999986886978149
and I-Disease 1 0.9999059438705444
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 1 0.9999605417251587
gene O 0 0.0038200239650905132
BRCA1 O 0 0.016780760139226913
encodes O 0 0.000557070248760283
a O 0 0.0005186580820009112
zinc O 1 0.5321539640426636
finger O 0 0.0032061312813311815
protein O 0 0.00045663377386517823
of O 0 0.0005444296402856708
unknown O 0 0.001571080880239606
function O 0 0.0007937445770949125
. O 0 0.0006156989256851375

Association O 0 0.0024660243652760983
of O 0 0.0009702445240691304
the O 0 0.0008782703662291169
BRCA1 O 0 0.004848070442676544
protein O 0 0.00029081752290949225
with O 0 8.439635712420568e-05
the O 0 0.00042649320675991476
DNA O 0 0.0021042118314653635
repair O 1 0.9993926286697388
protein O 0 0.002680745907127857
Rad51 O 1 0.7254628539085388
and O 0 0.00025032038684003055
changes O 0 0.00013004695938434452
in O 0 7.136591011658311e-05
the O 0 0.0001632584462640807
phosphorylation O 0 0.00028356717666611075
and O 0 0.00015652364527340978
cellular O 0 0.0006308248266577721
localization O 0 0.0007556028431281447
of O 0 0.00020686675270553678
the O 0 0.000257726147538051
protein O 0 0.00025662058033049107
after O 0 0.0005079993279650807
exposure O 0 0.0003433211240917444
to O 0 0.00011083014396717772
DNA O 0 0.0013867102097719908
- O 0 0.0018238333286717534
damaging O 0 0.007158191874623299
agents O 0 0.0001598968228790909
are O 0 1.7675329218036495e-05
consistent O 0 8.443604747299105e-05
with O 0 3.677038330351934e-05
a O 0 0.00017376700998283923
role O 0 0.000676933559589088
for O 0 0.00026010829606093466
BRCA1 O 0 0.11673618108034134
in O 0 0.0008045159047469497
DNA O 0 0.009223094210028648
repair O 1 0.9997381567955017
. O 0 0.003095606341958046

Here O 0 0.002962946891784668
, O 0 0.0004891257267445326
it O 0 0.00011036832438549027
is O 0 7.511793955927715e-05
shown O 0 0.00012995474389754236
that O 0 9.783166024135426e-05
mouse O 0 0.0017296498408541083
embryonic O 0 0.006237091030925512
stem O 0 0.0169638991355896
cells O 0 0.002988504944369197
deficient B-Disease 0 0.27902549505233765
in I-Disease 0 0.0006035427795723081
BRCA1 I-Disease 0 0.04376625642180443
are O 0 8.542417344870046e-05
defective O 0 0.0032855975441634655
in O 0 0.00011801267828559503
the O 0 0.00015189552505034953
ability O 0 7.476690370822325e-05
to O 0 5.653382686432451e-05
carry O 0 8.64094472490251e-05
out O 0 0.00019332962983753532
transcription O 0 0.0012689498253166676
- O 0 0.0010070436401292682
coupled O 0 0.0015348113374784589
repair O 1 0.926688015460968
of O 0 0.010243156924843788
oxidative O 1 0.9999769926071167
DNA O 1 0.9913260340690613
damage O 1 0.999983549118042
, O 0 0.0004908863920718431
and O 0 0.00020255870185792446
are O 0 6.800071423640475e-05
hypersensitive O 0 0.011224232614040375
to O 0 0.0010096634505316615
ionizing O 1 0.9987006187438965
radiation O 1 0.8609277606010437
and O 0 0.0008863578550517559
hydrogen O 0 0.005076355766505003
peroxide O 0 0.016542382538318634
. O 0 0.0008480593678541481

These O 0 0.0009182268404401839
results O 0 0.0006328988238237798
suggest O 0 0.000598955899477005
that O 0 0.0001983946276595816
BRCA1 O 0 0.012263838201761246
participates O 0 0.0015222852816805243
, O 0 0.0002887506561819464
directly O 0 0.0002622463507577777
or O 0 0.00018211064161732793
indirectly O 0 0.0005080749397166073
, O 0 0.00012550182873383164
in O 0 0.0001325733755948022
transcription O 0 0.0011927661253139377
- O 0 0.0023028652649372816
coupled O 0 0.0025036039296537638
repair O 1 0.9962796568870544
of O 0 0.07135061174631119
oxidative O 1 0.9999845027923584
DNA O 1 0.9919330477714539
damage O 1 0.9999731779098511
. O 0 0.0006530187674798071
. O 0 0.0005940636619925499

Truncation O 0 0.03572297841310501
mutations O 0 0.0012312398757785559
in O 0 0.0003972083795815706
the O 0 0.0006567861419171095
transactivation O 0 0.006755815353244543
region O 0 0.0008808550774119794
of O 0 0.0011817635968327522
PAX6 O 1 0.9999649524688721
result O 0 0.0010707254987210035
in O 0 0.0004294327518437058
dominant O 0 0.006278032902628183
- O 0 0.003182031214237213
negative O 0 0.0010085779940709472
mutants O 0 0.0065131280571222305
. O 0 0.0009838106343522668

PAX6 O 1 0.883220911026001
is O 0 0.0005178955034352839
a O 0 0.00038377533201128244
transcription O 0 0.0006768986349925399
factor O 0 0.00024267204571515322
with O 0 3.755398574867286e-05
two O 0 7.352813554462045e-05
DNA O 0 0.0003942327166441828
- O 0 0.0004904911620542407
binding O 0 0.0001357521687168628
domains O 0 0.0003561991034075618
( O 0 0.00031486214720644057
paired O 0 0.0009006393374875188
box O 0 0.0013999675866216421
and O 0 0.0003143327485304326
homeobox O 0 0.008894311264157295
) O 0 0.00010994238255079836
and O 0 0.00011243301560170949
a O 0 0.0003443866444285959
proline O 0 0.004189144354313612
- O 0 0.0015165964141488075
serine O 0 0.003575969021767378
- O 0 0.0014931714395061135
threonine O 0 0.004478981718420982
( O 0 0.0009664498502388597
PST O 1 0.9505865573883057
) O 0 0.0005443177651613951
- O 0 0.0011101040290668607
rich O 0 0.001495862496085465
transactivation O 0 0.00955916941165924
domain O 0 0.0020224698819220066
. O 0 0.001372362719848752

PAX6 O 1 0.9999288320541382
regulates O 0 0.06634282320737839
eye O 0 0.20867344737052917
development O 0 0.0012278720969334245
in O 0 0.00046000670408830047
animals O 0 0.0003384653537068516
ranging O 0 0.0005940673290751874
from O 0 0.000265177950495854
jellyfish O 0 0.0006806823657825589
to O 0 0.000179103939444758
Drosophila O 0 0.000893280899617821
to O 0 0.00034044228959828615
humans O 0 0.0008614081889390945
. O 0 0.00044317409629002213

Heterozygous O 0 0.004561467096209526
mutations O 0 0.0005578726995736361
in O 0 0.0002598856808617711
the O 0 0.0004893860314041376
human O 0 0.0009909713407978415
PAX6 O 1 0.9999474287033081
gene O 0 0.00037973065627738833
result O 0 0.00016765817417763174
in O 0 7.846482185414061e-05
various O 0 0.00011176151019753888
phenotypes O 0 0.0008891213801689446
, O 0 0.00027541062445379794
including O 0 0.0007461068453267217
aniridia B-Disease 1 1.0
, O 0 0.023967478424310684
Peters B-Disease 1 0.9999974966049194
anomaly I-Disease 1 0.9999986886978149
, O 0 0.0035432404838502407
autosomal B-Disease 1 0.977754533290863
dominant I-Disease 1 0.9999788999557495
keratitis I-Disease 1 1.0
, O 1 0.6401017904281616
and O 0 0.18399910628795624
familial B-Disease 1 0.9999996423721313
foveal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 1 0.9922921657562256

It O 0 0.0008357852348126471
is O 0 0.0002789315185509622
believed O 0 0.0004381539183668792
that O 0 5.901333861402236e-05
the O 0 0.0001984129921765998
mutated O 0 0.0008724310901015997
allele O 0 0.00038081820821389556
of O 0 0.00047901883954182267
PAX6 O 1 0.9986323714256287
produces O 0 0.0005574569222517312
an O 0 0.00019357368000783026
inactive O 0 0.0008803985547274351
protein O 0 0.0003821724094450474
and O 0 0.00032582294079475105
aniridia B-Disease 1 0.9999978542327881
is O 0 0.00043577986070886254
caused O 1 0.7164129018783569
due O 0 0.0010996524943038821
to O 0 0.0004915011813864112
genetic O 0 0.002518066205084324
haploinsufficiency O 1 0.9999358654022217
. O 0 0.0017720034811645746

However O 0 0.0012144382344558835
, O 0 0.0003865593171212822
several O 0 0.0003503929765429348
truncation O 0 0.003915703389793634
mutations O 0 0.0001815212017390877
have O 0 3.110327816102654e-05
been O 0 3.827361433650367e-05
found O 0 2.823133036145009e-05
to O 0 4.5460597903002053e-05
occur O 0 3.841109719360247e-05
in O 0 5.1828057621605694e-05
the O 0 0.0002741207426879555
C O 0 0.00168001523707062
- O 0 0.0011322307400405407
terminal O 0 0.0014206586638465524
half O 0 0.00025417431606911123
of O 0 0.00042966942419297993
PAX6 O 1 0.9986966252326965
in O 0 0.0006242239032872021
patients O 0 0.0004497990303207189
with O 0 0.0003392398066353053
Aniridia B-Disease 1 0.9999997615814209
resulting O 0 0.003719803411513567
in O 0 0.00030266883550211787
mutant O 0 0.0006389024201780558
proteins O 0 6.0533351643243805e-05
that O 0 3.599797855713405e-05
retain O 0 0.00017497691442258656
the O 0 0.0001457520411349833
DNA O 0 0.00035515596391633153
- O 0 0.00041400580084882677
binding O 0 0.00011080531112384051
domains O 0 0.00023328684619627893
but O 0 4.966814231011085e-05
have O 0 3.3603133488213643e-05
lost O 0 0.00025565471150912344
most O 0 4.206706216791645e-05
of O 0 0.0002103097504004836
the O 0 0.0006249698344618082
transactivation O 0 0.08996108174324036
domain O 0 0.002239256864413619
. O 0 0.0010489783016964793

It O 0 0.0007423320203088224
is O 0 0.0001366898650303483
not O 0 5.948455145698972e-05
clear O 0 0.00011509941396070644
whether O 0 0.0001146164140664041
such O 0 0.00014713699056301266
mutants O 0 0.004079991485923529
really O 0 0.0011634279508143663
behave O 0 0.0006369295879267156
as O 0 0.00022348751372192055
loss O 0 0.0008749335538595915
- O 0 0.000418776529841125
of O 0 0.0004131027963012457
- O 0 0.0007830338436178863
function O 0 0.0002832034952007234
mutants O 0 0.0010187334846705198
as O 0 0.00023191228683572263
predicted O 0 0.0005136259132996202
by O 0 0.00020340718037914485
haploinsufficiency O 1 0.881859540939331
. O 0 0.001200665719807148

Contrary O 0 0.002906144829466939
to O 0 0.0002193999825976789
this O 0 0.0001087249765987508
theory O 0 0.00031332834623754025
, O 0 8.705838990863413e-05
our O 0 0.00015031176735647023
data O 0 5.018405136070214e-05
showed O 0 0.00016166568093467504
that O 0 2.5919040126609616e-05
these O 0 2.657971708686091e-05
mutants O 0 0.00048746110405772924
are O 0 2.183993456128519e-05
dominant O 0 0.000533171696588397
- O 0 0.0004764945188071579
negative O 0 0.00015750745660625398
in O 0 0.00029748474480584264
transient O 0 0.00277772662229836
transfection O 0 0.010881188325583935
assays O 0 0.00046071369433775544
when O 0 0.00011564730084501207
they O 0 2.606727139209397e-05
are O 0 1.4623557945014909e-05
coexpressed O 0 0.0019757533445954323
with O 0 0.0001695321116130799
wild O 0 0.0015940844314172864
- O 0 0.004173491150140762
type O 0 0.004099058918654919
PAX6 O 1 0.9996092915534973
. O 0 0.0036580455489456654

We O 0 0.000619522703345865
found O 0 0.00016503491497132927
that O 0 4.219249603920616e-05
the O 0 0.00016093358863145113
dominant O 0 0.0015876400284469128
- O 0 0.0008646970964036882
negative O 0 0.00017990960623137653
effects O 0 0.0003961986512877047
result O 0 0.00012035731197101995
from O 0 0.00013589736772701144
the O 0 0.0002464437566231936
enhanced O 0 0.0004719218413811177
DNA O 0 0.00022588860883843154
binding O 0 0.00011002533574355766
ability O 0 9.694590698927641e-05
of O 0 0.00023564440198242664
these O 0 0.0002106370811816305
mutants O 0 0.00536316866055131
. O 0 0.0007919924682937562

Kinetic O 0 0.00533631443977356
studies O 0 0.0002898777020163834
of O 0 0.00048175326082855463
binding O 0 0.0003632924344856292
and O 0 0.00043263784027658403
dissociation O 0 0.002198685659095645
revealed O 0 0.0010564527474343777
that O 0 0.00010150091839022934
various O 0 0.00011489939788589254
truncation O 0 0.0034132767468690872
mutants O 0 0.0015359532553702593
have O 0 8.084913133643568e-05
3 O 0 0.0002789618738461286
- O 0 0.00036791403545066714
5 O 0 0.00020441079686861485
- O 0 0.0002653021365404129
fold O 0 0.0004094507312402129
higher O 0 0.00010071342694573104
affinity O 0 8.04779920144938e-05
to O 0 3.915006163879298e-05
various O 0 4.880120832240209e-05
DNA O 0 0.00025231539621017873
- O 0 0.00023086214787326753
binding O 0 4.0933948184829205e-05
sites O 0 5.33578495378606e-05
when O 0 4.7381767217302695e-05
compared O 0 5.389727448346093e-05
with O 0 2.482407035131473e-05
the O 0 0.00018209814152214676
wild O 0 0.0012888426426798105
- O 0 0.002913834759965539
type O 0 0.0035688013304024935
PAX6 O 1 0.9994737505912781
. O 0 0.002267019124701619

These O 0 0.0005056408699601889
results O 0 0.00019728225015569478
provide O 0 0.00010205471335211769
a O 0 0.0001366413926007226
new O 0 0.00013645282888319343
insight O 0 0.0005631772801280022
into O 0 9.615026647225022e-05
the O 0 0.00013736225082539022
role O 0 0.00025483922217972577
of O 0 0.000549692427739501
mutant O 1 0.8097727298736572
PAX6 O 1 0.999996542930603
in O 0 0.01459547970443964
causing O 1 0.9999833106994629
aniridia B-Disease 1 0.9999998807907104
. O 0 0.0008697195444256067
. O 0 0.0006081017781980336

Reversal O 1 0.7639964818954468
of O 1 0.9951217770576477
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 1 0.9999958276748657
excellent O 1 0.999653697013855
neuropsychologic O 1 0.9999940395355225
outcome O 0 0.0011156353866681457
in O 0 0.00021936527627985924
very B-Disease 0 0.00016261727432720363
- I-Disease 0 0.0004746128397528082
long I-Disease 0 0.0003332809719722718
- I-Disease 0 0.001000137417577207
chain I-Disease 0 0.001573877758346498
acyl I-Disease 0 0.003377282992005348
- I-Disease 0 0.0034550006967037916
coenzyme I-Disease 0 0.009120224043726921
A I-Disease 1 0.9326353073120117
dehydrogenase I-Disease 1 0.9999383687973022
deficiency I-Disease 1 0.9999996423721313
. O 0 0.004273276776075363

Very B-Disease 0 0.002455686451867223
- I-Disease 0 0.003422667970880866
long I-Disease 0 0.001041640993207693
- I-Disease 0 0.0017601713771000504
chain I-Disease 0 0.002220629947260022
acyl I-Disease 0 0.0022176504135131836
- I-Disease 0 0.0012154867872595787
coenzyme I-Disease 0 0.0016199874226003885
A I-Disease 0 0.0028435816057026386
dehydrogenase I-Disease 1 0.6048657894134521
( I-Disease 0 0.008246446028351784
VLCAD I-Disease 1 1.0
) I-Disease 0 0.008897168561816216
deficiency I-Disease 1 0.9999984502792358
is O 0 0.0004054631863255054
a O 0 0.002348831854760647
disorder O 1 0.9999979734420776
of O 1 0.9982118606567383
fatty O 1 0.9999768733978271
acid O 1 0.9547920227050781
beta O 0 0.0008275971631519496
oxidation O 0 0.00030367090948857367
that O 0 5.302554927766323e-05
reportedly O 0 0.00040472508408129215
has O 0 6.08497102803085e-05
high O 0 0.00023350627452600747
rates O 0 7.977214409038424e-05
of O 0 0.0003283872501924634
morbidity O 0 0.440806120634079
and O 0 0.0010804268531501293
mortality O 0 0.06064487248659134
. O 0 0.001391487312503159

We O 0 0.0006853227969259024
describe O 0 0.0003394810191821307
the O 0 0.00017516972729936242
outcome O 0 0.0001669650082476437
of O 0 0.0001320346782449633
a O 0 0.00028715046937577426
5 O 0 0.0004433933936525136
- O 0 0.0006108835805207491
year O 0 0.0002707689127419144
- O 0 0.0006433016387745738
old O 0 0.0018409332260489464
girl O 0 0.017781399190425873
with O 0 0.009017185308039188
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 0.013331468217074871
was O 0 0.010083254426717758
first O 0 0.00038076777127571404
seen O 0 0.00039049499901011586
at O 0 0.0003486432833597064
5 O 0 0.0001520325749879703
months O 0 0.00013376789866015315
of O 0 0.00020826877153012902
age O 0 0.001814170042052865
with O 0 0.4183555841445923
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 1 1.0
hepatomegaly B-Disease 1 1.0
, O 1 0.9999998807907104
encephalopathy B-Disease 1 1.0
, O 1 0.9259952902793884
and O 0 0.028885720297694206
hypotonia B-Disease 1 0.9999648332595825
. O 0 0.003343707649037242

Biochemical O 0 0.04200153052806854
studies O 0 0.0044677117839455605
indicated O 1 0.9919448494911194
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 1 0.9999969005584717
by O 0 0.000788810255471617
a O 0 0.0017345596570521593
stable O 0 0.007325236219912767
yet O 0 0.0008229362429119647
inactive O 0 0.003040943294763565
enzyme O 0 0.0013584383996203542
. O 0 0.0007124540861696005

Molecular O 0 0.0026890260633081198
genetic O 0 0.0007533474708907306
analysis O 0 0.00015567982336506248
of O 0 0.0004918366903439164
her O 0 0.002338226418942213
VLCAD O 1 0.9999988079071045
gene O 0 0.0014381209621205926
revealed O 0 0.001637579407542944
a O 0 0.0008331690914928913
T1372C O 1 0.9982757568359375
( O 0 0.0012456343974918127
F458L O 1 0.8722919821739197
) O 0 0.0003875722177326679
missense O 0 0.0015509009826928377
mutation O 0 0.0003728476585820317
and O 0 0.0002455319045111537
a O 0 0.0013981728116050363
1668 O 1 0.9980652928352356
ACAG O 1 0.9999823570251465
1669 O 1 0.9933059811592102
splice O 0 0.03752591088414192
site O 0 0.008063768967986107
mutation O 0 0.0022436014842242002
. O 0 0.0008832502644509077

After O 0 0.007479104679077864
initial O 0 0.0034300456754863262
treatment O 0 0.0063292039558291435
with O 0 0.0010949976276606321
intravenous O 1 0.9994962215423584
glucose O 1 0.9794848561286926
and O 0 0.0021317461505532265
carnitine O 1 0.9997968077659607
, O 0 0.00029621284920722246
the O 0 0.00025233608903363347
patient O 0 0.0003612028085626662
has O 0 0.00013972623855806887
thrived O 0 0.0011530728079378605
on O 0 0.0001570795284351334
a O 0 0.0002732382563408464
low O 0 0.0007551036542281508
- O 0 0.0008775392780080438
fat O 0 0.0010027115931734443
diet O 0 0.0005600749282166362
supplemented O 0 0.0003841697471216321
with O 0 0.00012888970377389342
medium O 0 0.0007328513893298805
- O 0 0.0013503142399713397
chain O 0 0.0020753114949911833
triglyceride O 0 0.008675526827573776
oil O 0 0.0022593538742512465
and O 0 0.0004803324700333178
carnitine O 0 0.42943885922431946
and O 0 0.0006885377806611359
avoidance O 0 0.1844702512025833
of O 0 0.029363613575696945
fasting O 0 0.28530827164649963
. O 0 0.0015953659312799573

Her O 1 0.978029191493988
ventricular O 1 0.9999998807907104
hypertrophy O 1 0.9999994039535522
resolved O 0 0.013021175749599934
significantly O 0 0.0007602361729368567
over O 0 0.00022101879585534334
1 O 0 0.0003151360433548689
year O 0 0.0002735758316703141
, O 0 0.00013507208495866507
and O 0 0.0002655526914168149
cognitively O 0 0.04328646510839462
, O 0 0.0002514048246666789
she O 0 0.00014461106911767274
is O 0 6.46214684820734e-05
in O 0 8.91818999662064e-05
the O 0 0.00020987507014069706
superior O 0 0.0011737797176465392
range O 0 0.00035821067285723984
for O 0 0.0002366955013712868
age O 0 0.0009530631359666586
. O 0 0.000848993135150522

Clinical O 0 0.0066550844348967075
recognition O 0 0.007062755059450865
of O 1 0.999921441078186
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 0.19123180210590363
important O 0 0.0005472410703077912
because O 0 0.00010612605547066778
it O 0 2.2088943296694197e-05
is O 0 2.2611848180531524e-05
one O 0 2.337903242732864e-05
of O 0 9.851637878455222e-05
the O 0 0.00026461301604285836
few O 0 0.0003326366131659597
directly O 0 0.001063016476109624
treatable O 1 0.9999980926513672
causes O 1 0.9996545314788818
of O 1 0.9999771118164062
cardiomyopathy B-Disease 1 1.0
in O 1 0.9999518394470215
children O 0 0.0882917270064354
. O 0 0.0003808928304351866
. O 0 0.0005540060228668153

Cloning O 0 0.002997329691424966
of O 0 0.0006209502462297678
a O 0 0.00021661302889697254
novel O 0 0.0003256661002524197
member O 0 0.0001233654038514942
of O 0 0.00014111514610704035
the O 0 0.00025466116494499147
low O 0 0.0011227075010538101
- O 0 0.0013568359427154064
density O 0 0.0007544916006736457
lipoprotein O 0 0.3543979227542877
receptor O 0 0.0020146938040852547
family O 0 0.0011413183528929949
. O 0 0.0007362808100879192

A O 0 0.0032742659095674753
gene O 0 0.0005502813146449625
encoding O 0 0.0003180835337843746
a O 0 0.00022135538165457547
novel O 0 0.0006165585946291685
transmembrane O 0 0.0009923828765749931
protein O 0 0.0003038814465980977
was O 0 0.0003887407365255058
identified O 0 7.45277211535722e-05
by O 0 2.8894130082335323e-05
DNA O 0 7.764961628708988e-05
sequence O 0 4.699906276073307e-05
analysis O 0 3.062739051529206e-05
within O 0 0.00010123964602826163
the O 0 0.0006530930986627936
insulin B-Disease 1 0.9768596291542053
- I-Disease 0 0.0790214017033577
dependent I-Disease 0 0.005463575944304466
diabetes I-Disease 1 0.9999998807907104
mellitus I-Disease 1 1.0
( O 1 0.9744852781295776
IDDM B-Disease 1 0.9999995231628418
) O 0 0.001354695064947009
locus O 0 0.00506322318688035
IDDM4 O 1 0.9978413581848145
on O 0 0.0018280299846082926
chromosome O 0 0.004748124163597822
11q13 O 1 0.9962649941444397
. O 0 0.001768004847690463

Based O 0 0.0005491331103257835
on O 0 0.000257175590377301
its O 0 0.00016992082237266004
chromosomal O 0 0.0017508098389953375
position O 0 0.0005321207572706044
, O 0 0.00011974269000347704
this O 0 5.875357601325959e-05
gene O 0 5.861691170139238e-05
is O 0 3.6559122236212716e-05
a O 0 8.551660721423104e-05
candidate O 0 0.0001426993840141222
for O 0 9.621015487937257e-05
conferring O 0 0.003759829793125391
susceptibility O 1 0.986598014831543
to O 0 0.006205445621162653
diabetes B-Disease 1 0.9999983310699463
. O 0 0.0034400078002363443

The O 0 0.00266425684094429
gene O 0 0.0009705967968329787
, O 0 0.0003869442152790725
termed O 0 0.0022917301394045353
low O 0 0.0010039666667580605
- O 0 0.000852363184094429
density O 0 0.0005372056621126831
lipoprotein O 0 0.003247753484174609
receptor O 0 0.00031069459510035813
related O 0 0.00019607307331170887
protein O 0 0.00027824786957353354
5 O 0 0.0003696860221680254
( O 0 0.0005055488436482847
LRP5 O 1 0.9978165626525879
) O 0 0.00015328326844610274
, O 0 8.297574822790921e-05
encodes O 0 0.00012685226101893932
a O 0 0.00014218705473467708
protein O 0 0.0001809454261092469
of O 0 0.0003034364781342447
1615 O 0 0.0076533411629498005
amino O 0 0.0002924373548012227
acids O 0 0.0001360114401904866
that O 0 3.1847954232944176e-05
contains O 0 7.371910760411993e-05
conserved O 0 0.00014831202861387283
modules O 0 0.0003323452838230878
which O 0 2.4225873858085833e-05
are O 0 7.192089469754137e-06
characteristic O 0 6.954896525712684e-05
of O 0 0.00014112294593360275
the O 0 0.0003621768846642226
low O 0 0.0006121288752183318
- O 0 0.0006336025544442236
density O 0 0.0005272633279673755
lipoprotein O 1 0.9841141700744629
( O 0 0.0010655238293111324
LDL O 1 0.9982848763465881
) O 0 0.0003612067666836083
receptor O 0 0.0005432733451016247
family O 0 0.00047613721108064055
. O 0 0.0007347114733420312

These O 0 0.0006388889742083848
modules O 0 0.0014844565885141492
include O 0 0.00020988307369407266
a O 0 0.000378373428247869
putative O 0 0.001915590837597847
signal O 0 0.0013498931657522917
peptide O 0 0.0007251076167449355
for O 0 0.00010227331222267821
protein O 0 0.0002113953814841807
export O 0 0.00042357854545116425
, O 0 0.00013080336793791503
four O 0 0.0002455082430969924
epidermal O 0 0.3637760877609253
growth O 0 0.0020767657551914454
factor O 0 0.002005679765716195
( O 0 0.0008367158588953316
EGF O 1 0.9793576002120972
) O 0 0.00023239615256898105
repeats O 0 0.00045124374446459115
with O 0 9.977187437471002e-05
associated O 0 0.0002312697470188141
spacer O 0 0.0034148243721574545
domains O 0 0.0009348102612420917
, O 0 0.00025761191500350833
three O 0 0.0003389348275959492
LDL O 1 0.9999210834503174
- O 0 0.01344346720725298
receptor O 0 0.0008959032711572945
( O 0 0.000515702529810369
LDLR O 1 0.9982560276985168
) O 0 0.0002657841541804373
repeats O 0 0.0005813022144138813
, O 0 0.00012807839084416628
a O 0 0.00019721566059160978
single O 0 0.00033396706567145884
transmembrane O 0 0.0021385978907346725
spanning O 0 0.0025227798614650965
domain O 0 0.0006310696480795741
, O 0 0.00015658512711524963
and O 0 0.00014696143625769764
a O 0 0.0006074598641134799
cytoplasmic O 0 0.0024005232844501734
domain O 0 0.0019799608271569014
. O 0 0.0010970707517117262

The O 0 0.0015755811473354697
encoded O 0 0.00041965104173868895
protein O 0 0.0002815212355926633
has O 0 5.154101017978974e-05
a O 0 7.920002099126577e-05
unique O 0 0.0001368236553389579
organization O 0 0.00017086805019062012
of O 0 0.0009566298103891313
EGF O 1 0.9999741315841675
and O 0 0.0026752264238893986
LDLR O 1 0.999997615814209
repeats O 0 0.0039644911885261536
; O 0 0.0002750983403529972
therefore O 0 0.00028776511317119
, O 0 0.00029106411966495216
LRP5 O 1 0.9949079155921936
likely O 0 0.00041600895929150283
represents O 0 0.00022501627972815186
a O 0 0.00010869999823626131
new O 0 8.278006862383336e-05
category O 0 0.00016349305224139243
of O 0 0.0002572356606833637
the O 0 0.0012932971585541964
LDLR O 1 0.9999983310699463
family O 0 0.005721323657780886
. O 0 0.0018258003983646631

Both O 0 0.0020623262971639633
human O 0 0.002233981853350997
and O 0 0.001126377610489726
mouse O 1 0.850583553314209
LRP5 O 1 0.9999998807907104
cDNAs O 1 0.9999653100967407
have O 0 0.00017395797476638108
been O 0 0.00010929461859632283
isolated O 0 0.00034227335709147155
and O 0 0.00010372970427852124
the O 0 0.00019810184312518686
encoded O 0 0.00011849992733914405
mature O 0 0.00016895421140361577
proteins O 0 4.417119998834096e-05
are O 0 9.500980013399385e-06
95 O 0 9.315037459600717e-05
% O 0 3.879283758578822e-05
identical O 0 7.153843762353063e-05
, O 0 6.766602018615231e-05
indicating O 0 0.00014576315879821777
a O 0 8.13430524431169e-05
high O 0 0.000208024270250462
degree O 0 0.0002701242920011282
of O 0 0.0003550865512806922
evolutionary O 0 0.0016557988710701466
conservation O 0 0.0009773512138053775
. O 0 0.0003166943497490138
. O 0 0.0005828461144119501

The O 0 0.009675011970102787
APC B-Disease 1 0.9425339698791504
variants O 0 0.005944489035755396
I1307K O 1 0.9972708821296692
and O 0 0.0012168132234364748
E1317Q O 1 0.9986540079116821
are O 0 0.0001875406305771321
associated O 0 0.0013964190147817135
with O 1 0.9713982939720154
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 0.3642672896385193
but O 0 0.0001621847623027861
not O 0 4.130367960897274e-05
always O 0 7.708212797297165e-05
with O 0 2.8282422135816887e-05
a O 0 0.00020290279644541442
family O 0 0.0006574496510438621
history O 0 0.0019793068058788776
. O 0 0.0011367491679266095

Classical O 0 0.09720852226018906
familial B-Disease 1 0.9999977350234985
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999203681945801
FAP B-Disease 1 0.9999984502792358
) O 0 0.0006571495905518532
is O 0 0.00020701278117485344
a O 0 0.0004465309320949018
high O 0 0.003693144302815199
- O 0 0.017039773985743523
penetrance O 1 0.9580462574958801
autosomal B-Disease 1 0.9899761080741882
dominant I-Disease 1 0.9999924898147583
disease I-Disease 1 0.9999997615814209
that O 0 0.0005366363329812884
predisposes O 1 0.9877034425735474
to O 0 0.00024610140826553106
hundreds O 0 0.0004954473697580397
or O 0 0.0002659433812368661
thousands O 0 0.0018911545630544424
of O 1 0.9997379183769226
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.999998927116394
carcinoma I-Disease 1 1.0
and O 0 0.0032352404668927193
that O 0 0.00013017226592637599
results O 0 0.00012634632003027946
from O 0 0.0001356865541310981
truncating O 0 0.0016064370283856988
mutations O 0 0.0001238146360265091
in O 0 0.00014638800348620862
the O 0 0.0006047274800948799
APC B-Disease 1 0.9952300786972046
gene O 0 0.0011630617082118988
. O 0 0.0006846882170066237

A O 0 0.008392682299017906
variant O 0 0.006343398243188858
of O 0 0.004067942965775728
FAP B-Disease 1 0.9999785423278809
is O 0 0.004047584719955921
attenuated B-Disease 1 0.9996570348739624
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999992847442627
, O 0 0.0007374499691650271
which O 0 9.329330350738019e-05
results O 0 9.350796608487144e-05
from O 0 0.00032739073503762484
germ O 1 0.999954342842102
- O 0 0.0023505084682255983
line O 0 0.0004824865027330816
mutations O 0 5.306136154104024e-05
in O 0 3.783303691307083e-05
the O 0 9.165344818029553e-05
5 O 0 0.00011611869558691978
and O 0 5.066698577138595e-05
3 O 0 0.00010415848373668268
regions O 0 7.692366489209235e-05
of O 0 0.00022557866759598255
the O 0 0.0008637724095024168
APC B-Disease 1 0.99978107213974
gene O 0 0.0012478787684813142
. O 0 0.0005941576673649251

Attenuated B-Disease 1 0.9999481439590454
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 1 0.551585853099823
have O 0 0.0004852619313169271
" O 0 0.0021449816413223743
multiple O 0 0.022758616134524345
" O 1 0.9999662637710571
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 0.0018590983236208558
typically O 0 9.038273128680885e-05
fewer O 0 5.1438826631056145e-05
than O 0 3.4204625990241766e-05
100 O 0 0.00012530059029813856
) O 0 4.344219632912427e-05
without O 0 6.517803558381274e-05
the O 0 0.00022977952903602272
florid O 0 0.008023014292120934
phenotype O 0 0.002153537003323436
of O 0 0.0014145930763334036
classical O 0 0.04362110048532486
FAP B-Disease 1 0.9999070167541504
. O 0 0.0038947006687521935

Another O 0 0.004856693558394909
group O 0 0.0008885564748197794
of O 0 0.0011116797104477882
patients O 0 0.0012951793614774942
with O 0 0.0006580774788744748
multiple O 0 0.11980022490024567
adenomas B-Disease 1 0.9999990463256836
has O 0 0.0003699712106026709
no O 0 0.00028114786255173385
mutations O 0 0.00016247825988102704
in O 0 0.0001367500954074785
the O 0 0.0003983489878010005
APC B-Disease 1 0.9985461235046387
gene O 0 0.00025795921101234853
, O 0 8.199286821763963e-05
and O 0 6.0278052842477337e-05
their O 0 5.9173547924729064e-05
phenotype O 0 0.00042467989260330796
probably O 0 0.00025182418175973
results O 0 5.113159568281844e-05
from O 0 4.337691279943101e-05
variation O 0 0.00012781706755049527
at O 0 0.0002965083986055106
a O 0 0.0003097290173172951
locus O 0 0.0008216652786359191
, O 0 0.00016974465688690543
or O 0 0.0001625357399461791
loci O 0 0.0007969922735355794
, O 0 0.00012365254224278033
elsewhere O 0 0.0001473029115004465
in O 0 0.00010874188592424616
the O 0 0.00038455319008789957
genome O 0 0.001126576098613441
. O 0 0.0006771876942366362

Recently O 0 0.004493172280490398
, O 0 0.00040800092392601073
however O 0 0.00015203403017949313
, O 0 8.102718129521236e-05
a O 0 0.00013804106856696308
missense O 0 0.0011613203678280115
variant O 0 0.0009039504802785814
of O 0 0.001044789096340537
APC B-Disease 1 0.9999966621398926
( O 0 0.005265480373054743
I1307K O 1 0.9997820258140564
) O 0 0.00022721792629454285
was O 0 0.0005174549878574908
described O 0 0.00041165531729348004
that O 0 5.854160917806439e-05
confers O 0 0.0004928861162625253
an O 0 0.00020300709002185613
increased O 0 0.000705456652212888
risk O 0 0.004782393574714661
of O 1 0.9999861717224121
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 1 0.7617220878601074
including O 0 0.0055871931836009026
multiple O 0 0.12305841594934464
adenomas B-Disease 1 0.9999974966049194
, O 0 0.0011646464699879289
in O 0 0.0012005778262391686
Ashkenazim O 1 0.8100875616073608
. O 0 0.0014389626448974013

We O 0 0.0008094045333564281
have O 0 9.870990470517427e-05
studied O 0 0.00014338601613417268
a O 0 0.0001283736783079803
set O 0 0.00018630940758157521
of O 0 0.00025581708177924156
164 O 0 0.0028265342116355896
patients O 0 0.0006986064254306257
with O 0 0.0010382833424955606
multiple O 1 0.9999592304229736
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.999977707862854
/ I-Disease 1 0.9999990463256836
or I-Disease 1 0.9980641007423401
carcinoma I-Disease 1 1.0
and O 0 0.0009618624462746084
analyzed O 0 0.0009600614430382848
codons O 0 0.0018921870505437255
1263 O 0 0.01701962575316429
- O 0 0.001641246140934527
1377 O 0 0.04282727465033531
( O 0 0.0008061066037043929
exon O 0 0.003279128111898899
15G O 0 0.006857691798359156
) O 0 7.506995461881161e-05
of O 0 0.00014551430649589747
the O 0 0.0004508243582677096
APC B-Disease 0 0.31152597069740295
gene O 0 0.0005379861104302108
for O 0 0.000419920397689566
germ O 1 0.9999699592590332
- O 0 0.00760841416195035
line O 0 0.002167666098102927
variants O 0 0.0013777089770883322
. O 0 0.0006061646854504943

Three O 0 0.0022455863654613495
patients O 0 0.000754723499994725
with O 0 0.00017696637951303273
the O 0 0.0008751798886805773
I1307K O 1 0.9973983764648438
allele O 0 0.0007170649478211999
were O 0 0.0002259545144625008
detected O 0 0.0004829415993299335
, O 0 7.523407111875713e-05
each O 0 4.3906875362154096e-05
of O 0 0.00032596744131296873
Ashkenazi O 0 0.005566785577684641
descent O 0 0.005938585847616196
. O 0 0.0012517882278189063

Four O 0 0.002939758589491248
patients O 0 0.0008668667869642377
had O 0 0.0005230263923294842
a O 0 0.0012384155998006463
germ O 1 0.9999896287918091
- O 0 0.012447736226022243
line O 0 0.0025162259116768837
E1317Q O 0 0.029522627592086792
missense O 0 0.0023581995628774166
variant O 0 0.0009923364268615842
of O 0 0.000762595736887306
APC O 1 0.9990050196647644
that O 0 0.00016910039994399995
was O 0 0.00034128312836401165
not O 0 3.161778295179829e-05
present O 0 8.292400889331475e-05
in O 0 5.7902670960174873e-05
controls O 0 0.0001293265086133033
; O 0 2.035019497270696e-05
one O 0 2.7426251108408906e-05
of O 0 5.922971831751056e-05
these O 0 2.6779134714161046e-05
individuals O 0 4.4991618779022247e-05
had O 0 0.00016971777949947864
an O 0 0.00011084514699177817
unusually O 0 0.00043757795356214046
large O 0 0.00013663643039762974
number O 0 9.437968401471153e-05
of O 0 0.0008255626889877021
metaplastic B-Disease 1 0.9999290704727173
polyps I-Disease 1 0.8968766331672668
of I-Disease 0 0.0016791925299912691
the I-Disease 0 0.007140881847590208
colorectum I-Disease 1 0.999836802482605
. O 0 0.0016346712363883853

There O 0 0.0013617329532280564
is O 0 0.0002756252360995859
increasing O 0 0.00029034793260507286
evidence O 0 0.0002064935106318444
that O 0 5.665450225933455e-05
there O 0 0.000119035154057201
exist O 0 0.00025536672910675406
germ O 1 0.9928763508796692
- O 0 0.0010897923493757844
line O 0 0.0005375355249270797
variants O 0 0.00012681815132964402
of O 0 0.000165197387104854
the O 0 0.0003759184619411826
APC B-Disease 1 0.9677029848098755
gene O 0 0.00026911048917099833
that O 0 7.696665852563456e-05
predispose O 0 0.0007198145030997694
to O 0 9.78042371571064e-05
the O 0 0.0002641715982463211
development O 0 0.0006845101597718894
of O 0 0.03297020122408867
multiple O 1 0.999993085861206
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999998807907104
carcinoma I-Disease 1 1.0
, O 0 0.03854796290397644
but O 0 0.00020475605560932308
without O 0 0.00015947870269883424
the O 0 0.0002979567798320204
florid O 0 0.0071104723028838634
phenotype O 0 0.0012240845244377851
of O 0 0.0005658778245560825
classical O 0 0.28436073660850525
FAP B-Disease 1 0.9999942779541016
, O 0 0.00031767316977493465
and O 0 0.00017268495867028832
possibly O 0 0.0002991285582538694
with O 0 7.274153176695108e-05
importance O 0 0.0024704954121261835
for O 1 0.8359071016311646
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 0 0.036930378526449203
in O 0 0.00025419300072826445
the O 0 0.0002995098184328526
general O 0 0.0003688847064040601
population O 0 9.064062032848597e-05
. O 0 0.00011476646614028141
. O 0 0.00036765559343621135

Genomic O 0 0.004238564986735582
structure O 0 0.003060623537749052
of O 0 0.0022042570635676384
the O 1 0.8093964457511902
human O 1 0.9999986886978149
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 0.9999998807907104
CLD B-Disease 1 1.0
) O 0 0.0020683666225522757
gene O 0 0.0009987644152715802
. O 0 0.0005683470517396927

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 0.9999997615814209
CLD B-Disease 1 1.0
) O 0 0.0020708523225039244
is O 0 0.0003641193616203964
caused O 0 0.0031265306752175093
by O 0 0.00010904966620728374
mutations O 0 0.0001221631682710722
in O 0 7.798517617629841e-05
a O 0 0.00020508939633145928
gene O 0 0.0001750471565173939
which O 0 6.594879960175604e-05
encodes O 0 0.0004684363666456193
an O 0 0.0008436216157861054
intestinal O 1 0.9999998807907104
anion O 1 0.9998726844787598
transporter O 1 0.9997435212135315
. O 0 0.002140746219083667

We O 0 0.0015790022443979979
report O 0 0.000322949344990775
here O 0 0.00020089608733542264
the O 0 0.00016436433361377567
complete O 0 0.0004654128570109606
genomic O 0 0.00031311545171774924
organization O 0 0.00018206601089332253
of O 0 0.00023768922255840153
the O 0 0.000648847664706409
human O 0 0.0017857286147773266
CLD B-Disease 1 0.9999712705612183
gene O 0 0.0006239271606318653
which O 0 0.00015273148892447352
spans O 0 0.0009864766616374254
approximately O 0 0.0008224392076954246
39kb O 1 0.7165687680244446
, O 0 0.00020616418623831123
and O 0 0.00012990071263629943
comprises O 0 0.0007561708334833384
21 O 0 0.0017580011626705527
exons O 0 0.005372223909944296
. O 0 0.0010207939194515347

All O 0 0.0020598263945430517
exon O 0 0.015134708024561405
/ O 0 0.004739285446703434
intron O 0 0.007224909961223602
boundaries O 0 0.00046929396921768785
conform O 0 0.0007636265363544226
to O 0 0.0002261129266116768
the O 0 0.0012651549186557531
GT O 1 0.9996854066848755
/ O 1 0.9748196601867676
AG O 1 0.9995452761650085
rule O 0 0.003276943927630782
. O 0 0.0015328454319387674

An O 0 0.0005300104967318475
analysis O 0 0.00011239742889301851
of O 0 0.0002832024183589965
the O 0 0.0005236007273197174
putative O 0 0.003372336970642209
promoter O 0 0.008808553218841553
region O 0 0.000701162323821336
sequence O 0 0.00029132753843441606
shows O 0 0.00021681448561139405
a O 0 0.0005628311773762107
putative O 0 0.028256000950932503
TATA O 1 0.999997615814209
box O 0 0.003409099532291293
and O 0 0.00036965636536478996
predicts O 0 0.0009714117622934282
multiple O 0 0.00031602566014043987
transcription O 0 0.0013526271795853972
factor O 0 0.0007994948537088931
binding O 0 0.00045745502575300634
sites O 0 0.0005678182351402938
. O 0 0.0005866392748430371

The O 0 0.0027110232040286064
genomic O 0 0.001787991146557033
structure O 0 0.0016092185396701097
was O 0 0.000694362330250442
determined O 0 0.00013622765254694968
using O 0 5.714703365811147e-05
DNA O 0 0.00012034422979922965
from O 0 4.022716893814504e-05
several O 0 4.2820993257919326e-05
sources O 0 5.223791958997026e-05
including O 0 7.687102333875373e-05
multiple O 0 0.0001368078519590199
large O 0 0.0005727354437112808
- O 0 0.0026796928141266108
insert O 0 0.004198835231363773
libaries O 0 0.028240686282515526
and O 0 0.0002580133150331676
genomic O 0 0.0005752049037255347
DNA O 0 0.0006730660679750144
from O 0 0.0006175413145683706
Finnish O 1 0.99895179271698
CLD B-Disease 1 0.9999995231628418
patients O 0 0.004487764555960894
and O 0 0.0011596649419516325
controls O 0 0.002650985959917307
. O 0 0.001430078991688788

Exon O 0 0.030993254855275154
- O 0 0.0031763508450239897
specific O 0 0.00039129130891524255
primers O 0 0.0016306869219988585
developed O 0 0.0004391005786601454
in O 0 0.00010991366434609517
this O 0 6.603999645449221e-05
study O 0 6.936589488759637e-05
will O 0 3.8410369597841054e-05
facilitate O 0 0.00012220419012010098
mutation O 0 8.916420483728871e-05
screening O 0 0.00011420468217693269
studies O 0 7.724622264504433e-05
of O 0 0.00022768460621591657
patients O 0 0.000448700156994164
with O 0 0.0004469426639843732
the O 1 0.9959874749183655
disease O 1 0.9999998807907104
. O 0 0.0028245379216969013

Genomic O 0 0.0033276835456490517
sequencing O 0 0.0011678559239953756
of O 0 0.0007288397173397243
a O 0 0.001770351780578494
BAC O 1 0.9996126294136047
clone O 1 0.9962766766548157
H O 1 0.9999263286590576
_ O 0 0.0009507593931630254
RG364P16 O 0 0.11592244356870651
revealed O 0 0.0009102763724513352
the O 0 0.00019211811013519764
presence O 0 0.00022874603746458888
of O 0 0.00016125739784911275
another O 0 0.0002844189293682575
, O 0 9.26364227780141e-05
highly O 0 0.0002033821801887825
homologous O 0 0.0003847256884910166
gene O 0 8.832287858240306e-05
3 O 0 0.0001454639423172921
of O 0 0.00017137026588898152
the O 0 0.000710941618308425
CLD B-Disease 1 0.9999902248382568
gene O 0 0.0002798468340188265
, O 0 6.726129504386336e-05
with O 0 4.0809147321851924e-05
a O 0 0.00011534443910932168
similar O 0 0.00010130810551345348
genomic O 0 0.0003255251795053482
structure O 0 0.0007152453763410449
, O 0 0.00010252798529108986
recently O 0 0.0001981384848477319
identified O 0 9.026488987728953e-05
as O 0 0.00017070943431463093
the O 0 0.001517710043117404
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 1 0.9954332709312439
( O 1 0.9140796065330505
PDS B-Disease 1 0.9999997615814209
) O 0 0.0007849613903090358
. O 0 0.0003779606195166707
. O 0 0.0004988244036212564

The O 0 0.010124923661351204
APCI1307K O 1 0.9999853372573853
allele O 0 0.0073526715859770775
and O 0 0.0018780285026878119
cancer B-Disease 1 0.998991072177887
risk O 0 0.00048786477418616414
in O 0 0.00019240904657635838
a O 0 0.000242426001932472
community O 0 0.00022555413306690753
- O 0 0.0003813024377450347
based O 0 4.4717948185279965e-05
study O 0 6.127396773081273e-05
of O 0 0.0003092111728619784
Ashkenazi O 0 0.005200038198381662
Jews O 0 0.004220056347548962
. O 0 0.0012798217358067632

Mutations O 0 0.004686710890382528
in O 0 0.0013413992710411549
APC O 1 0.9968795776367188
are O 0 0.00036829052260145545
classically O 0 0.00735934404656291
associated O 0 0.0008597525884397328
with O 0 0.0010284763993695378
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999994039535522
FAP B-Disease 1 1.0
) O 0 0.0012287326389923692
, O 0 0.00043093645945191383
a O 0 0.0010913776932284236
highly O 0 0.006638722028583288
penetrant O 1 0.9999874830245972
autosomal B-Disease 1 0.9999992847442627
dominant I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 0.9999997615814209
by O 1 0.9997795224189758
multiple O 1 0.9999988079071045
intestinal O 1 1.0
polyps B-Disease 1 1.0
and O 1 0.5762895345687866
, O 0 0.0007736514089629054
without O 0 0.0004920139908790588
surgical O 1 0.9931703805923462
intervention O 0 0.004417689982801676
, O 0 0.00016021091141737998
the O 0 0.0002542417496442795
development O 0 0.0015831730561330914
of O 1 0.9999732971191406
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.9999819993972778
CRC B-Disease 1 0.9999977350234985
) O 0 0.0009382035932503641
. O 0 0.0008745130617171526

APC B-Disease 1 0.6755074262619019
is O 0 0.001152831711806357
a O 0 0.004101617261767387
tumour O 1 1.0
- O 1 0.9596496820449829
suppressor O 1 0.9589479565620422
gene O 0 0.0004967371933162212
, O 0 0.0001644063595449552
and O 0 0.0002523201983422041
somatic O 0 0.006385406944900751
loss O 1 0.9734739661216736
occurs O 0 0.004761341959238052
in O 0 0.003778985468670726
tumours B-Disease 1 0.9999995231628418
. O 0 0.002954682568088174

The O 0 0.006571128033101559
germline O 1 0.9901421666145325
T O 1 0.9609861969947815
- O 0 0.0011106557212769985
to O 0 0.00024821044644340873
- O 0 0.0008015702478587627
A O 0 0.000988470739684999
transversion O 0 0.01425428967922926
responsible O 0 0.0005706663941964507
for O 0 0.00010591272439341992
the O 0 0.0006588352262042463
APC O 1 0.9877833724021912
I1307K O 1 0.9122062921524048
allele O 0 0.000499935180414468
converts O 0 0.0002724256191868335
the O 0 0.00015631111455149949
wild O 0 0.00021685892716050148
- O 0 0.0002488663885742426
type O 0 0.0001417557505192235
sequence O 0 7.04310295986943e-05
to O 0 7.455410377588123e-05
a O 0 0.0006711783353239298
homopolymer O 1 0.9999969005584717
tract O 1 0.9999992847442627
( O 0 0.212600976228714
A8 O 1 0.9999953508377075
) O 0 0.0003295489586889744
that O 0 0.00011127999459858984
is O 0 0.00021956951241008937
genetically O 0 0.0012689789291471243
unstable O 1 0.7630863189697266
and O 0 0.0006229550344869494
prone O 1 0.8205816745758057
to O 0 0.0010501851793378592
somatic O 0 0.05526464432477951
mutation O 0 0.0019407820655032992
. O 0 0.0008683705818839371

The O 0 0.005450326483696699
I1307K O 1 0.7739914655685425
allele O 0 0.001542686834000051
was O 0 0.000959439727012068
found O 0 0.00019127092673443258
in O 0 0.00033912842627614737
6 O 0 0.0018678512424230576
. O 0 0.0009078942821361125

1 O 0 0.0019677793607115746
% O 0 0.00034813565434888005
of O 0 0.0007481776410713792
unselected O 0 0.05118682235479355
Ashkenazi O 0 0.009800863452255726
Jews O 0 0.0023456013295799494
and O 0 0.0003786832094192505
higher O 0 0.0002888740273192525
proportions O 0 0.0007166775758378208
of O 0 0.0004207126912660897
Ashkenazim O 0 0.16548678278923035
with O 0 0.000188034275197424
family O 0 0.0005056915106251836
or O 0 0.00021143752383068204
personal O 0 0.0006760396063327789
histories O 0 0.000890500727109611
of O 0 0.0034202795941382647
CRC B-Disease 1 0.9999949932098389
( O 0 0.005262389313429594
ref O 1 0.9466884136199951
. O 0 0.00024225545348599553
2 O 0 0.0005023984704166651
) O 0 0.0002580949803814292
. O 0 0.00041096407221630216

To O 0 0.0007896901806816459
evaluate O 0 0.0005113529041409492
the O 0 0.00024166856019292027
role O 0 0.0005742736393585801
of O 0 0.0008115132222883403
I1307K O 1 0.9999879598617554
in O 0 0.01507494319230318
cancer B-Disease 1 0.999519944190979
, O 0 0.00026407037512399256
we O 0 0.00024931502412073314
genotyped O 0 0.24268659949302673
5 O 0 0.0007916155736893415
, O 0 0.0003805282758548856
081 O 0 0.02098889835178852
Ashkenazi O 0 0.002591583179309964
volunteers O 0 0.0009089407394640148
in O 0 0.00019306437752675265
a O 0 0.00033178814919665456
community O 0 0.00048318979679606855
survey O 0 0.0007482254877686501
. O 0 0.0006600928027182817

Risk O 0 0.005600656848400831
of O 0 0.007404348347336054
developing O 1 0.999943733215332
colorectal B-Disease 1 1.0
, I-Disease 1 0.9991723299026489
breast I-Disease 1 0.9999915361404419
and I-Disease 0 0.001686203177087009
other I-Disease 0 0.00035470793955028057
cancers I-Disease 1 0.80795818567276
were O 0 0.0004245532036293298
compared O 0 0.00042343081440776587
between O 0 0.0007506276597268879
genotyped O 1 0.9997974038124084
I1307K O 1 0.9998388290405273
carriers O 0 0.0009435599204152822
and O 0 0.0002547835756558925
non O 0 0.000619300699327141
- O 0 0.0007029520929791033
carriers O 0 0.00015588125097565353
and O 0 2.7683690859703347e-05
their O 0 2.7170581233804114e-05
first O 0 0.00023063291155267507
- O 0 0.0006218771450221539
degree O 0 0.0007976054330356419
relatives O 0 0.0016988451825454831
. O 0 0.0011114225490018725

Sperm O 0 0.002039730316027999
DNA O 0 0.0006722852122038603
analysis O 0 0.0001361095200991258
in O 0 0.00019416520080994815
a O 0 0.0011037214426323771
Friedreich B-Disease 1 0.9999759197235107
ataxia I-Disease 1 0.9999963045120239
premutation O 1 0.9999982118606567
carrier O 0 0.20636636018753052
suggests O 0 0.001283116638660431
both O 0 0.0004135787603445351
meiotic O 1 0.6128655076026917
and O 0 0.0006244233227334917
mitotic O 0 0.010525694116950035
expansion O 0 0.001644983422011137
in O 0 0.0003574049624148756
the O 0 0.0009469380020163953
FRDA B-Disease 1 0.9998821020126343
gene O 0 0.0016215413343161345
. O 0 0.000674850307404995

Friedreich B-Disease 1 0.9999895095825195
ataxia I-Disease 1 0.9999934434890747
is O 0 0.0035503122489899397
usually O 0 0.0009487161296419799
caused O 0 0.035523101687431335
by O 0 0.00012047580821672454
an O 0 0.00016108925046864897
expansion O 0 0.0005655974382534623
of O 0 0.0003087528166361153
a O 0 0.0006677783094346523
GAA O 0 0.0071174041368067265
trinucleotide O 0 0.035621777176856995
repeat O 0 0.0010314342798665166
in O 0 0.0001605782745173201
intron O 0 0.002365277847275138
1 O 0 0.00024132411635946482
of O 0 0.0004436773306224495
the O 0 0.0014669066295027733
FRDA B-Disease 1 0.9999744892120361
gene O 0 0.00222033285535872
. O 0 0.0010168731678277254

Occasionally O 0 0.002895618323236704
, O 0 0.0003852011577691883
a O 0 0.000576332095079124
fully O 0 0.0006489540683105588
expanded O 0 0.0004763278702739626
allele O 0 0.00023292412515729666
has O 0 5.635313209495507e-05
been O 0 4.5911172492196783e-05
found O 0 4.7387362428708e-05
to O 0 6.987257074797526e-05
arise O 0 0.00024185805523302406
from O 0 0.00010925970855168998
a O 0 0.00025265771546401083
premutation O 0 0.08698955178260803
of O 0 0.0004653352661989629
100 O 0 0.0005962431896477938
or O 0 0.00029247888596728444
less O 0 0.0002424440172035247
triplet O 0 0.007759192492812872
repeats O 0 0.002626290312036872
. O 0 0.0008346678223460913

We O 0 0.0008137860568240285
have O 0 8.699257887201384e-05
examined O 0 0.00031267243321053684
the O 0 0.0002179887524107471
sperm O 0 0.0002403298713034019
DNA O 0 0.0002906985755544156
of O 0 0.00024368944286834449
a O 0 0.0011895580682903528
premutation O 1 0.9993283748626709
carrier O 0 0.0054338653571903706
. O 0 0.0013678617542609572

This O 0 0.002260825829580426
mans O 0 0.016875460743904114
leucocyte O 0 0.190596342086792
DNA O 0 0.0011013866169378161
showed O 0 0.0006184065714478493
one O 0 0.00020394084276631474
normal O 0 0.0002723269572015852
allele O 0 0.00019673616043291986
and O 0 5.170666554477066e-05
one O 0 6.21876897639595e-05
allele O 0 8.589229400968179e-05
of O 0 0.00014912743063177913
approximately O 0 0.00030435260850936174
100 O 0 0.0007639711839146912
repeats O 0 0.0018497020937502384
. O 0 0.0005299304029904306

His O 0 0.0052135479636490345
sperm O 0 0.0019486850360408425
showed O 0 0.0006650915602222085
an O 0 0.00016185754793696105
expanded O 0 0.00032971423934213817
allele O 0 0.00018497298879083246
in O 0 0.00010563808609731495
a O 0 0.0002275379083584994
tight O 0 0.0006889893556945026
range O 0 0.00018934965191874653
centering O 0 0.0008401632658205926
on O 0 0.00014599294809158891
a O 0 0.00010966083209495991
size O 0 0.00011657989671221003
of O 0 0.0002959401754196733
approximately O 0 0.0004989804001525044
320 O 0 0.003443754743784666
trinucleotide O 0 0.30636996030807495
repeats O 0 0.005638143513351679
. O 0 0.0012335993815213442

His O 0 0.010505108162760735
affected O 0 0.005020840559154749
son O 0 0.16724829375743866
has O 0 0.0005892287008464336
repeat O 0 0.0010975636541843414
sizes O 0 0.0002608543145470321
of O 0 0.0007980684167705476
1040 O 0 0.0772690400481224
and O 0 0.001090230536647141
540 O 0 0.012555226683616638
. O 0 0.0013547595590353012

These O 0 0.00048386771231889725
data O 0 0.00016491880523972213
suggest O 0 0.00022160203661769629
that O 0 7.709411147516221e-05
expansion O 0 0.0005364555399864912
occurs O 0 0.00010094186291098595
in O 0 7.199683750513941e-05
two O 0 4.504803291638382e-05
stages O 0 0.00045057106763124466
, O 0 6.248301360756159e-05
the O 0 7.457421452272683e-05
first O 0 0.00019171716121491045
during O 0 0.0005960583221167326
meiosis O 0 0.001941257854923606
followed O 0 0.0002573592937551439
by O 0 6.204310193425044e-05
a O 0 0.00022216224169824272
second O 0 0.0009984723292291164
mitotic O 0 0.008025769144296646
expansion O 0 0.004680000711232424
. O 0 0.0007878291653469205

We O 0 0.0011730290716513991
also O 0 0.00027590023819357157
show O 0 0.0002169313229387626
that O 0 3.8907688576728106e-05
in O 0 6.752176705049351e-05
all O 0 5.958691326668486e-05
informative O 0 0.0004742524470202625
carrier O 0 0.0006290285382419825
father O 0 0.0010276027023792267
to O 0 0.00017191036022268236
affected O 0 0.0006730384775437415
child O 0 0.0013164738193154335
transmissions O 0 0.001079217647202313
, O 0 8.17087639006786e-05
with O 0 3.063481199205853e-05
the O 0 0.00010518616181798279
notable O 0 0.00022721444838680327
exception O 0 0.000202799667022191
of O 0 0.00021099408331792802
the O 0 0.0007027835818007588
premutation O 1 0.9946951270103455
carrier O 0 0.001026297570206225
, O 0 9.229941497324035e-05
the O 0 0.00013257995306048542
expansion O 0 0.0007463432848453522
size O 0 0.0005021573742851615
decreases O 0 0.001190870301797986
. O 0 0.00019815207633655518
. O 0 0.0003899655712302774

The O 0 0.005853971466422081
R496H O 0 0.22205309569835663
mutation O 0 0.0011766146635636687
of O 0 0.001405572984367609
arylsulfatase O 1 0.9997335076332092
A O 0 0.2005338817834854
does O 0 0.0006031972006894648
not O 0 0.0004306703631300479
cause O 1 0.9976811408996582
metachromatic B-Disease 1 0.9999998807907104
leukodystrophy I-Disease 1 0.9999997615814209
. O 0 0.009311644360423088

Deficiency B-Disease 1 0.9999957084655762
of I-Disease 0 0.264249712228775
arylsulfatase I-Disease 1 0.9999938011169434
A I-Disease 1 0.9991021156311035
( O 0 0.014005457051098347
ARSA O 1 0.9998821020126343
) O 0 0.0009355979273095727
enzyme O 0 0.0021534713450819254
activity O 0 0.0026458115316927433
causes O 1 0.9994068145751953
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 1 0.9990478157997131
MLD B-Disease 1 0.9999998807907104
) O 0 0.0024856464006006718
. O 0 0.0012331741163507104

A O 0 0.0032730211969465017
number O 0 0.00043349136831238866
of O 0 0.002032605931162834
ARSA O 1 0.9995315074920654
gene O 0 0.0014362834626808763
mutations O 0 0.0006378774996846914
responsible O 0 0.0011618066346272826
for O 0 0.0006235817563720047
MLD B-Disease 1 0.9999996423721313
have O 0 0.0003880428266711533
been O 0 0.0003619637282099575
identified O 0 0.000573192723095417
. O 0 0.0005299803451634943

Recently O 0 0.004328188020735979
, O 0 0.00043154528248123825
the O 0 0.0006384507287293673
R496H O 0 0.1489877551794052
mutation O 0 0.0006650877767242491
of O 0 0.0010309446370229125
ARSA O 1 0.9999797344207764
was O 0 0.0017360466299578547
proposed O 0 0.00025738481781445444
to O 0 5.944122312939726e-05
be O 0 4.448342224350199e-05
a O 0 0.0001607838785275817
cause O 0 0.0011671442771330476
of O 0 0.005295917857438326
MLD B-Disease 1 1.0
( O 0 0.006311861332505941
Draghia O 1 0.999882698059082
et O 0 0.011067341081798077
al O 0 0.0042832694016397
. O 0 0.0001602164120413363
, O 0 0.00014914861822035164
1997 O 0 0.0013620015233755112
) O 0 0.0003500459424685687
. O 0 0.0006893132231198251

We O 0 0.0010494295274838805
have O 0 0.00015210754645522684
investigated O 0 0.0008950841729529202
the O 0 0.0006184472003951669
R496H O 1 0.9834123849868774
mutation O 0 0.0004734186513815075
and O 0 0.00013764413597527891
found O 0 9.00301311048679e-05
this O 0 5.5806634918553755e-05
mutation O 0 0.00010724827006924897
at O 0 0.00019924732623621821
a O 0 8.265614451374859e-05
relatively O 0 6.254739128053188e-05
high O 0 0.00012546259677037597
frequency O 0 2.8784859750885516e-05
in O 0 2.7952717573498376e-05
an O 0 3.8088062865426764e-05
African O 0 0.0001864337973529473
American O 0 0.00012511349632404745
population O 0 3.094127168878913e-05
( O 0 6.351449701469392e-05
f O 0 0.00021302441018633544
= O 0 0.00027755473274737597
0 O 0 0.00011321170313749462
. O 0 4.735583206638694e-05
09 O 0 0.0012530526146292686
, O 0 0.00017402535013388842
n O 0 0.0006095627904869616
= O 0 0.000854872923810035
61 O 0 0.0013000884791836143
subjects O 0 0.0016135636251419783
) O 0 0.0007526248809881508
. O 0 0.0007056479225866497

The O 0 0.008200829848647118
ARSA O 1 0.9982313513755798
enzyme O 0 0.0023683873005211353
activity O 0 0.00042732112342491746
in O 0 0.00014042199472896755
subjects O 0 0.00019036885350942612
with O 0 7.441281923092902e-05
and O 0 0.00011137597903143615
without O 0 0.00010377837315900251
the O 0 0.0004985463456250727
R496H O 1 0.9998457431793213
mutation O 0 0.0005407975986599922
was O 0 0.0007905938546173275
determined O 0 0.00022892732522450387
and O 0 8.232647087424994e-05
found O 0 8.40095744933933e-05
to O 0 7.817892037564889e-05
be O 0 0.00014882796676829457
normal O 0 0.0005869871820323169
. O 0 0.0005188981886021793

It O 0 0.0008922236156649888
is O 0 0.0004422304918989539
therefore O 0 0.00027625690563581884
concluded O 0 0.000583184533752501
that O 0 6.297844083746895e-05
the O 0 0.0003104639472439885
R496H O 1 0.8244363069534302
mutation O 0 0.0005401647067628801
of O 0 0.0013276467798277736
ARSA O 1 0.9999847412109375
does O 0 0.0003658378846012056
not O 0 7.512023148592561e-05
negatively O 0 0.00013205608411226422
influence O 0 0.00018889701459556818
the O 0 0.0002421640238026157
activity O 0 0.0004945650580339134
of O 0 0.0008441435056738555
ARSA O 1 0.9999737739562988
and O 0 0.0005206557107158005
is O 0 0.00015228401753120124
not O 0 9.206769755110145e-05
a O 0 0.0004165868158452213
cause O 0 0.013303587213158607
of O 0 0.12430886924266815
MLD B-Disease 1 1.0

Down O 0 0.023629430681467056
- O 0 0.0024273376911878586
regulation O 0 0.0006880806758999825
of O 0 0.0008925948059186339
transmembrane O 0 0.019815392792224884
carbonic O 1 0.9983159303665161
anhydrases O 1 0.9999858140945435
in O 1 0.9871605634689331
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9870294332504272
lines O 0 0.0008897408260963857
by O 0 0.00012733509356621653
wild O 0 0.0005740136839449406
- O 0 0.0010396369034424424
type O 0 0.0008594625978730619
von B-Disease 0 0.08778448402881622
Hippel I-Disease 1 0.9996459484100342
- I-Disease 0 0.4197152256965637
Lindau I-Disease 1 0.9650780558586121
transgenes O 0 0.2183835208415985
. O 0 0.0024850694462656975

To O 0 0.0012635563034564257
discover O 0 0.0012424716260284185
genes O 0 0.00021925965847913176
involved O 0 0.00029181985883042216
in O 0 0.00031795253744348884
von B-Disease 0 0.11664637923240662
Hippel I-Disease 1 0.9998356103897095
- I-Disease 1 0.8546154499053955
Lindau I-Disease 1 0.9993240833282471
( O 0 0.005015359725803137
VHL B-Disease 1 0.9999709129333496
) O 0 0.0012015547836199403
- O 0 0.0040422603487968445
mediated O 0 0.009147826582193375
carcinogenesis O 1 0.9993749260902405
, O 0 0.0008609502692706883
we O 0 0.0006873970269225538
used O 0 0.003798093181103468
renal B-Disease 1 1.0
cell I-Disease 1 0.9999998807907104
carcinoma I-Disease 1 1.0
cell O 1 0.9994387030601501
lines O 0 0.007359002251178026
stably O 0 0.016832251101732254
transfected O 0 0.006702621933072805
with O 0 0.0001560897653689608
wild O 0 0.0009826752357184887
- O 0 0.0019432182889431715
type O 0 0.002675459021702409
VHL O 1 0.9999722242355347
- O 0 0.006772447843104601
expressing O 0 0.0030466224998235703
transgenes O 0 0.031466420739889145
. O 0 0.0016389130614697933

Large O 0 0.0023931078612804413
- O 0 0.001996345119550824
scale O 0 0.0015346709406003356
RNA O 0 0.0008824940887279809
differential O 0 0.00044822346535511315
display O 0 0.0007104939431883395
technology O 0 0.000368559209164232
applied O 0 8.691703988006338e-05
to O 0 6.055794801795855e-05
these O 0 3.078737063333392e-05
cell O 0 0.00032012976589612663
lines O 0 0.00017192740051541477
identified O 0 6.206001853570342e-05
several O 0 4.272595469956286e-05
differentially O 0 0.0007414917345158756
expressed O 0 0.00013276084791868925
genes O 0 8.645230991533026e-05
, O 0 5.120278729009442e-05
including O 0 5.6787564972182736e-05
an O 0 0.0002159465366275981
alpha O 0 0.0019745437894016504
carbonic O 0 0.23651622235774994
anhydrase O 1 0.9751781225204468
gene O 0 0.0006738551310263574
, O 0 0.00041186242015101016
termed O 0 0.012538424693048
CA12 O 1 0.9999659061431885
. O 0 0.0025084526278078556

The O 0 0.0025170939043164253
deduced O 0 0.0018062888411805034
protein O 0 0.000406133069191128
sequence O 0 0.0002147064806194976
was O 0 0.00028947892133146524
classified O 0 0.00017558127001393586
as O 0 6.716086500091478e-05
a O 0 0.00010773041140055284
one O 0 0.00012498829164542258
- O 0 0.0005579071585088968
pass O 0 0.0007737413397990167
transmembrane O 0 0.0054053873755037785
CA O 0 0.0033077204134315252
possessing O 0 0.0010900627821683884
an O 0 0.00021594282588921487
apparently O 0 0.0010593336774036288
intact O 0 0.00125307054258883
catalytic O 0 0.0011921675177291036
domain O 0 0.00024428684264421463
in O 0 0.00018222008657176048
the O 0 0.00042924017179757357
extracellular O 0 0.015244768932461739
CA O 0 0.23885785043239594
module O 0 0.040512923151254654
. O 0 0.0014927561860531569

Reintroduced O 0 0.015122558921575546
wild O 0 0.0044305166229605675
- O 0 0.0034036666620522738
type O 0 0.002813816536217928
VHL B-Disease 1 0.9985565543174744
strongly O 0 0.000780597678385675
inhibited O 0 0.0009316289215348661
the O 0 0.00023720246099401265
overexpression O 0 0.000651950016617775
of O 0 0.0002367474080529064
the O 0 0.0006030721706338227
CA12 O 1 0.9999470710754395
gene O 0 0.000251561141340062
in O 0 0.0001711041113594547
the O 0 0.0007536514895036817
parental O 0 0.1050751581788063
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9999877214431763
lines O 0 0.021113639697432518
. O 0 0.0012152078561484814

Similar O 0 0.001067815232090652
results O 0 0.00033776555210351944
were O 0 0.00020172222866676748
obtained O 0 0.00017859472427517176
with O 0 0.00027839222457259893
CA9 O 1 0.9900158047676086
, O 0 0.0003018667921423912
encoding O 0 0.00016871403204277158
another O 0 0.000436267233453691
transmembrane O 0 0.0022991825826466084
CA O 0 0.00177870225161314
with O 0 0.00013555593614000827
an O 0 0.00028314677183516324
intact O 0 0.003386041382327676
catalytic O 0 0.005953190848231316
domain O 0 0.0015804058639332652
. O 0 0.0007565438863821328

Although O 0 0.0006514053675346076
both O 0 0.00015997215814422816
domains O 0 0.00039867343730293214
of O 0 0.0005626257043331861
the O 0 0.0018781671533361077
VHL B-Disease 1 0.9999775886535645
protein O 0 0.0007675395463593304
contribute O 0 0.0003133743302896619
to O 0 9.141898772213608e-05
regulation O 0 0.0002050397451967001
of O 0 0.0005146869225427508
CA12 O 1 0.9999947547912598
expression O 0 0.0006260650116018951
, O 0 0.00017549943004269153
the O 0 0.0003342986456118524
elongin O 0 0.023112645372748375
binding O 0 0.00038310859235934913
domain O 0 0.0005589064676314592
alone O 0 0.0006994057912379503
could O 0 0.00035757143632508814
effectively O 0 0.002201785333454609
regulate O 0 0.0036639973986893892
CA9 O 1 0.9993465542793274
expression O 0 0.003650023601949215
. O 0 0.0016380349406972528

We O 0 0.0023026501294225454
mapped O 0 0.006125482730567455
CA12 O 1 0.9989376664161682
and O 0 0.0028654702473431826
CA9 O 1 0.9969155788421631
loci O 0 0.0028105860110372305
to O 0 0.0004718098498415202
chromosome O 0 0.0023702920880168676
bands O 0 0.006432060617953539
15q22 O 1 0.9998080134391785
and O 0 0.0028321188874542713
17q21 O 1 0.9995480179786682
. O 0 0.0019483615178614855

2 O 0 0.0039507620967924595
respectively O 0 0.0017103120917454362
, O 0 0.00035128049785271287
regions O 0 0.00041187263559550047
prone O 0 0.002315645106136799
to O 0 0.0003222892992198467
amplification O 0 0.002035163575783372
in O 0 0.0004106727137695998
some O 0 0.0005356002948246896
human O 0 0.0034561764914542437
cancers B-Disease 1 0.9976999163627625
. O 0 0.0013901572674512863

Additional O 0 0.0017536274390295148
experiments O 0 0.0007627026061527431
are O 0 3.906495476257987e-05
needed O 0 0.00014171197835821658
to O 0 4.5383840188151225e-05
define O 0 0.00010870621918002144
the O 0 0.0001500611542724073
role O 0 0.00044377290760166943
of O 0 0.001415657694451511
CA O 1 0.998790442943573
IX O 1 0.9999922513961792
and O 0 0.001923034549690783
CA O 0 0.27120664715766907
XII O 1 0.9976844787597656
enzymes O 0 0.0005783913074992597
in O 0 9.327791485702619e-05
the O 0 0.00010282298171659932
regulation O 0 0.0001157755104941316
of O 0 0.0002188225626014173
pH O 0 0.0008770101703703403
in O 0 0.00015213555889204144
the O 0 0.00035992031916975975
extracellular O 0 0.0019514089217409492
microenvironment O 0 0.005737665109336376
and O 0 0.00013983940880279988
its O 0 0.00011821417137980461
potential O 0 0.00037315100780688226
impact O 0 0.0007055558380670846
on O 0 0.0018657997716218233
cancer B-Disease 1 0.9999836683273315
cell O 1 0.9836892485618591
growth O 0 0.0042225755751132965
. O 0 0.0007233779178932309

A O 0 0.0030835294164717197
gene O 0 0.0005045686848461628
encoding O 0 0.00028340393328107893
a O 0 0.00037682786933146417
transmembrane O 0 0.002217154251411557
protein O 0 0.0006632085423916578
is O 0 0.0001685418392298743
mutated O 0 0.0006133532151579857
in O 0 0.0003492575779091567
patients O 0 0.00285715633071959
with O 0 0.4686247408390045
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 1 1.0
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 0.028105823323130608
. O 0 0.0015094787813723087

Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.999876856803894
WFS B-Disease 1 0.9999997615814209
; O 0 0.05502811819314957
OMIM O 1 0.9999994039535522
222300 O 1 0.9999924898147583
) O 0 0.0006899546715430915
is O 0 0.0003230355214327574
an O 0 0.0005925181903876364
autosomal B-Disease 1 0.999390721321106
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 1.0
defined O 1 0.9991490840911865
by O 0 0.16264240443706512
young O 1 0.9642553925514221
- O 1 0.9481693506240845
onset O 1 0.9999903440475464
non O 1 0.9896404147148132
- O 1 0.9997186064720154
immune O 1 0.9999938011169434
insulin B-Disease 1 0.9999266862869263
- I-Disease 1 0.995749831199646
dependent I-Disease 1 0.5035809278488159
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.999994158744812
progressive O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
. O 1 0.965719997882843

Linkage O 0 0.009767239913344383
to O 0 0.0006599506596103311
markers O 0 0.0015854074154049158
on O 0 0.0007611314067617059
chromosome O 0 0.002823812887072563
4p O 1 0.9999258518218994
was O 0 0.002308298833668232
confirmed O 0 0.0003595778835006058
in O 0 0.00019029623945243657
five O 0 0.00030016215168870986
families O 0 0.00031257292721420527
. O 0 0.000683966965880245

On O 0 0.0012407402973622084
the O 0 0.0003800272534135729
basis O 0 0.00019392374088056386
of O 0 0.0010135869961231947
meiotic O 1 0.9999908208847046
recombinants O 1 0.9999998807907104
and O 1 0.9866160154342651
disease O 1 1.0
- O 1 0.974990963935852
associated O 0 0.0008873174083419144
haplotypes O 0 0.001735181431286037
, O 0 0.00030555337434634566
the O 0 0.0007560169906355441
WFS B-Disease 1 0.9997237324714661
gene O 0 0.00051538972184062
was O 0 0.0006719880038872361
localized O 0 0.0009001228027045727
to O 0 0.00019292561046313494
a O 0 0.0010580417001619935
BAC O 1 0.998336911201477
/ O 0 0.009633561596274376
P1 O 0 0.35354405641555786
contig O 0 0.012511343695223331
of O 0 0.0005538940895348787
less O 0 0.00017304379434790462
than O 0 0.00012718461221084
250 O 0 0.0007444026996381581
kb O 0 0.004927413538098335
. O 0 0.0008601322770118713

Mutations O 0 0.0015462951269000769
in O 0 0.0003301049000583589
a O 0 0.00037021146272309124
novel O 0 0.0007839648751541972
gene O 0 0.0007199393003247678
( O 0 0.000563936831895262
WFS1 O 1 0.9937711358070374
) O 0 0.00013278656115289778
encoding O 0 0.00011090658517787233
a O 0 0.00014713699056301266
putative O 0 0.0009843019070103765
transmembrane O 0 0.0011120048584416509
protein O 0 0.00032361072953790426
were O 0 8.463353879051283e-05
found O 0 7.348474900936708e-05
in O 0 6.486108031822369e-05
all O 0 4.229159094393253e-05
affected O 0 0.00010542052768869326
individuals O 0 3.8002875953679904e-05
in O 0 0.00017606074106879532
six O 0 0.0008022812544368207
WFS B-Disease 1 0.9999775886535645
families O 0 0.0003236807824578136
, O 0 0.0001403194764861837
and O 0 0.00010004874638980255
these O 0 3.800664489972405e-05
mutations O 0 0.0001248956104973331
were O 0 0.00012567466183099896
associated O 0 0.00020567748288158327
with O 0 0.0002530260826461017
the O 1 0.9540578722953796
disease O 1 1.0
phenotype O 1 0.9969108700752258
. O 0 0.002130771055817604

WFS1 O 1 0.9997933506965637
appears O 0 0.0026973418425768614
to O 0 0.00023010026779957116
function O 0 0.00013549934374168515
in O 0 0.00010148021829081699
survival O 0 0.000541437417268753
of O 0 0.0005374833126552403
islet O 0 0.39260929822921753
beta O 0 0.003974972292780876
- O 0 0.004485230427235365
cells O 0 0.0010281228460371494
and O 0 0.00022910881671123207
neurons O 0 0.0015497677959501743
. O 0 0.00020631877123378217
. O 0 0.0003742141998372972

Stable O 0 0.007250472437590361
interaction O 0 0.0005905904690735042
between O 0 0.0002499550173524767
the O 0 0.00021111420937813818
products O 0 0.00016664102440699935
of O 0 0.0002165002515539527
the O 0 0.0007472235593013465
BRCA1 O 1 0.9978489875793457
and O 0 0.0011028442531824112
BRCA2 O 1 0.999887228012085
tumor B-Disease 1 0.9999977350234985
suppressor O 1 0.9716947674751282
genes O 0 0.0003459432628005743
in O 0 0.0003353059873916209
mitotic O 0 0.02130950801074505
and O 0 0.0014513472560793161
meiotic O 1 0.9998376369476318
cells O 0 0.019298909232020378
. O 0 0.0013937443727627397

BRCA1 O 1 0.9959750771522522
and O 0 0.0019514497835189104
BRCA2 O 0 0.012375087477266788
account O 0 0.00017937533266376704
for O 0 5.3329975344240665e-05
most O 0 3.87050022254698e-05
cases O 0 4.482186341192573e-05
of O 0 0.0002895807847380638
familial O 1 0.9874138832092285
, O 0 0.0020698218140751123
early O 0 0.475430428981781
onset O 1 0.9999998807907104
breast B-Disease 1 0.9999991655349731
and I-Disease 1 0.9751511216163635
/ I-Disease 1 0.9999996423721313
or I-Disease 1 0.9999979734420776
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
and O 0 0.000957757409196347
encode O 0 0.0006640914944000542
products O 0 0.000261082750512287
that O 0 6.149301043478772e-05
each O 0 4.1316950955661014e-05
interact O 0 0.00020432895689737052
with O 0 0.00022685035946778953
hRAD51 O 1 0.9882966876029968
. O 0 0.002320577623322606

Results O 0 0.0014609553618356586
presented O 0 0.0011793874436989427
here O 0 0.0006052436074241996
show O 0 0.000771673338022083
that O 0 0.00026063830591738224
BRCA1 O 0 0.23617003858089447
and O 0 0.000926080800127238
BRCA2 O 0 0.42769014835357666
coexist O 0 0.0015010294737294316
in O 0 0.0002978411503136158
a O 0 0.00047893295413814485
biochemical O 0 0.004289727192372084
complex O 0 0.003024839796125889
and O 0 0.000556241488084197
colocalize O 1 0.9885087609291077
in O 0 0.0008934183861128986
subnuclear O 1 0.9872233867645264
foci O 0 0.00857880711555481
in O 0 0.0006544957286678255
somatic O 0 0.003705498995259404
cells O 0 0.00044930126750841737
and O 0 9.907267667585984e-05
on O 0 0.0001251542998943478
the O 0 0.0001432998978998512
axial O 0 0.0007542108069173992
elements O 0 0.0007874501752667129
of O 0 0.0013754304964095354
developing O 0 0.009946904145181179
synaptonemal O 1 0.9999611377716064
complexes O 1 0.977192223072052
. O 0 0.0019047182286158204

Like O 0 0.014926976524293423
BRCA1 O 1 0.9960475564002991
and O 0 0.003930645529180765
RAD51 O 1 0.999984622001648
, O 0 0.002549689495936036
BRCA2 O 0 0.05771861597895622
relocates O 0 0.015268138609826565
to O 0 0.0010030058911070228
PCNA O 1 0.9889765381813049
+ O 0 0.0012366169830784202
replication O 0 0.00035949356970377266
sites O 0 0.00010939221101580188
following O 0 0.00016357463027816266
exposure O 0 0.0004729202773887664
of O 0 0.000542130961548537
S O 1 0.9508390426635742
phase O 0 0.09598331898450851
cells O 0 0.0013298443518579006
to O 0 0.0005028958548791707
hydroxyurea O 0 0.18389540910720825
or O 0 0.0026772702112793922
UV O 1 0.9986932873725891
irradiation O 0 0.01240105926990509
. O 0 0.0011523882858455181

Thus O 0 0.005374798085540533
, O 0 0.001911571016535163
BRCA1 O 1 0.5338993668556213
and O 0 0.000672186550218612
BRCA2 O 0 0.1505698263645172
participate O 0 0.0003784206637647003
, O 0 0.00015027049812488258
together O 0 0.0001348921359749511
, O 0 9.12623800104484e-05
in O 0 8.274920401163399e-05
a O 0 0.00026585895102471113
pathway O 0 0.004979589954018593
( O 0 0.0004057503247167915
s O 0 0.0009917746065184474
) O 0 8.236197027144954e-05
associated O 0 5.3141928219702095e-05
with O 0 3.253448085160926e-05
the O 0 0.0001505942636867985
activation O 0 0.0003300583048257977
of O 0 0.0003762662236113101
double O 0 0.0027199063915759325
- O 0 0.00205051526427269
strand O 0 0.0015174616128206253
break O 0 0.0023951942566782236
repair O 1 0.9894776940345764
and O 0 0.0006861567380838096
/ O 0 0.010674790479242802
or O 0 0.0008374464814551175
homologous O 0 0.00444191787391901
recombination O 0 0.004744407255202532
. O 0 0.0011107102036476135

Dysfunction O 1 0.9996730089187622
of O 0 0.0043024285696446896
this O 0 0.0008854513289406896
pathway O 0 0.4073847532272339
may O 0 0.00020434842735994607
be O 0 6.633057637372985e-05
a O 0 0.00011277608427917585
general O 0 0.0002166355261579156
phenomenon O 0 0.0003184318484272808
in O 0 6.490315718110651e-05
the O 0 7.377015572274104e-05
majority O 0 4.707293919636868e-05
of O 0 0.00012292072642594576
cases O 0 0.000181952171260491
of O 0 0.005086359567940235
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 0.9999969005584717
/ I-Disease 1 1.0
or I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0019357879646122456
. O 0 0.0011860653758049011

A O 0 0.007167754229158163
novel O 0 0.00307144271209836
Arg362Ser O 1 0.560685932636261
mutation O 0 0.00043490692041814327
in O 0 0.0001379470049869269
the O 0 0.0004006893723271787
sterol O 0 0.008031731471419334
27 O 0 0.0032687971834093332
- O 0 0.0023528398014605045
hydroxylase O 0 0.006291058845818043
gene O 0 0.0005444477428682148
( O 0 0.0005169397336430848
CYP27 O 1 0.9991330504417419
) O 0 0.00015898555284366012
: O 0 0.00010018354805652052
its O 0 5.82102220505476e-05
effects O 0 0.000228964228881523
on O 0 0.00022101162176113576
pre O 0 0.0017456357600167394
- O 0 0.0006937504513189197
mRNA O 0 0.0005042325938120484
splicing O 0 0.0007824923377484083
and O 0 0.00021570947137661278
enzyme O 0 0.0009273777832277119
activity O 0 0.0008925079018808901
. O 0 0.00048445432912558317

A O 0 0.004858240019530058
novel O 0 0.0018166725058108568
C O 0 0.0009893670212477446
to O 0 8.097635873127729e-05
A O 0 0.0003475829726085067
mutation O 0 0.0001065554897650145
in O 0 6.418045813916251e-05
the O 0 0.00023634237004444003
sterol O 0 0.0042346506379544735
27 O 0 0.001666342606768012
- O 0 0.001434769481420517
hydroxylase O 0 0.004519191104918718
gene O 0 0.0004858675820287317
( O 0 0.0005271797999739647
CYP27 O 1 0.9996399879455566
) O 0 0.00030764276743866503
was O 0 0.000522153393831104
identified O 0 0.00013744636089541018
by O 0 0.0001005460653686896
sequencing O 0 0.0007462035282514989
amplified O 0 0.00277781393378973
CYP27 O 1 0.9979382157325745
gene O 0 0.00033838368835859
products O 0 0.00017953378846868873
from O 0 9.442010923521593e-05
a O 0 0.0004004573856946081
patient O 0 0.0009548081434331834
with O 0 0.0009219007915817201
cerebrotendinous B-Disease 1 1.0
xanthomatosis I-Disease 1 1.0
( O 1 0.9622570872306824
CTX B-Disease 1 0.9999984502792358
) O 0 0.0016920012421905994
. O 0 0.0010095930192619562

The O 0 0.003369530662894249
mutation O 0 0.0013075853930786252
changed O 0 0.0012448278721421957
the O 0 0.0009653547895140946
adrenodoxin O 0 0.04421437904238701
cofactor O 0 0.01226496510207653
binding O 0 0.0008460294338874519
residue O 0 0.0042596678249537945
362Arg O 0 0.09289362281560898
to O 0 0.0011864884290844202
362Ser O 1 0.9883710145950317
( O 0 0.0033483761362731457
CGT O 1 0.9996552467346191
362Arg O 1 0.9879165887832642
to O 0 0.002185857156291604
AGT O 1 0.9999979734420776
362Ser O 1 0.9997075200080872
) O 0 0.0004837782762479037
, O 0 0.00016090059943962842
and O 0 0.0001273866801057011
was O 0 0.0008392127347178757
responsible O 0 0.0011080058757215738
for O 0 0.0003572383720893413
deficiency O 1 0.9999841451644897
in O 0 0.0003821091668214649
the O 0 0.0004793641855940223
sterol O 0 0.10693595558404922
27 O 0 0.0025335124228149652
- O 0 0.001145983231253922
hydroxylase O 0 0.002581554464995861
activity O 0 0.0001961295201908797
, O 0 3.7925183278275654e-05
as O 0 7.641568663530052e-05
confirmed O 0 8.214642002712935e-05
by O 0 3.579163603717461e-05
expression O 0 0.00011067994637414813
of O 0 0.00019291126227471977
mutant O 0 0.0012451889924705029
cDNA O 0 0.001303655793890357
into O 0 0.0005668608355335891
COS O 1 0.9989491105079651
- O 0 0.0028429029043763876
1 O 0 0.0011653032852336764
cells O 0 0.0009587287786416709
. O 0 0.0003685638075694442

Quantitative O 0 0.0016917178872972727
analysis O 0 0.00020205506007187068
showed O 0 0.00028118997579440475
that O 0 4.3235544580966234e-05
the O 0 0.0001412482961313799
expression O 0 0.00020919222151860595
of O 0 0.0003694893675856292
CYP27 O 1 0.9997206330299377
gene O 0 0.0002645917993504554
mRNA O 0 0.00020016457710880786
in O 0 6.10684001003392e-05
the O 0 0.00012367527233436704
patient O 0 0.0002968520566355437
represented O 0 0.00039103362360037863
52 O 0 0.0017354582669213414
. O 0 0.0010616705985739827

5 O 0 0.0018872504588216543
% O 0 0.0002392464375589043
of O 0 0.00040519412141293287
the O 0 0.0008589438511990011
normal O 0 0.001624376862309873
level O 0 0.0020683342590928078
. O 0 0.0008174700196832418

As O 0 0.0020754800643771887
the O 0 0.0007496849284507334
mutation O 0 0.0005631455569528043
occurred O 0 0.0014251662651076913
at O 0 0.00046413872041739523
the O 0 0.00028417608700692654
penultimate O 0 0.0025331536307930946
nucleotide O 0 0.0002311938878847286
of O 0 0.00016733602387830615
exon O 0 0.0011796794133260846
6 O 0 0.0004587285511661321
( O 0 0.00011426393029978499
- O 0 0.000167076475918293
2 O 0 9.945878991857171e-05
position O 0 0.0001060630165738985
of O 0 0.00010666609887266532
exon O 0 0.0012143017956987023
6 O 0 0.0007577845244668424
- O 0 0.000706902879755944
intron O 0 0.0032437643967568874
6 O 0 0.0004395591386128217
splice O 0 0.0014586185570806265
site O 0 0.000375683099264279
) O 0 5.170957592781633e-05
of O 0 9.901138400891796e-05
the O 0 0.0002259833854623139
gene O 0 0.0002633924887049943
, O 0 8.125397289404646e-05
we O 0 7.741730951238424e-05
hypothesized O 0 0.0002559025015216321
that O 0 5.060739567852579e-05
the O 0 0.00025867443764582276
mutation O 0 0.00034776743268594146
may O 0 0.0002622548199724406
partially O 0 0.0011679360177367926
affect O 0 0.00019569280266296118
the O 0 0.00016283745935652405
normal O 0 0.00021747846039943397
splicing O 0 0.0005146207404322922
efficiency O 0 0.0002792463346850127
in O 0 0.00012441183207556605
exon O 0 0.0010834025451913476
6 O 0 0.0005433215410448611
and O 0 0.00017160769493784755
cause O 0 0.0008824364631436765
alternative O 0 0.00032612498034723103
splicing O 0 0.0010211645858362317
elsewhere O 0 0.00040320854168385267
, O 0 8.699978934600949e-05
which O 0 4.9440273869549856e-05
resulted O 0 0.0003018898714799434
in O 0 0.00015947474457789212
decreased O 0 0.0011929537868127227
transcript O 0 0.0008838530629873276
in O 0 0.00017448408470954746
the O 0 0.0004541501111816615
patient O 0 0.0012843477306887507
. O 0 0.0010339238215237856

Transfection O 0 0.051403775811195374
of O 0 0.00523009430617094
constructed O 1 0.8110713362693787
minigenes O 1 0.9996575117111206
, O 0 0.00040066742803901434
with O 0 0.00010160086821997538
or O 0 0.0001321497984463349
without O 0 8.501330012222752e-05
the O 0 0.00014604043099097908
mutation O 0 0.0001696058316156268
, O 0 0.00011075017391704023
into O 0 0.00036960141733288765
COS O 1 0.999864935874939
- O 0 0.0017653113463893533
1 O 0 0.0004299150314182043
cells O 0 0.0002068048488581553
confirmed O 0 7.599355012644082e-05
that O 0 2.094446972478181e-05
the O 0 0.0002041875704890117
mutant O 0 0.002152590546756983
minigene O 1 0.9934959411621094
was O 0 0.0017055122880265117
responsible O 0 0.00042042869608849287
for O 0 5.8667468692874536e-05
a O 0 0.00010850054968614131
mRNA O 0 0.0002380148507654667
species O 0 1.8765145796351135e-05
alternatively O 0 0.00014167778135742992
spliced O 0 0.0003699267690535635
at O 0 0.00023778215108904988
an O 0 0.00014474957424681634
activated O 0 0.0017211564118042588
cryptic O 0 0.000999827403575182
5 O 0 0.00033197193988598883
splice O 0 0.0019197912188246846
site O 0 0.0011212615063413978
88 O 0 0.0013174350606277585
bp O 0 0.0017130108317360282
upstream O 0 0.00047321111196652055
from O 0 7.760697189951316e-05
the O 0 9.204311936628073e-05
3 O 0 0.00017498561646789312
end O 0 0.0003561551566235721
of O 0 0.00036529733915813267
exon O 0 0.0050422814674675465
6 O 0 0.0023707509972155094
. O 0 0.001150360330939293

Our O 0 0.002094860887154937
data O 0 0.00026169783086515963
suggest O 0 0.0001235200761584565
that O 0 2.3930924726300873e-05
the O 0 9.707763092592359e-05
C O 0 0.0003078813315369189
to O 0 5.709000106435269e-05
A O 0 0.0003169211558997631
mutation O 0 0.00011626141349552199
at O 0 0.0001783867337508127
the O 0 0.000171680047060363
penultimate O 0 0.0023875930346548557
nucleotide O 0 0.00020642226445488632
of O 0 0.00014824513345956802
exon O 0 0.0009215999743901193
6 O 0 0.0003047201898880303
of O 0 0.00021209959231782705
the O 0 0.0005050700274296105
CYP27 O 1 0.999981164932251
gene O 0 0.0003261508245486766
not O 0 4.843022543354891e-05
only O 0 8.162869198713452e-05
causes O 0 0.0017275671707466245
the O 0 0.0016524301609024405
deficiency B-Disease 1 0.9999984502792358
in I-Disease 0 0.0004298576677683741
the I-Disease 0 0.0007188397576101124
sterol I-Disease 0 0.07681743055582047
27 I-Disease 0 0.0028114148881286383
- I-Disease 0 0.002195991575717926
hydroxylase I-Disease 0 0.0054031601175665855
activity I-Disease 0 0.0006271225865930319
, O 0 0.0001266327890334651
but O 0 9.791464981390163e-05
also O 0 0.00012258654169272631
partially O 0 0.0006184206577017903
leads O 0 0.0004587607108987868
to O 0 0.00014851722517050803
alternative O 0 0.00035249284701421857
pre O 0 0.0010607141302898526
- O 0 0.0004286127514205873
mRNA O 0 0.00032073617330752313
splicing O 0 0.0002724084770306945
of O 0 0.00017429205763619393
the O 0 0.00029422686202451587
gene O 0 0.0007879147888161242
. O 0 0.0005469365860335529

To O 0 0.0009067989303730428
our O 0 0.00046981946798041463
knowledge O 0 0.0004742637393064797
, O 0 0.00011414261825848371
this O 0 3.557582385838032e-05
is O 0 3.9087091863621026e-05
the O 0 7.287434709724039e-05
first O 0 0.00015529122902080417
report O 0 7.942040974739939e-05
regarding O 0 0.00014562034630216658
effects O 0 0.0003021789307240397
on O 0 0.00020104998839087784
pre O 0 0.0009496119455434382
- O 0 0.0003101367619819939
mRNA O 0 9.67128507909365e-05
splicing O 0 8.537531539332122e-05
of O 0 5.2080238674534485e-05
a O 0 6.96246133884415e-05
mutation O 0 8.287247328553349e-05
at O 0 0.00013444873911794275
the O 0 0.00011259330494794995
- O 0 0.00024459915584884584
2 O 0 0.00012195087765576318
position O 0 7.484236994059756e-05
of O 0 0.00010597627988317981
a O 0 0.00030871693161316216
5 O 0 0.0006368767353706062
splice O 0 0.005116927437484264
site O 0 0.004021158441901207
. O 0 0.000990601722151041

ATM O 0 0.12078246474266052
germline O 0 0.040963102132081985
mutations O 0 0.0012738651130348444
in O 0 0.0009493970428593457
classical O 0 0.2019142210483551
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999959468841553
telangiectasia I-Disease 1 0.9999994039535522
patients O 0 0.0011052953777834773
in O 0 0.00033245841041207314
the O 0 0.0004971326561644673
Dutch O 0 0.0018153638811782002
population O 0 0.00019178188813384622
. O 0 0.00039988651406019926

Germline O 0 0.12511123716831207
mutations O 0 0.0011825182009488344
in O 0 0.0003146397939417511
the O 0 0.0003804080479312688
ATM O 0 0.002344300737604499
gene O 0 0.00022261450067162514
are O 0 2.2258192984736525e-05
responsible O 0 0.00022083257499616593
for O 0 0.00017716966976877302
the O 0 0.005364911165088415
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9999396800994873
A B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999854564666748
T I-Disease 1 0.9999939203262329
) O 0 0.00046482167090289295
. O 0 0.00039967100019566715

In O 0 0.0014469517627730966
our O 0 0.000619575206656009
study O 0 0.00012875556421931833
, O 0 7.661707059014589e-05
we O 0 3.642635783762671e-05
have O 0 2.0608733393601142e-05
determined O 0 7.717583503108472e-05
the O 0 0.00015884326421655715
ATM O 0 0.0013090339489281178
mutation O 0 0.00016537233022972941
spectrum O 0 0.00014941635890863836
in O 0 0.00013159062655176967
19 O 0 0.0005440778331831098
classical O 0 0.001713261823169887
A B-Disease 1 0.9999812841415405
- I-Disease 1 0.9999498128890991
T I-Disease 1 0.9999988079071045
patients O 0 0.0003080706810578704
, O 0 5.944133590674028e-05
including O 0 4.7537992941215634e-05
some O 0 4.152369365328923e-05
immigrant O 0 0.00019482853531371802
populations O 0 6.878616113681346e-05
, O 0 4.3170246499357745e-05
as O 0 5.3641560953110456e-05
well O 0 3.234543328289874e-05
as O 0 5.229094676906243e-05
12 O 0 0.00015554687706753612
of O 0 0.00020774517906829715
Dutch O 0 0.0011132837971672416
ethnic O 0 0.0003585547092370689
origin O 0 0.0006010986980982125
. O 0 0.000556570419576019

Both O 0 0.0010610537137836218
the O 0 0.0008843037649057806
protein O 0 0.0008732117130421102
truncation O 0 0.004604844376444817
test O 0 0.0007229165639728308
( O 0 0.00040944761713035405
PTT O 0 0.006480049341917038
) O 0 9.874492388917133e-05
and O 0 7.036101305857301e-05
the O 0 0.00017472633044235408
restriction O 0 0.0003548929817043245
endonuclease O 0 0.0024507876951247454
fingerprinting O 0 0.002001377986744046
( O 0 0.0006123415660113096
REF O 1 0.9029737710952759
) O 0 0.00011703021300490946
method O 0 6.06226603849791e-05
were O 0 5.0901864597108215e-05
used O 0 5.3767289500683546e-05
and O 0 6.748693704139441e-05
compared O 0 0.00010157238284591585
for O 0 3.58910983777605e-05
their O 0 4.876208186033182e-05
detection O 0 0.0004305110778659582
efficiency O 0 0.0005637513822875917
, O 0 0.00011211407399969175
identifying O 0 0.00024144700728356838
76 O 0 0.0003452772507444024
% O 0 5.2297233196441084e-05
and O 0 5.1819362852256745e-05
60 O 0 0.00011073295900132507
% O 0 3.408759948797524e-05
of O 0 9.216423495672643e-05
the O 0 0.0003763651184272021
mutations O 0 0.00048227678053081036
, O 0 0.00029214919777587056
respectively O 0 0.0010959180071949959
. O 0 0.0006298546213656664

Most O 0 0.0018438971601426601
patients O 0 0.0009110546670854092
were O 0 0.0002146016777260229
found O 0 0.00027296331245452166
to O 0 0.00021268769341986626
be O 0 0.0003603803925216198
compound O 0 0.02089294232428074
heterozygote O 0 0.02485266886651516
. O 0 0.0013052361318841577

Seventeen O 0 0.00781332328915596
mutations O 0 0.0005889777094125748
were O 0 0.00011556989920791239
distinct O 0 9.895768016576767e-05
, O 0 7.468601688742638e-05
of O 0 0.00011466364958323538
which O 0 7.458637264790013e-05
10 O 0 0.00012545540812425315
were O 0 8.309340773848817e-05
not O 0 5.128747579874471e-05
reported O 0 0.0003111255937255919
previously O 0 0.000843546527903527
. O 0 0.0006720987730659544

Mutations O 0 0.001961356494575739
are O 0 0.00012689120194409043
small O 0 0.00020606692123692483
deletions O 0 0.0011305742664262652
or O 0 0.00034125937963835895
point O 0 0.0011422503739595413
mutations O 0 0.0005978636909276247
frequently O 0 0.00044288221397437155
affecting O 0 0.0016032266430556774
splice O 0 0.008156167343258858
sites O 0 0.0017705346690490842
. O 0 0.0008891577599570155

Moreover O 0 0.005911555606871843
, O 0 0.0008304810035042465
a O 0 0.0008264080388471484
16 O 0 0.0028166654519736767
. O 0 0.0011082729324698448

7 O 0 0.007434418424963951
- O 0 0.0022124501410871744
kb O 0 0.0024848319590091705
genomic O 0 0.00047804726636968553
deletion O 0 0.00027910235803574324
of O 0 0.0001343658077530563
the O 0 0.00017396693874616176
3 O 0 0.00019537584739737213
end O 0 0.00021206562814768404
of O 0 9.191733988700435e-05
the O 0 0.0001691923098405823
gene O 0 0.00010705996101023629
, O 0 4.769247243530117e-05
most O 0 3.5532557376427576e-05
likely O 0 7.785514026181772e-05
a O 0 6.820463750045747e-05
result O 0 7.925698446342722e-05
of O 0 0.00014462431136053056
recombination O 0 0.0002469664323143661
between O 0 0.00011884937703143805
two O 0 9.624943049857393e-05
LINE O 0 0.006558076944202185
elements O 0 0.001028044382110238
, O 0 0.00027318226057104766
was O 0 0.0012441201834008098
identified O 0 0.0007077812333591282
. O 0 0.000677466276101768

The O 0 0.0020174675155431032
most O 0 0.0002844447153620422
frequently O 0 0.0002951945352833718
found O 0 0.00016786949709057808
mutation O 0 0.00017688439402263612
, O 0 9.200195199809968e-05
identified O 0 8.18489643279463e-05
in O 0 6.675356416963041e-05
three O 0 8.262549090432003e-05
unrelated O 0 0.0004761576419696212
Turkish O 0 0.001922308816574514
A B-Disease 1 0.9999794960021973
- I-Disease 1 0.9998252987861633
T I-Disease 1 0.9999806880950928
individuals O 0 0.00014323896903079003
, O 0 0.00016579356451984495
was O 0 0.0005775754107162356
previously O 0 0.00026276891003362834
described O 0 0.00021370673493947834
to O 0 6.093489355407655e-05
be O 0 3.2524367270525545e-05
a O 0 0.0001453372387913987
Turkish O 0 0.0010693412041291595
A B-Disease 1 0.9965187311172485
- I-Disease 1 0.9976447224617004
T I-Disease 1 0.9999798536300659
founder O 0 0.23830965161323547
mutation O 0 0.001372064114548266
. O 0 0.0006773668574169278

The O 0 0.0013303350424394011
presence O 0 0.0007657890673726797
of O 0 0.0004650873888749629
a O 0 0.0008025997085496783
founder O 0 0.007396429777145386
mutation O 0 0.00035128352465108037
among O 0 0.00010483656660653651
relatively O 0 7.172983896452934e-05
small O 0 4.302959860069677e-05
ethnic O 0 5.2903069445164874e-05
population O 0 2.0769814000232145e-05
groups O 0 1.2098694242013153e-05
in O 0 4.0004590118769556e-05
Western O 0 0.0003128137905150652
Europe O 0 0.000324955559335649
could O 0 9.179803601000458e-05
indicate O 0 0.00010700096026994288
a O 0 0.0001442214852431789
high O 0 0.0004214085347484797
carrier O 0 0.000354656542185694
frequency O 0 6.655233300989494e-05
in O 0 6.946067878743634e-05
such O 0 7.732891390332952e-05
communities O 0 0.00021662002836819738
. O 0 0.00047174780047498643

In O 0 0.0017404293175786734
patients O 0 0.000429934065323323
of O 0 0.00040806664037518203
Dutch O 0 0.001043827971443534
ethnic O 0 0.00027148600202053785
origin O 0 0.00014480231038760394
, O 0 0.00014058088709134609
however O 0 0.00010353620018577203
, O 0 7.666838064324111e-05
no O 0 0.00010124438267666847
significant O 0 0.0002809905563481152
founder O 0 0.04501309245824814
effect O 0 0.0006092255935072899
could O 0 0.000267280382104218
be O 0 0.00010034588194685057
identified O 0 0.00037696026265621185
. O 0 0.0005932527710683644

The O 0 0.00211365707218647
observed O 0 0.0006465711048804224
genetic O 0 0.0003329341998323798
heterogeneity O 0 0.000730733445379883
including O 0 0.0001539655786473304
the O 0 0.00021596834994852543
relative O 0 0.000291724456474185
high O 0 0.00037299058749340475
percentage O 0 0.00016085256356745958
of O 0 0.00019518424232956022
splice O 0 0.007743685506284237
- O 0 0.001760861137881875
site O 0 0.0009042210294865072
mutations O 0 0.00023270389647223055
had O 0 0.0001915797620313242
no O 0 0.0001615123765077442
reflection O 0 0.0006729788146913052
on O 0 0.00030542287277057767
the O 0 0.0007514978642575443
phenotype O 0 0.0029348426032811403
. O 0 0.0007030746783129871

All O 0 0.00222275429405272
patients O 0 0.001320436829701066
manifested O 0 0.008214586414396763
classical O 0 0.004708647262305021
A B-Disease 1 0.9999603033065796
- I-Disease 1 0.9973709583282471
T I-Disease 1 0.9995405673980713
and O 0 0.0003002946323249489
increased O 0 0.00048587823403067887
cellular O 0 0.0021993773989379406
radioresistant O 1 0.9216704964637756
DNA O 0 0.0022213482297956944
synthesis O 0 0.003813039045780897
. O 0 0.000902818632312119

Determination O 0 0.0041116997599601746
of O 0 0.0010216262890025973
the O 0 0.0004977699718438089
genomic O 0 0.0007542931707575917
structure O 0 0.0006973445997573435
of O 0 0.00041355349821969867
the O 0 0.0011025721905753016
COL4A4 O 1 0.9999957084655762
gene O 0 0.00044111598981544375
and O 0 0.00015211118443403393
of O 0 0.0006898882566019893
novel O 0 0.03597167879343033
mutations O 1 0.7369191646575928
causing O 1 0.9999972581863403
autosomal B-Disease 1 0.9999994039535522
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9986276626586914

Autosomal B-Disease 1 0.9999747276306152
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 1 0.9962574243545532
a O 1 0.9985383749008179
progressive O 1 0.9999996423721313
hematuric B-Disease 1 1.0
glomerulonephritis I-Disease 1 1.0
characterized O 1 0.9999397993087769
by O 1 0.5261140465736389
glomerular B-Disease 1 0.9999998807907104
basement I-Disease 1 1.0
membrane I-Disease 1 0.9999674558639526
abnormalities I-Disease 1 0.9999754428863525
and O 0 0.0003683512913994491
associated O 0 0.00020964907889720052
with O 0 9.105714707402512e-05
mutations O 0 0.00011211781384190544
in O 0 8.830451406538486e-05
either O 0 9.78237294475548e-05
the O 0 0.000299584906315431
COL4A3 O 1 0.9999439716339111
or O 0 0.00041032678564079106
the O 0 0.000538524822331965
COL4A4 O 1 0.9999734163284302
gene O 0 0.00025041322805918753
, O 0 6.972945993766189e-05
which O 0 3.3642609196249396e-05
encode O 0 0.0001445865200366825
the O 0 0.00032510835444554687
alpha3 O 0 0.2573450207710266
and O 0 0.0007223191787488759
alpha4 O 1 0.9998055100440979
type O 1 0.9987792372703552
IV O 1 1.0
collagen O 1 1.0
chains O 1 0.9992634654045105
, O 0 0.0011518646497279406
respectively O 0 0.0016028472455218434
. O 0 0.000724661338608712

To O 0 0.0009808298200368881
date O 0 0.0009548445814289153
, O 0 0.00025322442525066435
mutation O 0 0.0001543978287372738
screening O 0 0.00014886829012539238
in O 0 5.816377233713865e-05
the O 0 9.44939602049999e-05
two O 0 6.064625267754309e-05
genes O 0 0.00011348472617100924
has O 0 0.00014432508032768965
been O 0 0.00017472199397161603
hampered O 0 0.00196101819165051
by O 0 9.876602416625246e-05
the O 0 0.0001939296635100618
lack O 0 0.0004783471522387117
of O 0 0.0005327045801095665
genomic O 0 0.0012666343245655298
structure O 0 0.004661844577640295
information O 0 0.0005031067994423211
. O 0 0.0007547879358753562

We O 0 0.0010442830389365554
report O 0 0.00026216983678750694
here O 0 0.00017294878489337862
the O 0 0.00010521845251787454
complete O 0 0.0002228009543614462
characterization O 0 0.0004757683491334319
of O 0 0.00017569529882166535
the O 0 0.00021983010810799897
48 O 0 0.0002642310573719442
exons O 0 0.00047681850264780223
of O 0 0.00020277804287616163
the O 0 0.0006607811083085835
COL4A4 O 1 0.9999752044677734
gene O 0 0.00034428786602802575
, O 0 8.601122681284323e-05
a O 0 0.0001315286644967273
comprehensive O 0 0.0003857064002659172
gene O 0 0.0002442088152747601
screen O 0 0.00036698777694255114
, O 0 6.647399277426302e-05
and O 0 4.32902124885004e-05
the O 0 7.35664289095439e-05
subsequent O 0 0.0002481773553881794
detection O 0 0.000308850547298789
of O 0 0.0002254438295494765
10 O 0 0.00027600498287938535
novel O 0 0.0005193395190872252
mutations O 0 0.00020132947247475386
in O 0 0.00016571738524362445
eight O 0 0.0019191423198208213
patients O 1 0.8434146642684937
diagnosed O 1 0.9999996423721313
with O 1 0.9639124274253845
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9996862411499023

Furthermore O 0 0.004157805349677801
, O 0 0.00045912095811218023
we O 0 0.00010454627044964582
identified O 0 0.00019830914970953017
a O 0 0.00020943130948580801
glycine O 0 0.0009992108680307865
to O 0 0.00015028397319838405
alanine O 0 0.0010620609391480684
substitution O 0 0.0006178292096592486
in O 0 0.00013884634245187044
the O 0 0.0004800214373972267
collagenous O 1 0.9536120891571045
domain O 0 0.0005901633412577212
that O 0 0.00011417843779781833
is O 0 0.00012277756468392909
apparently O 0 0.0003444419999141246
silent O 0 0.0009024858009070158
in O 0 0.00012787971354555339
the O 0 0.00024971633683890104
heterozygous O 0 0.00020014395704492927
carriers O 0 0.00025826558703556657
, O 0 0.00011044548591598868
in O 0 0.00024181194021366537
11 O 0 0.0014830153668299317
. O 0 0.0010133746545761824

5 O 0 0.0012083458714187145
% O 0 0.0001614281500224024
of O 0 0.00018228089902549982
all O 0 8.356015314348042e-05
control O 0 0.00039715631282888353
individuals O 0 6.943908374523744e-05
, O 0 9.106183279072866e-05
and O 0 6.535728607559577e-05
in O 0 6.699481309624389e-05
one O 0 8.338964835274965e-05
control O 0 0.00020038876391481608
individual O 0 8.021351095521823e-05
homozygous O 0 0.00022269620967563242
for O 0 6.83254620525986e-05
this O 0 0.00015941380115691572
glycine O 0 0.002773742889985442
substitution O 0 0.0034949288237839937
. O 0 0.0007015085429884493

There O 0 0.0009518670267425478
has O 0 0.00025207927683368325
been O 0 0.0001334126282017678
no O 0 7.538862701039761e-05
previous O 0 0.00012036327825626358
finding O 0 0.00010910562559729442
of O 0 0.0001731200609356165
a O 0 0.0002712024434003979
glycine O 0 0.0010221967240795493
substitution O 0 0.0004643416032195091
that O 0 3.4494398278184235e-05
is O 0 3.162990833516233e-05
not O 0 1.7160680727101862e-05
associated O 0 5.5694141337880865e-05
with O 0 5.264192805043422e-05
any O 0 0.00016107298142742366
obvious O 0 0.0019012890988960862
phenotype O 0 0.002526341238990426
in O 0 0.0006229816935956478
homozygous O 0 0.0014805163955315948
individuals O 0 0.0003098456363659352
. O 0 0.0009905578335747123

Founder O 1 0.9984005093574524
BRCA1 O 1 0.998050332069397
and O 0 0.003382805734872818
BRCA2 O 0 0.4443780779838562
mutations O 0 0.0006637675105594099
in O 0 0.0004228382313158363
French O 0 0.13541319966316223
Canadian O 1 0.9999160766601562
breast B-Disease 1 1.0
and I-Disease 1 0.9999960660934448
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.018890196457505226
. O 0 0.002122204750776291

We O 0 0.0006165489321574569
have O 0 6.926171772647649e-05
identified O 0 0.00010609417950036004
four O 0 5.5957982112886384e-05
mutations O 0 5.539814446819946e-05
in O 0 3.364565782248974e-05
each O 0 2.1711100998800248e-05
of O 0 0.00025637136423029006
the O 0 0.1950635313987732
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999997615814209
- O 1 0.9986081719398499
susceptibility O 1 0.5916979908943176
genes O 0 0.00039127710624597967
, O 0 0.0002479786053299904
BRCA1 O 0 0.36730533838272095
and O 0 0.000419288786360994
BRCA2 O 0 0.04104038327932358
, O 0 0.00021582673070952296
in O 0 0.00016568008868489414
French O 0 0.006048970390111208
Canadian O 1 0.9984723925590515
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999998807907104
and O 1 0.9999780654907227
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.0013143351534381509
from O 0 0.0013916488969698548
Quebec O 0 0.1545257866382599
. O 0 0.0014359524939209223

To O 0 0.0021683089435100555
identify O 0 0.0022584523539990187
founder O 1 0.7215935587882996
effects O 0 0.015349016524851322
, O 0 0.0002549925702624023
we O 0 0.00014754357107449323
examined O 0 0.0004365560889709741
independently O 0 0.0001647371391300112
ascertained O 0 0.00136166054289788
French O 0 0.0023718804586678743
Canadian O 0 0.004815433174371719
cancer B-Disease 0 0.010219915769994259
families O 0 0.00011683598131639883
for O 0 4.932273441227153e-05
the O 0 0.0001284992031287402
distribution O 0 6.881804438307881e-05
of O 0 0.0001741398882586509
these O 0 7.353458931902424e-05
eight O 0 0.0008525971206836402
mutations O 0 0.0009677915368229151
. O 0 0.0007002828060649335

Mutations O 0 0.0011695035500451922
were O 0 0.0002451562031637877
found O 0 7.553527393611148e-05
in O 0 8.67942871991545e-05
41 O 0 0.0003906792844645679
of O 0 0.00038909094291739166
97 O 0 0.0036094305105507374
families O 0 0.0006671141018159688
. O 0 0.0010178594384342432

Six O 0 0.0010053665610030293
of O 0 0.0006913181277923286
eight O 0 0.0005983752198517323
mutations O 0 0.0002425633283564821
were O 0 9.165335359284654e-05
observed O 0 0.0001865351659944281
at O 0 0.0005070994957350194
least O 0 0.00019892519048880786
twice O 0 0.0006937518483027816
. O 0 0.0004018321633338928

The O 0 0.0068365405313670635
BRCA1 O 1 0.9881792068481445
C4446T O 1 0.996987521648407
mutation O 0 0.0009468397474847734
was O 0 0.0007538465433754027
the O 0 0.00017322837084066123
most O 0 8.428553701378405e-05
common O 0 8.18417829577811e-05
mutation O 0 0.00011881809768965468
found O 0 9.586114902049303e-05
, O 0 8.876767969923094e-05
followed O 0 0.0002739453921094537
by O 0 0.00011236184218432754
the O 0 0.0007572897593490779
BRCA2 O 1 0.9955790638923645
8765delAG O 1 0.9998468160629272
mutation O 0 0.003552356967702508
. O 0 0.0011453741462901235

Together O 0 0.0017875725170597434
, O 0 0.00035748587106354535
these O 0 5.297243478707969e-05
mutations O 0 6.956049764994532e-05
were O 0 4.8238522140309215e-05
found O 0 3.854984970530495e-05
in O 0 5.345369936549105e-05
28 O 0 0.0001991931931115687
of O 0 0.0001364468625979498
41 O 0 0.00030851271003484726
families O 0 8.533201616955921e-05
identified O 0 7.844192441552877e-05
to O 0 7.329585059778765e-05
have O 0 7.738232670817524e-05
a O 0 0.00034726003650575876
mutation O 0 0.001038998132571578
. O 0 0.0006498585571534932

The O 0 0.0016331978840753436
odds O 0 0.0014354787999764085
of O 0 0.0004237093962728977
detection O 0 0.0004383548512123525
of O 0 0.00015453450032509863
any O 0 8.189347136067227e-05
of O 0 0.0001472823932999745
the O 0 0.00034945725928992033
four O 0 0.0004389890527818352
BRCA1 O 0 0.29390981793403625
mutations O 0 0.0004933011368848383
was O 0 0.003293416230008006
18 O 0 0.0026624100282788277
. O 0 0.0010280816350132227

7x O 1 0.6899081468582153
greater O 0 0.0014112850185483694
if O 0 0.0001929395948536694
one O 0 6.71322486596182e-05
or O 0 6.0796228353865445e-05
more O 0 4.5421165850711986e-05
cases O 0 0.00018499734869692475
of O 1 0.99933260679245
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 0.0011437443317845464
also O 0 0.00012948617222718894
present O 0 0.00012848731421399862
in O 0 0.00016687570314388722
the O 0 0.000388033950002864
family O 0 0.0014722441555932164
. O 0 0.0009952964028343558

The O 0 0.002004239009693265
odds O 0 0.0013729811180382967
of O 0 0.00039051694329828024
detection O 0 0.0005618213326670229
of O 0 0.00016812402463983744
any O 0 7.812392141204327e-05
of O 0 0.00018354989879298955
the O 0 0.00033225439256057143
four O 0 0.00044347369112074375
BRCA2 O 0 0.013290729373693466
mutations O 0 0.0005287351086735725
was O 0 0.001697984174825251
5 O 0 0.0012601610505953431
. O 0 0.0007903949008323252

3x O 0 0.05466710031032562
greater O 0 0.001561676966957748
if O 0 0.00019355355470906943
there O 0 8.182025339920074e-05
were O 0 5.2587642130674794e-05
at O 0 0.00012577428424265236
least O 0 4.445606828085147e-05
five O 0 5.0917889893753454e-05
cases O 0 9.971670806407928e-05
of O 0 0.0037354116793721914
breast B-Disease 1 0.9999996423721313
cancer I-Disease 1 0.9999827146530151
in O 0 0.0008908138843253255
the O 0 0.0012776909861713648
family O 0 0.0018528449581936002
. O 0 0.0012539648450911045

Interestingly O 0 0.007151931989938021
, O 0 0.00037519275792874396
the O 0 0.00024316909548360854
presence O 0 0.0003480158920865506
of O 0 0.00045042074634693563
a O 0 0.002670522080734372
breast B-Disease 1 0.9999690055847168
cancer I-Disease 1 0.998664379119873
case O 0 0.0007926917169243097
< O 0 0.0010920609347522259
36 O 0 0.00018563556659501046
years O 0 9.222779044648632e-05
of O 0 0.00015416156384162605
age O 0 0.00041026342660188675
was O 0 0.0005685057258233428
strongly O 0 0.00016154334298335016
predictive O 0 9.499883890384808e-05
of O 0 7.93100698501803e-05
the O 0 0.00010529534483794123
presence O 0 0.00014103148714639246
of O 0 0.00010036502499133348
any O 0 5.6568609579699114e-05
of O 0 0.00020141855929978192
the O 0 0.0004636248922906816
eight O 0 0.0006067417562007904
mutations O 0 0.00052218372002244
screened O 0 0.0015214780578389764
. O 0 0.0005482252454385161

Carriers O 0 0.0019542400259524584
of O 0 0.00035433770972304046
the O 0 0.0003675604530144483
same O 0 0.00017618114361539483
mutation O 0 0.0001904926757561043
, O 0 6.303131522145122e-05
from O 0 5.6745662732282653e-05
different O 0 2.4418250177404843e-05
families O 0 7.487321272492409e-05
, O 0 6.675076292594895e-05
shared O 0 0.00019166708807460964
similar O 0 0.00015770942263770849
haplotypes O 0 0.0010203623678535223
, O 0 0.00016792728274594992
indicating O 0 0.0004195074725430459
that O 0 5.869679807801731e-05
the O 0 0.00022311406792141497
mutant O 0 0.0011089530307799578
alleles O 0 0.00018373900093138218
were O 0 8.920214895624667e-05
likely O 0 9.818942635320127e-05
to O 0 4.623568747774698e-05
be O 0 3.588709296309389e-05
identical O 0 6.172860594233498e-05
by O 0 3.552090493030846e-05
descent O 0 0.00016529145068489015
for O 0 5.229264570516534e-05
a O 0 0.00015432952204719186
mutation O 0 0.00010695985110942274
in O 0 0.00011505410657264292
the O 0 0.0003436081169638783
founder O 0 0.006618492305278778
population O 0 0.00042558746645227075
. O 0 0.0005661810282617807

The O 0 0.0017040383536368608
identification O 0 0.0007641569245606661
of O 0 0.00129750557243824
common O 0 0.004454140085726976
BRCA1 O 1 0.9999306201934814
and O 0 0.0023673283867537975
BRCA2 O 1 0.9531197547912598
mutations O 0 0.0003516046272125095
will O 0 0.00015909626381471753
facilitate O 0 0.00043324450962245464
carrier O 0 0.0007162180845625699
detection O 0 0.00035157802631147206
in O 0 0.00020187134214211255
French O 0 0.0036092111840844154
Canadian O 1 0.9510267972946167
breast B-Disease 1 0.9999988079071045
cancer I-Disease 1 0.9999996423721313
and O 1 0.999943733215332
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.0033905855379998684
. O 0 0.0015913712559267879

Are O 0 0.003013002220541239
Dp71 O 1 0.9980474710464478
and O 0 0.006470423191785812
Dp140 O 1 0.9999822378158569
brain O 1 0.9999451637268066
dystrophin O 1 0.9806875586509705
isoforms O 0 0.0016404569614678621
related O 0 0.0008149042259901762
to O 0 0.0009345412836410105
cognitive B-Disease 1 0.9999173879623413
impairment I-Disease 1 0.9999998807907104
in O 1 0.9999953508377075
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 1 0.9999843835830688

Molecular O 0 0.00483179884031415
study O 0 0.0005466666189022362
and O 0 0.00037609520950354636
neuropsychological O 0 0.0016896389424800873
analysis O 0 0.00010452942660776898
were O 0 0.00014559453120455146
performed O 0 0.00041696641710586846
concurrently O 0 0.0007931205327622592
on O 0 0.0005409654695540667
49 O 0 0.0017935161013156176
patients O 0 0.0021903046872466803
with O 0 0.05978929251432419
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999998807907104
DMD B-Disease 1 1.0
) O 0 0.0006628502742387354
in O 0 0.00012686822446994483
order O 0 9.83089703368023e-05
to O 0 3.0219585823942907e-05
find O 0 5.238697849563323e-05
a O 0 8.141879516188055e-05
molecular O 0 0.00014951956109143794
explanation O 0 0.000182446077815257
for O 0 8.878122753230855e-05
the O 0 0.0004898249171674252
cognitive B-Disease 1 0.7127989530563354
impairment I-Disease 1 0.9998061060905457
observed O 0 0.0009270650916732848
in O 0 0.0006394259980879724
most O 0 0.0012289821170270443
DMD B-Disease 1 0.9999998807907104
patients O 0 0.0371527373790741
. O 0 0.0015784980496391654

Complete O 0 0.002359578851610422
analysis O 0 0.00015000450366642326
of O 0 0.0003692937607411295
the O 0 0.0010125788394361734
dystrophin O 1 0.9765388369560242
gene O 0 0.0006723505211994052
was O 0 0.0010817585280165076
performed O 0 0.0004815032589249313
to O 0 0.00011400687071727589
define O 0 0.00020455254707485437
the O 0 0.0003109120880253613
localization O 0 0.001576326903887093
of O 0 0.00041724572656676173
deletions O 0 0.002014219295233488
and O 0 0.0002743994991760701
duplications O 0 0.002179534640163183
in O 0 0.0002067768364213407
relation O 0 0.00024897840921767056
to O 0 0.000160439609317109
the O 0 0.00037954049184918404
different O 0 0.0004126907151658088
DMD B-Disease 1 0.9999978542327881
promoters O 1 0.7292643189430237
. O 0 0.00246584159322083

Qualitative O 0 0.00222013215534389
analysis O 0 0.0002278974570799619
of O 0 0.00048157255514524877
the O 0 0.0009622987709008157
Dp71 O 1 0.9941353797912598
transcript O 0 0.0016149745788425207
and O 0 0.00012679904466494918
testing O 0 0.00011408353748265654
for O 0 2.720877637329977e-05
the O 0 9.485898044658825e-05
specific O 0 3.249522342230193e-05
first O 0 0.00016103644156828523
exon O 0 0.0011146339820697904
of O 0 0.00041649985359981656
Dp140 O 1 0.9768503904342651
were O 0 0.0003044527256861329
also O 0 0.0001163459091912955
carried O 0 0.0003399016859475523
out O 0 0.0003631416766438633
. O 0 0.0006073533440940082

Neuropsychological O 0 0.02220206893980503
analysis O 0 0.0007353551336564124
assessed O 0 0.0011729677207767963
verbal O 0 0.0020854275207966566
and O 0 0.0007018846808932722
visuospatial O 1 0.9965039491653442
intelligence O 0 0.0019406491192057729
, O 0 0.00036838537198491395
verbal O 0 0.004965123254805803
memory O 1 0.986047625541687
, O 0 0.0005877176881767809
and O 0 0.0005034944042563438
reading O 0 0.0020905607379972935
skills O 0 0.00477987015619874
. O 0 0.0010372822871431708

Comparison O 0 0.0019958624616265297
of O 0 0.0011562719009816647
molecular O 0 0.0011846274137496948
and O 0 0.00042029988253489137
psychometric O 0 0.01051707100123167
findings O 0 0.0009651036816649139
demonstrated O 0 0.0012400373816490173
that O 0 0.00018159633327741176
deletions O 0 0.0011618430726230145
and O 0 0.00020858712377958
duplications O 0 0.0027465922757983208
that O 0 0.00010642064444255084
were O 0 0.00015818366955500096
localized O 0 0.0003815238596871495
in O 0 0.0001209016190841794
the O 0 0.0002178144350182265
distal O 0 0.0018910554936155677
part O 0 0.0002868950832635164
of O 0 0.00030088069615885615
the O 0 0.00035122776171192527
gene O 0 0.00021027488401159644
seemed O 0 0.00035632308572530746
to O 0 8.974135562311858e-05
be O 0 7.726066542090848e-05
preferentially O 0 0.0004329161311034113
associated O 0 0.000371652829926461
with O 0 0.0006563803181052208
cognitive B-Disease 1 0.9998119473457336
impairment I-Disease 1 0.9999966621398926
. O 0 0.012115580029785633

Two O 0 0.0021874478552490473
altered O 0 0.005584297701716423
Dp71 O 1 0.7599019408226013
transcripts O 0 0.0016796252457424998
and O 0 0.00017349682457279414
two O 0 0.00011586198525037616
deleted O 0 0.0008788907434791327
Dp140 O 0 0.005789858754724264
DNA O 0 0.000295157398795709
sequences O 0 0.00010531893349252641
were O 0 5.3175539505900815e-05
found O 0 4.7136865759966895e-05
in O 0 8.046616858337075e-05
four O 0 0.00022608425933867693
patients O 0 0.0015871193027123809
with O 0 0.18313558399677277
severe O 1 1.0
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 1.0
. O 1 0.999178946018219

These O 0 0.0005494393408298492
findings O 0 0.0002913061762228608
suggest O 0 0.0001448467664886266
that O 0 2.260469045722857e-05
some O 0 2.0352485080366023e-05
sequences O 0 5.0118338549509645e-05
located O 0 0.00015401655400637537
in O 0 6.0675527493003756e-05
the O 0 0.00017127372848335654
distal O 0 0.0019323823507875204
part O 0 0.00027994130505248904
of O 0 0.00018837327661458403
the O 0 0.0003231528971809894
gene O 0 0.00018647609977051616
and O 0 9.74116483121179e-05
, O 0 5.400469672167674e-05
in O 0 5.5748016166035086e-05
particular O 0 8.190018706955016e-05
, O 0 0.00011072092456743121
some O 0 0.0001351555692963302
DMD B-Disease 1 0.9997419714927673
isoforms O 0 0.0002832677564583719
expressed O 0 0.00012931392120663077
in O 0 0.00015564924979116768
the O 0 0.000801707967184484
brain O 1 0.9993544220924377
may O 0 0.00023581158893648535
be O 0 5.3603875130647793e-05
related O 0 0.00011405145050957799
to O 0 0.00011629521031863987
the O 0 0.000898457074072212
cognitive B-Disease 1 0.9995973706245422
impairment I-Disease 1 0.999993085861206
associated O 0 0.01525935810059309
with O 0 0.14228498935699463
DMD B-Disease 1 1.0
. O 0 0.0021678702905774117
. O 0 0.001549075124785304

I1307K O 1 0.9993403553962708
APC O 1 0.9986288547515869
and O 0 0.002378286560997367
hMLH1 O 1 0.9649291634559631
mutations O 0 0.00047116854693740606
in O 0 0.00022752575750928372
a O 0 0.0003453598765190691
non O 0 0.0004468660044949502
- O 0 0.0003560139157343656
Jewish O 0 0.0003182118234690279
family O 0 0.00029151621856726706
with O 0 0.00028719560941681266
hereditary B-Disease 1 0.999998927116394
non I-Disease 1 0.9999996423721313
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.04813973978161812

We O 0 0.001163310487754643
describe O 0 0.0012431956129148602
a O 0 0.0005099992849864066
French O 0 0.002273896476253867
Canadian O 0 0.0075982315465807915
hereditary B-Disease 1 0.9999854564666748
non I-Disease 1 0.9999815225601196
- I-Disease 1 0.9999997615814209
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.9999924898147583
HNPCC B-Disease 1 1.0
) O 0 0.0021096905693411827
kindred O 0 0.05154828354716301
which O 0 0.00027456015232019126
carries O 0 0.00033192356931976974
a O 0 0.00037845910992473364
novel O 0 0.0007840381585992873
truncating O 0 0.00811817031353712
mutation O 0 0.0008792571607045829
in O 0 0.0009363729623146355
hMLH1 O 1 0.9947437047958374
. O 0 0.0021435171365737915

Interestingly O 0 0.008253956213593483
, O 0 0.0009413761436007917
the O 0 0.0016284945886582136
I1307K O 1 0.998881995677948
APC O 1 0.9980120658874512
polymorphism O 0 0.00212589162401855
, O 0 0.00018555292626842856
associated O 0 0.00010892692080233246
with O 0 4.592860204866156e-05
an O 0 0.00015379334217868745
increased O 0 0.0004889446427114308
risk O 0 0.004827197175472975
of O 1 0.9999949932098389
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.054727211594581604
is O 0 0.00018593248387333006
also O 0 5.9070534916827455e-05
present O 0 8.078831888269633e-05
in O 0 0.00010617200314300135
this O 0 8.826830890029669e-05
family O 0 0.0005369118880480528
. O 0 0.0006609256379306316

The O 0 0.004968639463186264
I1307K O 1 0.9617077112197876
polymorphism O 0 0.0019679591059684753
has O 0 0.00016400676395278424
previously O 0 0.0001849839318310842
only O 0 3.602312062866986e-05
been O 0 4.4446616811910644e-05
identified O 0 5.4504282161360607e-05
in O 0 5.284599319566041e-05
individuals O 0 4.248663390171714e-05
of O 0 0.00042422552360221744
self O 0 0.47154659032821655
- O 0 0.024375729262828827
reported O 0 0.0006971884286031127
Ashkenazi O 0 0.0016719251871109009
Jewish O 0 0.0011213020188733935
origins O 0 0.002887638984248042
. O 0 0.0009383358992636204

In O 0 0.0009008122142404318
addition O 0 0.00035899507929570973
, O 0 0.00010624360584188253
in O 0 7.612816989421844e-05
this O 0 4.0299430111190304e-05
family O 0 0.0002543381997384131
, O 0 0.00010321799345547333
there O 0 0.00010621767432894558
appears O 0 0.0002376221091253683
to O 0 5.5967801017686725e-05
be O 0 3.971009937231429e-05
no O 0 7.261788414325565e-05
relationship O 0 0.00016053509898483753
between O 0 0.00023560663976240903
the O 0 0.0005417874781414866
I1307K O 1 0.9807124137878418
polymorphism O 0 0.0006536977598443627
and O 0 0.00011028889275621623
the O 0 0.00022408155200537294
presence O 0 0.00047084433026611805
or O 0 0.0002827545686159283
absence O 0 0.0022987888660281897
of O 1 0.71037757396698
cancer B-Disease 1 0.999997615814209
. O 0 0.0007484907982870936
. O 0 0.0011348266853019595

Identification O 0 0.0008451938629150391
of O 0 0.0005717092426493764
a O 0 0.00045716509339399636
novel O 0 0.0004937442718073726
mutation O 0 0.00013641253462992609
of O 0 0.0002961095015052706
the O 0 0.0009364067809656262
CPO O 0 0.3273569941520691
gene O 0 0.00018691581499297172
in O 0 0.00012637319741770625
a O 0 0.00034081219928339124
Japanese O 0 0.009447632357478142
hereditary B-Disease 1 0.999957799911499
coproporphyria I-Disease 1 0.999994158744812
family O 0 0.008397387340664864
. O 0 0.0015821763081476092

Hereditary B-Disease 1 0.9999834299087524
coproporphyria I-Disease 1 0.9999990463256836
( O 1 0.9618801474571228
HCP B-Disease 1 0.9999926090240479
) O 0 0.0009474027901887894
is O 0 0.0003472721145953983
an O 0 0.00047314027324318886
autosomal B-Disease 1 0.9036877155303955
dominant I-Disease 1 0.9999927282333374
disease I-Disease 1 0.9999998807907104
characterized O 1 0.9997499585151672
by O 0 0.0014314360450953245
a O 1 0.5493262410163879
deficiency B-Disease 1 1.0
of I-Disease 1 0.9998414516448975
coproporphyrinogen I-Disease 1 1.0
oxidase I-Disease 1 0.9990857839584351
( O 0 0.0014068933669477701
CPO O 1 0.8287003636360168
) O 0 0.0001477575715398416
caused O 0 0.00045694963773712516
by O 0 6.027926065144129e-05
a O 0 0.0002036618097918108
mutation O 0 0.0001949606667039916
in O 0 0.00019390674424357712
the O 0 0.0008719973266124725
CPO O 1 0.8493014574050903
gene O 0 0.0012988705420866609
. O 0 0.0009606370003893971

Only O 0 0.0007586309802718461
11 O 0 0.0008835141779854894
mutations O 0 0.00019847125804517418
of O 0 0.00018201308557763696
the O 0 0.0002835947088897228
gene O 0 0.00016609134036116302
have O 0 5.9355414123274386e-05
been O 0 0.0001999734085984528
reported O 0 0.0005121807917021215
in O 0 0.0008652394753880799
HCP B-Disease 1 0.999990701675415
patients O 0 0.007634864654392004
. O 0 0.001817295211367309

We O 0 0.0009777265368029475
report O 0 0.0002612894750200212
another O 0 0.00038806794327683747
mutation O 0 0.0001389479439239949
in O 0 0.00016980549844447523
a O 0 0.0004379581077955663
Japanese O 0 0.0038301993627101183
family O 0 0.001768102403730154
. O 0 0.0013348794309422374

Polymerase O 0 0.017783423885703087
chain O 0 0.006215563975274563
reaction O 0 0.002002134220674634
- O 0 0.0009683060925453901
single O 0 0.00039899718831293285
strand O 0 0.0005884166457690299
conformational O 0 0.0005158205167390406
polymorphism O 0 0.0003071714600082487
and O 0 9.66241568676196e-05
direct O 0 0.0001046722536557354
sequence O 0 0.00011977706890320405
analyses O 0 0.00016701690037734807
demonstrated O 0 0.00036789788282476366
a O 0 0.00016598812362644821
C O 0 0.0005948023754172027
to O 0 0.00014990427007433027
T O 0 0.001364109106361866
substitution O 0 0.00025645102141425014
in O 0 0.00011334564624121413
exon O 0 0.0005602401797659695
1 O 0 0.0001316224952461198
of O 0 0.0001644762814976275
the O 0 0.00031376388506032526
CPO O 0 0.005683409050107002
gene O 0 0.00018516181444283575
at O 0 0.0002452490443829447
nucleotide O 0 0.0002114474045811221
position O 0 0.00015792492195032537
85 O 0 0.00024206684611272067
, O 0 8.82790845935233e-05
which O 0 5.4631564125884324e-05
lies O 0 0.0003758792590815574
in O 0 0.00010913974983850494
the O 0 0.0003153566212859005
putative O 0 0.002652436261996627
presequence O 0 0.028270773589611053
for O 0 0.0003131569246761501
targeting O 0 0.0006218516500666738
to O 0 0.00037579736090265214
mitochondria O 0 0.006507857237011194
. O 0 0.0009075916605070233

This O 0 0.000608130416367203
mutation O 0 0.00041028024861589074
changes O 0 0.00018789252499118447
the O 0 0.00024654882145114243
codon O 0 0.0004994015325792134
for O 0 7.365487545030192e-05
glutamine O 0 0.0002953448856715113
to O 0 6.948332884348929e-05
a O 0 0.00017134510562755167
termination O 0 0.0008580621215514839
codon O 0 0.0010383852059021592
at O 0 0.0005701205809600651
amino O 0 0.000465488265035674
acid O 0 0.0006637753685936332
position O 0 0.0005996364634484053
29 O 0 0.0022672831546515226
. O 0 0.0009494368568994105

MaeI O 0 0.27266767621040344
restriction O 0 0.0020070949103683233
analysis O 0 0.00020889303414151073
showed O 0 0.00026424843235872686
two O 0 5.7267272495664656e-05
other O 0 6.402080180123448e-05
carriers O 0 0.00023247150238603354
in O 0 0.00013544043758884072
the O 0 0.0004963717656210065
family O 0 0.0013098339550197124
. O 0 0.0010985060362145305

The O 0 0.004824251867830753
C O 0 0.14304190874099731
- O 0 0.020460914820432663
T O 0 0.04043665528297424
mutation O 0 0.00023502015392296016
is O 0 8.063200948527083e-05
located O 0 0.00024195676087401807
within O 0 0.0001245971507159993
a O 0 0.00016371910169254988
recently O 0 0.00024861618294380605
proposed O 0 0.00016692347708158195
putative O 0 0.0008562138536944985
alternative O 0 0.00027279078494757414
translation O 0 0.00033317392808385193
initiation O 0 0.0011572338407859206
codon O 0 0.0014014334883540869
( O 0 0.00045017394586466253
TIC O 0 0.03566119819879532
- O 0 0.0008609735523350537
1 O 0 0.0003310266765765846
) O 0 5.6007840612437576e-05
, O 0 4.997973519493826e-05
supporting O 0 0.00013103728997521102
that O 0 9.551277616992593e-05
TIC O 1 0.9942474365234375
- O 0 0.0010141694219782948
1 O 0 0.00026771219563670456
is O 0 6.997712625889108e-05
the O 0 0.0001677841937635094
real O 0 0.0006003761664032936
TIC O 0 0.2800600528717041
rather O 0 0.0003187164547853172
than O 0 0.00028638626099564135
TIC O 1 0.9967659711837769
- O 0 0.0021943519823253155
2 O 0 0.0006269456353038549
. O 0 0.00026006667758338153
. O 0 0.00041978328954428434

Human B-Disease 0 0.005864173639565706
complement I-Disease 0 0.01614348776638508
factor I-Disease 1 0.9973787069320679
H I-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 1 0.999630331993103
with O 1 0.9999986886978149
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9999765157699585

This O 0 0.0003909232618752867
study O 0 0.00015539833111688495
reports O 0 0.00012627562682610005
on O 0 0.00010939481580862775
six O 0 0.00018824830476660281
cases O 0 0.00017682973702903837
of O 0 0.00395225640386343
deficiency B-Disease 1 1.0
in I-Disease 0 0.002170409308746457
the I-Disease 0 0.0011784328380599618
human I-Disease 0 0.0004456003080122173
complement I-Disease 0 0.0005925280856899917
regulatory I-Disease 0 0.0003734600904863328
protein I-Disease 0 0.0005707746604457498
Factor I-Disease 0 0.0021433327347040176
H I-Disease 1 0.9997411370277405
( O 0 0.0009663385571911931
FH O 0 0.1911807507276535
) O 0 8.83595275809057e-05
in O 0 7.020692282821983e-05
the O 0 8.901095134206116e-05
context O 0 0.00032721098978072405
of O 0 0.0010547327110543847
an O 1 0.9976279139518738
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.9999496936798096

Five O 0 0.0005940820556133986
of O 0 0.0005336801405064762
the O 0 0.0004239496192894876
cases O 0 0.00015751975297462195
were O 0 0.0001572550245327875
observed O 0 0.00014658230065833777
in O 0 0.00012921704910695553
children O 0 0.00028520694468170404
presenting O 0 0.0029225891921669245
with O 1 0.9674153923988342
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 1.0
HUS B-Disease 1 1.0
) O 1 0.8801797032356262
. O 0 0.003255663439631462

Two O 0 0.0006422314327210188
of O 0 0.0008395382901653647
the O 0 0.0010228744940832257
children O 0 0.0007348248618654907
exhibited O 0 0.05811575427651405
a O 0 0.12242870032787323
homozygous O 1 0.9949514865875244
deficiency O 1 0.9999998807907104
characterized O 0 0.08304299414157867
by O 0 0.00028433598345145583
the O 0 0.0004720762080978602
absence O 0 0.0005479812971316278
of O 0 0.0002633693802636117
the O 0 0.0005026477738283575
150 O 0 0.0006978558376431465
- O 0 0.0007138799410313368
kD O 0 0.0026498339138925076
form O 0 0.00016918862820602953
of O 0 0.00034729449544101954
Factor O 0 0.002171818632632494
H O 1 0.9991783499717712
and O 0 0.00019485641678329557
the O 0 0.00017128091712947935
presence O 0 0.0003491137467790395
, O 0 0.00012227808474563062
upon O 0 0.00031394732650369406
immunoblotting O 0 0.021723022684454918
, O 0 9.846716420724988e-05
of O 0 9.205523383570835e-05
the O 0 0.0001778867153916508
42 O 0 0.0008111696224659681
- O 0 0.0008359564817510545
kD O 0 0.007008360233157873
Factor O 0 0.0012612418504431844
H O 1 0.8219012022018433
- O 0 0.0005512149655260146
like O 0 0.00022303793230094016
protein O 0 0.0002738417242653668
1 O 0 0.00037688910379074514
( O 0 0.00036581468884833157
FHL O 0 0.3806496262550354
- O 0 0.0008896712679415941
1 O 0 0.0003221888327971101
) O 0 6.254757317947224e-05
and O 0 7.638516399310902e-05
other O 0 9.590429544914514e-05
FH O 1 0.8213755488395691
- O 0 0.0015645810635760427
related O 0 0.0007485892274416983
protein O 0 0.0011001229286193848
( O 0 0.0011644191108644009
FHR O 1 0.999935507774353
) O 0 0.0010029614204540849
bands O 0 0.0032055352348834276
. O 0 0.001044773031026125

Southern O 0 0.010431177914142609
blot O 0 0.01073422096669674
and O 0 0.0005715564475394785
PCR O 0 0.0008633871912024915
analysis O 0 5.8305835409555584e-05
of O 0 0.0001570096064824611
DNA O 0 0.00021649470727425069
of O 0 0.000253304373472929
one O 0 0.00028814782854169607
patient O 0 0.0009023768943734467
with O 0 0.0006129821413196623
homozygous O 1 0.6932081580162048
deficiency O 1 0.9999996423721313
ruled O 0 0.0019002958433702588
out O 0 0.00016490323469042778
the O 0 0.00017119715630542487
presence O 0 0.00015279526996891946
of O 0 9.696569031802937e-05
a O 0 8.459859964204952e-05
large O 0 0.00013330251385923475
deletion O 0 0.00026797110331244767
of O 0 0.00021541390742640942
the O 0 0.0006982233608141541
FH O 1 0.997426450252533
gene O 0 0.0003298582450952381
as O 0 0.0001764839398674667
the O 0 0.0004627043381333351
underlying O 1 0.7489059567451477
defect O 1 0.9999910593032837
for O 0 0.003030917141586542
the O 1 0.9973464012145996
deficiency O 1 1.0
. O 0 0.0051729134283959866

The O 0 0.0015599532052874565
other O 0 0.00014348297554533929
four O 0 0.0002053187054116279
children O 0 0.00027243600925430655
presented O 0 0.0006718970253132284
with O 0 0.0008040832472033799
heterozygous O 1 0.5326614379882812
deficiency O 1 1.0
and O 0 0.004159883130341768
exhibited O 1 0.9248006939888
a O 0 0.0018513031536713243
normal O 0 0.0010197315132245421
immunoblotting O 0 0.21702361106872559
pattern O 0 0.0005679866299033165
of O 0 0.00026127201272174716
proteins O 0 0.00017798748740460724
of O 0 0.0004054631863255054
the O 0 0.0020132861100137234
FH O 1 0.9997344613075256
family O 0 0.0027666932437568903
. O 0 0.0011002859100699425

Factor B-Disease 1 0.9990406632423401
H I-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9999997615814209
is O 0 0.0005019940435886383
the O 0 0.0008691904949955642
only O 0 0.0008337918552570045
complement B-Disease 1 0.9998626708984375
deficiency I-Disease 1 1.0
associated O 0 0.45581063628196716
with O 0 0.308877170085907
HUS B-Disease 1 1.0
. O 0 0.01089226920157671

These O 0 0.000373599526938051
observations O 0 0.0004300830769352615
suggest O 0 0.0003134843136649579
a O 0 0.00030618850723840296
role O 0 0.0008617747225798666
for O 0 0.00035237526753917336
FH O 1 0.9995457530021667
and O 0 0.001338717993348837
/ O 0 0.2211546152830124
or O 0 0.0016889505786821246
FH O 1 0.998808741569519
receptors O 0 0.0006520016468130052
in O 0 0.00026096057263202965
the O 0 0.0005191458039917052
pathogenesis O 1 0.9992938041687012
of O 1 0.9962564706802368
idiopathic O 1 1.0
HUS B-Disease 1 1.0
. O 1 0.723987340927124
. O 0 0.002959856763482094

Further O 0 0.0013526787515729666
evidence O 0 0.0004844367504119873
for O 0 0.00013144976401235908
a O 0 0.00033020495902746916
major O 0 0.0016540405340492725
ancient O 0 0.13849696516990662
mutation O 0 0.3648916184902191
underlying O 1 0.9999957084655762
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 1 0.9996005892753601
linkage O 1 0.9990111589431763
disequilibrium O 1 0.9951307773590088
studies O 0 0.00021344299602787942
in O 0 0.00020970983314327896
the O 0 0.00036648663808591664
Japanese O 0 0.002160232048481703
population O 0 0.00019436578440945596
. O 0 0.00037663374678231776

The O 1 0.9659820199012756
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.999980092048645
DM B-Disease 1 1.0
) O 0 0.0016151205636560917
mutation O 0 0.00034894756390713155
is O 0 9.893569222185761e-05
an O 0 0.0002436773502267897
unstable O 1 0.5904940366744995
( O 0 0.0013707124162465334
CTG O 1 0.9989678859710693
) O 0 0.00023421665537171066
n O 0 0.00035823715734295547
repeat O 0 0.0005391355371102691
, O 0 6.443852180382237e-05
present O 0 9.578173921909183e-05
at O 0 0.00012448494089767337
a O 0 9.657451300881803e-05
copy O 0 0.00012151546980021521
number O 0 2.4953331376309507e-05
of O 0 8.698718738742173e-05
5 O 0 0.0002193675609305501
- O 0 0.0003077002475038171
37 O 0 0.0002279804612044245
repeats O 0 0.0003933869011234492
on O 0 0.0001838897296693176
normal O 0 0.0002222073671873659
chromosomes O 0 0.00012427737237885594
but O 0 4.551811798592098e-05
amplified O 0 0.00034673072514124215
to O 0 6.350577314151451e-05
50 O 0 0.00021608782117255032
- O 0 0.0005168520146980882
3000 O 0 0.0015852798242121935
copies O 0 0.0003642528608907014
on O 0 0.0006383656291291118
DM B-Disease 1 0.9999444484710693
chromosomes O 0 0.0041567194275557995
. O 0 0.0010068900883197784

Previous O 0 0.00411858269944787
findings O 0 0.0007351110689342022
in O 0 0.000276748847682029
Caucasian O 0 0.002036269987002015
populations O 0 0.00014444210682995617
of O 0 0.0003720771928783506
a O 0 0.0027327907737344503
DM B-Disease 1 1.0
founder O 1 0.9779306650161743
chromosome O 0 0.0010195780778303742
raise O 0 0.00030113381217233837
a O 0 0.00010630400356603786
question O 0 9.487716306466609e-05
about O 0 3.374880907358602e-05
the O 0 6.937911530258134e-05
molecular O 0 0.00021888221090193838
events O 0 0.00022604154946748167
involved O 0 0.0002082306455122307
in O 0 0.00017969270993489772
the O 0 0.0004931781440973282
expansion O 0 0.00428443867713213
mutation O 0 0.0012696533231064677
. O 0 0.0007341645541600883

To O 0 0.0009163827053271234
investigate O 0 0.0009198486222885549
whether O 0 0.00026166337192989886
a O 0 0.00041520039667375386
founder O 0 0.0031531876884400845
chromosome O 0 0.00045028552995063365
for O 0 0.00017277439474128187
the O 0 0.0009450929937884212
DM B-Disease 1 0.9999998807907104
mutation O 0 0.0004735441179946065
exists O 0 0.00013601598038803786
in O 0 5.959379268460907e-05
the O 0 0.00012696626072283834
Japanese O 0 0.0008648952934890985
population O 0 5.840209632879123e-05
, O 0 0.00010091414878843352
we O 0 0.00015364661521743983
genotyped O 0 0.003107439260929823
families O 0 0.00011542167339939624
using O 0 9.064598270924762e-05
polymorphic O 0 0.0007084257085807621
markers O 0 0.0012960481690242887
near O 0 0.003432036377489567
the O 0 0.0010361011372879148
( O 0 0.0009657001937739551
CTG O 1 0.9253939986228943
) O 0 0.00038676810800097883
n O 0 0.0008636934217065573
repeat O 0 0.0012769050663337111
region O 0 0.0008982195286080241
and O 0 0.00045389129081740975
constructed O 0 0.008490178734064102
haplotypes O 0 0.0064529613591730595
. O 0 0.001460369094274938

Six O 0 0.001776244374923408
different O 0 0.0002217214641859755
haplotypes O 0 0.0012176863383501768
were O 0 0.00031287045567296445
found O 0 0.0004695164388976991
and O 0 0.0007670605555176735
DM B-Disease 1 0.9999991655349731
alleles O 0 0.0012147986562922597
were O 0 0.00040697617805562913
always O 0 0.0005205023917369545
haplotype O 0 0.0015281307278200984
A O 0 0.0027572617400437593
. O 0 0.0016137495404109359

To O 0 0.0007063738885335624
find O 0 0.0003343569696880877
an O 0 0.00011479350359877571
origin O 0 0.00010293706873198971
of O 0 0.00021768052829429507
the O 0 0.0005030031898058951
( O 0 0.0009688874706625938
CTG O 1 0.9966740608215332
) O 0 0.0003204702225048095
n O 0 0.0005601560114882886
repeat O 0 0.0006646505789831281
mutation O 0 0.00013887177919968963
and O 0 3.924733027815819e-05
to O 0 2.942507853731513e-05
investigate O 0 0.00016151329327840358
the O 0 0.00012906076153740287
mechanism O 0 0.00015494822582695633
of O 0 0.00012631028948817402
the O 0 0.00017972494242712855
expansion O 0 0.0005507906316779554
mutation O 0 4.993547554477118e-05
in O 0 2.662010410858784e-05
the O 0 8.409270230913535e-05
Japanese O 0 0.0005090536433272064
population O 0 2.532636972318869e-05
we O 0 1.4721759725944139e-05
have O 0 6.383155323419487e-06
studied O 0 7.224187720566988e-05
90 O 0 0.00024211553682107478
Japanese O 0 0.0023754280991852283
DM B-Disease 1 0.9999498128890991
families O 0 0.0003247669665142894
comprising O 0 0.0004019787011202425
190 O 0 0.0009371976484544575
affected O 0 0.0005171883967705071
and O 0 0.0002114536619046703
130 O 0 0.0011248313821852207
unaffected O 0 0.004022305831313133
members O 0 0.0004703085869550705
. O 0 0.0007302694721147418

The O 0 0.0019543718080967665
results O 0 0.0006019678548909724
suggest O 0 0.00028723260038532317
that O 0 5.261759361019358e-05
a O 0 0.0001272023218916729
few O 0 8.740876364754513e-05
common O 0 0.00016284910088870674
ancestral O 0 0.006491965148597956
mutations O 0 0.00025355254183523357
in O 0 0.00016835502174217254
both O 0 0.00013547039998229593
Caucasian O 0 0.0031050958205014467
and O 0 0.00030850269831717014
Japanese O 0 0.0061555844731628895
populations O 0 0.00010498893971089274
have O 0 1.89195889106486e-05
originated O 0 8.493680797982961e-05
by O 0 2.0561719793477096e-05
expansion O 0 0.00019288515613880008
of O 0 0.00011100667325081304
an O 0 9.013304224936292e-05
ancestral O 0 0.0017655593110248446
n O 0 0.0007175758364610374
= O 0 0.0004260695131961256
5 O 0 0.0001633274368941784
repeat O 0 0.00030924598104320467
to O 0 7.103443931555375e-05
n O 0 0.00029320703470148146
= O 0 0.0005176271661184728
19 O 0 0.0005643368349410594
- O 0 0.0005742760840803385
37 O 0 0.00099596893414855
copies O 0 0.000743841112125665
. O 0 0.0005136658437550068

These O 0 0.0005076126544736326
data O 0 0.00020462060638237745
support O 0 0.000279863626929
multistep O 0 0.001772237243130803
models O 0 0.0005117447581142187
of O 0 0.0009604589431546628
triplet O 1 0.6265444159507751
repeat O 0 0.005543275270611048
expansion O 0 0.001507971785031259
that O 0 5.319618503563106e-05
have O 0 1.6192430848605e-05
been O 0 2.5789940991671756e-05
proposed O 0 7.181170803960413e-05
for O 0 7.06542341504246e-05
both O 0 0.0005438192165456712
DM B-Disease 1 1.0
and O 0 0.1838611513376236
Friedreichs B-Disease 1 0.9999996423721313
ataxia I-Disease 1 0.999997615814209
. O 0 0.0022727230098098516
. O 0 0.0019312679069116712

The O 0 0.002003558212891221
molecular O 0 0.0011147578479722142
basis O 0 0.0007956730551086366
of O 0 0.371128648519516
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.0014590541832149029
the O 0 0.0009728474542498589
western O 0 0.0011428664438426495
Cape O 0 0.0040553780272603035
, O 0 0.00029533758061006665
South O 0 0.0015921579906716943
Africa O 0 0.0014826185069978237
. O 0 0.0005861642421223223

Deficiency B-Disease 1 0.9999679327011108
of I-Disease 0 0.00422643544152379
the I-Disease 0 0.002787378616631031
sixth I-Disease 1 0.9435105323791504
component I-Disease 0 0.003344674129039049
of I-Disease 0 0.0006967450608499348
human I-Disease 0 0.0009275430929847062
complement I-Disease 0 0.003326614387333393
( O 0 0.0021419625263661146
C6 O 1 0.999997615814209
) O 0 0.00018104241462424397
has O 0 7.645154983038083e-05
been O 0 6.333619239740074e-05
reported O 0 5.74379664612934e-05
in O 0 2.955187846964691e-05
a O 0 5.909747051191516e-05
number O 0 3.0468097975244746e-05
of O 0 9.125515498453751e-05
families O 0 8.312304998980835e-05
from O 0 0.00011455545609351248
the O 0 0.00017597211990505457
western O 0 0.0005683870404027402
Cape O 0 0.004105967935174704
, O 0 0.00031464220955967903
South O 0 0.0014285987708717585
Africa O 0 0.002076246775686741
. O 0 0.0008789664716459811

Meningococcal B-Disease 1 0.9999997615814209
disease I-Disease 1 0.9999995231628418
is O 0 0.0008782009244896472
endemic O 0 0.003464355133473873
in O 0 0.000277074082987383
the O 0 0.0005227221408858895
Cape O 0 0.002038107253611088
and O 0 0.00015592317504342645
almost O 0 0.0001203065985464491
all O 0 6.298301013885066e-05
pedigrees O 0 0.00064404949080199
of O 0 0.0009613951551727951
total O 1 0.9790018796920776
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 1 0.9998823404312134
C6Q0 O 1 1.0
) O 0 0.00041346484795212746
have O 0 0.00010353304242016748
been O 0 0.000178968723048456
ascertained O 0 0.001474571879953146
because O 0 0.00033449503825977445
of O 0 0.001823350554332137
recurrent O 1 0.9999996423721313
disease O 1 1.0
. O 1 0.6580275893211365

We O 0 0.0007020503398962319
have O 0 9.004223102238029e-05
sequenced O 0 0.00029015421750955284
the O 0 0.00010173329792451113
expressed O 0 8.381801308132708e-05
exons O 0 0.00043234165059402585
of O 0 0.0002511709462851286
the O 0 0.0009043493773788214
C6 O 1 0.9999929666519165
gene O 0 0.00027799358940683305
from O 0 0.00011408255522837862
selected O 0 0.00010765350452857092
cases O 0 4.778242146130651e-05
and O 0 5.425867493613623e-05
have O 0 2.7573032639338635e-05
found O 0 8.021212852327153e-05
three O 0 0.0001533692266093567
molecular O 0 0.002335590310394764
defects O 1 0.9999737739562988
leading O 1 0.5655809044837952
to O 0 0.0008745292434468865
total O 0 0.32109078764915466
deficiency O 1 1.0
879delG O 1 0.9999994039535522
, O 0 0.00041089870501309633
which O 0 7.911698776297271e-05
is O 0 4.930880822939798e-05
the O 0 0.0001439894112991169
common O 0 0.00036198546877130866
defect O 1 0.9995423555374146
in O 0 0.00047581028775312006
the O 0 0.000763808551710099
Cape O 0 0.006810720544308424
and O 0 0.00037730488111265004
hitherto O 0 0.00260090921074152
unreported O 0 0.0016794572584331036
, O 0 0.00030735103064216673
and O 0 0.00027867904282175004
1195delC O 1 0.9967488050460815
and O 0 0.0007900869240984321
1936delG O 1 0.9999150037765503
, O 0 0.0003092805272899568
which O 0 6.695603224216029e-05
have O 0 2.6177880499744788e-05
been O 0 7.185937283793464e-05
previously O 0 0.00017120531992986798
reported O 0 0.0001475033350288868
in O 0 0.00014247056969907135
African O 0 0.0023216940462589264
- O 0 0.004446129314601421
Americans O 0 0.0006478935829363763
. O 0 0.0008674973505549133

We O 0 0.001193390809930861
also O 0 0.0002775235625449568
show O 0 0.0003398339613340795
that O 0 8.772272849455476e-05
the O 0 0.00040226272540166974
879delG O 1 0.9983904361724854
and O 0 0.003668832825496793
1195delC O 1 0.9999995231628418
defects O 1 0.9999979734420776
are O 0 0.0001824321661842987
associated O 0 0.0002216277935076505
with O 0 0.000289611954940483
characteristic O 1 0.9999790191650391
C6 O 1 1.0
/ O 1 0.9999794960021973
C7 O 1 0.9999977350234985
region O 0 0.0027264638338238
DNA O 0 0.0014260582393035293
marker O 0 0.00381339224986732
haplotypes O 0 0.0019687246531248093
, O 0 0.00018652058497536927
although O 0 0.00012304245319683105
small O 0 0.00010624583956087008
variations O 0 0.00023717826115898788
were O 0 0.00033968777279369533
observed O 0 0.000836153223644942
. O 0 0.0007382726762443781

The O 0 0.010633782483637333
1936delG O 1 0.9999213218688965
defect O 1 0.9999619722366333
was O 0 0.008304083719849586
observed O 0 0.00032954770722426474
only O 0 8.091985364444554e-05
once O 0 0.00021456404647324234
in O 0 9.14611155167222e-05
the O 0 0.0002642385952640325
Cape O 0 0.0019831652753055096
, O 0 0.0001527180866105482
but O 0 6.787037273170426e-05
its O 0 7.555112824775279e-05
associated O 0 0.00037851431989111006
haplotype O 0 0.0017588940681889653
could O 0 0.0004387600056361407
be O 0 0.00022573400929104537
deduced O 0 0.0025273493956774473
. O 0 0.0009448499768041074

The O 0 0.0010744162136688828
data O 0 0.0001404104841640219
from O 0 0.00012107825750717893
the O 0 0.0001938135683303699
haplotypes O 0 0.0009020317811518908
indicate O 0 0.00019561035151127726
that O 0 3.6276571336202323e-05
these O 0 2.4714985556784086e-05
three O 0 0.0001337218564003706
molecular O 0 0.0014075534418225288
defects O 1 0.9997381567955017
account O 0 0.00014346354873850942
for O 0 0.00013882966595701873
the O 0 0.0010379867162555456
defects O 1 0.9998984336853027
in O 0 0.00016528309788554907
all O 0 9.116417641052976e-05
the O 0 0.00022335670655593276
38 O 0 0.0008887380245141685
unrelated O 0 0.002333198208361864
C6Q0 O 1 0.9999735355377197
individuals O 0 0.00015943977632559836
we O 0 7.227998139569536e-05
have O 0 2.620530540298205e-05
studied O 0 0.0001394473947584629
from O 0 0.00027047269395552576
the O 0 0.0005788956768810749
Cape O 0 0.006862584967166185
. O 0 0.0010872383136302233

We O 0 0.0008716948796063662
have O 0 0.0001637408131500706
also O 0 0.0001231449277838692
observed O 0 0.00016041267372202128
the O 0 0.00034404275356791914
879delG O 1 0.9963594079017639
defect O 1 0.9959145188331604
in O 0 0.0006731337052769959
two O 0 0.0005776161560788751
Dutch O 1 0.9832128882408142
C6 B-Disease 1 1.0
- I-Disease 1 0.9995050430297852
deficient I-Disease 1 0.9998998641967773
kindreds O 0 0.028476251289248466
, O 0 0.00029355555307120085
but O 0 0.0001246650208486244
the O 0 0.000527905416674912
879delG O 1 0.9993981122970581
defect O 1 0.9992355108261108
in O 0 0.0005464447312988341
the O 0 0.0007580138044431806
Cape O 0 0.011561788618564606
probably O 0 0.000462109106592834
did O 0 7.303269376279786e-05
not O 0 1.8255706891068257e-05
come O 0 4.018989420728758e-05
from O 0 6.327799201244488e-05
The O 0 0.0003051478124689311
Netherlands O 0 0.0008886613650247455
. O 0 0.0003296199720352888
. O 0 0.0005813783500343561

Complement B-Disease 1 0.999882698059082
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 0.002996631432324648
seven O 0 0.0017175348475575447
further O 0 0.001569037907756865
molecular O 0 0.08803033828735352
defects O 1 0.9999432563781738
and O 0 0.0005540076526813209
their O 0 0.00048750892165116966
associated O 0 0.0013564223190769553
marker O 0 0.2705661356449127
haplotypes O 0 0.018575454130768776
. O 0 0.002700083190575242

Seven O 0 0.0025259300600737333
further O 0 0.0010720641585066915
molecular O 0 0.0017939378740265965
bases O 0 0.005207502748817205
of O 1 0.9959371089935303
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 0.0012874030508100986
described O 0 0.004731431137770414
. O 0 0.0014128158800303936

All O 0 0.0005920865805819631
these O 0 8.276948938146234e-05
new O 0 0.0002906276495195925
molecular O 0 0.0019258380634710193
defects O 1 0.9973104000091553
involve O 0 0.0011268567759543657
single O 0 0.000553828664124012
- O 0 0.0007621297263540328
nucleotide O 0 0.0004792220424860716
events O 0 0.00031061048503033817
, O 0 0.00012053718091920018
deletions O 0 0.000645600666757673
and O 0 0.00011876272037625313
substitutions O 0 0.0004859868495259434
, O 0 5.5522643378935754e-05
some O 0 2.6407329642097466e-05
of O 0 0.00011140953574795276
which O 0 0.00011931152403121814
alter O 0 0.0006890924996696413
splice O 0 0.0030903383158147335
sites O 0 0.0004634021897800267
, O 0 0.00013137234782334417
and O 0 0.00016500217316206545
others O 0 0.0005107990582473576
codons O 0 0.00280376267619431
. O 0 0.0006787209422327578

They O 0 0.0005635714042000473
are O 0 5.083982250653207e-05
distributed O 0 7.191093027358875e-05
along O 0 0.00030984770273789763
the O 0 0.000776478264015168
C7 O 1 0.9999873638153076
gene O 0 0.000467713107354939
, O 0 0.0001105703559005633
but O 0 4.361417086329311e-05
predominantly O 0 9.423965821042657e-05
towards O 0 0.0002641484315972775
the O 0 0.00030327626154758036
3 O 0 0.0008703951607458293
end O 0 0.002124606166034937
. O 0 0.00053001957712695

All O 0 0.000612767762504518
were O 0 0.00033023394644260406
found O 0 0.00020763310021720827
in O 0 0.0003898381255567074
compound O 0 0.011023967526853085
heterozygous O 0 0.0008563341107219458
individuals O 0 0.0002839172084350139
. O 0 0.0008709941757842898

The O 0 0.05077401176095009
C6 O 1 0.9999994039535522
/ O 1 0.9989026784896851
C7 O 1 0.999992847442627
marker O 0 0.03720498085021973
haplotypes O 0 0.004027864895761013
associated O 0 0.0008249547681771219
with O 0 0.00050294806715101
most O 0 0.03871879726648331
C7 B-Disease 1 1.0
defects I-Disease 1 0.9999998807907104
are O 0 0.0004549560253508389
tabulated O 0 0.0025341720320284367
. O 0 0.0003755207289941609
. O 0 0.0006338749080896378

A O 0 0.008527124300599098
genome O 0 0.0016973037272691727
- O 0 0.0010040063643828034
wide O 0 0.00033888150937855244
search O 0 0.00028512810240499675
for O 0 0.00016531225992366672
chromosomal O 0 0.1713513731956482
loci O 0 0.025689825415611267
linked O 0 0.2977864742279053
to O 0 0.001717627514153719
mental O 1 0.9999984502792358
health O 1 0.9832040071487427
wellness O 1 0.9987363219261169
in O 0 0.0004611051408573985
relatives O 0 0.0007875470328144729
at O 0 0.0032376155722886324
high O 0 0.00404707808047533
risk O 0 0.0016494375886395574
for O 0 0.0021601058542728424
bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
among O 1 0.9962367415428162
the O 1 0.8791427612304688
Old O 1 0.9874661564826965
Order O 0 0.002182216849178076
Amish O 0 0.012333694845438004
. O 0 0.0008602282614447176

Bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 0.9999998807907104
BPAD B-Disease 1 1.0
; O 1 0.9999876022338867
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 0 0.004930716007947922
is O 0 0.00021993198606651276
characterized O 0 0.0005556702963076532
by O 0 0.0001760021405061707
episodes O 0 0.0006261873641051352
of O 0 0.00346316653303802
mania B-Disease 1 1.0
and O 0 0.31640833616256714
/ O 1 0.9986913800239563
or O 0 0.002992254216223955
hypomania B-Disease 1 0.9999245405197144
interspersed O 0 0.004489727318286896
with O 0 0.00035215396201238036
periods O 0 0.0015420817071571946
of O 0 0.003705590730533004
depression B-Disease 1 0.9999983310699463
. O 0 0.0025119653437286615

Compelling O 0 0.006298551335930824
evidence O 0 0.0009111558320000768
supports O 0 0.0003946612123399973
a O 0 0.00019178225193172693
significant O 0 0.00026804726803675294
genetic O 0 0.0003588717372622341
component O 0 0.0007573922630399466
in O 0 0.0002639958693180233
the O 0 0.0006373613141477108
susceptibility O 0 0.0063255103304982185
to O 0 0.0007973576430231333
develop O 0 0.16640175879001617
BPAD B-Disease 1 0.9999998807907104
. O 0 0.004831621889024973

To O 0 0.0016612664330750704
date O 0 0.001318878959864378
, O 0 0.00035189674235880375
however O 0 0.00017910890164785087
, O 0 0.00016777955170255154
linkage O 0 0.0007914078887552023
studies O 0 7.850845577195287e-05
have O 0 3.7208064895821735e-05
attempted O 0 0.000489450350869447
only O 0 6.200098869157955e-05
to O 0 0.00013123285316396505
identify O 0 0.0003180004714522511
chromosomal O 0 0.11215779930353165
loci O 0 0.006103671155869961
that O 0 0.00024437863612547517
cause O 0 0.3205784559249878
or O 0 0.00029386550886556506
increase O 0 0.00011328449181746691
the O 0 0.00031545918318443
risk O 0 0.000467807607492432
of O 0 0.0011527492897585034
developing O 1 0.8407590389251709
BPAD B-Disease 1 1.0
. O 0 0.0038332573603838682

To O 0 0.000720732903573662
determine O 0 0.00023292189871426672
whether O 0 0.00019111669098492712
there O 0 0.00019330364011693746
could O 0 0.0001357832516077906
be O 0 0.0001482820516685024
protective O 0 0.002950335619971156
alleles O 0 0.00032955745700746775
that O 0 9.240844519808888e-05
prevent O 0 0.0009113707346841693
or O 0 0.0002768649719655514
reduce O 0 0.00033525004982948303
the O 0 0.0003251508460380137
risk O 0 0.0002102030994137749
of O 0 0.0007371843094006181
developing O 1 0.8898437023162842
BPAD B-Disease 1 1.0
, O 0 0.00022761558648198843
similar O 0 5.584550672210753e-05
to O 0 4.812613406102173e-05
what O 0 4.6637956984341145e-05
is O 0 5.827430868521333e-05
observed O 0 6.896763079566881e-05
in O 0 7.727989577688277e-05
other O 0 0.0001800626632757485
genetic B-Disease 1 0.9999818801879883
disorders I-Disease 1 1.0
, O 1 0.8114499449729919
we O 0 0.0007738607237115502
used O 0 0.0015398168470710516
mental O 1 0.9999924898147583
health O 1 0.9655240178108215
wellness O 1 0.9998242259025574
( O 0 0.0005478846142068505
absence O 0 0.0008678676094859838
of O 0 0.0006722852122038603
any O 0 0.0031867397483438253
psychiatric B-Disease 1 1.0
disorder I-Disease 1 1.0
) O 0 0.0013355216942727566
as O 0 0.00031787256011739373
the O 0 0.0003404601593501866
phenotype O 0 0.00047288573114201427
in O 0 0.0001939078647410497
our O 0 0.0003597477625589818
genome O 0 0.00039926485624164343
- O 0 0.00044869884732179344
wide O 0 0.0002947311440948397
linkage O 0 0.0012017389526590705
scan O 0 0.0004341580206528306
of O 0 0.00018510020163375884
several O 0 0.0001455263700336218
large O 0 0.00039524631574749947
multigeneration O 1 0.975382924079895
Old O 0 0.005135399755090475
Order O 0 0.001049006823450327
Amish O 0 0.005779153201729059
pedigrees O 0 0.0016776121919974685
exhibiting O 0 0.0011505529982969165
an O 0 0.0003459143918007612
extremely O 0 0.0007926294929347932
high O 0 0.002209782600402832
incidence O 0 0.26134708523750305
of O 1 0.8069683909416199
BPAD B-Disease 1 1.0
. O 0 0.005644313991069794

We O 0 0.0011949342442676425
have O 0 0.00010904570808634162
found O 0 0.00012123051419621333
strong O 0 0.00015097584400791675
evidence O 0 0.00012481868907343596
for O 0 6.547044904436916e-05
a O 0 0.00020856842456851155
locus O 0 0.0008941984269768
on O 0 0.0004964105901308358
chromosome O 0 0.0023719100281596184
4p O 1 0.9996532201766968
at O 0 0.005722948350012302
D4S2949 O 1 0.7516567707061768
( O 0 0.0007975780172273517
maximum O 0 0.0010936434846371412
GENEHUNTER O 1 0.9927070736885071
- O 0 0.002251748461276293
PLUS O 0 0.0015489276265725493
nonparametric O 0 0.0037005695048719645
linkage O 0 0.0014098508981987834
score O 0 0.00031288000172935426
= O 0 0.0004160371609032154
4 O 0 0.00029741012258455157
. O 0 6.324233982013538e-05
05 O 0 0.002214771695435047
, O 0 0.00016038210014812648
P O 0 0.001243006787262857
= O 0 0.00032500425004400313
5 O 0 9.400289127370343e-05
. O 0 2.0855299226241186e-05
22 O 0 0.00011245242785662413
x O 0 0.00013851812400389463
10 O 0 0.00016346767370123416
( O 0 0.00012337882071733475
- O 0 0.0004185895377304405
4 O 0 0.00039319173083640635
) O 0 0.0001373080158373341
; O 0 0.00013661310367751867
SIBPAL O 0 0.12048086524009705
Pempirical O 0 0.011839812621474266
value O 0 0.0002926055167336017
< O 0 0.0006459502037614584
3 O 0 0.0001468405534978956
x O 0 0.000178978982148692
10 O 0 0.00020868222054559737
( O 0 0.00017105160804931074
- O 0 0.0003336172958370298
5 O 0 0.00029662461020052433
) O 0 0.00011156921391375363
) O 0 7.210469630081207e-05
and O 0 8.200991578632966e-05
suggestive O 0 0.0005458764499053359
evidence O 0 0.00018983232439495623
for O 0 5.676060391124338e-05
a O 0 0.0003286691789980978
locus O 0 0.0012127282097935677
on O 0 0.000651466310955584
chromosome O 0 0.0025962931104004383
4q O 1 0.9917768239974976
at O 0 0.0029230229556560516
D4S397 O 1 0.789943277835846
( O 0 0.0007267208420671523
maximum O 0 0.0006726774154230952
GENEHUNTER O 1 0.9965452551841736
- O 0 0.00122010987251997
PLUS O 0 0.0011786360992118716
nonparametric O 0 0.0023595101665705442
linkage O 0 0.0008858040091581643
score O 0 0.0001958273642230779
= O 0 0.00026876945048570633
3 O 0 0.00016961715300567448
. O 0 4.935021206620149e-05
29 O 0 0.00021785535500384867
, O 0 7.963532698340714e-05
P O 0 0.0008567344630137086
= O 0 0.0003166584065183997
2 O 0 9.960694296751171e-05
. O 0 2.2624853954766877e-05
57 O 0 0.00010053101868834347
x O 0 0.00010336575360270217
10 O 0 0.00011979249393334612
( O 0 0.0001183447748189792
- O 0 0.0003288070729468018
3 O 0 0.0003134658036287874
) O 0 0.00010554646723903716
; O 0 0.0001207525419886224
SIBPAL O 0 0.090910904109478
Pempirical O 0 0.010291870683431625
value O 0 0.0003277079958934337
< O 0 0.0006082182517275214
1 O 0 0.00015265228284988552
x O 0 0.000155507426825352
10 O 0 0.0001149776580859907
( O 0 0.00012935115955770016
- O 0 0.00028999190544709563
3 O 0 0.00019845270435325801
) O 0 8.381769293919206e-05
) O 0 3.758089223993011e-05
that O 0 2.613437936815899e-05
are O 0 3.2878320780582726e-05
linked O 0 0.0008852779283188283
to O 0 0.0008159151184372604
mental O 1 0.9999982118606567
health O 1 0.9998058676719666
wellness O 1 0.9999784231185913
. O 0 0.004965636879205704

These O 0 0.0005664778873324394
findings O 0 0.0003318808157928288
are O 0 4.05439714086242e-05
consistent O 0 0.00015921355225145817
with O 0 8.164909377228469e-05
the O 0 0.0002776595647446811
hypothesis O 0 0.00023567788593936712
that O 0 7.295973045984283e-05
certain O 0 8.295928273582831e-05
alleles O 0 0.00021963439940009266
could O 0 0.00018428538169246167
prevent O 0 0.0006722596008330584
or O 0 0.00018508626089897007
modify O 0 0.0003562991041690111
the O 0 0.0002895584038924426
clinical O 0 0.0007895532762631774
manifestations O 1 0.9043391346931458
of O 1 0.9985219836235046
BPAD B-Disease 1 1.0
and O 0 0.0935356616973877
perhaps O 0 0.0028437573928385973
other O 0 0.00038708699867129326
related O 0 0.21591947972774506
affective B-Disease 1 1.0
disorders I-Disease 1 1.0
. O 1 0.9913773536682129

Segregation O 1 0.9998154044151306
distortion O 1 0.9999891519546509
in O 1 0.9985730648040771
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.34051185846328735

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.999993085861206
DM B-Disease 1 1.0
) O 0 0.0016113758319988847
is O 0 0.00019960269855801016
an O 0 0.0002641061437316239
autosomal B-Disease 1 0.5451014637947083
dominant I-Disease 1 0.9999973773956299
disease I-Disease 1 1.0
which O 0 0.000651308277156204
, O 0 0.00014851524611003697
in O 0 9.314672934124246e-05
the O 0 0.00016202108236029744
typical O 0 0.0005895236390642822
pedigree O 0 0.0010283401934430003
, O 0 9.833448712015525e-05
shows O 0 7.985433330759406e-05
a O 0 0.00016878079622983932
three O 0 0.0002780680952128023
generation O 0 0.0032711161766201258
anticipation O 0 0.004927343688905239
cascade O 0 0.32143545150756836
. O 0 0.0014484587591141462

This O 0 0.0011202801251783967
results O 0 0.0012298660585656762
in O 0 0.0034008680377155542
infertility B-Disease 1 0.9999991655349731
and O 1 0.9999945163726807
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
CDM B-Disease 1 0.9999997615814209
) O 0 0.0002631000825203955
with O 0 6.950546958250925e-05
the O 0 0.0002288420218974352
disappearance O 0 0.0017713885754346848
of O 0 0.0015659566270187497
DM B-Disease 1 1.0
in O 0 0.001603857846930623
that O 0 0.000406814826419577
pedigree O 0 0.003875862108543515
. O 0 0.000807375181466341

The O 0 0.0019981595687568188
concept O 0 0.001822749269194901
of O 0 0.0015014882665127516
segregation O 1 0.9993896484375
distortion O 1 0.9998014569282532
, O 0 0.0003131864941678941
where O 0 0.0001153002303908579
there O 0 6.239095819182694e-05
is O 0 5.545586463995278e-05
preferential O 0 0.00020175454847048968
transmission O 0 0.00026412177248857915
of O 0 0.00016376141866203398
the O 0 0.0002661160833667964
larger O 0 0.0002065833396045491
allele O 0 0.000177058856934309
at O 0 0.00034682248951867223
the O 0 0.0006688737194053829
DM B-Disease 1 0.9999996423721313
locus O 0 0.005055868532508612
, O 0 0.0002312739088665694
has O 0 6.651311559835449e-05
been O 0 6.866628973511979e-05
put O 0 0.0001889381092041731
forward O 0 0.00023643790336791426
to O 0 0.00012059947766829282
explain O 0 0.0004938793135806918
partially O 0 0.0010709019843488932
the O 0 0.00036998672294430435
maintenance O 0 0.0027680457569658756
of O 0 0.002641361439600587
DM B-Disease 1 1.0
in O 0 0.0007775223930366337
the O 0 0.0010132254101336002
population O 0 0.0003514880081638694
. O 0 0.0005652438849210739

In O 0 0.0006194364978000522
a O 0 0.0005286043742671609
survey O 0 0.0003309351741336286
of O 0 0.000646899570710957
DM B-Disease 1 0.999996542930603
in O 0 0.0005874676280654967
Northern O 0 0.0011755593586713076
Ireland O 0 0.0006030353251844645
, O 0 0.00023334154684562236
59 O 0 0.0009851101785898209
pedigrees O 0 0.0022665075957775116
were O 0 0.0006070964154787362
ascertained O 0 0.00451298151165247
. O 0 0.0011358356568962336

Sibships O 1 0.6073919534683228
where O 0 0.0009395481320098042
the O 0 0.0002926791494246572
status O 0 0.00010528771963436157
of O 0 0.00013069339911453426
all O 0 6.554884021170437e-05
the O 0 0.00020476465579122305
members O 0 9.017129923449829e-05
had O 0 0.00018233773880638182
been O 0 0.00010867179662454873
identified O 0 7.717127300566062e-05
were O 0 5.447943840408698e-05
examined O 0 0.00017635288531892002
to O 0 3.7846137274755165e-05
determine O 0 7.570799061795697e-05
the O 0 0.00016502011567354202
transmission O 0 0.00044641830027103424
of O 0 0.0003265394188929349
the O 0 0.0029747551307082176
DM B-Disease 1 1.0
expansion O 0 0.006341060157865286
from O 0 0.00034181377850472927
affected O 0 0.00031883135670796037
parents O 0 7.477845792891458e-05
to O 0 9.673663589637727e-05
their O 0 0.00020931132894475013
offspring O 0 0.00173404929228127
. O 0 0.0007622778648510575

Where O 0 0.0020552591886371374
the O 0 0.0014197530690580606
transmitting O 0 0.004629871807992458
parent O 0 0.0010645543225109577
was O 0 0.0020229502115398645
male O 0 0.001066968310624361
, O 0 0.0005107170436531305
58 O 0 0.002550788689404726
. O 0 0.0014977225800976157

3 O 0 0.0014441325329244137
% O 0 0.00016898289322853088
of O 0 0.0002579827851150185
the O 0 0.00032126158475875854
offspring O 0 0.0005838182987645268
were O 0 0.0001602587290108204
affected O 0 0.00018970204109791666
, O 0 6.0619251598836854e-05
and O 0 3.428672789596021e-05
in O 0 3.175130768795498e-05
the O 0 8.494968642480671e-05
case O 0 0.00010116851626662537
of O 0 0.00013880821643397212
a O 0 0.00031681093969382346
female O 0 0.0017500744434073567
transmitting O 0 0.0076150777749717236
parent O 0 0.0005821299855597317
, O 0 0.00034485611831769347
68 O 0 0.0024892075452953577
. O 0 0.0008348105475306511

7 O 0 0.005927522201091051
% O 0 0.0009109253878705204
were O 0 0.0006332524353638291
affected O 0 0.001727307098917663
. O 0 0.0010138526558876038

Studies O 0 0.0013407429214566946
on O 0 0.001209211884997785
meiotic O 1 0.7709041237831116
drive O 0 0.005515872035175562
in O 0 0.0013623232953250408
DM B-Disease 1 0.9999991655349731
have O 0 0.00019682306447066367
shown O 0 0.00018651701975613832
increased O 0 0.00018371344776824117
transmission O 0 0.00019773970416281372
of O 0 9.810108167584985e-05
the O 0 0.00018492256640456617
larger O 0 0.00014390678552445024
allele O 0 0.00022773149248678237
at O 0 0.0004924817476421595
the O 0 0.0007080193608999252
DM B-Disease 1 0.9999879598617554
locus O 0 0.003479044185951352
in O 0 0.0008105409797281027
non O 0 0.0034798176493495703
- O 0 0.040110353380441666
DM O 1 0.999995231628418
heterozygotes O 0 0.025868013501167297
for O 0 0.001383059425279498
CTGn O 1 0.997665286064148
. O 0 0.00406127143651247

This O 0 0.0007835010765120387
study O 0 0.0002097232500091195
provides O 0 0.00011952879867749289
further O 0 0.00013146232231520116
evidence O 0 0.00018702063243836164
that O 0 6.808246689615771e-05
the O 0 0.0006566693773493171
DM B-Disease 1 0.9999995231628418
expansion O 0 0.010799451731145382
tends O 0 0.0009039504802785814
to O 0 0.00015282764798030257
be O 0 0.00019130339205730706
transmitted O 0 0.0008335328311659396
preferentially O 0 0.0016679044347256422
. O 0 0.0006191135616973042

Diagnosis O 1 0.9961320161819458
of O 1 0.9950867295265198
hemochromatosis B-Disease 1 1.0
. O 0 0.4607457220554352

If O 0 0.02390841767191887
untreated O 1 0.9999994039535522
, O 1 0.9812886714935303
hemochromatosis B-Disease 1 1.0
can O 0 0.21984809637069702
cause O 1 0.9999938011169434
serious O 1 0.999998927116394
illness O 1 1.0
and O 0 0.16912536323070526
early B-Disease 1 0.8416428565979004
death I-Disease 1 0.9864752888679504
, O 0 0.0001606882578926161
but O 0 8.772908040555194e-05
the O 0 0.0003506680077407509
disease O 1 0.9997913241386414
is O 0 0.00019166966376360506
still O 0 0.00024398844107054174
substantially O 0 0.0010884922230616212
under O 0 0.0018121169414371252
- O 1 0.9907406568527222
diagnosed O 1 0.9999394416809082
. O 0 0.0014971321215853095

The O 0 0.0037005944177508354
cornerstone O 0 0.0912332683801651
of O 0 0.0018974130507558584
screening O 0 0.0006787675083614886
and O 0 0.00031102533102966845
case O 0 0.00045174124534241855
detection O 0 0.0006118212477304041
is O 0 0.00010387303336756304
the O 0 0.0001750912342686206
measurement O 0 0.00034823024179786444
of O 0 0.0007756437407806516
serum O 1 0.9909143447875977
transferrin O 1 0.9956803321838379
saturation O 0 0.0027159331366419792
and O 0 0.0002708830579649657
the O 0 0.001181681058369577
serum O 0 0.1440649777650833
ferritin O 1 0.9348435997962952
level O 0 0.0037598011549562216
. O 0 0.0009602682548575103

Once O 0 0.004990171175450087
the O 0 0.0016257826937362552
diagnosis O 0 0.03677184879779816
is O 0 0.0003543368657119572
suspected O 0 0.003596755675971508
, O 0 0.00046240712981671095
physicians O 0 0.0005671191611327231
must O 0 0.00028348714113235474
use O 0 0.0007142713293433189
serum O 1 0.9893753528594971
ferritin O 1 0.9999502897262573
levels O 0 0.020805353298783302
and O 0 0.001319593284279108
hepatic O 1 0.9999955892562866
iron O 1 0.9999998807907104
stores O 0 0.005573182366788387
on O 0 0.0022931809071451426
liver O 1 0.9990957975387573
biopsy O 0 0.018558047711849213
specimens O 0 0.0008607430499978364
to O 0 0.0002296017191838473
assess O 0 0.0005097524262964725
patients O 0 0.00015136705769691616
for O 0 4.342811371316202e-05
the O 0 0.00020564904843922704
presence O 0 0.0009451808873564005
of O 0 0.2765534222126007
iron B-Disease 1 1.0
overload I-Disease 1 0.9999998807907104
. O 0 0.0040442016907036304

Liver O 1 0.9999949932098389
biopsy O 1 0.9936538934707642
is O 0 0.0006463456084020436
also O 0 0.00018103049660567194
used O 0 8.780290227150545e-05
to O 0 5.085678640170954e-05
establish O 0 0.00024580012541264296
the O 0 0.00026748282834887505
presence O 0 0.0004548020660877228
or O 0 0.00022487387468572706
absence O 0 0.0014668627409264445
of O 0 0.12467782944440842
cirrhosis B-Disease 1 1.0
, O 0 0.009048172272741795
which O 0 0.0002793094317894429
can O 0 0.00021415362425614148
affect O 0 0.0010300080757588148
prognosis O 1 0.9909799695014954
and O 0 0.0006850145873613656
management O 0 0.007595266215503216
. O 0 0.0016330890357494354

A O 0 0.004524298012256622
DNA O 0 0.0015657575568184257
- O 0 0.0007111299782991409
based O 0 8.965368033386767e-05
test O 0 0.00011829265713458881
for O 0 6.414528616005555e-05
the O 0 0.0003659721987787634
HFE O 1 0.997917115688324
gene O 0 0.00040010616066865623
is O 0 0.000144558260217309
commercially O 0 0.0003212606825400144
available O 0 2.945607411675155e-05
, O 0 3.918031507055275e-05
but O 0 1.8948554497910663e-05
its O 0 1.6156704077729955e-05
place O 0 7.510204159189016e-05
in O 0 7.383378397207707e-05
the O 0 0.00023136190429795533
diagnosis O 0 0.19516751170158386
of O 1 0.9926522374153137
hemochromatosis B-Disease 1 1.0
is O 1 0.5822709798812866
still O 0 0.0008309950353577733
being O 0 0.0005923889111727476
evaluated O 0 0.0011477596126496792
. O 0 0.0006402989383786917

Currently O 0 0.0013773494865745306
, O 0 0.00035395449958741665
the O 0 0.0001754097465891391
most O 0 9.583318751538172e-05
useful O 0 0.00012051568774040788
role O 0 0.0002369944704696536
for O 0 4.836648440686986e-05
this O 0 3.713001206051558e-05
test O 0 8.273405546788126e-05
is O 0 2.4236920580733567e-05
in O 0 3.591102722566575e-05
the O 0 0.00013039910118095577
detection O 0 0.0005635542329400778
of O 0 0.0013351113302633166
hemochromatosis B-Disease 1 1.0
in O 0 0.0005467817536555231
the O 0 0.00038283347385004163
family O 0 0.00022236820950638503
members O 0 6.582565401913598e-05
of O 0 0.00014069568715058267
patients O 0 0.0001387446973240003
with O 0 8.533331129001454e-05
a O 0 0.00047112361062318087
proven O 0 0.0028053121641278267
case O 0 0.0003208493290003389
of O 0 0.0007972132880240679
the O 0 0.39889028668403625
disease O 1 0.9999982118606567
. O 0 0.002228813711553812

It O 0 0.0006899619475007057
is O 0 0.00026429101126268506
crucial O 0 0.0016392922261729836
to O 0 0.0014482944970950484
diagnose O 1 0.999998927116394
hemochromatosis B-Disease 1 1.0
before O 1 0.9999997615814209
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 1 0.9999996423721313
because O 1 0.9849293828010559
phlebotomy O 1 0.9999995231628418
therapy O 1 0.9998975992202759
can O 0 0.0012651658616960049
avert O 1 0.999995231628418
serious O 1 1.0
chronic O 1 1.0
disease O 1 1.0
and O 1 0.9995086193084717
can O 0 0.00017826532712206244
even O 0 0.00011384370736777782
lead O 0 0.00017288480012211949
to O 0 0.00011093461216660216
normal O 0 0.00047879607882350683
life O 0 0.00085318589117378
expectancy O 0 0.0017900995444506407
. O 0 0.00023875081387814134
. O 0 0.0004934511380270123

Prevalence O 0 0.01002754457294941
of O 0 0.0019116164185106754
the O 0 0.003721758024767041
I1307K O 1 0.9999494552612305
APC B-Disease 1 0.9993665814399719
gene O 0 0.0007687854813411832
variant O 0 0.0008598586427979171
in O 0 0.0001299710856983438
Israeli O 0 0.00047836516750976443
Jews O 0 0.0003163828805554658
of O 0 0.0001583640114404261
differing O 0 5.329509440343827e-05
ethnic O 0 0.0001285870821448043
origin O 0 0.00019545895338524133
and O 0 0.00048313173465430737
risk O 1 0.7355577349662781
for O 1 0.9990459084510803
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.45304346084594727

BACKGROUND O 0 0.036122653633356094
& O 0 0.13975152373313904
AIMS O 0 0.007298571988940239
Israeli O 0 0.001552532077766955
Jews O 0 0.0006853338563814759
of O 0 0.000285483110928908
European O 0 0.0003023968602064997
birth O 0 0.0014405216788873076
, O 0 0.00018727779388427734
i O 0 0.0004607760929502547
. O 0 0.00012203603546367958
e O 0 0.00020434317411854863
. O 0 8.521784184267744e-05
, O 0 0.00014338328037410975
Ashkenazim O 0 0.0032329715322703123
, O 0 0.00019775741384364665
have O 0 8.166855695890263e-05
the O 0 0.000757072470150888
highest O 1 0.9998489618301392
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 1 0.9994916915893555
of O 0 0.0033287054393440485
any O 0 0.0004192678024992347
Israeli O 0 0.0014063925482332706
ethnic O 0 0.00036657502641901374
group O 0 0.00034602571395225823
. O 0 0.0004980027442798018

The O 0 0.005974194034934044
I1307K O 1 0.9946012496948242
APC B-Disease 1 0.9800287485122681
gene O 0 0.001228551147505641
variant O 0 0.001226436230354011
was O 0 0.0007150585879571736
found O 0 0.0001507337437942624
in O 0 0.00026787735987454653
6 O 0 0.0013475302839651704
. O 0 0.0006797605892643332

1 O 0 0.0010198239469900727
% O 0 0.00021492318774107844
of O 0 0.00026299498858861625
American O 0 0.0006002680165693164
Jews O 0 0.0005151355871930718
, O 0 0.00011771091521950439
28 O 0 0.0002216398570453748
% O 0 3.862679659505375e-05
of O 0 0.00013609939196612686
their O 0 0.00034617504570633173
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 1 0.9994934797286987
, O 0 0.0007055756286717951
but O 0 7.175255450420082e-05
not O 0 4.3320280383341014e-05
in O 0 0.00011870010348502547
non O 0 0.0006227620760910213
- O 0 0.0012324894778430462
Jews O 0 0.0017173689557239413
. O 0 0.0008375183097086847

We O 0 0.001340197864919901
assessed O 0 0.0015054941177368164
the O 0 0.0009083218174055219
I1307K O 1 0.6856272220611572
prevalence O 0 0.0022139118518680334
in O 0 0.00024442336871288717
Israeli O 0 0.0006164417136460543
Jews O 0 0.00032957407529465854
of O 0 0.0001273032685276121
differing O 0 7.7947108366061e-05
ethnic O 0 0.000142090575536713
origin O 0 0.00022288106265477836
and O 0 0.0004788681981153786
risk O 0 0.47736984491348267
for O 1 0.995884120464325
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.604647696018219

METHODS O 0 0.002071820432320237
DNA O 0 0.000658643722999841
samples O 0 0.0001916957990033552
from O 0 0.0002414069458609447
500 O 0 0.0007756193517707288
unrelated O 0 0.00040076981531456113
Jews O 0 0.00036359456134960055
of O 0 0.0002893944620154798
European O 0 0.00025038913008756936
or O 0 0.0002556459221523255
non O 0 0.0003130235127173364
- O 0 0.00034873822005465627
European O 0 0.00010495319293113425
origin O 0 7.256569369928911e-05
, O 0 4.0729712054599077e-05
with O 0 3.9756774640409276e-05
or O 0 8.829491707729176e-05
without O 0 8.681027247803286e-05
a O 0 0.00019720850104931742
personal O 0 0.0007203181157819927
and O 0 0.0004627389134839177
/ O 0 0.18955622613430023
or O 0 0.00028548226691782475
family O 0 0.00031751967617310584
history O 0 0.0007777494611218572
of O 0 0.0029257675632834435
neoplasia B-Disease 1 0.9999970197677612
, O 0 0.00035427097463980317
were O 0 0.00015080404409673065
examined O 0 0.00027188542298972607
for O 0 7.428548269672319e-05
the O 0 0.0003043403849005699
I1307K O 0 0.15088698267936707
variant O 0 0.0007013768190518022
by O 0 7.699133129790425e-05
the O 0 0.0001823528582463041
allele O 0 0.00021585698414128274
- O 0 0.00032225920585915446
specific O 0 0.00011285783693892881
oligonucleotide O 0 0.0039504095911979675
( O 0 0.0011043524136766791
ASO O 1 0.9994450211524963
) O 0 0.0005999710992909968
method O 0 0.0005293228314258158
. O 0 0.00075193599332124

RESULTS O 0 0.0022876542061567307
In O 0 0.0004205072473268956
persons O 0 0.00043677774374373257
at O 0 0.0007773508550599217
average O 0 0.0005909751052968204
risk O 0 0.0008056708611547947
for O 0 0.008426457643508911
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 1 0.6254330277442932
I1307K O 1 0.999993085861206
was O 0 0.005546349100768566
found O 0 0.00019665085710585117
in O 0 0.0001863619836512953
5 O 0 0.0005314605077728629
. O 0 0.00041172580677084625

0 O 0 0.0006301170215010643
% O 0 0.00012339340173639357
of O 0 0.0002216024586232379
120 O 0 0.00046597840264439583
European O 0 0.0002898777020163834
and O 0 0.0002691197150852531
1 O 0 0.0010054224403575063
. O 0 0.0006605752278119326

6 O 0 0.0029541838448494673
% O 0 0.00021919928258284926
of O 0 0.00025184627156704664
188 O 0 0.001681746100075543
non O 0 0.0008214139961637557
- O 0 0.0005573983071371913
European O 0 0.00016161914390977472
Jews O 0 0.00047013035509735346
( O 0 0.00021563564951065928
P O 0 0.0019599676597863436
= O 0 0.000565416063182056
0 O 0 0.000294837896944955
. O 0 0.00018663051014300436
08 O 0 0.0038278456777334213
) O 0 0.00045259384205564857
. O 0 0.0007614934002049267

It O 0 0.0007220514817163348
occurred O 0 0.0025543724186718464
in O 0 0.0003765044966712594
15 O 0 0.0009514970588497818
. O 0 0.0007348269573412836

4 O 0 0.0018335876520723104
% O 0 0.000259557826211676
of O 0 0.00033865365548990667
52 O 0 0.0006565942312590778
Ashkenazi O 0 0.0011763335205614567
Israelis O 0 0.00043218504288233817
with O 0 0.00018562035984359682
familial O 1 0.9988492727279663
cancer B-Disease 1 0.9999954700469971
( O 0 0.009325642138719559
P O 1 0.9059269428253174
= O 0 0.0012858808040618896
0 O 0 0.0002672266273293644
. O 0 0.00012567933299578726
02 O 0 0.0037918519228696823
) O 0 0.0001513090537628159
and O 0 9.30720561882481e-05
was O 0 0.000520248431712389
not O 0 4.6111952542560175e-05
detected O 0 0.0002550642821006477
in O 0 8.197284478228539e-05
51 O 0 0.00044860198977403343
non O 0 0.00044630872434936464
- O 0 0.0003227323468308896
European O 0 0.0001396905427100137
Jews O 0 0.0008119216072373092
at O 0 0.003133751219138503
increased O 0 0.004675069823861122
cancer B-Disease 1 0.9996603727340698
risk O 0 0.0025360542349517345
. O 0 0.0012199175544083118

Colorectal B-Disease 1 0.999998927116394
neoplasia I-Disease 1 0.9999958276748657
occurred O 1 0.9980975985527039
personally O 0 0.008753279224038124
or O 0 0.00019677277305163443
in O 0 0.00010892204591073096
the O 0 8.45344111439772e-05
families O 0 4.0224138501798734e-05
of O 0 0.00010708476474974304
13 O 0 0.00027487106854096055
of O 0 0.0002777670742943883
20 O 0 0.0007246948080137372
Ashkenazi O 0 0.0028709645848721266
I1307K O 1 0.9863088726997375
carriers O 0 0.0006170101114548743
, O 0 9.754271013662219e-05
8 O 0 0.00023030067677609622
of O 0 0.00015232773148454726
whom O 0 0.0002617193094920367
also O 0 0.00014311254199128598
had O 0 0.00017982194549404085
a O 0 0.0002211536921095103
personal O 0 0.0005019305972382426
or O 0 0.0002687848173081875
family O 0 0.0004620533436536789
history O 0 0.0018088658107444644
of O 0 0.34078654646873474
noncolonic O 1 0.9999998807907104
neoplasia B-Disease 1 0.9999990463256836
. O 0 0.0035459822975099087

CONCLUSIONS O 0 0.009240635670721531
The O 0 0.004766030237078667
I1307K O 1 0.9993529915809631
APC O 1 0.9990887641906738
variant O 0 0.0022893177811056376
may O 0 0.0002482573327142745
represent O 0 0.00016538336058147252
a O 0 0.00020976744417566806
susceptibility O 0 0.0011721624759957194
gene O 0 0.00035291252424940467
for O 0 0.0004161349206697196
colorectal B-Disease 1 1.0
, I-Disease 0 0.0007235303637571633
or I-Disease 0 0.0004090607981197536
other I-Disease 0 0.00014216740964911878
, I-Disease 0 0.0003601778007578105
cancers I-Disease 0 0.48725438117980957
in O 0 0.0003517203440424055
Ashkenazi O 0 0.004914766643196344
Jews O 0 0.0013980596559122205
, O 0 0.0003234700998291373
and O 0 0.0001813312992453575
partially O 0 0.0013802946778014302
explains O 0 0.0004500250506680459
the O 0 0.000332423864165321
higher O 0 0.0006939112208783627
incidence O 1 0.8410180807113647
of O 1 0.999947190284729
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.0047964490950107574
European O 0 0.0012681451626121998
Israelis O 0 0.0027996753342449665
. O 0 0.0010824553901329637

Systematic O 0 0.003594891866669059
analysis O 0 0.0006577379535883665
of O 0 0.0018638134934008121
coproporphyrinogen O 1 0.9999899864196777
oxidase O 1 0.9947274327278137
gene O 0 0.010059070773422718
defects O 1 0.9999384880065918
in O 0 0.0016768401255831122
hereditary B-Disease 1 0.9999985694885254
coproporphyria I-Disease 1 0.9999996423721313
and O 0 0.008188610896468163
mutation O 0 0.0017933864146471024
update O 0 0.003471267642453313
. O 0 0.0008883748087100685

Hereditary B-Disease 1 0.9999911785125732
coproporphyria I-Disease 1 0.9999990463256836
( O 1 0.8861954212188721
HC B-Disease 1 0.9999998807907104
) O 0 0.0030311616137623787
is O 0 0.0011166587937623262
an O 0 0.004057815298438072
acute O 1 1.0
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 1 0.9997701048851013
autosomal O 1 0.9999773502349854
dominant O 1 0.9999940395355225
inheritance O 1 0.9998655319213867
caused O 1 0.9999964237213135
by O 0 0.0012095954734832048
deficient B-Disease 1 0.883528470993042
activity I-Disease 0 0.0008195480913855135
of I-Disease 0 0.0019202708499506116
coproporphyrinogen I-Disease 1 0.9999983310699463
III I-Disease 1 0.9999998807907104
oxidase I-Disease 1 0.986127495765686
( O 0 0.0023907001595944166
CPO O 1 0.6191297173500061
) O 0 0.0006421537254936993
. O 0 0.0005616698181256652

Clinical O 0 0.008996747434139252
manifestations O 1 0.5279299020767212
of O 0 0.1232360303401947
the O 1 0.999482274055481
disease O 1 0.9999996423721313
are O 0 0.00027218315517529845
characterized O 0 0.004243375733494759
by O 0 0.0007772574317641556
acute O 1 0.999998927116394
attacks O 1 0.9980721473693848
of O 1 0.9999988079071045
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 1 0.9990917444229126
precipitated O 1 0.9999997615814209
by O 0 0.001135077327489853
drugs O 0 0.0058774566277861595
, O 0 0.0004657139361370355
fasting O 0 0.003581745084375143
, O 0 0.0004668592009693384
cyclical O 1 0.9716317653656006
hormonal O 1 0.9996414184570312
changes O 0 0.0024304466787725687
, O 0 0.007227225694805384
or O 1 0.9983620047569275
infectious B-Disease 1 1.0
diseases I-Disease 1 1.0
. O 0 0.049024924635887146

Skin O 1 1.0
photosensitivity O 1 0.9999998807907104
may O 0 0.06608013808727264
also O 0 0.0006033594254404306
be O 0 0.00022710526536684483
present O 0 0.0008797403424978256
. O 0 0.0008935648365877569

The O 0 0.0016448120586574078
seven O 0 0.0009085200144909322
exons O 0 0.001739442814141512
, O 0 0.0002234044368378818
the O 0 0.0004445984086487442
exon O 0 0.0035271889064460993
/ O 0 0.0015531976241618395
intron O 0 0.0025523079093545675
boundaries O 0 0.00023460287775378674
and O 0 7.6766409620177e-05
part O 0 0.00017019810911733657
of O 0 0.00013913633301854134
3 O 0 0.0001946174306795001
noncoding O 0 0.0005831664893776178
sequence O 0 8.312321733683348e-05
of O 0 0.00011870938760694116
the O 0 0.0003780816914513707
CPO O 0 0.06068387255072594
gene O 0 0.00016437718295492232
were O 0 6.45354448352009e-05
systematically O 0 0.00019809597870334983
analyzed O 0 9.412811050424352e-05
by O 0 4.2208790546283126e-05
an O 0 0.0001051480503519997
exon O 0 0.0024480402935296297
- O 0 0.0007150157471187413
by O 0 0.00018975396233145148
- O 0 0.0011112361680716276
exon O 0 0.004972889553755522
denaturing O 0 0.015878798440098763
gradient O 0 0.011370914988219738
gel O 1 0.7063516974449158
electrophoresis O 0 0.012363332323729992
( O 0 0.0016157705103978515
DGGE O 1 0.9995311498641968
) O 0 0.00022934724984224886
strategy O 0 0.00030638003954663873
followed O 0 0.0002290790871484205
by O 0 5.537537799682468e-05
direct O 0 0.00010416612349217758
sequencing O 0 0.00022037573216948658
in O 0 0.000139566051075235
seven O 0 0.00044157711090520024
unrelated O 0 0.0015493925893679261
heterozygous O 0 0.0014958040555939078
HC B-Disease 1 0.999994158744812
patients O 0 0.0055190748535096645
from O 0 0.0011992478976026177
France O 0 0.010948757641017437
, O 0 0.0004964058753103018
Holland O 0 0.0029150154441595078
, O 0 0.00022257819364313036
and O 0 0.0002313879522262141
Czech O 0 0.0031393314711749554
Republic O 0 0.003579135751351714
. O 0 0.0018449806375429034

Seven O 0 0.002773476764559746
novel O 0 0.001744382898323238
mutations O 0 0.0002984124585054815
and O 0 0.00013373819820117205
two O 0 0.00012346259609330446
new O 0 0.0002940443519037217
polymorphisms O 0 0.0012886825716122985
were O 0 0.0005912184715270996
detected O 0 0.002813474042341113
. O 0 0.0011810444993898273

Among O 0 0.001167960581369698
these O 0 0.00011616254778346047
mutations O 0 0.00014894225751049817
two O 0 6.842430593678728e-05
are O 0 3.703170295921154e-05
missense O 0 0.0014888521982356906
( O 0 0.0007207043818198144
G197W O 1 0.9986574649810791
, O 0 0.0007246620371006429
W427R O 1 0.9929050803184509
) O 0 0.00014381142682395875
, O 0 7.774845289532095e-05
two O 0 4.6833436499582604e-05
are O 0 4.091256050742231e-05
nonsense O 0 0.0016393119003623724
( O 0 0.0005199532024562359
Q306X O 1 0.9986212253570557
, O 0 0.0006015319959260523
Q385X O 1 0.9979031085968018
) O 0 0.000212589162401855
, O 0 6.0604052123380825e-05
two O 0 3.8224883610382676e-05
are O 0 1.8313125110580586e-05
small O 0 0.00011503303539939225
deletions O 0 0.0017997733084484935
( O 0 0.0007306463667191565
662de14bp O 1 0.9509152173995972
; O 0 0.0004753426765091717
1168del3bp O 0 0.019647644832730293
removing O 0 0.001860025804489851
a O 0 0.0003722613037098199
glycine O 0 0.0012271853629499674
at O 0 0.00041975389467552304
position O 0 0.0003278936492279172
390 O 0 0.0017768177203834057
) O 0 0.00012770085595548153
, O 0 5.0884926167782396e-05
and O 0 3.5857603506883606e-05
one O 0 4.511114093475044e-05
is O 0 5.109552512294613e-05
a O 0 0.00016290423809550703
splicing O 0 0.0008917285013012588
mutation O 0 0.0005119884153828025
( O 0 0.0006416832911781967
IVS1 O 1 0.9998703002929688
- O 0 0.004458525683730841
15c O 0 0.02632271684706211
- O 0 0.0023179221898317337
- O 0 0.0012521817116066813
> O 0 0.0015088581712916493
g O 0 0.000681919336784631
) O 0 9.512701217317954e-05
which O 0 7.368704973487183e-05
creates O 0 0.00025070871924981475
a O 0 0.0002569268108345568
new O 0 0.0002263739297632128
acceptor O 0 0.0013836430152878165
splice O 0 0.00922336895018816
site O 0 0.0042474702931940556
. O 0 0.0011792363366112113

The O 0 0.002876131795346737
pathological O 0 0.004615785088390112
significance O 0 0.0012084564659744501
of O 0 0.00043665204429998994
the O 0 0.0006382608553394675
point O 0 0.001066548633389175
mutations O 0 0.0006127086817286909
G197W O 1 0.9988546371459961
, O 0 0.00045995632535777986
W427R O 1 0.9975144863128662
, O 0 0.00025099143385887146
and O 0 0.00012618473556358367
the O 0 0.0002717921161092818
in O 0 0.00025911207194440067
- O 0 0.0012826870661228895
frame O 0 0.0035765431821346283
deletion O 0 0.0028533099684864283
390delGly O 1 0.5100166201591492
were O 0 0.0002166280901292339
assessed O 0 0.00022822144092060626
by O 0 4.031918433611281e-05
their O 0 3.129500328213908e-05
respective O 0 0.00012538532610051334
expression O 0 0.00018766531138680875
in O 0 0.0001296050031669438
a O 0 0.00019601026724558324
prokaryotic O 0 0.0004906918038614094
system O 0 0.00018146101501770318
using O 0 0.00014159634883981198
site O 0 0.0011790817370638251
- O 0 0.0012418966507539153
directed O 0 0.0010139442747458816
mutagenesis O 0 0.004815875552594662
. O 0 0.0009155588340945542

These O 0 0.0004013783182017505
mutations O 0 0.00046947746886871755
resulted O 0 0.0006050659576430917
in O 0 0.00013553164899349213
the O 0 0.0002923110732808709
absence O 0 0.0009098774171434343
or O 0 0.00021323675173334777
a O 0 0.00035032667801715434
dramatic O 0 0.001934557338245213
decrease O 0 0.0017292372649535537
of O 0 0.0022788336500525475
CPO O 1 0.9873077273368835
activity O 0 0.0028109669219702482
. O 0 0.0007653017528355122

The O 0 0.0014324014773592353
two O 0 0.0005873760674148798
polymorphisms O 0 0.0015788204036653042
were O 0 0.00024070734798442572
localized O 0 0.0007692471262998879
in O 0 0.000171680047060363
noncoding O 0 0.0006505249766632915
part O 0 0.00016492603754159063
of O 0 9.839844278758392e-05
the O 0 0.00014801138604525477
gene O 0 8.160814468283206e-05
1 O 0 0.0001086643387679942
) O 0 4.202031414024532e-05
a O 0 0.00016824509657453746
C O 0 0.0010156295029446483
/ O 0 0.0011614226968958974
G O 0 0.0016010573599487543
polymorphism O 0 0.0004188793245702982
in O 0 0.00018087952048517764
the O 0 0.0004678335099015385
promotor O 0 0.024885427206754684
region O 0 0.0008428847650066018
, O 0 0.00026991008780896664
142 O 0 0.0011498027015477419
bp O 0 0.0014557557879015803
upstream O 0 0.000495201617013663
from O 0 7.297797128558159e-05
the O 0 0.0001487703702878207
transcriptional O 0 0.000688756350427866
initiation O 0 0.0011477695079520345
site O 0 0.000881759449839592
( O 0 0.00036264778464101255
- O 0 0.0011344191152602434
142C O 0 0.3639133870601654
/ O 0 0.002481861039996147
G O 0 0.0028633195906877518
) O 0 0.00012330355821177363
, O 0 5.262602644506842e-05
and O 0 5.340620919014327e-05
2 O 0 0.00014093630306888372
) O 0 5.2247934945626184e-05
a O 0 0.00012952050019521266
6 O 0 0.0005066158482804894
bp O 0 0.0021398814860731363
deletion O 0 0.0003474522673059255
polymorphism O 0 0.00016257245442830026
in O 0 5.2929663070244715e-05
the O 0 0.00012383093417156488
3 O 0 0.000172012674738653
noncoding O 0 0.0005123061710037291
part O 0 0.00014838615607004613
of O 0 0.00019660717225633562
the O 0 0.0006360341794788837
CPO O 1 0.7333715558052063
gene O 0 0.0003434672544244677
, O 0 0.00017354812007397413
574 O 0 0.0030905059538781643
bp O 0 0.001951880636624992
downstream O 0 0.0005771269206888974
of O 0 0.00015859400446061045
the O 0 0.00012487202184274793
last O 0 0.00018556584836915135
base O 0 0.000270536431344226
of O 0 0.00014748561079613864
the O 0 0.00034016105928458273
normal O 0 0.000729396240785718
termination O 0 0.002093324437737465
codon O 0 0.001655452186241746
( O 0 0.0005276516312733293
+ O 0 0.0026793594006448984
574 O 0 0.024158239364624023
delATTCTT O 1 0.9249707460403442
) O 0 0.0012458236888051033
. O 0 0.0011490493780001998

Five O 0 0.007935749366879463
intragenic O 1 0.9994794726371765
dimorphisms O 1 0.9987888932228088
are O 0 0.00013254329678602517
now O 0 0.00017466521239839494
well O 0 0.00011135335080325603
characterized O 0 0.00032473908504471183
and O 0 9.5772797067184e-05
the O 0 0.00016060416237451136
high O 0 0.0005438652588054538
degree O 0 0.0003623578231781721
of O 0 0.0007682146388106048
allelic O 0 0.007328398991376162
heterogeneity O 0 0.002692365786060691
in O 0 0.0007530538714490831
HC B-Disease 1 0.9999903440475464
is O 0 0.0004650549672078341
demonstrated O 0 0.00034106182283721864
with O 0 4.241821443429217e-05
seven O 0 6.450917135225609e-05
new O 0 4.6371515054488555e-05
different O 0 1.996415448957123e-05
mutations O 0 3.645259130280465e-05
making O 0 6.56506817904301e-05
a O 0 8.311052806675434e-05
total O 0 0.00010594253399176523
of O 0 0.00046250413288362324
nineteen O 0 0.017329968512058258
CPO O 1 0.999897837638855
gene B-Disease 0 0.006164873484522104
defects I-Disease 1 0.9998964071273804
reported O 0 0.0008468694286420941
so O 0 0.00014288198144640774
far O 0 0.00029582568095065653
. O 0 0.00016902948846109211
. O 0 0.00037442491156980395

Coincidence O 0 0.00844105239957571
of O 0 0.0012872056104242802
two O 0 0.00040445546619594097
novel O 0 0.0009561707847751677
arylsulfatase O 0 0.4100092649459839
A O 0 0.0021598089952021837
alleles O 0 0.0005081085837446153
and O 0 0.0003019419382326305
mutation O 0 0.0007083548698574305
459 O 0 0.013520848006010056
+ O 0 0.004805807489901781
1G O 0 0.2478378266096115
> O 0 0.0010595768690109253
A O 0 0.0003939791349694133
within O 0 0.00012441942817531526
a O 0 0.0001878477487480268
family O 0 0.0003847026382572949
with O 0 0.0005243518971838057
metachromatic B-Disease 1 0.9999997615814209
leukodystrophy I-Disease 1 0.9999992847442627
: O 0 0.0009512282558716834
molecular O 0 0.0004432710411492735
basis O 0 0.00014884103438816965
of O 0 0.0005055879009887576
phenotypic O 0 0.006305687595158815
heterogeneity O 0 0.011310841888189316
. O 0 0.0014036227948963642

In O 0 0.0010062898509204388
a O 0 0.0004457734466996044
family O 0 0.00026502530090510845
with O 0 7.297560659935698e-05
three O 0 0.00016959126514848322
siblings O 0 0.0011439392110332847
, O 0 0.00015463592717424035
one O 0 0.0001650611957302317
developed O 0 0.0004847051459364593
classical O 0 0.0026672258973121643
late O 1 0.9936953186988831
infantile O 1 1.0
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 1 0.9973092079162598
MLD B-Disease 1 1.0
) O 0 0.0005550761125050485
, O 0 0.0002113567024935037
fatal O 0 0.3249222934246063
at O 0 0.0007119356305338442
age O 0 0.00024512840900570154
5 O 0 0.0002232415572507307
years O 0 0.00012395900557748973
, O 0 9.242130181519315e-05
with O 0 0.00019641847757156938
deficient O 1 0.9733381867408752
arylsulfatase O 1 0.9998121857643127
A O 1 0.6439453363418579
( O 0 0.0013585853157564998
ARSA O 1 0.9987185001373291
) O 0 0.00021533873223233968
activity O 0 0.00023409209097735584
and O 0 0.00011855100456159562
increased O 0 0.0007176808430813253
galactosylsulfatide O 1 0.9999376535415649
( O 0 0.012805869802832603
GS O 1 0.9999995231628418
) O 0 0.0017889209557324648
excretion O 0 0.009186772629618645
. O 0 0.0010887711541727185

The O 0 0.0014399195788428187
two O 0 0.0002862221735995263
other O 0 0.00024208043760154396
siblings O 0 0.0016819325974211097
, O 0 0.0002832820755429566
apparently O 0 0.0007087690755724907
healthy O 0 0.0005243924097158015
at O 0 0.0002732117136474699
12 O 0 0.00022627011639997363
( O 0 0.00012510456144809723
1 O 0 0.00024783940170891583
/ O 0 0.0005008314037695527
2 O 0 0.0001962619717232883
) O 0 4.114006878808141e-05
and O 0 4.7856119635980576e-05
15 O 0 8.746620733290911e-05
years O 0 0.00012439332203939557
, O 0 8.805149991530925e-05
respectively O 0 0.00019813318795058876
, O 0 6.987076631048694e-05
and O 0 6.910614320077002e-05
their O 0 7.347192877205089e-05
father O 0 0.0033864763099700212
, O 0 0.0004650467890314758
apparently O 0 0.0014230229426175356
healthy O 0 0.0008794284658506513
as O 0 0.00021874663070775568
well O 0 0.00014681996253784746
, O 0 0.00022244754654821008
presented O 0 0.0016057946486398578
ARSA O 1 0.9997745156288147
and O 0 0.0021123839542269707
GS O 1 0.9999371767044067
values O 0 0.00037945981603115797
within O 0 0.0002100344281643629
the O 0 0.0002701098856050521
range O 0 0.0004425216175150126
of O 0 0.0026420021895319223
MLD B-Disease 1 1.0
patients O 0 0.18819542229175568
. O 0 0.0018836753442883492

Mutation O 0 0.0028816673438996077
screening O 0 0.0006111590773798525
and O 0 0.00014109576295595616
sequence O 0 0.00017267672228626907
analysis O 0 6.519842281704769e-05
disclosed O 0 0.00034351847716607153
the O 0 0.00016442922060377896
involvement O 0 0.0005168732604943216
of O 0 0.0003373947984073311
three O 0 0.00013690351624973118
different O 0 0.00013909893459640443
ARSA O 1 0.9996103644371033
mutations O 0 0.0003318516828585416
being O 0 0.00016828681691549718
the O 0 0.0001804941421141848
molecular O 0 0.00028265779837965965
basis O 0 0.00014536369417328387
of O 0 0.0006938139558769763
intrafamilial O 1 0.9951632022857666
phenotypic O 0 0.01358463428914547
heterogeneity O 0 0.012204255908727646
. O 0 0.0024208873510360718

The O 0 0.007212959695607424
late O 0 0.18442219495773315
infantile O 1 0.9999762773513794
patient O 0 0.06367722153663635
inherited O 1 0.9997138381004333
from O 0 0.0018701365916058421
his O 0 0.004221693612635136
mother O 0 0.001917939749546349
the O 0 0.0005575101240538061
frequent O 0 0.00041061066440306604
0 O 0 0.00032127537997439504
- O 0 0.0006628698902204633
type O 0 0.0004462921933736652
mutation O 0 0.0003063143522012979
459 O 0 0.005850991699844599
+ O 0 0.0025684870779514313
1G O 0 0.22290949523448944
> O 0 0.0010540286311879754
A O 0 0.0005556920659728348
, O 0 9.592917922418565e-05
and O 0 5.8659188653109595e-05
from O 0 0.00010133304022019729
his O 0 0.00044515388435684144
father O 0 0.0019702627323567867
a O 0 0.0005217295256443322
novel O 0 0.0007456743041984737
, O 0 0.0001523518585599959
single O 0 0.0003189197741448879
basepair O 0 0.10361304879188538
microdeletion O 0 0.020641852170228958
of O 0 0.0008708788664080203
guanine O 0 0.0016858773306012154
at O 0 0.0004349683003965765
nucleotide O 0 0.00023993469949346036
7 O 0 0.00019459796021692455
in O 0 9.020810102811083e-05
exon O 0 0.0012436824617907405
1 O 0 0.0006114609423093498
( O 0 0.0006851465441286564
7delG O 1 0.6191162467002869
) O 0 0.000622347928583622
. O 0 0.0005413007456809282

The O 0 0.0033337827771902084
two O 0 0.001018277369439602
clinically O 0 0.03269891440868378
unaffected O 0 0.004291381221264601
siblings O 0 0.0011946731247007847
carried O 0 0.0003697557549457997
the O 0 0.0003651279548648745
maternal O 0 0.0020823562517762184
mutation O 0 0.0007935200119391084
459 O 0 0.09404852241277695
+ O 0 0.005726787261664867
1G O 1 0.9525871276855469
> O 0 0.001335982116870582
A O 0 0.0005423208349384367
and O 0 7.887314859544858e-05
, O 0 6.424230377888307e-05
on O 0 7.58392852731049e-05
their O 0 4.508903293753974e-05
paternal O 0 0.0006791013875044882
allele O 0 0.00032115104841068387
, O 0 0.00012742180842906237
a O 0 0.00023982491984497756
novel O 0 0.0005231736577115953
cytosine O 0 0.0008270374382846057
to O 0 0.0001474615855840966
thymidine O 0 0.0017766655655577779
transition O 0 0.0009911488741636276
at O 0 0.0006230458966456354
nucleotide O 0 0.0010025802766904235
2435 O 0 0.014830094762146473
in O 0 0.00036996626295149326
exon O 0 0.0025227845180779696
8 O 0 0.0005520099075511098
, O 0 0.0001263893354916945
resulting O 0 0.00026983139105141163
in O 0 0.00012162188795628026
substitution O 0 0.0006717299111187458
of O 0 0.0005301123019307852
alanine O 0 0.0028268839232623577
464 O 0 0.007948112674057484
by O 0 0.0006359195685945451
valine O 1 0.5507256388664246
( O 0 0.0017783493967726827
A464V O 1 0.997246503829956
) O 0 0.0011063062120229006
. O 0 0.001080143265426159

The O 0 0.0036755185574293137
fathers O 0 0.005439739674329758
genotype O 0 0.003949482925236225
thus O 0 0.000963654718361795
was O 0 0.0077162547968328
7delG O 1 0.9998051524162292
/ O 1 0.9634904265403748
A464V O 1 0.9977533221244812
. O 0 0.003298237221315503

Mutation O 0 0.006968238390982151
A464V O 1 0.990656316280365
was O 0 0.0019216265063732862
not O 0 8.836483175400645e-05
found O 0 0.00012211938155815005
in O 0 0.00022990706202108413
18 O 0 0.0013638513628393412
unrelated O 0 0.42381730675697327
MLD B-Disease 1 1.0
patients O 0 0.003401773050427437
and O 0 0.0005147689371369779
50 O 0 0.0012163404608145356
controls O 0 0.0014500857796519995
. O 0 0.0009153382270596921

A464V O 1 0.9973727464675903
, O 0 0.001995259430259466
although O 0 0.0004588798910845071
clearly O 0 0.0013507669791579247
modifying O 0 0.005043387413024902
ARSA O 1 0.9999089241027832
and O 0 0.006346732843667269
GS O 1 1.0
levels O 0 0.005558297038078308
, O 0 0.00024353244225494564
apparently O 0 0.000624859647359699
bears O 0 0.00047546011046506464
little O 0 0.0004560654633678496
significance O 0 0.0005172446253709495
for O 0 0.0001337008288828656
clinical O 0 0.0010511104483157396
manifestation O 1 0.9997918009757996
of O 1 0.9991768002510071
MLD B-Disease 1 1.0
, O 0 0.004071305505931377
mimicking O 0 0.009986238554120064
the O 0 0.0019232770428061485
frequent O 0 0.004469661507755518
ARSA O 1 0.99992835521698
pseudodeficiency O 1 0.9992169141769409
allele O 0 0.004745136946439743
. O 0 0.0017225268529728055

Our O 0 0.002301456406712532
results O 0 0.00046606731484644115
demonstrate O 0 0.0004001252236776054
that O 0 5.4396692576119676e-05
in O 0 7.856118463678285e-05
certain O 0 0.00014170170470606536
genetic O 0 0.0019274079240858555
conditions O 1 0.9996286630630493
MLD B-Disease 1 1.0
- O 1 0.9995656609535217
like O 0 0.004635676741600037
ARSA O 1 0.999907374382019
and O 0 0.0013978906208649278
GS O 1 0.9999897480010986
values O 0 0.0003085203643422574
need O 0 8.962043648352847e-05
not O 0 2.3867176423664205e-05
be O 0 3.446855043875985e-05
paralleled O 0 0.0007859643083065748
by O 0 0.00018787711451295763
clinical O 0 0.28402239084243774
disease O 1 0.9999991655349731
, O 0 0.0005150793585926294
a O 0 0.000551841570995748
finding O 0 0.00031769712222740054
with O 0 0.0002537585678510368
serious O 1 0.7056103944778442
diagnostic O 0 0.2588688135147095
and O 0 0.0030990501400083303
prognostic O 1 0.9994230270385742
implications O 0 0.02899206057190895
. O 0 0.0015704556135460734

Moreover O 0 0.00785236619412899
, O 0 0.0012275358894839883
further O 0 0.0022240292746573687
ARSA O 1 0.9863944053649902
alleles O 0 0.0014921055408194661
functionally O 0 0.0019592256285250187
similar O 0 0.00023100615362636745
to O 0 0.00029164575971663
A464V O 1 0.9960922598838806
might O 0 0.0003648205893114209
exist O 0 7.947374251671135e-05
which O 0 2.5251076294807717e-05
, O 0 3.339392787893303e-05
together O 0 3.573992944438942e-05
with O 0 4.4171116314828396e-05
0 O 0 0.00021131277026142925
- O 0 0.0009940842865034938
type O 0 0.0008442295365966856
mutations O 0 0.0004470221174415201
, O 0 0.0003371211641933769
may O 0 0.0010452992282807827
cause O 1 0.9283197522163391
pathological O 1 0.9999967813491821
ARSA O 1 1.0
and O 1 0.9988653659820557
GS O 1 1.0
levels O 0 0.016908254474401474
, O 0 0.00017474799824412912
but O 0 3.3160962630063295e-05
not O 0 2.6194311431027018e-05
clinical O 0 0.0002749084960669279
outbreak O 0 0.08540671318769455
of O 0 0.004577213432639837
the O 1 0.9995571970939636
disease O 1 1.0
. O 0 0.0009410702041350305
. O 0 0.001032618572935462

Human O 1 0.9993994235992432
MLH1 O 1 0.9999998807907104
deficiency O 1 1.0
predisposes O 1 0.9999901056289673
to O 1 0.5012065172195435
hematological B-Disease 1 0.9999990463256836
malignancy I-Disease 1 0.9999998807907104
and O 1 0.9396710395812988
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9989243149757385
1 I-Disease 0 0.03768832981586456
. O 0 0.0009382089483551681

Heterozygous O 0 0.007357138674706221
germ O 1 0.9994764924049377
- O 0 0.004997905343770981
line O 0 0.0013653862988576293
mutations O 0 0.00017987408500630409
in O 0 0.00012708434951491654
the O 0 0.0003755930520128459
DNA O 0 0.0015690044965595007
mismatch O 1 0.9987238049507141
repair O 1 0.999657392501831
genes O 0 0.0007236668607220054
lead O 0 0.002364031272009015
to O 0 0.0012913787504658103
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.08298420161008835

The O 0 0.16993804275989532
disease O 1 0.999996542930603
susceptibility O 1 0.7269694805145264
of O 0 0.02783932164311409
individuals O 0 0.00024671319988556206
who O 0 0.0006381137063726783
constitutionally O 0 0.0011987070320174098
lack O 0 0.0004153040936216712
both O 0 0.00016125585534609854
wild O 0 0.000906764471437782
- O 0 0.0010104515822604299
type O 0 0.0004771117528434843
alleles O 0 0.0002920614497270435
is O 0 0.00018170857219956815
unknown O 0 0.00107481237500906
. O 0 0.0008326667011715472

We O 0 0.0007249086047522724
have O 0 9.364841389469802e-05
identified O 0 0.00017624565225560218
three O 0 0.00013497886538971215
offspring O 0 0.0003183720400556922
in O 0 0.0003244574763812125
a O 0 0.0033910723868757486
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 0.9987276196479797
who O 0 0.022905029356479645
developed O 1 0.7016423940658569
hematological B-Disease 1 0.9999972581863403
malignancy I-Disease 1 0.9999996423721313
at O 0 0.06393782794475555
a O 0 0.00027423049323260784
very O 0 8.874372724676505e-05
early O 0 0.00015412215725518763
age O 0 0.00014708675735164434
, O 0 7.287727203220129e-05
and O 0 6.457120616687462e-05
at O 0 0.00016479179612360895
least O 0 4.193272616248578e-05
two O 0 2.0528374079731293e-05
of O 0 0.00010692477371776477
them O 0 0.00010093589662574232
displayed O 0 0.0010073718149214983
signs O 0 0.002161651151254773
of O 0 0.0017721696058288217
neurofibromatosis B-Disease 1 0.9999992847442627
type I-Disease 1 0.9834044575691223
1 I-Disease 0 0.06560170650482178
( O 0 0.0018832291243597865
NF1 B-Disease 1 0.9968540072441101
) O 0 0.0008507152670063078
. O 0 0.0007011991110630333

DNA O 0 0.0015777398366481066
sequence O 0 0.00032925218692980707
analysis O 0 8.972339128376916e-05
and O 0 0.0001022549913614057
allele O 0 0.0003092869883403182
- O 0 0.0003151498385705054
specific O 0 0.00011119217379018664
amplification O 0 0.0004413608112372458
in O 0 9.073644469026476e-05
two O 0 0.00010040064080385491
siblings O 0 0.0007653520442545414
revealed O 0 0.0009310387540608644
a O 0 0.0008730074041523039
homozygous O 0 0.0028191281016916037
MLH1 O 1 0.9993491768836975
mutation O 0 0.000982123427093029
( O 0 0.0008316676830872893
C676T O 1 0.9982882142066956
- O 0 0.015082457102835178
- O 0 0.0051932004280388355
> O 0 0.005410695914179087
Arg226Stop O 1 0.9805902242660522
) O 0 0.0009428701596334577
. O 0 0.0008059837855398655

Thus O 0 0.0029249428771436214
, O 0 0.0008706082589924335
a O 0 0.001472380245104432
homozygous O 0 0.007198672741651535
germ O 1 0.9998723268508911
- O 0 0.05195029452443123
line O 0 0.013549714349210262
MLH1 O 1 0.9997907280921936
mutation O 0 0.002236632164567709
and O 0 0.0012710497248917818
consequent O 1 0.9999682903289795
mismatch O 1 1.0
repair O 1 1.0
deficiency O 1 1.0
results O 0 0.004765644203871489
in O 0 0.0005952147184871137
a O 0 0.0014513266505673528
mutator O 1 0.9995734095573425
phenotype O 0 0.006792518310248852
characterized O 0 0.006043175235390663
by O 0 0.001066051423549652
leukemia B-Disease 1 1.0
and O 1 0.9984183311462402
/ O 1 0.9999991655349731
or O 1 0.999941349029541
lymphoma B-Disease 1 1.0
associated O 0 0.031605176627635956
with O 0 0.0027097200509160757
neurofibromatosis B-Disease 1 0.9999998807907104
type I-Disease 1 0.9884992241859436
1 I-Disease 0 0.010491258464753628
. O 0 0.0003918121801689267
. O 0 0.0003934333799406886

Missense O 0 0.01859874837100506
mutations O 0 0.0008952470379881561
in O 0 0.0002732640423346311
the O 0 0.00022671434271614999
most O 0 0.00012316230277065188
ancient O 0 0.0008814075263217092
residues O 0 0.0005360093782655895
of O 0 0.0005481808329932392
the O 0 0.0012968990486115217
PAX6 O 1 0.9983766078948975
paired O 0 0.0016430143732577562
domain O 0 0.0005514556542038918
underlie O 0 0.0027841508854180574
a O 0 0.0007703386945649981
spectrum O 0 0.002578101819381118
of O 1 0.9751160144805908
human O 1 0.9999998807907104
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 1.0
. O 1 0.9994039535522461

Mutations O 0 0.0016161220846697688
of O 0 0.0009835445089265704
the O 0 0.0017584387678653002
human O 0 0.006618840154260397
PAX6 O 1 0.9999979734420776
gene O 1 0.5123897790908813
underlie O 1 0.9999984502792358
aniridia B-Disease 1 1.0
( O 1 0.9994975328445435
congenital B-Disease 1 1.0
absence I-Disease 1 0.9956339001655579
of I-Disease 1 0.9661428928375244
the I-Disease 1 0.9975547194480896
iris I-Disease 1 0.999887228012085
) O 0 0.0003356975212227553
, O 0 0.00014542220742441714
a O 0 0.00033706045360304415
rare O 0 0.001219407538883388
dominant O 0 0.49500375986099243
malformation B-Disease 1 0.9999996423721313
of I-Disease 1 0.9970996379852295
the I-Disease 1 0.9997014403343201
eye I-Disease 1 0.999976396560669
. O 0 0.0022893352434039116

The O 0 0.005087141878902912
spectrum O 0 0.0037163235247135162
of O 0 0.0020449666772037745
PAX6 O 1 0.9999847412109375
mutations O 0 0.0036943722516298294
in O 0 0.005592279601842165
aniridia B-Disease 1 1.0
patients O 0 0.0016224393621087074
is O 0 0.00018418770923744887
highly O 0 0.00019178737420588732
biased O 0 0.00025548337725922465
, O 0 4.788821024703793e-05
with O 0 3.285878847236745e-05
92 O 0 0.00030578533187508583
% O 0 3.798370744334534e-05
of O 0 9.838814003160223e-05
all O 0 8.912493649404496e-05
reported O 0 0.0002447353908792138
mutations O 0 0.0001756114070303738
leading O 0 0.0006039462168700993
to O 0 0.00016324414173141122
premature O 0 0.0012061219895258546
truncation O 0 0.0012695506447926164
of O 0 0.0003317279915791005
the O 0 0.00039954623207449913
protein O 0 0.00035977934021502733
( O 0 0.00026018472271971405
nonsense O 0 0.0016669471515342593
, O 0 0.00020492912153713405
splicing O 0 0.0007582613034173846
, O 0 0.00019801498274318874
insertions O 0 0.0015507024945691228
and O 0 0.0001877134491223842
deletions O 0 0.0009694771142676473
) O 0 0.00012469047214835882
and O 0 6.154534639790654e-05
just O 0 0.0001575029455125332
2 O 0 0.00016736668476369232
% O 0 4.7769844968570396e-05
leading O 0 0.00019433650595601648
to O 0 4.86526514578145e-05
substitution O 0 0.00020507491717580706
of O 0 0.00010168489825446159
one O 0 0.00012412010983098298
amino O 0 0.00018901197472587228
acid O 0 0.00029690840165130794
by O 0 5.925090590608306e-05
another O 0 0.0003023328317794949
( O 0 0.0003645438118837774
missense O 0 0.002110032131895423
) O 0 0.0004343273176345974
. O 0 0.000512730039190501

The O 0 0.0028416516724973917
extraordinary O 0 0.002222997834905982
conservation O 0 0.0008361524669453502
of O 0 0.0003925649798475206
the O 0 0.0007123720133677125
PAX6 O 1 0.9022224545478821
protein O 0 0.0005001237150281668
at O 0 0.00044670669012703
the O 0 0.00020792827126570046
amino O 0 0.0003892764216288924
acid O 0 0.000719187140930444
level O 0 0.000592655676882714
amongst O 0 0.0009418237605132163
vertebrates O 0 0.002278428291901946
predicts O 0 0.0010085251415148377
that O 0 0.00011441505193943158
pathological O 0 0.005809809546917677
missense O 0 0.0032583908177912235
mutations O 0 0.00019067329412791878
should O 0 7.084402022883296e-05
in O 0 8.160658762790263e-05
fact O 0 0.0001258018601220101
be O 0 5.3991516324458644e-05
common O 0 8.241900650318712e-05
even O 0 8.854753104969859e-05
though O 0 5.5722935940138996e-05
they O 0 2.4986498829093762e-05
are O 0 1.868738945631776e-05
hardly O 0 0.00038755632704123855
ever O 0 0.0006113426643423736
seen O 0 0.0009296736097894609
in O 0 0.0010649383766576648
aniridia B-Disease 1 0.9999988079071045
patients O 0 0.008109873160719872
. O 0 0.0014516209485009313

This O 0 0.0005519622936844826
indicates O 0 0.0005465728463605046
that O 0 5.199657243792899e-05
there O 0 7.175700011430308e-05
is O 0 6.570392724825069e-05
a O 0 0.00021159987954888493
heavy O 0 0.0033561510499566793
ascertainment O 1 0.9488730430603027
bias O 0 0.000968668726272881
in O 0 0.00018072059901896864
the O 0 0.00021660869242623448
selection O 0 0.00019234117644373327
of O 0 0.0003254553594160825
patients O 0 0.00037743168650195
for O 0 0.00024300868972204626
PAX6 O 1 0.9997808337211609
mutation O 0 0.0003181050415150821
analysis O 0 6.474526890087873e-05
and O 0 6.133317947387695e-05
that O 0 7.017613825155422e-05
the O 0 0.0004095194162800908
missing O 0 0.0029483793769031763
PAX6 O 1 0.9998857975006104
missense O 0 0.01578247919678688
mutations O 0 0.0014162319712340832
frequently O 0 0.0007248554611578584
may O 0 0.0006511319661512971
underlie O 0 0.013839444145560265
phenotypes O 0 0.002057529054582119
distinct O 0 0.0004674648225773126
from O 0 0.0013557430356740952
textbook O 1 0.9960643649101257
aniridia B-Disease 1 0.9999991655349731
. O 0 0.003918925765901804

Here O 0 0.002219980116933584
we O 0 0.00029954066849313676
present O 0 0.0002497063542250544
four O 0 0.0002605481131467968
novel O 0 0.001489542773924768
PAX6 O 1 0.9986459612846375
missense O 0 0.004915191326290369
mutations O 0 0.0003063998883590102
, O 0 8.665039058541879e-05
two O 0 5.699404937331565e-05
in O 0 0.0001565282727824524
association O 0 0.00040751969208940864
with O 0 0.00036066994653083384
atypical O 1 0.9998971223831177
phenotypes O 1 0.9994903802871704
ectopia B-Disease 1 0.9999997615814209
pupillae I-Disease 1 0.9999990463256836
( O 0 0.0039429450407624245
displaced B-Disease 0 0.006430542562156916
pupils I-Disease 0 0.004408407490700483
) O 0 0.001125326962210238
and O 0 0.012112167663872242
congenital B-Disease 1 1.0
nystagmus I-Disease 1 0.9999998807907104
( O 0 0.06716932356357574
searching B-Disease 0 0.00580964982509613
gaze I-Disease 1 0.5946643948554993
) O 0 0.00018446680041961372
, O 0 6.987070810282603e-05
and O 0 3.343468051753007e-05
two O 0 3.998071770183742e-05
in O 0 0.00011748886754503474
association O 0 0.00022312662622425705
with O 0 0.00012046271876897663
more O 0 0.00034943674108944833
recognizable O 1 0.9986101388931274
aniridia B-Disease 1 0.9999998807907104
phenotypes O 1 0.8333776593208313
. O 0 0.0024446924217045307

Strikingly O 0 0.009335075505077839
, O 0 0.0005732678691856563
all O 0 0.0001089077049982734
four O 0 0.00010307753836968914
mutations O 0 8.456619252683595e-05
are O 0 1.6797228454379365e-05
located O 0 0.0002792908053379506
within O 0 0.00021013779041823
the O 0 0.0007033527945168316
PAX6 O 1 0.9941474199295044
paired O 0 0.0010911532444879413
domain O 0 0.00035655839019455016
and O 0 0.00016520936333108693
affect O 0 0.00022892319248057902
amino O 0 0.00022202375112101436
acids O 0 0.00013590707385446876
which O 0 3.160614869557321e-05
are O 0 1.2481989870138932e-05
highly O 0 7.637168164364994e-05
conserved O 0 0.00013048456457909197
in O 0 7.702982111368328e-05
all O 0 7.816408469807357e-05
known O 0 0.0003552887064870447
paired O 0 0.0006718413205817342
domain O 0 0.0010254541411995888
proteins O 0 0.0008460914250463247
. O 0 0.0007448305259458721

Our O 0 0.002245834330096841
results O 0 0.0003555387374944985
support O 0 0.00020057646906934679
the O 0 0.00013834414130542427
hypothesis O 0 0.00012464600149542093
that O 0 2.2862592231831513e-05
the O 0 7.015137089183554e-05
under O 0 0.0001364268100587651
- O 0 0.00021624942019116133
representation O 0 8.4506202256307e-05
of O 0 0.00035552179906517267
missense O 0 0.0037366182077676058
mutations O 0 0.0004949201247654855
is O 0 0.0002715729642659426
caused O 0 0.047029852867126465
by O 0 0.0004208810278214514
ascertainment O 1 0.9994893074035645
bias O 0 0.002104319864884019
and O 0 0.0001811308175092563
suggest O 0 0.0001866109378170222
that O 0 3.1973271688912064e-05
a O 0 0.00012689895811490715
substantial O 0 0.00044794418499805033
burden O 0 0.0021179858595132828
of O 0 0.07174909859895706
PAX6 B-Disease 1 1.0
- I-Disease 1 0.9999011754989624
related I-Disease 1 0.8070274591445923
disease I-Disease 1 0.9999984502792358
remains O 0 0.1147124171257019
to O 0 0.00023499327653553337
be O 0 0.00019785945187322795
uncovered O 0 0.0033346209675073624
. O 0 0.0003643084492068738
. O 0 0.0005655780551023781

The O 0 0.003458821913227439
chromosomal O 0 0.005065645091235638
order O 0 0.0005612958339042962
of O 0 0.0006728835869580507
genes O 0 0.00039128196658566594
controlling O 0 0.0012136739678680897
the O 0 0.0008249225793406367
major O 0 0.4003053903579712
histocompatibility O 1 0.9999997615814209
complex O 1 0.9623972773551941
, O 0 0.0007353159599006176
properdin O 1 0.9965153932571411
factor O 0 0.0023331039119511843
B O 0 0.0038768823724240065
, O 0 0.00023090311151463538
and O 0 0.00029540230752900243
deficiency B-Disease 1 0.9998973608016968
of I-Disease 0 0.0014711398398503661
the I-Disease 0 0.0019547923002392054
second I-Disease 0 0.002895758952945471
component I-Disease 0 0.0020696427673101425
of I-Disease 0 0.0008748034597374499
complement I-Disease 0 0.0023034634068608284
. O 0 0.000630288734100759

The O 0 0.001394954277202487
relationship O 0 0.0005255112191662192
of O 0 0.0004332354583311826
the O 0 0.0005005839630030096
genes O 0 0.0002861550892703235
coding O 0 0.0006418918492272496
for O 0 0.00015363415877800435
HLA O 1 0.8487017750740051
to O 0 0.00016814116679597646
those O 0 5.759911800851114e-05
coding O 0 0.00031961893546395004
for O 0 0.0001974919141503051
properdin O 1 0.98411625623703
Factor O 0 0.003592940280213952
B O 0 0.010620330460369587
allotypes O 1 0.8531531691551208
and O 0 0.00033026793971657753
for O 0 0.0002783736272249371
deficiency B-Disease 1 0.999890923500061
of I-Disease 0 0.000770299753639847
the I-Disease 0 0.0010205188300460577
second I-Disease 0 0.001154100988060236
component I-Disease 0 0.0011564349988475442
of I-Disease 0 0.0005409092409536242
complement I-Disease 0 0.0033591382671147585
( O 0 0.0012396351667121053
C2 O 1 0.9995423555374146
) O 0 0.00016952563601080328
was O 0 0.0004300752771086991
studied O 0 0.00022261215781327337
in O 0 9.31866088649258e-05
families O 0 0.00011572507355595008
of O 0 0.0008143259328790009
patients O 1 0.7613001465797424
with O 1 0.9997077584266663
connective O 1 1.0
tissue O 1 1.0
disorders O 1 1.0
. O 1 0.9998114705085754

Patients O 0 0.004512566141784191
were O 0 0.0005302524659782648
selected O 0 0.0003894286055583507
because O 0 0.00012474373215809464
they O 0 5.100871931063011e-05
were O 0 0.00014199547877069563
heterozygous O 0 0.00040593231096863747
or O 0 0.0005748628755100071
homozygous O 0 0.004672432783991098
for O 0 0.007645417470484972
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.07440638542175293

12 O 0 0.0023306943476200104
families O 0 0.0003317678638268262
with O 0 0.00017622816085349768
15 O 0 0.0008672179537825286
matings O 0 0.0068805767223238945
informative O 0 0.0036049161572009325
for O 0 0.006726371590048075
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 0.00602674251422286
found O 0 0.0013952305307611823
. O 0 0.0012652537552639842

Of O 0 0.004377805627882481
57 O 0 0.004880280699580908
informative O 0 0.0031803029123693705
meioses O 0 0.3189148008823395
, O 0 0.0003627619007602334
two O 0 0.0001323917240370065
crossovers O 0 0.0006674181786365807
were O 0 0.0001560823293402791
noted O 0 0.0002688058011699468
between O 0 0.00047857750905677676
the O 0 0.06310359388589859
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 0.0011772357393056154
and O 0 0.0004506109980866313
the O 0 0.003491484560072422
HLA O 1 0.9999991655349731
- O 0 0.008523858152329922
B O 0 0.0011819831561297178
gene O 0 0.00011138277477584779
, O 0 2.859211599570699e-05
with O 0 2.3061886167852208e-05
a O 0 9.40688987611793e-05
recombinant O 0 0.0003845187311526388
fraction O 0 0.00019782020535785705
of O 0 0.00027765691629610956
0 O 0 0.0004670369962695986
. O 0 0.00034968656837008893

035 O 1 0.9443745613098145
. O 0 0.008413542062044144

A O 0 0.005001978483051062
lod O 0 0.008509451523423195
score O 0 0.00036270328564569354
of O 0 0.00027988734655082226
13 O 0 0.0006156865856610239
was O 0 0.0006207715487107635
calculated O 0 0.00019394594710320234
for O 0 0.00013072702859062701
linkage O 0 0.004360835067927837
between O 0 0.4805586338043213
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 1 0.9959285855293274
HLA O 1 1.0
- O 0 0.18475748598575592
B O 0 0.0009513538680039346
at O 0 0.00020256546849850565
a O 0 5.680954927811399e-05
maximum O 0 3.898851355188526e-05
likelihood O 0 5.704733484890312e-05
value O 0 1.3918952390667982e-05
of O 0 4.4132215407444164e-05
the O 0 0.00017831395962275565
recombinant O 0 0.0007907761028036475
fraction O 0 0.0002825316914822906
of O 0 0.0004186898877378553
0 O 0 0.0005832379101775587
. O 0 0.0005664469208568335

04 O 1 0.8633009195327759
. O 0 0.007133391220122576

18 O 0 0.0018965047784149647
families O 0 0.00023773862631060183
with O 0 0.0001453783770557493
21 O 0 0.0005112079670652747
informative O 0 0.000467959966044873
matings O 0 0.0010039217304438353
for O 0 8.605536277173087e-05
both O 0 0.0001533583999844268
properdin O 1 0.9841548204421997
Factor O 0 0.0032368674874305725
B O 0 0.0077719492837786674
allotype O 1 0.995707094669342
and O 0 0.001143173431046307
HLA O 1 0.9999902248382568
- O 0 0.012706665322184563
B O 0 0.002900482388213277
were O 0 0.0003686685231514275
found O 0 0.0005782248335890472
. O 0 0.000497670320328325

Of O 0 0.003705747192725539
72 O 0 0.005244697444140911
informative O 0 0.0022883738856762648
meioses O 0 0.3004906475543976
, O 0 0.00036391758476383984
three O 0 0.00021922998712398112
recombinants O 0 0.1453787088394165
were O 0 0.0002596964768599719
found O 0 0.00013252926873974502
, O 0 7.523378008045256e-05
giving O 0 0.00010700167331378907
a O 0 0.00014014350017532706
recombinant O 0 0.0004927973495796323
fraction O 0 0.0002486339653842151
of O 0 0.0002951787901110947
0 O 0 0.00047255298704840243
. O 0 0.0005281331250444055

042 O 1 0.9962188601493835
. O 0 0.010132458060979843

A O 0 0.00478048762306571
lod O 0 0.006506670732051134
score O 0 0.00029574555810540915
of O 0 0.00027279104688204825
16 O 0 0.0008181529701687396
between O 0 0.0009844041196629405
HLA O 1 0.9999802112579346
- O 0 0.003398772794753313
B O 0 0.0014006083365529776
and O 0 0.00017539903637953103
Factor O 0 0.0007816386641934514
B O 0 0.0022310696076601744
allotypes O 0 0.169280543923378
was O 0 0.0007390117389149964
calculated O 0 0.0001395124418195337
at O 0 0.00017106253653764725
a O 0 6.721436511725187e-05
maximum O 0 6.626918184338138e-05
likelihood O 0 9.668886923464015e-05
value O 0 3.165760790579952e-05
of O 0 5.746996248490177e-05
the O 0 0.0001775305427145213
recombinant O 0 0.0005963191506452858
fraction O 0 0.00035523096448741853
of O 0 0.0003399033157620579
0 O 0 0.0007167758885771036
. O 0 0.0006100121536292136

04 O 1 0.7097349166870117
. O 0 0.010394169948995113

A O 0 0.005855964496731758
crossover O 0 0.004737216047942638
was O 0 0.0014654874103143811
shown O 0 0.0001875560119515285
to O 0 4.4206091843079776e-05
have O 0 3.489819573587738e-05
occurred O 0 0.0003612881700973958
between O 0 0.0001132445249822922
genes O 0 7.010590343270451e-05
for O 0 7.45153593015857e-05
Factor O 0 0.0005175592959858477
B O 0 0.0012360081309452653
and O 0 0.0004559463413897902
HLA O 1 0.9999885559082031
- O 0 0.03237031772732735
D O 0 0.0032164170406758785
, O 0 8.192667155526578e-05
in O 0 0.00010544746328378096
which O 0 0.00022225119755603373
HLA O 1 0.999561607837677
- O 0 0.004816616419702768
D O 0 0.0050330511294305325
segregared O 1 0.5015459656715393
with O 0 0.0006786504527553916
HLA O 1 0.9999841451644897
- O 0 0.00399672519415617
A O 0 0.002178437542170286
and O 0 0.0005992510705254972
B O 0 0.003708332311362028
. O 0 0.0007873522117733955

These O 0 0.0005185421323403716
studies O 0 0.0001809871755540371
suggest O 0 0.00017642960301600397
that O 0 4.0660015656612813e-05
the O 0 0.00011459402594482526
genes O 0 0.00012063283793395385
for O 0 0.00018649388221092522
Factor O 0 0.003406600560992956
B O 1 0.9743179678916931
and O 1 0.712430477142334
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 0.00016636268992442638
located O 0 0.0007390962564386427
outside O 0 0.0003818058467004448
those O 0 7.119699876056984e-05
for O 0 0.00013482090434990823
HLA O 1 0.9996968507766724
, O 0 0.0001168001108453609
that O 0 3.2514009944861755e-05
the O 0 9.146704542217776e-05
order O 0 7.29627936379984e-05
of O 0 0.0003421795554459095
genese O 1 0.995998740196228
is O 0 0.0004689107881858945
HLA O 1 0.9996916055679321
- O 0 0.0007856430602259934
A O 0 0.0006655443576164544
, O 0 0.00012838089605793357
- O 0 0.00040502010961063206
B O 0 0.0006887271883897483
, O 0 0.0001474348537158221
- O 0 0.0007647265447303653
D O 0 0.0019610649906098843
, O 0 0.00029441656079143286
Factor O 0 0.0020354175940155983
B O 0 0.18396416306495667
allotype O 1 0.9999905824661255
, O 1 0.9463182687759399
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 0.0005605921614915133
that O 0 0.00010048146941699088
the O 0 0.00022823797189630568
genes O 0 0.00023649880313314497
coding O 0 0.0011048059677705169
for O 0 0.0016148238210007548
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 0.014290648512542248
Factor O 0 0.04044082760810852
B O 0 0.0029545885045081377
allotypes O 0 0.005353412590920925
are O 0 1.570776839798782e-05
approximately O 0 7.139544322853908e-05
3 O 0 0.00011571458162507042
- O 0 0.00021923522581346333
- O 0 0.00019481702474877238
5 O 0 0.0001864261575974524
centimorgans O 0 0.0019393268739804626
from O 0 0.00015849301416892558
the O 0 0.0003855402464978397
HLA O 1 0.9992409944534302
- O 0 0.001223574043251574
A O 0 0.001374289975501597
and O 0 0.0008470151806250215
HLA O 1 0.9999803304672241
- O 0 0.02211151458323002
B O 0 0.005052839405834675
loci O 0 0.001273622503504157
, O 0 0.0001207859386340715
and O 0 6.130219844635576e-05
that O 0 5.254277857602574e-05
the O 0 0.00017430500884074718
apparent O 0 0.0014618139248341322
lack O 0 0.0006866080802865326
of O 0 0.0010503579396754503
recombinants O 1 0.999329686164856
between O 0 0.0007435270817950368
the O 0 0.0008393494645133615
Factor O 0 0.0016319185961037874
B O 0 0.006283818744122982
gene O 0 0.0015658469637855887
and O 0 0.004737112671136856
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 0.0009781133849173784
suggests O 0 0.00020674725237768143
that O 0 2.419885822746437e-05
these O 0 1.2025968317175284e-05
two O 0 2.457987648085691e-05
genes O 0 5.380134825827554e-05
lie O 0 0.0003665449912659824
in O 0 0.00010003672650782391
close O 0 0.0003709102456923574
proximity O 0 0.0003231729206163436
to O 0 9.016931289806962e-05
one O 0 0.0001552074681967497
another O 0 0.0006247041746973991
. O 0 0.0004209770995657891

Distribution O 0 0.002395531628280878
of O 0 0.0022817845456302166
emerin O 1 0.9979557991027832
and O 0 0.0010648135794326663
lamins O 1 0.8887244462966919
in O 0 0.0005515218363143504
the O 0 0.0011411583982408047
heart O 1 0.9987216591835022
and O 0 0.0006539918831549585
implications O 0 0.002165575511753559
for O 0 0.0008467338629998267
Emery B-Disease 1 0.999909520149231
- I-Disease 1 0.999993085861206
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.8496937155723572

Emerin O 1 0.8522040247917175
is O 0 0.0006675071781501174
a O 0 0.0005669878446497023
nuclear O 0 0.001632501371204853
membrane O 0 0.0006806114106439054
protein O 0 0.0001622054842300713
which O 0 5.8474768593441695e-05
is O 0 7.733776146778837e-05
missing O 0 0.0005240028840489686
or O 0 0.0005370858707465231
defective O 1 0.978753924369812
in O 0 0.002385220490396023
Emery B-Disease 1 0.999832272529602
- I-Disease 1 0.9999728202819824
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999988079071045
EDMD B-Disease 1 1.0
) O 0 0.006854711566120386
. O 0 0.0019509483827278018

It O 0 0.0007446808740496635
is O 0 0.00018672413716558367
one O 0 0.0001013579749269411
member O 0 0.00016253680223599076
of O 0 0.0001751112868078053
a O 0 0.00018878033733926713
family O 0 0.000429239560617134
of O 0 0.0018892473308369517
lamina O 1 0.9999994039535522
- O 1 0.6630983352661133
associated O 0 0.00027221505297347903
proteins O 0 0.0001587104779900983
which O 0 9.367021266371012e-05
includes O 0 0.00035128885065205395
LAP1 O 1 0.9999860525131226
, O 0 0.0007902352954261005
LAP2 O 1 0.9998934268951416
and O 0 0.0014748709509149194
lamin O 0 0.17823880910873413
B O 0 0.029687894508242607
receptor O 0 0.004251000937074423
( O 0 0.0016985281836241484
LBR O 1 0.9994681477546692
) O 0 0.0012914938852190971
. O 0 0.0010087653063237667

A O 0 0.0033308828715234995
panel O 0 0.0010173998307436705
of O 0 0.0006813418585807085
16 O 0 0.0016966259572654963
monoclonal O 0 0.002873769961297512
antibodies O 0 0.0012665741378441453
( O 0 0.0006540479953400791
mAbs O 0 0.006677537690848112
) O 0 0.0001306360645685345
has O 0 3.915954221156426e-05
been O 0 3.925736018572934e-05
mapped O 0 0.00014732650015503168
to O 0 6.16995312157087e-05
six O 0 0.00010436687443871051
specific O 0 4.979837467544712e-05
sites O 0 0.0001267485204152763
throughout O 0 0.0001893901062430814
the O 0 0.00034295208752155304
emerin O 0 0.08370053023099899
molecule O 0 0.0006212367443367839
using O 0 0.00022685251315124333
phage O 0 0.0031292883213609457
- O 0 0.0010683474829420447
displayed O 0 0.0009681078372523189
peptide O 0 0.0008261533221229911
libraries O 0 0.00019534939201548696
and O 0 8.619580330559984e-05
has O 0 6.455858238041401e-05
been O 0 6.15032113273628e-05
used O 0 9.780497930478305e-05
to O 0 0.00017761281924322248
localize O 0 0.00850195623934269
emerin O 1 0.9910534024238586
in O 0 0.0008042418630793691
human O 0 0.0013087390689179301
and O 0 0.0016309694619849324
rabbit O 1 0.9996652603149414
heart O 1 0.9999955892562866
. O 0 0.0020954550709575415

Several O 0 0.00371831888332963
mAbs O 0 0.015615197829902172
against O 0 0.001053118729032576
different O 0 0.0002839970402419567
emerin O 1 0.9865808486938477
epitopes O 0 0.008535339497029781
did O 0 0.0004009690892416984
not O 0 0.00010418710007797927
recognize O 0 0.0006521921022795141
intercalated O 0 0.026292409747838974
discs O 0 0.002558379899710417
in O 0 0.0003568450338207185
the O 0 0.0012037386186420918
heart O 1 0.9999499320983887
, O 0 0.0002708195534069091
though O 0 9.79725518845953e-05
they O 0 4.947026900481433e-05
recognized O 0 0.0002987392363138497
cardiomyocyte O 1 0.7447210550308228
nuclei O 0 0.0025271668564528227
strongly O 0 0.00026900091324932873
, O 0 7.245699089253321e-05
both O 0 5.9567257267190143e-05
at O 0 0.0003227514389436692
the O 0 0.0003301096148788929
rim O 0 0.0042191846296191216
and O 0 0.00025493494467809796
in O 0 0.00036085653118789196
intranuclear O 1 0.9980446100234985
spots O 0 0.0026978051755577326
or O 0 0.0005846931017003953
channels O 0 0.0005412245518527925
. O 0 0.0005128099583089352

A O 0 0.017489463090896606
polyclonal O 0 0.04779043793678284
rabbit O 0 0.019165638834238052
antiserum O 0 0.027356687933206558
against O 0 0.0025269947946071625
emerin O 1 0.9685961008071899
did O 0 0.0005136744002811611
recognize O 0 0.0003472653334029019
both O 0 0.0001923699746839702
nuclear O 0 0.0020404234528541565
membrane O 0 0.0014133567456156015
and O 0 0.0003995062143076211
intercalated O 1 0.8544878363609314
discs O 0 0.0024704672396183014
but O 0 9.149529796559364e-05
, O 0 8.314381557283923e-05
after O 0 0.00022898583847563714
affinity O 0 0.0002853064797818661
purification O 0 0.005571398884057999
against O 0 0.0005564679740928113
a O 0 0.0005460893153212965
pure O 0 0.012033876031637192
- O 0 0.0028087771497666836
emerin O 0 0.1374967247247696
band O 0 0.0007742237066850066
on O 0 0.0001599489914951846
a O 0 0.00018297761562280357
western O 0 0.0004307286289986223
blot O 0 0.0063502853736281395
, O 0 0.0002611225936561823
it O 0 0.0001513220340711996
stained O 0 0.04897657409310341
only O 0 0.00022300859563983977
the O 0 0.0005901617114432156
nuclear O 0 0.005254761781543493
membrane O 0 0.004243014845997095
. O 0 0.0007155167986638844

These O 0 0.0005206281784921885
results O 0 0.00027324919938109815
would O 0 0.0001232297217939049
not O 0 4.4231099309399724e-05
be O 0 4.5946297177579254e-05
expected O 0 0.00014397209451999515
if O 0 0.00011195085971849039
immunostaining O 0 0.02108255960047245
at O 0 0.0016395545098930597
intercalated O 0 0.05683879181742668
discs O 0 0.0014437736244872212
were O 0 0.0001342564501101151
due O 0 0.0001787245273590088
to O 0 4.404279025038704e-05
a O 0 8.378356142202392e-05
product O 0 9.45701394812204e-05
of O 0 0.00013771162775810808
the O 0 0.00045175288687460124
emerin O 1 0.9996826648712158
gene O 0 0.0003717288782354444
and O 0 0.00012743200932163745
, O 0 9.2172937002033e-05
therefore O 0 5.290589251671918e-05
, O 0 3.413144440855831e-05
cast O 0 7.761008600937203e-05
some O 0 4.825692667509429e-05
doubt O 0 0.0003024083562195301
upon O 0 0.0001954906474566087
the O 0 0.0003437578270677477
hypothesis O 0 0.0007607261068187654
that O 0 0.0006988448440097272
cardiac B-Disease 1 1.0
defects I-Disease 1 1.0
in O 1 0.9999258518218994
EDMD B-Disease 1 1.0
are O 0 0.00040485759382136166
caused O 0 0.05423348397016525
by O 0 0.00016550166765227914
absence O 0 0.0011154254898428917
of O 0 0.0023130278568714857
emerin O 1 0.9999874830245972
from O 0 0.009296296164393425
intercalated O 1 0.9983311295509338
discs O 0 0.2673882246017456
. O 0 0.0018555147107690573

Although O 0 0.00445906538516283
emerin O 1 0.9168220162391663
was O 0 0.0019413233967497945
abundant O 0 0.0009430593345314264
in O 0 0.00013157969806343317
the O 0 0.000295286881737411
membranes O 0 0.0008606844930909574
of O 0 0.001003599027171731
cardiomyocyte O 1 0.9999916553497314
nuclei O 0 0.15626965463161469
, O 0 0.0003058136207982898
it O 0 7.062129589030519e-05
was O 0 0.00038316118298098445
absent O 0 0.00041841479833237827
from O 0 0.00013887998647987843
many O 0 8.534568041795865e-05
non O 0 0.0010165984276682138
- O 0 0.0035076243802905083
myocyte O 1 0.9995355606079102
cells O 0 0.0009140621405094862
in O 0 0.00022612608154304326
the O 0 0.0010727655608206987
heart O 1 0.9997066855430603
. O 0 0.00152593816164881

This O 0 0.00037354498635977507
distribution O 0 0.0002725238155107945
of O 0 0.0004272612277418375
emerin O 1 0.9991942048072815
was O 0 0.0011862111277878284
similar O 0 9.077962022274733e-05
to O 0 5.356075052986853e-05
that O 0 2.958791628770996e-05
of O 0 0.00016184149717446417
lamin O 0 0.003471764037385583
A O 0 0.0010309906210750341
, O 0 0.00010878710600081831
a O 0 0.00012562586925923824
candidate O 0 0.00014171791553962976
gene O 0 0.00010233458306174725
for O 0 7.885629747761413e-05
an O 0 0.0001642518473090604
autosomal O 0 0.0013174220221117139
form O 0 0.002666465938091278
of O 1 0.9991840720176697
EDMD B-Disease 1 1.0
. O 0 0.015443622134625912

In O 0 0.0029149972833693027
contrast O 0 0.002405368024483323
, O 0 0.0013070212444290519
lamin O 1 0.8235191106796265
B1 O 1 0.9998264908790588
was O 0 0.00499943271279335
absent O 0 0.0029808368999511003
from O 0 0.0008605405455455184
cardiomyocyte O 1 0.9987220168113708
nuclei O 0 0.035658374428749084
, O 0 0.0003632067237049341
showing O 0 0.0008964582229964435
that O 0 0.0002608041395433247
lamin O 1 0.9465207457542419
B1 O 1 0.9998148083686829
is O 0 0.00018495570111554116
not O 0 5.515487282536924e-05
essential O 0 0.0002914311771746725
for O 0 8.479082316625863e-05
localization O 0 0.0008630953379906714
of O 0 0.0003600064374040812
emerin O 1 0.9626654386520386
to O 0 0.00034009048249572515
the O 0 0.0008415942429564893
nuclear O 0 0.012981507927179337
lamina O 1 0.9793298840522766
. O 0 0.0017826950643211603

Lamin O 1 0.9989339709281921
B1 O 1 0.9998899698257446
is O 0 0.001200639409944415
also O 0 0.0004373427655082196
almost O 0 0.0005196648417040706
completely O 0 0.001831668778322637
absent O 0 0.004453442059457302
from O 0 0.003543934551998973
skeletal O 1 0.9999996423721313
muscle O 1 0.9999996423721313
nuclei O 1 0.9998615980148315
. O 0 0.005135482642799616

In O 0 0.009362985379993916
EDMD B-Disease 1 0.9999969005584717
, O 0 0.0009010517387650907
the O 0 0.00047796161379665136
additional O 0 0.0003377949760761112
absence O 0 0.001515429699793458
of O 0 0.002584092551842332
lamin O 1 0.9998000264167786
B1 O 1 0.9999991655349731
from O 1 0.8736105561256409
heart O 1 0.9999997615814209
and O 1 0.987342357635498
skeletal O 1 1.0
muscle O 1 1.0
nuclei O 1 0.999976396560669
which O 0 0.0011093566427007318
already O 0 0.0004486843245103955
lack O 0 0.0010857809102162719
emerin O 1 0.9993932247161865
may O 0 0.0002508280158508569
offer O 0 7.549927977379411e-05
an O 0 6.32017690804787e-05
alternative O 0 0.00011011560127371922
explanation O 0 0.0001870625710580498
of O 0 0.000167965074069798
why O 0 0.0004714389506261796
these O 0 0.0001080668589565903
tissues O 0 0.011412392370402813
are O 0 8.133832307066768e-05
particularly O 0 0.00046638594358228147
affected O 0 0.0008404218824580312
. O 0 0.0003042806638404727
. O 0 0.000672053312882781

Genetic O 0 0.0020725163631141186
mapping O 0 0.0013183532282710075
of O 0 0.001133324927650392
the O 0 0.0038168574683368206
copper B-Disease 1 0.9999874830245972
toxicosis I-Disease 1 0.9999170303344727
locus O 0 0.004524336662143469
in O 0 0.0006785182049497962
Bedlington O 0 0.0271855890750885
terriers O 0 0.0035039593931287527
to O 0 0.0002493071660865098
dog O 0 0.001544435741379857
chromosome O 0 0.0004554142360575497
10 O 0 0.0001842396886786446
, O 0 6.599164044018835e-05
in O 0 5.6822227634256706e-05
a O 0 0.00016000114555936307
region O 0 0.0005115957465022802
syntenic O 0 0.16071708500385284
to O 0 0.0002934198419097811
human O 0 0.0006748696905560791
chromosome O 0 0.0021035270765423775
region O 0 0.0041480716317892075
2p13 O 1 0.999985933303833
- O 0 0.4921407699584961
p16 O 0 0.11668938398361206
. O 0 0.0012202906655147672

Abnormal O 1 0.9999923706054688
hepatic B-Disease 1 1.0
copper I-Disease 1 0.9999997615814209
accumulation I-Disease 1 0.9996888637542725
is O 0 0.00031023877090774477
recognized O 0 0.00021600151376333088
as O 0 0.00026685543707571924
an O 0 0.0006412452203221619
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 1 0.9999619722366333
man O 1 0.999993085861206
, O 0 0.001189911039546132
mouse O 0 0.003247775137424469
, O 0 0.00044275051914155483
rat O 0 0.3131082057952881
and O 0 0.0007705354364588857
dog O 0 0.011228910647332668
. O 0 0.0013893014984205365

The O 0 0.004074400290846825
major O 0 0.019969245418906212
cause O 1 0.9935652613639832
of O 1 0.9989246726036072
hepatic B-Disease 1 1.0
copper I-Disease 1 1.0
accumulation I-Disease 1 0.999994158744812
in O 0 0.0014290933031588793
man O 0 0.004407252185046673
is O 0 0.00015131251711864024
a O 0 0.00033133989199995995
dysfunctional O 0 0.08702993392944336
ATP7B O 1 0.9999972581863403
gene O 0 0.002016991376876831
, O 0 0.000691899738740176
causing O 1 0.9999897480010986
Wilson B-Disease 1 0.9999991655349731
disease I-Disease 1 1.0
( O 1 0.9987707734107971
WD B-Disease 1 0.9999984502792358
) O 0 0.0017124522710219026
. O 0 0.001262791221961379

Mutations O 0 0.0016121399821713567
in O 0 0.0006057272548787296
the O 0 0.0010522778611630201
ATP7B O 1 0.9999639987945557
genes O 0 0.0003785855369642377
have O 0 6.57689233776182e-05
also O 0 0.00010864134674193338
been O 0 0.00012511349632404745
demonstrated O 0 0.000585651898290962
in O 0 0.00044497783528640866
mouse O 0 0.003156482707709074
and O 0 0.001071233651600778
rat O 1 0.9203531742095947
. O 0 0.0014208236243575811

The O 0 0.007698276545852423
ATP7B O 1 0.9999719858169556
gene O 0 0.0011869808658957481
has O 0 0.0002896161167882383
been O 0 0.00013899285113438964
excluded O 0 0.00022932823048904538
in O 0 9.701988165033981e-05
the O 0 0.00029156875098124146
much O 0 0.0010473201982676983
rarer O 1 0.7653646469116211
human O 1 0.9764684438705444
copper B-Disease 1 1.0
overload I-Disease 1 1.0
disease O 1 1.0
non B-Disease 1 0.9918439984321594
- I-Disease 0 0.44961288571357727
Indian I-Disease 0 0.005057573784142733
childhood I-Disease 1 0.9995761513710022
cirrhosis I-Disease 1 1.0
, O 0 0.001983555033802986
indicating O 0 0.004106568172574043
genetic O 0 0.0016686231829226017
heterogeneity O 0 0.01206393726170063
. O 0 0.0022167491260915995

By O 0 0.0010898472974076867
investigating O 0 0.0020014294423162937
the O 0 0.001636206521652639
common O 0 0.00216625165194273
autosomal O 1 0.9986122846603394
recessive O 1 0.9999995231628418
copper B-Disease 1 1.0
toxicosis I-Disease 1 1.0
( O 1 0.9680873155593872
CT B-Disease 1 0.9876621961593628
) O 0 0.0003954206476919353
in O 0 0.00033404570422135293
Bedlington O 0 0.276847243309021
terriers O 0 0.01302692573517561
, O 0 0.0002240217145299539
we O 0 5.6153145123971626e-05
have O 0 2.0824551029363647e-05
identified O 0 6.197893526405096e-05
a O 0 6.847248005215079e-05
new O 0 0.00012791082554031163
locus O 0 0.0008000634261406958
involved O 0 0.0006976935546845198
in O 0 0.02340002916753292
progressive O 1 1.0
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.989348292350769

We O 0 0.0010339135769754648
examined O 0 0.0008504295255988836
whether O 0 0.00030279840575531125
the O 0 0.0009169066906906664
WD B-Disease 1 0.9921820163726807
gene O 0 0.002541306894272566
ATP7B O 1 0.9998973608016968
was O 0 0.0028318290133029222
also O 0 0.00026144046569243073
causative O 0 0.0021438549738377333
for O 0 0.00022760732099413872
CT B-Disease 0 0.003281716024503112
by O 0 0.00011387920676497743
investigating O 0 0.0005442474503070116
the O 0 0.0004536458000075072
chromosomal O 0 0.039842694997787476
co O 0 0.004585332702845335
- O 0 0.0023717537987977266
localization O 0 0.004387328401207924
of O 0 0.0014958638930693269
ATP7B O 1 0.9999961853027344
and O 0 0.0012955248821526766
C04107 O 1 0.9809093475341797
, O 0 0.00018968719814438373
using O 0 7.786286732880399e-05
fluorescence O 0 0.0003943774208892137
in O 0 0.00015945953782647848
situ O 0 0.002642776118591428
hybridization O 0 0.0006017099949531257
( O 0 0.00042024513822980225
FISH O 0 0.0018451190553605556
) O 0 0.00039696405292488635
. O 0 0.00047494913451373577

C04107 O 1 0.9257259964942932
is O 0 0.0009060821030288935
an O 0 0.0003860793949570507
anonymous O 0 0.0010235343361273408
microsatellite O 0 0.006906577851623297
marker O 0 0.0034775102976709604
closely O 0 0.000795989646576345
linked O 0 0.002761338371783495
to O 0 0.0011012660106644034
CT B-Disease 1 0.8486694693565369
. O 0 0.0020007379353046417

However O 0 0.0036180084571242332
, O 0 0.0020160183776170015
BAC O 1 0.9952912330627441
clones O 0 0.017991822212934494
containing O 0 0.003147534793242812
ATP7B O 1 0.9999353885650635
and O 0 0.0011312579736113548
C04107 O 0 0.025760628283023834
mapped O 0 0.0005972223589196801
to O 0 0.00014612553059123456
the O 0 0.00040957648889161646
canine O 0 0.0046352059580385685
chromosome O 0 0.0017984247533604503
regions O 0 0.0010043656220659614
CFA22q11 O 1 0.9999386072158813
and O 0 0.0016411803662776947
CFA10q26 O 1 0.9999828338623047
, O 0 0.0006597878527827561
respectively O 0 0.0004821145557798445
, O 0 0.0001646950258873403
demonstrating O 0 0.001261771540157497
that O 0 0.00023453173344023526
WD B-Disease 1 0.9912214279174805
cannot O 0 0.0002639309095684439
be O 0 0.0001328717771684751
homologous O 0 0.0009651423897594213
to O 0 0.0005665681674145162
CT B-Disease 0 0.37727460265159607
. O 0 0.001387970638461411

The O 0 0.007001729682087898
copper O 1 0.9987732768058777
transport O 0 0.013469390571117401
genes O 0 0.00252920133061707
CTR1 O 1 0.9999784231185913
and O 0 0.0015322479885071516
CTR2 O 1 0.9999878406524658
were O 0 0.0007174579077400267
also O 0 0.00026052375324070454
excluded O 0 0.00042001568363048136
as O 0 0.000104150538390968
candidate O 0 0.00014868556172586977
genes O 0 0.0001394823775626719
for O 0 0.00016191514441743493
CT B-Disease 0 0.04943900555372238
since O 0 0.00033782623359002173
they O 0 4.756574708153494e-05
both O 0 5.782812513643876e-05
mapped O 0 0.0003107879310846329
to O 0 0.00023090398462954909
canine O 0 0.007140029221773148
chromosome O 0 0.0047666048631072044
region O 0 0.009653844870626926
CFA11q22 O 1 0.999970555305481
. O 0 0.003360974369570613

2 O 0 0.007576745934784412
- O 0 0.0064575206488370895
22 O 0 0.0037326510064303875
. O 0 0.0011841366067528725

5 O 0 0.010201685130596161
. O 0 0.003754225792363286

A O 0 0.003384918672963977
transcribed O 0 0.0011741319904103875
sequence O 0 0.00021572344121523201
identified O 0 0.00014332737191580236
from O 0 0.00013043342914897949
the O 0 0.00042762921657413244
C04107 O 1 0.9766905903816223
- O 0 0.003078627400100231
containing O 0 0.0011721942573785782
BAC O 1 0.6775785684585571
was O 0 0.0006701579550281167
found O 0 9.982440678868443e-05
to O 0 6.0018330259481445e-05
be O 0 4.393644485389814e-05
homologous O 0 0.00022092735162004828
to O 0 5.349760249373503e-05
a O 0 0.00010893128637690097
gene O 0 0.00011935932707274333
expressed O 0 0.00011950451880693436
from O 0 0.00018666005053091794
human O 0 0.0007895992021076381
chromosome O 0 0.007989129051566124
2p13 O 1 0.9999815225601196
- O 0 0.025851808488368988
p16 O 0 0.013277697376906872
, O 0 0.00016349383804481477
a O 0 0.00013463821960613132
region O 0 0.00028837707941420376
devoid O 0 0.0015092603862285614
of O 0 0.00027335292543284595
any O 0 0.0002969939087051898
positional O 0 0.00342142884619534
candidate O 0 0.00138280785176903
genes O 0 0.0008815137553028762
. O 0 0.0007872569840401411

Molecular O 0 0.0016313717933371663
analysis O 0 0.00012129433889640495
of O 0 0.00022934528533369303
the O 0 0.00045022330596111715
APC B-Disease 1 0.7504838705062866
gene O 0 0.0002423344849376008
in O 0 0.00012571681872941554
205 O 0 0.0006260705995373428
families O 0 0.00012594947475008667
: O 0 0.0001429336261935532
extended O 0 0.0005451503093354404
genotype O 0 0.0014233615947887301
- O 0 0.0008675667340867221
phenotype O 0 0.0010127003770321608
correlations O 0 0.0005413959152065217
in O 0 0.0005316943279467523
FAP B-Disease 1 0.9906037449836731
and O 0 0.0002845502458512783
evidence O 0 0.0002496327506378293
for O 0 9.501432214165106e-05
the O 0 0.00021630260744132102
role O 0 0.0008409113506786525
of O 0 0.0009508885559625924
APC B-Disease 1 0.9970667958259583
amino O 0 0.0013979050563648343
acid O 0 0.00307520036585629
changes O 0 0.0011942618293687701
in O 1 0.9365184307098389
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 1 0.9999992847442627
. O 0 0.013869262300431728

BACKGROUND O 0 0.027830110862851143
/ O 0 0.014291288331151009
AIMS O 0 0.00757240504026413
The O 0 0.0011245178757235408
development O 0 0.0023948834277689457
of O 1 0.999254047870636
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.0008355009485967457
a O 0 0.0004092696763109416
variable O 0 0.00012342892296146601
range O 0 0.00013016034790780395
of O 0 0.0004290158103685826
extracolonic O 1 0.9995290040969849
manifestations O 1 0.9969272017478943
in O 0 0.011770707555115223
familial B-Disease 1 0.9999998807907104
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999406337738037
FAP B-Disease 1 0.9999986886978149
) O 0 0.00039511837530881166
is O 0 0.00010817471047630534
the O 0 8.88794893398881e-05
result O 0 9.827973553910851e-05
of O 0 0.00015268343850038946
the O 0 0.0006017934647388756
dominant O 0 0.00337816309183836
inheritance O 0 0.004441975150257349
of O 1 0.9371876120567322
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 1 0.9992552399635315
APC B-Disease 1 0.999995231628418
) O 0 0.0016990149160847068
gene O 0 0.0011006082640960813
mutations O 0 0.0012124485801905394
. O 0 0.0009240091312676668

In O 0 0.0006352320779114962
this O 0 0.00015993951819837093
study O 0 9.210457210429013e-05
, O 0 6.384246808011085e-05
direct O 0 5.444962516776286e-05
mutation O 0 5.043732380727306e-05
analysis O 0 2.0846033294219524e-05
of O 0 0.0001234138908330351
the O 0 0.0006660621147602797
APC B-Disease 1 0.9991130232810974
gene O 0 0.0004996067727915943
was O 0 0.0009240140207111835
performed O 0 0.0003966026415582746
to O 0 8.99430233403109e-05
determine O 0 0.0001950246369233355
genotype O 0 0.0012620474444702268
- O 0 0.0007939565111882985
phenotype O 0 0.0007379786693491042
correlations O 0 0.0004702495934907347
for O 0 0.00011952765635214746
nine O 0 0.0014628118369728327
extracolonic O 1 0.9998217225074768
manifestations O 1 0.7848001718521118
and O 0 0.0003045679768547416
to O 0 0.00014992186333984137
investigate O 0 0.0004562271642498672
the O 0 0.0003420461725909263
incidence O 0 0.001365278265438974
of O 0 0.0017700165044516325
APC B-Disease 1 0.9999251365661621
mutations O 0 0.0005668613594025373
in O 0 0.0007914938614703715
non O 1 0.7576467990875244
- O 1 0.9999814033508301
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.007376047316938639

METHODS O 0 0.006139543838799
The O 0 0.0024019067641347647
APC B-Disease 1 0.9478012919425964
gene O 0 0.0008628412033431232
was O 0 0.0006298372172750533
analysed O 0 0.00048105805763043463
in O 0 0.00012977416918147355
190 O 0 0.0007576614734716713
unrelated O 0 0.0014001388335600495
FAP B-Disease 1 0.9200061559677124
and O 0 0.0005813343450427055
15 O 0 0.003402300179004669
non O 1 0.8099892735481262
- O 1 0.9999740123748779
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 0.029723476618528366
using O 0 0.0009916371200233698
denaturing O 1 0.7930896282196045
gradient O 0 0.018056275323033333
gel O 0 0.010184643790125847
electrophoresis O 0 0.0013023167848587036
, O 0 0.00011989464837824926
the O 0 0.00016783874889370054
protein O 0 0.00027846440207213163
truncation O 0 0.002210520673543215
test O 0 0.00032001410727389157
, O 0 8.25092793093063e-05
and O 0 0.0001036712565110065
direct O 0 0.0002334786404389888
sequencing O 0 0.0012877433327957988
. O 0 0.0006832333747297525

RESULTS O 0 0.008412548340857029
Chain O 0 0.005745172966271639
terminating O 0 0.003946317825466394
signals O 0 0.0010440382175147533
were O 0 0.00017086966545321047
only O 0 6.562095950357616e-05
identified O 0 0.00010405802458990365
in O 0 0.00012403454456944019
patients O 0 0.00017341080820187926
belonging O 0 0.000515539781190455
to O 0 0.00020843265519943088
the O 0 0.0007528946152888238
FAP B-Disease 1 0.9981562495231628
group O 0 0.0004362381005194038
( O 0 0.000591442221775651
105 O 0 0.0021237037144601345
patients O 0 0.0008588203927502036
) O 0 0.000393074267776683
. O 0 0.0005759191117249429

Amino O 0 0.004302680026739836
acid O 0 0.0017587174661457539
changes O 0 0.0002112833462888375
were O 0 0.0001008797189570032
identified O 0 9.073245746549219e-05
in O 0 8.157998672686517e-05
four O 0 0.00013525948452297598
patients O 0 0.00012148338282713667
, O 0 4.778278525918722e-05
three O 0 5.547205000766553e-05
of O 0 0.00018161885964218527
whom O 0 0.00035945739364251494
belonged O 0 0.0015021560247987509
to O 0 0.00020787595713045448
the O 0 0.0005232173716649413
non O 0 0.0012139353202655911
- O 0 0.0026929073501378298
FAP O 1 0.9986748695373535
group O 0 0.001422725967131555
of O 1 0.9998027682304382
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9999278783798218
. O 0 0.004285264760255814

Genotype O 0 0.035417310893535614
- O 0 0.006867656949907541
phenotype O 0 0.0021047925110906363
correlations O 0 0.0008751628338359296
identified O 0 0.00032820762135088444
significant O 0 0.00019291494390927255
differences O 0 0.0002358727651881054
in O 0 0.00012799672549590468
the O 0 0.00023169149062596262
nature O 0 0.00048241266631521285
of O 0 0.00043661793461069465
certain O 0 0.000573491386603564
extracolonic O 1 0.9999852180480957
manifestations O 1 0.9997001886367798
in O 0 0.02159259468317032
FAP B-Disease 1 0.9999910593032837
patients O 0 0.0005166564951650798
belonging O 0 0.0006417738040909171
to O 0 0.0001761944149620831
three O 0 0.00025102015933953226
mutation O 0 0.0006431539077311754
subgroups O 0 0.0027283707167953253
. O 0 0.001258396776393056

CONCLUSIONS O 0 0.007938061840832233
Extended O 0 0.0055885519832372665
genotype O 0 0.004869782831519842
- O 0 0.0022621427197009325
phenotype O 0 0.0009562588529661298
correlations O 0 0.0004735147231258452
made O 0 0.00019537325715646148
in O 0 0.0001252869697054848
this O 0 5.7877165090758353e-05
study O 0 5.056426743976772e-05
may O 0 6.695368210785091e-05
have O 0 1.4463298612099607e-05
the O 0 5.564386447076686e-05
potential O 0 7.92706705396995e-05
to O 0 5.30448742210865e-05
determine O 0 5.103353760205209e-05
the O 0 0.00011886014544870704
most O 0 8.120076381601393e-05
appropriate O 0 0.0001331503299297765
surveillance O 0 0.0006225573597475886
and O 0 0.0004893012810498476
prophylactic O 1 0.9513428211212158
treatment O 1 0.9629313349723816
regimens O 0 0.3130745589733124
for O 0 0.000344347907230258
those O 0 0.00022217535297386348
patients O 0 0.0002697657619137317
with O 0 0.00015685321704950184
mutations O 0 0.00047238494153134525
associated O 0 0.00036872035707347095
with O 0 0.0005056635127402842
life O 1 0.9250415563583374
threatening O 1 0.9999281167984009
conditions O 1 0.7600893378257751
. O 0 0.0012777707306668162

This O 0 0.0007010407862253487
study O 0 0.00022727208852302283
also O 0 9.707541175885126e-05
provided O 0 0.0001398779422743246
evidence O 0 0.00011844298569485545
for O 0 8.291278209071606e-05
the O 0 0.0003542135818861425
pathological O 0 0.04399134963750839
nature O 0 0.0010852861450985074
of O 0 0.0008270507678389549
amino O 0 0.0008105680462904274
acid O 0 0.0009839325211942196
changes O 0 0.0001887871912913397
in O 0 0.00023517529189120978
APC O 0 0.41542819142341614
associated O 0 0.00026220534346066415
with O 0 0.00011708222882589325
both O 0 0.0003858257259707898
FAP B-Disease 1 0.9996567964553833
and O 0 0.0023136266972869635
non O 1 0.9988332390785217
- O 1 0.9999971389770508
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9995883107185364
. O 0 0.001024065539240837
. O 0 0.0011829833965748549

Inherited B-Disease 1 1.0
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 1 0.9999816417694092
cancer B-Disease 1 0.9999995231628418
risk O 0 0.007917900569736958
of O 0 0.020395401865243912
the O 1 0.6033726334571838
APC O 1 0.9999924898147583
I1307K O 1 0.9998270869255066
polymorphism O 0 0.005052736960351467
. O 0 0.0010465682717040181

Germ O 1 0.999968409538269
- O 0 0.026159975677728653
line O 0 0.0032090856693685055
and O 0 0.00040190585423260927
somatic O 0 0.002144644735381007
truncating O 0 0.0039978413842618465
mutations O 0 0.00030237261671572924
of O 0 0.0002809246943797916
the O 0 0.0007360001327469945
APC B-Disease 1 0.9923829436302185
gene O 0 0.0002013851481024176
are O 0 1.9532570149749517e-05
thought O 0 0.00012980301107745618
to O 0 0.00018002817523665726
initiate O 0 0.021638326346874237
colorectal B-Disease 1 1.0
tumor I-Disease 1 0.9999997615814209
formation O 1 0.9999796152114868
in O 1 0.9967196583747864
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 1 0.9999997615814209
sporadic O 1 1.0
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 0 0.2524903118610382
respectively O 0 0.003045502817258239
. O 0 0.0008582232403568923

Recently O 0 0.006388314533978701
, O 0 0.0009630518034100533
an O 0 0.0008098403923213482
isoleucine O 1 0.909987211227417
- O 0 0.004427076783031225
- O 0 0.00171280512586236
> O 0 0.0019389153458178043
lysine O 0 0.0015992349945008755
polymorphism O 0 0.0004891814314760268
at O 0 0.000624528038315475
codon O 0 0.0023283418267965317
1307 O 0 0.01614159345626831
( O 0 0.0005737795727327466
I1307K O 0 0.008916615508496761
) O 0 0.00016691948985680938
of O 0 0.00020473577023949474
the O 0 0.0004829157842323184
APC B-Disease 1 0.9635775089263916
gene O 0 0.0003042820899281651
has O 0 4.514268221100792e-05
been O 0 3.790529808611609e-05
identified O 0 4.433638241607696e-05
in O 0 4.327469287090935e-05
6 O 0 0.00019208842422813177
% O 0 5.687828888767399e-05
- O 0 0.0001705239701550454
7 O 0 0.0002026611182373017
% O 0 3.781601117225364e-05
of O 0 0.00010133440082427114
the O 0 0.00029563167481683195
Ashkenazi O 0 0.0026626428589224815
Jewish O 0 0.0012696521589532495
population O 0 0.0003280236851423979
. O 0 0.0004600549873430282

To O 0 0.0015104825142771006
assess O 0 0.0014417965430766344
the O 0 0.0005045710713602602
risk O 0 0.00026146313757635653
of O 0 0.0002623851178213954
this O 0 0.0001556241768412292
common O 0 0.00034059880999848247
APC B-Disease 1 0.9991401433944702
allelic O 1 0.7375695705413818
variant O 1 0.8891092538833618
in O 0 0.3359602689743042
colorectal O 1 1.0
carcinogenesis O 1 0.9999998807907104
, O 0 0.0007178278756327927
we O 0 0.00011412391904741526
have O 0 2.5102406652877107e-05
analyzed O 0 8.197816350730136e-05
a O 0 9.543301712255925e-05
large O 0 0.00015695870388299227
cohort O 0 0.0009892648085951805
of O 0 0.00044522815733216703
unselected O 0 0.03549867495894432
Ashkenazi O 0 0.004775949753820896
Jewish O 0 0.0019007173832505941
subjects O 0 0.0017491539474576712
with O 0 0.0009686881094239652
adenomatous B-Disease 1 0.9999992847442627
polyps I-Disease 1 0.999976396560669
and O 0 0.0020114807412028313
. O 0 0.0014593993546441197
or O 1 0.9998390674591064
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 0.0006961168255656958
for O 0 0.00026145190349780023
the O 0 0.0015757447108626366
APC O 1 0.9995649456977844
I1307K O 1 0.9992589354515076
polymorphism O 0 0.005100873298943043
. O 0 0.0012430489296093583

The O 0 0.006967152468860149
APC O 1 0.9921916127204895
I1307K O 1 0.9255986213684082
allele O 0 0.000891940901055932
was O 0 0.0005843117833137512
identified O 0 0.00014582711446564645
in O 0 8.552915824111551e-05
48 O 0 0.00018149284005630761
( O 0 9.55364594119601e-05
10 O 0 9.067571227205917e-05
. O 0 3.367820681887679e-05
1 O 0 0.00012919263099320233
% O 0 5.827425775351003e-05
) O 0 6.443409074563533e-05
of O 0 0.0004155466449446976
476 O 0 0.3809530735015869
patients O 0 0.0021769593004137278
. O 0 0.0012953528203070164

Compared O 0 0.0010954838944599032
with O 0 9.86167651717551e-05
the O 0 0.0001361919566988945
frequency O 0 6.668765126960352e-05
in O 0 2.7615635190159082e-05
two O 0 1.7325726730632596e-05
separate O 0 2.6506613721721806e-05
population O 0 2.6623605663189664e-05
control O 0 0.00010880119953071699
groups O 0 3.9988342905417085e-05
, O 0 9.345117723569274e-05
the O 0 0.0004858254687860608
APC O 1 0.9995287656784058
I1307K O 1 0.9996680021286011
allele O 0 0.00070827582385391
is O 0 9.096385474549606e-05
associated O 0 6.148280954221264e-05
with O 0 3.2256037229672074e-05
an O 0 7.962136442074552e-05
estimated O 0 0.00018767193250823766
relative O 0 0.00019756253459490836
risk O 0 0.00016786341439001262
of O 0 0.0005709697143174708
1 O 0 0.0020045540295541286
. O 0 0.0009808536851778626

5 O 0 0.007431745063513517
- O 0 0.0060701556503772736
1 O 0 0.0033371178433299065
. O 0 0.0016906405799090862

7 O 0 0.010534989647567272
for O 0 0.0024702786467969418
colorectal B-Disease 1 0.9999991655349731
neoplasia I-Disease 1 0.9999146461486816
( O 0 0.001131582772359252
both O 0 0.0002808785648085177
P O 0 0.38237690925598145
= O 0 0.0014152552466839552
. O 0 0.00031368312193080783
01 O 0 0.016448862850666046
) O 0 0.0006047543720342219
. O 0 0.0005785793182440102

Furthermore O 0 0.0028779907152056694
, O 0 0.0003897927817888558
compared O 0 0.00037074461579322815
with O 0 0.0002681888872757554
noncarriers O 1 0.999735414981842
, O 0 0.0014478147495537996
APC O 1 0.999468982219696
I1307K O 1 0.9991462230682373
carriers O 0 0.0010034522274509072
had O 0 0.0003291586472187191
increased O 0 0.00018829891632776707
numbers O 0 0.00015668715059291571
of O 0 0.0009279329678975046
adenomas B-Disease 1 0.9999933242797852
and O 1 0.858466625213623
colorectal B-Disease 1 1.0
cancers I-Disease 1 0.9999794960021973
per O 0 0.0007625615689903498
patient O 0 0.0007876273011788726
( O 0 0.0003011162916664034
P O 0 0.00318353483453393
= O 0 0.0004717244009952992
. O 0 0.00010288467456120998
03 O 0 0.0026321946643292904
) O 0 9.484106703894213e-05
, O 0 6.456455594161525e-05
as O 0 4.232972423778847e-05
well O 0 3.853790258290246e-05
as O 0 0.0001066558324964717
a O 0 0.00022154919861350209
younger O 0 0.0013005727669224143
age O 0 0.0011474064085632563
at O 0 0.011849530972540379
diagnosis O 0 0.2864609956741333
. O 0 0.001648249221034348

We O 0 0.0015939592849463224
conclude O 0 0.0017501049442216754
that O 0 0.00026404517120681703
the O 0 0.0010316775878891349
APC O 1 0.9832417964935303
I1307K O 1 0.994335949420929
variant O 0 0.0035690702497959137
leads O 0 0.00147813290823251
to O 0 0.000492397986818105
increased O 0 0.004238391760736704
adenoma B-Disease 1 1.0
formation O 1 0.9901106953620911
and O 0 0.0004309454816393554
directly O 0 0.0001782813051249832
contributes O 0 0.000203625691938214
to O 0 4.55602457805071e-05
3 O 0 8.046854782151058e-05
% O 0 3.493316035019234e-05
- O 0 0.00010729941277531907
4 O 0 8.241790055762976e-05
% O 0 2.5869971068459563e-05
of O 0 5.996221807436086e-05
all O 0 0.0001502753875683993
Ashkenazi O 0 0.2599203586578369
Jewish O 1 0.9997312426567078
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.004984722007066011

The O 0 0.0018582118209451437
estimated O 0 0.0007638594252057374
relative O 0 0.0005718261236324906
risk O 0 0.0002625750785227865
for O 0 0.00011739301407942548
carriers O 0 0.0004375483258627355
may O 0 0.00017764297081157565
justify O 0 0.0004085209220647812
specific O 0 5.3541341912932694e-05
clinical O 0 0.00013515749014914036
screening O 0 0.00011594233365030959
for O 0 3.754739373107441e-05
the O 0 0.00016125892580021173
360 O 0 0.0007225766312330961
, O 0 8.099034312181175e-05
000 O 0 0.00030076398979872465
Americans O 0 7.119136716937646e-05
expected O 0 0.00011610718502197415
to O 0 7.848008681321517e-05
harbor O 0 0.0012614423176273704
this O 0 0.00010680360719561577
allele O 0 0.00025721898418851197
, O 0 8.137322583934292e-05
and O 0 6.986670632613823e-05
genetic O 0 0.00016995130863506347
testing O 0 0.00013267784379422665
in O 0 6.43632301944308e-05
the O 0 9.07938156160526e-05
setting O 0 0.0001613511994946748
of O 0 0.0001407520321663469
long O 0 0.0002339229395147413
- O 0 0.0004226718156132847
term O 0 0.00024042546283453703
- O 0 0.00025821730378083885
outcome O 0 0.00019528162374626845
studies O 0 6.937065336387604e-05
may O 0 0.0001639157853787765
impact O 0 0.0005586748011410236
significantly O 0 0.0009226416004821658
on O 0 0.17944972217082977
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 1 0.9999796152114868
in O 0 0.0007056607282720506
this O 0 0.00019454120774753392
population O 0 0.0001288390631088987
. O 0 0.0002540485584177077

Localization O 0 0.016413060948252678
of O 0 0.0017608492635190487
human O 0 0.001012462074868381
BRCA1 O 0 0.008678792044520378
and O 0 0.00013914669398218393
its O 0 0.00010188269516220316
loss O 0 0.0008900732500478625
in O 0 0.00020968247554264963
high O 0 0.001512649585492909
- O 0 0.0015735652996227145
grade O 0 0.02054489031434059
, O 0 0.00035481888335198164
non B-Disease 0 0.0022227608133107424
- I-Disease 1 0.8853726983070374
inherited I-Disease 1 0.999997615814209
breast I-Disease 1 0.9999994039535522
carcinomas I-Disease 1 0.9999997615814209
. O 0 0.009119835682213306

Although O 0 0.0009567695669829845
the O 0 0.0004245151358190924
link O 0 0.0007572817848995328
between O 0 0.0005735392333008349
the O 0 0.0018053235253319144
BRCA1 O 1 0.999990701675415
tumour B-Disease 1 1.0
- O 1 0.9986587762832642
suppressor O 1 0.9902241826057434
gene O 0 0.000894316821359098
and O 0 0.0007404445204883814
hereditary B-Disease 1 0.9999997615814209
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 0.0023058075457811356
established O 0 0.0003683811519294977
, O 0 6.535236752824858e-05
the O 0 9.089976811083034e-05
role O 0 0.00021439942065626383
, O 0 6.877553823869675e-05
if O 0 3.4255815990036353e-05
any O 0 3.4811841032933444e-05
, O 0 5.0885992095572874e-05
of O 0 0.00032536202343180776
BRCA1 O 1 0.6792985200881958
in O 0 0.0009569947724230587
non B-Disease 0 0.19320513308048248
- I-Disease 1 0.9444435238838196
familial I-Disease 1 0.9998496770858765
cancers I-Disease 1 0.9999881982803345
is O 0 0.0014307111268863082
unclear O 0 0.0015675901668146253
. O 0 0.0010891166748479009

BRCA1 O 1 0.9909103512763977
mutations O 0 0.001748474664054811
are O 0 0.00011190729856025428
rare O 0 0.0006720814271830022
in O 0 0.0005998570704832673
sporadic B-Disease 0 0.37403085827827454
cancers I-Disease 1 0.9993002414703369
, O 0 0.00032999474206008017
but O 0 0.00013735622633248568
loss O 0 0.0008758410112932324
of O 0 0.0007449158001691103
BRCA1 O 1 0.9983320832252502
resulting O 0 0.0026086310390383005
from O 0 0.00046621658839285374
reduced O 0 0.0005630999803543091
expression O 0 0.0002572150551714003
or O 0 0.00017715207650326192
incorrect O 0 0.0007032094290480018
subcellular O 0 0.002681975020095706
localization O 0 0.002075874013826251
is O 0 0.0001307191705564037
postulated O 0 0.0006050740485079587
to O 0 6.533721898449585e-05
be O 0 4.103533137822524e-05
important O 0 9.228340059053153e-05
in O 0 0.00013576523633673787
non B-Disease 0 0.0012584410142153502
- I-Disease 1 0.6341204047203064
familial I-Disease 1 0.9999977350234985
breast I-Disease 1 1.0
and I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 0.02801520563662052

Epigenetic O 0 0.31005042791366577
loss O 1 0.9980533123016357
, O 0 0.0007287549669854343
however O 0 0.0002869842865038663
, O 0 9.879766730591655e-05
has O 0 6.195139576448128e-05
not O 0 2.4913621018640697e-05
received O 0 8.772691217018291e-05
general O 0 0.0003771425108425319
acceptance O 0 0.0007112384773790836
due O 0 0.0005241375183686614
to O 0 0.00022623993572779
controversy O 0 0.0014605143805965781
regarding O 0 0.00042875821236521006
the O 0 0.0003466763882897794
subcellular O 0 0.003911084495484829
localization O 0 0.002593795070424676
of O 0 0.0005510621122084558
BRCA1 O 0 0.01273454912006855
proteins O 0 0.00020060822134837508
, O 0 9.138054883806035e-05
reports O 0 6.952071998966858e-05
of O 0 6.90330343786627e-05
which O 0 3.979554458055645e-05
have O 0 1.7827209376264364e-05
ranged O 0 0.00022476840240415186
from O 0 9.431581565877423e-05
exclusively O 0 0.0001605194847797975
nuclear O 0 0.0006341958651319146
, O 0 6.74522525514476e-05
to O 0 6.0220714658498764e-05
conditionally O 0 0.000973623595200479
nuclear O 0 0.0005413388134911656
, O 0 6.868894706713036e-05
to O 0 8.337104372913018e-05
the O 0 0.0005377051420509815
ER O 1 0.9996554851531982
/ O 0 0.01755237765610218
golgi O 1 0.5666366815567017
, O 0 0.00031539960764348507
to O 0 0.00024644940276630223
cytoplasmic O 0 0.0016004398930817842
invaginations O 0 0.013717384077608585
into O 0 0.0008950406336225569
the O 0 0.001236757030710578
nucleus O 0 0.006600331049412489
. O 0 0.0010690081398934126

In O 0 0.0007954065804369748
an O 0 0.00033663830254226923
attempt O 0 0.0005565581377595663
to O 0 0.00016552282613702118
resolve O 0 0.000787566474173218
this O 0 0.00010871793347178027
issue O 0 0.00018790362810250372
, O 0 0.00012842216528952122
we O 0 6.734634371241555e-05
have O 0 6.0983664297964424e-05
comprehensively O 0 0.0024866536259651184
characterized O 0 0.001857483177445829
19 O 0 0.0055859824642539024
anti O 1 0.9857394099235535
- O 1 0.9736636281013489
BRCA1 O 1 0.9966413974761963
antibodies O 0 0.003838500939309597
. O 0 0.0011995163513347507

These O 0 0.001147387782111764
reagents O 0 0.002742515644058585
detect O 0 0.0009145004441961646
a O 0 0.0005671218386851251
220 O 0 0.001463680644519627
- O 0 0.0011693553533405066
kD O 0 0.004218791611492634
protein O 0 0.0004055601020809263
localized O 0 0.0005542437429539859
in O 0 0.00016480956401210278
discrete O 0 0.0003680248628370464
nuclear O 0 0.001100047491490841
foci O 0 0.0014649578370153904
in O 0 0.00017063748964574188
all O 0 0.0003116715815849602
epithelial O 1 0.9979337453842163
cell O 0 0.00839201733469963
lines O 0 0.0007187288138084114
, O 0 7.717473636148497e-05
including O 0 0.00010405285865999758
those O 0 9.916209091898054e-05
derived O 0 0.00040034326957538724
from O 0 0.0014530011685565114
breast B-Disease 1 0.9998427629470825
malignancies I-Disease 1 0.9995824694633484
. O 0 0.0025907917879521847

Immunohistochemical O 1 0.8601232767105103
staining O 0 0.23014813661575317
of O 0 0.009400779381394386
human O 0 0.19000951945781708
breast O 1 0.9992668032646179
specimens O 0 0.0017795608146116138
also O 0 0.0005711365956813097
revealed O 0 0.002743110293522477
BRCA1 O 0 0.18538407981395721
nuclear O 0 0.006857347674667835
foci O 0 0.051742494106292725
in O 0 0.002722711768001318
benign O 1 0.9999982118606567
breast O 1 0.9999977350234985
, O 1 0.5525907874107361
invasive B-Disease 1 0.9999996423721313
lobular I-Disease 1 1.0
cancers I-Disease 1 0.9999996423721313
and O 0 0.4566100537776947
low B-Disease 1 0.9950324296951294
- I-Disease 1 0.993622362613678
grade I-Disease 1 0.9997790455818176
ductal I-Disease 1 0.9999995231628418
carcinomas I-Disease 1 0.9999979734420776
. O 0 0.0030018158722668886

Conversely O 0 0.012964247725903988
, O 0 0.0015894051175564528
BRCA1 O 0 0.027375448495149612
expression O 0 0.0009192150901071727
was O 0 0.0022339129354804754
reduced O 0 0.0006001226720400155
or O 0 0.00020578555995598435
undetectable O 0 0.0014232898829504848
in O 0 9.142937051365152e-05
the O 0 6.592421414097771e-05
majority O 0 3.323748387629166e-05
of O 0 0.00020717016013804823
high O 0 0.0031894571147859097
- O 0 0.03514806553721428
grade O 1 0.9928489923477173
, O 0 0.0013808016665279865
ductal B-Disease 1 0.9999997615814209
carcinomas I-Disease 1 0.9999998807907104
, O 0 0.0007015754817984998
suggesting O 0 0.0006165841477923095
that O 0 8.83774773683399e-05
absence O 0 0.0004809656529687345
of O 0 0.0009866750333458185
BRCA1 O 1 0.9992293119430542
may O 0 0.0003817141696345061
contribute O 0 0.00026296640862710774
to O 0 7.627808372490108e-05
the O 0 0.00025872004334814847
pathogenesis O 0 0.012843296863138676
of O 0 0.0004523367970250547
a O 0 0.00038355952710844576
significant O 0 0.0002825912379194051
percentage O 0 0.00029671424999833107
of O 0 0.0006959768943488598
sporadic B-Disease 1 0.9998342990875244
breast I-Disease 1 0.9999998807907104
cancers I-Disease 1 0.9999985694885254
. O 0 0.0011231460375711322
. O 0 0.0010958898346871138

